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Optimization of Oleosin 30G Production for Echocardiography
Abstract
Provided they are uniform in size, monodisperse microbubbles behave as contrast agents to enhance
echocardiographic imaging. Compounds like Oleosin 30G with surfactant-like properties help stabilize
microbubbles - thereby ensuring their uniform size. Designed herein is an industrial-scale plant to produce
medical-grade Oleosin 30G with a process consisting of three steps: 1) upstream production via recombinant
E. coli in an integrated batch bioprocessing model, 2) downstream purification, and 3) processing by
microfluidic manifolds. Ultimately Oleosin 30G-coated microbubbles are manufactured, ready for injection
within one month. Owing to its unique properties and cost-effective production, Oleosin 30G has the
potential to outcompete current market leader Definity®. Altogether, overall yield of Oleosin 30G constitutes
7.39 kg/year to provide for 100% market saturation. Financial analysis indicates pursuing Oleosin 30G for
echocardiography applications is very profitable with a 296% return on investment and holds potential for
production expansion should the market demand increase.
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April 18, 2017 
University of Pennsylvania 
School of Engineering and Applied Science  
Department of Chemical and Biomolecular Engineering 
220 S. 33rd Street 
Philadelphia, PA 19104 
Dear Professors Vrana and Wattenbarger: 
Enclosed is an optimized process design to manufacture Oleosin 30G on an industrial scale. 
Produced by recombinant E. coli, Oleosin 30G is an amphiphilic protein with surfactant-like 
properties capable of stabilizing uniformly-sized, monodisperse microbubbles. These 
microbubbles then function as contrast agents in echocardiography. Successful FDA approval is 
assumed for eventual market launch.  
Upstream operations include a seed bag bioreactor followed by a production bioreactor wherein 
E. coli grows in SB-Kanamycin media supplemented with glucose. Downstream operations
include disk stage centrifugation, high-pressure homogenization to release cytosolic Oleosin 30G
and cobalt affinity and anion exchange chromatographies to remove extraneous cellular material
and endotoxins. Ultrafiltration/diafiltration and bulk microfiltration follow to resuspend and
sterilize the isolated Oleosin 30G. Microfluidic manifolds package this product into microbubble
suspensions at 1 mg/mL concentration. Single doses containing 10 mL of this solution fit for IV
injection are stable up to one month at 4ºC. Pharmaceutical-grade shipping will distribute the
doses nationally.
This amounts to 7.39 kg Oleosin 30G produced annually - which is 100% market saturation. 
Internal rate of return (IRR) is 145.5%, net present value (NPV) is $376.5 million and return on 
investment (ROI) is 296.4% - more than four-fold higher than an un-optimized process from 
2016. Our process requires $14.4 million working capital for a 15-year facility life span.  
All calculations herein stem from original experimental data, references from Dr. Daniel 
Hammer's laboratory at the University of Pennsylvania, or the literature. Please do not hesitate to 
reach out should any questions arise. 
Sincerely, 
______________________          ______________________          ______________________ 
      Annette Krysiewicz   Andrew Parsons    Sergio Rodriguez-Labra 
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1. Abstract 
Provided they are uniform in size, monodisperse microbubbles behave as contrast agents 
to enhance echocardiographic imaging. Compounds like Oleosin 30G with surfactant-like 
properties help stabilize microbubbles - thereby ensuring their uniform size. Designed herein is 
an industrial-scale plant to produce medical-grade Oleosin 30G with a process consisting of three 
steps: 1) upstream production via recombinant E. coli in an integrated batch bioprocessing 
model, 2) downstream purification, and 3) processing by microfluidic manifolds. Ultimately 
Oleosin 30G-coated microbubbles are manufactured, ready for injection within one month. 
Owing to its unique properties and cost-effective production, Oleosin 30G has the potential to 
outcompete current market leader Definity®. Altogether, overall yield of Oleosin 30G 
constitutes 7.39 kg/year to provide for 100% market saturation. Financial analysis indicates 
pursuing Oleosin 30G for echocardiography applications is very profitable with a 296% return 
on investment and holds potential for production expansion should the market demand increase. 
 
Disciplines: 
Biochemical Engineering | Chemical Engineering | Engineering 
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2. Introduction 
2.1 Project Background 
Ultrasound imaging is an essential diagnostic tool in modern medicine. Not only is it 
cost-effective and safe, its use it also increasing. Medical schools across the United States, 
including the Perelman School of Medicine at the University of Pennsylvania, are integrating 
advanced ultrasound analysis into their curricula as a crucial skillset for future healthcare 
providers. This phenomenon at the educational level is indicative of ultrasound’s increasing 
utility in clinical diagnosis. 
But while ultrasound imaging alone is an important clinical technique, recent years have 
seen several new technologies emerge to improve it. One of them is microbubbles, which can 
visually enhance ultrasound imaging by increasing resonance and signal image. Tiny gaseous 
bubbles coated with a chemical having surfactant-like properties – like Oleosin 30G – can 
improve ultrasound wave scattering by alternatingly expanding and compressing. So long as they 
are uniform and monodisperse, the microbubbles promote even distribution of motion across the 
acoustic waves – which produces better image resolution.1 Oleosin 30G helps ensure the required 
size uniformity and stability of microbubbles, allowing for clearer echocardiographic images of 
heart anatomy. These higher-resolution scans can reduce the number of repeat scans, provider 
better imaging of targeted therapeutic areas, and better patient care.2 
Our project concentrates on applying Oleosin 30G to one specific type of ultrasound 
imaging – echocardiography, otherwise known as a sonogram of the heart. Patients with heart 
conditions – everything from heart attacks to hemochromatosis, cardiomyopathy to myocarditis – 
often receive echocardiographic imaging for diagnostic purposes. Namely, the imaging helps 
healthcare providers evaluate heart function, blood pumping capacity, diastolic function, ejection 
fraction, and where the problem is localized. Structures often identifiable in echocardiography 
include both ventricles and atria, the mitral and tricuspid valves, ventricular septa, and other core 
anatomical elements. Importantly, the technique is non-invasive, quick, and has no known risks 
or side effects. 
Cardiomyopathy, heart muscle disease, is a condition often diagnosed with 
echocardiography. Accounting for 443,000 deaths globally in 2013 (affecting 7.9 million people 
total), various types of cardiomyopathy have much to gain from higher-quality imaging. Contrast 
agents to improve echocardiography are a promising step toward this end.3 
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America has a relatively underdeveloped market for contrast agents fit for ultrasound 
applications. Development of contrast agents like Oleosin 30G dates back to the 1990s, when the 
FDA approved the first successful agents applying human albumin shell coatings to stabilize 
bubbles (Albunex®). Later developments included phospholipid-based contrast agents (for 
example, Optison® and Definity®). Disadvantages of these agents include shell rigidity and 
varying bubble size – both of which are unideal for medical microbubble stabilization. As of 
2015, 600,000 echocardiograms are conducted annually in the United States using contrast 
agents for improved resolution.4 Need for an improved agent like Oleosin 30G is high.  
Found in vascular plant oil bodies, Oleosin is a plant-derived structural protein. 
Importantly, the protein has amphiphilic properties – it has two hydrophilic regions and one 
hydrophobic domain. Herein lies its potential as a surfactant-type molecule. R&D in the 
laboratory of Dr. Daniel Hammer at the University of Pennsylvania has yielded Oleosin 30, a 
genetically engineered recombinant version of Oleosin produced by eliminating 57 amino acids 
from the protein’s hydrophobic domain to hinder secondary structure formation. This protein-
scale change allows Oleosin 30 to function as a random coil surfactant capable of self-assembly.5 
R&D has also attached a 6-histidine tag to the protein’s C-terminus to assuage purification.  
Oleosin 30G is an altered form of Oleosin 30 wherein five glycine amino acid groups are 
added to the hydrophobic domain to increase flexibility. The literature indicates this functionality 
is promising in producing stable, uniformly-sized monodisperse bubbles.5 Combined with a 
pluronic block copolymer, Oleosin 30G shows potential to fit an unmet need in the current 
market.6 
Using Casey et al.’s preliminary process design as a blueprint, an optimized process to 
manufacture Oleosin 30G on an industrial scale was designed. The overarching purpose of was 
to increase the production bioreactor’s titer by selecting the optimal conditions for cell growth 
and protein expression. The process design relies extensively on experimental data collected 
from flask-sized vessels in Dr. Daniel Hammer’s laboratory in the Department of Chemical and 
Biomolecular Engineering at the University of Pennsylvania, 96-well plates fit for Tecan 
analysis, and runs in a 3.9 L bioreactor, again at the University of Pennsylvania. This means the 
process has robust grounding in hands-on, concrete experimental evidence.  
The process produces, packages, and distributes Oleosin 30G-coated microbubbles for 
100% market saturation in the United States. The process commences with a small seed bag 
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bioreactor that grows Escherichia coli (BL 21 E. coli) cells to inoculate a large production 
bioreactor. The cells are grown in Super Broth-Kanamycin media with glucose and oxygen until 
growth plateaus, at which point isopropyl β-D-1-thiogalactopyranoside (IPTG) is added to 
induce protein expression via a plasmid expressing Oleosin 30G in the cells. Oleosin 30G 
production is cytosolic, meaning it remains inside cells and cell lysis is necessary to recover it.5 
Accordingly, the cells are centrifuged and homogenized to release the intracellular protein, 
which appears in both soluble (in aqueous solution) and insoluble total protein fractions. 
Thorough pharmaceutical-grade downstream purification then commences, the first steps of 
which are cobalt affinity and anion exchange chromatographies to remove extraneous cellular 
material and all lipopolysaccharide-originated endotoxins. These steps are followed by 
ultrafiltration/diafiltration and bulk microfiltration to resuspend Oleosin 30G in the desired 
buffer and remove any remaining bacteria for FDA-approved standards. Quality assurance and 
lab validation checks will be conducted to ensure safety of the final product. 
For packaging, the purified Oleosin 30G protein solution (1 mg/mL) will be processed by 
microfluidic molds to produce uniformly sized, stable microbubbles filled with nitrogen gas in 
the desired buffer solution. So long as they are kept at 4°C, the microbubbles are stable for up to 
one month. Final suspensions will be packaged in individual doses and stored in sterile glass 
vials - convenient for echocardiography technicians and healthcare providers. Vials will be 
shipped to order around the country using pharmaceutical-grade shipping. 
An economic analysis of the process was performed and shows significant promise in 
profitability metrics. With consistent market growth and unmet needs on the consumer end, there 
looks to be a good opportunity for Oleosin 30G to enter the market. 
 
2.2 High Cell Density Culture 
 Much laboratory-scale protein production employs relatively low cell density cultures 
(that is, cells grown at lower concentrations). This type of culture is convenient for a number of 
reasons. For one, low cell density cultures require fewer nutrients all together than high cell 
density cultures. Another reason is they take less time to grow – mainly because scaling-up 
sequentially from low concentration cultures is unnecessary. A third reason concerns logistical 
issues like ensuring adequate oxygenation, which is easier in low cell density cultures than in 
their high-density counterparts.   
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 However, industrial-scale protein production often requires high cell density culture. 
Maximizing protein production (that is, overall titer achieved by a given bioreactor) requires 
growing cells at exceedingly high concentrations. Historically, recombinant E. coli has been the 
most widely used host for this purpose, achieving high yields and productivities alike. Scientists 
are constantly exploring new ways to enhance a given strain’s protein production capabilities, for 
example by decreasing its protease levels. Other strategies to increase protein production include 
using different promoters to regulate protein expression, achieving co-expression of chaperonins, 
and reducing culture temperature. Added benefits of high cell density culture include increased 
cost-effectiveness, reduced culture volume, enhanced downstream processing (for purification), 
lower production costs and reduced investment in equipment.7,17 To this end, BL21, an E. coli 
strain known for its increased protein production (in part owing to its reduced Lon and OmpT 
protease activity), is used herein to produce Oleosin 30G. Because this project’s objective is to 
produce Oleosin 30G as profitably and effectively as possible, all R&D efforts are intended at 
reaching high cell density culture (at which optical density readings may exceed 100). This is in 
contrast to routine laboratory cell culture, which normally show optical density readings below 5. 
To contextualize the experiments conducted in later sections, the following paragraphs detail key 
concerns of high cell density culture that said experiments aim to overcome. 
 The first concern of interest is choosing an appropriate microorganism to maximize 
production bioreactor titer. Choosing a microorganism capable of high protein production via an 
appropriate plasmid is critical. BL21 E. coli is selected as the model microorganism because it is 
well-characterized in the literature for its high protein expression.8,16 The microorganism is 
transfected with pUC19 plasmid vector that contains the genetic information necessary for 
translation of Oleosin 30G as well as antibiotic resistance to allow selectivity of E. coli carrying 
the plasmid. Notably, the Oleosin 30G region in the plasmid is fused to a region coding for green 
fluorescent protein (GFP), a protein with 238 amino acid residues (26.9kDa) that exhibits green 
fluorescence when irradiated with blue or ultraviolet light. This functionality is useful because it 
allows measurement of Oleosin 30G production by measuring GFP fluorescence in samples 
taken from the experimental bioreactor. In other words, green fluorescence of samples is 
indicative of Oleosin 30G production. (Note Oleosin 30G – GFP fusion is only used for 
experimental purposes. In the actual industrial process, Oleosin 30G would not be fused to GFP). 
Isopropyl β-D-1-thiogalactopyrranoside (IPTG) is used to induce protein production by “turning 
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on” the plasmid. The compound is a molecular mimic of allolactose, a lactose metabolite used to 
activate transcription of the lac operon – thereby inducing protein expression of genes under 
control of the lac operator. Therefore addition of IPTG to the bioreactor “turns on” protein 
expression of Oleosin 30G.  
Cell growth generally consists of four phases: the lag phase (wherein no cell growth is 
observed because cells are adjusting to the growth conditions and developing), log phase 
(wherein exponential cell growth occurs), stationary phase (wherein no net cell growth occurs), 
and death phase (wherein net cell death occurs). Timing of IPTG addition to the bioreactor 
depends on the cell line, bioreactor conditions, and other parameters. That said, it is added to the 
bioreactor once cell growth (as measured by optical density) plateaus – that is, once the 
stationary phase commences.  As described in the experimental sections below, this occurs 
anywhere from 2.5 to 5 hours into the run from the time of inoculum introduction into the 
bioreactor. In the final process design, this occurs 9.3 hours from the time inoculum is introduced 
into the production bioreactor. According to the literature, cell growth after IPTG-mediated 
induction of protein expression tends to taper off. In theory, this is because much cellular energy 
is re-directed toward protein production as opposed to cell growth.9 However, some of the 
experiments performed for this process design indicate cell growth continues after induction 
commences. More details are included in the experimental sections. 
 The second concern of interest that arises in high cell density culture concerns 
fermentation variables. These include temperature, pH, inducer concentration (in this case, 
IPTG), and dissolved oxygen content – all of which can influence transcription, translation, 
proteolytic activity, secretion, production levels, and protein stability.10,11, 14 Data collected in the 
laboratory indicate the growth and production phases in the bioreactor may require different 
settings for these variables for optimal final titer. For example, temperature should be maintained 
at 36-37°C (36°C is ideal because there is a steep drop-off in cell growth beyond 37°C) for the 
growth phase versus 25°C for the production phase, and pH should be maintained neutral at 7.0. 
Drawing on the literature, the experiments conducted below were designed to characterize the 
ideal ranges for each variable. General ranges were identified using 96-well plates, and more 
specific settings were identified in a 3.9L bioreactor. To prevent accumulation of carbon dioxide 
and acetate formation, enriched oxygen sources (50% and 100%) were used. Specifically, pO2 
was maintained at 30-40% throughout the cell growth and protein expression phases. This was 
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done by regulating the oxygen source and duty cycle for stirring. Importantly, it was difficult 
when OD reached its maximum value to maintain adequate oxygenation. We thus recommend 
copious stirrers in the production bioreactor and 100% source oxygen to minimize difficulty. The 
oxygen uptake rate (OUR) in our experiments peaked at 80 mg/L-hr. Overall, conducting design 
of experiments (DOE) rigorously is the best way to characterize the appropriate ranges in 
advanced R&D. 
 The third concern of interest for achieving high cell density culture is choosing the 
optimal nutrient composition and feeding strategy, which include media contents and glucose 
concentration. Cells grown at higher concentrations require more nutrients to sustain their 
growth and protein production. Often this means supplementing media with large quantities of 
salts, additional yeast extract, casein, and other nutrient sources. This also means keeping 
glucose levels high such that cells have sufficient energy to complete protein production. 
Ultimately these factors are crucial in attaining the >100 g/L dry cell mass benchmark common 
in industrial settings. Both the seed bag and production bioreactors designed contain cells in 
Super Broth (SB) media with Kanamycin (an antibiotic used to select for E. coli cells carrying 
the pUC19 plasmid). SB media contains 32g pancreatic digest of casein, 20g yeast extract, 5g 
NaCl, and 5mL NaOH (1N solution) per 1 L media, which is more than triple the amount of 
pancreatic digest of casein and yeast extract as typical LB broth. Because these ingredients 
contain copious salts, sugars, and protein, they enable the BL21 E. coli to reach higher 
concentrations. As for glucose – a monosaccharide added to provide energy to growing and 
protein-producing cells – the literature indicates keeping glucose levels low (< 5 g/L) for the cell 
growth phase (that is, prior to IPTG addition) is ideal. In contrast, the literature suggests 
increasing glucose levels (> 5 g/L) during the protein expression phase (that is, after IPTG 
addition) is ideal.12, 15 Experiments detailed in further sections explore optimal glucose levels.  
 The experimental design was bifurcated – on one hand using 96-well plates, on the other 
hand using a 3.9 L bioreactor. The 96-well plates – each containing 200 μL reaction contents – 
were used to characterize general ranges for the variables of interest, namely pH, temperature, 
glucose concentration, IPTG concentration, starting inoculum concentration, and others. These 
plates were especially useful because they allowed us to perform many small-scale experiments 
at once. We transitioned to the 3.9 L bioreactor after establishing general ranges in the 96-well 
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plates. The bioreactor was used to narrow down these ranges and pin-point specific parameters 
ideal for growth and production. 
While the R&D conducted in the experiments below is incomplete (that is, only a fraction 
of 100 g/L dry cell mass was achieved), it shows important optimization benchmarks relative to 
previous data. We are confident – with further industrial R&D infrastructure, DOE analysis, and 
longitudinal optimization – high cell density culture is feasible for this process. We especially 
recommend industrial R&D explore molecular-scale options like increasing protease inhibition, 
altering the promoters in the plasmid regulating Oleosin 30G transcription, and possibly testing 
other plasmids to increase the production bioreactor’s titer. This objective provides the guiding 
framework for the process design. 
 
2.3 Baseline from Senior Design Project 2016 
 References to Casey et al. – a senior design project from 2016 – appear throughout this 
written report. While Casey et al. designed a process to produce Oleosin 30G industrially, they 
rely on limited, un-optimized data for their calculations. To build on their model, this senior 
design project concentrated on the optimization of final bioreactor titer. Grounded in 
experimental evidence, our report constitutes an improved version of the process designed by 
Casey et al. Just what improvements were made is detailed in further sections. 
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2.4 Project Charter 
Project 
Name 
Optimization of Oleosin 30G Production for Echocardiography 
Leaders Annette Krysiewicz, Andrew Parsons, Sergio Rodriguez- Labra 
Project 
Scope 
In Scope: 
• Process design for 7.39 kg/yr Oleosin 30G via large-scale fermentation 
• Experimental optimization to identify optimal conditions for recombinant E. 
coli BL21 high cell density culture 
• Analysis of cell growth rates, total protein, Oleosin 30G protein gels, and 
other lab-scale data 
• Purification, ranging from cell lysis and affinity chromatography to filtration 
• Testing for purity, sterility, and endotoxin presence 
• Microbubble production using custom-designed microfluidic devices 
• Packaging/shipping of suspended microbubbles 
• Adherence to health/safety regulations for IV-administered compounds 
• Observance of process integrity and compliance by adhering to GMP (good 
manufacturing processes) 
• Costs associated with FDA approval and clinical trials  
Out of Scope: 
• Development of recombinant Oleosin 30G (gifted from Dr. Daniel Hammer) 
• Advanced R&D 
• General characterization of Oleosin 30G 
• Design of microfluidic device for microbubble production 
• Efficacy testing of microbubbles 
• FDA approval for use as an echocardiographic contrast agent 
• Clinical trials 
Deliverables Business Opportunity Assessment 
• What is the current market for echocardiographic contrast agents? 
• How does the size distribution of Oleosin 30G-stabilized contrast agent 
compare to the distribution of a currently employed contrast agent? 
Technical Feasibility Assessment  
• Is producing 7.39kg/yr Oleosin 30G at an ROI exceeding 72% feasible? 
Experimental Optimization Assessment 
• What bioreactor conditions produce best titer for Oleosin 30G? 
• How does one achieve high cell density culture? 
Manufacturing Capability Assessment 
• How much capital investment will the facility need to produce Oleosin 30G? 
• How much capital investment does microbubble production require? 
• How can the process satisfy FDA requirements? 
Timeline Laboratory experiments, early R&D optimization, process design, facility and 
economic analysis will be completed in five months. 
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3. Market Analysis 
3.1 Innovation Map 
 Figure 3.1 shows other ultrasound contrast that serve as the basis for this application of 
Oleosin. The figure shows that customers value contrast agents due to for main propositions: 
uniform bubble size that increases bubble stability and lifetime, increased image resolution, 
reduction of the need to repeat scans, and simple administration. Upon entry to market, Oleosin 
will be the only product that fulfills all four customer value propositions. Currently, the 
ultrasound contrast agent market in the US consists of two types of contrast agents defined by 
their bubble coating. The first category includes bubble coatings made of human albumin. 
Albunex®13 and Optison® are the main competitors in this category. The effectiveness of these 
contrast agents is limited by their thick coating and resulting surface tension and rigidity that 
reduce bubble resonance.19 In the second category, which includes Definity® and Imagent®, the 
bubble coating consists of phospholipids. These newer technologies improved upon the previous 
by offering a thin and less rigid coating allowing for more resonance. Oleosin improves upon 
both previous categories by offering a flexible coating as well as a core filled with nitrogen gas. 
The previously mentioned competitors contain air or octafluoropropane gas, which has been 
shown to be less stable and less safe compared to nitrogen gas.4 Furthermore, Oleosin 
differentiates from the current market by allowing for manipulation of bubble size for use in 
different ultrasound applications. 
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Figure 3.1. Innovation Map for Echocardiography Contrast Agents.20 This figure 
demonstrates Oleosin’s readiness for market entry due to its ability to meet of customer needs 
and technological differentiation from its competitors.  
 
3.2 Market Competitive Assessment  
Unlike many pharmaceutical areas that have been explored for decades or longer, the 
field of ultrasound contrast agents is relatively new. Sparked by FDA approvals in the 1990s, the 
market for contrast agents experienced great initial growth, but has stabilized in recent years. 
With a competitive advantage over current competitors, Oleosin has the potential to infiltrate this 
young market attain full market penetration. Although, Oleosin could be optimized for various 
types of ultrasound, this analysis will focus on its application for echocardiography as this is the 
intended purpose for this project. 
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 The market for echocardiography in the U.S. increased significantly from the mid-1990s 
to the early 2000s. This growth can be attributed to FDA approvals of Albunex®, Optison®, 
Definity®, and Imagent®, in 1994, 1997, 2001, and 2002, respectively. The improvement in 
echocardiographic imaging due to these contrast agents let to an 9.2% annual increase in 
echocardiography incidence from 1998 to 2005.21 However, little improvement in this field in 
the following years caused the growth rate to decrease to 3.4% from 2005 to 2011.22 
The market for contrast agents constitutes only a fraction of the total echocardiography 
market. This is due to the fact that contrast agents are only employed in a follow-up procedure in 
the case of a suboptimal first echocardiogram, where contrast agent was not used. Therefore, 
contrast agents are used in approximately 5% to 10% of resting echocardiography procedures, 
and 30% of stress echocardiography, which as less common.23 Due to the smaller growth of 
echocardiography incidence in recent years, the number of contrast enhanced echocardiograms 
has remained relatively constant. In the U.S., there were approximately 700,000 injections in 
2010 and 600,000 in 2015.24 This market demand is expected to remain relatively constant in 
upcoming years. Despite their infrequent use, contrast agents have been proven as cost effective. 
Cost savings for using contrast agents result from reduced repeat scans. According to the 
American society of Echocardiography 75% to 90% of suboptimal echocardiograms can be 
improved through the use of contrast agents.23 According to Medicare, the costs of contrast 
agents amounts to approximately $62 per person, and on average $184 per person was saved by 
avoiding additional echocardiogram procedures. This results in a cost benefit of about $122 per 
person.25  
Currently, the market for echocardiogram contrast agents encomposes several 
competeing products. The two categories include microbubbles coated in human albumin, such 
as Albunex® and Optison®, and those coated in phospholipids, such as Definity® and 
Imagent®. All of these competitors have faced efficacy issues. Albunex, the first FDA approved 
microbubble formulation consists of rather diverse microbubble sizes ranging from 1 to 15µm in 
diameter. Ultrasound image quality tends to improve with microbubble size consistency, thus 
this contrast agent is not optimal. In addition, the albumin coating consists of disulfide bonds 
covalently crosslinked with cystein residues. This relatively rigid structure does not allow for 
much microbubble resonance during echocardiography, which limits the efficacy. Optison was 
the next FDA approved contrast agent. These microbubbles are filled with octafluoropropane 
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gas, which has a low solubility that increases circulation time compared to the air filled Albunex 
microbubbles. Phospholipid coated contrast agents are able to attain higher efficacy than their 
albumin coated predecessors. The phospholipid coating has a low surface tension that stabilizes 
the microbubble, increasing its circulation time.26 In addition, this less rigid membrane allows for 
more resonance, which improved image quality. However, studies have shown that during 
ultrasound phospholipid microbubbles exhibit compression, but almost no expansion beyond 
their original size.4 This reduces efficacy because the scattering of ultrasound waves is 
proportional to the size of the microbubble, thus the expansion of the bubble is the most 
influential in improving image quality.  
Oleosin’s properties improve upon the shortcomings of current competing products. 
Unlike current contrast agents that are filled with either air or octafluoropropane gas, Oleosin 
coated microbubbles are filled with nitrogen gas. Nitrogen gas allows for a longer bubble 
lifetime during circulation as has also proven to be a safe alternative.4 Oleosin forms a thin 
surfactant-like layer covering approximately 10% of the bubble’s surface. This allows for 
optimal flexibility and resonance. Thus, Oleosin is an improvement to phospholipid coatings 
because it allows bubble to contract, but also expand, leading to improved image quality. 
Furthermore, Oleosin coating results in a very uniform bubble size and distribution which further 
enhances imaging resolution and accuracy.  In addition to its superior imaging results, Oleosin 
also prevails its competitors from a practical perspective. Definity® is sold as a solid that must 
be activated by mixing with Vialmix® solution. This requires additional training for the 
preparation process and allows for operator error. Oleosin covered microbubbles account for this 
inconvenience because they are shipped and finished products ready for injection. Oleosin 
further differentiates itself in the contrast agent market due to its potential for optimization for 
each type of echocardiography. This is achieved by altering relative concentrations of Oleosin 
and pluronic in the microfluidic device.  
Oleosin’s main competitor is Definity®, who currently occupies 90% of the market for 
contrast agents and reports annual revenues of over $100 million.27,28 Following its FDA 
approval in 2001, Definity® quickly gained market share and was adopted over Optison® due to 
its improved functionality. It is probable that Oleosin will follow a similar route to market 
penetration and will be quickly adopted over Definity®. Based on the cost effectiveness of using 
contrast agents and the ability of Oleosin to improve image quality above the standards met by 
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current competitors, Oleosin is predicted to achieve full market penetration. This sets the target 
market at 600,000 annual contrast agent injections for echocardiography in the U.S. Assuming 
that Oleosin is successful in fully penetrating this market, this demand requires the production of 
7.34 kg of Oleosin per year. The process described in following sections is based on this 
production goal. 
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4. Customer Requirements 
The target customers for Oleosin are patients receiving echocardiograms. Specifically, 
Oleosin coated microbubble contrast agent will be administered to patients whose first 
echocardiogram was suboptimal. The product requirements that will address the needs of these 
patients are appropriate dosing and efficacy in improving echocardiogram readability and 
diagnostic accuracy, ease of product use, and convenient shelf life.20 
 The contrast agent dosage is an important customer requirement as it impacts the efficacy 
and safety of the product. Although Oleosin dosage will have to be optimized in clinical trials, 
prescribed doses for currently available contrast agents will provide valuable guidelines. One 
competing contrast agent, Albunex® is administered in doses ranging from 3.4 to 10 mL, with 
4x108 microbubbles per mL. The average microbubble diameter is 4 µm and the optimal 
microbubble suspension dose is 0.033 to 0.5 mL.kg.29 Oleosin dosage will be tested in similar 
ranges during clinical trials and FDA regulations will be followed. The dosage will be optimized 
along with other parameters to maximize product efficacy. Oleosin will be produced at a 
concentration of 1 mg/mL in the suspension to maximize bubble stability. During clinical trials, 
microbubble size and distribution will be examined in order to determine which parameters 
result improve echocardiography resolution. 
 Product packaging and easy administration are another important customer requirement. 
Oleosin will be sold as a turnkey product. Oleosin isolation, purification, packaging, and dosage 
will be conducted in the production facility. The finished product will be sold directly to 
hospitals, radiology clinics, and other echocardiogram facilities. This eliminates the need for 
medical facilities to purchase microfluidic devices that are needed to prepare the microbubble 
suspension. In addition, selling Oleosin as a product that is ready to be administered reduces 
need for additional technician training, eliminates preparation time, and reduces the potential for 
operator error. It is important that the final product has an adequate shelf life so that it can be 
shipped to the medical facility and still be effective upon administration. The current shelf life 
for Oleosin suspension is 30 days. However, it is recommended that the product be administered 
within 7 days of production to ensure optimal microbubble size and distribution. This shelf life 
allow facilities to order a week’s worth of the product and still maintain its optimal 
characteristics.  
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5. CTQ Variables  
Not applicable. 
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6. Product Concepts 
Not applicable. 
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7. Superior Product Concepts 
Not applicable. 
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8. Competitive (Patent) Analysis 
Not applicable. 
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9. Preliminary Process Synthesis 
Figures 9.1 and 9.2 show the process flow diagrams that served as the starting points 
upon which this project aimed to improve. Figure 9.1 shows the overall process flow and Figure 
9.2 shows the upstream and downstream flow diagrams that were developed by the 2016 senior 
design project at the University of Pennsylvania.20 The figures outline the main components of 
the process. In the upstream production phase, recombinant E. coli cells are grown and Oleosin 
production is induced with the addition of IPTG. In the downstream purification phase, cells are 
lysed and Oleosin is isolated and purified. In the final step, quality control tests are conducted 
and the Oleosin is assembled and packaged into a final product that is ready for use. 
Data collected during this year’s project is presented in the following section (section 10). 
Based on these findings changes were made to the process in Figure 9.2. These improvements 
are highlighted in section 12. 
 
Figure 9.1. Oleosin Process Flow Diagram from 2016. 20 
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Figure 9.2. Upstream and Downstream Process Flow Diagram from 2016. 20 
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10. Assembly of Database 
10.1 Experimental Summary 
A study was conducted to determine the operating conditions that would result in optimal 
Oleosin production in the production bioreactor. All experiments were conducted in the 
Chemical and Biomolecular Engineering Laboratory at the University of Pennsylvania. Oleosin-
producing recombinant BL21 E. coli were obtained from Dr. Hammer’s lab. Ranges for cell 
growth and protein production conditions were obtained from literature on high cell density 
culture as discussed previously. Following standard industry procedures, initial experiments were 
conducted in 96-well plates. This method allowed for the vast data collection for multiple 
manipulated variables. The most promising operating conditions from the 96-well plate 
experiments were selected for further optimization in a laboratory scale bioreactor. Table 10.1 
summarizes the parameters for manipulated variables in the 96-well plate experiments and the 
optimal parameters that were selected for later experiments. Table 10.2 summarizes the 
parameters for manipulated variables in bioreactor experiments and the results of each run. 
Manipulated variables that are not listed in a certain experiment were not changed from the 
previous experiment (i.e. well plate #2 was run at the same temperature at well plate #3). 
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Table 10.1. 96-well Plate Experiment Summary. For the two growth phase experiments, 
manipulated variables include temperature, glucose concentration, media, and pH. For the 
production phase experiment, manipulated variables include temperature, media, initial optical 
density, and IPTG concentration. Reasons for indeterminate results will be explained in the 
following sections.  
96-well Plate Experiments 
Phase 
Experiment 
Number 
Manipulated 
Variables 
Parameters 
Investigated 
Optimal 
Parameters 
Growth 
1 
Temperature 37ºC 37ºC 
Media 
Miller, Lenox, SB, 
SOB Miller, SB 
[Glucose] 0, 1, 2, 3, 4, 6 g/L indeterminate 
2 
Media Miller, SB SB 
[Glucose] 0, 10, 20 g/L 0 g/L 
pH 6, 7, 8 7 
Production 3 
Temperature 25ºC 25ºC 
Media SB SB 
Initial OD 0.3, 0.4, 0.5 indeterminate 
[IPTG] 0.1, 0.5, 1 mM indeterminate 
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Table 10.2. Bioreactor Experiment Summary. For the two growth phase experiments, 
manipulated variables include temperature, glucose concentration, pH, agitation rate, and pO2. 
For the two growth and production phase experiments, manipulated variables include 
temperature during growth and production, pO2, IPTG concentration, and glucose concentration 
during growth and production. 
Bioreactor Experiments 
Phase 
Experiment 
Number Manipulated Variables 
Parameters 
Investigated Results 
Growth 
1 
Temperature 37ºC Max OD 1.49 
pH 7 Dry Mass 10.81 g/L 
Agitation Rate 300 rpm Growth Rate 1.075 hr-1 
pO2 30% Doubling Time 0.64 hr 
Glucose Rate 1 mL/min 
2 
Temperature 36ºC Max OD 1.34 
pO2 40% Dry Mass 9.72 g/L 
[Glucose] 1 g/L 
Growth Rate 0.971 hr-1 
Doubling Time 0.71 hr 
Growth 
and 
Production 
3 
Temperature (growth) 36ºC Max OD 1.96 
Temperature (production) 25ºC Dry Mass 14.2 g/L 
pO2 30% Growth Rate 0.459 hr-1 
[IPTG] 0.5 mM Doubling Time 1.51 hr 
4 
[Glucose] (growth) 1 g/L 
Max OD 1.31 
Dry Mass 9.5 g/L 
[Glucose] (production) 5 g/L Growth Rate 0.781 hr-1 
[IPTG] 1 mM Doubling Time 0.89 hr 
 
10.2 96-well plate Experiments 
 Experiments in the 96-well plates were conducted in 2 stages. The first two plates 
examined different conditions for E. coli cell growth. The variables that were investigated 
included: media composition, glucose concentration, temperature and pH. The plates were 
incubated in the Infinite F200 Microplate Reader by Tecan. This instrument measured optical 
density at 630 nm (OD) which was correlated to cell concentration as a function of time. The 
third plate examined conditions for protein production. Manipulated variables included IPTG 
concentration, temperature, and initial cell concentration. Fluorescence readings from the 
microplate reader were used to track protein production. Each plate was covered by a 
semipermeable membrane that allowed for gas exchange, but prevented evaporation from 
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reducing the volume in each well. E. coli were grown overnight in an incubator shaker at 37℃ at 
220 rpm in preparation for the experiment. Well plates were prepared in the biosafety cabinets to 
reduce the risk of contamination. An aqueous glucose solution was prepared at half its maximum 
solubility, 454.5 g/L.30 
  
10.2.1 Plate 1 Procedure 
 The first 96-well plate was prepared using four different types of media and six 
different glucose concentrations. The four media selected were LB Lennox, LB Miller, 
Super Optimal Broth (SOB) and Super Broth (SB) due to their known high protein 
production in E. coli. Media were prepared according to the recipes from the The 
Handbook of Microbiological Media, which can be found in Appendix 12.31 Media was 
sterilized by autoclaving and 50 µg/mL of kanamycin were added to each. The pH of 
each media based on the recipe was found to be 6.98, 6.85, 6.75, 7.20 for LB Lennox, LB 
Miller, SOB and SB, respectively. Since each pH was near neutral and the media were 
left unadjusted. Glucose concentrations tested in the plate were 0, 1, 2, 3, 4, and 6 g/L. A 
volume of 10 µL of cells from the overnight cell culture were added to each well along 
with 90 µL of media with glucose for a total volume of 100 µL in each well. Each media 
with each glucose concentration was run in triplicate. The microplate reader was set to 
incubate at 37℃, a known temperature for maximum E. coli growth. The Tecan was set 
for 50 15 minute cycles amounting to 13.3 hours in total. Each incubation cycle consisted 
of 2 shaking actions and 1 waiting time for 2 minutes. Each shaking was performed for 
300 seconds and a 1 mm amplitude in a linear mode. Optical density was measured 
following each waiting time with 25 flashes and no settling time.  
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10.2.2 Plate 1 Results  
 
Figure 10.1. Optical Density Over Time. The figure shows average optical density, 
adjusted for blank, for each media as a function of time. LB Lennox is shown in orange. 
LB Miller is shown in green. SOB media is shown in blue. SB Media is shown in red. 
Raw data from this plate can be found in Appendix 20. 
 
The results for the first 96-well plate are shown in Figure 10.1. The optical density 
of the blank (media without cells) was subtracted from each sample. The samples that 
followed expected growth patterns were averaged and plotted as a function of time. Some 
samples did not follow typical growth patterns probably due to an error in adding the cell 
culture, cell death, or other contamination. These were not included in the average. In 
addition, there was no significant difference in the growth curves of wells containing 
different glucose concentrations in the same media. Therefore, optical density for each 
media was averaged across varying glucose concentrations. 
Figure 10.1 shows that the growth rate, the slope of the curve during the growth 
period, was not significantly different across different media. Thus, the efficacy of each 
media was based on the maximum optical density reached by the cells during the 
stationary phase. The maximum optical densities were found to be 0.25, 0.35, 0.25, and 
0.40 for LB Lennox, LB Miller, SOB, and SB, respectively. Based on this data, it was 
concluded that SB and LB Miller were the most suitable media for E. coli growth because 
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they allowed cells to reach the highest concentration. These two media were selected for 
further investigation in the second 96-well plate.  
 
10.2.3 Plate 2 Procedure 
The second 96-well plate was prepared using two media, SB and LB Miller. 
These media were selected because cell grown in these media reached the highest 
maximum concentration in the first 96-well plate. Media were sterilized by autoclaving 
and 50 µg/mL of kanamycin were added to each. This plate assessed the effect of pH on 
E. coli growth. E. coli are known to grow well near neutral conditions, so pH of 6, 7 and 
8 were tested in septuplicates. The pH was adjusted by added 1M NaOH and 1M HCl as 
needed. No glucose was added to the wells with varying pH because it was not observed 
to have an effect on cell growth in the first 96-well plate. However, growing E. coli in 
media with glucose is common industry practice. Therefore, the effect of glucose was 
further investigated by introducing larger glucose concentrations. Both media were tested 
in septuplicate with glucose concentrations of 0, 10 and 20 g/L. The pH was not adjusted 
in these wells. Twenty µL of cells from the overnight cell culture were added to each well 
along with 180 µL of media with or without glucose, NaOH, and HCl for a total volume 
of 200 µL in each well. The sample in the volume was increased from 100 µL in the first 
plate to 200 µL in this plate to mimic the protocol used in high cell density cultures.32 
The incubation settings were also altered in order to replicate conditions for high cell 
density cultures. The microplate reader was set to incubate at 37℃ for 50 15 minute 
cycles amounting to 13.3 hours in total. Each incubation cycle consisted of 1 shaking 
actions and no waiting time. Each shaking was performed for 800 seconds and a 3 mm 
amplitude in an orbital mode. OD was measured following each shaking period with 25 
flashes and 100 ms settling time. 
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10.2.4 Plate 2 Results 
Table 10.3. Plate 2 Results Summary. The table shows the results of the second 96-well 
plate for LB Miller and SB media. The average maximum OD, adjusted for blank, as well 
as the pH and glucose concentration that led to optimal growth are shown. Raw data from 
this plate can be found in Appendix 21. 
Media LB Miller SB 
Maximum OD 0.42 0.66 
Optimal pH 7 7 
Optimal Glucose 
Concentration (g/L) 
0 0 
 
The results for the second 96-well plate are summarized in Table 14.1. The optical 
density of the blank (media without cells) was subtracted from each sample. The samples 
that followed expected growth patterns were averaged and plotted as a function of time. 
Only samples following expected growth patterns were included in the average. Also, only 
samples with 0 g/L glucose and pH of 7 were included in the maximum optical density 
average because this was shown to be the optimal conditions. Glucose concentrations of 
10 and 20 g/L led to more variable growth patterns. This may have been due to the fact 
that glucose has been shown to inhibit E. coli growth at low cell concentrations.33 At low 
cell concentrations the nutrients in the media are enough to support cell growth. Thus, in 
later bioreactor runs glucose was added after the culture reached a certain OD 
measurement. A pH of 7 also showed the most consistent expected growth patterns and 
thus was selected as the optimal pH. The maximum optical density reached by cells in LB 
Miller and SB were 0.42 and 0.66, respectively. Based on this data, it was concluded that 
SB was the optimal media since it allowed for the greatest E. coli growth. This media was 
selected for further investigation in the third 96-well plate.  
 
10.2.5 Plate 3 Procedure 
 Unlike the first and second plate, which measured absorbance to monitor cell 
growth, the third plate focused on protein production by measuring the fluorescence of 
Oleosin’s GFP tag. This plate monitored the effect different initial cell concentrations at 
the point of IPTG addition, as well as different IPTG concentrations. The third plate was 
prepared using SB media, which was determined to be the optimal media for E. coli cell 
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growth in the second plate. The media were sterilized by autoclaving and 50 µg/mL of 
kanamycin were added. The media was at a pH of 7 and no glucose was added, as these 
were the optimal conditions determined in the second plate. Initial optical densities of 
0.3, 0.4 and 0.5 were selected for this plate. Typical IPTG concentrations for protein 
production in E. coli range from 0.1 mM to 1 mM. For this plate, IPTG concentrations of 
0.1, 0.5, and 1 mM were selected. Sextuplicate samples of each initial optical density and 
each IPTG concentration were prepared. Twenty µL of cells from the overnight cell 
culture were added to each well along with 180 µL of media with IPTG for a total 
volume of 200 µL in each well. Incubation settings were similar to those used for the 
second plate. The microplate reader was set to incubate at 25℃ for 50 15 minute cycles 
amounting to 13.3 hours in total. The temperature was lowered from the 37℃ used for 
growth because protein expression has been found to be more successful at lower 
temperatures ranging from 20℃ to 30℃. Each incubation cycle consisted of 1 shaking 
actions and no waiting time. Each shaking was performed for 750 seconds and a 3 mm 
amplitude in an orbital mode. Fluorescence was measured following each shaking period 
with 25 flashes and on settling time. The excitation wavelength was 485 nm and emission 
wavelength was 535 nm and the gain was set to 58.  
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10.2.6 Plate 3 Results 
 
Figure 10.2. Fluorescence Over Time. The figure shows average fluorescence for each 
initial optical density as a function of time. Blanks are not accounted for. Wells with an 
initial OD of 0.3 are shown in blue. Wells with an initial OD of 0.4 are shown in green. 
Well with an initial OD of 0.5 are shown in red. Raw data from this plate can be found in 
Appendix 22. 
 
Figure 10.2 shows the results of the third 96-well plate. There were two 
unexpected results from this experiment. First, the data was not adjusted for blank 
because the blank had a higher fluorescence (approximately 42,000) than any of the wells 
with cells. Thus, subtracting the blank would result in negative values for the 
fluorescence for the samples. Second, the fluorescence was lower for cells with higher 
cell concentrations. This is unexpected because a higher cell concentration should make 
more protein, resulting in a higher fluorescence. Based on these unexpected results, it was 
concluded that the cell matter scatters the fluorescence signal. Thus the signal is greatest 
in wells without cells (the blanks) and lowest in wells with the most cells (initial OD = 
0.5). Based on this data, it was determined that protein grown in the bioreactor would 
have to be purified before it could be quantified. The data from Figure 10.2 cannot be 
used to determine optimal IPTG concentration nor optimal initial OD at the point of 
IPTG concentration. However, the data shows that the fluorescence for all samples 
plateaued and reached maximum protein production approximately 3 hours after IPTG 
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addition. Thus, a production period of approximately 3 hours would be sufficient for the 
bioreactor.    
 
 10.3 Bioreactor Experiments 
 Bioreactor experiments were performed in a 3.7L Bioengineering RALF bioreactor. 
BioLogics software was used to control and record temperature, pH, pO2 (percent oxygen 
saturation), and agitation speed. The pH probe and oxygen meter were calibrated prior to each 
run. Five ml samples were collected at every 15 minutes. Optical density at 630 nm was 
measured by the Infinite F200 Microplate Reader by Tecan in triplicate for each sample. One 
Touch Ultra Mini Glucose Meter by Lifescan was used to measure glucose in each sample. Like 
the 96-well plates, experiments in the bioreactor were also conducted in 2 stages. The first two 
bioreactor runs tested operating conditions for E. coli cell growth. The third and fourth bioreactor 
runs began with a growth phase and then examined operating conditions for the production phase 
after IPTG addition. E. coli were grown overnight in an incubator shaker at 37℃ at 220 rpm in 
preparation for the experiment. An aqueous glucose solution was prepared at half its maximum 
solubility, 454.5 g/L.30 
 
10.3.1 Run 1 Procedure 
For the first bioreactor run, 2.2 L of SB media was prepared. Half a liter of 
deionized (DI) water was added to the media and the solution was sterilized by 
autoclaving in the bioreactor. The bioreactor was allowed to reach equilibrium at a 
temperature of 37℃, pH of 7, and pO2 of 30%. The agitation rate was kept constant 
throughout the run at 300 rpm. The bioreactor media was inoculated with 300 mL of the 
overnight culture, bringing the working volume in the reactor to 3 L. Glucose was 
pumped into the bioreactor immediately following inoculation. The glucose pumping rate 
was manually adjusted with a desired rate of 1 mL/min. The pH was maintained at 7 by 
adding 1M NaOH and 1M HCl as needed. pO2 was manually controlled by adjusting the 
sparging rate from an air tank. As cells grew and oxygen consumption rate increased, the 
air tank was exchanged for a 50% oxygen tank, as later a 100% oxygen tank. Samples 
were collected every 15 minutes for 6 hours and 15 minutes. Antifoaming agent was 
32 
 
added as needed when the bubbles from the bioreactor rose into the pipes controlling 
ventilation.  
 
10.3.2 Run 1 Results 
 
Figure 10.3. Optical Density Over Time for Bioreactor Run 1. The figure shows 
average OD for each sample, adjusted for blank and normalized by the original OD on an 
ln scale as a function of time. Selected points representing the log phase are shown in 
orange, while the remaining parts of the curve are shown in blue. A linear regression on 
the log phase data in MS Excel produced the following equation where y is ln(OD/ODo) 
and x is time in hours. The R2 value for this equation is 0.993 revealing a good linear 
correlation. Raw data from this plate can be found in Appendix 23. 
 
𝑦𝑦 = 1.075𝑥𝑥 + 0.052 
Figure 10.3 shows the results of the first bioreactor run. According to the plot, the 
cells were in the lag phase for approximately 1 hour before entering the log phase. The 
previous equation characterizes the log phase and the slope gives a growth rate of 1.075 
hr-1. The doubling rate, calculated using the following equation where µg is the growth 
rate. 
33 
 
𝑡𝑡1
2�
=
ln (2)
𝜇𝜇𝑔𝑔
 
The doubling time was calculated to be 0.64 hr. The growth rate and doubling 
time are comparable to typical E. coli growth.34 After approximately 4 hours, the cell 
growth plateaued at a maximum OD of 1.49, which correlates to a dry cell mass of 10.81 
g/L (see Appendix 1). 
Despite the successful growth cell growth during this run, several problems were 
encountered during the experiment. The glucose pumping system was manually 
controlled by setting a cycle time and specifying a percent duty cycle, or the portion of 
the cycle during with pumping occurs. For a small desired flow rate, such as 1 mL/min, 
this system was found to be highly inaccurate. The cycle time and percent duty cycle 
were frequently adjusted throughout the experiment. As a result the desired pumping rate 
of 1 mL/min could not be attained and the amount of glucose measured in the samples 
ranged from 1.63 to 134 g/L. Another issue encountered in this experiment was that the 
pO2 levels were very variable. The pO2 was controlled by the same cycle system as the 
glucose pumping. The presence of only one student controlling the reactor, collecting 
samples, and taking measurements made it difficult to closely monitor the pO2. These 
issues would have affected the cell growth. Thus, changes were made to the procedure in 
the second bioreactor run in an attempt to rectify these issues. 
 
10.3.3 Run 2 Procedure 
 For the second bioreactor run, 2.2 L of SB media was prepared. Half a liter of DI 
water was added to the media and the solution was sterilized by autoclaving in the 
bioreactor. The bioreactor was allowed to reach equilibrium at a temperature of 36℃, pH 
of 7, and pO2 of 40%. While optimal E. coli growth occurs at 37℃, cell death may occur 
at 38℃, so the temperature of the bioreactor was reduced from 37℃ to 36℃, to account 
for the possibility of a temperature gradient in the reactor. Thus, this reduced temperature 
would allow for a 1℃ temperature gradient without causing cell death. The agitation rate 
was kept constant throughout the run at 300 rpm. The bioreactor media was inoculated 
with 300 mL of the overnight culture, bringing the working volume in the reactor to 3 L. 
Following inoculation, 450 mL of media and cells were pumped out in order to reduce 
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the overall volume to 2.55L. This done to reduce the amount of antifoaming agent that 
would be required as the bubbles would be less likely to reach the pipes at the top of the 
reactor with this smaller working volume. To account for the issue with glucose addition 
during the first bioreactor run, glucose was manually pipetted into the reactor. Glucose 
was added after the OD reached a value of 0.5 in order to prevent growth inhibition at 
low cell concentrations. The desired glucose concentration was 1g/L. The pH was 
maintained at 7 by adding 1M NaOH and 1M HCl as needed. The pO2 was controlled 
with the same cycle system used in the first run. However, one student was delegated to 
solely monitoring pH and pO2 in an effort to avoid the difficulties encountered in the first 
run. Samples were collected every 15 minutes for 5 hours and 15 minutes. 
  
10.3.4 Run 2 Results  
 
Figure 10.4. Optical Density Over Time for Bioreactor Run 2. The figure shows 
average OD for each sample, adjusted for blank and normalized by the original OD on a 
ln scale as a function of time. Selected points representing the log phase are shown in 
orange, while the remaining parts of the curve are shown in blue. A linear regression on 
the log phase data in MS Excel produced the following equation where y is ln(OD/ODo) 
and x is time in hours. The R2 value for this equation is 0.990 revealing a good linear 
correlation. Raw data from this plate can be found in Appendix 24. 
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𝑦𝑦 = 0.971𝑥𝑥 − 0.649 
 
 Figure 10.4 shows the results of the second bioreactor run. Similar to the first run, 
cells were in the lag phase for approximately 1 hour before entering the log phase. The 
previous equation characterizes the log phase and the slope gives a growth rate of 0.971 
hr-1. The doubling rate was calculated to be 0.71 hr. After approximately 3.5 hours, the 
cell growth plateaued at a maximum OD of 1.34, which corresponds to a dry cell mass of 
9.72 g/L. The difference in the maximum cell concentration and growth rate between the 
first and second run is less than 10%. Thus, this can be attributed to the expected 
variation between laboratory batches. This variability would be reduced on an industrial 
scale where more sophisticated control systems are utilized.  
 
10.3.5 Run 3 Procedure 
For the third bioreactor run, 2.5 L of SB media was prepared and sterilized by 
autoclaving in the bioreactor. The bioreactor was allowed to reach equilibrium at a 
temperature of 36℃, pH of 7, and pO2 of 30%. The agitation rate was kept constant 
throughout the run at 300 rpm. The bioreactor media was inoculated with 1 L of the 
overnight culture, bringing the working volume in the reactor to 3.5 L. Following 
inoculation, 1 L of media and cells were pumped out in order to reduce the overall 
volume to 2.5L. A larger initial cell concentration was introduced in an effort to reduce 
the growth phase which would allow more time for the production phase. Glucose 
concentration, pH, and pO2 was controlled following the same procedure as in the second 
run. Five ml samples were collected every 15 minutes for 6 hours. When the growth 
began to plateau, IPTG was added at a concentration of 0.5 mM in the reactor and the 
temperature was lowered to 25℃. Beginning right before IPTG addition, 15 mL samples 
were collected every 30 minutes for protein analysis.  
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10.3.6 Run 3 Results 
 
Figure 10.5. Optical Density over Time for Bioreactor Run 3. The figure shows 
average OD for each sample, adjusted for blank and normalized by the original OD on a 
ln scale as a function of time. Selected points representing the log phase are shown in 
orange, while the remaining parts of the curve are shown in blue. A linear regression on 
the log phase data in MS Excel the following equation where y is ln(OD/ODo) and x is 
time in hours. The R2 value for this equation is 0.943 revealing a good linear correlation. 
Raw data from this plate can be found in Appendix 25. 
  
𝑦𝑦 = 0.459𝑥𝑥 − 0.205 
 
 Figure 10.5 shows the results of the second bioreactor run. Similar to the two 
previous runs, cells were in the lag phase for approximately 1 hour before entering the 
log phase. The previous equation the log phase and the slope gives a growth rate of 0.459 
hr-1. The doubling rate was found to be 1.51 hr. The increased initial cell concentration 
may have contributed to the reduced growth rate compared to the previous two runs. The 
log phase lasted approximately 2 hours. However, growth continued at a slower rate after 
IPTG addition. The cells reached a maximum OD of 1.96, which corresponds to a dry 
cell mass of 14.21 g/L. The procedure was changed in the fourth run in an attempt to 
drive protein production and reduce cell growth following IPTG addition.  
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10.3.7 Run 4 Procedure 
For the fourth bioreactor run, 1 L of SB media was prepared and sterilized by 
autoclaving in the bioreactor. The bioreactor was allowed to reach equilibrium at a 
temperature of 36℃, pH of 7, and pO2 of 30%. The agitation rate was kept constant 
throughout the run at 300 rpm. The bioreactor media was inoculated with 1 L of the 
overnight culture, bringing the working volume in the reactor to 2 L. Five ml samples 
were collected every 15 minutes for 5 hours and 45 minutes. Glucose concentration, pH, 
and pO2 was controlled following the same procedure as in the second run. However, the 
glucose concentration was increased to 5 g/L during the production phase to provide 
more energy for protein production. In order to further induce protein production and 
reduce the growth observed after IPTG addition in the third bioreactor, IPTG 
concentration was increased to 1 mM. In addition the reactor was allowed to equilibrate 
to 25℃ before IPTG addition. Beginning right before IPTG addition, 45 mL samples 
were collected every 30 minutes for protein analysis.  
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10.3.8 Run 4 Results 
 
Figure 10.6. Optical Density over Time for Bioreactor Run 4. The figure shows 
average OD for each sample, adjusted for blank and normalized by the original OD on a 
ln scale as a function of time. Selected points representing the log phase are shown in 
orange, while the remaining parts of the curve are shown in blue. A linear regression on 
the log phase data in MS Excel produced the following equation where y is ln(OD/ODo) 
and x is time in hours. The R2 value for this equation is 0.979 revealing a good linear 
correlation. Raw data from this plate can be found in Appendix 26. 
  
𝑦𝑦 = 0.781𝑥𝑥 − 0.021 
 
 Figure 10.6 shows the results of the second bioreactor run. Unlike previous runs, 
this experiment did not experience a noticeable lag phase. This was probably due to the 
large amount of cell culture (50% of the working volume) that was used to inoculate the 
bioreactor. This large starting volume meant that the cells did not experience much 
change to their environment and thus were able to start growing almost immediately 
fueled by the nutrients in the additional media. The previous equation characterizes the 
log phase and the slope gives a growth rate of 0.781 hr-1. The doubling rate was found to 
be 0.89 hr. The log phase lasted approximately 2 hours. Unlike the previous bioreactor 
run, there was almost no net growth following IPTG addition. Cells reached a maximum 
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OD of 1.31, which corresponds to a dry cell mass of 9.5 g/L. Although the third 
bioreactor achieved higher final cell concentrations, cell growth continued after IPTG 
introduction. In the fourth bioreactor, conditions were altered to ensure protein 
production was prioritized over cell growth after IPTG addition. Thus, the data from the 
fourth bioreactor was used in the process design in order to provide a more realistic 
model. 
 
 10.4 Protein Analysis 
 The results of the third 96-well plate experiment showed that cell matter scattered the 
fluorescent signal. Thus, protein had to be separated from other cell matter in order to quantify 
Oleosin production. The following outlines the procedure followed for purifying protein for 
samples collected from bioreactor runs 3 and 4. The procedure was based on that used in Dr. 
Hammer’s lab, but slightly altered based on the lab’s available resources. 
 
10.4.1 Protein Separation Procedure 
The sample collection volume was recorded for each sample. The samples were 
centrifuged at 5,000 RCF for 5 minutes to pellet the bacteria. Supernatant was discarded. 
The pellet was massed and frozen in the -20℃ freezer overnight. The bacteria pellets 
were then thawed for approximately 10 minutes. Five mL of B-PER Complete Bacterial 
Protein Extraction Reagent and 0.5 mL of 10X Protease Inhibitor (Sigma P2714) were 
added for every 1 g of pellet. The solution was vortexed until it became homogeneous. 
The samples were centrifuged at 7197 RCF for 30 minutes at room temperature (25℃). 
The supernatant was collected and analyzed for soluble protein content. Denaturing 
buffer was prepared with PBS in 20 mM imidazole and 8 M urea. The pellet was 
resuspended in 5 mL of denaturing buffer for every 1 gram of the original pellet. The 
solution was vortexed until it became homogeneous. The samples were centrifuged at 
7197 RCF for 30 minutes at room temperature (25℃). The supernatant was collected and 
analyzed for insoluble protein content. 
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10.4.2 Protein Quantification 
Polyacrylamide gel electrophoresis (PAGE) is a common biochemical assay used 
to separate different proteins by their different molecular sizes as they travel through a 
gel matrix. This method was used to quantify oleosin and total protein content in both 
soluble and insoluble fractions of the samples taken from the bioreactors. First, the total 
soluble and insoluble protein concentration in each sample was measured in the 
nanodrop. Twenty µL samples were prepared consisting of 2 µL10X NuPAGE Reducing 
Agent, 5 µL 4X LDS Sample Buffer, 2 µL of protein sample and 11 µL of water, except 
for the insoluble bioreactor 4 samples where 1 µL of protein and 12 µL of water were 
used due to higher soluble protein concentration. Samples were heated in a hot block at 
100℃ for 10 minutes to unfold the protein. Fifteen µL of the 20 µL samples were 
pipetted into each well in the gel. The ladder used was the Precision Plus Kaleidoscope 
1610375, which contains bands for protein at 250, 150, 100, 75, 50, 37, 25, 20, 15, and 
10 kD. The gel electrophoresis was run at 200 V for 45 minutes. The gel was then 
removed and placed in 50% methanol and 7% acetic acid solution overnight. The solution 
was poured off and the gel was washed with ultrapure water for 5 minutes. Water was 
poured off and GelCodeTM Blue Stain Reagent from Thermo Scientific was used to 
cover the gel. The Gel was placed on a shaker for 2 hours to allow for staining. The stain 
reagent was washed off and the gel was rinsed with water and shaken for an hour. The 
gels were imaged, and they showed the separated proteins in the sample separated in a 
multitude of distinct bands. Most of them were constant throughout the samples except 
for one band which seemed to increase in intensity from the early to the late samples 
taken from the bioreactor, as seen in in Figure 10.7. The gels were analyzed using ImageJ 
software to confirm the right molecular size of the protein band to confirm it was Oleosin 
and Photoshop CC’s advanced quantification toolkit to calculate the percent of protein in 
the gel that was Oleosin by integrating the relative intensities of their bands on the gel 
compared to the rest of the protein. See Appendices 10 and 11 for raw data and 
calculation details. 
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Figure 10.7. PAGE-Separated Oleosin in the Insoluble Fraction of Bioreactor #4. 
Band 1 – 11:28AM Sample; Band 2- 12:27 PM Sample; Band 3- 1:38 PM Sample; Band 
4- 2:30 PM Sample; Band 5- 3:05 PM Sample. Oleosin concentration is a function of 
band. 
 
After quantitative analysis, it was found that the percent of protein being Oleosin 
increased over time on both runs; For bioreactor run #3 reaching 2.57% and 2.68% for 
the soluble and insoluble fractions, respectively. Bioreactor #4 reached 3.33% and 2.48% 
for the soluble and insoluble fractions, respectively. Adjusting for the protein loaded on 
each gel lane as measured by the nanodrop it was found that the conditions from 
bioreactor #4 greatly increased Oleosin production, and a mathematic model was 
developed to scale up for the design of the bioreactors in this process design. See 
Appendix 11 for the details. 
 
10.5. Other Considerations 
The strain of BL21 E. coli used for the production of Oleosin is classified as a non-
hazardous Biological Safety Level One (BSL-1) recombinant bacteria by the Center for Disease 
Contrl and Prevention Guidelines.77 No special biological or radiation safety equipment or attire 
is necessary. However, as common precaution practice in the industry, all equipment and 
materials in contact with biological sample will be sterilized prior to disposal. None of the raw 
materials used in the process are considered toxic for humans given basic industry safety 
precautions are taken. 
 
 
 
 
 
1  2  3  4  5 
42 
 
11. PFD and Material Balances 
Figures 11.1 and 11.2 show the process flow diagrams. Data collected during this year’s 
project is presented in the previous section (section 10). Based on these findings changes were 
made to the process in Figure 11.2. These improvements are highlighted in section 12. 
 
 
Figure 11.1. Oleosin Overall Process Flow Diagram. 
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Figure 11.2. Upstream and Downstream Process Flow Diagrams. The process includes all batch operations, 
including bioreactors, centrifugations, homogenizers, chromatography columns, ultrafiltration/diafiltration, and 
microfiltration equipment with all associated pumps, storage and mixing tanks, and flow streams. 
44 
 
11.1 Process Summary 
The Oleosin production process begins by inoculating a small bioreactor (P-1), which 
grows enough cells to inoculate the larger production bioreactor (P-2). In this highly-controlled 
25 L bioreactor the cells will be grown for 10.3 hours until they reach dry mass of 100 g cells per 
liter. At this point, the temperature will be lowered, glucose concentration increased, and IPTG 
will be added to induce the production of Oleosin for an additional 3 hours. Then, the 
bioreactor’s contents will be transferred  to a tank (P-3), after which they will flow through a 
disk stack centrifugation unit (P-4) that will separate the Oleosin-containing solids from the 
liquid media. This sudge will be pumped into a high pressure homogenizer (P-5) to mechanically 
and chemically lyse the cells releasing the Oleosin, and then will be resuspended in denaturing 
buffer in a tank (P-6). After this, the solution will be run through a cobalt affinity 
chromatography column (P-7) to separate the Oleosin from most of the cell debris. Following its 
elution from the column, the Oleosin solution will be transferred to a collection tank (P-8) from 
where it will be pumped to an ion exchange chromatography column (P-9) to remove about 99% 
of the endotoxins still present in the solution. Then, the contents will be eluted into another 
collection tank (P-10), from where they will be pumped into an ultrafiltradion/diafilttration unit 
(P-11) to further purify the Oleosin, and bring it to the specified concentration of 1 mg/mL. 
Finally, this solution will be pumped through a microfiltration unit (P-12) for the final 
purification step to remove 99% of the remaining endotoxins to ensure the product’s safety for 
intravenous injection application under current FDA regulations. The solution will end in a 
product storage tank (P-13) from where it will move on to quality control testing, microfluidic 
processing and final packaging. 
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Table 11.1 summarizes the overall mass balance for the process. The inputs for the entire 
process include cells used to inoculate the inoculum bioreactor, media and kanamycin for both 
reactors, 70% glucose solution and IPTG added to the second bioreactor, B-PER added to the 
homogenizer and the various buffers. The final output into the product tank consists of Oleosin 
and buffer. Cells, endotoxin, and Oleosin are produced in the bioreactors. Finally, all the 
materials are either consumed during production, lost in processing, or removed as waste. 
Specification sheets in section 15 specify the inputs and outputs for each individual unit in the 
process. 
 
Table 11.1. Overall Component Mass Balance. All values are in units of kg per batch. Details 
on the step-by-step mass balance are found in the specification sheets of each unit. 
Component Input Output Production Consumption/Loss/Waste Balance 
Cells 4.71E-05 0 1.49 1.49 0 
Media 15.43 0 0 15.43 0 
Kanamycin 7.44E-04 0 0 7.44E-04 0 
Endotoxin 0 0 2.91E-03 2.91E-03 0 
70% Glucose Solution 0.94 0 0 0.94 0 
IPTG 3.62E-04 0 0 3.62E-04 0 
B-PER 6.64 0 0 6.64 0 
Buffers 706.65 27.53 0 679.12 0 
Oleosin 0 2.74E-02 4.69E-02 1.95E-02 0 
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12. Process Descriptions 
12.1 Production Process 
12.1.1 Inoculum Bioreactor (P-1) 
 The inoculum bioreactor consists of a 200mL disposable bag bioreactor. A new 
bag with a working volume of 120 mL will be used for each batch. The bag will be filled 
with sterile SB media (see Appendix 12 for formulation) and 50 mg/L kanamycin. SB 
media will be used instead of LB Miller that was used in the 2016 Oleosin. This change 
was based on SB media consistently outperforming other media types in regard to 
achieving higher maximum OD in 96-well plate experiments. Glucose will not be added 
to this reactor due to the experimental evidence of glucose inhibiting growth at low cell 
concentrations.  Media will be inoculated with 1.2 mL of frozen stock of BL21 E. coli at 
a concentration of 7.6x108 cells/mL. The bioreactor will rock the culture at 300 rpm, with 
a pH of 7, temperature of 36℃, and dissolved oxygen of 40% to mirror the conditions set 
in the fourth bioreactor experiment. Sterile air will be pumped in by an integrated air 
pump. Cells will be grown for 5.04 hours, including a one hour lag phase, until a 
concentration of 8.49x108 cells/mL is reached. This concentration was changed from last 
year’s value of 1x109 cells/mL because this was the maximum concentration attained by 
the fourth bioreactor run. In addition the growth period was reduced from the 12 hour 
used in last year’s project to 5.04 hours which is based on the experimentally determined 
growth rate, 0.781 hr-1 and one hour lag phase. The contents of the inoculum bioreactor 
are then used as inoculum for the production bioreactor. The empty bag is then sanitized 
with bleach to inactivate any remaining bacteria and disposed. This step is taken for 
every unit using disposable bags in the process after every batch. 
 
12.1.2 Production Bioreactor (P-2) 
 The production bioreactor consists of a 25L single-use plastic biocontainer. Prior 
to inoculation, 14.76 L of sterile SB media and 50 mg/L kanamycin will be pumped into 
the biocontainer by a peristaltic pump. The 0.12 L of culture from the inoculum 
bioreactor will then be pumped in amounting to an initial working volume of 14.88 L. 
This working volume was adjusted from last year’s value of 11.6L based on calculations 
with protein yields from experiments. Sterile 70% glucose solution in water will be added 
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throughout the growth and production phases. Glucose concentration will be maintained 
at 1 g/L during the growth phase and 5 g/L during the production phase. This will 
increase the working volume by 0.75 L throughout the entire run (see Appendix 14). 
Thus, final working volume of the reactor will be 15.63 L. The bioreactor will be 
continuously stirred at 300 rpm, at pH of 7 and a temperature of 36℃. The sterile 100% 
oxygen will be sparged into the bioreactor to achieve a dissolved oxygen of 40%. A PID 
controller will maintain pH, temperature, dissolved oxygen, foam level, glucose 
concentration and agitation at the desired operating conditions. Growth will continue 
until cells reach 100 g/L dry mass that is achieved in high cell density cultures. Assuming 
that the experimental growth rate of 0.781 hr-1 is achieved at high cell density the growth 
period will last for 10.27 hours including a 1 hour lag time.  
Once the desired cell dry mass is reached, protein production will be induced by 
adding isopropyl β-D-1-thiogalactopyrranoside (IPTG). The addition of 0.36 g of IPTG 
will be required to reach a concentration of 1 mM in the bioreactor. Last year’s 
production time of 5 hours was shortened to 3 hours as that was the time required to 
reach maximum protein production in the 96-well plates. In addition, operating 
temperature was reduced to 25℃ and glucose was increased to 5 g/L to increase protein 
production. This process was calculated to produce 46.9 g of Oleosin per batch (see 
Appendix 3).  
 
12.1.3 Cell Culture Storage Tank (P-3) 
 Once protein production is complete, the contents of the biocontainer will be 
pumped via peristaltic pump into a 25 L disposable bag storage tank. Contents will be 
transferred to this tank so that preparation for the next batch in the production bioreactor 
can begin immediately. This is crucial since the production bioreactor serves at the 
bottleneck of the process.   
  
12.2 Purification Process 
12.2.1 Disk Stack Centrifugation (P-4) 
The cell culture from the storage bag will be transferred into the disk stack 
centrifuge. A pump is not needed for this transfer because the centrifuge creates 
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overpressure in the bag which results in a siphoning effect into the centrifuge. The 
centrifuge will be run at is minimum flow rate, 200 L/hour. This unit will separate the 
solid and liquid components of the culture. Approximately 97% of liquid components, 
including remaining media, water, and dissolves glucose, IPTG, and kanamycin will be 
pumped into to the waste tank. The remaining solid cells, endotoxin, and protein and the 
3% of unseparated liquids will form a cell sludge for further purification. 
 
12.2.2 High Pressure Homogenization (P-5) 
The sludge from the centrifugation will be pumped into the high pressure 
homogenizer via peristaltic pump. This unit lyses the cells so that the protein can be 
extracted. The homogenizer unit pumps the cell sludge at a high velocity through fixed-
geometry microchannels. The sludge undergoes a pressure change of up to 2,000 atm, 
which generates great shear stress that will mechanically lyse cells. Cells will also be 
lysed chemically through the addition of bacterial protein extraction agent (B-PER) with 
DNAse and EDTA-Free protease inhibitor. B-PER separates the soluble protein from the 
cells matter. The process requires 3 passes to obtain full homogenization with a flow rate 
of 13 L/hr. The flow rate was increased from last year’s value of 3 L/hr to account for the 
increased volume from B-PER based on the protocol followed during experimentation. 
 
12.2.3 Cell Sludge Resuspension Tank (P-6) 
The cell sludge from the homogenizer will be pumped into a 25 L disposable bag 
via peristaltic pump. Denaturing buffer will simultaneously be pumped into the bag via 
peristaltic pump. The denaturing buffer ensures that the insoluble protein is isolated. The 
volume of denaturing buffer was changed to 5 L of buffer per kg of cells in order to 
mirror the experimental protocol. Simultaneous pumping of the two inputs will ensure 
that they are well mixed.  
 
12.2.4 Cobalt Affinity Chromatography (P-7) 
 The cobalt affinity chromatography column will separate the Oleosin from the 
remaining cell debris and other reagents from previous units. This is accomplished 
through a series of buffers. The buffer composition and column sizing is explained in 
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Appendix 4. The volume of the column is 5.56L. First, the column is washed with 10 
column volumes of denaturing/equilibration buffer. The cell suspension in denaturing 
buffer will then by fed into the column. The Oleosin is tagged with a his-tag, an amino 
acid chain of 6 histidine residues at the end of the protein. The his-tag has a strong 
binding interaction with the cobalt resin in the column. This will ensure that Oleosin is 
separated as other material flow through the unit and are directed to the waste tank. A 
cobalt-based resin was selected due to its higher purity in protein isolation.35 The column 
is then washed with 10 column volumes of wash buffer to remove any other protein or 
debris that may have a weak affinity for the resin. Then, 10 column volumes of elution 
buffer are fed into the column. Elution buffer alters buffering conditions so that Oleosin 
no longer binds to the resin. Elution buffer with the collected Oleosin is pumped into an 
affinity chromatography collection tank. A conservative approach was applied that 
assumed all endotoxin remains with the Oleosin. Last year’s project reported some 
endotoxin removal in the affinity column. However after industrial consultation, an ion 
exchange column was added to the process to eliminate endotoxin. After the elution 
buffer and Oleosin are transferred to the collection tank, the column is washed with 10 
column volumes of regeneration buffer. Regeneration buffer regenerates the resin, which 
can be regenerated 25 times before protein purity decreases below 90%.  
  
12.2.5 Affinity Chromatography Collection Tank (P-8) 
The elution buffer and Oleosin are transferred into a 100L disposable bag 
collection tank. The solution remains in the tank until it is pumped into the ion exchange 
column. This collection tank ensures that the desired flow rate into the ion exchange 
column is met. 
 
12.2.6 Ion Exchange Column (P-9) 
Once all product from the cobalt affinity chromatography has been collected, it 
will be transferred to an ion exchange chromatography column. This step will remove 
99% of all the endotoxins originating from the E. coli. Pierce High-Capacity Endotoxin 
Removal Resin will be used. Because it consists of positively charged porous cellulose 
beads covalently attached to ϵ-poly-L-lysine, the resin will bind negatively charged 
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endotoxins, isolating them from the remainder product material. Specifically, interaction 
between the anionic phosphate in endotoxin lipopolysaccharides (LPS) and the cationic 
polymixin B ligands in the resin accounts for this result. The volume of the column is 
17.21L. This unit requires buffers similar to cobalt affinity chromatography. See 
Appendix 5 for buffer compositions and column sizing. The column is first equilibrated 
with 5 reactor volumes of equilibration buffer to ensure that the pH is between 6 and 8. 
The contents of the affinity chromatography tank are then pumped in via peristaltic 
pump. The protein is eluted with 2 bed volumes of elution buffer. The bed is then 
regenerated and endotoxin is removed with 5 bed volumes of regeneration buffer, 
followed by 5 bed volumes of wash buffer and 5 bed volumes of endotoxin-free ultrapure 
water. These contents are directed to the waste tank. Regeneration must be performed 
after each batch and the resin must be replaced after 25 uses. 
 
12.2.7 Ion Exchange Collection Tank (P-10) 
After the ion exchange chromatography is complete, contents along with elution 
buffer will be transferred to a collection tank fitted with a 50L disposable bag. This step 
ensures cleaning procedures may commence in the ion exchange chromatography 
column. Contents will then be pumped to ultrafiltration/diafiltration for final sterilization 
and buffer preparation. 
 
12.2.8 Ultrafiltration and Diafiltration (P-11) 
The contents of the ion exchange collection tank will then be separated by a 
ultrafiltration/diafiltration process. This will require the addition of clean elution buffer 
with the same composition as the elution buffer used in the ion exchange column. The 
cassette filters in the unit will have a molecular weight cut off (MWCO) of 10kDa. This 
will ensure that Oleosin, which has a molecular weight of 15 kDa remains in the retentate 
while smaller particles and buffer flow through the permeate. Elution buffer will ensure 
that the final product has an Oleosin concentration of 1 mg/mL.  
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12.2.9 Microfiltration (P-12) 
 Sterile microfiltration will serve as the final purification step. This will ensure that 
any endotoxins that may not have been removed in the ion exchange column will not be 
removed along with other contaminants that may have accumulated during the process. 
This unit will ensure that FDA regulations are met for injectable solutions. The unit has 
positively charged filter membrane that will cause negatively charged endotoxins, nucleic 
acids, and viruses to attach to the filter.  Each batch will be run through the unit three 
times. Each pass will remove 99% of remaining endotoxins. 
  
12.2.10 Product Storage Tank (P-13) 
 Contents from the microfiltration unit will be pumped via peristaltic pump into 
the final 25 L disposable bag storage tank. Oleosin in the solution has a concentration of 
1 mg/mL. Solid triblock copolymer, pluronic P-188 will be added to the tank to a final 
concentration of 10 mg/mL.2 The contents of this tank will move on to QC testing, 
microfluidic processing and packaging.  
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13. Energy Balance and Utility Requirements 
Not applicable. Utility costs are included in section 18. 
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14. Equipment List and Unit Descriptions 
14.1 Major Unit Specifications 
14.1.1 Inoculum Bioreactor (P-1) 
 The control tower and wave bag rocker for the inoculum bioreactor will be 
purchased from Sartorius Stedim Biotechnology Group for $49,000 and $9,300, 
respectively.36 Disposable 0.2L bags will be purchased for each batch from HyClone for 
$174.37 The operating conditions in the bioreactor will be maintained at 36℃, pH of 7.0, 
dissolved oxygen at 40% by the PI controlled that is incorporated in the control tower. 
The reactor will operate at room pressure, approximately 1 atm. The growth period will 
continue for 5.04 hours, including an hour of lag time. The disposable nature of the bags 
in this and other units reduces the probability of cross-contamination between batches 
and reduces time needed for CIP and SIP procedures. The unit will require 5.37 hours for 
preparation, growth, and cleaning. The recovery from the inoculum bioreactor is 97%. 
 
14.1.2 Production Bioreactor (P-2) 
A PadReactor system will be purchased from Pall for $150,000.38 The unit has 
dimensions of 84.5 x 94.0 x 136.0 cm. Disposable 25 L cubic ultra-low-density 
polyethylene (ULDPE) AllegroTM TK8 bioprocess film biocontainers will be purchased 
for each batch from Pall for $300.39 The biocontainers integrate an internal mixing paddle 
coupled with a dynamic sparger, which are enclosed in a ULDPE to reduce shear stress. 
The total reactor volume was optimized at 25 L in order to meet the demand for Oleosin 
injection through the year. Since the final product is stable for 30 days, but recommended 
for injection within a week of production, it is crucial to ensure production does not 
exceed demand to avoid product expiration. In addition, the ez-Control PID control 
system will be purchased from Applikon for $500.40 This will maintain operating 
conditions at a pH of 7.0, dissolved oxygen at 40%, and a temperature of 36℃ during 
growth and 25℃ during production. The controller will also monitor glucose 
concentration to maintain it at 1 g/L during growth and 5 g/L during production. The 
reactor will operate at room pressure, approximately 1 atm. The growth period will 
continue for 10.27 hours, including an hour of lag time. Following IPTG addition, the 
production period will last for 3 hours. Approximately, 1.5 hours are allocated for 
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cleaning and preparation for the next batch. The recovery from the production bioreactor 
is 97% 
 
14.1.3 Cell Culture Storage Tank (P-3) 
After protein production the contents of the biocontainer will be transferred into a 
25 L disposable bag storage tank. The disposable bag will be purchased from Hyclone for 
$100.37 The contents will be pumped at a rate of 1.04 L/min for 15 minutes. This quick 
removal allows preparation and cleaning can begin for the next batch in the production 
bioreactor. The contents will then be pumped into the centrifuge via a peristaltic pump. 
The recovery from the storage bag, and the pumps and pipes throughout the production 
phase is 97%. Thus the overall recovery from production is 91.3%.  
  
14.1.4 Disk Stack Centrifugation (P-4) 
A Culturefuge 100 disk stack centrifuge will be purchased from Alfa Laval for 
$46,500.41 The unit will operate at room temperature and pressure, 25℃ and 1 atm. The 
flow rate through the unit is 200 L/hr. The separated liquid is directed to the waste tank, 
while the sludge product is pumped into the homogenizer unit. Centrifugation will 
proceed for approximately 2 minutes to ensure as maximum material recovery. Including 
CIP and SIP procedures, this unit will require 2.8 hours. The recovery from the centrifuge 
is 95%.  
 
14.1.5 High Pressure Homogenization (P-5) 
A M-7125 Microfluidizer will be purchased from IKA Process Technology for 
$8,000.42 The unit will operate at room temperature 25℃. The pressure change within the 
unit will be 2,000 atm. For every 1 kg of cells, 5 L of B-PER extraction agent with 
DNAse and EDTA-Free protease inhibitor will be added to the homogenizer. After B-
PER addition, the suspension will occupy a volume of approximately 8.22 L. This 
volume will be pumped through the homogenizer three times at a flow rate of 13 L/hr, 
amounting to 1.9 hours. The total time required for homogenization including CIP and 
SIP procedures is 3.8 hours. Recovery from this unit is 95% 
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14.1.6 Cell Sludge Resuspension Tank (P-6) 
The cell sludge from the homogenizer will be pumped into a 25 L disposable bag. 
The disposable bag will be purchased from Hyclone for $100.37 The 8.22 L of cell cludge 
will be pumped at a rate of 32.88 L/hr. The denaturing buffer will simultaneously be 
pumped into the bag at a rate of 24 L/hr. Each batch will require 6L of denaturing buffer 
for the 1.2 kg of cells entering the column (5 L buffer per 1 kg of cells). The pumping in 
process will last 15 minutes. The final 14.22 L suspension will be pumped into the cobalt 
affinity column via peristaltic pump. 
 
14.1.7 Cobalt Affinity Chromatography (P-7) 
A stainless steel Resolute Chromatography Column will be purchased from Pall 
Corporation for $190,000.43 The total volume in the column will be 5.56 L, with a 
diameter of 280 mm and height of 91 mm (see Appendix 4 for calculations). The column 
will be packed with HisPur Cobalt Superflow Agarose resin that will be purchased from 
Thermo Scientific for $5,680 per L.44 The column will require 3.39 L of resin. According 
to the manual, the resin allows for a linear velocity of 150 cm/hr and has a binding 
capacity of 11.11 mg Oleosin/mL resin. The column will operate at 4℃ and 1 atm. The 
total time for this unit will be 2.89 hours, including 1.87 hours for denaturing, wash and 
elution buffer, 0.60 hours for regeneration, and 0.42 hours for CIP. Recovery from this 
unit is 90%.  
 
14.1.8 Affinity Chromatography Collection Tank (P-8) 
The elution buffer and Oleosin from the cobalt column will be pumped into a 100 
L disposable bag via peristaltic pump. The disposable bag will be purchased from 
Hyclone for $250.37 The total time for this unit is 0.46 hours, including pumping into the 
ion exchange column. 
 
14.1.9 Ion Exchange Column (P-9) 
A polymethyl methacrylate ChromXACT 400/100 column will be purchased from 
GE Healthcare Life Sciences for $100,000.45 The total volume in the column will be 
17.21 L, with a diameter of 400 mm and height of 140 mm (see Appendix 5 for 
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calculations). The column will be packed with Pierce High-Capacity Endotoxin Removal 
Resin that will be purchased from Thermo Scientific for $4,940 per L.46 The column will 
require 10.5L of resin. According to the manual, the resin allows for a linear velocity of 
150 cm/hr and has a binding capacity of 2.0x109 endotoxin units/ L resin. The column 
will operate at 4℃ and 1 atm. The total time for this unit will be 2.94 hours, 
including 0.93 hours for equilibrium, sample transfer and elution buffer, 1.37 hours for 
regeneration, and 0.64 hours for CIP. Oleosin recovery from this unit is 90% and 99% of 
endotoxins are removed. 
 
14.1.10 Ion Exchange Collection Tank (P-10) 
After the ion exchange chromatography is complete, contents along with elution 
buffer will be transferred to the 50 L collection tank purchased from Hyclone for $200 
per disposable bag.37 The contents will be pumped out at a rate of 124 L/min for 15 
minutes. Contents will be pumped to ultrafiltration/diafiltration for final sterilization and 
buffer preparation. 
 
14.1.11 Ultrafiltration and Diafiltration (P-11) 
An ultrafiltration/diafiltration unit will be purchased from EMD Millipore for 
$1,000.47 The unit has disposable cassette filters that are stabilized by cassette holders. A 
new filter will be purchased for each batch for $200 from EMD Millipore. The molecular 
weight cut off for the filter is 10 kDa. The effective filtration surface area is 1.14 m2 and 
the flow rate is 4 L/min. The unit will be operational for 0.26 hours and SIP will take an 
additional 2 hours. The recovery from this unit is 95%. The unit will operate at 4℃ and 1 
atm. 
 
14.1.12 Microfiltration (P-12) 
Millipak disposable unit filters will be purchased from EMD Millipore for $177 
per filter.48 Filters will be replaced after each batch. The filters have positively charged 
Durapore PVDF membranes with a 0.22 micron pore size and a surface area of 100 cm2. 
The flow rate through the filter will be 16.5 L/min. The unit will remove 99% of any 
remaining endotoxins during each pass. The recovery from this unit is 95%. Each batch 
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will be run through the unit three times, which will last 0.09 hours. The unit will operate 
at 4℃ and 1 atm. 
 
14.1.13 Product Storage Tank (P-13) 
The product storage tank consists of a 25 L disposable bag that will be 
purchased from Hyclone for $100.37 Contents from the microfiltration unit will be 
pumped via peristaltic pump into the final storage tank for 15 minutes at a flow rate of 
99.1 L/hour. The solution in the product storage tank consists of 1 mg/mL Oleosin. 
Triblock copolymer, pluronic P-188, is added to the tank until a pH of 7.2 is achieved. 
The overall recovery for downstream purification is 64.0%. Thus, the overall process 
recovery for production and purification is 58.41% 
   
14.2Additional Units 
14.2.1 Microfluidic Processing and Packaging 
 Purified Oleosin solution from the purification process will undergo microfluidic 
processing to ensure the final product is ready for use. Eight microfluidic devices will be 
used simultaneously with an equal volume of the final product flowing at a rate of 1000 
µL/hr through each device. Nitrogen gas will be supplied by a pressure regulator at 
99.999% purity and a pressure between 15 and 20 psi. Each batch will produce 1,978 10 
mL doses with 4x108 microbubbles/mL. Microbubble creation will be induced with a 
slight pressure increase between 2 and 5 psi at the gas inlet upon initial flow. The desired 
dose of Oleosin is 1 mg/mL; however, vials will contain 1.245 mg/mL. This will account 
for administer error as well as the possibility of some Oleosin remaining in solution 
instead of adhering to the microbubble surface. The final product will be kept in 
pharmaceutical-grade glass vials at 4℃ until shipment. 
  
14.2.2 Microfluidic Device Master Fabrication 
The 8 microfluidic devices consist of disposable molds achieved from a master 
copy. Molds are disposed of after each batch. Two master copies will be purchased. 
Master copy fabrication requires the following procedure. A negative photoresist SU-8 
2010 is thinned by an SU-8 developer until a 3:1 ratio is reached. The SU-8 2010 is spin-
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coated onto silicon wafer. This continues until a thickness of 5 μm. Using a MA4 Mask 
Aligner, purchased from Karl Suss for $40,000, the photoresist is patterned through a 
transparency photomask to UV light.49 Sylgard 184 PDMS and cross-linker are mixed at 
a 12:1 ratio. The mixture is then kept in a desiccator to allow trapped air to escape and 
then poured onto a photoresist pattern and cured at 65°C for one hour. Curing results in 
PDMS becoming a flexible solid and makes the membrane highly compliant. The PDMS 
replica are peeled off the designed wafer. PDMS is spin-coated on a glass slide to bind it 
to the membrane.2 
   
14.2.3 Pumps and Tubing 
Peristaltic pumps will be used to transfer contents between each unit operation. 
Peristaltic pumps were chosen over centrifugal pumps because they are more effective for 
viscous fluids. Thirty small Masterflex will be purchased from Cole-Parmer.50 Each 
pump costs $2,037 and supports flow rates ranging from 0.006 to 3,400 mL/min. Pumps 
will operate at the room temperature in the production facility. Sterile tubing will connect 
pipes to unit operations. The overall recovery from pipes and tubing is 97% during the 
production and purification process.  
 
14.2.4 Biosafety Cabinet 
A biosafety cabinet will be used to provide a sterile cell culture space. Cell stocks 
for inoculation will be prepared in the biosafety cabinet. For each inoculation, 1.2 mL of 
cell stock with a concentration of 7.6x108 cell/mL will be prepared in 1.5mL tubes. The 
biosafety cabinet is included in the rent at the rented lab space. 
 
14.2.5 Refrigeration 
 Three different refrigerators will be required in the facility. A -80°C freezer is 
needed to maintain frozen cell stock and certain reagents. This will be purchased from 
Thermo Scientific for $30,000. Four -20°C freezers will be required to reagent storage. 
This will be purchased from Thermo Scientific for $8,700 each. Four 4°C refrigerators 
will be used for final product storage before shipment. These will be purchased from 
Thermo Scientific for $3,400 each.51 Utility costs are included in annual expenses. 
59 
 
 
14.2.6 Waste Holding Tank 
All waste from the production and purification process will be pumped into a 
2,000L stainless steel waste holding tank. The tank will be purchased from Sharpsville 
Container for $500.52 An 18-log reduction of bacteria will be achieved by maintaining the 
tank at 130°C for 2 minutes. This will eliminate the possibility of environmental 
contamination once the waste is disposed. The waste contents will also be neutralized for 
a pH of 7.0 before being discarded by laboratory facility.  
 
14.2.7 Water-for-Injection Generator 
FDA standards require WFI for injectable products in order to ensure sterility. 
Thus, a still will be needed to purify water that is added to reagents, such as buffers and 
for conducting CIP. The still will be purchased from Paul Mueller Company from 
$20,000.53 
 
14.2.8 Clean Steam Generator 
A clean steam generator will use WFI from the still to generate clean steam. This 
steam will be used for SIP. The generator will be purchased from BMT USA for 
$60,000.54  
 
14.2.9 Buffer Transfer Bags 
Buffers for both the cobalt affinity and ion exchange chromatography columns 
will be prepared in disposable bags. For each batch 8 sterile bags with holders will be 
required. The bags and holders will be purchased from HyClone at varying sizes as 
required for each type of buffer.37 
 
14.2.10 Filter Integrity Test 
A filter integrity test will be purchased from Millipore for $3,500.55 This will be 
used to ensure that all filters are functional and do not have any tears or blockages prior 
to each batch. This is important in minimizing loss from manufacturing error. 
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14.2.11 Purified Air Generator 
To ensure purity of air in the facility, a purified air generator will be purchased 
from Domnick Hunter for $2,500.56 
 
14.2.12 Incubator Shaker 
An incubator shaker will be purchased from Sheldon Manufacturing for $4,500.57 
This will be used to incubate inoculation cell cultures at 37°C until the reach a cell 
concentration of 7.6x108 cells/mL. 
 
14.3 Quality Control Lab Equipment 
To ensure that QC specifications and FDA regulations are met product verification tests 
will be conducted prior to microfluidic processing. Only about 10 ug of Oleosin from each batch 
will be required for these tests, so there will not be a significant impact on final product yield.  
 
14.3.1 MALDI-TOF Mass Spectrometry Unit 
Matrix Assisted Laser Desorption/Ionization—Time of Flight Mass Spectrometry 
will be used to verify the molecular weight of the isolated protein. The molecular weight 
for Oleosin 30G is approximately 15kDa. The unit will be purchased from Shimadzu for 
$288,000.58 
 
14.3.2 Protein Gel Materials 
A protein gel will be run with a sample from each batch to confirm the identity of 
the protein. The gel will require the following materials: hydrochloric acid, 30% 
acrylamide, SDS ammonium persulfate, TEMED, glycine, EDTA, 50% glycerol, 
mercaptoethanol, bromophenol blue, and pre-stained molecular weight markers. All of 
these materials will be purchased from BioRad for $1,540.59 
 
14.3.3 NanoDrop 
A NanoDrop 2000 UV-Vis Spectrophotometer will be used to determine the final 
Oleosin concentration the product solution. This concentration will be used to determine 
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the dilution required prior to microfluidic processing. The device will be purchased from 
Thermo Scientific for $9,100.60 
 
14.3.4 Endotoxin Kit 
An endotoxin kit will measure endotoxin levels in the final product to ensure that 
FDA regulations are met. A new kit will be purchased from Lonza for $1,000 after every 
192 tests.61 
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15. Specification Sheets 
The following pages contain the specification sheets for all unit operations. Description 
and function, vendor, operation, characteristics, operating conditions, and purchase cost are all 
detailed. 
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15. 1 Inoculum Bioreactor (P-1) 
 
Description and Function Inoculum for the production bioreactor will be prepared and 
grown in a 0.2L (with working volume of 116mL) disposable 
bag bioreactor. The bag will be placed in a rocker to prevent cell 
settling. The purchased unit will also include a control tower to 
monitor aeration, pH, temperature, and rocking speed. The bags 
are made of plastic and sterilized. 
 
 
Vendor Sartorius Stedim Biotechnology Group 
 
 
Operation Batch 
 
  
Materials Handled  Input (kg/batch) Output (kg/batch) 
 Cells 4.71x10-5 1.10x10-3 
 Media 1.20x10-1 1.19x10-1 
 Kanamycin 5.80x10-6 5.80x10-6 
 Endotoxin 0 4.87x10-11 
    
    
    
Characteristics Model: 
Material Construction: 
Percent Yield: 
Sterilization: 
Rocking speed: 
Volume: 
BIOSTAT RM 
Sterile plastic bag, stainless steel unit 
97% 
Disposable bag, CIP/SIP for base 
300 rpm 
0.2 L 
  
Operating Conditions Temperature:  
Pressure:  
pH: 
pO2: 
Growth time: 
36ºC 
1 atm 
7.0 
40% 
5.04 hours 
  
  
Purchase Cost Control tower: $49,000 
Rocker: $9,300 
Bags: $174/bag 
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15.2 Production Bioreactor (P-2) 
 
Description and Function The production bioreactor with a disposable plastic biocontainer 
will be used for cell growth to a desired cell concentration and 
protein (Oleosin 30G) production using induction by IPTG. The 
total reactor volume is 25L (with an initial working volume of 
14.88L and final working volume of 15.63L after glucose 
addition). The controller, ez-Control from Applikon will be 
purchased separately to monitor and control the pH, temperature, 
pO2, foam level, glucose and agitation rate. 
 
Vendor Pall 
 
Operation Batch 
  
Materials Handled  Input (kg/batch) Output (kg/batch) 
 Cells 1.07x10-3 1.49 
 Media 15.4 14.7 
 Kanamycin 7.44x10-4 7.44x10-4 
 Endotoxin 4.72x10-11 2.91x10-3 
 70% Glucose Solution 0.940 0.112 
 IPTG 3.62x10-4 3.64x10-4 
 Oleosin 0 4.69x10-2 
    
    
Characteristics Model: 
Material Construction: 
Dimensions: 
Percent Yield: 
Sterilization: 
 
Agitation speed: 
Volume: 
PadReactor System  
Disposable ULDPE biocontainer 
84.5cm x 94.0cm x 136.0cm 
97% 
Disposable biocontainer, CIP/SIP 
for base 
300 rpm 
25 L 
  
Operating Conditions Temperature:  
Pressure:  
pH: 
pO2: 
Growth Time: 
Protein Production Time: 
36ºC (growth), 25ºC (production) 
1 atm 
7.0 
40% 
10.27 hours 
3 hours 
  
  
Purchase Cost Bioreactor: 
Controller: 
Biocontainer: 
$150,000 
$500 
$300/biocontainer 
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15.3 Cell Culture Storage Tank (P-3) 
 
Description and Function The disposable cell culture storage bag will be used to clear 
out the production bioreactor quickly upon completion of the 
fermentation and protein production periods. This will enable 
CIP and SIP procedures to begin promptly. 
 
 
Vendor Hyclone 
 
 
Operation Batch 
 
    
Characteristics Material Construction: 
Volume: 
Sterilization: 
Sterile plastic 
25 L 
Disposable 
 
  
Operating Conditions Temperature:  
Pressure:  
 
25ºC  
1 atm 
 
  
  
Purchase Cost $100/bag  
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15.4 Disk Stack Centrifuge (P-4) 
 
Description and Function The centrifuge will be used to separate the cells and product (solids) 
from the spent media (liquid). 
 
 
Vendor Alfa-Laval 
 
 
Operation Batch 
 
 
Materials Handled  Input (kg/batch) Output (kg/batch) 
Cells 1.40 1.40 
Media 13.8 4.15x10-1 
IPTG 3.40x10-4 1.02x10-5 
Kanamycin 6.99x10-4 2.10x10-5 
Endotoxin 2.74x10-3 2.74x10-3 
 Oleosin 
70% Glucose Solution 
4.40x10-2 
0.11 
4.40x10-2 
3.14x10-3 
 Waste 0 13.5 
    
    
Characteristics Model: 
Centrifuge Type: 
Material Construction: 
Finish: 
Flowrate: 
Percent Yield: 
Sterilization: 
Culturefuge 100 
Disk Stack 
Stainless steel 
Electro-polished 
2,000 L/hr capacity 
95% 
CIP/SIP 
  
  
Operating Conditions Temperature:  
Pressure:  
Flowrate: 
25ºC 
1 atm 
200 L/hr 
  
  
  
  
Purchase Cost $46,500/unit  
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15.5 High Pressure Homogenizer (P-5) 
 
Description and Function The high pressure homogenizer is used to lyse cells after 
centrifugation to release expressed Oleosin along with cell debris 
and other excess proteins. The device utilizes an extremely high 
pressure pump with a downstream valve for homogenization. The 
quick pressure drop results in extreme turbulence in flow, resulting 
in grinding of cells and release of the product. 
 
 
Vendor IKA Process Technology  
 
 
Operation Batch 
 
 
Materials Handled  Input (kg/batch) Output (kg/batch) 
Cells 1.33 1.33 
B-PER 6.64 6.64 
Endotoxin 2.60x10-3 2.60x10-3 
 Oleosin 4.18x10-2 4.18x10-2 
 Media 0.394 0.394 
 IPTG 9.69x10-6 9.69x10-6 
 Kanamycin 1.99x10-5 1.99x10-5 
 70% Glucose Solution 2.99x10-3 2.99x10-3 
 
    
    
Characteristics Model: 
Material Construction: 
Flowrate: 
Maximum Pressure: 
Percent Yield: 
M-7125 Series Microfluidizer 
Stainless steel 
13 L/hr capacity 
2000 atm 
95% 
  
  
Operating Conditions Temperature:  
Pressure:  
25ºC 
2000 atm 
  
  
  
  
Purchase Cost $8,000/unit  
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15.6 Cell Sludge Resuspension Tank (P-6) 
 
Description and Function The cell sludge resuspension bag will be used to resuspend the 
sludge product from the microfluidic homogenizer in 
denaturing buffer to prepare for binding in the cobalt affinity 
chromatography column.  
 
 
Vendor Hyclone 
 
 
Operation Batch 
 
    
Characteristics Material Construction: 
Volume: 
Sterilization: 
Sterile plastic 
25 L 
Disposable 
 
  
Operating Conditions Temperature:  
Pressure:  
 
4ºC in cold room  
1 atm 
 
  
  
Purchase Cost $100/bag  
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15.7 Cobalt Affinity Chromatography Column (P-7) 
 
Description and Function The cobalt affinity chromatography column will be used to bind 
the Oleosin 30G protein and separate it from most of the cell 
debris, buffers, and B-PER. 
 
 
Vendor Pall Corporation 
 
 
Operation Batch 
 
 
Materials Handled  Input (kg/batch) Output (kg/batch) 
Cells 1.20 0 
Buffers 313 83.5 
Endotoxin 2.34x10-3 2.34x10-3 
B-PER 
Oleosin 
5.98 
3.77x10-2 
0 
3.77x10-2 
Media 0.355 0 
IPTG 8.72x10-6 0 
Kanamycin 1.79x10-5 0 
70% Glucose Solution 2.69x10-3 0 
Waste 0 237 
    
    
Characteristics Model: 
Material Construction: 
Volume: 
Diameter: 
Height: 
Max Linear Flowrate: 
Percent Yield: 
Sterilization: 
Regeneration: 
Purity: 
Resin: 
Resolute Chromatography Column 
Stainless steel 
5.56 L 
280 mm 
91 mm 
1200 cm/hr 
90% 
CIP/SIP 
25 times 
≥ 90% 
HisPur Cobalt Superflow Agarose 
    
Operating Conditions Temperature: 
Pressure: 
Linear Flowrate: 
4ºC in cold room 
1 atm 
150 cm/hr 
  
Purchase Cost Column: 
 
$190,000 
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15.8 Affinity Chromatography Product Collection Tank (P-8) 
 
Description and Function The product from affinity chromatography that is eluted from 
the column in the elution buffer will be directed to a 
disposable holding bag. All other column flow-through will 
be directed to the waste tank.  
 
 
Vendor Hyclone 
 
 
Operation Batch 
 
    
Characteristics Material Construction: 
Volume: 
Sterilization: 
Sterile plastic 
100 L 
Disposable 
 
  
Operating Conditions Temperature:  
Pressure:  
 
4ºC in cold room  
1 atm 
 
  
  
Purchase Cost $250/bag  
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15.9 Ion Exchange Chromatography Column (P-9) 
 
Description and Function The anion exchange chromatography column will be used to bind 
the Oleosin 30G protein and separate it from endotoxins. Pierce 
High-Capacity Endotoxin Removal Resin, an anion exchange 
chromatography resin manufactured by Thermo Scientific, will 
be used. 99% of endotoxins will be removed. 
 
 
Vendor GE Healthcare Life Sciences 
 
 
Operation Batch 
 
 
Materials Handled  Input (kg/batch) Output (kg/batch) 
Buffers 477 34.4 
Endotoxin 2.10x10-3 2.10x10-5 
Oleosin 3.39x10-2 3.39x10-2 
Waste 0 4.42x10-2 
    
    
Characteristics Model: 
Material Construction: 
Volume: 
Diameter: 
Height: 
Max Linear Flowrate: 
Percent Yield: 
Sterilization: 
Purity: 
Resin: 
 
ChromXACT 400/100 Column 
Polymethyl methacrylate 
17.21 L 
400 mm 
120 mm 
300 cm/hr 
90% 
CIP/SIP 
≥ 90% 
Pierce High-Capacity Endotoxin 
Removal Resin 
    
Operating Conditions Temperature: 
Pressure: 
Linear Flowrate: 
4ºC in cold room 
1 atm 
150 cm/hr 
  
Purchase Cost Column: 
 
$100,000 
 
 
 
  
 
  
72 
 
15.10 Ion Affinity Chromatography Product Collection Tank (P-10) 
 
Description and Function The product from ion exchange chromatography that is eluted 
from the column in the elution buffer will be directed to a 
disposable holding bag. All other column flow-through will 
be directed to the waste tank. 
 
 
Vendor Hyclone 
 
 
Operation Batch 
 
    
Characteristics Material Construction: 
Volume: 
Sterilization: 
Sterile plastic 
50 L 
Disposable 
 
  
Operating Conditions Temperature:  
Pressure:  
 
4ºC in cold room  
1 atm 
 
  
  
Purchase Cost $200/bag  
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15.11 Ultrafiltration-Diafiltration (P-11) 
 
Description and Function The first step in purification after the chromatography column will 
be an ultrafiltration-diafiltration (UFDF) step using casette filters, 
stabilized with a cassette holder. The filter will have a 10 kDa 
MWCO to allow for oleosin to stay in the retentate (15 kDa in size) 
and allowing smaller particles to filter through. It is assumed that 
95% of oleosin will be recovered in this step, with a 5% loss 
associated with filtration through the cassette membrane. 
 
 
Vendor EMD Millipore 
 
 
Operation Batch 
 
 
Materials Handled  Input (kg/batch) Output (kg/batch) 
Buffer 31.0 30.5 
Oleosin 30G 3.05x10-2 3.05x10-2 
Endotoxin 1.89x10-5 1.89x10-5 
Waste 0 4.71x10-1 
 
   
Characteristics Model: 
Membrane Filter Material: 
Filtration Area: 
Flow Rate: 
Maximum Pressure Drop: 
Sterilization: 
 
Percent Yield: 
 
Pellicon 3 cassettes 
Regenerated cellulose, polyethylene 
1.14m2 
4 L/min 
2 atm 
Disposable cassettes, SIP for 
stainless steel holder 
95% 
 
  
  
Operating Conditions Temperature:  
Pressure:  
4 ºC in cold room 
1 atm 
  
  
  
Purchase Cost Stainless steel cassette holder:  
100 pack of Ultracel membranes:  
$995 
$479.08/pack 
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15.12 Bulk Filtration (Microfiltration) (P-12) 
 
Description and 
Function 
The final step in purification after ultrafiltration-diafiltration 
(UFDF) will be a microfiltration to dispose of endotoxins. 
Disposable Durapore filter membranes will be used with pore size 
of 0.22 µm. These filters are ideal for sterilization and clarification 
of protein solutions, allowing other small proteins to pass through 
to waste, with oleosin left in the retentate. The filters are housed in 
a disposable Millipak holder unit as well. Each batch will pass 
through the unit 3 times, removing 99% of endotoxins each time. 
 
 
Vendor EMD Millipore 
 
 
Operation Batch 
 
 
Materials Handled  Input (kg/batch) Output (kg/batch) 
Buffer 29.0 29.0 
Oleosin 30G 2.90x10-2 2.90x10-2 
Endotoxin 1.80x10-5 1.80x10-11 
Waste 0 1.80x10-5 
 
   
Characteristics Model: 
Membrane Filter Material: 
Filtration Area: 
Maximum Pressure Drop: 
Sterilization: 
Percent Yield: 
Flow Rate: 
Millipak® Disposable Units, 0.22um 
Durapore PVDF 
100 cm2 
4.1 atm 
Disposable 
95% 
16.5 L/min 
  
  
Operating Conditions Temperature:  4 ºC in cold room  
Pressure: 1 atm 
  
  
Purchase Cost Pack of 3 disposable  
membranes and holders: $530/pack 
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15.13 Product Storage Tank (P-13) 
 
Description and Function A final 35 L disposable bag will be used to collect the product 
solution from bulk microfiltration. Solid pluronic P-188 will 
be mixed into the solution (using a wave rocker moving at 
300 rpm) to prepare the final solution for microfluidic 
packaging. 
 
 
Vendor Hyclone 
 
 
Operation Batch 
 
    
Characteristics Material Construction: 
Volume: 
Sterilization: 
Sterile plastic 
25 L 
Disposable 
 
  
Operating Conditions Temperature:  
Pressure:  
 
4ºC in cold room 
1 atm 
 
  
  
Purchase Cost $100/bag  
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15.14 Waste Holding Tank  
 
Description and Function All waste that contacts the cell culture or the protein product 
at any point in the process will be directed to a stainless steel 
2,000 L holding tank. This waste includes all spent media, 
water, buffers, and cell debris. Heat inactivation and 
neutralization will be conducted before disposal is taken care 
of by the rented facility. 
 
 
Vendor Sharpsville Container 
 
 
Operation Batch 
 
    
Characteristics Material Construction: 
Volume: 
Sterilization: 
Stainless Steel 
2,000 L 
CIP/SIP 
 
  
Operating Conditions Temperature:  
Pressure:  
 
25-130ºC  
1 atm 
 
  
  
Purchase Cost $500  
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15.15 Peristaltic Pumps 
 
Description and Function Peristaltic pumps are used to transfer unit contents throughout 
the process. The consistent flow ensures accuracy in 
dispensing flow from unit to unit. A brushless motor allows 
for speed control of the pump. 
 
 
Vendor Cole Parmer 
 
 
Operation Batch 
 
    
Characteristics 
Model: 
Material Construction: 
Flowrate: 
Maximum Pressure Drop: 
 
Masterflex L/S Digital Drive 
Stainless Steel 
0.006-3,400 mL/min 
2.07 atm 
 
 
  
 
  
  
Operating Conditions Temperature:  
Pressure:  
 
4-36ºC 
1 atm 
 
  
  
Purchase Cost $2,037/pump  
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16. Equipment Cost Summary 
Table 16.1. Equipment Purchase Costs and Vendors 
Equipment Description Number Type Vendor Purchase Cost 
Bare 
Module 
Cost 
Inoculum Bioreactor 1 Process Machinery (P-1) Sartorius Stedim $49,000 $157,300 
WAVE Mixers 1 Process Machinery (P-1) Sartorius Stedim $9,300 $29,900 
Production Bioreactor 1 Process Machinery (P-2) Pall $150,000 $481,500 
Bioreactor Controller 1 Computers, Software, Etc. (P-2) Applikon $500 $1,600 
Disk Stack Centrifuge 1 Process Machinery (P-4) Alfa-Laval $46,500 $149,300 
High Pressure 
Homogenizer 1 Process Machinery (P-5) 
IKA Process 
Tech. $8,000 $25,700 
Cobalt Affinity Column 1 Process Machinery (P-7) Pall $190,000 $609,900 
Ion Exchange Column 1 Process Machinery (P-9) GE Healthcare $100,000 $321,000 
Buffer Mixers/Holders 8 Process Machinery (P-7, P-9) Hyclone $216,000 $693,400 
UFDF Pellicon Holder 1 Process Machinery (P-11) EMD Millipore $2,000 $6,400 
Microfluidic Device 
Master 1 Process Machinery Karl Suss $40,000 $128,400 
Waste Tank 1 Storage Sharpsville Container $500 $1,600 
-80ºC Freezer 1 Storage Thermo Scientific $30,000 $96,300 
-20ºC Freezer 4 Storage Thermo Scientific $34,800 $111,700 
Refrigerators 4 Storage Thermo Scientific $13,600 $43,700 
Peristaltic Pumps 30 Other Equipment Cole Parmer $40,700 $130,800 
Clean Steam Generator 1 Other Equipment BMT USA $60,000 $192,600 
Clean Air Generator 1 Other Equipment Domnick Hunter $2,500 $8,000 
Nanodrop1000 1 Other Equipment Thermo Scientific $9,100 $29,200 
MALDI-TOF 1 Other Equipment Shimadzu $288,000 $924,500 
Incubator Shaker 1 Other Equipment Sheldon Manufacturing $4,500 $14,400 
Filter Integrity Tester 1 Other Equipment EMD Millipore $3,500 $11,200 
Water for Injection 
Supplier 1 Other Equipment Paul Mueller $20,000 $64,200 
Protein Gel 5 Other Equipment BioRad $7,700 $24,700 
Endotoxin Kit 5 Other Equipment Lonza $5,000 $16,100 
Other Control Units 20 Computers, Software, Etc. Omega $6,000 $19,300 
Total 1,337,200 4,292,700 
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Table 16.1 shows the purchase cost for all process machinery, storage units, controllers, 
and other equipment needed in the facility. The total purchase cost is $1,337,200. With a bare 
module factor of 3.21, the bare module cost is $4,292,700. Purchase costs were obtained from 
the manufacturer’s websites and phone calls with the vendor.  
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17. Fixed Capital Investment Summary 
Not applicable. See section 16 for Equipment Cost Summary. 
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18. Operating Costs 
18.1 Variable Costs 
Table 18.1. Raw Material Costs 
Raw 
Material Required Ratio 
Cost of Raw 
Material 
Cost per 
mg 
Oleosin 
Annual 
Cost Vendor 
SB Media 6.086E-04 L per mg of Oleosin 30G $42.10 
per 
L $0.0256 $189,400 Teknova 
70% 
Glucose 
Solution 
3.038E-05 L per mg of Oleosin 30G $16.02 
per 
L $0.0096 $3,600 Teknova 
Kanamycin 3.020E-08 kg per mg of Oleosin 30G $7,360.00 
per 
kg $0.0002 $1,600 
Thermo 
Scientific 
IPTG 1.468E-08 kg per mg of Oleosin 30G $36,900.00 
per 
kg $0.0005 $4,000 Tocris 
B-PER 2.697E-04 L per mg of Oleosin 30G $390.00 
per 
L $0.1052 $777,200 Biovision 
Cobalt 
Column 
Resin 
5.505E-06 L per mg of Oleosin 30G $5,680.00 
per 
L $0.0313 $231,000 
Thermo 
Scientific 
Ion Affinity 
Resin 1.705E-05 
L per mg of 
Oleosin 30G $4,940.00 
per 
L $0.0842 $622,400 
Thermo 
Scientific 
Urea 3.371E-03 kg per mg of Oleosin 30G $33.90 
per 
kg $0.1143 $844,400 
Science 
Co. 
Imidazole 2.620E-05 kg per mg of Oleosin 30G $149.03 
per 
kg $0.0039 $28,900 MP Bio 
MES Buffer 8.812E-06 kg per mg of Oleosin 30G $324.80 
per 
kg $0.0029 $21,200 
Sigma 
Aldrich 
Na3PO4 3.236E-05 
kg per mg of 
Oleosin 30G $42.00 
per 
kg $0.0014 $10,000 
Sigma 
Aldrich 
NaCl 4.308E-04 kg per mg of Oleosin 30G $10.38 
per 
kg $0.0045 $33,000 
Sigma 
Aldrich 
Guanidine 
HCl 1.060E-03 
kg per mg of 
Oleosin 30G $27.80 
per 
kg $0.0295 $217,700 LabSpend 
Nonionic 
Detergent 1.849E-05 
kg per mg of 
Oleosin 30G $199.00 
per 
kg $0.0037 $27,200 
Sigma 
Aldrich 
NaOH 2.794E-05 kg per mg of Oleosin 30G $20.00 
per 
kg $0.0006 $4,100 
Sigma 
Aldrich 
Ethanol 
95% 3.493E-03 
L per mg of 
Oleosin 30G $7.20 
per 
L $0.0251 $185,800 Carolina 
P-188 1.118E-02 kg per mg of Oleosin 30G $82.33 
per 
kg $0.9202 $6,800,400 
Spectrum 
Chemical 
Total $1.36 $10,001,900  
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Table 18.1 shows the cost for all raw materials needed for the process. The total cost per 
mg of Oleosin is approximately $1.36. The annual cost for all raw materials is $10,001,900. All 
costs were obtained from the manufacturer’s websites and phone calls with the vendor.  
Super Broth (SB) media will be purchased as a source of nutrients for cells growing in 
both the inoculum and production bioreactor. 70% glucose solution in water is added to the 
production bioreactor as an additional energy source to support the high cell density culture. 
Kanamycin is the antibiotic that must be added to both the inoculum and production bioreactor. 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) will be added to the production bioreactor in 
order to induce protein expression in the cells. Bacterial Protein Extraction Reagent (B-PER) will 
be added to the homogenizer in order to lyse cells and solubilize soluble protein. B-PER 
Complete will be purchased, which contains necessary ingredients such as DNase and protease 
inhibitor. HisPur Cobalt Superflow Agarose will serve as the resin in the cobalt affinity column. 
Oleosin will attach to the resin and be separated from cell debris that flows through the column. 
Pierce High-Capacity Endotoxin Removal Resin will be the resin in the ion exchange column. 
Endotoxins will attach to the resin and be removed from the batch. Urea, imidazole, MES buffer, 
Na3Po4, NaCl, Guanidine HCl, nonionic detergent, NaOH, 95% ethanol solution in water will be 
purchased as the constituents of the various buffers flowing through both columns. Poloxamer 
188 (P-188) will be purchased and added to the final product tank. This is a triblock copolymer 
that adjusts the solution pH and prepares it for microfluidic processing. 
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Table 18.2. Additional Variable Costs for Process  
Unit Disposable Unit Cost 
Number 
per 
Batch 
Cost 
per 
Batch 
Annual 
Cost Vendor 
P-1 0.2L Bag $174 1 $174 $52,200 Hyclone 
P-2 25L Biocontainer $300 1 $300 $90,000 Pall 
P-3 250L bag $100 1 $100 $30,000 Hyclone 
P-6 25L bag $100 1 $100 $30,000 Hyclone 
P-7 100L Denaturing Buffer Bag $250 1 $250 $75,000 Hyclone 
P-7 100L Wash Buffer Bag $250 1 $250 $75,000 Hyclone 
P-7 100L Elution Buffer Bag $250 1 $250 $75,000 Hyclone 
P-7 100L Regeneration Buffer Bag $250 1 $250 $75,000 Hyclone 
P-8 100L bag $250 1 $250 $75,000 Hyclone 
P-9 100L Equilibrium Buffer Bag $250 1 $250 $75,000 Hyclone 
P-9 50L Wash Buffer Bag $200 1 $200 $60,000 Hyclone 
P-9 100L Elution Buffer Bag $250 1 $250 $75,000 Hyclone 
P-9 100L Regeneration Buffer Bag $250 1 $250 $75,000 Hyclone 
P-10 50L bag $200 1 $200 $60,000 Hyclone 
P-11 Filter $5 1 $5 $1,500 EMD Millipore 
P-12 Filter $177 1 $177 $53,000 EMD Millipore 
P-13 25L bag $100 1 $100 $30,000 Hyclone 
Total $3,356 $1,006,700  
 
Table 18.2 shows additional variable costs for disposable parts of the process. The total 
cost per batch is $3,356. The total annual cost is $1,006,700. All costs were obtained from the 
manufacturer’s websites and phone calls with the vendor.  
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Table 18.3. Utility Costs 
Utility Required Ratio Utility Cost Cost per mg Oleosin 
Annual 
Cost 
Water $0.0812 L per mg of Oleosin 30G $0.005 per L $0.000420 $3,100 
Electricity $0.300 kWh per mg of Oleosin 30G $0.070 per kWh $0.021000 $155,200 
Refrigeration $0.000255 kWh per mg of Oleosin 30G $0.197 per kWh $0.000050 $400 
Total $0.021 $158,700 
 
Table 18.3 shows additional utility costs associated with the process and facility. The 
total cost per mg Oleosin is $0.021. The total annual cost is $158,700.  
The water for injection generator in the plant is able to convert regular tap water to WFI. 
Thus, WFI does not have to be purchased. Instead water utility costs are based on the estimated 
provided by the Medford, Massachusetts Department of Public Works, Water and Sewer 
Division.62 The calculated water utility cost is about $0.005 per kWh per mg Oleosin.  The clean 
steam generator, will generate any steam needed with SIP using WFI from the WFI generator. 
Thus, steam is included in the water utility cost. 
Electricity costs are based on required kW-hr necessary for the process and the costs 
outlined in “Energy Benchmarking in the Pharmaceutical Industry.”63 The calculated electricity 
utility cost is about $0.07 per kWh per mg Oleosin. 
Refrigeration costs were calculated for the 4°C cold room in the plant, where protein 
purification processes will take place. The calculated refrigeration utility cost is about $0.197 per 
kWh per mg Oleosin. (See Appendix 7 for calculations) The refrigeration costs of the other 
storage refrigerators were assumed negligible compared to this utility cost. 
 
  
85 
 
Table 18.4. Other Variable Costs and Working Capital. 
 
 Table 18.4 summaries other variable costs and working capital. It was assumed that 3% 
of sales would account for selling/transfer expenses. In addition, 4.8% of sales would be invested 
in direct research. R&D will play an optimal role in optimizing E. coli growth so that high cell 
densities can be reached. Inventory will be shipped within a week because the product is most 
effective within that time period. Ten days of raw material will be kept on site and more will be 
purchased as needed. 
18.2 Plant Lifespan 
The overall operational lifespan of the plant has been designed to be about 15 years. This 
lifespan was selected to account for the overall lifespan and depreciation of the major 
equipments, market progressive receptivity to the Oleosin 30G product, and the duration of the 
protected intellectual property rights over the product. Should the facility shut down before the 
15 years, there could be some salvage value in the plant’s physical assets. 
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18.3 Fixed Costs 
Fixed costs are summarized in Figure 18.1.  
 
Figure 18.1. Fixed Cost Summary. 
 
The plant will be run for 24 hours per day for 5 days a week for 50 weeks a year. Six 
batches will be completed each week, amounting to 300 batches per year. There will be 3 shifts, 
8 hours each. Five operators will be scheduled for each shift. One operator will monitor the 
upstream production, two will work in downstream purification, and the last two will monitor 
Fixed Costs
Operations
Operators per Shift: 5 (assuming 3 shifts)
Direct Wages and Benefits: $27 /operator hour
Direct Salaries and Benefits: 15% of Direct Wages and Benefits
Operating Supplies and Services: 6% of Direct Wages and Benefits
Technical Assistance to Manufacturing: per year, for each Operator per Shift
Control Laboratory: per year, for each Operator per Shift
Maintenance
Wages and Benefits: 4.50% of Total Depreciable Capital
Salaries and Benefits: 25.00% of Maintenance Wages and Benefits
Materials and Services: 100.00% of Maintenance Wages and Benefits
Maintenance Overhead: 5.00% of Maintenance Wages and Benefits
Operating Overhead
General Plant Overhead: 7.10% of Maintenance and Operations Wages and Benefits
Mechanical Department Services: 2.40% of Maintenance and Operations Wages and Benefits
Employee Relations Department 5.90% of Maintenance and Operations Wages and Benefits
Business Services 7.40% of Maintenance and Operations Wages and Benefits
Property Taxes and Insurance
Property Taxes and Insurance: 2.00% of Total Depreciable Capital
Straight Line Depreciation
Direct Plant: 8.00% of Total Depreciable Capital, less 1.18 times the Allocated Costs 
for Utility Plants and Related Facilities
Allocated Plant: 6.00% of 1.18 times the Allocated Costs for Utility Plants and Related Facilities
Other Annual Expenses
Rental Fees (Office and Laboratory Space): $3,550,000
Licensing Fees: $0
Miscellaneous: $1,006,637
Depletion Allowance
Annual Depletion Allowance: $0
Other One-Time Expenses
FDA Approval $20,000,000
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microfluidic processing and QC testing. Operators will be payed direct wages and benefits of 
$27 per hour.  
Annual rental fees for the facility amount to $3,550,000. The facility is located in 
Medford, MA, USA. This location was chosen for its proximity to top universities and the 
existing biotechnology hub in the Boston area. The cost of land in this area is about $31 per 
square foot.64 The rented facility is a 5053 square foot Cunnings Properties’’ Lab-Ready Suite. 
This rental space can be reconstructed if needed for the process. As discussed, the expected 
operational life of the plant is 15 years and a 15-year depreciation schedule was used. 
The cost of FDA approval was included as a one-time upfront expense in the year prior to 
first sales. This cost was estimated to be $20,000,000 by Dr. Scott Diamond of the Department of 
Chemical and Biomolecular Engineering at the University of Pennsylvania.  
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19. Other Important Considerations 
19.1 Scheduling 
 The process provides for 300 batches per year, the designed biopharmaceutical plant 
operating five days per week, twenty-four hours per day. This requires three eight-hour shifts per 
day. Because the plant runs continuously on a twenty-four hour schedule, no intermediary 
storage is necessary. Altogether the plant operates 250 days per year (of a total 251 business 
days), and calculations assume 90% productivity (that is, 10% of batches are unviable for various 
reasons). 
 Six batches per week are produced, and the production bioreactor – as seen in the Gantt 
chart below – is the bottleneck. Start to finish, each batch takes 27.9 hours to complete. This 
does not include time for testing or packaging because these can occur concurrently with unit 
operations and thus do not constrain the batch time. Three of six batches in a given week are 
shown with all unit operations to the left. 
 There will be one employee in charge of the growth and production department, two 
employees for the downstream purification department, and two other employees for the 
microfluidic processing and testing department. This amounts to fifteen full-time employees each 
working forty hours per week.  
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Figure 19.1. Process Gantt Chart. Cleaning times shown 
in black. Note bottleneck for production reactor. 
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Times for both bioreactors and chromatography columns were calculated in the 
appendices. Centrifugation and ultrafiltration/diafiltration times were determined using vendor 
sheets and buffer volumes for the preceding steps. CIP/SIP times were calculated using 
manufacturer protocols. 
 
19.2 Steam-in-Place Requirements 
 To eliminate any possible biological contaminants between batches, all non-disposable 
equipment must be steam sterilized in place (SIP) after CIP unless otherwise noted. The process 
will require 50 psi (138°C) saturated steam for 40 minutes, ensuring that every part of the 
equipment reaches 121°C for 20 minutes as required by the FDA.65 Equipment will then be 
cooled via forced convection by room temperature air. Cooling times were estimated for each 
piece of equipment based on the size or based upon the vendor sheets. Barring microfiltration, 
product collection tanks, and chromatography columns all units undergo SIP between batches to 
ensure full sterilization.  
 
19.3 Clean-in-Place Requirements 
 Clean-in-place procedures ensure the process meets FDA regulations and Current Good 
Manufacturing Practices (cGMP). Essentially, this means all equipment coming in contact with 
process materials is treated as biowaste. Namely, relevant equipment will undergo appropriate 
CIP protocols in between each batch, as shown in the Gantt chart. Cleaning procedures begin 
with a rinse using Water for Injection (WFI), followed by a detergent flush. A second circulation 
of detergent will be flushed, followed by an intermediate WFI rinse. An acid solution will then 
be added to clear any remaining cellular debris. Finally, a WFI rinse will clear remaining 
detergent from the system, with an air blow to remove moisture as the final step.66 Because the 
costs of these materials are considered negligible relative to other considerations in the 
forthcoming profitability analysis, they are unimportant cost-wise. Barring microfiltration, 
product collection tanks, and ultrafiltration/diafiltration, all units undergo CIP between batches 
to ensure full sterilization.  
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19.4 Waste Treatment and Environmental Effects 
 All biowaste will undergo heating to 80°C (to inactivate live cultures) followed by 
heating to 121°C for 1 minute to kill all E. coli-derived organisms. Disposal of the biowaste will 
be contracted to a waste disposal service, a more cost-effective option relative to on-site disposal. 
Fees for these services as well as waste transportation are incorporate in the financial analysis. 
All equipment coming in contact with this biowaste must be autoclaved to ensure sterilization for 
future batches. All other waste will be directed to a neutralization tank, where pH will be 
adjusted to 7.0 for waste disposal into the local sewage system. For costs sake, this service will 
also be contracted out to a third party. 
 Landfill waste is minimized to reduce the carbon footprint resulting from the process. No 
hazardous chemicals or toxins are produced – disposal of said materials is thus not a concern. 
Alongside regular CIP and SIP procedures, the plant will host a quality management team on a 
twice per year. Hygienic conditions and occupational health standards will be met for all 
employees and equipment, with regular quality ventilation. Every batch will undergo quality and 
sterilization assessment at various checkpoints throughout before being added to other batches. 
Storage tanks between unit operations to regulate potential failed batches or corrupted materials 
and prevent further problems downstream. Finally testing and quality assurance will be 
performed before the product is sent for packaging, proper FDA-approved labeling and dosage 
information. Explosion-proof electrical equipment will be used in all steps involving steps. 
 
19.5 FDA Regulations 
 Because contrast agents are administered intravenously to systemic circulation, Food and 
Drug Administration regulations apply. There have been past instances of acute myocardial 
infarction, acute coronary syndromes, worsening or decompensated heart failure, arrhythmias, 
respiratory failure, emphysema, pulmonary emboli, and pulmonary hypertension-related illnesses 
following contrast agent injection.67 These have resulted in eleven patient deaths between 2001 
and 2007, which prompted the FDA to issue a “black box” warning advising patients of the risk 
for “severe cardiopulmonary reactions.” The warning also requires a 30-minute monitoring 
period after injection for all patients with pre-existing hypertension or heart conditions. Because 
these regulations apply to contrast agents sold as Definity® Injectable Suspension and Optison®, 
they are also anticipated to concern Oleosin 30G.68 
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 Aside from these concerns, Oleosin 30G must also meet endotoxin regulations because it 
is produced via E. coli. The Limulus Amebocyte Lysate (LAL) gel clot method will be used to 
verify the final product’s endotoxin concentration meets said regulations. Samples collected 
during endotoxin testing will comply with requirements of the WFI Monographs in USP 2355.69 
 Poloxamer 188 (P-188) – also known as Pluronic F-68 – is used to make the microbubble 
suspensions fit for pharmaceutical-grade shipping. The FDA approved P-188 as a therapeutic 
agent to reduce viscosity in the blood before transfusions. Moreover, P-188 has passed all 
required immunotoxicity tests.70 
  
19.6 Water for Injections (WFI) 
 The WFI system will include a backvalve to protect source water and sanitary clamped 
piping, valves, and instruments made of 316 L steel to distribute and store required water. Piping 
will be sloped so water drains completely. Instruments must pass integrity testing, or they will be 
replaced. Tests for residual chlorine, pH, and conductivity will be conducted monthly, and all 
media must pass growth promotion testing. 
 Temperature of WFI distribution during peak flow will be 80°C, and daily 
microbiological monitoring at the WFI still will proceed. Samples from the supply loop will be 
collected on twenty days throughout the year and tested for compliance with regulations. 
Samples sizes will be 100-300 mL.  
 Finally, total heterotrophic plate count (endorsed by Section 9215 of the Standard 
Methods for the Examination of Water and Wastewater) will be used with plate count agar to 
detect microbiological agents present in the water. Colonies identified will be tested for 
pathogenicity. Plate counts may not exceed 10 CFU/mL for any given sample.71  
 
19.7 Intellectual Property 
 To address intellectual property concerns surrounding Oleosin 30G, a patent filing for the 
Oleosin 30G formulation will be submitted alongside the corresponding New Drug Application 
(NDA) to the FDA. Protected twenty years under the U.S. Patent Office, approval exclusivity 
would be granted at the time of NDA approval.72 Casey et al. also note “Oleosin 30G would be 
classified as a New Chemical Exclusivity (NCE) with a five-year protection period, preventing 
any other competitors from filing an Abbreviated New Drug Application (ANDA) during this 
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period. Records with the FDA must also be kept up to date in order to include the patent holding 
in the FDA’s Orange Book.”20 These provisions help ensure the patent’s exclusivity. 
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20. Profitability Analysis 
20.1 Market Analysis and Pricing 
Oleosin’s marketing and pricing strategy is based on the market share and pricing of its 
main competitor, Definity®. Table 20.1 outlines the pricing strategies for both Definity® and 
Oleosin. The price per dose of Oleosin during the first year of sales (2019) will be equal to the 
current price per dose of Definity®. This will price Oleosin at $218.58 per dose in 2019. This is 
equal to $17.56 per mg assuming each dose contains 12.45 mg of Oleosin. Assuming that 
Definity® will continue to increase its price in upcoming years, Oleosin will quickly gain market 
share because it will be the less costly alternative. After 2019, Oleosin will follow a similar price 
increase schedule as Definity®. Since Definity’s® pricing after 2018 is unknown, Oleosin will 
increase by 5% each year after 2026. Table 20.1 also outlines Definity’s® market share from 
2010 to 2016. Oleosin is predicted to follow a similar pattern in gaining market share over 
Definity® as Definity® did with Optison®. This will ensure that Oleosin manages to fully 
saturate the market.  
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Table 20.1. Pricing Strategy for Definity® and Oleosin. Price per dose and market share for 
Definity® were obtained from the manufacturer’s website.27 
 Definity® Oleosin 
Year 
Price Per 
Dose 
Percent 
Increase 
Market 
Share 
Price Per 
Dose 
Price per 
mg 
Percent 
Increase 
2010 $125.00 0.00% 63.00% - - - 
2011 $130.00 4.00% 63.82% - - - 
2012 $136.00 4.62% 70.39% - - - 
2013 $142.80 5.00% 77.56% - - - 
2014 $157.08 10.00% 87.47% - - - 
2015 $172.79 10.00% 91.05% - - - 
2016 $198.71 15.00% 91.72% - - - 
2017 $218.58 10.00% - - - - 
2018 - - - - - - 
2019 - - - $218.58 $17.56 - 
2020 - - - $227.32 $18.26 4.00% 
2021 - - - $237.82 $19.10 4.62% 
2022 - - - $249.71 $20.06 5.00% 
2023 - - - $274.68 $22.06 10.00% 
2024 - - - $302.15 $24.27 10.00% 
2025 - - - $347.47 $27.91 15.00% 
2026 - - - $382.22 $30.70 10.00% 
2027 - - - $401.33 $32.24 5.00% 
2028 - - - $421.40 $33.85 5.00% 
2029 - - - $442.46 $35.54 5.00% 
2030 - - - $464.59 $37.32 5.00% 
2031 - - - $487.82 $39.18 5.00% 
2032 - - - $512.21 $41.14 5.00% 
2033 - - - $537.82 $43.20 5.00% 
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20.2 Profitability Measures 
 This process has the potential to become a very profitable venture. Figure 20.1 
summarizes the profitability measures. The internal rate of return (IRR) is 145.5%. Optimization 
of the process was able to improve this value from the 77.45% IRR from the 2016 project. The 
net present value (NPV) in 2017 is $376,483,400, which also increased from last year’s NPV of 
$214,124,800. The return on investment is 296.36%, compared to the 2016 project ROI of 
78.57%. These values are based on the production of 7.39 kg of Oleosin and full market 
saturation.  
 
Figure 20.1. Profitability Measures. The profitability analysis spreadsheet was used to 
calculate the values in the figure. 
 
 Figure 20.2 summarizes the variable costs, fixed costs, investment summary, and 
working capital. The total variable costs amount to $25,148,600, which increased from last 
year’s cost of $13,868,400. This increase is largely due to the increased raw material cost that 
came from buffers needed for the ion exchange column, that was not included in last year’s 
process. The cost of raw materials per mg of Oleosin increased from $0.47 to $1.35. The total 
fixed cost for this process is $6,556,400. This values decreased from last year’s fixed cost of 
$14,620,700. This cost reduction was mainly due to fewer shifts, and thus fewer operators in our 
batch schedule. The total permanent investment required is $6,240,300. In 2016 the total 
Profitability Measures
The Internal Rate of Return (IRR) for this project is 145.50%
The Net Present Value (NPV) of this project in 2017 is 376,483,400$  
ROI Analysis (Third Production Year)
Annual Sales 110,096,220    
Annual Costs (26,172,318)     
Depreciation (499,222)          
Income Tax (30,867,131)     
Net Earnings 52,557,548      
Total Capital Investment 17,734,108      
ROI 296.36%
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permanent investment was $32,856,100. This large cost reduction stems from a more detailed 
equipment costing approach. The total working capital is $14,403,500. This can be compared to 
last year’s working capital of $39,003,700.  
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Variable Cost Summary
Variable Costs at 100% Capacity:
General Expenses
Selling / Transfer Expenses: 3,893,052$              
Direct Research: 6,228,883$              
Allocated Research: 648,842$                 
Administrative Expense: 2,595,368$              
Management Incentive Compensation: 1,622,105$              
Total General Expenses 14,988,250$            
Raw Materials $1.353424 per mg of Oleosin 30G $10,001,802
Byproducts $0.000000 per mg of Oleosin 30G $0
Utilities $0.021460 per mg of Oleosin 30G $158,590
Total Variable Costs 25,148,643$            
Fixed Cost Summary
Operations
Direct Wages and Benefits 842,400$                 
Direct Salaries and Benefits 126,360$                 
Operating Supplies and Services 50,544$                   
Technical Assistance to Manufacturing -$                        
Control Laboratory -$                        
Total Operations 1,019,304$              
Maintenance
Wages and Benefits 250,725$                 
Salaries and Benefits 62,681$                   
Materials and Services 250,725$                 
Maintenance Overhead 12,536$                   
Total Maintenance 576,668$                 
Operating Overhead
General Plant Overhead: 91,034$                   
Mechanical Department Services: 30,772$                   
Employee Relations Department: 75,648$                   
Business Services: 94,880$                   
Total Operating Overhead 292,334$                 
Property Taxes and Insurance
Property Taxes and Insurance: 111,434$                 
Other Annual Expenses
Rental Fees (Office and Laboratory Space): 3,550,000$              
Licensing Fees: -$                        
Miscellaneous: 1,006,637$              
Total Other Annual Expenses 4,556,637$              
Total Fixed Costs 6,556,377$              
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Figure 20.2. Cost Summary. The profitability analysis spreadsheet was used to calculate the 
values in the figure. 
Investment Summary
Total Bare Module Costs:
Fabricated Equipment -$                        
Process Machinery 2,602,636$              
Spares -$                        
Storage 253,269$                 
Other Equipment 1,415,738$              
Catalysts -$                        
Computers, Software, Etc. 20,865$                   
Total Bare Module Costs: 4,292,508$             
Direct Permanent Investment
Cost of Site Preparations: 214,625$                 
Cost of Service Facilities: 214,625$                 
Allocated Costs for utility plants and related facilities: -$                        
Direct Permanent Investment 4,721,759$             
Total Depreciable Capital
Cost of Contingencies & Contractor Fees 849,917$                 
Total Depreciable Capital 5,571,676$             
Total Permanent Investment
Cost of Land: 111,434$                 
Cost of Royalties: -$                        
Cost of Plant Start-Up: 557,168$                 
Total Permanent Investment - Unadjusted 6,240,277$             
Site Factor 1.00
Total Permanent Investment 6,240,277$             
Working Capital
2018 2019 2020
Accounts Receivable 5,759,584$              1,279,908$             1,279,908$                
Cash Reserves 95,794$                   21,288$                  21,288$                     
Accounts Payable (450,954)$               (100,212)$               (100,212)$                  
Oleosin 30G Inventory 1,343,903$              298,645$                298,645$                   
Raw Materials 147,972$                 32,883$                  32,883$                     
Total 6,896,299$              1,532,511$             1,532,511$                
Present Value at 15% 5,996,781$             1,158,798$             1,007,651$               
Total Capital Investment 14,403,507$           
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 Figure 20.3 shows the cash flow summary for the process. It is important to note that the 
cost for FDA approval is included as a fixed cost in 2018, the year before first sales. This cost 
was not included in the fixed cost in the previous figure. 
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20.3 Operating Capacity 
A production capacity of 90% was selected to account for disruptions such as regulatory 
checks, unexpected maintenance, and failed batches. It is important to note that the current 
process design is not operating at its maximum capacity. The process could be redesigned to 
allow for higher quantities of Oleosin production with the same equipment. Currently, the 
production bioreactor is the bottleneck of the process, and it reaches a maximum volume of 
15.63 L. However, the 25 L bioreactor has a maximum 20 L working volume. There is room to 
increase the working volume in the bioreactor to produce higher Oleosin yields with the same 
process design in place. Analysis of this possibility (See Appendix 18) showed that increasing 
the inital volume to 18.73 L, and running for 1.3 hours longer could produce a yield of up to 
60.51 g of Oleosin in the bioreactor; an increase of 29% in Oleosin production. This, of course, 
would increase operational costs due to a longer batch process time and increase raw material 
costs. A cost-benefit analysis is required to find the optimal process scheduling depending on the 
increase in Oleosin product demand. As the market currently stands, there is no necessity to 
increase to this productivity. 
 
20.4 Sensitivity Analysis 
 
Figure 20.4. Oleosin Production Costs. The figure shows all the components contributing to 
the cost of producing Oleosin over the 15-year life-span of the plant. The three largest costs are 
general expenses, raw materials, and other fixed costs. 
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Figure 20.4 shows how the different fixed and variable expenses, as well as the capital 
investment all contribute to the cost of producing Oleosin. A fair comparison was generated by 
calculating the cost of production per mg of Oleosin per year. Raw materials, including all 
substances and chemicals required to run the batches from beginning to end, contribute about 
$1.35 per mg of Oleosin, which represents the second largest expense, about 29% of the relative 
cost. Disposables refers to all the disposable materials used for each batch such as sterilized bags 
for each bioreactor. Utilities were calculated to be rather inconsequential to the production costs. 
General expenses as explained in section 18, represent a percentage of the sales revenue and are 
the largest contributors to the cost of production. However, given the potential opportunities in 
increasing the efficiency of production and finding new purposes for Oleosin, this is a justifiable 
expense. Operations include all wages and operating supplies. Other fixed costs include overhead 
and business services, rental services, property taxes, and insurance, which represent the third 
largest component adding to the cost. The total capital investment (TCI) component was 
calculated as the TCI of the plant payed over the lifespan of the plant with an annual 8% interest 
divided by the number of mg of Oleosin produced throughout 15 years of production. 
 
 
 
 
 
 
 
 
 
 
 
Figure 20.5. Cumulative Net Present Value of the Plant over 15-Year Lifespan. NPV turns 
positive by the end of 2019 and continues to progressively increase over time as Oleosin 
saturates the market by 2022. 
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A sensitivity analysis showing the effects of changing variable costs and product price on 
the internal rate of return are showned in Figures 20.6 and 20.7.  
 
Figure 20.6. Sensitivity Analysis of Variable Cost on IRR. The orange dot represents the 
current design’s variable cost, while the blue line indicates the IRR’s sensitivity to the variable 
costs changing by as much as ±50%. The sensitivity is relatively low. 
 
Figure 20.7. Sensitivity Analysis of Product Price on IRR. The orange dot represents the 
current design’s product price per dose, while the blue line indicates the IRR’s sensitivity to the 
variable costs changing by as much as ±50%. The IRR is found to be much more dependent of 
the selling price of product rather than its variable costs. 
 
 Figure 20.8 on the following page offers a more comprehensive table representation of 
this data. 
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$12,606,732 $15,128,078 $17,649,425 $20,170,771 $22,692,118 $25,213,464 $27,734,810 $30,256,157 $32,777,503 $35,298,850 $37,820,196
$8.78 84.58% 81.16% 77.78% 74.44% 71.14% 67.88% 64.66% 61.51% 58.41% 55.37% 52.40%
$10.54 101.41% 98.02% 94.65% 91.30% 87.98% 84.69% 81.43% 78.20% 75.01% 71.87% 68.77%
$12.29 117.45% 114.09% 110.75% 107.43% 104.12% 100.84% 97.57% 94.33% 91.12% 87.94% 84.78%
$14.05 132.74% 129.43% 126.14% 122.85% 119.58% 116.33% 113.09% 109.86% 106.66% 103.47% 100.30%
$15.80 147.34% 144.08% 140.84% 137.60% 134.38% 131.16% 127.96% 124.77% 121.59% 118.43% 115.28%
$17.56 161.28% 158.09% 154.90% 151.71% 148.54% 145.37% 142.21% 139.07% 135.93% 132.80% 129.68%
$19.32 174.62% 171.48% 168.35% 165.22% 162.10% 158.98% 155.88% 152.77% 149.68% 146.59% 143.52%
$21.07 187.39% 184.30% 181.23% 178.16% 175.09% 172.03% 168.97% 165.92% 162.88% 159.84% 156.81%
$22.83 199.62% 196.60% 193.58% 190.56% 187.55% 184.54% 181.53% 178.54% 175.54% 172.55% 169.57%
$24.58 211.35% 208.38% 205.42% 202.46% 199.50% 196.54% 193.59% 190.64% 187.70% 184.76% 181.83%
$26.34 222.61% 219.70% 216.79% 213.88% 210.98% 208.07% 205.17% 202.28% 199.38% 196.49% 193.61%
Variable Costs
P
ro
d
u
ct
 P
ri
ce
Figure 20.8. IRR as a Function of Product Selling Price and Variable Costs. Internal Rate of Return (IRR) 
calculated for a range of ±50% above and below the current process design set point. 
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20.5 Worst-Case Scenario: Redesign of the Process with the Experimental Cell Yield 
20.5.1 Case Description and Design 
All prior calculations assume a cell yield of 1,488 g of cell mass; that is, 100 g per 
initial unit volume. This is an assumption based on industry practice and literature that 
suggests this is an attainable target. However, this is an assumption. Therefore, a “worst-
case scenario,” defined as a case where achieving cell densities higher than those 
experimentally proven in the 3.9 L bioreactor studies is unattainable, is considered as 
well as its effects on the financial analysis of the business model. 
Experimentally, the highest cell density achieved was 9.48 g/L. Based on this 
target and the methods previously explained, a new Oleosin production bioreactor was 
designed. For the purposes of this scenario, given the wide implications of such a large 
change in cell yield on the overall process design,  a key compromise was necessary: to 
compensate for the lower yield, the volume of the bioreactor was increased so that the 
same target amount of Oleosin is produced at a lower cell concentration (see Appendix 
19). In summary, the new bioreactor optimized for this low cell concentration yield 
would still produce the necessary 46.9 g  at this stage of the process. 
 
20.5.2 Financial Analysis 
A new mass balance was calculated to estimate the new required raw material 
costs for the new process. The results were surprisingly positive, with the new design 
reaching an ROI of 292.3% and an IRR of 143.2%, at the low, but experimentally  proven 
cell density of 9.45 g/L. The figures below outline the financials of this alternative 
process.  
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Profitability Measures
The Internal Rate of Return (IRR) for this project is 143.22%
The Net Present Value (NPV) of this project in 2017 is 371,431,000$   
ROI Analysis (Third Production Year)
Annual Sales 110,096,220     
Annual Costs (27,728,883)     
Depreciation (499,222)          
Income Tax (30,291,202)     
Net Earnings 51,576,912       
Total Capital Investment 17,645,008       
ROI 292.30%
Variable Cost Summary
Variable Costs at 100% Capacity:
General Expenses
Selling / Transfer Expenses: 3,893,052$              
Direct Research: 6,228,883$              
Allocated Research: 648,842$                 
Administrative Expense: 2,595,368$              
Management Incentive Compensation: 1,622,105$              
Total General Expenses 14,988,250$            
Raw Materials $1.597910 per mg of Oleosin 30G $11,808,557
Byproducts $0.000000 per mg of Oleosin 30G $0
Utilities $0.020991 per mg of Oleosin 30G $155,124
Total Variable Costs 26,951,931$            
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Fixed Cost Summary
Operations
Direct Wages and Benefits 842,400$                 
Direct Salaries and Benefits 126,360$                 
Operating Supplies and Services 50,544$                   
Technical Assistance to Manufacturing -$                         
Control Laboratory -$                         
Total Operations 1,019,304$              
Maintenance
Wages and Benefits 250,725$                 
Salaries and Benefits 62,681$                   
Materials and Services 250,725$                 
Maintenance Overhead 12,536$                   
Total Maintenance 576,668$                 
Operating Overhead
General Plant Overhead: 91,034$                   
Mechanical Department Services: 30,772$                   
Employee Relations Department: 75,648$                   
Business Services: 94,880$                   
Total Operating Overhead 292,334$                 
Property Taxes and Insurance
Property Taxes and Insurance: 111,434$                 
Other Annual Expenses
Rental Fees (Office and Laboratory Space): 3,550,000$              
Licensing Fees: -$                         
Miscellaneous: 1,156,637$              
Total Other Annual Expenses 4,706,637$              
Total Fixed Costs 6,706,377$              
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Figure 20.9. Cost Summary of Worst-Case Scenario. 
Investment Summary
Total Bare Module Costs:
Fabricated Equipment -$                         
Process Machinery 2,602,636$              
Spares -$                         
Storage 253,269$                 
Other Equipment 1,415,738$              
Catalysts -$                         
Computers, Software, Etc. 20,865$                   
Total Bare Module Costs: 4,292,508$              
Direct Permanent Investment
Cost of Site Preparations: 214,625$                 
Cost of Service Facilities: 214,625$                 
Allocated Costs for utility plants and related facilities: -$                         
Direct Permanent Investment 4,721,759$              
Total Depreciable Capital
Cost of Contingencies & Contractor Fees 849,917$                 
Total Depreciable Capital 5,571,676$              
Total Permanent Investment
Cost of Land: 111,434$                 
Cost of Royalties: -$                         
Cost of Plant Start-Up: 557,168$                 
Total Permanent Investment - Unadjusted 6,240,277$              
Site Factor 1.00
Total Permanent Investment 6,240,277$              
Working Capital
2018 2019 2020
Accounts Receivable 5,759,584$              1,279,908$              1,279,908$                 
Cash Reserves 95,641$                   21,253$                   21,253$                      
Accounts Payable (530,991)$                (117,998)$                (117,998)$                  
Oleosin 30G Inventory 1,343,903$              298,645$                 298,645$                    
Raw Materials 174,702$                 38,823$                   38,823$                      
Total 6,842,838$              1,520,631$              1,520,631$                 
Present Value at 15% 5,950,294$              1,149,815$             999,839$                   
Total Capital Investment 14,340,226$            
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20.5.3 Worst-Case Scenario Conclusions 
The process was re-designed with additional expenses for a larger bioreactor 
($50,000 more), larger volumes of raw materials, and utilities to process the larger 
volumes of media from the bioreactor. The results show that these changes did not 
significantly affect the overall profitability of the process. The ROI (in the third year) 
decreased from $296.37 in the original process to $292.30 % in the re-designed process. 
Sensitivity analysis overall did not differ significantly from the figures in the original 
process design. 
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21. Conclusions and Recommendations 
The Oleosin characterization studies presented here demonstrate the feasibility of a 
process design for Oleosin 30G production. The accompanying business model satisfies the 
demand for microbubble contrast agents for echocardiograms in the United States and generates 
a promising 296% ROI. 
Building on last year’s work, the optimization studies done this year were able to 
improve the biologic kinetics of production by controlling key parameters such as temperature, 
media type, pH, dissolved oxygen concentration, and glucose concentration. For instance, E. coli 
growth rate was increased from 0.59 hr-1 to 0.78 hr-1 which constitutes a profound improvement 
in the exponential growth model. In addition, the production of Oleosin with respect to cell 
density was experimentally characterized as cells grew, reaching 3.15% of the cells’ mass after 
only 3 hours of IPTG-induced production. Furthermore, the design was improved to maximize 
production, increasing  percent yield from 46.1% to 58.4%, while minimizing costs.  
Based on the literature and industrial experience, reaching 100 g/L dry cell concentration 
is a highly achievable goal considering the control of the optimized parameters as outlined in this 
report. However, this cell density should still be confirmed by cell growth study in a bioreactor 
with similar dimensions and conditions to those outlined in this report. For this reason, an 
alternative process design was developed for a low bioreactor Oleosin yield, dependent on the 
maximum cell growth achieved. Preliminary financial analysis on this alternative process proved 
that the plant would still remain financially feasible with a 292% ROI even at low yields of 9.45 
g/L dry cell mass, which were experimentally reached in this study. 
Comparing the product with the main potential competitor in the market, Definity®, there 
is significant evidence to believe Oleosin 30G could saturate the market and gain over 90% of its 
market share within the first few years of it entering the market.  
The plant design proposed here allows for the production of approximately 600,000 doses 
throughout the year with uniformly sized, monodispersed Oleosin-coated microbubbles in 
solution. This final assembly of the product in doses that are ready for injection will ensure high 
quality and consistent efficacy, which will channel market share growth. With a stable shelf life 
of one month, Oleosin will require prompt delivery of fresh product to readily satisfy the demand 
for contrast agents in echocardiography throughout the whole year in the United States. 
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Furthermore, once built, the designed plant could accommodate increased production yields of 
up to 29% with the same equipment if the market demand for the product were to increase. 
Once clinical efficacy and safety of the product are confirmed and FDA approval for 
market entry is attained, the preliminary experimental and financial studies in this report promise 
lucrative opportunities for market saturation with Oleosin 30G’s superior product. 
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24. Appendices 
Appendix 1: Cell Concentration and Optical Density 
 A relationship between optical density and cell concentration was determined for use in 
cell growth calculations. First, the average cell concentration was calculated by serially diluting 
cells onto nutrient agar plates.  This method allows for the counting of cells in a highly dilute 
sample, wherein colony forming units (CFU) are formed. Table A1.1 shows the number of CFUs 
counted in serially diluted plates. 
 
Table A1.1. Serial Dilution Plate CFU Counts. TMTC stands for too many to count. Colony 
forming units consisted of BL21 E. coli cells. Concentration of cells were calculated for plates 
containing 30-300 CFUs. 
Plate # 1 2 3 4 5 6 
Dilution 10-4 10-4 10-5 10-5 10-6 10-6 
# of CFUs TMTC TMTC 48 50 8 6 
Avg. # Cells - - 4.9 × 108 - - 
 
Average Cell Concentration was calculated as follows:  
 
# 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶
𝑚𝑚𝑚𝑚
=
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑏𝑏𝑎𝑎𝑏𝑏𝑡𝑡𝑎𝑎𝑎𝑎𝑏𝑏𝑎𝑎 𝑏𝑏𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡𝑎𝑎𝑐𝑐
𝑐𝑐𝑏𝑏𝑚𝑚𝑐𝑐𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 × 𝑎𝑎𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑏𝑏𝑐𝑐 𝑚𝑚𝑚𝑚 𝑎𝑎𝑎𝑎𝑎𝑎𝑚𝑚𝑏𝑏𝑎𝑎𝑐𝑐 𝑡𝑡𝑐𝑐 𝑎𝑎𝑚𝑚𝑎𝑎𝑡𝑡𝑎𝑎
 
# 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶
𝑚𝑚𝑚𝑚
=
49 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶
10−5 × (10𝜇𝜇𝑚𝑚 × . 001𝑚𝑚𝑚𝑚1𝜇𝜇𝑚𝑚 )
 
# 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶
𝑚𝑚𝑚𝑚
= 4.9 × 108
𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶
𝑚𝑚𝑚𝑚
 
 
Figure A1.1 shows a standard curve for cell concentration as a function of optical density. This 
curve was generated from OD values at different % cell suspensions of the overnight growth 
culture.  
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Figure A1.1. Plot of Cell Concentration vs OD. Average blank value was subtracted from each 
optical density data point. Optical density was shown to have a direct linear relationship with cell 
concentration.  
 
The linear relationship between OD and cell concentration is defined by: 
𝑦𝑦 = 6.71 × 108𝑥𝑥 − 3.01 × 107 
where         𝑦𝑦 = 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚 𝑏𝑏𝑐𝑐𝑐𝑐𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐, 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝑚𝑚𝑐𝑐
 
𝑥𝑥 = 𝑂𝑂𝑂𝑂 𝑐𝑐𝑜𝑜 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚 𝐶𝐶𝑐𝑐𝐶𝐶𝑎𝑎𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐𝑐𝑐,𝑐𝑐𝑐𝑐𝑏𝑏𝑡𝑡𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 
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Appendix 2: Biowaste System Design 
Assumptions: 
1. The final cell concentration in the production culture is 3.96x1011 cells/mL. Upon 
removal from the process the bacteria will be inactivated in the waste tank. 
2. Inactivation kinetics are first order. 
3. The decimal reduction time for E. coli at 121°C is 2.3x10-13 minutes. 
 
For the assumed final cell concentration, the waste tank will contain: 
 
3.96 × 1011
𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶
𝑚𝑚𝑚𝑚
 × 14.877
𝑚𝑚
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
 ×  1000
𝑚𝑚𝑚𝑚
𝑚𝑚
= 5.89 × 1015
𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶 𝑡𝑡𝑐𝑐 𝑏𝑏𝑐𝑐𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
 
  
First order inactivation kinetics: 
ln �
𝑁𝑁
𝑁𝑁0
� =  −𝑘𝑘𝑡𝑡 
log �
𝑁𝑁
𝑁𝑁0
� = −
𝑡𝑡
𝑂𝑂
 
Substitution: 
𝑘𝑘 =
2.303
𝑂𝑂
 
where N = microbial population at any time, t 
N0 = initial microbial population 
D = decimal reduction time; time required for a 1-log (or 10-fold) cycle reduction 
in the microbial population 
 
For a 25-log reduction in the microbial population: 
 
𝑁𝑁 = 5.89 × 10−10𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶/𝑚𝑚𝑚𝑚 
 
Thus, there is a 5.89x10-10 chance that a single E. coli will be active after heat 
inactivation in each batch.  
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To determine time for heat deactivation: 
−25 =  −
𝑡𝑡
2.3 × 10−13
 
𝑡𝑡 =  5.75 × 10−12 𝑚𝑚𝑏𝑏𝑐𝑐𝑐𝑐𝑡𝑡𝑎𝑎𝐶𝐶 
 
Therefore, bio-waste tank will be heated to 121°C and maintained at this temperature for 
one minute to inactivate bacteria. 
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Appendix 3: Batch Sizing 
Assumptions: 
1. The process is designed to run 300 batches per year. The plant will be operational for 24 
hours, 5 days a week, 50 weeks per year. Six batches will be completed each week. 
2. The ultimate goal is to produce 7.39 kg Oleosin 30G per year. This will allow for 100% 
market saturation. 
3. Based on the fourth bioreactor experiment, the specific growth rate for this strain of 
BL21 recombinant E. coli grown under the same optimized conditions is 0.781 hr-1.  
4. Frozen stock of E. coli will be prepared at concentration of 7.6x108 cells/mL 
5. Oxygen limitations will not be a concern for the growth periods and will be held constant 
using PID control at 40% dissolved O2.  
6. Recovery from upstream production is 91.27%, recovery from downstream purification is 
64.00%, recovery from microfluidic processing and packaging is 99.40%, and overall 
recovery of the protein product is 58.06%. 
 
 
Table A3.1. Inoculum Batch Sizing. Cell concentrations were calculated using the growth rate 
from fourth bioreactor experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
Inoculum 
Working volume 0.116 L 
Initial cell concentration 7.86E+06 cells/mL 
Specific growth rate 0.781 1/hr 
Growth time 5.04 hr 
Final cell concentration 8.49E+08 cells/mL 
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Table A3.2. Production Bioreactor Batch Sizing. Cell concentrations were calculated using the 
growth rate from fourth bioreactor experiment. 
 
 
 
 
 
 
 
 
 
Table A3.3. Overall Production Statistics. Batch sizing was conducted to meet 100% market 
saturation. 
Annual Production 
Oleosin produced per batch 0.0469 kg/batch 
Production percent yield 91.27 % 
Oleosin recovered in production 0.0428 kg/batch 
Purification percent yield 64.00 % 
Oleosin recovered in purification 0.0274 kg/batch 
Overall Oleosin percent yield 58.41 % 
Productivity 90 % 
Batches per year 300 batches/yr 
Days/batch 5 days/batch 
Active plant days per year 250 days/yr 
Protein recovered per year 7.39 kg/yr 
 
 
 
 
 
 
  
Production Bioreactor 
Initial Working volume 14.877 L 
Initial cell concentration 8.49E+08 cells/mL 
Specific growth rate 0.781 1/hr 
Target cell concentration 3.96E+11 cells/mL 
Growth time 10.27 hr 
Protein production time 3 hr 
Oleosin produced 0.0469 kg 
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Appendix 4: Cobalt Affinity Chromatography Sizing and Timing 
The cobalt affinity chromatography column size and volumes of solution needed were 
calculated according to the protocol for the HisPur® cobalt affinity resin. The given binding 
capacity of the resin and the mass of Oleosin entering the column were used to calculated the 
volume of resin required per batch. This calculation assumes that all Oleosin that passes through 
the column will bind to the resin, and disregards the 90% recovery from the unit. This 
assumption ensures that recovery is not limited by the binding capacity of the resin. Random 
packing was assumed with a void fraction of 0.39 as no other data could be found in the 
literature. The column volume was calculated as follows: 
𝑀𝑀𝑎𝑎𝐶𝐶𝐶𝐶 𝑐𝑐𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝑡𝑡𝑐𝑐 𝑡𝑡ℎ𝑎𝑎 𝑏𝑏𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 (𝑎𝑎)
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗
𝑚𝑚 𝑎𝑎𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐
 𝑎𝑎 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐
= 𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎
𝑚𝑚
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
 
37.66
𝑎𝑎
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗
1 𝑚𝑚 𝑎𝑎𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐
11.11 𝑎𝑎 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐
=  3.39𝑚𝑚 
𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 ∗
1
1 − 𝑉𝑉𝑐𝑐𝑏𝑏𝑐𝑐 𝐶𝐶𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐
= 𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 
3.39 𝑚𝑚 ∗
1
1 − .39
= 5.56𝑚𝑚 
 
The data sheet for the resin allows for 25 regenerations before resin must be replaced. The 
amount of resin needed on an annual basis was calculated as follows: 
𝑇𝑇𝑐𝑐𝑡𝑡𝑎𝑎𝑚𝑚 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑐𝑐𝑜𝑜 𝑎𝑎𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐 𝑎𝑎𝑎𝑎𝑟𝑟𝑐𝑐𝑏𝑏𝑎𝑎𝑎𝑎𝑐𝑐
𝑦𝑦𝑎𝑎𝑎𝑎𝑎𝑎
=
𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐 
 𝐵𝐵𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗
𝐵𝐵𝑎𝑎𝑡𝑡𝑏𝑏ℎ𝑎𝑎𝐶𝐶
𝑦𝑦𝑎𝑎𝑎𝑎𝑎𝑎
∗
1
𝑁𝑁𝑐𝑐𝑚𝑚𝑏𝑏𝑎𝑎𝑎𝑎 𝑐𝑐𝑜𝑜 𝐶𝐶𝐶𝐶𝑎𝑎𝐶𝐶 𝑏𝑏𝑎𝑎𝑜𝑜𝑐𝑐𝑎𝑎𝑎𝑎 𝑂𝑂𝑏𝑏𝐶𝐶𝑏𝑏𝑎𝑎𝑎𝑎𝑐𝑐𝑏𝑏𝑐𝑐𝑎𝑎
 
40.68
𝑚𝑚 𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐
𝑦𝑦𝑎𝑎𝑎𝑎𝑎𝑎
= 3.39 
𝑚𝑚 𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐
𝐵𝐵𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗ 300
𝐵𝐵𝑎𝑎𝑡𝑡𝑏𝑏ℎ𝑎𝑎𝐶𝐶
𝑌𝑌𝑎𝑎𝑎𝑎𝑎𝑎
∗
1
25 𝐶𝐶𝐶𝐶𝑎𝑎𝐶𝐶
 
 
A conservative approach was used in calculating the batch time and amount of buffer 
needed, by using the maximum column volumes of buffer suggested in the protocol.  
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Table A4.1. Calculated Material Requirements for Chromatography Buffers. Compositions 
and volumes required were obtained from the HisPur® Superflow Agarose resin vendor sheet. 
Masses required were calculated using the maximum protocol volumes listed.  
Buffer Composition Protocol Volumes Composition Amount per Batch 
Denaturing/Equilibrium 3x-10x column volume 
5mM  Imidazole 
20mM Sodium 
Phosphate 300mM 
sodium chloride 
8M Urea 
Imidazole                                   0.646kg 
 
Sodium Phosphate                      0.491kg 
 
Sodium Chloride                         0.554kg 
 
Urea                                             83.03kg 
 
MES                                            0.217kg 
 
Guanidine HCl                              6.37kg 
 
Detergent                                     0.111kg 
 
Ultrapure Water                          267.32L 
 
Wash 6x-10x column volume 
15mM Imidazole 
20mM Sodium 
Phosphate 300mM 
sodium chloride 
8M Urea 
Elution 4x-10x column volume 
150mM Imidazole 
20mM Sodium 
Phosphate 300mM 
sodium chloride 
8M Urea 
Regeneration 10x column volume 20mM MES 
CIP 
2x column volume 
5x column volume 
water 
6M guanidine HCl 
1% nonionic 
detergent 
 
𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐  𝑅𝑅𝑐𝑐𝑐𝑐 𝑡𝑡𝑏𝑏𝑚𝑚𝑎𝑎 = 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑐𝑐𝑜𝑜 𝑤𝑤𝑎𝑎𝑡𝑡𝑎𝑎𝑎𝑎 ∗
1
𝑚𝑚𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎 𝑜𝑜𝑚𝑚𝑐𝑐𝑤𝑤 𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎 ∗ 𝑏𝑏𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 𝑏𝑏𝑎𝑎𝑐𝑐𝐶𝐶𝐶𝐶 𝐶𝐶𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐
 
2.89 ℎ𝑎𝑎𝐶𝐶 =
267,320 𝑚𝑚𝑚𝑚
150 𝑏𝑏𝑚𝑚ℎ𝑎𝑎 ∗ (14 𝑏𝑏𝑚𝑚)
2 ∗ 𝜋𝜋
= 1.87 ℎ𝑎𝑎𝐶𝐶 𝑎𝑎𝑐𝑐𝑐𝑐 𝑡𝑡𝑚𝑚𝑎𝑎 + 0.60 ℎ𝑎𝑎𝐶𝐶 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 + 0.42 ℎ𝑎𝑎𝐶𝐶 𝐶𝐶𝐶𝐶𝐶𝐶 
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Appendix 5: Ion Exchange Chromatography Sizing and Timing 
The ion exchange chromatography column size and volumes of solution needed were 
calculated according to the protocol for the Pierce High-Capacity Endotoxin Removal Resin. The 
given binding capacity of the resin and the mass of endotoxin entering the column were used to 
calculate the volume of resin required per batch. Random packing was assumed with a void 
fraction of 0.39 as no other data could be found in the literature. The column volume was 
calculated as follows: 
𝑀𝑀𝑎𝑎𝐶𝐶𝐶𝐶 𝐸𝐸𝑐𝑐𝑐𝑐𝑐𝑐𝑡𝑡𝑐𝑐𝑥𝑥𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝑡𝑡𝑐𝑐 𝑡𝑡ℎ𝑎𝑎 𝑏𝑏𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 (𝑎𝑎)
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗
𝑚𝑚 𝑎𝑎𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐
 𝑎𝑎 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐
= 𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎
𝑚𝑚
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
 
2.1
𝑎𝑎
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗
1 𝐸𝐸𝐶𝐶
100 ∗ 10−12𝑎𝑎
∗
1 𝑚𝑚 𝑎𝑎𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐
 2.0 ∗ 109𝐸𝐸𝐶𝐶
=  10.5 𝑚𝑚 
𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 ∗
1
1 − 𝑉𝑉𝑐𝑐𝑏𝑏𝑐𝑐 𝐶𝐶𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐
= 𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 
10.5 𝑚𝑚 ∗
1
1 − .39
= 17.21 𝑚𝑚 
The data sheet for the resin allows for 25 regenerations before resin must be replaced. 
The amount of resin needed on an annual basis was calculated as follows: 
𝑇𝑇𝑐𝑐𝑡𝑡𝑎𝑎𝑚𝑚 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑐𝑐𝑜𝑜 𝑎𝑎𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐 𝑎𝑎𝑎𝑎𝑟𝑟𝑐𝑐𝑏𝑏𝑎𝑎𝑎𝑎𝑐𝑐
𝑦𝑦𝑎𝑎𝑎𝑎𝑎𝑎
=
𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐 
 𝐵𝐵𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗
𝐵𝐵𝑎𝑎𝑡𝑡𝑏𝑏ℎ𝑎𝑎𝐶𝐶
𝑦𝑦𝑎𝑎𝑎𝑎𝑎𝑎
∗
1
𝑁𝑁𝑐𝑐𝑚𝑚𝑏𝑏𝑎𝑎𝑎𝑎 𝑐𝑐𝑜𝑜 𝐶𝐶𝐶𝐶𝑎𝑎𝐶𝐶 𝑏𝑏𝑎𝑎𝑜𝑜𝑐𝑐𝑎𝑎𝑎𝑎 𝑂𝑂𝑏𝑏𝐶𝐶𝑏𝑏𝑎𝑎𝑎𝑎𝑐𝑐𝑏𝑏𝑐𝑐𝑎𝑎
 
 
126
𝑚𝑚 𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐
𝑦𝑦𝑎𝑎𝑎𝑎𝑎𝑎
= 10.5 
𝑚𝑚 𝑅𝑅𝑎𝑎𝐶𝐶𝑏𝑏𝑐𝑐
𝐵𝐵𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗ 300
𝐵𝐵𝑎𝑎𝑡𝑡𝑏𝑏ℎ𝑎𝑎𝐶𝐶
𝑌𝑌𝑎𝑎𝑎𝑎𝑎𝑎
∗  
1
25 𝐶𝐶𝐶𝐶𝑎𝑎𝐶𝐶
 
 
A conservative approach was used in calculating the batch time and amount of buffer 
needed, by using the maximum column volumes of buffer suggested in the protocol.  
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Table A5.1. Calculated Material Requirements for Chromatography Buffers. Compositions 
and volumes required were obtained from the Pierce High-Capacity Endotoxin Removal Resin 
vendor sheet. Masses required were calculated using the maximum protocol volumes listed.  
Buffer Composition Protocol Volumes Composition Amount per Batch 
Equilibrium 5x column volume 10mM Sodium Phosphate 
 
Sodium Phosphate                        0.220kg 
 
Sodium Hydroxide                        0.688kg 
 
Ethanol                                            3.77kg 
 
Sodium Chloride                           10.06kg 
 
Guanidine HCl                              19.73kg 
 
Detergent                                       0.344kg 
 
Ultrapure Water                            499.09L 
 
Elution 1-2x column volume 
20mM Sodium 
Phosphate 
 
Regeneration 5x column volume 
0.2M Sodium 
Hydroxide 95% 
ethanol 
Wash 
5x column volume 
5x column volume 
water 
2M Sodium 
Chloride 
CIP 
2x column volume 
5x column volume 
water 
6M guanidine HCl 
1% nonionic 
detergent 
 
𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐  𝑅𝑅𝑐𝑐𝑐𝑐 𝑡𝑡𝑏𝑏𝑚𝑚𝑎𝑎 = 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑐𝑐𝑜𝑜 𝑤𝑤𝑎𝑎𝑡𝑡𝑎𝑎𝑎𝑎 ∗
1
𝑚𝑚𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎 𝑜𝑜𝑚𝑚𝑐𝑐𝑤𝑤 𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎 ∗ 𝑏𝑏𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 𝑏𝑏𝑎𝑎𝑐𝑐𝐶𝐶𝐶𝐶 𝐶𝐶𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐
 
2.94 ℎ𝑎𝑎𝐶𝐶 =
499,090 𝑚𝑚𝑚𝑚 + 55,600 𝑚𝑚𝑚𝑚
150 𝑏𝑏𝑚𝑚ℎ𝑎𝑎 ∗ (20 𝑏𝑏𝑚𝑚)
2 ∗ 𝜋𝜋
= 0.93 ℎ𝑎𝑎𝐶𝐶 𝑎𝑎𝑐𝑐𝑐𝑐 𝑡𝑡𝑚𝑚𝑎𝑎 + 1.37 ℎ𝑎𝑎𝐶𝐶 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 + 0.64 ℎ𝑎𝑎𝐶𝐶 𝐶𝐶𝐶𝐶𝐶𝐶 
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Appendix 6: Mass per Dose Calculation 
Mass per dose calculations were adopted from the data collected by 2016 project.20 
Nitrogen gas and liquid, with known Oleosin composition, flow rates were measured during the 
creation of the microbubbles with a microfluidic device. The average gas volume in one dose 
was based upon that of the current contrast agent, Albunex. A calculation based on liquid and gas 
flow rate was used as opposed to using a surface area calculation. This was done because the 
fraction of Oleosin from solution that forms the microbubble surface is not known. 
𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑎𝑎𝑎𝑎𝐶𝐶 𝑎𝑎𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑏𝑏𝑐𝑐 𝑎𝑎𝑚𝑚𝑏𝑏𝑐𝑐𝑐𝑐𝑎𝑎𝑥𝑥 𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎 = 𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎 𝑎𝑎𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 (𝑚𝑚𝑚𝑚) ∗ �
𝑐𝑐𝑐𝑐𝑚𝑚𝑏𝑏𝑎𝑎𝑎𝑎 𝑐𝑐𝑜𝑜 𝑏𝑏𝑐𝑐𝑏𝑏𝑏𝑏𝑚𝑚𝑎𝑎𝐶𝐶
𝑚𝑚𝑚𝑚 � ∗ 𝑎𝑎𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑐𝑐𝑜𝑜 𝑐𝑐𝑐𝑐𝑎𝑎 𝑏𝑏𝑐𝑐𝑏𝑏𝑏𝑏𝑚𝑚𝑎𝑎 (µ𝑚𝑚) 
771.8 µ𝑚𝑚 = 7.2𝑚𝑚𝑚𝑚 �4 ∗ 108
𝑏𝑏𝑐𝑐𝑏𝑏𝑏𝑏𝑚𝑚𝑎𝑎𝐶𝐶
𝑚𝑚𝑚𝑚
� (
4
3
 𝜋𝜋(. 004𝑚𝑚𝑚𝑚)3) 
 
(𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑎𝑎𝑎𝑎𝐶𝐶 𝑎𝑎𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑏𝑏𝑐𝑐 𝑎𝑎𝑚𝑚𝑏𝑏𝑐𝑐𝑐𝑐𝑎𝑎𝑥𝑥 𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎 (µ𝑚𝑚))
(𝑎𝑎𝑎𝑎𝐶𝐶 𝑜𝑜𝑚𝑚𝑐𝑐𝑤𝑤 𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎 𝑏𝑏𝑐𝑐 𝑚𝑚𝑏𝑏𝑏𝑏𝑐𝑐𝑜𝑜𝑚𝑚𝑐𝑐𝑏𝑏𝑐𝑐𝑏𝑏𝑏𝑏 𝑐𝑐𝑎𝑎𝑎𝑎𝑏𝑏𝑏𝑏𝑎𝑎 ( µ𝑚𝑚ℎ𝑐𝑐𝑐𝑐𝑎𝑎))
�𝑚𝑚𝑏𝑏𝑟𝑟𝑐𝑐𝑏𝑏𝑐𝑐 𝑜𝑜𝑚𝑚𝑐𝑐𝑤𝑤 𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎(
µ𝑚𝑚
ℎ𝑐𝑐𝑐𝑐𝑎𝑎
� ∗ [𝑐𝑐𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐](
µ𝑎𝑎
µ𝑚𝑚
) =
𝑐𝑐𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐
𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎 
 
771.8 µ𝑚𝑚𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎
62 µ𝑚𝑚ℎ𝑎𝑎
∗ 1000
µ𝑚𝑚
ℎ𝑎𝑎
∗ 1
µ𝑎𝑎 𝑐𝑐𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐
µ𝑚𝑚
= 12,450
 µ𝑎𝑎 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐
𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎
 
The production capacity of the plant was calculated as follows: 
7.39 𝑘𝑘𝑎𝑎 𝑐𝑐𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐
300 𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ𝑎𝑎𝐶𝐶
∗
1.0 × 109µ𝑎𝑎
1 𝑘𝑘𝑎𝑎
∗
1 𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎 
12,450 µ𝑎𝑎 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐
= 1978.58
𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎𝐶𝐶
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
 
1978.58 𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎𝐶𝐶
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗
300 𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ𝑎𝑎𝐶𝐶 
𝑦𝑦𝑎𝑎𝑎𝑎𝑎𝑎
= 593,574
𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎𝐶𝐶
𝑦𝑦𝑎𝑎𝑎𝑎𝑎𝑎
 
Thus, at full capacity the plant could produce enough doses to meet the entire market 
demand (about 600,000 doses/year).  
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Appendix 7: Utility Requirements for the Refrigerated Room 
The following data was adopted from the 2016 project.20 
Assumptions: 
1. Source for R-values are provided by North Carolina University in an article titled 
“Design of Cooling Facilities: Structural & Energy Requirements.” 
2. Field heat is equal to 10 percent of the heat given off through conduction.  
3. 21 OC (room temperature) assumed to be the “outside temperature” as the cold room is 
located in the interior of the building.  
4. Costs for refrigerators in the lab for storage of final materials are included in the 
electricity requirements calculations.  
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Table A7.1. Building Heating Cost Calculation 
Heat Conduction 
Building Dimensions  
Wall Width (ft.) 9 
Wall Length (ft.) 12 
Wall Height (ft.) 7 
  
Temperature Difference   
Outside (C) 21 
Inside (C) 4 
  
R-values 
Walls  16 sq ft/F Btu 
Ceiling 20 sq ft/F Btu 
Floor 11 sq ft/F Btu 
  
Heat Conduction  
Walls  408 Btu/hr 
Ceiling 91.8 Btu/hr 
Floor 166.90 Btu/hr 
Total 666.70 Btu/hr 
  
Service Load  
Total 66.67 Btu/hr 
  
Total Heat 733.38 Btu/hr 
  
Price Calculations  
Price of Utilities  19.7 cents per kilowatt 
hr 
Price per year (cents) 37071. 13 cents/year 
Price per year (dollars) 370.7113 dollars/year 
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Appendix 8: Endotoxin Level Calculation 
 Endotoxins are lipopolysaccharides (LPS) on the surface of E. coli cells. If endotoxins 
are present in the product at significant concentrations, they can result in a pyrogenic (fever 
producing) response once injected in humans. The FDA limits endotoxins for intravenous 
injections to 0.5 endotoxin units (EU) per kg body mass. An endotoxin unit equals about 100pg 
of E. coli lipopolysaccharides.  
Assuming a high estimate of 4.94x10-19 kg endotoxin per E. coli cell, the mass of 
endotoxins produced per batch in the reactor was calculated as follows:73 
4.94 × 10−19
𝑘𝑘𝑎𝑎 𝑚𝑚𝐶𝐶𝐿𝐿
𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚
∗ 3.59 × 1011
𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶
𝑚𝑚𝑚𝑚
 × 14.877
𝑚𝑚
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗ 1000
𝑚𝑚𝑚𝑚
𝑚𝑚
= 2.91 × 10−3  
𝑘𝑘𝑎𝑎 𝑚𝑚𝐶𝐶𝐿𝐿
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
  
  
 Assuming a 99% reduction of endotoxin mass in the column and in each pass through the 
bulk filtration, the amount of endotoxin in EU after the ion exchange column and two bulk 
filtration steps was then calculated as follows:   
2.91 ∗ 10−3
𝑘𝑘𝑎𝑎 𝑚𝑚𝐶𝐶𝐿𝐿
𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
∗ 1% ∗ 1% ∗ 1% ∗ 1% ∗
1015 𝑎𝑎𝑎𝑎
𝑘𝑘𝑎𝑎
∗
1 𝐸𝐸𝐶𝐶
100 𝑎𝑎𝑎𝑎 
∗
1 𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
1978 𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎𝐶𝐶
= .1471
𝐸𝐸𝐶𝐶
𝑐𝑐𝑐𝑐𝐶𝐶𝑎𝑎
 
 
Based on the FDA guidelines of 0.5 EU/kg of body mass, the product is safe for any 
patient above 0.29 kg, well within the range of any patient. 
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Appendix 9: Dry Mass Calculation 
 The following protocol was followed to measure dry mass in the bioreacctor samples. A 
weigh boat containing a clean filter was massed. The cell matter and protein that constitute the 
cell mass remained in the filter while the media flowed through the filter. A bioreactor sample 
comtaining approximately 3 mL of was vacumn filtered using the same filter. The filter unit was 
removed and placed in the weight boat. The weigh boat and the filter were placed in the 
microwave oven and microwaved for 3 minutes. The weight boat and filter was then removed 
and massed. The drying step was repeated until change in mass was less than 0.01 grams. Dry 
mass was calculated according as follows: 
𝑂𝑂𝑎𝑎𝑦𝑦 𝑀𝑀𝑎𝑎𝐶𝐶𝐶𝐶 �
𝑎𝑎
𝑚𝑚
� =
𝑀𝑀𝐹𝐹 −𝑀𝑀𝐼𝐼
𝑉𝑉
 
Where: 
MF = mass of weigh boat and filter after final drying (g) 
MI = mass of weigh boat and clean filter (g) 
V = volume of filtered sample (L)  
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Appendix 10: Oleosin Band Identification in Protein Gel 
ImageJ Software was used to identify which band in the protein gel was Oleosin so the 
Oleosin could be quantified based on the intensity of that band. A relationship was developed 
between migration distance in the gel, measured in pixels, and the molecular weight of a protein 
in kDa. Figure A10.1 depicts this relationship for the standard ladder, Precision Plus 
Kaleidoscope 1610375, which contains bands for protein at 250, 150, 100, 75, 50, 37, 25, 20, 15, 
and 10 kDa.  
 
Figure A10.1. Log(MW) vs. Migration Distance. The migration distance measured in pixels 
represent the distance the protein bands moved from the top of the gel as measured by ImageJ. A 
linear regression on this data in MS Excel produced the relationship shown in the figure where y 
is log(MW) and x is the migration distance in pixels. The R2 value for this equation is 0.993 
revealing a strong linear correlation.  
 
𝑦𝑦 = −8.51 × 10−4𝑥𝑥 + 2.28 
Where: 
𝑦𝑦 =  𝑚𝑚𝑐𝑐𝑎𝑎 (𝑀𝑀𝑐𝑐𝑚𝑚𝑎𝑎𝑏𝑏𝑐𝑐𝑚𝑚𝑎𝑎𝑎𝑎 𝑊𝑊𝑎𝑎𝑏𝑏𝑎𝑎ℎ𝑡𝑡 (𝑘𝑘𝑂𝑂𝑎𝑎)) 
𝑥𝑥 =  𝑀𝑀𝑏𝑏𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑂𝑂𝑏𝑏𝐶𝐶𝑡𝑡𝑎𝑎𝑐𝑐𝑏𝑏𝑎𝑎 (𝑎𝑎𝑏𝑏𝑥𝑥𝑎𝑎𝑚𝑚𝐶𝐶) 
 
y = -8.51×10-4x + 2.28
R² = 0.993
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 This relationship was used to confirm the identity of the band in the gel that contained 
Oleosin. The known molecular weight of Oleosin is 15 kDa. In addition, Oleosin contained GFP 
(Green Fluorescent Protein) with a molecular weight of 27 kDa and a His-tag with a molecular 
weight of 1 kDa. Thus the expected molecular weight is 43 kDa. The band depicted in Appendix 
11 was  closest to this predicted weight, and thus predicted to be Oleosin. The migration distance 
of this band was found to be 724 pixels in ImageJ. Its molecular weight was calculated as 
follows: 
log (𝑀𝑀𝑊𝑊) = −8.51 × 10−4(724 𝑎𝑎𝑏𝑏𝑥𝑥𝑎𝑎𝑚𝑚𝐶𝐶) + 2.28 
𝑀𝑀𝑊𝑊 = 10−8.51×10−4×�724 𝑝𝑝𝑝𝑝𝑝𝑝𝑐𝑐𝑐𝑐𝑐𝑐�+2.28  
𝑀𝑀𝑊𝑊 =  46 𝑘𝑘𝑂𝑂𝑎𝑎 
 
 The percent difference between the calculated and expected molecular weights was 
calculated as follows: 
% 𝑂𝑂𝑏𝑏𝑜𝑜𝑜𝑜𝑎𝑎𝑎𝑎𝑎𝑎𝑐𝑐𝑏𝑏𝑎𝑎 =
|𝐶𝐶𝑎𝑎𝑚𝑚𝑏𝑏𝑐𝑐𝑚𝑚𝑎𝑎𝑡𝑡𝑎𝑎𝑐𝑐 𝑀𝑀𝑊𝑊 −𝐾𝐾𝑐𝑐𝑐𝑐𝑤𝑤𝑐𝑐 𝑀𝑀𝑊𝑊|
𝐾𝐾𝑐𝑐𝑐𝑐𝑤𝑤𝑐𝑐 𝑀𝑀𝑊𝑊
× 100 
% 𝑂𝑂𝑏𝑏𝑜𝑜𝑜𝑜𝑎𝑎𝑎𝑎𝑎𝑎𝑐𝑐𝑏𝑏𝑎𝑎 =
|46 𝑘𝑘𝑂𝑂𝑎𝑎 − 43 𝑘𝑘𝑂𝑂𝑎𝑎|
43 𝑘𝑘𝑂𝑂𝑎𝑎
× 100 
% 𝑂𝑂𝑏𝑏𝑜𝑜𝑜𝑜𝑎𝑎𝑎𝑎𝑎𝑎𝑐𝑐𝑏𝑏𝑎𝑎 = 7.0 % 
 
The percent difference between the two molecular weights was less than 10%, which is 
within the range of accuracy of this method.77 Thus, it was concluded that the selected band in 
the gel contained Oleosin. 
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Appendix 11: Calculation of [Oleosin] in Experiments and Oleosin Production Model 
Assumptions and Justifications: 
1. Oleosin does not degrade over time.  
2. The gel analysis procedure succdeded in recovering and detecting all Oleosin in 
each sample. While some Oleosin might have been lost during the buffer 
exchanges or left on the last pellet, we prefer to slightly underestimate rather than 
overestimate Oleosin production. 
3.  The models is valid at larger cell densities provided the bioreactor conditions are 
maintained. pH, dissolved oxygen, and glucose concentration will be held 
constant. (The case in which this assumption is not made was also considered and 
discussed in Appendix 19). 
 
Results of polyacrylamide gels are shown in Figures A11.1 and A11.2 where the 
confirmed Oleosin 30G bands are boxed by a red rectangle. 
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Figure A11.1. Soluble Protein Gel Electrophoresis. Soluble Protein Gel Electrophoresis. 
Lanes are numbered from left to right. Lane 1- Ladder; Lane 2- Bioreactor Run 3 2:00 PM 
Sample; Lane 3- Bioreactor Run 3 2:30 PM Sample; Lane 4- Bioreactor Run 3 3:00 PM Sample; 
Lane 5- Bioreactor Run 3 3:30 PM Sample; Lane 6- Bioreactor Run 3 4:00 PM Sample; Lane 7- 
Bioreactor Run 4 11:28 AM Sample; Lane 8- Bioreactor Run 4 12:27 PM Sample; Lane 9- 
Bioreactor Run 4 1:38 PM Sample; Lane 10- Bioreactor Run 4 2:30 PM Sample; Lane 11- 
Bioreactor Run 4 3:05 PM Sample; Lane 12- Blank; Lane 13- Ladder. Red square indicates the 
separated bands composed of the produced Oleosin 30G. 
 
 
 
1       2      3       4       5        6      7      8       9      10    11      12    13 
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Figure A11.2. Insoluble Protein Gel Electrophoresis. Lanes are numbered from left to right. 
Lane 1- Ladder; Lane 2- Blank; Lane 3- Bioreactor Run 3 2:00 PM Sample; Lane 4- Bioreactor 
Run 3 2:30 PM Sample; Lane 5- Bioreactor Run 3 3:00 PM Sample; Lane 6- Bioreactor Run 3 
3:30 PM Sample; Lane 7- Bioreactor Run 3 4:00 PM Sample; Lane 8- Bioreactor Run 4 11:28 
AM Sample; Lane 9- Bioreactor Run 4 12:27 PM Sample; Lane 10- Bioreactor Run 4 1:38 PM 
Sample; Lane 11- Bioreactor Run 4 2:30 PM Sample; Lane 12- Bioreactor Run 4 3:05 PM 
Sample; Lane 13- Ladder. 
 
To calculate the Oleosin concentration from the PAGE gel assay, the integrated density 
(or brightness) of each Oleosin band was compared to that of all bands on each lane of the gel 
after subtracting the background signal (brightness of the gel itself) with Photoshop CC software. 
This provided percent protein loaded on the gels that was Oleosin. 
 
% 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑡𝑡ℎ𝑎𝑎𝑡𝑡 𝑏𝑏𝐶𝐶 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 =
𝐶𝐶𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎𝑐𝑐 𝑐𝑐𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑡𝑡𝑦𝑦 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑎𝑎𝑐𝑐𝑐𝑐 − 𝐵𝐵𝑎𝑎𝑏𝑏𝑘𝑘𝑎𝑎𝑎𝑎𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝐶𝐶𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡𝑎𝑎𝑎𝑎 𝑐𝑐𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑡𝑡𝑦𝑦 𝑐𝑐𝑜𝑜 𝑎𝑎𝑚𝑚𝑚𝑚 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑏𝑏𝑎𝑎𝑐𝑐𝑐𝑐𝐶𝐶 − 𝐵𝐵𝑎𝑎𝑏𝑏𝑘𝑘𝑎𝑎𝑎𝑎𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
 
 
On both gels (soluble and insoluble protein) the Oleosin concentration was calculated 
using the protein concentration measured via Nanodrop as shown in the following equations: 
1       2      3        4       5       6       7      8         9     10     11     12    13 
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𝐶𝐶𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑚𝑚𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐 𝑏𝑏𝑐𝑐 𝑎𝑎𝑎𝑎𝑚𝑚 = (𝐶𝐶𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝑐𝑐𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐)⋅(𝑎𝑎𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑚𝑚𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐 𝑏𝑏𝑐𝑐 𝑎𝑎𝑎𝑎𝑚𝑚) 
 
𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 𝑚𝑚𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐 𝑐𝑐𝑐𝑐 𝑎𝑎𝑎𝑎𝑚𝑚 = (% 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑡𝑡ℎ𝑎𝑎𝑡𝑡 𝑏𝑏𝐶𝐶 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐)⋅(𝐶𝐶𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑚𝑚𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐) 
 
𝑇𝑇𝑐𝑐𝑡𝑡𝑎𝑎𝑚𝑚 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑏𝑏𝑚𝑚𝑎𝑎 𝑐𝑐𝑎𝑎 𝑏𝑏𝑐𝑐𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑏𝑏𝑚𝑚𝑎𝑎 𝑜𝑜𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐
=
(𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑚𝑚𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐 𝑐𝑐𝑐𝑐 𝑎𝑎𝑎𝑎𝑚𝑚)⋅(𝑎𝑎𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝐶𝐶𝑎𝑎𝑚𝑚𝑎𝑎𝑚𝑚𝑎𝑎 𝑏𝑏𝑐𝑐 𝐶𝐶𝑐𝑐𝑚𝑚𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡 𝑏𝑏𝑐𝑐𝑜𝑜𝑜𝑜𝑎𝑎𝑎𝑎)
(𝑎𝑎𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑚𝑚𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐 𝑐𝑐𝑐𝑐 𝑎𝑎𝑎𝑎𝑚𝑚)
 
 
𝐶𝐶𝑐𝑐𝑐𝑐𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎
=
(𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑏𝑏𝑚𝑚𝑎𝑎 𝑜𝑜𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 + 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑏𝑏𝑚𝑚𝑎𝑎 𝑜𝑜𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐)
𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑡𝑡𝑎𝑎𝑘𝑘𝑎𝑎𝑐𝑐 𝑜𝑜𝑎𝑎𝑐𝑐𝑚𝑚 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎
 
 
The last data point from bioreactor run #4 is shown below as a sample calculation: 
 
𝐶𝐶𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑚𝑚𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐 𝑏𝑏𝑐𝑐 𝑎𝑎𝑎𝑎𝑚𝑚 = �10.31
𝑚𝑚𝑎𝑎
𝑚𝑚𝑚𝑚
� ⋅(2 µ𝑚𝑚)⋅ �
1 µ𝑎𝑎⋅𝑚𝑚𝑚𝑚
𝑚𝑚𝑎𝑎⋅µ𝑚𝑚
� =  20.62𝜇𝜇𝑎𝑎 
  
𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 𝑚𝑚𝑐𝑐𝑎𝑎𝑐𝑐𝑎𝑎𝑐𝑐 𝑐𝑐𝑐𝑐 𝑎𝑎𝑎𝑎𝑚𝑚 = (. 0333)⋅(20.62 𝑐𝑐𝑎𝑎) =  0.687 𝜇𝜇𝑎𝑎 
 
𝑇𝑇𝑐𝑐𝑡𝑡𝑎𝑎𝑚𝑚 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑏𝑏𝑚𝑚𝑎𝑎 𝑜𝑜𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 =
(0.687 𝜇𝜇𝑎𝑎)⋅(6.785 𝑚𝑚𝑚𝑚)
(1 𝜇𝜇𝑚𝑚)
= 4.66 𝑚𝑚𝑎𝑎 
 
𝐶𝐶𝑐𝑐𝑐𝑐𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 = (4.66+5.66 𝑚𝑚𝑔𝑔)
34.14 𝑚𝑚𝑐𝑐
= 0.302 𝑚𝑚g/mL 
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Figure A11.3. Bioreactor Run #4 [Oleosin] over Time. Since Oleosin is present in both 
soluble and insoluble fractions, demonstrate the need to extract it from both in the process 
design. IPTG was added at 3.0 hours. Thus, with these operating conditions 0.3 g/L Oleosin were 
produced 3 hours after protein induction. 
 
The results from all calculations are shown in Figure A11.3. Oleosin production 
increased over time as expected. Oleosin was found in both soluble and insoluble fractions 
agreeing with results from Dr. Hammer’s laboratory. Furthermore, the amount of insoluble 
oleosin appeared to increase over time relative to the soluble amount. This provided compelling 
evidence to design our process to collect the Oleosin in both fractions. The cells had already 
produced Oleosin before IPTG addition, an important detail for forthcoming calculations. 
Summing the Oleosin found in the insoluble and soluble fractions and comparing them 
between the two bioreactors runs gives Figure A11.2. It is clear that the described optimized 
conditions for bioreactor run #4 improved the production of Oleosin, both increasing the amount 
of Oleosin prior to IPTG addition and increasing the rate at which the Oleosin was produced (the 
linear correlation slope was 0.0161 relative to 0.0138 g/L/hour previously). 
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Figure A11.2. Comparison between Total [Oleosin] in Bioreactor Runs #3 and #4. The 
optimized conditions from bioreactor run #4 greatly improve Oleosin production. The optimized 
Oleosin production is found to be 0.0161 g/L/hour. The line indicates the point in which IPTG 
was added. 
Similarly, total protein concentration in bioreactor and percent protein was found for all 
samples by: 
 
𝑇𝑇𝑐𝑐𝑡𝑡𝑎𝑎𝑚𝑚 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑏𝑏𝑚𝑚𝑎𝑎 𝑐𝑐𝑎𝑎 𝑏𝑏𝑐𝑐𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑏𝑏𝑚𝑚𝑎𝑎 𝑜𝑜𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐
= (𝐶𝐶𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝑐𝑐𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑏𝑏𝑐𝑐 𝑜𝑜𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐) ∗ (𝑎𝑎𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑐𝑐𝑜𝑜 𝐶𝐶𝑎𝑎𝑚𝑚𝑎𝑎𝑚𝑚𝑎𝑎) 
 
𝐶𝐶𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝑐𝑐𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎
=
(𝐶𝐶𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑏𝑏𝑚𝑚𝑎𝑎 𝑜𝑜𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 + 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑏𝑏𝑚𝑚𝑎𝑎 𝑜𝑜𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐)
𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑡𝑡𝑎𝑎𝑘𝑘𝑎𝑎𝑐𝑐 𝑜𝑜𝑎𝑎𝑐𝑐𝑚𝑚 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎
 
 
% 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 𝑎𝑎𝐶𝐶 𝑎𝑎 𝑜𝑜𝑐𝑐𝑐𝑐𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑐𝑐𝑜𝑜 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐
=
𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝑐𝑐𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎
𝐶𝐶𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝑐𝑐𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎
∗ 100% 
 
The Oleosin production model consists of two phases – cell growth and protein 
production. Before any IPTG or other plasmid-inducing parameter is applied to the bioreactor, 
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the cells produce some Oleosin, the concentration of which then increases during the protein 
production phase after IPTG addition.  
 
Total amount of protein was calculated at 4.75 g/L in the reactor. Considering that the 
total cell dry mass was about 9.48 g/L: 
 
% 𝑐𝑐𝑜𝑜 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚 𝑐𝑐𝑎𝑎𝑦𝑦 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 𝑡𝑡ℎ𝑎𝑎𝑡𝑡 𝑏𝑏𝐶𝐶 𝑎𝑎𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑏𝑏𝑐𝑐 =
(4.75 𝑎𝑎/𝑚𝑚)
(9.48 𝑎𝑎/𝑚𝑚)
= 0.501 𝑐𝑐𝑎𝑎 50.1% 
 
% 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝐵𝐵𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎 𝑐𝑐𝑐𝑐𝑏𝑏𝑡𝑡 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚 𝑐𝑐𝑎𝑎𝑦𝑦 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶
=
𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐𝑐𝑐𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡𝑎𝑎𝑎𝑎𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 (𝑎𝑎/𝑚𝑚)
𝑂𝑂𝑎𝑎𝑦𝑦 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 (𝑎𝑎/𝑚𝑚)
∗ 100% 
 
Plugging in values prior to IPTG addition (during growth phase) gives: 
𝐶𝐶𝑎𝑎𝑎𝑎𝑏𝑏𝑎𝑎𝑐𝑐𝑡𝑡 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎 𝑐𝑐𝑐𝑐𝑏𝑏𝑡𝑡 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚 𝑐𝑐𝑎𝑎𝑦𝑦 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 =
0.162 𝑎𝑎/𝑚𝑚
 6.75 𝑎𝑎/𝑚𝑚
∗ 100% = 2.4% 
 
Plugging in values from three hours after IPTG addition (during production phase) gives:  
% 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑏𝑏𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎 𝑐𝑐𝑐𝑐𝑏𝑏𝑡𝑡 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚 𝑐𝑐𝑎𝑎𝑦𝑦 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 =
0.302 𝑎𝑎
9.48 𝑎𝑎
⋅100% = 3.19% 
 
About 2.4% of the total cell’s mass is Oleosin before IPTG induction. This means at the 
beginning Oleosin increases exponentially along with the exponential growth of the cells. During 
a production phase after three hours, however, Oleosin increases to 3.19% of the dry cell mass 
achieved. Using the cell growth model from Appendix 13, the expected production of Oleosin 
over time is modeled in Figure A11.3. 
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Figure A11.3. Oleosin Production Model in Production Bioreactor over Time. Cells start 
expressing Oleosin before IPTG is added, reaching around 2.4% of the total cell mass. Later, as 
indicated by the line, Oleosin production is induced via IPTG addition, temperature is lowered to 
25ºC, and [glucose] is increased to 5 g/L. Under these conditions the overall Oleosin mass 
content should reach 3.15% of the total dry mass for the production target of 46.88 g. 
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Appendix 12: Media Compositions 
Four different types of media were used during 96-well plate and bioreactor experiments. 
These include LB Miller, LB Lenox, Superbroth (SB), and Super Optimal Broth (SOB). All 
media were prepared according to the procedures outlined in The Handbook of Microbiological 
Media.31 Tables A12.1, A12.2, A12.3, and A12.4 outline the composition for one liter of each 
media. DI water was added to each mixture to reach the desired volume of media. The media 
were then autoclaved at 121ºC for 2 hours. 
Table A12.1. Composition of LB Miller Media. 
Ingredient 
Grams per 
Liter of 
Media 
NaCl 10.0 
Pancreatic Digest 
of Casein 
10.0 
Yeast Extract 5.0 
 
Table A12.2. Composition of LB Lenox Media 
Ingredient 
Grams per 
Liter of 
Media 
NaCl 5.0 
Pancreatic Digest 
of Casein 
10.0 
Yeast Extract 5.0 
 
Table A12.3. Composition of SB Media 
Ingredient 
Grams per 
Liter of 
Media 
NaCl 5.0 
Pancreatic Digest 
of Casein 
32.0 
Yeast Extract 20.0 
NaOH (1N 
solution) 
5.0 mL 
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Table A12.4. Composition of SOB Miller Media 
Ingredient 
Grams per 
Liter of 
Media 
NaCl 0.5 
Pancreatic Digest 
of Casein 
20.0 
Yeast Extract 5.0 
MgSO4 2.4 
KCl 0.186 
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Appendix 13: Cell Growth Model 
Assumptions/Justifications: 
1. The bioreactor is well-mixed and homogeneous, so each tested sample accurately 
represents the bioreactor contents. Given the small (2-3 L) working volume and 
mechanical stirring, this is a valid assumption. 
2. There is no cell growth or loss between the time one collects the sample and the time the 
sample is measured. This interval was minimized by testing most samples within 5 
minutes from their initial collection. 
3. Cell growth over time remains constant throughout the log phase when conditions are 
kept steady. Glucose concentration, dissolved oxygen and pH remain at optimized 
steady-state values to ensure this.  
4. Oxygen remains adequate and evenly distributed even at target higher cell densities. 
 
The estimated time for the lag phase and the cell growth rate were calculated from experimental 
data. The highest growth rate was found to be 0.781 hours-1. Using this growth rate leads to the 
following model for the log phase: 
 
𝑀𝑀𝑓𝑓 =  𝑀𝑀𝑝𝑝𝑎𝑎𝑟𝑟∗𝑡𝑡 =  𝑀𝑀𝑝𝑝𝑎𝑎0.781⋅𝑡𝑡  
Where:  
Mf = final cell mass (g) 
Mi = Initial cell mass (g) 
r = Cell growth rate (hours-1) 
 t = time since bioreactor inoculation (hours)  
 
Rearranging: 
 
𝑡𝑡 =
1
0.781 1/ℎ𝑐𝑐𝑐𝑐𝑎𝑎
ln (
𝑀𝑀𝑓𝑓
𝑀𝑀𝑝𝑝
) 
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Figure A13.1. Sample Growth Curve. If an initial dry cell mass of 1 g inoculates the 
bioreactor, after 10 hours the dry mass will increase to 1200 g or 1.2 kg according to the 
experimental growth rate. 
 
While cells cannot grow exponentially at the same growth rate indefinitely, the literature 
indicates even at glucose-limiting conditions the exponential growth can be sustained over 25 
hours – longer than our process design. Pending experimental confirmation, we conclude the 
growth rate will remain relatively constant throughout production. 
Using this model, required log phase growth times to reach the final cell mass of 1.10g of 
cells in the bag bioreactor and 1.49 kg in the production bioreactor were 4.04 and 9.27 hours, 
respectively. 
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Appendix 14: Glucose Consumption Model 
Assumptions/Justifications: 
1. The bioreactor is well-mixed and homogeneous, so each tested sample accurately 
represents the bioreactor contents. Given the small  (2-3 L) working volume and 
mechanical stirring, this is a valid assumption. 
2. There is no glucose consumption between the time one collects the sample and the time 
the sample is measured. This interval was minimized by testing most samples within 5 
minutes from their initial collection. 
3. When the production phase begins, all media’s initial energetic nutrients are depleted and 
glucose consumption accounts for 100% of energy needs.  
4. Glucose consumption per cell over time remains constant throughout both log and 
stationary phases. Glucose concentrations are kept constant through each phase. 
 
The literature has reported that while glucose addition to E. coli cultures leads to higher cell 
densities, it may also have an inhibitory effect on growth. This was supported by our 96-well 
experiments, which show that glucose addition at the beginning of the run slowed cell growth. 
To achieve the high cell densities this process requires, however, glucose is critical. This is 
because – as discussed in the introduction – glucose requirements for high cell density culture 
differ from those for small-scale, low density culture.  
Experimentally, the best cell growth results were achieved during bioreactor run #4. The 
glucose consumption was then extrapolated for the highest cell densities obtained from a 
production bioreactor at high cell density. Given the dynamic volume of the bioreactor as 
glucose solution was added, cell densities were converted to total cell mass.  
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Figure A14.1. [Glucose] Added vs [Glucose] Measured over Time. Note the difference is the 
glucose that the cells consume. 
 
The glucose consumption rate (RG) on the bioreactor was found as a function of cell 
mass. It is defined as: 
𝐺𝐺𝐶𝐶 = 𝑅𝑅𝐺𝐺 · 𝑀𝑀 
Where: 
GC = Glucose consumption over time (g/minute) 
RG = Rate of glucose consumption (g /(minute·g cell)) 
  M = Total cell mass (g cell) 
 
Where RG is experimentally calculated as: 
𝑅𝑅𝐺𝐺 =
𝛥𝛥 𝐺𝐺
(𝛥𝛥𝑡𝑡)
 
 
RG = Rate of glucose consumption (g /minute) 
ΔG = Cumulative glucose added to bioreactor – Glucose measured in bioreactor (g) 
Δt = Change in time (minute) 
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Figure A14.2. Last Four Calculated Glucose Consumption Rates from Bioreactor Run #4. 
The plot shows the glucose consumption is relatively constant. 
 
Thus, from Figure A14.2 the following glucose rate consumption as a function of total cell mass 
is obtained: 
 
𝑅𝑅𝐺𝐺 =  0.00118 �
𝑎𝑎 𝐺𝐺𝑚𝑚𝑐𝑐𝑏𝑏
min∗ (𝑎𝑎 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶)
� 
Then, 
𝐺𝐺𝐶𝐶 = 0.00118 · 𝑀𝑀 
 
This model accounts for the increase in glucose demand as cells grow. Importantly, it 
assumes that this is the glucose consumption rate trend over the whole bioreactor run. If the 
glucose consumption rate were to change later in the cell growth phase, it would slow down and 
lead to slightly lower consumption rates than those estimated by this model. Nonetheless, the 
model allows am estimation of how the bioreactor’s controller needs to add glucose over time 
and how much total glucose is required per batch. See Appendix 15 for detailed calculations. 
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Appendix 15: Glucose Consumption Calculations 
Using the Glucose consumption rate model in Section 14 (Eq. 14.#), we can calculate the 
total amount of glucose we need to continuously add to sustain the exponential cell growth. 
 
𝑇𝑇 (
𝑎𝑎 𝑎𝑎𝑚𝑚𝑐𝑐𝑏𝑏𝑐𝑐𝐶𝐶𝑎𝑎
min
) =  0.0255⋅𝐺𝐺 
 
Thus, the total glucose consumption (T) is given by: 
 
𝐺𝐺 = 𝑜𝑜(𝑡𝑡) = (1.07)𝑎𝑎0.781∗𝑡𝑡 
 
𝑇𝑇𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑔𝑔𝑟𝑟𝑔𝑔𝑔𝑔𝑡𝑡ℎ = ∫ 0.0255 ∙ 𝐺𝐺 𝑐𝑐𝑡𝑡 
𝑡𝑡𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓
𝑡𝑡𝑓𝑓𝑓𝑓𝑓𝑓𝑖𝑖𝑓𝑓𝑓𝑓𝑓𝑓
  During cell growth phase 
 
After this phase, IPTG will be added and cell growth will plateau as cell focus in 
producing Oleosin. As our experiments demonstrated, after this point cell mass will remain 
approximately constant. Thus, their glucose consumption will be: 
 
𝑇𝑇𝑝𝑝𝑟𝑟𝑔𝑔𝑡𝑡𝑐𝑐𝑝𝑝𝑝𝑝 𝑝𝑝𝑟𝑟𝑔𝑔𝑝𝑝𝑝𝑝𝑐𝑐𝑡𝑡𝑝𝑝𝑔𝑔𝑝𝑝 = 0.0255 ∙ 𝐺𝐺𝑓𝑓𝑝𝑝𝑝𝑝𝑓𝑓𝑐𝑐  During Production phase 
 
Thus, running the bioreactor for 15.36 hours (1 hour of lag phase where we don’t add 
glucose + 11.36 calculated growth time + 3.16 hours of production phase) 
𝑇𝑇 = � 0.0255 ∙ (1.07)𝑎𝑎0.781∗𝑡𝑡𝑐𝑐𝑡𝑡 
9.27
0
+ 0.0255(1488𝑎𝑎 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶)(
60 𝑚𝑚𝑏𝑏𝑐𝑐𝑐𝑐𝑡𝑡𝑎𝑎𝐶𝐶
1 ℎ𝑐𝑐𝑐𝑐𝑎𝑎
)(3 ℎ𝑐𝑐𝑐𝑐𝑎𝑎𝐶𝐶) 
    
𝑇𝑇 = 2.90 + 6.83 Kg 
T = 9.73 Kg 
 
Total glucose consumption for each bioreactor per batch is calculated to be a little more 
than 9.73 Kg which will be slowly added as to maintain a constant 1g/L glucose concentration 
during cell growth, and of 5 g/L during protein production. This glucose will be slowly added by 
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a controller as it is consumed. The highest sterile commercially available solution, sterilized 70% 
glucose solution will be purchased from Teknova for this purpose. 
To calculate the accurate amount of glucose required per batch, it is important to consider 
not only the glucose that is consumed, but how much extra glucose is required to keep the 
concentration at the said levels, as well as consider how the progressive addition of concentrated 
glucose solution progressively increases the volume on the reactor, further diluting the added 
glucose. 
To account for this, first the density of the 70% glucose solution (1.257 Kg/L) is used to 
calculate the volume of glucose added per glucose gram. 
 
𝑊𝑊𝑎𝑎𝑏𝑏𝑎𝑎ℎ𝑡𝑡 𝑐𝑐𝑜𝑜 1𝑚𝑚 𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 = (1𝑚𝑚)⋅(1.257 𝐾𝐾𝑎𝑎/𝑚𝑚) =  1.257 𝐾𝐾𝑎𝑎 
 
𝐺𝐺𝑚𝑚𝑐𝑐𝑏𝑏𝑐𝑐𝐶𝐶𝑎𝑎 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 𝑏𝑏𝑐𝑐 1𝑚𝑚 𝐶𝐶𝑐𝑐𝑚𝑚𝑐𝑐𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 = (0.70)⋅(1.257𝐾𝐾𝑎𝑎) = 0.88 𝐾𝐾𝑎𝑎 
 
𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 𝑎𝑎𝑐𝑐𝑐𝑐𝑎𝑎𝑐𝑐 𝑡𝑡𝑐𝑐 𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 𝑜𝑜𝑐𝑐𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑦𝑦 1𝑎𝑎 𝐺𝐺𝑚𝑚𝑐𝑐𝑏𝑏𝑐𝑐𝐶𝐶𝑎𝑎 =
(1 𝑎𝑎 𝐺𝐺𝑚𝑚𝑐𝑐𝑏𝑏𝑐𝑐𝐶𝐶𝑎𝑎)
�0.88𝑎𝑎 𝐺𝐺𝑚𝑚𝑐𝑐𝑏𝑏𝑐𝑐𝐶𝐶𝑎𝑎𝑚𝑚𝑚𝑚 �
= 1.136𝑚𝑚𝑚𝑚 
 
This discreet bioreactor dilution was modeled to add more glucose than that consumed to 
make up for the dilution. 
 
Glucose Added =  Glucose Consumed +  Dilution Make up 
 
Given the increasing amounts of glucose consumption and accelerating volume increase, 
this amounts to: 
 
Glucose Added =  Glucose Consumed +  0.88⋅(Δ volume)⋅e^(Δ volume) 
 
Where Δ Volume (ml) = 1.136⋅(𝐺𝐺𝑚𝑚𝑐𝑐𝑏𝑏𝑐𝑐𝐶𝐶𝑎𝑎 𝐶𝐶𝑐𝑐𝑐𝑐𝐶𝐶𝑐𝑐𝑚𝑚𝑎𝑎𝑐𝑐) 
 
Thus, the final glucose addition model for growth phase as a function of time is 
determined as: 
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𝑇𝑇 (𝑡𝑡) = 0.0255 ∙ (1.07)𝑎𝑎0.781∗𝑡𝑡 + (1.136)(0.0255 ∙ (1.07)𝑎𝑎0.781∗𝑡𝑡)𝑎𝑎(1.136)⋅0.0255∙(1.07)𝑐𝑐0.781∗𝑖𝑖 
 
𝑇𝑇 (𝑡𝑡) = �1 + 𝑎𝑎(1.136)⋅0.0255∙(1.07)𝑐𝑐0.781∗𝑖𝑖�[0.0255 ∙ (1.07)𝑎𝑎0.781∗𝑡𝑡] 
 
𝑇𝑇𝑔𝑔𝑟𝑟𝑔𝑔𝑔𝑔𝑡𝑡ℎ 𝑝𝑝ℎ𝑓𝑓𝑐𝑐𝑐𝑐 (𝑡𝑡) = �1 + 𝑎𝑎0.031𝑐𝑐
0.781∗𝑖𝑖�[0.0053𝑎𝑎0.781∗𝑡𝑡] 
 
Whereas for the production phase, it was experimentally modeled as: 
 
Glucose Added =  Glucose Consumed + 1.34 g 
 
𝑇𝑇𝑝𝑝𝑟𝑟𝑔𝑔𝑡𝑡𝑐𝑐𝑝𝑝𝑝𝑝 𝑝𝑝𝑟𝑟𝑔𝑔𝑝𝑝𝑝𝑝𝑐𝑐𝑡𝑡𝑝𝑝𝑔𝑔𝑝𝑝(𝑡𝑡) = 0.0255⋅(1488)⋅(𝑡𝑡) + 1.34 
 
𝑇𝑇𝑝𝑝𝑟𝑟𝑔𝑔𝑡𝑡𝑐𝑐𝑝𝑝𝑝𝑝 𝑝𝑝𝑟𝑟𝑔𝑔𝑝𝑝𝑝𝑝𝑐𝑐𝑡𝑡𝑝𝑝𝑔𝑔𝑝𝑝(𝑡𝑡) = 37.97⋅(𝑡𝑡) + 1.34 
 
In this way, the exact behavior on the bioreactor in terms of dynamic volume and glucose 
consumption was modeled as a function of time, and the exact total amount of glucose, and thus, 
70% Glucose solution was calculated by just integrating both models over their duration times. 
The growth phase lasting 9.27 hours, and production lasting another 3 hours. The model’s results 
are shown in Figures A15.1, A15.2, and A15.3 and demonstrate how glucose levels are 
maintained at specified levels.  
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Figure A15.1. Model of Glucose Consumption and Glucose Added by Controller. Glucose is 
added every 6 minutes (unit time) over the whole run of the bioreactor. No glucose is added 
during the cells’ lag phase. Then, at t = 1 hour, an initial 14.9g of Glucose would be added to 
bring the concentration up to 1g/L. As the cells consume the glucose, more glucose would be 
added as scheduled by the orange points. The line indicates the beginning of the production 
phase at time 10.27 hours, where cells would be induced by the addition of IPTG to focus on 
Oleosin’s production when glucose concentration will be brought to 5 g/L by the addition of 
71.37g of glucose, and then maintained until the end of the run. 
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Figure A15.2. Glucose Concentration in Bioreactor with a Fitted Model. No glucose is added 
during the lag phase’s first hour, then it is increased to 1 g/L and then, at time 10.27 hours it is 
increased to 5 g/L at the point in which IPTG is added and the production phase starts. The 
developed model is able to maintain the levels well.  
 
 
 
 
 
 
 
 
 
 
Figure A15.3. Model of Production Bioreactor’s Working Volume over Time. It starts at the 
initial volume of 14.88L, and increases as glucose is added to sustain the cell growth. The line 
indicates the start of the production phase where cells are induced to stop growing and focus on 
Oleosin’s production. Final bioreactor volume is calculated to be 15.63 L; well below the 
maximum working volume of the selected 25L bioreactor.  
  
0
1
2
3
4
5
6
0 2 4 6 8 10 12 14
Gl
uc
os
e 
Co
nc
en
tr
at
io
n 
(g
/L
)
TIme since inoculation (hours)
14.8
14.9
15
15.1
15.2
15.3
15.4
15.5
15.6
15.7
0 2 4 6 8 10 12 14
Vo
lu
m
e 
Bi
or
ea
ct
or
 (L
)
Time since inoculation (hours)
156 
 
Appendix 16: Calculation of Bioreactor Times 
Total bioreactor time consists of three distinct phases: the lag phase, log phase, and 
production phase (alternatively, the stationary phase). Experimental data from both Tecan 
microplate readers and all bioreactor runs suggests a consistent lag phase of one hour, 
independent of initial cell concentration. This phase is assumed to take the same time in both 
bioreactors (seed and production). 
The seed bag bioreactor only spans the lag and log phases as its contents are transferred 
to the production bioreactor before it reaches a stationary phase. Time is calculated with the 
following equation: 
 
𝑡𝑡 =
1
𝑎𝑎
ln (
𝑀𝑀𝑓𝑓
𝑀𝑀𝑝𝑝
) 
Where: 
Mf = final cell mass (g) = 1.10 g cells 
Mi = Initial cell mass (g) = 4.71 mg cells or 0.00471 g cells 
r = Calculated cell growth rate (hours-1) = 0.781 hours-1 
 t = Time since bioreactor inoculation (hours) 
 
𝑡𝑡 =
1
0.781 1ℎ𝑎𝑎
ln �
1.10 𝑎𝑎 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶
0.00471 𝑎𝑎 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶
� =  4.04 ℎ𝑐𝑐𝑐𝑐𝑎𝑎𝐶𝐶 
 
The time for content transfer to the production bioreactor and cleaning was estimated to 
be 20 minutes or 0.33 hours. Thus, total time for the seed bag bioreactor = 1 + 4.04 + 0.33 hours 
= 5.37 hours. For the production bioreactor, the time consists of two parts; time to reach the 
target 100 g/L cell density during the growth log phase, and production time to reach the target 
minimum Oleosin mass yield of 46.9 g/batch. 
 
For the cell growth phase: 
𝑇𝑇𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡 𝐶𝐶𝑏𝑏𝑐𝑐𝑎𝑎𝑚𝑚 𝐶𝐶𝑎𝑎𝑚𝑚𝑚𝑚 𝑀𝑀𝑎𝑎𝐶𝐶𝐶𝐶 = (100 𝑎𝑎/𝑚𝑚)⋅(14.89𝑚𝑚) =   1489 𝑎𝑎 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶 
 
Including a conservative 3% cell mass loss in the transfer and pumping between bioreactors: 
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𝑡𝑡 =
1
0.781 1ℎ𝑎𝑎
ln �
1489 𝑎𝑎 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶
(1.10 𝑎𝑎 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚𝐶𝐶)(1 − 0.03)
� =  9.27 ℎ𝑐𝑐𝑐𝑐𝑎𝑎𝐶𝐶 
 
For the production phase, it was experimentally shown that 3 hours after IPTG induction 
3.15% of the overall cell mass is Oleosin. Thus, by this time 46.9 g of Oleosin has been 
produced. Time for transferring cells out of bioreactor (considering the pump’s volumetric flow 
capacity and total working volume) as well as cleaning time is estimated at 1.5 hours maximum. 
This means the production bioreactor’s total time is calculated as: 
 
𝑇𝑇𝑐𝑐𝑡𝑡𝑎𝑎𝑚𝑚 𝑡𝑡𝑏𝑏𝑚𝑚𝑎𝑎 𝑜𝑜𝑐𝑐𝑎𝑎 𝑎𝑎𝑎𝑎𝑐𝑐𝑐𝑐𝑐𝑐𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 =  1 +  9.27 +  3 +  1.5 =  14.77 ℎ𝑐𝑐𝑐𝑐𝑎𝑎𝐶𝐶 
 
Cell growth estimated by the equations above is shown in Figure A16.1: 
 
 
Figure A16.1. Model of Cell Growth over Time in Production Bioreactor. The cells go 
through a 1-hour lag phase, and then begin to exponentially grow at the experimentally-
calculated rate of 0.781 hour-1. Finally, at time 10.27 hours since inoculation the model reaches 
its target cell mass of 1488 g cells (dry mass), at which point IPTG is added, Temperature 
lowered, and glucose concentration increased to trump cell growth and promote the cells 
focusing on Oleosin production. If the stationary phase is reached at this point, cells will indeed 
stabilize around this cell density for the 3 hours of production  
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Appendix 17: Calculation of Number of Batches per Year and Bioreactor Volume 
Six batches per week will be run for 50 weeks to maximize production while maintaining 
a reliable supply throughout the whole year. The annual target is therefore 300 batches per year. 
With a target annual production of 7.39 kg of Oleosin per year and assuming a typical 
90% production capacity due to potential failed batches or unplanned downtime, the amount of 
Oleosin that must be produced by each batch is: 
 
𝑇𝑇𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡 𝑜𝑜𝑏𝑏𝑐𝑐𝑎𝑎𝑚𝑚 𝑎𝑎𝑎𝑎𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑐𝑐 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑎𝑎𝑎𝑎𝑎𝑎 𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ =
7.39 𝐾𝐾𝑎𝑎
300 𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ𝑎𝑎𝐶𝐶
∙ (0.90) = 0.0274 𝑘𝑘𝑎𝑎/𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ 
 
Considering that Oleosin is lost throughout the process (58.4% overall recovery), the 
amount of Oleosin that must be produced in the bioreactor is: 
 
𝑇𝑇𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑡𝑡 𝑏𝑏𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑎𝑎𝑎𝑎𝑐𝑐𝑐𝑐𝑐𝑐𝑏𝑏𝑡𝑡𝑏𝑏𝑐𝑐𝑐𝑐 𝑎𝑎𝑎𝑎𝑎𝑎 𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ =
0.024 𝑘𝑘𝑎𝑎/𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ
0.584
= 0.0469 𝑘𝑘𝑎𝑎/𝑏𝑏𝑎𝑎𝑡𝑡𝑏𝑏ℎ 
 
The goal of the bioreactor is to produce 100 g/L dry cell mass. In addition, experiments 
showed that after a 3 hour production phase 3.15% of the total total cell mass will be Oleosin. 
Thus, the final reactor volume that is necessary is: 
 
𝐶𝐶𝑏𝑏𝑐𝑐𝑎𝑎𝑚𝑚 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑀𝑀𝑎𝑎𝐶𝐶𝐶𝐶 (𝑎𝑎)= 
�𝐶𝐶𝑏𝑏𝑐𝑐𝑎𝑎𝑚𝑚 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 𝑐𝑐𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑡𝑡𝑦𝑦 �
𝑎𝑎
𝑚𝑚
�� ∗ �
𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 (𝑎𝑎)
𝐶𝐶𝑎𝑎𝑚𝑚𝑚𝑚 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 (𝑎𝑎)
� ∗ [𝑅𝑅𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 (𝑚𝑚)] 
Rearranging: 
⎣
⎢
⎢
⎢
⎡
[𝑅𝑅𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 (𝑚𝑚)] =
[𝐶𝐶𝑏𝑏𝑐𝑐𝑎𝑎𝑚𝑚 𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 (𝑎𝑎)]
[(𝐶𝐶𝑏𝑏𝑐𝑐𝑎𝑎𝑚𝑚 𝑏𝑏𝑎𝑎𝑚𝑚𝑚𝑚 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 𝑐𝑐𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑡𝑡𝑦𝑦 �𝑎𝑎𝑚𝑚�]⋅ �
𝑂𝑂𝑚𝑚𝑎𝑎𝑐𝑐𝐶𝐶𝑏𝑏𝑐𝑐 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 (𝑎𝑎)
𝐶𝐶𝑎𝑎𝑚𝑚𝑚𝑚 𝑚𝑚𝑎𝑎𝐶𝐶𝐶𝐶 (𝑎𝑎) �⎦
⎥
⎥
⎥
⎤
 
 
Plugging in the appropriate values gives: 
𝑅𝑅𝑎𝑎𝑟𝑟𝑐𝑐𝑏𝑏𝑎𝑎𝑎𝑎𝑐𝑐 𝐵𝐵𝑏𝑏𝑐𝑐𝑎𝑎𝑎𝑎𝑎𝑎𝑏𝑏𝑡𝑡𝑐𝑐𝑎𝑎 𝑊𝑊𝑐𝑐𝑎𝑎𝑘𝑘𝑏𝑏𝑐𝑐𝑎𝑎 𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑎𝑎 = 46.9 𝑔𝑔 𝑂𝑂𝑐𝑐𝑐𝑐𝑔𝑔𝑐𝑐𝑝𝑝𝑝𝑝
(100𝑔𝑔 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐/𝐿𝐿)⋅(0.0315 𝑔𝑔 𝑂𝑂𝑐𝑐𝑐𝑐𝑔𝑔𝑐𝑐𝑝𝑝𝑝𝑝/𝑔𝑔 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐)
= 14.88   
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Appendix 18: Maximum Capacity of Bioreactor 
The 25L Bioreactor model was used to calculate the maximum amount of Oleosin it 
could produce given the maximum cell dry mass of 100 g/L and 20L maximum working volume 
constraint. This model assumed that the E. coli growth rate would not change and that the 
bioreactor would be able to keep its parameters constant as it was originally designed, with this 
larger working volume. 
The bioreactor would still be inoculated with the same number of cells from the 
inoculator bioreactor, which would be diluted in a total starting volume of 18.73 L of SB media. 
The bioreactor would run for 11.58 hours, point at which it would reach 100 g of dry cell mass 
and enter the stationary phase, when the temperature would be reduced, IPTG would be added, 
and glucose concentration increased to enter the production phase for 3 hours. At the end of the 
run, the bioreactor will contain about 19.54 L of solution (due to the added glucose solution), and 
a total of 60.5 g of Oleosin, representing an increase of 29% Oleosin production up from the 46.9 
g of the base design process. Figures A18.1 through A18.2 show the results of such analysis. 
However, currently, the market has no demand for a higher productivity, and reducing the 
number of batches per year jeopardizes the high flexibility, quality control, and freshness of the 
product. For these reasons, it is suggested to only increase the productivity as the demand for 
Oleosin increases above the current 100% saturated market. 
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Figure A18.1. Working Volume over Time. The production bioreactor working volume starts 
at the initial volume of 18.7L, and increases as glucose is added to sustain the cell growth. The 
line indicates the start of the production phase where cells are induced to stop growing and focus 
on Oleosin’s production. Final bioreactor volume is calculated to be 19.7 L; well below the 
maximum working volume of the selected 200L bioreactor. 
 
 
Figure A18.2. [Cells] over Time. Cells go through a 1-hour lag phase, and then begin to 
exponentially grow at the experimentally-calculated rate of 0.781 hour-1. At time 10.27 hours 
the model reaches its target cell mass of 1488 g cells (dry mass), at which point IPTG is added, 
temperature is lowered, and glucose concentration to promote protein. 
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Figure A18.3. Cell Mass Over Time. Mass trends mirror concentration trends from Figure 
A19.2. Maximum cell mass reached is 1900 g. 
 
 
Figure A18.4. Model of Glucose Consumption and Glucose Added by a Controller. Glucose 
is added every 6 minutes (unit time) over the whole run of the bioreactor. No glucose is added 
during the lag phase. Then, at t = 1 hour, an initial 14.9g of Glucose would be added to bring the 
concentration up to 1g/L. As the cells consume the glucose, more glucose would be added as 
scheduled by the orange points. The line indicates the beginning of the production phase at time 
10.27 hours, where cells would be induced by the addition of IPTG to focus on Oleosin’s 
production when [glucose] will be brought to 5 g/L by the addition of 71.37g of glucose, and 
then maintained until the end of the run. 
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Figure A18.5. Oleosin Production in Bioreactor over Time. As it was experimentally 
demonstrated, cells start expressing Oleosin before IPTG is added, reaching around 2.4% of the 
total cell mass. Thus, as the cells grow, so does their content of Oleosin during the cell growth 
phase. Then, at the point indicated by the line Oleosin production is induced via IPTG, addition, 
lowered temperature, and increased glucose concentration. Based on the experiments, under 
these conditions the overall Oleosin mass content should reach 3.15% of the cell dry mass, the 
Oleosin production target of 46.88 g. 
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Appendix 19: Worst-Case Scenario 
All prior calculations assume a cell yield of 1,488 g of cell mass; that is, 100 g per initial 
unit volume. This is an assumption based on industry practice and literature that suggests this is 
an attainable target. However, this is an assumption. Therefore, a “worst-case scenario,” defined 
as a case where achieving cell densities higher than those experimentally proven in the 3.9 L 
bioreactor studies is unattainable, is considered as well as its effects on the financial analysis of 
the business model. 
Experimentally, the highest cell density achieved was 9.48 g/L. Based on this target and 
the methods previously explained, a new Oleosin production bioreactor was designed. For the 
purposes of this scenario, given the wide implications of such a large change in cell yield on the 
overall process design,  a key compromise was necessary: to compensate for the lower yield, the 
volume of the bioreactor was increased so that the same target amount of Oleosin is produced at 
a lower cell concentration. This, however, increases the volumetric flow of the production 
bioreactor’s products. It is assumed the pumps can be adjusted to handle this increased 
volumetric flow in the same time until the media is removed at the centrifuge stage. 
First, the initial volume on the bioreactor was increased to allow for more cells to be 
grown per batch at this lower cell concentration while keeping in mind the higher limit of the 
bioreactor’s working volume. 
Without changing the inoculation reactor feeding into the production bioreactor, a total of 
1.07 g of cells inoculate the vessel with the new optimized volume of 153.5L. Similarly to the 
previous bioreactor design, a controller will progressively add glucose to the bioreactor and 
increase its volume over time. 
As previously discussed, literature studies show that the cell growth rate can be sustained 
past 20 hours, independent of volume. Given the final cell mass yield will remain the same, the 
production bioreactor running time will be the same, including its 1-hour lag time. After 10.27 
hours, 9.45 g/L dry cell mass is attained in the bioreactor at the growth rate measured in the lab. 
At this point IPTG would be added, and conditions changed to enter the production phase. 
Production time would remain at 3 hours. At the end of the run, the bioreactor would have 
produced about 46.9 g of Oleosin, which is the same quantity that has been calculated to be the 
necessary at this stage. Figures A19.1 through A19.4 show the results from this new bioreactor 
model, optimized for this lower cell concentration yield. 
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Figure A19.1. Model of Cell Growth over Time in Production Bioreactor. The net cell mass 
expansion essentially does not change in comparison to the original process. The cells go 
through a 1-hour lag phase, and then begin to exponentially grow at the experimentally-
calculated rate of 0.781 hour-1. Finally, at time 10.27 hours since inoculation the model reaches 
its target cell mass of 1488 g cells (dry mass), at which point IPTG is added, Temperature 
lowered, and glucose concentration increased to trump cell growth and promote the cells 
focusing on Oleosin production. If the stationary phase is reached at this point, cells will indeed 
stabilize around this cell density for the 3 hours of production time as it was experimentally 
demonstrated. The cell concentration reaches at most the proven cell mass yield of 9.45 g/L. 
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Figure A19.2. [Glucose] and Working Volume over Time. No glucose is added during the lag 
phase’s first hour, then it is increased to 1 g/L and then, at time 10.27 hours it is increased to 5 
g/L at the point in which IPTG is added and the production phase starts. The developed model 
does well maintaining the glucose levels. The production bioreactor’s starts at the initial volume 
of 153.5L, and increases as glucose is added to sustain the cell growth. The line indicates the 
start of the production phase where cells are induced to stop growing and focus on Oleosin’s 
production. Final bioreactor volume is calculated to be 155.01 L; well below the maximum 
working volume of the selected 200L bioreactor. 
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Figure A19.3. Model of Glucose Consumption and Glucose Added by a Controller. every 6 
minutes (unit time) over the whole run of the bioreactor. No glucose is added during the cells’ 
lag phase. Then, at t = 1 hour, an initial 14.9g of Glucose would be added to bring the 
concentration up to 1g/L. As the cells consume the glucose, more glucose would be added as 
scheduled by the orange points. The line indicates the beginning of the production phase at time 
10.27 hours, where cells would be induced by the addition of IPTG to focus on Oleosin’s 
production when glucose concentration will be brought to 5 g/L by the addition of 71.37g of 
glucose, and then maintained until the end of the run. 
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Figure A19.4. Oleosin Production Model in Production Bioreactor over Time. As it was 
experimentally demonstrated, cells start expressing oleosin before IPTG is added, reaching 
around 2.4% of the total cell mass. Thus, as the cells grow, so does their content of Oleosin 
during the cell growth phase. Then, at the point indicated by the line Oleosin production is 
induced via IPTG, addition, lowered temperature, and increased glucose concentration. Based on 
the experiments, under these conditions the overall Oleosin mass content should reach 3.15% of 
the cells’ dry mass, the Oleosin production target of 46.88 g. 
 
Results indicate the required Oleosin yields are still met at the experimentally-backed cell 
dry mass of 9.45 g/L at the cost of a larger bioreactor and larger operational costs in terms of 
media, and glucose. A preliminary financial analysis was performed to estimate the profitability 
of a process with this yield. Although it is evidently lower, it is important to stress that this dry 
cell mass yield could still be improved with further research and thus, provides the worst case 
scenario for the bioreactor’s Oleosin production. 
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Appendix 20: 96-well plate #1 Raw Data 
 
Figure A20.1. 96-well Plate Run 1 with LB Lennox. Plots A through F contain triplicates with LB 
Lennox media and increasing glucose concentrations. Plots A, B, C, D, E, and F contain 0, 1, 2, 3, 4, 6 
g/L of glucose respectively. The pH of each media was naturally around 7 and was not adjusted. OD was 
adjusted for blanks. 
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Figure A20.2. 96-well Plate Run 1 with LB Miller. Plots A through F contain triplicates with LB 
Miller media and increasing glucose concentrations. Plots A, B, C, D, E, and F contain 0, 1, 2, 3, 4, 6 
g/L of glucose respectively. The pH of each media was naturally around 7 and was not adjusted. OD was 
adjusted for blanks. 
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Figure A20.3. 96-well Plate Run 1 with SOB. Plots A through F contain triplicates with SOB media 
and increasing glucose concentrations. Plots A, B, C, D, E, and F contain 0, 1, 2, 3, 4, 6 g/L of glucose 
respectively. The pH of each media was naturally around 7 and was not adjusted. OD was adjusted for 
blanks. 
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Figure A20.4. 96-well Plate Run 1 with SB. Plots A through F contain triplicates with SB media and 
increasing glucose concentrations. Plots A, B, C, D, E, and F contain 0, 1, 2, 3, 4, 6 g/L of glucose 
respectively. The pH of each media was naturally around 7 and was not adjusted. OD was adjusted for 
blanks. 
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Appendix 21: 96-well Plate #2 Raw Data 
 
Figure A21.1. 96-well Plate Run 2 with LB Miller and Changing pH. Plots A through C contain 
septuplicates with LB Miller media and increasing pH. Plots A, B, and C show samples with a pH of 6, 
7, and 8, respectively. No glucose was added to the wells. OD was adjusted for blanks.  
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Figure A21.2. 96-well Plate Run 2 with SB and Changing pH. Plots A through C contain 
septuplicates with SB media and increasing pH. Plots A, B, and C show samples with a pH of 6, 7, and 
8, respectively. No glucose was added to the wells. OD was adjusted for blanks. 
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Figure A21.3. 96-well Plate Run 2 with LB Miller and Changing Glucose Concentration. Plots A 
through C contain septuplicates with LB Miller media and increasing glucose concentration. Plots A, B, 
and C show samples with 0, 10, and 20 g/L of glucose, respectively. The pH of each media was 
naturally around 7 and was not adjusted. OD was adjusted for blanks. 
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Figure A21.4. 96-well Plate Run 2 with SB and Changing Glucose Concentration. Plots A through 
C contain septuplicates with SB media and increasing glucose concentration. Plots A, B, and C show 
samples with 0, 10, and 20 g/L of glucose, respectively. The pH of each media was naturally around 7 
and was not adjusted. OD was adjusted for blanks. 
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Appendix 22: 96-well Plate #3 Raw Data 
 
Figure A22.1. 96-well Plate Run 3 with SB and ODo of 0.3. Plots A through C contain sextuplicates at 
an initial optical density of 0.3 with SB media and increasing IPTG concentration. Plots A, B, and C 
show samples with 0.1, 0.5, and 1 mM IPTG, respectively. The pH of each media was naturally around 
7 and was not adjusted. No glucose was added. OD was not adjusted for blanks for reasons discussed in 
section 10. 
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Figure A22.2. 96-well Plate Run 3 with SB and ODo of 0.4. Plots A through C contain sextuplicates at 
an initial optical density of 0.4 with SB media and increasing IPTG concentration. Plots A, B, and C 
show samples with 0.1, 0.5, and 1 mM IPTG, respectively. The pH of each media was naturally around 
7 and was not adjusted. No glucose was added. OD was not adjusted for blanks for reasons discussed in 
section 10. 
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Figure A22.3. 96-well Plate Run 3 with SB and ODo of 0.5. Plots A through C contain sextuplicates at 
an initial optical density of 0.5 with SB media and increasing IPTG concentration. Plots A, B, and C 
show samples with 0.1, 0.5, and 1 mM IPTG, respectively. The pH of each media was naturally around 
7 and was not adjusted. No glucose was added. OD was not adjusted for blanks for reasons discussed in 
section 10. 
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Appendix 23: Bioreactor #1 Raw Data 
 
Figure A23.1. Bioreactor Run 1 Percent Oxygen Saturation. The figure shows the measured pO2 for 
bioreactor run 1 in blue. The desired 30% pO2 is shown in orange. The time is in hours since the start of 
the run. Data was saved for only a portion of the run due to a technical error with the control software.  
 
 
Figure A23.2. Bioreactor Run 1 pH. The figure shows the measured pH for bioreactor run 1 in blue. 
The desired pH of 7 is shown in orange. The time is in hours since the start of the run. Data was saved 
for only a portion of the run due to a technical error with the control software.  
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Figure A23.3. Bioreactor Run 1 Temperature. The figure shows the measured temperature for 
bioreactor run 1 in blue. The desired temperature of 37°C is shown in orange. The time is in hours since 
the start of the run. Data was saved for only a portion of the run due to a technical error with the control 
software.  
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Appendix 24: Bioreactor #2 Raw Data 
 
Figure A24.1. Bioreactor Run 2 Percent Oxygen Saturation. The figure shows the measured pO2 for 
bioreactor run 2 in blue. The desired 40% pO2 is shown in orange. The time is in hours since the start of 
the run. Data was saved for only a portion of the run due to a technical error with the control software.  
 
 
Figure A24.2. Bioreactor Run 2 pH. The figure shows the measured pH for bioreactor run 2 in blue. 
The desired pH of 7 is shown in orange. The time is in hours since the start of the run. Data was saved 
for only a portion of the run due to a technical error with the control software.  
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Figure A24.3. Bioreactor Run 2 Temperature. The figure shows the measured temperature for 
bioreactor run 2 in blue. The desired temperature of 36°C is shown in orange. The time is in hours since 
the start of the run. Data was saved for only a portion of the run due to a technical error with the control 
software. 
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Appendix 25: Bioreactor #3 Raw Data 
 
Figure A25.1. Bioreactor Run 3 Percent Oxygen Saturation. The figure shows the measured pO2 for 
bioreactor run 3 in blue. The desired 40% pO2 is shown in orange. The time is in hours since the start of 
the run. Data was saved for only a portion of the run due to a technical error with the control software.  
 
 
Figure A25.2. Bioreactor Run 3 pH. The figure shows the measured pH for bioreactor run 3 in blue. 
The desired pH of 7 is shown in orange. The time is in hours since the start of the run. Data was saved 
for only a portion of the run due to a technical error with the control software.  
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Figure A25.3. Bioreactor Run 3 Temperature. The figure shows the measured temperature for 
bioreactor run 3 in blue. The desired production temperature of 25°C is shown in orange. The time is in 
hours since the start of the run. Data was saved for only a portion of the run due to a technical error with 
the control software. 
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Appendix 26: Bioreactor #4 Raw Data 
 
Figure A26.1. Bioreactor Run 4 Percent Oxygen Saturation. The figure shows the measured pO2 for 
bioreactor run 4 in blue. The desired 30% pO2 is shown in orange. The time is in hours since the start of 
the run. Data was saved for only a portion of the run due to a technical error with the control software.  
 
Figure A26.2. Bioreactor Run 4 pH. The figure shows the measured pH for bioreactor run 4 in blue. 
The desired pH of 7 is shown in orange. The time is in hours since the start of the run. Data was saved 
for only a portion of the run due to a technical error with the control software.  
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Figure A26.3. Bioreactor Run 4 Temperature. The figure shows the measured temperature for 
bioreactor run 4 in blue. The desired production temperature of 25°C is shown in orange. The time is in 
hours since the start of the run. Data was saved for only a portion of the run due to a technical error with 
the control software. 
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Appendix 27: Vendor Sheets and MSDSs 
 Contained on the following pages are vendor sheets for all equiptment and MSDSs for all 
materials. 
Features of the BIOSTAT® RM basic include:
– Setting of rocking rate and angle 
–  Individual temperature control of two bags 
(2 L, 10 L) or one bag (20 L, 50 L)
–  Independent gassing of two bags  
(0–500 ml/min) or one bag (0–1000 ml/min)
–  Setting of the bag configuration:  
will automatically select the right gassing 
and temperature control parameters of  
the system
–  Integrated Air | CO2 mixing by optional 
 gassing module
–  Air supply, switchable between internal  
air pump or process gas
–  Positioning of the platform for harvest  
and sampling
–  2 Filter heaters made of PC, plug directly 
into rocker base
–  Color coded plugs and socket for easy  
operation
–  Tube and cable organizer at the sides  
of the bag holder
–  Security function, check plug in of filter 
heater when gassing is switched on
– Alarm display
–  3 different user level  
(Administrator, User, Locked)
– Trend display for data visualization
– Time and date display
– Selection of control mode: Local or DCU
– Potential free alarm contact
–  RS232 serial interface for communication 
with PC running
–  Optional Ethernet interface with  
communication protocol for connection  
to third party software
–  Optional ProfiBus DP interface with  
communication protocol for connection  
to third party software
– Service Interval Display
Introduction
The BIOSTAT® RM is a single use, wave-mixed 
bioreactor for culture volumes from 100 mL 
to 300 L. The system consists of a rocker unit 
with bag holder, a digital controller and  
a  disposable bag. The bag, which forms the 
 cultivation chamber, is mounted on the 
 rocker platform and contains the medium  
and the cells. Due to the wave in the bag, 
 generated by the moving platform, the  media 
surface is renewed constantly, providing 
 bubble-free aeration with low sheer.
Applications
–  Cultivation with or without pH and DO 
feedback control
–  Cultivation of mammalian, insect and  
plant cells
– Cultivation of stem cells
– Seed bioreactor
–  Cost efficient cell mass, protein,  
Mab & vaccine production
BIOSTAT® RM Product family description
The RM product family comprises four 
 different bioreactor sizes, 20 L, 50 L, 200 L 
and 600 L in different configurations. For 
applications where advanced control is not 
required instruments are available without pH 
and DO measurement (basic systems). For 
more complex processes optical systems with 
sophisticated feedback control for all process 
parameters including pH and DO are available 
as well as perfusion systems for fully auto-
mated continuous cultivations. BIOSTAT® RM 
20 and 50 share the identical rocker unit and 
differ in size of the bag  holder, which can be 
exchanged from 20 L to 50 L and vice versa.
Basic systems
Basic systems are designed for stand alone 
bench top use and allow controlling rocking 
rate, angle, and temperature. An internal 
 gassing module can be added for aeration 
with air and CO2 to work with a fixed CO2 
concentration of 0–15% in the process gas. 
The digital controller is directly integrated 
into the rocker unit and operated with  
an easy to use colour touch screen directly  
on the rocker. 
BIOSTAT® RM
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Optical systems
The BIOSTAT® RM Optical provides full process 
automation with sophisticated feed back 
 control. In addition to the rocker unit, it com-
prises a BIOSTAT® DCU (digital control unit) 
tower. The control tower is connected to the 
rocking unit for monitoring and controlling 
the culture, including pO2, pH, agitation, and 
temperature in batch and fed batch mode  
of operation. Pre-calibrated, single-use  
optical sensors are included in the bag for  
the  measurement of DO and pH.
Perfusion systems
The BIOSTAT® RM Perfusion systems allow 
fully automated, continuous processes. The 
single-use bag is equipped with optical pH 
and DO probes. It contains an internal perfu-
sion membrane for efficient cell retention. 
The feed and harvest pumps are controlled by 
gravimetric flow controllers, which monitor 
the weight of the feed and harvest containers 
to ensure precise flow rates.
Order Code Description Perfusion Rate  
(L/day)
Type of Pump Weighing Capacity  
Balances (kg)
Readability  
Balances (g)
DH-----PRM11 Perfusion Option 1 – 120 VAC 2–55 int. WM102 60 1
DH-----PRM12 Perfusion Option 1 – 230 VAC 2–55 int. WM102 60 1
DH-----PRM21 Perfusion Option 2 – 120 VAC 2–55 int. WM102 300 10
DH-----PRM22 Perfusion Option 2 – 230 VAC 2–55 int. WM102 300 10
DH-----PRM31 Perfusion Option 3 – 120 VAC 23–1100 ext. WM323 300 10
DH-----PRM32 Perfusion Option 3 – 230 VAC 23–1100 ext. WM323 300 10
DH-----PRM41 Perfusion Option 4 – 120 VAC 23–1100 ext. WM323 600 20
DH-----PRM42 Perfusion Option 4 – 230 VAC 23–1100 ext. WM323 600 20
DH-----PRM51 Perfusion Option 5 – 120 VAC 23–1100 ext. WM323 1500 20
DH-----PRM52 Perfusion Option 5 – 230 VAC 23–1100 ext. WM323 1500 20
Different perfusion configurations are 
 available depending on the working volume, 
the required perfusion rate and the maximum 
feed and harvest container weight.
Twin systems
The BIOSTAT® RM 20, RM 50 and RM 200 
 systems are available as Single and Twin 
 systems. One controller can independently 
control the temperature, gas flow, pH and DO 
of two bags. The bags can be mounted on  
two different rockers (Twin Rocker) or on the 
same rocker (Twin Controller). The BIOSTAT® 
RM 20 and RM 50 are available either in  
Twin Rocker or Twin Controller configuration, 
also as mixed RM 20 | RM 50 Twin variants. 
The BIOSTAT® RM200 always comes as 
Twin Controller model.
Model max. 
 working 
volume (L)
           system type Twin availability temperature control*
basic optical perfusion Twin 
rocker
Twin  
controller
heating 
only
heating| 
cooling
20 10 + + + +* + + +
50 25 + + + +* + + +
200 100 + + + +**
600 300 + + +**
* only for optical and perfusion
** on request
BIOSTAT® RM 200, single-use bioreactor BIOSTAT® RM 600 optical, 
large scale  single-use bioreactor
BIOSTAT® RM digital control unit (DCU)
–  Cabinet contains measurement & control 
hardware, pumps & gassing system
–  Separate from rocker unit (RM 20, RM 50, 
RM 600) or installed on a same skid 
(RM 200)
–  Graphical user interface with colour display 
and touch screen operation
–  Integrated amplifiers for temperature, 
 pressure, single use DO and pH sensors
–  Integrated control loops for temperature, 
DO, pH, rocker speed, rocker angle, gas flow 
and substrate
–  Fully automated perfusion control using 
gravimetric flow controllers (Perfusion 
 systems)
– Multi-channel DO cascade control
– Calibration of DO and pH sensors
– In-process DO and pH recalibration
–  Time-controlled profile function for all 
 process parameters
– Optional password and logbook function
– Trend display for up to 6 process values
Gassing module
– Outlet to overlay aeration
– 4-fold gas mixing of air, N2, O2 and CO2
–  One mass flow min for total flow  
(see technical data for flow rates)
–  One separate mass flow controller for CO2 
(see technical data for flow rates)
– Rotameters for air, N2, O2, and CO2
– Control via pH/DO controller
–  Measurement of bag pressure (RM 20, 
RM 50, RM 200). Control of bag pressure 
(RM 600)
–  Double safety feature: Electronic shut off 
plus mechanical pressure release valve to 
protect from overpressure
–  Filter Heater on exhaust filter to prevent 
formation of condensate and avoid filter 
blockage
Pumps
– Two integrated digital peristaltic pumps
–  Two additional integrated or external 
 analogue feed pumps available on request 
(standard with perfusion configuration)
Temperature control
Choice between heating only and heating | 
cooling by optional thermostat unit
Heating Only
– Electrical heating blankets on bag holder
–  Simultaneous, independent control of  
two bags on one platform (RM 20, RM 50, 
RM 200) or one bag (RM 600)
– Temperature range: ambient to 40°C 
–  Automatic safety shutdown for prevention 
of overheating
Heating | Cooling
–  Stainless steel temperature coil mounted  
on bag holder.
– Thermostat for heating
–  Cooling water to be connected to cooling 
water supply or external chiller
– Circulation pump
– Quick coupling connectors 
–  Temperature range: 8°C above cooling 
water to 40°C
–  Automatic safety shutdown for prevention 
of overheating
Agitation System & Bag Holder
– Bag holder mounted on rocking platform
– Clamping rails to hold down bag
– Material stainless steel or ABS
–  Detachable or swivelling top for easy access 
probes, ports and sample lines
Sensors
–  Disposable optical chemical sensors DO are 
installed in every optical and perfusion bag
–  Sensors are pre-calibrated and supplied 
with calibration parameters
– Range:  pH: 6.5 – 8.5  
DO: 0 – 100%
–  PT100 reusable sensors for temperature 
measurement
SCADA Software BioPAT® MFC S/DA
– Part of every bioreactor package
– Plug and play configuration
– Online data acquisition
– Sample data management
– Enhanced plotting
– Export functions
– Easy to use programming interface
–  Upgrade to advanced BioPAT® MFCS/Win 
control software possible
BIOSTAT® RM 20 basic, with mounted lid
BIOSTAT® RM 20 basic, without lid
BIOSTAT® RM 20
Features & Benefits
–  Single use Bioreactor with very low 
 operation costs
–  Based on proven rocking motion (“wave 
induced motion”) principle
–  Basic systems provide flexible, autonomous 
stand-alone systems for simple cultivations
–  Optical and Perfusion systems are designed 
for high end applications
– Large working volume range in one bag
– Flexible gassing system
–  Gas flow adjustments via rotameters and 
mass flow controllers
–  Double pressure safety control to avoid 
overpressure in bag
– Advanced cascaded DO control
–  Intuitive touch screen interface for easy 
operation
– Easy bag installation 
–  Supervisory Process Control software 
(BioPAT® MFCS/DA) included
Technical Specifications
 BIOSTAT® RM 20 | 50 
basic
BIOSTAT® RM 20 | 50 
optical & perfusion
BIOSTAT® RM 200 
optical & perfusion
BIOSTAT® RM 600 
optical
Volume
Total volume up to 20 L (RM50:50 L) up to 20 L (RM50:50 L) up to 200 L 600 L
Minimum working volume  
(bags with sensors may require 
higher minimum volumes)
0.1 L (RM50:5 L) 0.1 L (RM50:5 L) 10 L 60 L
Maximum working volume 10 L (RM50:25 L) 10 L (RM50:25 L) 100 L 300 L
Bag Holder
ABS + +
Stainless steel + +
Clamping rails for bag fixation + + + +
Pressure sensor with gassing  
safety shut off 
+ + + +
Proportional valve to maintain  
bag pressure at constant level
N/A N/A N/A +
Redundant overpressure  
relieve valve
– + + +
Sensor clamps for secure  
 fixation of glass fiber cables
N/A 2 4 2
Filter heater 2 2 2 2
Controller
Integrated into rocker +
DCU control tower N/A + + +
Potential free alarm contact + [max 0.5 A] (+) (+) (+)
Color touch screen + + + +
Different user level log in + (+) (+) (+)
Logbook function N/A (+) (+) (+)
Temperature Control 
Temperature modes Heating Only Only Heating or 
Heating|Cooling 
Only Heating or 
(Heating|Cooling) 
Only Heating or 
(Heating|Cooling) 
Temperature range,  
heating only 
RT –40°C RT –40°C RT –40°C RT –40°C
Temperature range heating | 
cooling 
N/A 8°C above cooling water 
–40°C 
8°C above cooling water 
–40°C 
8°C above cooling water 
–40°C 
pT 100 probes and  
temperature amplifiers
2 2 2 1
Heating power, heating only 2 + 140 W (48 VAC) 2 + 140 W (48 VAC) 2 + 650 W 1 + 1500 W 
Heating power,  
heating | cooling
N/A 1 + 1000 W 2 + 1000 W 2 + 1000 W 
Overtemperature protection + + + +
Gassing module basic rocker
Maximum total flow (ml/min) (0–1000, or 2 + 0–500), 
± 5% 
N/A N/A N/A
Fixed CO2 gassing (%) (0–15) N/A N/A N/A
Internal air pump (+) N/A N/A N/A
BIOSTAT® RM 20 | 50 
basic
BIOSTAT® RM 20 | 50 
optical & perfusion
BIOSTAT® RM 200 
optical & perfusion
BIOSTAT® RM 600 
optical
Gassing module optical systems
Rotameter
– O2 N/A + + +
– N2 N/A + + +
– CO2 N/A + + +
– Air N/A + + +
Mass flow controllers for:
– CO2 N/A 0–500 mL/min + +
– total flow (Air, O2, N2) N/A RM20: 0.02–1 L/min 
RM50: 0.2–10 L/min
+ +
Multi-channel DO  
cascade control
N/A + + +
Agitation
Rocker speed (rpm),  
electronic adjustment
8–42 ± 1 8–42 ± 1 6–20 ± 1 2–16 ± 1
Rocker angle (°),  
electronic adjustment
4–10°, ± 0,3°, 4–10°, ± 0,3°, 4–10° ± 0.3° 4–10° ± 0.3°
DO and pH Measurement
pH range N/A 6.5–8.5 6.5–8.5 6.5–8.5
DO range N/A 0–100% 0–100% 0–100%
Amplier for optical single-use  
DO sensor
N/A 1 2 2
Amplier for optical single-use  
pH sensor
N/A 1 2 2
Recalibration function for:
– Disposable DO sensor N/A + + +
– Disposable pH sensor N/A + + +
Interface:
– RS232 1 2 2 2
– Ethernet (1) 1 1 1
- Profibus DB (1) N/A N/A N/A
– Analogue IN N/A 2 2 2
– Analogue OUT N/A 2 2 2
BioPAT® MFCS/DA + + + +
Pumps & Balances
Digital pumps WM102 N/A 3
Analogue pumps WM313D N/A (2)
Analogue pumps  
(via analogue OUT)
N/A (up to 2)
External balances N/A (up to 2)
Measurement of media weight 
(integrated balance)
(+) (+) (+) (+)
Sartorius Stedim Biotech GmbH 
August-Spindler-Strasse 11 
37079 Goettingen, Germany
Phone +49.551.308.0 
Fax +49.551.308.3289 
www.sartorius-stedim.com 
BIOSTAT® RM 20 | 50 
basic
BIOSTAT® RM 20 | 50 
optical & perfusion
BIOSTAT® RM 200 
optical & perfusion
BIOSTAT® RM 600 
optical
Power Supply
Rocker 120 V–230 VAC | 
1-phase | 6.3 A
+ + N/A N/A
Control tower:  
120 VAC | 1-phase | 16 A
N/A country specific N/A N/A
Control tower:  
230 VAC | 1-phase | 16 A
N/A country specific N/A N/A
Complete System:  
208 VAC | 3-phase TN-S | 32 A
N/A N/A country specific country specific
Complete system:  
400 VAC | 3-phase TN-S | 32 A
N/A N/A country specific country specific
Laboratory Supply
Process gasses pressure (barg) 1.0–1–5 1.3–1.5 1.3–1.5 1.3–1.5
Gas specifications according 
to ISO 8573-1
–  Particle size: < 0.1 mm amount:
max. 0.1 mg/m3 (class 1)
+ + + +
–  Condensate: dew point < +3°C
(Class 4)
+ + + +
– Oil: < 0.01 mg/m3 (Class 1) + + + +
– Germs Class 0 + + + +
Quick Couling for gas tubes, 
Festo Type (OD 4 mm)
+
Hose barb for gas tubing, 
ID 6 mm
N/A + + x
Cooling water (for heating 
cooling system only)
N/A (+) (+) (+)
Hardware Dimensions & Weight
W + H + D (mm) RM20:  
765 + 600 + 400 mm 
RM50:  
1085 + 600 + 450 mm
BIOSTAT® RM Control 
Tower 
320 + 735 + 565 mm
plus size of basic rocker
1998 + 1241 + 830 mm 1790 + 1470 + 1330 cm
Weight RM 20: 30 kg 
RM 50: 32.2 kg
BIOSTAT® RM Control 
Tower 
50 kg plus weight of  
basic rocker
272 kg 340 kg
* Available from Q1/2012
(+) optional, needs to be ordered separately
USA Toll-Free +1.800.368.7178 
UK +44.1372.737159 
France +33.442.845600 
Italy +39.055.63.40.41 
Spain +34.90.2110935 
Japan +81.3.3740.5407 Sp
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PadReactor® System
Single-use, stirred bioreactor
Highlights and Benefits
Cube-shaped design incorporating a mixing paddle coupled with a dynamic sparger device:
– Low shear stress bioreactor as the superior mixing capabilities enables to mix at very low speed
– Superior oxygenation and high kLa maintained due to a fully integrated sparging device distributing 
better the bubbles
Proven to be effective for cultivation of suspended and adherent cells on microcarriers
Linearly scalable from 10 L to 1200 L
User friendly single-use bioreactor designed to be used in cGMP environments
– Quick biocontainer installation and fast set-up enabling start up time to be decreased by 2 to 4 hours
per batch
– Limited footprint with an easy access to every part of the bioreactor
– Easy observation of the cells during the cultivation and harvest throught a fully transparent front cover
– No need for CIP/SIP, avoiding cross contamination risks
USD2944a(1)
2
Overview
The PadReactor system is a single-use bioreactor specifically
designed to fulfill the needs of cell culturists. It is perfectly suited
to laboratory environments, process development centers, 
clinical material supply and flexible cGMP manufacturing. 
The PadReactor system offers a platform, which gives the 
end user the opportunity to choose a preferred controller or 
use Pall recommended controller (ez-Control from Applikon).
Its innovative cube-shaped biocontainer design integrates a
highly efficient internal mixing paddle coupled with a dynamic
sparger. The system is non-invasive as the paddle and the
sparger are enclosed in a medical grade ultra low-density 
polyethylene resin (ULDPE) sleeve, made from the same 
contact material as the biocontainer itself. The paddle is 
coupled on top of the vessel with the mechanical mixing head. 
The superior mixing capabilities and the innovative sparging
device enable the PadReactor bioreactor to achieve greater 
productivity compared to cylindrical bioreactors. 
The PadReactor utilizes disposable mixing biocontainers made
from Allegro™ TK8 bioprocess film. The product-contacting
layer of the Allegro TK8 film is blow-extruded in-house by Pall
Life Sciences under cleanroom conditions using medical-grade
ULDPE. It is then laminated to create a gas barrier film of 
exceptional cleanliness, strength, and clarity that is animal
derived component free (ADCF) and complies fully with USP
Class VI requirements.
The PadReactor single-use bioreactor consists of the following:
Drive Unit – The flexible drive unit allows the system to cultivate
cells in disposable biocontainers. One drive unit is adapted for
various disposable mixing biocontainer sizes. Each system
comes with the appropriate mixing stick for your container.
Mobile Retaining Tank – The purpose of the retaining tank is to
support the mixing biocontainer and provide mobility before and
after operation. Various tank sizes and options are available.
Bioreactor Vessel – The reactor vessel uses an innovative 
biocontainers design that allows a non-invasive connection 
to the mixer. Mixing is achieved when the integrated paddle/
sparger inside the biocontainer rotates within the biocontainer.
Controller (optional) – ez-Control from Applikon configured to
work with PadReactor system.
PadReactor Biocontainer and Holder
Available biocontainer sizes, 25 L, 50 L, 125 L, 250 L, 600 L
and 1200 L with cube-shape geometry
Film material: Allegro TK8 multi-layer film with contact layer in
ULDPE, gamma sterilizable, USP - Class VI compliant, fully
ADCF (Animal Derived Component Free)
Temperature control via jacketed container
Mixing is achieved when the integrated paddle/sparger
inside the biocontainer rotates.
Line Description
1...4 Multi port fitment - can be used for: nutrient addition, gas
exhaust/foam trap, acid addition, media filling, inoculation...
5...8 Multi port fitment - can be used for: nutrient addition, gas
exhaust/foam trap, acid addition, media filling, inoculation...
9 Disposable bioreactor biocontainer 
(Pall Life Sciences Allegro TK8 ADCF film)
10 Sampling port
11 Perfusion connection/extra sampling connection
12 Connection for pH, T or DO probe with Kleenpak™ sterile 
connector
13 Sensing probe assembly to be connected to (12) by Kleenpak
sterile connector
14 Easy drain connector
15 Micro (20 μm) or macro (2 mm holes) rigid and in motion 
sparger device
16 Pall Life Sciences paddle mixing stick surrounded by sleeve
17 Gas inlet through sparger device
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Mixing Capabilities Model 
The PadReactor system utilizes a cube-shaped vessel design
agitated with a paddle-shaped mixing element rotating in an
elliptical motion. The corners of the vessel act as baffles to 
prevent vortexing and ensure robust mixing with very low 
shear stress. In order to model the mixing capabilities of the
PadReactor system, Computational Fluid Dynamics (CFD) 
analysis has been conducted in different volumes and at different
mixing speeds. As demonstrated on pictures mixing, turbulent
but low shear mixing is easily achieved, even at low speeds. 
The cube-shaped vessel and paddle mixing element design of
the PadReactor system provides effective mixing advantages.
These advantages have been shown to require lower power
input, improved gas transfer and improved productivity when
compared to bioreactors with cylindrical vessels. (For additional
information, please refer to the Pall Life Science poster
“Engineering Analysis of Mixing in Pall Life Science Bioreactors
using Computational Fluid Dynamics”.)
PadReactor System Weight and Dimensions
Dimension 25 L 50 L 125 L
Biocontainer Holder (w x d x h) 465 x 365 x 785 mm 515 x 425 x 785 mm 700 x 525 x 785 mm
Drive Unit (w x d x h) 845 x 940 x 1360 mm 845 x 940 x 1360 mm 845 x 940 x 1360 mm 
Biocontainer Holder 48 kg 57 kg 80 kg
Drive Unit Weight 250 kg 250 kg 250 kg
Jacket Liquid Volume 0.4 L 0.6 L 1.4 L
Dimension 250 L 600 L 1200 L
Biocontainer Holder (w x d x h) 880 x 690 x 1375 mm 1010 x 880 x 1375 mm 1200 x 1155 x 1375 mm
Drive Unit (w x d x h) 1140 x 1035 x 1960 mm 1140 x 1035 x 1960 mm 1140 x 1035 x 1960 mm 
Biocontainer Holder 125 kg 232 kg 288 kg
Drive Unit Weight 325 kg 325 kg 325 kg
Jacket Liquid Volume 2 L 4.25 L 5.25 L
Velocity Vectors in the 
PadReactor System
Liquid flow path in the 
PadReactor System
Indicative performance rates 
For 25/50/125 liter biocontainer holders For 250/600/1200 liter biocontainer holders for 25 liter biocontainer holder
Working temperature range: -45 °C / +200 °C Working temperature range: -30 °C / +120 °C Heating rate: 22 °C/hour 
(20 to 37 °C in 45 min)
Heater power: 3.5 kW Heater power: 6 kW Cooling rate: 4 °C/hour
Cooling capacity at 20 °C: 0.80 kW Cooling capacity at 20 °C: 4.6 kW Indicative performance rates
for 250 liter bag holder:  
Pump pressure/suction max: 0.7/0.4 bar Pump pressure max: 3.2 bar Heating rate: 8 °C/hour 
(20 to 37 °C in 2 hours)
Pump flow maximum pressure / suction: 25/23 L/min Pump flow maximum pressure: 40 L/min Cooling rate: 4 °C/hour
Maximum bath volume: 8 L Maximum bath volume: 18 L
Overall dimensions (W x D x H): 285 x 430 x 688 mm Overall dimensions (W x D x H): 550 x 650 x 970 mm
Thermostatic Cooling/Heating Bath Guidelines (TCU, Required) 
Corporate Headquarters
Port Washington, NY, USA
+1.800.717.7255  toll free (USA)
+1.516.484.5400  phone
biopharm@pall.com  e-mail
European Headquarters
Fribourg, Switzerland
+41 (0)26 350 53 00  phone
LifeSciences.EU@pall.com  e-mail
Asia-Pacific Headquarters
Singapore
+65 6389 6500  phone
sgcustomerservice@pall.com  e-mail
International Offices
Pall Corporation has offices and plants throughout the world in: Argentina, Australia, Austria,
Belgium, Brazil, Canada, China, France, Germany, India, Indonesia, Ireland, Italy, Japan,
Korea, Malaysia, New Zealand, Norway, Philippines, Poland, Russia, Singapore, South
Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam.
Distributors in all major industrial areas of the world. To locate the Pall office or distributor
nearest you, visit www.pall.com/contact.
The information provided in this literature was reviewed for accuracy at the time of publication.
Product data may be subject to change without notice. For current information consult your
local Pall distributor or contact Pall directly. 
© 2015, Pall Corporation. Pall,    , Allegro, Kleenpak and PadReactor are trademarks of Pall Corporation. 
® indicates a trademark registered in the USA and TM indicates a common law trademark. Filtration.
Separation. Solution. is a service mark of Pall Corporation. 
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Visit us on the Web at www.pall.com/bioreactors
E-mail us at bioreactors@pall.com
Simple and accurate process control for research
and pilot plant bioreactors and fermentors
Applikon Biotechnology
S I M P L E  A N D  A C C U R A T E  P R O C E S S  C O N T R O L  F O R  R E S E A R C H  A N D  P I L O T  P L A N T  B I O R E A C T O R S  A N D  F E R M E N T O R S
ez-Control
Easy operation 
 The intuitive color touch screen display gives a clear 
overview of all process parameters. Data is presented 
numerically, in line graphs and bar charts.
Security 
 The system has three user levels: Viewer, Operator and 
Engineer all with their own access rights.
Using the touch screen interface the user can alter the 
configuration of the system. This enables the system to 
be used for different cultures without adding or removing 
hardware. Just select the desired operation mode from the 
display and start the next culture.
Easy updates 
 Software updates are easy when functional updates 
are available. Just connect the USB key with the software 
update to the USB port and the system will automatically 
load the latest firmware.
Advanced computer 
interface 
 The computer connection uses an Ethernet interface. 
This means that you can plug it into a network and col-
lect the data from anywhere in the network using one of 
Applikon’s BioXpert software or other SCADA programs, 
for which an OPC server is available.
Easy communication
 The integrated web server allows access to the machi-
ne using standard internet browsers. Via the browser the 
machine can be operated and actual process data can be 
viewed. Your standard software can be used to view or 
control the system in the laboratory while you are at your 
desk.
Expandibility
 The optional ADDA board offers an additional 8 analog 
inputs, 4 analog outputs, 8 digital inputs and 8 digital 
outputs.
 This additional I/O power can be used to connect 
Biomass monitors, balances, gas analyzers, variable speed 
pumps, fixed speed pumps valves and other 
equipment to the ez-Control.
 Virtually any bioprocess can be controlled through the 
standard 5 control loops and the controlled 14 outputs. 
With the ADDA card the total I/O count even reaches an 
impressive 21 inputs and 26 control outputs. This is in 
addition to the 2 integrated alarm outputs (process alarm 
and device alarm).
 Other options include bottle racks for liquid additions 
and a set of lifting brackets for transport of  ez-Control.
The system controls pH, Temperature, Dissolved Oxygen, Foam/Level and Agitation.  
The color touch screen interface easily guides the user through operation of the controller. 
The adaptive control features allow the user to focus on the process while the controller keeps 
tight control on the important process parameters. 
The controller’s unique design make it easy to use, provides a small footprint, is flexible and 
accurate thus giving it capabilities that are beyond any other laboratory process control system.
TFT color touch screen 
interface for easy navigation 
and clear data display
Gas mixing and easy gas 
selection system
Up to 4 gas rotameters and 
up to 4 mass f low control lers 
for f lexible gas supply
Pump section with up to
3 easy access f ixed speed pumps
for control led l iquid addit ion
Ethernet computer interface al lows 
easy integration of the ez-Control ler 
into your network
Emergency stop switches
the system to safe posit ion
in case of emergency
Sensor connections for:
Optional ADDA card
for addit ional I/O
User fr iendly detachable
and autoclavable bott le
rack accommodates up
to 3 l iquid addit ion bott les
Temperature section for thermocirculator,
cooling water valve or heating blanket.Quick release 
connections for condensor and heat exchanger
ez-Control is an easy
to use control system
Motor and 
Encoder (motor)
pH and DO
Temperature and
Foam/Level
USB connection
Applikon Biotechnology
Affordable
 ez-Control can be ordered as part of Applikon’s 
BioBundle Family, therefore making this advanced system 
very affordable. 
Enhanced documentation 
and validation 
 ez-Control was developed and documented in com-
pliance with GAMP 4 guidelines to enable users to fully 
validate the system for their process.
The system is 21CFR part 11 compliant. The validation 
documentation package is available as an option.
Adaptive control
 What makes this controller smart is its capability 
to use adaptive control technology to automatically 
set the PID values. This results in shorter development 
times and reduced time to market for your new pro-
ducts.
 The adaptive process control can determine the 
optimal process conditions while the process is run-
ning.  This is particularly useful when viscosity of the 
culture increases during the process or when other 
physical properties of the process change.  The adap-
tive mode guarantees the best process control perfor-
mance without the need to be a control specialist.
Dissolved oxygen 
measurement and 
control
 Dissolved Oxygen is measured using a standard pola-
rographic oxygen sensor. The system can accommodate 
up to 3 mass flow controllers for accurate gas flow control, 
up to 3 rotameters with optional solenoid on/off control 
valves for gas supply to the culture.
Temperature
measurement
and control
 Temperature is measured using a Pt-100 sensor and 
can be controlled using a built-in thermocirculator, a 
silicone heating blanket or a cooling water valve.  
pH measurement
and control
 pH is measured using a standard pH probe and can 
be controlled via a choice of acid pump, CO2 mass flow 
controller, CO2 rotameter with solenoid on/off control valve 
and an alkali pump.
Foam/Level
measurement
and control
 Foam/Level is measured through a conductivity sen-
sor (adjustable tripping point) and is controlled using an 
antifoaming agent pump or medium addition or removal 
pump.
Agitation measurement 
and control
 The powerful but quiet permanent magnet dc stir-
rer motor uses an incremental encoder for feedback. 
This guarantees accurate stirrer speed control over the 
full stirrer speed range independent of the viscosity of the 
culture.
S p e c i f i c a t i o n   
Dimensions H, D, W (mm) 710, 400, 370
Voltage 115/230 Vac
Power 1300 VA
IP rating Top, left side and front side: IP54, Right side and rear: IP20 (sensor connections)
Weight  approx. 40 kg (depending on confi guration)
Utility connections  
 Gas (air, Oxygen Nitrogen CO2) 6 mm O.D. festo quick connectors
 Water in Quick release connector with hose barb for 6 mm I.D. tubing
 Water out Quick release connector with hose barb for 6 mm I.D. tubing
 Electricity Euro connector
Utility pressure Gas (air, Oxygen Nitrogen CO2):  2barg, Water: 2 barg
Control loops Number 5; pH, Temperature, Dissolved Oxygen, Foam/Level and Agitation
 Type Three term PID for pH, Temperature, Dissolved Oxygen and Agitation, 
  on/off control for Foam/Level 
 Adaptive auto tuning Selectable for pH, Temperature and Dissolved Oxygen
Temperature Measurement range 0 - 150°C
 Measurement accuracy 0.1°C
pH Measurement range 0 - 14 pH
 Measurement accuracy 0.01 pH
Dissolved Oxygen Measurement range 0 - 120% saturation (both air and pure oxygen via automatic 
  dynamic range)
 Measurement accuracy 0.10%
Foam/Level Measurement range Conductivity range:  26 or 200 µSiemens
Agitation Measurement range P100: 10 - 1250 rpm, 
  P140 10 - 2000 rpm, 
  P310 10 - 1250 rpm, 
  P1000 10 - 1000 rpm
 Measurement accuracy  +/- 0.1% full scale
Alarm 2 potential free alarm contacts  Process alarm and device alarm
Communication Interfaces Ethernet (RJ45 connector) 10 - 100 Mbps
 USB version 1, 3 connections of which one is a host
 Compatible SCADA software BioXpert Lite, BioXpert 2 and BioXpert XP
 Other communication functionality Integrated webserver for remote diagnostics and remote operation 
  Firmware updates via USB key
Actuators  
Pumps Number Up to 3 built-in
 Voltage 24 Vdc
 Type Fixed speed
 Speed 20 rpm
 Liquid fl ow Depending on tubing size up to 33 ml/min
 Additional software functions Totalizer (dosed volume), timer control, Control via SCADA, 
  lower and upper limit setting via control loops.
A U T O C L A V A B L E  S Y S T E M SS I M P L E  A N D  C C U R A T E  P R O C E S S  C O N T R O L  F O R  R E S E A R C H  A N D  P I L O T  P L A N T  B I O R E A C T O R S  A N D  F E R M E N T O R S
 
ez-Control
Rotameters Number up to 4
 Solenoid on/off valve up to 4
 Solenoid on/off valve voltage 24 Vdc
 Gas fl ow Up to 30 l/min
 Additional software functions Totalizer (dosed volume), timer control, Control via SCADA, 
  lower and upper limit setting via control loops.
Mass Flow Controllers Number up to 4
 Voltage 24 Vdc
 Communication with controller RS 485
 Flow Up to 30 l/min
 Additional software functions Totalizer (dosed volume), Control via SCADA, 
  lower and upper limit setting via control loops.
Standards GAMP 4 Yes
 GAMP class 2 (Firmware)
 21CFR part 11 system can be used in a 21CFR part 11 compliant environment
 CE CE certifi ed
 UL UL compliant
 CSA CSA compliant
Options ADDA card 8 x analog inputs (0 - 10 Vdc), 
  4 x analog outputs (0/4 - 20 mA or 0 - 5 Vdc or 0 - 10 Vdc), 
  8 x digital inputs (24 Vdc) and 
  8 x digital outputs (dry contact, maximum switchable 24Vdc 1A)
 Bottle rack small volume For 3 x 0.5 liter bottles 
 Bottle rack large volume For 2 x 1 liter bottles and 1 x 0.5 liter bottle 
 Set lifting brackets The handles attach to the side of the controller for easy lifting and moving
S p e c i f i c a t i o n   
Applikon Biotechnology BV De Brauwweg 13, P.O. Box 149, 3100 AC Schiedam, The Netherlands.
Phone: +31 10 298 35 66. Fax: +31 10 437 96 48. E-mail: biotech@applikon.com
www.applikon.com Ap
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M-7125 and M-7250 Basic Biopharmaceutical 
Microfluidizer Processor for Economical 
Manufacturing of Clinical and Production Batches
Recommended for non-sterile processing 
• Nano-emulsions (with and without API)
• Nano-dispersions
• Microencapsulation
• Deagglomeration
• Cell disruption
Key benefits
• Guaranteed scale up from lab and pilot Microfluidizer processors
• Validatable under 21 CFR to cGMP
• Easy to operate with simple manual controls
• Easy to maintain with most maintenance points easily accessed
• Key process parameter monitoring
• CIP process with no equipment takedown required
• Thermally sensitive materials processed safely
• More efficient processing, usually requiring fewer passes than other 
processing machinery
• Batch to batch process reproducibility assured 
Key features
• Up to 15 lpm @ 690 bar 
(4.0 gpm @ 10,000 psi) flow 
rates 
• Up to 7.5 lpm @ 1,379 bar 
(2.0 gpm @ 20,000 psi) 
product flow rates
• Up to 5.1 lpm @ 2,068 bar 
(1.3 gpm @ 30,000 psi) 
product flow rates
• Low product holdup volume 
(<1 liter)
• Small batch capable 
(minimum 12 liters)
• All product paths are 
sanitary grade and BPE 
compliant
• Ultra Clean In Place (UCIP) 
using supplied feed pump or 
customer’s CIP system pump
• Process pressure monitoring 
with signal transfer to 
customer’s data acquisition 
system
• All instruments and valves 
are sanitary grade, BPE 
compliant
• Complete document turn 
over package for validation 
support including IQ/OQ 
documentation, material 
certification and calibrations
• On-site start-up assistance, 
operator and maintenance 
training 
• Optional motor starter panel 
and process interlocks
• Optional product 
temperature sensing by 
RTD with signal output to 
customer’s data system
• Optional FAT, SAT and IQ/OQ 
execution by our technical 
staff
M-7125, M-7250 Basic BioPharmaceutical  
Microfluidizer® Processor TB-BP7.B-2
Since 1984, Microfluidics has provided life 
sciences and formulation scientists with critical 
tools used in the development and production of 
pharmaceutical formulations and recombinant 
technologies. High shear fluid processing, 
Microfluidics’ proprietary technology, uniformly 
reduces droplet and particle size to enable 
the production of stable nano-emulsions, 
nano-suspensions, liposomes and the nano-
encapsulation of actives. In addition it offers the 
most efficient method for disruption of yeast, 
E.coli, plant and mammalian cells. 
Discovery to 
Commercialization
As a result of recent advances in high 
throughput screening and drug discovery, many 
new chemical compounds have been identified 
as possible drug candidates.  Unfortunately, 
many of these compounds show poor water 
solubility and often are only marginally soluble 
in oil-based solvents. The ultrahigh shear 
force developed by Microfluidizer processors 
solves this problem by reducing the particle 
size of active pharmaceutical ingredients to 
therapeutically relevant sizes that enables the 
production of drug products with improved 
bioavailability and stability.    
Cell Disruption for 
Biotechnology 
From the gentle disruption of cultured cells for 
virus isolation to the challenging disruption 
of yeast and other fungi, Microfluidics 
offers technologies to meet the variable and 
demanding needs for cell membrane disruption. 
This technology provides exacting process 
control for highly reproducible and efficient 
cell breakage while keeping temperatures under 
precise control to prevent denaturing.  
Getting To Full Production
Results obtained on all laboratory units will scale 
up easily and in a linear manner to production 
volumes when the same operating conditions 
are employed. Basic Microfluidizer processors 
include Ultra Clean In Place (UCIP) to eliminate 
the need for disassembly and Clean Out of 
Place (COP). Validation support documentation 
including IQ/OQ is included to ensure your 
ability to comply with 21CFR guidelines.
Specifications
M-7125 M-7250
Pressure Range up to 689, 1379, or 2068 bar  (10,000, 20,000 or 30,000 psi)
Product Flow Rate* up to 7.56 lpm (2.0 gpm) up to 15.12 lpm (4.0 gpm)
Product Feed 
Temperature Range
-10ºC to 75°C 
(14ºF  to 165°F)
Power Requirement 18.6 kw (25 hp)  37.3 kw (50 hp)
Utility Requirements • Cooling water for hydraulic oil heat exchanger 
• Cooling water for process fluid heat exchanger
• Compressed air for feed pump and cycling control switches requires 
0.65 m3/min @ 6.2 bar (23 scfm @ 90 psi) minimum with -37ºC to 
-18ºC (-35ºF to 0ºF) dew point
Dimensions** L x W x H 196 x 79 x 145 cm (77"x 31"x 57") 
Weight with oil** 816 kg (1,800 lbs)  1089 kg (2,400 lbs)
*based on water **all weights and dimensions are approximate
Basic BioPharm Microfluidizer Processor Includes
• Features and documentation to enable validation under 21 CFR for cGMP, including;
• Turnover documentation package for validation
• IQ/OQ documentation
• Startup and training
• Product wetted surfaces finished to 0.5µm (20 Ra) nominal, electropolished and 
passivated
• Feed pump, pharma grade
• UCIP - Ultra Clean In Place piping
• Manual controls
• Stainless steel construction
• CE compliant
• Interaction chamber selected for your application
• Proprietary high pressure diaphragm priming valve
Available Options
• Factory Acceptance Testing (FAT)
• Site Acceptance Testing (SAT)
• Installation Qualification / Operational Qualification (IQ/OQ) Execution
• Product heat exchanger - pharma grade, double tubesheet style
• Motor starter panel 
• Explosion proof (XP) compliant version available
• ATEX compliant version available
• Product inlet strainer
• Dual product temperature sensing and read outs (two RTDs with two digital displays with 
signal retransmission in a black anodized enclosure)
• Single product temperature sensor and display (one RTD and digital display with signal 
retransmission in black anodized enclosure)
European OfficeGlobal Headquarters
90 Glacier Drive, Suite 1000
Westwood, MA 02090 USA
Tel: 1-800-370-5452 or: 617-969-5452 
Fax: 617-965-1213
e-mail: mixinginfo@idexcorp.com 
www.microfluidicscorp.com
Bramley Drive, Vale Park West,
Evesham, Worcestershire, WR11 1JH, UK 
Tel:  (+44) (0) 1386 769 007 
Fax: (+44) (0) 870 1911116
Email: mixinginfo@idexcorp.com
www.microfluidicscorp.com
© 2009 by Microfluidics.  All rights reserved.  Printed in U.S.A. on 
recycled FSC certified stock using vegetable based inks.  12/13 CDI .2K
Description
Resolute columns are ideally suited for process purification in the
biopharmaceutical industry. A patented nozzle valve provides all column
functions required for packing, unpacking and running of the column in a
closed system. Based on established and well proven designs, the Resolute
column provides improved column performance and true linear scalability
combined with reproducible column packing methods for today’s high
performance media.
Pall continues to work closely with the biopharmaceutical manufacturing
industry to advance the state of the art for both chromatographic
performance and productivity. The packing process is controlled by a slurry
packing system which,
combined with a Resolute column, offers a complete solution for
process chromatography from development to manufacturing
scale. 
Features and Benefits
Standard column diameters from 280 mm to 1200 mm – all with
selectable bed heights from  100 mm up to 600 mm  
Bed Height: fixed or adjustable (200 mm adjustment)
Nozzle Valve: choice of manually operated Resolute DM, or
pneumatically actuated Resolute DP columns
Choice of bed supports in polyethylene or stainless steel
Piston seal and precision bore tube eliminates need for
additional mechanical compression or pneumatic activation of
adjuster seals
Compatible with a wide range of Chromatographic Media
 
Sanitary Design
 Fully flushed flow path and adjuster seal for clean-in-place (CIP)
Minimum dead space fixed cell seal arrangement
Reduced risk of corrosion
non metallic nozzle flow path for high  salt and low pH conditions
forged stainless steel tube eliminates weld seams on tube wall and
flanges
Visible valve flow path aids detection of entrapped air
Sanitary clamp terminations
Leachate free acrylic tube — no phthalates
Peroxide cured seals — no sulphur containing leachate
Process wetted materials meet regulatory requirements
Column Options
Standard Columns
Actuated nozzle valve; fits 400 to 1200 mm diameter columns
Bed supports:
Contact Us: www.pall.com/contact
Resolute® Chromatography Columns
Polyethylene 10/20/60 µm
Stainless steel 10/20/50 µm
Lockable castors and adjustable feet supplied as standard*
Up to 1000 mm diameter only.
Engineered Columns
Operating pressure up to 7 bar
Columns from 400 mm to 2000 mm diameter
Certification to ASME Div VIII sec 1 or PD5500.CE where applicable
End-cell Rotation Frames (ERF)
Alternative materials: Hastalloy C22, Stainless Steel 1.4435, 1.4439
Hydraulic Actuators — see technical specifications for operating modes
View additional chromatography columns.
Products in this datasheet may be covered by one or more patents including :
EP 1 085 931
US 6,446,679
Specifications
Material Specifications
Process Wetted Components
Column Tube Acrylic (cast PMMA) or Stainless Steel 316L (1.4404)
Distribution Cell Polypropylene
Nozzle Body PVDF/Acrylic(1)
Process Terminations and Slurry Nozzle Tip PEEK
Slurry Inlet Port 180 and 280 mm columns: (2) PEEK
400 to 1200 mm columns: (2) Stainless Steel 316L
Bed Support Polyethylene sinter or Stainless Steel mesh
Seals EPDM (Peroxide cured) 
FEP encapsulated silicone
Wiper Blade PTFE
External Components
Stand, Adjustable Feet Stainless Steel 316L
Castor Stainless Steel 304L
Castor Tyre Polyurethane
(1) PVDF/PVDF version available for increased chemical resistance.
(2) Components not in mobile phase flow path.
Column Specifications
Resolute Fixed and Adjustable Columns
180 – 1200 mm (7 – 47 in.) diameter
Operating Pressure 180 – 280 mm (7 – 11 in.):  
5 bar (73) psi 
400 – 1200 mm (15.7 – 47 in.): 
3 bar (44) psi
Operating Temperature 2 – 30 ºC (35 – 86 °F)
Bed Support, Type and Rating Stainless Steel Mesh:
10, 20, 50 µm
Polyethylene Sinter: 
10, 20, 60 µm
Product Flow Path Stainless Steel surface finish 
< 0.6 µm Ra, Electropolished
Exterior Components Stainless Steel surface finish 
< 0.9 µm Ra, Electropolished
Pressure Retaining Plates Stainless Steel surface finish 
< 1.5 µm Ra, 240 (UK) Grit Sateen
Column Frame Stainless Steel surface finish 
Bright polished
Media Transfer Nozzle DM: 
Manual actuation 
DP: 
Manual control with pneumatic actuation
Hydraulic Actuators (Optional)
Type Mode of Operation Application
HEP
Hydraulic
Endcell
Positioning
Hydraulic linear actuator when column is empty or primed and has an open flow
path with < 1 bar column pressure
Set up prior to Pack in Place and
Maintenance
DAP
Dynamic Axial
Packing
Hydraulic linear actuator when column is empty or filled with slurry and has an open
flow path with < 3.0 bar column pressure
Flow Packing at optimal linear
velocity
/M Option
Hoist-free
Maintenance
Actuators and integral support and safety devices move and secure Top Adjuster
and Column Tube (/M option available for either HEP or DAP model)
Access to top and bottom bed
supports and seals for changeout
Ordering Information
This is a list of typical part numbers for this product range. For part numbers and configurations that are that
are not listed, please contact your Pall representative.
Column Capacity and Ordering Information
Description Diameter CSA Adjustable Height Adjustable Capacity Operating Pressure
Resolute 280 280 mm (11.in.) 620 cm2 100 – 300 mm 6.2 – 18.5 L 5 bar (73 psi)
Resolute 400 400 mm (15.7 in.) 1260 cm2 100 – 300 mm 12.6 – 37.7 L 3 bar (44 psi)
Resolute 600 600 mm (23.6 in.) 2830 cm2 100 – 300 mm 28.3 – 84.8 L 3 bar (44 psi) 
Resolute 800
800 mm (2.6 ft) 5030 cm2 100 – 300 mm 50.3 – 150 L 3 bar (44 psi)
Resolute 1000 1000 mm (3.2 ft) 7850 cm2 100 – 300 mm 79 – 235 L 3 bar (44 psi)
Resolute 1200 1200 mm (3.9 ft) 11310 cm2 100 – 300 mm 113 – 339 L 3 bar (44 psi)
Resolute 1400 1400 mm (4.6 ft) 15390 cm2 100 – 300 mm 154 – 461 L 3 bar (44 psi)
Resolute 1600 1600 mm (5.2 ft) 20110 cm2 100 – 300 mm 201 – 603 L 3 bar (44 psi)
Resolute 1800 1800 mm (5.9 ft) 25450 cm2 100 – 300 mm 255 – 763 L 3 bar (44 psi)
Resolute 2000 2000 mm (6.6 ft) 31420 cm2 100 – 300 mm 314 – 942 L 3 bar (44 psi)
 
Contact Information
Pall Office(s)
Pall Austria Filter GmbH
Thaliastrasse 85
A-1160 Wien
Austria
Phone: ++43 1 49192 300 for
Life Science
Phone: ++43 1 49192 600 for
Industrial 
Fax: ++43 1 49192 400
Email: Pall-Austria-
Office@europe.pall.com
© 2014, Pall Corporation, Pall, and other names are trademarks of Pall Corporation.
® indicates a registered trademark in the USA.
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Number Description 
25228 HisPur Cobalt Superflow Agarose, 10mL settled resin 
25229 HisPur Cobalt Superflow Agarose, 50mL settled resin 
25230 HisPur Cobalt Superflow Agarose, 250mL settled resin 
25231 HisPur Cobalt Superflow Agarose, 1000mL settled resin 
 Binding Capacity: ≥ 30mg/mL of settled resin for a 27kDa 6xHis-tagged protein from a bacterial 
source 
 Resin: Highly crosslinked 6% Superflow agarose 
 Supplied: 50% slurry in a 20% ethanol solution 
 
 Storage: Upon receipt store at 4°C. Product shipped at ambient temperature.  
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Introduction 
The Thermo Scientific HisPur Cobalt Superflow Agarose enables high-yield, high-purity purification of polyhistidine-tagged 
proteins. This immobilized metal affinity chromatography (IMAC) purification support consists of a cobalt-charged 
tetradentate chelator immobilized onto Superflow 6% agarose, which exhibits minimal metal leaching and is compatible with 
a wide range of chemicals and pH values. The highly crosslinked Superflow Support has a high dynamic binding capacity 
across a wide range of flow rates and is stable to multiple reuses making it ideal for large-scale FPLC purifications.  
The HisPur Cobalt Superflow Agarose protocol uses gentle wash and elution conditions to typically produce > 90% pure 
target protein after purification. Protein purities achieved with the Cobalt Superflow Resin are generally higher than those 
achieved with nickel IMAC resins, resulting in the Cobalt Superflow Resin being a valuable tool for users interested in one-
step purifications. 
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  Table 1. Properties of Thermo Scientific HisPur Cobalt Superflow Agarose. 
Support: Superflow 6 Resin, 6% highly crosslinked agarose 
Bead Size: 60-160µm 
Recommended Linear Flow 
R t  
 
≤ 150cm/hr (for binding, washing and elution steps) 
 Maximum Linear Flow Rate
†: 1200cm/hr 
Metal Loading: 
 
≥ 11µMol Co2+/mL resin 
 Binding Capacity: Typical Static Capacity: ~30mg 6xHis-GFP/mL resin 
  Typical Dynamic Capacity*: ~20mg 6xHis-GFP/mL resin 
Chemical Compatibility: 1M acetic acid, pH 2; 1% SDS, pH 7; 6M guanidine HCl; 70% 
ethanol:  ≥ 1 week at 37°C                                                                           
8M urea, 10mM DTT, 5mM TCEP: ≥ 2 hours at 22°C 
pH Limits: pH 3-9 (≥1 week at 4°C)    
pH 2-3 or 9-12 (≥ 2 hours at 22°C) 
Storage Solution: 20% ethanol 
Reuse: Up to 25 times 
†Maximum linear flow-rate conditions:                                                                                                                                                   
Column dimensions (w × h): 13mm × 38mm (5mL resin)                                                                                                              
Ultrapure water at room temperature                                                                                                                                                      
Linear flow rate = volumetric flow rate (mL/min) × 60 (min/hr)/cross sectional area (cm2) 
*Dynamic binding conditions (10% breakthrough):                                                                                                                             
Sample: 1mg/mL 6xHis-GFP (27kDa) pure protein in 20mM NaH2PO4, 300mM NaCl, 5mM imidazole                                              
Column dimensions (w × h): 5mm × 50mm (1mL resin)                                                                                                                           
Flow rate: 1mL/min 
 
Important Product Information  
• Protein yield and purity are dependent upon the expression level, conformation and solubility characteristics of the 
recombinant fusion protein, as well as the buffer conditions and flow rates used. Therefore, it is important to optimize 
these parameters before attempting a large-scale purification. For best results, perform a small-scale test to estimate the 
expression level and determine the solubility of each His-tagged protein. Decreasing the flow rate during the sample load 
will increase binding capacity. 
• To avoid sample loss, try not to exceed the maximum resin binding capacity for the target protein for the purification 
conditions used. Volumes will vary based on the protein and expression efficiency and will have to be determined and 
optimized for each over-expressed protein. Typically over-expressed proteins represent 1-30% of the final sample 
protein concentration. Adjust resin or sample volume as appropriate. 
• Optimization of the lysis procedure is critical for maximizing protein yield. Some methods for protein extraction include 
using commercially available detergent-based reagents, such as Thermo Scientific B-PER Bacterial Protein Extraction 
Reagent with Enzymes (Product No. 90078), and mechanical methods, such as freeze/thaw cycles, sonication or French 
press. Add EDTA-free protease inhibitors, such as Thermo Scientific Halt Protease Inhibitor Cocktail, EDTA-free 
(Product No. 78437), to protect proteins from degradation.  
• Overexpressed proteins can be sequestered in inclusion bodies. The Cobalt Superflow Resin is compatible with 
purification under native or denaturing conditions. Inclusion bodies containing His-tagged proteins can be solubilized in 
8M urea, 6M guanidine or Thermo Scientific Inclusion Body Solubilization Reagent (Product No. 78115) and purified 
with the Cobalt Superflow Resin, but a denaturant must be added to buffers so the protein remains soluble throughout the 
procedure.  
• For liquid chromatography (LC) applications, use highly pure buffer components and ultrapure water. Use low-
absorbance imidazole (Fisher Scientific, Product No. BP 305-50) to avoid UV interference. Degas or filter buffers 
through a 0.45μm filter before use.  
• Avoid using chelators such as EDTA, which will disrupt the function of the cobalt resin and potentially strip cobalt from 
the resin.  
• Reducing agents, such as 10mM DTT and 5mM TCEP, have been tested and do not affect function of the resin; 
however, avoid using higher concentrations of these reducing agents. 
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Recommended Buffers 
Note: For some specific proteins or expression systems, adjustments to the imidazole concentration may be required to 
decrease nonspecific binding or increase yield. 
For native conditions: 
• Equilibration Buffer: 20mM sodium phosphate, 300mM sodium chloride, 5mM imidazole; pH 7.4 
• Wash Buffer: 20mM sodium phosphate, 300mM sodium chloride, 10-15mM imidazole; pH 7.4 
• Elution Buffer: 20mM sodium phosphate, 300mM sodium chloride, 150mM imidazole; pH 7.4 
 
For denaturing conditions: 
• Equilibration Buffer: 20mM sodium phosphate, 300mM sodium chloride, 6M guanidine•HCl, 5mM imidazole; pH 7.4 
• Wash Buffer: 20mM sodium phosphate, 300mM sodium chloride, 6M guanidine•HCl, 10-15mM imidazole; pH 7.4 
• Elution Buffer: 20mM sodium phosphate, 300mM sodium chloride, 6M guanidine•HCl, 150mM imidazole; pH 7.4 
 
For regeneration: 
• MES Buffer: 20mM 2-(N-morpholine)-ethanesulfonic acid, 0.1M sodium chloride; pH 5.0 
• Ultrapure water 
• 20% ethanol in ultrapure water 
 
For clean-in-place: 
• 6M guanidine•HCl with 1% non-ionic detergent 
• Ultrapure water 
 
Procedure for Purification of His-tagged Proteins Using an LC System  
Note: Monitor and collect all fractions during a purification to avoid accidental loss of target protein. User can adjust sample 
collection based on their needs and comfort level with the purification methods used. Maximum flow rates will be dependent 
on application and equipment used. The procedure may be performed at room temperature or 4°C. 
 
Additional Materials Required 
• Suitable LC system 
• Empty column for resin packing (follow column manufacturer’s protocol for packing) 
• Recommended buffers (see Recommended Buffers Section) and volumes (see below) 
 
1. Pack an appropriate-sized column with resin according to column manufacturer’s protocol. Ensure the packing flow rate 
is at least 20% faster than the flow rate to be used during purification. 
2. Equilibrate the column and all buffers to working temperature. Perform purifications at room temperature or at 4°C. 
Ensure that all solutions are degassed.  
3. Prepare the LC system by washing pumps and filling tubing with buffer. To avoid introducing air into the system, allow 
a few drops of buffer to flow from the tubing into the column top. Connect column to the tubing.  
4. Equilibrate the column with 5-10 column volumes of the Equilibration Buffer at a flow rate of 300cm/hr or less 
(150cm/hr recommended). 
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5. Apply any sample volume that does not exceed column-binding capacity for target protein at a flow rate of 300cm/hr or 
less (150cm/hr recommended).  
Note: Binding capacity is flow rate- and protein-dependent. Decreasing the flow rate during the sample load will 
increase binding capacity. Higher flow rates will decrease production time but may result in losing a small portion of the 
target protein in the flow-through fraction.  
Note: For maximum binding, prepare sample by mixing protein extract 1:1 with Equilibration Buffer (to adjust the 
sample to the ionic strength and pH of the Equilibration Buffer) before applying to the column.  
Note: If the sample contains insoluble matter, centrifuge or filter (0.45μm filter) before use.  
6. Wash the resin at a flow rate of 300cm/hr or less (150cm/hr recommended) with 10-15 column volumes of Wash Buffer 
or until the absorbance approaches baseline.  
Note: Due to the gentle binding characteristics of cobalt IMAC resin, excessive washing can elute target protein from the 
column. 
7. Elute at a flow rate of 300cm/hr or less (150cm/hr recommended) with approximately 5-10 column volumes of Elution 
Buffer and collect fractions.  
Note: Monitor protein elution by measuring the absorbance of the fractions at 280nm. The eluted protein can be directly 
analyzed by SDS-PAGE. To remove excess imidazole for downstream applications, use gel filtration or dialysis (e.g., 
Thermo Scientific Zeba Spin Desalting Columns or Slide-A-Lyzer Dialysis Cassettes; see the Thermo Scientific Related 
Products Section).  
8. Regenerate column by washing with 10 column volumes of Regeneration Buffer, followed by 10 column volumes of 
ultrapure water at a flow rate of 300cm/hr or less (150cm/hr recommended). The column is now ready for reuse (return  
to step 1), storage (proceed to step 9) or routine clean-in-place procedures (see the Procedure for Resin Cleaning-In-
Place).   
9. For storage, equilibrate the column with 5 column volumes of 20% ethanol. Seal column and store at 4oC. 
 
Procedure for Purification of His-tagged Proteins by Batch Method 
Note: The procedure may be performed at room temperature or 4°C. The Cobalt Superflow Resin allows for customization of 
your purification strategy. Purification conditions can be scaled as needed and performed in several formats. A batch method 
based on centrifugation is included below.  Alternatively, methods based on vacuum filtration or gravity flow can be used to 
collect flow-through, wash and elution fractions.  
 
A. Additional Materials Required 
• Sample-handling containers, such as centrifugation bottle or spin filters/columns 
• Recommended buffers (see Recommended Buffers Section) and volumes (see below) 
• End-over-end rotary mixer or equivalent mixing apparatus 
 
B. Procedure 
1. Add the required amount of Cobalt Superflow Resin to a container with 3-4X greater volume. Centrifuge for 2 minutes at 
700 × g and carefully remove and discard the supernatant. 
2. Add two resin-bed volumes of Equilibration Buffer and mix until the resin is fully suspended. 
3. Centrifuge for 2 minutes at 700 × g and carefully remove and discard buffer.  
4. Prepare sample by mixing the protein extract with Equilibration Buffer to a volume greater than or equal to the resin bed 
volume.   
5. Add the prepared protein extract to the tube and mix slowly for 30 minutes ensuring the resin remains suspended. For 
best results, use an end-over-end rotary mixer. 
6. Centrifuge for 2 minutes at 700 × g and carefully remove supernatant. If desired, save supernatant for downstream 
analysis. 
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7. Wash the resin with two resin-bed volumes of Wash Buffer. Centrifuge for 2 minutes at 700 × g and carefully remove 
supernatant. If desired, save supernatant for downstream analysis. 
8. Repeat wash step three times. 
9. Elute bound His-tagged proteins by resuspending resin bed in one resin-bed volume of Elution Buffer. Mix slowly for  
10 minutes ensuring that resin remains suspended. 
10. Centrifuge for 2 minutes at 700 × g. Carefully remove and save the supernatant.  
11. Repeat elution steps 9-10 two to four times, saving each supernatant fraction in a separate tube. 
12. Monitor protein elution by measuring the absorbance of the fractions at 280nm or by Thermo Scientific Coomassie Plus 
(Bradford) Assay Reagent (Product No. 23238) or Pierce 660nm Protein Assay (Product No. 22660). Dilute the samples 
at least 1:2 to decrease the imidazole concentration before performing the protein assay to avoid interference with the 
assay. The eluted protein can be directly analyzed by SDS-PAGE. To remove excess imidazole for other downstream 
applications, use gel filtration or dialysis (e.g., Thermo Scientific Zeba Spin Desalting Columns or Slide-A-Lyzer 
Dialysis Cassettes). 
13. Regenerate the resin by resuspending resin with 10 resin-bed volumes of Regeneration Buffer. Centrifuge tube for              
2 minutes at 700 × g and discard the supernatant. Repeat once. 
14. Resuspend resin with 10 resin-bed volumes of ultrapure water. Centrifuge tube for 2 minutes at 700 × g. Discard 
supernatant. Repeat once. The column is now ready for reuse (return to step 1), storage (proceed to step 15) or routine 
clean-in-place procedures (see the Procedure for Resin Cleaning-in-Place).   
15. For storage, re-suspend resin with 1 column volume of 20% ethanol. Seal column and store at 4°C. 
  
Procedure for Resin Cleaning-in-Place  
Note: The Cobalt Superflow Resin can be used multiple times without affecting protein yield or purity. To prevent cross 
contamination of samples, designate a given column to one specific fusion protein. If an increase in backpressure is observed, 
the following cleaning procedures can be followed. 
1. To remove precipitated or denatured proteins and hydrophobic substances, wash resin with 2 volumes of                         
6M guanidine•HCl plus 1% nonionic detergent (e.g., Thermo Scientific Triton X-100 Surfact-Amps Detergent Solution, 
Product No. 28314) with 10 minutes of contact time, followed by 5 volumes of ultrapure water at a flow rate of less than 
300cm/hr (150cm/hr recommended). 
2. Store resin in 20% ethanol at 4°C. 
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Troubleshooting 
Problem Possible Cause Solution 
Low protein yield Poor expression of soluble protein  Optimize expression conditions (e.g., lower temperature during 
induction, vary induction time, optimize codon usage for 
expression system) 
His-tagged protein formed 
inclusion bodies 
Alter growth conditions to minimize inclusion body formation 
and maximize soluble protein yield; alternatively, solubilize 
inclusion bodies and perform the purification with a 
compatible denaturant (e.g., Thermo Scientific Inclusion Body 
Solubilization Reagent, Product No. 78115) 
Insufficient cell lysis and 
extraction 
Optimize cell lysis protocol 
Fusion protein did not bind to the 
column 
Verify the sequence  
Perform an ELISA or Western blot using an antibody against 
the His tag to confirm the His tag is present 
Flow rate was too fast Decrease flow rate during binding to allow for greater 
residence time and increased binding of fusion protein 
Column washing was too extensive Reduce imidizole concentration in wash buffer  
Reduce amount of wash buffer used 
Poor protein 
purity 
Insufficiently washed Increase duration of wash  
Modify imidazole concentration and pH of the Equilibration or 
Wash Buffer 
Column was dirty Follow clean-in-place procedure to remove nonspecifically 
bound proteins 
Slow column flow Column was overloaded Apply less protein extract onto the column  
Extract was too viscous or highly 
particulate 
Dilute lysate with Equilibration Buffer to decrease viscosity  
Centrifuge lysate at higher speed to remove particulate 
 
Related Thermo Scientific Products 
25214-7 HisPur Ni-NTA Superflow Agarose  
25236-9 Pierce™ Glutathione Superflow Agarose  
89896-8 Pierce Centrifuge Columns 
87785 Halt™ Protease Inhibitor Cocktail (100X), EDTA-free 
88661 Pierce Protease Inhibitor Tablets, EDTA-free 
88270 Pierce High Capacity Endotoxin Removal Resin 
90078 B-PER™ Bacterial Protein Extraction Reagent with Enzymes 
88282 Pierce LAL Chromogenic Endotoxin Quantitation Kit 
23238 Coomassie Plus™ (Bradford) Assay Reagent 
22660 Pierce 660nm Protein Assay Reagent 
78115 Inclusion Body Solubilization Reagent 
89891-4 Zeba Spin Desalting Columns, 7K MWCO 
87730-8 Slide-A-Lyzer™ G2 Dialysis Cassettes, 10K MWCO 
28313-4 Triton™ X-100 Surfact Amps™ Detergent Solution 
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Triton is a trademark of The Dow Chemical Company.  
 
This product (“Product”) is warranted to operate or perform substantially in conformance with published Product specifications in effect at the time of sale, 
as set forth in the Product documentation, specifications and/or accompanying package inserts (“Documentation”) and to be free from defects in material and 
workmanship. Unless otherwise expressly authorized in writing, Products are supplied for research use only. No claim of suitability for use in applications 
regulated by FDA is made. The warranty provided herein is valid only when used by properly trained individuals. Unless otherwise stated in the 
Documentation, this warranty is limited to one year from date of shipment when the Product is subjected to normal, proper and intended usage. This 
warranty does not extend to anyone other than the original purchaser of the Product (“Buyer”). 
No other warranties, express or implied, are granted, including without limitation, implied warranties of merchantability, fitness for any particular 
purpose, or non infringement. Buyer’s exclusive remedy for non-conforming Products during the warranty period is limited to replacement of or 
refund for the non-conforming Product(s).  
There is no obligation to replace Products as the result of (i) accident, disaster or event of force majeure, (ii) misuse, fault or negligence of or by Buyer, (iii) 
use of the Products in a manner for which they were not designed, or (iv) improper storage and handling of the Products. 
 
Current product instructions are available at www.thermoscientific.com/pierce. For a faxed copy, call 800-874-3723 or contact your local distributor. 
© 2012 Thermo Fisher Scientific Inc. All rights reserved. Unless otherwise indicated, all trademarks are property of Thermo Fisher Scientific Inc. and its 
subsidiaries. Printed in the USA. 
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Life Sciences
ChromXACT columns
The ChromXACT platform consists of fixed-bed height 
chromatography columns specifically developed for 
standardized large-scale purification of biopharmaceuticals 
in a GMP environment. The robust columns are high-quality 
options for cost-efficient purification processes. The 
ChromXACT column (Fig 1) has a sanitary, user-friendly 
design that allows easy handling, cleaning, and maintenance. 
A built-in swivel stand allowing easy maintenance is a key 
feature of the column. Other design features include an 
improved pack-in-place nozzle to simplify column operation 
and disposable bed supports that make cleaning operations 
easier and reduce risk of cross-contamination.
The ChromXACT platform offers:
• Focused functionality
• Smart design for easy use and maintenance
• A viable option for GMP manufacturing
General description
ChromXACT columns are available in 400, 600, and 800 mm 
diameters and a variety of tube heights from 15 to 30 cm 
(see “Ordering information”). The columns are pressure rated 
for operation at 3.8 bar (0.38 MPa, 55.11 psi) and are intended 
for use with well-established GE Healthcare Life Sciences 
media (resins) such as the Sepharose™ Fast Flow and High 
Performance families. The range of column tubes enables 
tailoring of the columns to meet specific process requirements. 
Focused functionality
Cost-effective process performance 
The novel design of ChromXACT columns is focused 
on the critical aspects of purification; non-essential 
components have been minimized, while ensuring effective 
chromatographic performance. The reduced number of 
components included in the columns enables easy and 
efficient packing, cleaning, and maintenance operations.
Fig 1. ChromXACT columns for large-scale purification processes.
Contained packing
All column operations are performed in a “closed system” 
environment, resulting in less risk of the operator coming in 
contact with hazardous chemicals and of the target product 
being exposed to contamination. In this way, overall safety 
and hygienic operation are improved. Manual operations are 
simplified, and by following the general packing methods 
that come as part of the documentation with the column, 
reproducible column packing can be achieved. (for more 
information, study application note 29-0967-16).
Smart design 
Simplified operation
Once the column is assembled, no lifting gear is required for 
packing, operation, unpacking, or cleaning-in-place (CIP). 
As column operations are easily performed, this frees up 
resources and thereby simplifying large-scale operations.
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Distribution system
The column features reliable and efficient distribution 
systems at both the top and bottom of the column. As the 
flow profiles are the same for both distribution systems, 
the column can be used in a bidirectional manner. Uniform 
mobile-phase distribution is further facilitated by the use of 
disposable bed supports of either 10 μm or 20 μm porosity. 
The choice of bed support is dependent of the mean particle 
size of the chromatography medium.
Pack-in-place nozzles
The ChromXACT column utilizes two simplified, manually 
operated, pack-in-place nozzles at the top and bottom of the 
column for packing and unpacking. The user-friendly design 
of the handles allows for smooth and easy nozzle control 
(Fig 2). The inner diameters of the various ports on the two 
identical pack-in-place nozzles are provided in Table 1. The 
ChromXACT column SPI and SPO nozzle ports have the same 
dimensions for all column sizes, whereas the MP port sizes 
are larger for larger diameter ChromXACT columns.
PACK position
When the nozzle is in the PACK position (middle 
position), the nozzle tip is halfway inserted into the 
column, allowing liquids or slurry to be pumped into 
the column through the slurry port inlet.  
MP = mobile phase inlet; SPI = slurry port inlet;  
SPO = slurry port outlet.
MP
SPI
SPO
RUN position
When the nozzle is in the RUN position, the nozzle tip 
is level with the bed support. The fluid path through 
the nozzle into the column is closed and the slurry will 
pass through the SPO. This position is used when filling 
the pack tubings and when establishing pack flow 
velocity prior to packing. This is also the position used 
during run as the mobile phase is accessible via MP.
UNPACK position
When the nozzle is in the UNPACK position, the nozzle 
is fully extended into the column. This position opens 
a passage behind the nozzle and liquid and slurry 
can exit the column through the slurry port outlet. 
Cleaning solution can be pumped through the 
nozzles and sprayed into the column. In this way, 
cleaning is easy and effective, with no need to 
dismantle the column.
Fig 2. The three positions of the ChromXACT nozzle when packing from the top.
Built-in swivel stand
The change-over process when switching between column 
tubes is straightforward and can be easily performed by the 
operator or other production personnel with appropriate 
training. The ChromXACT column utilizes a practical swivel 
stand that facilitates the change-over process through 
simplified access to the bed support and meshes of the 
distribution system at the top of the column (Fig 3). The swivel 
stand also enables easy maintenance, such as the changing 
of seals, O-rings, and more.
Table 1. Dimensions of the ChromXACT nozzle ports
Nozzle port Inner diameter of port (i.d.) Connector size
SPI 19 mm TC 50
SPO 22.1 mm TC 50
MP 400 14 mm TC 25
MP 600 19 mm TC 50
MP 800 22.1 mm TC 50
Fig 3. The ChromXACT column features a swivel-stand design that allows 
easy access to bed supports and simplified maintenance.
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Consistent performance
Height equivalent to a theoretical plate (HETP) tests 
demonstrate consistent chromatographic performance 
with ChromXACT columns (Fig 4 and Table 2). Results from 
packed bed stability endurance tests show that the column 
performance remains good after prolonged use. 
Fig 4. HETP tests on three different packs of DEAE Sepharose Fast Flow 
medium in a 400 mm, 20 cm column tube height ChromXACT column 
demonstrate consistency of chromatographic performance. Runs were 
conducted using a pulse injection of 0.1 column volumes of 2% acetone in 
water and an elution velocity of 30 cm/h.
Table 2. Consistency of performance with the ChromXACT platform can be 
demonstrated using HETP tests with DEAE Sepharose Fast Flow medium and 
various combinations of ChromXACT columns and bed heights (results fall 
within the preassigned acceptance range)
Column  
diameter (mm)
Results Bed height (cm)
15 20 30
400 Plates/m 4200 3700 3600
400 A
s
* 1.1 1.4 1.4
600 Plates/m 3300 4300 4000
600 A
s
* 1.4 1.3 1.2
800 Plates/m 3200 3000 3100
800 A
s
* 1.4 1.2 1.1
*Peak asymmetry factor
Fig 5. The column can be lowered to allow removal of the column tube for 
maintenance or replacement. 
Easy maintenance
The pack-in-place nozzles and a decreased number of 
o-rings and seals in the ChromXACT columns allow for low 
maintenance cost. The swivel-stand design of ChromXACT 
columns (Fig 3) offers many practical advantages during 
maintenance, such as hoist-free handling and easy access to 
column tubes and disposable bed supports (Fig 5).
GE Healthcare service agreements are tailored to keep your 
column operating in good condition throughout the column 
lifecycle. Several preventive maintenance packages are 
available when purchasing the ChromXACT column. Contact 
your GE Healthcare sales representative for additional 
information.
Principle of operation
The ChromXACT column nozzles have three positions, which 
are set manually by means of a lever mechanism. The three 
positions enable packing, operation, and unpacking/cleaning 
to be performed.
The ChromXACT column can be packed using a membrane 
pump or a dedicated packing station, together with 
appropriate accessories (see “Ordering information”).
Scalability
ChromXACT columns are designed with medium- to large-
scale production in mind. Scaling up a chromatographic 
process is easily performed with maintained reproducibility 
and convenience.
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Customized solutions
Column dimensions
ChromXACT columns are available in three dimensions, 
400, 600, and 800 mm (Table 3). The columns are designed 
and constructed around the same design principle. There 
are eight standard column configurations (see “Ordering 
information”). Bed volume flexibility is achieved through 
column tubes that are available in 1 cm height increments 
from 15 to 30 cm.
Packing equipment
The column can be packed using separate membrane pump, 
pressure sensor, and flow meter. 
The ChromXACT columns can also be used with a packing 
station (Fig 6). Using a packing station makes column priming 
and packing a simple operation, reducing the operator’s time 
to a minimum. For operation, packing stations only require a 
supply of compressed air. To select appropriate equipment 
for your set-up, see “Accessories”.
Table 3. Weights, volumes, and dimensions of ChromXACT columns
Description Max operating 
pressure (bar)
Volume (L) Column tube  
height (cm)
Weight, empty 
column (kg)
Footprint  
(mm × mm)
ChromXACT 400 3.8 18.8 to 37.7 Min. 15, Max. 30 Min. 120, Max. 126 730 × 750
ChromXACT 600 3.8 42.4 to 84.8 Min. 15, Max. 30 Min. 233, Max. 247 950 × 750
ChromXACT 800 3.8 75.4 to 150.8 Min. 15, Max. 30 Min. 495, Max. 512 1200 × 970
Fig 6. A packing station such as the one illustrated above can be used 
with the ChromXACT column. For more details about set-up, please 
contact your local GE Healthcare representative.
Sanitary design
One key aspect of GMP production is operation at hygienic 
standards. The design of ChromXACT columns allows operation 
at high standards of hygiene, and the efficiency of column 
sanitization has been investigated by microbiological challenge 
testing. A column packed with Sepharose Fast Flow medium 
was challenged with E. coli and incubated for 16 to 20 h at 
room temperature before being treated with 1 M sodium 
hydroxide (NaOH) and then sampled. The results show 
sanitization with 1 M NaOH to be effective. Despite the high 
levels of microbiological challenge, no challenging organisms 
were found after sanitization. 
Full study details are described in Application note: Sanitization 
of ChromXACT columns, GE Healthcare, 29-0529-98, Edition AA 
(2013).
Materials of construction 
ChromXACT column tube is made from acrylic and the 
disposable bed supports are constructed from polyethylene 
with 10 μm or 20 μm porosity (see Table 4 for a list of 
materials for column construction). The materials in contact 
with process fluid used in the ChromXACT column have been 
chosen for their biological and chemical compatibility with 
samples, buffers, and solutions normally used during column 
operation and sanitization procedures. These materials 
comply with USP Class VI as well as FDA 21 CFR Part 177 and 
are free from animal-derived components in compliance with 
EMEA/410/01 Rev 2. 
Table 4. Material of construction for ChromXACT columns
Operating part Material
Column tube PMMA*/Acrylic
Bottom and top backing plate Stainless steel 316
Distributor PP†
Distributor meshes PP†
Support meshes PP†
Stream stoppers PP†
Mobile-phase tube PP†
Bed support screw PEEK‡
Bed support net PE§
O-rings EPDM¶ and FEP**
* PMMA = poly(methyl methacrylate); † PP = polypropylene; ‡ PEEK = polyether ether ketone;
§ PE = polyethylene; ¶ EPDM = ethylene propylene diene monomer;
** FEP = fluorinated ethylene propylene
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Chemical resistance
Construction materials in the ChromXACT column are 
resistant to most chemical agents used in chromatography, 
including buffer solutions for adsorption, elution, and 
washing, and to solutions effective in cleaning, sanitization, 
and storage. Table 5 lists the general chemical resistance of 
the ChromXACT column.
Documentation and support
Comprehensive regulatory support documentation (EC 
declaration of conformity, material conformity, material 
certificates, production records) is provided with the column. 
Installation and operation qualification (IQ/OQ) packages are 
available as an option. Regulatory support documentation 
simplifies validation and thereby reduces start-up time, 
enabling the usage of the column in GMP production of 
biopharmaceuticals.
The same level of documentation is available for all  
column sizes. 
To improve the handling and to maximize up-time on the 
ChromXACT column, a comprehensive solution suite including 
a thorough documentation package is available. The column 
comes with regulatory information, column operating 
instructions, general specification, site preparation guide, 
assembly drawings, and a spare part and accessory list. 
As an option, accessories, spare parts, and services (IQ/OQ, 
preventive maintenance packages) can be ordered.
Installation and framework specifications
ChromXACT column characteristics are listed in Table 6.
Table 5. Chemical resistance of ChromXACT columns
Chemical Conc. (% v/v) Time/cycle restrictions Comments
1-propanol 20% 1 to 16 h Bed support degassing/priming
Acetic acid 25% 3 h CIP
Acetone 2% 1 h Function test
Ammonium sulfate 2 M 5 h Adsorption
Ethanol 20% 12 mo and max 0.5 bar Storage
Ethanol 70% 1 h Wiping external surfaces*
Ethanol/acetic acid 20%/10% 3 h CIP
Guanidine hydrochloride 6 M 5 h CIP
Hydrochloric acid 0.1 M (pH 1) 1 h CIP
Hydrogen peroxide 10% 1 h Fume, wiping external surfaces
Isopropanol 10%/30% 1 h CIP
Phosphoric acid 5% 16 h For passivation of stainless steel parts
Per-acetic acid 4% 1 h Fume, wiping external surfaces
Sodium chloride 0 to 3 M 3 h Purification, CIP
Sodium hydroxide 1 M (pH 14) 24 h CIP
Sodium hydroxide 0.01 M (pH 12) 12 mo Storage
Sodium sulfate 1 M 3 h Adsorption
Sodium hydroxide/ethanol 1 M/20% 3 h CIP
Urea 8 M 5 h Purification, CIP
Commonly used aqueous buffers  
for chromatographic use 
 
10 to 250 mM  
pH 3 to 10 24 h Equilibration, adsorption, elution
*70% ethanol should not be used with acrylic surfaces, for example column tubes
Table 6. ChromXACT column characteristics
ChromXACT 400 ChromXACT 600 ChromXACT 800
Load bearing (transportation) Max column weight* (kg) 126 247 512
Column moved with forklift 
Min. space† L × H (mm) 950 × 1300 950 × 1300 1170 × 1300
Load bearing (transportation) 
Max. column weight‡ - not including accessory equipment (kg) 164 331 662
Footprint L × W (mm) 730 × 750 950 × 750 1200 × 970
Service access area L × W (mm) 1730 × 1750 1950 × 1750 2200 × 1970
* Empty column with 30 cm column tube height
† Minimum space requirements, including 10 cm clearance margins, when moving ChromXACT through doors, corridors, and elevators.
‡ Weight of packed column with 30 cm column tube height
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Ordering information
ChromXACT columns and column tubes:  
Standard configurations
Column i.d /tube height Code number
ChromXACT 400 mm/15 cm 29-0282-95
ChromXACT 400 mm/20 cm 29-0282-96
ChromXACT 400 mm/25 cm 29-0282-97
ChromXACT 400 mm/30 cm 29-0282-98
ChromXACT 600 mm/15 cm 29-0283-00
ChromXACT 600 mm/20 cm 29-0283-01
ChromXACT 600 mm/25 cm 29-0283-02
ChromXACT 600 mm/30 cm 29-0283-03
ChromXACT 800 mm/15 cm 29-0283-06
ChromXACT 800 mm/20 cm 29-0283-07
ChromXACT 800 mm/25 cm 29-0283-08
ChromXACT 800 mm/30 cm 29-0283-09
For ordering other configurations, please contact your local sales representative.
Accessories
Packing can be conducted using a packing station or a manual membrane pump. Recommended accessories  
and number of packs to be purchased for the two different packing setups are provided below.
Item
Units/
pack
Number of recommended packs of each item
Code number
Packing station Membrane pump
400 mm 600 mm 800 mm 400 mm 600 mm 800 mm
Tie rod kits
Tie rod kit, short for tube heights ≤ 20 cm 1 - - - - - - 29-0377-71
Tie rod kit, long for tube heights > 20 cm 1 - - - - - - 29-0377-72
Bed support tool* 
(for assembling/disassembling  
of bed support nut) 1 - - - - - - 29-0301-22
Connectors
Connector TC 25/i.d. 10 mm–TC 25/i.d. 14 mm 1 - - - - - - 29-0497-65
Connector TC 25/i.d. 10 mm–TC 50/i.d. 22 mm 1 - - - - - - 18-1174-11
Connector TC 25/i.d. 14 mm–TC 50/i.d. 22 mm 1 1 - - 1 - - 18-1174-12
Flow meter
Flow capacity appropriate for  
the pump flow rate, TC50-ports, 6 bar 1 1 1 1 1 1 1
No available 
GE Healthcare 
product
Media stirrer 150 mm 1 1 1 1 1 1 1 28-9191-04
Membrane valve 
Manual diaphragm valve i.d. 15.75 mm, 2 × TC 25 1 - - - - - - 28-9382-07
Manual diaphragm valve i.d. 22.1 mm, 2 × TC 50 1 - - - - - - 28-9382-08
MP tube support 1 2 2 2 2 2 2 29-0556-95
Nozzle o-ring mounting tool† 
(for mounting of o-rings on nozzle tip) 1 - - - - - - 18-1161-75
O-ring disassembling tools
O-ring pick, plastic for o-ring removal 1 1 1 1 1 1 1 29-0327-69
O-ring removal tool 1 - - - - - - 28-9820-31
Pallet lifter 
Min. lifting weight 800 kg. Min. lifting height  
800 mm. Max. fork span 540 mm. 1 1 1 1 1 1 1
No available 
GE Healthcare 
product
ChromXACT column tubes
For buying additional individual column tubes, consult the 
table below:
Column  
tube height
Code number Code number Code number
i.d. 400 mm i.d. 600 mm i.d. 800 mm
15 cm 29-0364-74 29-0359-20 29-0872-68
16 cm 29-0364-75 29-0359-21 29-0872-74
17 cm 29-0364-76 29-0359-22 29-0872-75
18 cm 29-0364-77 29-0359-23 29-0872-76
19 cm 29-0364-78 29-0359-24 29-0872-77
20 cm 29-0364-79 29-0359-25 29-0872-78
21 cm 29-0364-81 29-0359-29 29-0872-79
22 cm 29-0364-82 29-0359-30 29-0872-80
23 cm 29-0364-83 29-0359-31 29-0872-81
24 cm 29-0364-84 29-0359-32 29-0872-82
25 cm 29-0364-85 29-0359-33 29-0872-83
26 cm 29-0364-86 29-0359-34 29-0872-85
27 cm 29-0364-87 29-0359-35 29-0872-86
28 cm 29-0364-88 29-0359-36 29-0872-87
29 cm 29-0364-89 29-0359-37 29-0872-88
30 cm 29-0364-90 29-0359-38 29-0872-89
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Item
Units/
pack
Number of recommended packs of each item
Code number
Packing station Membrane pump
400 mm 600 mm 800 mm 400 mm 600 mm 800 mm
Pneumatic regulator
Air filter regulator for membrane pump  
up to 100 L/min flow rate 1 - - - 1 1 - 28-9268-30
Air filter regulator for membrane pump  
up to 200 L/min flow rate 1 - - - - - 1 29-0661-76
Pneumatic connector kit 1 - - - 1 1 1 29-0662-52
Pressure gauge
Pressure gauge, 0-6 bar, TC 25 1 1 - - 1 - - 28-9343-23
Pressure gauge, 0-6 bar, TC 50 1 - 1 1 1 2 2 28-9343-24
Rupture disc
Rapture disc 4.2 bar, TC 25 1 - - - - - - 29-0139-97
Rapture disc 4.2 bar, TC 50, i.d. 1” 1 2 2 - 2 2 - 29-0139-98
Rapture disc 4.2 bar, TC 50, i.d. 1.5” 1 - - 2 - - 2 29-0921-81
Shutter valve, 3 ports, 2-way
Shutter valve, 3-port, 2-way i.d. 15.75 mm, TC 25 1 1 - - 1 - - 44-5499-90
Shutter valve, 3-port, 2-way i.d. 22 mm, TC 50 1 1 2 2 3 4 4 44-1583-01
Shutter valve, 4 ports, 4-way
Shutter valve, 4-port, 4-way i.d. 10 mm, TC 25 1 - - - - - - 18-1012-57
Shutter valve, 4-port, 4-way i.d. 20 mm, TC 50 1 - - - 1 1 1 44-2302-01
TC-clamp
TC 25-clamp 5 2 - - 2 - - 28-9381-90
TC 50-clamp 5 5 6 6 7 8 8 28-9381-91
TC-gasket
TC-gasket, i.d. 15.8 mm, TC 25 5 2 - - 2 - - 28-9381-88
TC-gasket, i.d. 22.1 mm, TC 50 5 5 5 5 7 6 6 28-9668-86
TC-gasket, i.d. 34.9 mm, TC 50  
(For pressure gauge TC 50) 5 - 2 2 - 2 2 28-9381-89
T-junctions
T-junction with short outlet i.d. 15.75 mm, 3 × TC 25 1 - - - - - - 29-0521-07
T-junction with short outlet i.d. 22 mm, 3 × TC 50 1 2 2 - 2 2 - 44-5509-89
T-junction i.d. 34.8 mm, 3 × TC 50 1 - - 2 - - 2 28-9381-71
Tool kit 1 1 1 1 1 1 1 29-0287-43
Tubing (PVC) with TC 25 connections
Tubing  i.d. 10 mm, 900 mm 1 - - - - - - 18-1012-62
Tubing  i.d. 10 mm, 1400 mm 1 - - - - - - 18-1012-63
Tubing  i.d. 10 mm, 1700 mm 1 - - - - - - 18-1012-64
Tubing  i.d. 10 mm, 2000 mm 1 - - - - - - 18-1012-87
Tubing  i.d. 14 mm, 750 mm 1 - - - - - - 18-1027-28
Tubing  i.d. 14 mm, 1800 mm 1 1 - - 1 - - 18-1027-29
Tubing (PVC) with TC 50 connections
Tubing  i.d. 19 mm, 900 mm 1 - - - - - - 28-4042-30
Tubing  i.d. 19 mm, 1400 mm 1 - - - - - - 28-4042-35
Tubing  i.d. 19 mm, 2000 mm 1 5 3 - 7 5 - 28-4042-32
Tubing  i.d. 19 mm, 4000 mm 1 5 5 - 5 5 - 28-4042-33
Tubing (PVC) with TC 50 connections
Tubing  i.d. 25 mm, 900 mm 1 - - - - - - 29-0950-32
Tubing  i.d. 25 mm, 1400 mm 1 - - - - - - 29-0950-34
Tubing  i.d. 25 mm, 2000 mm 1 - - 3 - - 5 29-0950-36
Tubing  i.d. 25 mm, 4000 mm 1 - - 5 - - 5 29-0950-38
Tubing (PTFE) with TC 50 connections
Tubing  i.d. 38.1 mm, 2000 mm 1 - 3 3 - 3 3 28-9381-38
Tubing  i.d. 38.1 mm, 5000 mm 1 - - - - - - 28-9381-39
Tubing holder
(For upper SPI and SPO tubing) 1 1 1 1 1 1 1 29-0278-73
* A bed support tool is provided with each column at delivery
†  GE Healthcare recommendation is to replace the entire nozzle available as spare part, see Operating instructions 29-0224-41
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Recommended packing station and pump for ChromXACT columns
Item
Units/
pack
No. of recommended packs Pump flow  
capacity (L/min)
Required air  
supply (m3/min)
Code number
400 mm 600 mm 800 mm
Packing station
Chromaflow™ packing station Pack 50 1 1 - - 50 0.5 18-1163-74
Chromaflow packing station Pack 100 1 - 1 - 100 1.0 18-1162-08
Chromaflow packing station Pack 200 1 - - 1 200 1.5 Custom ordering
Single pump
Membrane pump (60 L/min) 1 1 - - 60 0.5 29-0339-65
Membrane pump (100 L/min) 1 - 1 - 100 1.0 28-9206-12
Membrane pump (200 L/min) 1 - - 1 200 1.5 29-0647-54
Related literature
Application notes Code number
Sanitization of ChromXACT columns 29-0529-98
Packing of ChromXACT columns 29-0967-16
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Number Description 
88270 Pierce High-Capacity Endotoxin Removal Resin, 10mL of settled resin supplied as 50% slurry in 
20% ethanol 
88271 Pierce High-Capacity Endotoxin Removal Resin, 100mL of settled resin supplied as 50% slurry in 
20% ethanol 
88272 Pierce High-Capacity Endotoxin Removal Resin, 250mL of settled resin supplied as 50% slurry in 
20% ethanol 
88273 Pierce High-Capacity Endotoxin Removal Spin Column, 0.25mL, 5 columns, each column contains 
25% slurry in 20% ethanol 
88274 Pierce High-Capacity Endotoxin Removal Spin Column, 0.50mL, 5 columns, each column contains 
25% slurry in 20% ethanol 
88275 Pierce High-Capacity Endotoxin Removal Spin Column, 0.50mL, 25 columns, each column 
contains 25% slurry in 20% ethanol 
88276 Pierce High-Capacity Endotoxin Removal Spin Column, 1.0mL, 5 columns, each column contains 
25% slurry in 20% ethanol 
88277 Pierce High-Capacity Endotoxin Removal Spin Column, 1.0mL, 25 columns, each column contains 
25% slurry in 20% ethanol 
 
 Storage: Upon receipt store at 4°C. Product shipped at ambient temperature.  
 
Introduction 
The Thermo Scientific™ Pierce™ High Capacity Endotoxin Removal Resin contains porous cellulose beads that have been 
surface modified with covalently attached, modified ε-poly-L-lysine. Modified polylysine has a high affinity for endotoxins 
with the affinity ligand eliminating toxicity associated with alternative technologies using polymixin B ligands and sodium 
deoxycholate buffers. The binding capacity of 2,000,000 Endotoxin Units (EU)/mL allows endotoxin levels to be reduced by 
99% in samples containing 10,000EU/mL; typical protein samples processed with the resin have a final endotoxin 
concentration below 5EU/mL. The resin is offered in a slurry format for custom packing of endotoxin removal columns for 
gravity flow or continuous flow (10-15 mL/hour) applications or a spin column format for the fast, single-use batch method. 
Removal of endotoxins from differing volumes of biological samples can be done in ≥ 1 hour (see Table 1). 
Endotoxins consist of lipopolysaccharides (LPS), which are biologically active, structural components of the outer cell 
membrane of all gram-negative bacteria. Small amounts of endotoxin in recombinant protein preparations can cause side 
effects, including endotoxin shock, tissue injury and death in host organisms; therefore, it is essential to remove endotoxins 
from drugs, injectables and other biological products. 
One milliliter of this resin can reduce the endotoxin concentration from a 1mL sample containing 10,000EU to < 5EU. 
MAN0016351 
Rev A.0 
Pub. Part No. 2162373.3  
Pierce High-Capacity Endotoxin 
Removal Resin 
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Procedure Summary 
 
 
Important Product Information 
• All materials (e.g., containers, buffers and pipette tips) must be endotoxin-free. Use endotoxin-free water to prepare 
buffers and other solutions. 
• Endotoxin binding to the resin occurs at pH 6-8; Equilibrate the resin with an endotoxin-free buffer at neutral pH that 
includes 10-50mM sodium phosphate buffer or Tris-HCl buffer containing 0.1-0.2M NaCl. Check the sample pH and 
adjust to pH 6-8 with 0.1M NaOH or 0.1M HCl.  
• The speed of sample application and wash depends on the sample endotoxin state. Free endotoxin can bind quickly to the 
resin, but protein-bound endotoxin may require longer incubation, slower flow rates and/or multiple recycling of the 
sample through the column. Tightly bound endotoxin may be incubated overnight at room temperature or 4°C in batch 
mode with gentle shaking. 
• Resins can be used a minimum of five times without loss of endotoxin-removal efficiency. 
• Sample volumes vary depending on the chosen pre-loaded column size (see Table 1). 
Table 1. Sample volumes for the Thermo 
Scientific Pierce High-Capacity Endotoxin 
Removal Columns. 
Column size (mL) Sample volume (mL) 
0.25 0.5-1.0 
0.50 1.0-4.0 
1.0 2.0-10.0 
 
Additional Materials Required  
• Endotoxin-free, ultrapure water 
• Endotoxin-free 15mL conical collection tubes (for 0.25mL and 0.5mL spin columns) 
• Endotoxin-free 50mL conical collection tubes (for 1.0mL spin columns) 
• Regeneration buffer: 0.2N NaOH for overnight incubation at room temperature OR 0.2N NaOH and 95% ethanol for       
1-2 hours of incubation at room temperature 
Note: Regenerate the column before the first use and after each subsequent use. 
• 2M NaCl solution: If possible, use ready-made endotoxin-free NaCl solution; alternatively, dissolve pure sodium 
chloride crystals in endotoxin-free water 
• Variable-speed centrifuge with rotor and carriers capable of handling 15mL and 50mL conical collection tubes  
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Endotoxin Removal Procedure using the Column Method 
• Regenerate the resin before the first use and after each subsequent use.  
• Equilibrate all solutions and the resin to room temperature before use. 
• Degas the resin slurry before applying to the column to prevent air bubbles from clogging the column and reducing flow. 
1. To degas the resin, place slurry in a suction filter flask and degas with gentle stirring. 
2. Pour the degassed resin slurry into an appropriately sized column and allow the resin to settle.  
3. Regenerate the resin by washing with five resin-bed volumes of 0.2N NaOH overnight at room temperature OR five 
resin-bed volumes of 0.2N NaOH in 95% ethanol for 1-2 hours at room temperature. 
4. Wash with five resin-bed volumes of 2M NaCl.  
5. Wash with five resin-bed volumes of endotoxin-free, ultrapure water. 
6. Equilibrate with five resin-bed volumes of endotoxin-free buffer. 
7. Apply sample to the column at a flow rate of 10-15mL/hr and collect the flow-through (see the Important Product 
Information Section). 
8. Elute the protein by adding endotoxin-free buffer and collecting fractions; one or two resin-bed volume elutions are 
sufficient.  
9. Determine the endotoxin concentration of the processed sample. Use caution to prevent sample contamination from 
dust or contaminated tubes subsequent to endotoxin removal. Store solutions frozen or assay them before use to 
ensure sterility. 
10. Regenerate the resin as described in Steps 3-5 and store the column in 20% ethanol at 2-8°C. 
 
Endotoxin Removal Procedure using the Batch Method with Spin Columns   
• Regenerate the resin before the first use and after each subsequent use. For regeneration and equilibration (steps 1-10), 
use regeneration buffer in 2mL volumes for the 0.25mL column, 3.5mL volumes for the 0.5mL column and 8mL 
volumes for the 1mL column. 
• Wear appropriate gloves while handling the spin columns. Use caution to prevent sample contamination during the 
endotoxin-removal procedure. 
1. Equilibrate the spin column to room temperature. 
2. Twist off the column’s bottom closure and loosen the top cap. Place the spin column into a collection tube. Centrifuge 
the column at 500 × g for 1 minute to remove the storage solution. Discard the storage solution. 
3. Remove the column cap and insert the bottom plug. To regenerate, add 0.2N NaOH, replace the cap, invert the column 
several times until the resin is suspended in the solution and incubate overnight at room temperature, OR add 0.2N 
NaOH in 95% ethanol, replace the cap, invert the column several times until the resin is suspended in the solution and 
incubate 1-2 hours at room temperature. 
4. Loosen the cap and remove the bottom plug. Place the column in a collection tube and centrifuge at 500 × g for 1 minute 
to remove the solution. Discard the solution. 
5. Remove the cap and insert the bottom plug. Add 2M NaCl, replace the cap and invert the column several times until the 
resin is suspended in the solution. 
6. Loosen the cap and remove the bottom plug. Place the column in a collection tube and centrifuge at 500 × g for 1 minute 
to remove the solution. Discard the solution. 
7. Remove the cap and insert the bottom plug. Add endotoxin-free, ultrapure water. Replace the cap and invert the column 
several times until the resin is suspended in the solution. 
8. Loosen the cap and remove the bottom plug. Place the column in a collection tube and centrifuge at 500 × g for 1 minute 
to remove the solution. Discard the solution. 
9. Remove the cap and insert the bottom plug. Add endotoxin-free buffer, replace the cap and invert the column several 
times until the resin is suspended in the solution. 
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10. Loosen the cap and remove the bottom plug. Place the column in a collection tube and centrifuge at 500 × g for 1 minute 
to remove the solution. Discard the solution. Repeat steps 9 and 10 two additional times. 
11. Remove the cap and insert the bottom plug. Add the sample to the resin, replace the cap and invert the column several 
times until the resin is suspended in the solution. 
12. Incubate the column with gentle end-over-end mixing at room temperature or 4°C for 1 hour. Incubation time can be 
extended depending on the sample type and requirements (see the Important Product Information Section). 
13. Loosen the cap and remove the bottom plug. Place column in a collection tube and centrifuge at 500 × g for 1 minute to 
collect the sample. 
14. Determine the endotoxin concentration of the processed sample. Use caution to prevent sample contamination after 
endotoxin removal. Store solutions at -20°C or assay before use to ensure sterility. 
15. Regenerate the resin as described in step 3 and store the column in 20% ethanol at 2-8°C. 
 
Troubleshooting 
Problem Possible Cause Solution 
Low endotoxin 
removal efficiency 
Sample pH was not within a neutral range Adjust sample to pH 6-8 
Incubation time was not sufficient Increase the incubation time for the 
batch method  
Endotoxin was bound to the target protein Recycle the sample through the column 
several times 
The removal or detection system was contaminated by 
extrinsic LPS 
Use endotoxin-free labware and buffers 
Low protein/sample 
recovery  
Target protein aggregated with endotoxin and was 
removed 
Increase NaCl concentration in the 
sample and equilibration buffer to 0.4M 
Nonspecific binding of sample to the resin 
 
Related Thermo Scientific Products 
88282 Pierce LAL Chromogenic Endotoxin Quantitation Kit 
89896, 7, 8 Pierce Centrifuge Columns, (2mL, 5mL and 10mL, respectively), 25/pkg 
23225 Pierce BCA Protein Assay Kit 
22660 Pierce 660nm Protein Assay 
 
Products are warranted to operate or perform substantially in conformance with published Product specifications in effect at the time of sale, as set forth in 
the Product documentation, specifications and/or accompanying package inserts (“Documentation”). No claim of suitability for use in applications regulated 
by FDA is made. The warranty provided herein is valid only when used by properly trained individuals. Unless otherwise stated in the Documentation, this 
warranty is limited to one year from date of shipment when the Product is subjected to normal, proper and intended usage. This warranty does not extend to 
anyone other than Buyer. Any model or sample furnished to Buyer is merely illustrative of the general type and quality of goods and does not represent that 
any Product will conform to such model or sample. 
NO OTHER WARRANTIES, EXPRESS OR IMPLIED, ARE GRANTED, INCLUDING WITHOUT LIMITATION, IMPLIED WARRANTIES OF 
MERCHANTABILITY, FITNESS FOR ANY PARTICULAR PURPOSE, OR NON INFRINGEMENT. BUYER’S EXCLUSIVE REMEDY FOR NON-
CONFORMING PRODUCTS DURING THE WARRANTY PERIOD IS LIMITED TO REPAIR, REPLACEMENT OF OR REFUND FOR THE NON-
CONFORMING PRODUCT(S) AT SELLER’S SOLE OPTION. THERE IS NO OBLIGATION TO REPAIR, REPLACE OR REFUND FOR PRODUCTS 
AS THE RESULT OF (I) ACCIDENT, DISASTER OR EVENT OF FORCE MAJEURE, (II) MISUSE, FAULT OR NEGLIGENCE OF OR BY BUYER, 
(III) USE OF THE PRODUCTS IN A MANNER FOR WHICH THEY WERE NOT DESIGNED, OR (IV) IMPROPER STORAGE AND HANDLING OF 
THE PRODUCTS. 
Unless otherwise expressly stated on the Product or in the documentation accompanying the Product, the Product is intended for research only and is not to 
be used for any other purpose, including without limitation, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses, or 
any type of consumption by or application to humans or animals. 
Current product instructions are available at thermofisher.com. For a faxed copy, call 800-874-3723 or contact your local distributor. 
© 2016 Thermo Fisher Scientific Inc. All rights reserved. Unless otherwise indicated, all trademarks are property of Thermo Fisher Scientific Inc. and its 
subsidiaries. Printed in the USA. 
Typical Applications
Concentration, desalting or buffer
exchange of:
• Protein solutions
• Polysaccharide solutions
• Virus suspensions
Harvest, washing or clarification of:
• Cell cultures and lysates
• Colloidal suspensions
• Viral cultures
Superior TFF Performance
For research, process development,
scale-up and production, Pellicon 2
filters and holders offer the following
benefits:
Consistent High Flux and High
Product Recovery
Millipore’s Biomax® polyethersulfone
and Ultracel® PLC-composite regen-
erated cellulose membranes have 
void-free structures that guard against
leakage of solutes through microdefects
normally associated with voids
beneath the thin skins of conventional
UF membranes (Figures1and 2).
These void-free membranes are
more permeable, resulting in high-flux
with equivalent or superior product
retention (Figure 3). These void-free
membranes provide the advantages 
of fast, high yield processing and
smaller systems.
The long established Durapore®
hydrophilic PVDF microfiltration mem-
brane is well known for its exceptional
combination of high flux, low protein
binding and high product recoveries.
Pellicon 2 Filters 
and Holders
High-performance tangential flow filters 
for biopharmaceutical process development,
scale-up/scale-down and concentration/
purification/cell harvesting applications
®
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! Leading-edge void-free
membranes to match virtually
any separation challenge
! Short flow path for higher
flux and higher resolution
separation capability 
! Choice of flow channel
configuration providing
process optimization
capability
! Predictable, fast, scale-up
! True linear scalability from
laboratory size modules to
industrial assemblies for
processing thousands of liters 
Figure 1. Void-free Biomax 10 modified
polyethersulfone membrane
Figure 2. Conventional 10 kD polyether-
sulfone membrane with sub-surface voids
2
Easy, Reliable Linear Scale-Up from
the Lab to the Production Plant 
Pellicon 2 Mini filters scale-up easily
and reliably from the laboratory to the
production plant (Figures 4 and 5).
By ensuring every flow channel has
the same length, height and turbulence
promoter as well as flow direction and
materials of construction, we maintain
the same ultrafilter/microfilter perfor-
mance at all scales. Thus, rapid and
reliable translation of processes from
lab to manufacturing scale is easily
achieved. 
Linear Scale-Up
Mini filters (0.1 m2/1.1 ft2) and holders
are designed for laboratory ultrafiltra-
tion/microfiltration of 100 mL to10 L
volumes, yet scale up linearly to
Pellicon 2 Cassette (0.5 m2/5.4 ft2)
and Maxi (2.5 m2/26.9 ft2) filters
used in the pilot or manufacturing
plant to process volumes from one liter
to thousands of liters.
Thus, whether you operate 0.1 m2
or 100 m2 of installed area, every
Pellicon 2 filter operates with the same
pressure drop, flow velocity and con-
centration profile for true, rapid and
simple linear scale-up.
Pellicon 2 Filters Proof of Performance
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Improved Flux
Feed pressure: 5.6 bar/80 psi
Retentate pressure: 2.1 bar/30 psi
Temperature: 10 – 13.5 °C
Initial volume 28 L
Final volume: 2 L
Conclusion
Pellicon 2 filters with Biomax membranes provide up
to two-times the process flux of conventional
cassettes resulting in faster processing and smaller
systems.
Figure 3. Flux versus BSA concentration
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Linear Scalability
Temperature: 8 °C
Feed to retentate pressure drop: 2.8 bar/40 psi
Conclusion
(Figures 4 and 5) Pellicon 2 family of cassette filters
scale linearly from 0.1 to 0.5 to 2.5 m2 (1.1 to 5.4
to 26.9 ft2) sizes for rapid, accurate and safe
process scale-up and transfer.
Figure 5. Flux versus average transmem-
brane pressure on a 10% BSA solution.
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Improved Reliability
Conclusion
The void-free structure of Biomax membranes is
demonstrated by low, linear air diffusion values. This
performance ensures better process reliability and
safety and better product retention for higher yields.
Figure 6. Integrity test comparison-air flow
through wetted cassettes
Greater Process Reliability and
Reproducibility
The combination of defect-free 
membranes with Millipore’s highly 
reliable manufacturing processes,
offers greater consistency of process
parameters.
The high quality of Millipore’s 
ultrafiltration membranes is further
ensured by our pioneering multiple-
solute mixed-dextran retention profile
test. Unlike the single solute protein
retention test, Millipore’s retention 
profile test measures and ensures
reproducible retention performance 
of our UF membranes over the entire
range of molecular weights retained
by the membrane, not ¡ust at one or
two molecular weights.
Low Product Loss
Pellicon 2 filters have a low minimum
working volume – as low as 175 mL
of retentate volume per square meter 
of membrane area. This low retentate
volume permits high concentration 
factors to be reached with low starting
volumes and maximizes the recovery
of small sample volumes.
To prevent product loss, Pellicon 2 
filters are 100% tested in manufacturing
to ensure that every filter is integral.
In addition, Biomax and Ultracel
membranes are exposed to a new
high-pressure integrity test that provides
greater sensitivity. The integrity test
procedure and specifications are 
supplied so users can confirm integrity
at high pressure when the filter is
installed (Figure 6). 
Biocompatibility
All wetted parts have been tested and
meet the requirements of the USP
Class VI biological test for plastics.
Superior Filter Quality
Pellicon cassettes are subjected to a
complete array of quality control
release tests.
A Certificate of Quality is included
with every cassette.
Each casette is identified with a
unique serial number.
Validatable
Since 1973, Pellicon filters and 
systems have been successfully used
for development and scale-up of
processes for manufacturing injectable
protein and polysaccharide drugs, in
the serum fractionation, biotechnology,
vaccine and pharmaceutical 
industries.
Pellicon 2 filters and systems were
developed based upon Millipore’s
experience serving these applications,
and are supported by an extensive
Validation Support Data Package
proving performance claims and
demonstrating the suitability of these
filters for drug manufacturing in 
validated processes. This package is
available upon request.
Millipore can further assist your 
validation efforts through:
• Design and fabrication of standard
and custom turnkey TFF systems for
drug manufacturing facilities
• Installation and operational
qualification services for these
systems
• Validation support services for
tangential flow filter use in drug
manufacturing processes.
• Training on TFF process scale-up,
optimization and development.
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A Choice of Feed Channel Screens
For optimal performance in a range 
of applications Pellicon 2 filters
incorporate three types of 
feed-channel screens:
• Type A screen (tight screen) is
optimized to operate Biomax
membranes with maximum flux with
low-viscosity solutions.
• Type C screen (coarse screen) is
optimized to operate PLC series
membranes with maximum flux. 
The Type C screen is also
available with Biomax-50,100,
300, 500 and Biomax 1000
membranes for concentration and
diafiltration of viscous solutions.
• Type V screen (open channel) is
optimized for very viscous solutions
or solutions with higher levels of
suspended solids.
Normalized Recirculation Rates
Parameter Unit Typical ∆P
Screen Type A         C         V
Recirculation Rate L/min/m2 4/6      5/35
Differential Pressure bar/psi 1.4/20 0.4/6
Screen Selection Guidelines
Solution Type Screen Type
Dilute protein solution or low viscosity solutions A screen  
(MAbs, interferons) (tight screen)
Concentrated protein solutions or high viscosity solutions C screen 
(IgG, biopolymers) (course screen)
High viscosity solutions (polysaccharides, V screen
certain microfiltration or clarification applications) (loose screen)
For More Detailed Information
Request literature number P17512 –
User Guide for Pellicon Filters.
Specifications
Temperature Range
Mini, Cassette and Maxi: 
4 to 50 °C
Maximum Forward Transmembrane Pressure
Device Size (m2) Biomax Ultracel
0.1 6.8 bar (100 psi) Max 6.8 bar (100 psi) Max
0.5 6.8 bar (100 psi) at 30 °C 3.4 bar (50 psi) at 30 °C
2.5 6.8 bar (100 psi) at 30 °C 3.4 bar (50 psi) at 30 °C
Maximum Reverse Transmembrane Pressure
Device Size (m2) Biomax Ultracel
0.1 0.33 bar (5 psi) 0.33 bar (5 psi)
0.5 0.33 bar (5 psi) 0.33 bar (5 psi)
2.5 0.33 bar (5 psi) 0.33 bar (5 psi)
Prefiltration Required
Mini, Cassette and Maxi:
100 µm
Dimensions
Device Width Length Thickness
Mini 5.6 cm 21 cm 1.5 cm (V screen-2.16 cm)
Cassette 17.8 cm 21 cm 1.5 cm (V screen-2.16 cm)
Maxi 17.8 cm 21 cm 7.6 cm (V screen-9.0 cm)
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Membrane Selection Guideline
Membrane Type Materials Benefits
Biomax Modified polyethersulfone Highest flux ultrafiltration membrane
Excellent chemical resistance
Void-free structure for higher yield and reliability
Ultracel PLC Regenerated cellulose Extremely low protein binding hydrophilic membrane
(ideal for protein solutions <20 g/L)
PLC membranes are composite Highest product recovery and improved performance
membranes cast on a microporous with difficult to process streams (antifoams, lipids,
substrate for defect-free membranes protein transmission applications)
with superior adhesion.
Brings higher resolution, improved
yields and superior back-pressure
resistance
Durapore Hydrophilic PVDF Very hydrophilic microporous membrane for cell 
harvest or clarification applications
Pellicon 2 Membrane Selection Chart
Approximate Molecular Weight Membrane NMWL (kD) Membrane pH
(range of solutes retained >99%, kD) or Microns Material Range
High Flux Biomax Membranes – Void-free for Higher Yield and Reliability
12 – 25 (growth factors, hormones) Biomax-5 5 modified polyethersulfone 1 – 14
25 – 50 (growth factors, hormones) Biomax-8 8 modified polyethersulfone 1 – 14
50 –100 (albumin, hemoglobin) Biomax-10 10 modified polyethersulfone 1 – 14
100 –140 (enzymes) Biomax-30 30 modified polyethersulfone 1 – 14
140 – 300 (IgG’s) Biomax-50 50 modified polyethersulfone 1 – 14
300 – 500 (small viruses and antigens) Biomax-100 100 modified polyethersulfone 1 – 14
>500 (IgM’s, large viruses) Biomax-300 300 modified polyethersulfone 1 – 14
>0.03 µm (large viruses, colloids, particulates) Biomax-500 500 modified polyethersulfone 1 – 14
>0.03 µm (large viruses, cells, colloids, particulates) Biomax-1000 1000 modified polyethersulfone 1 – 14
Ultracel PLC Series – for High Recoveries
8 –18 (proinsulin, hematopoetic factors) PLCCC 5 regenerated cellulose 2 – 13
18 – 60 (hemoglobin, enzymes) PLCGC 10 regenerated cellulose 2 – 13
60 – 200 (monoclonal IgG’s) PLCTK 30 regenerated cellulose 2 – 13
200 – 500 (small viruses, viral antigens) PLCHK 100 regenerated cellulose 2 – 13
>500 (large viruses, IgM’s) PLCMK 300 regenerated cellulose 2 – 13
>0.03 µm (large viruses, cells, colloids, particulates) PLCXK 1000 regenerated cellulose 2 – 13
Durapore Membranes – for Microporous Applications
Clarify cell lysates and protein solutions, VVPP 0.1 µm hydrophilic PVDF 2 – 11
clarify viral cultures
Harvest & wash colloidal suspensions, bacterial cells; GVPP 0.22 µm hydrophilic PVDF 2 – 11
clarify protein solutions and viral cultures
Harvest & wash colloidal suspensions, cell & viral HVMP 0.45 µm hydrophilic PVDF 2 – 11
cultures, clarify protein solutions & viral cultures
Harvest cell cultures or colloidal suspensions DVPP 0.65 µm hydrophilic PVDF 2 – 11
 
Ordering Information
Pellicon 2 Filters
Filters with A Screens (Tight Screen) Filters with Type C Screens (Coarse Screen)
Membrane 0.1 m2/1.1 ft2 0.5 m2/5.4 ft2 2.5 m2/26.9 ft2 0.1 m2/1.1 ft2 0.5 m2/5.4 ft2 2.5 m2/26.9 ft2
Biomax Series – Modified Polyethersulfone
Biomax 5 P2B0 05A 01 P2B0 05A 05 P2B0 05A 25 + + +
Biomax 8 P2B0 08A 01 P2B0 08A 05 P2B0 08A 25 + + +
Biomax 10 P2B0 10A 01 P2B0 10A 05 P2B0 10A 25 + + +
Biomax 30 P2B0 30A 01 P2B0 30A 05 P2B0 30A 25 + + +
Biomax 50 P2B0 50A 01 P2B0 50A 05 P2B0 50A 25 P2B0 50C 01 P2B0 50C 05 P2B0 50C 25
Biomax 100 P2B1 00A 01 P2B1 00A 05 P2B1 00A 25 P2B1 00C 01 P2B1 00C 05 P2B1 00C 25
Biomax 300 + + + P2B3 00C 01 P2B3 00C 05 P2B3 00C 25
Biomax 500 + + + P2B5 00C 01 P2B5 00C 05 P2B5 00C 25
Biomax 1000 + + + P2B0 1MC 01 P2B0 1MC 05 P2B0 1MC 25
Ultracel PLC Series – Regenerated Cellulose, Composite Construction
5 kD NA NA NA P2C0 05C 01 P2C0 05C 05 P2C0 05C 25
10 kD NA NA NA P2C0 10C 01 P2C0 10C 05 P2C0 10C 25
30 kD NA NA NA P2C0 30C 01 P2C0 30C 05 P2C0 30C 25
100 kD NA NA NA P2C1 00C 01 P2C1 00C 05 P2C1 00C 25
300 kD NA NA NA P2C3 00C 01 P2C3 00C 05 P2C3 00C 25
1000 kD NA NA NA P2C0 1MC 01 P2C0 1MC 05 P2C0 1MC 25
Durapore – Hydrophilic PVDF
0.1 µm + + + P2VV PPC 01 P2VV PPC 05 P2VV PPC 25
0.22 µm + + + P2GV PPC 01 P2GV PPC 05 P2GV PPC 25
0.45 µm + + + P2HV MPC 01 P2HV MPC 05 P2HV MPC 25
0.65 µm + + + P2DV PPC 01 P2DV PPC 05 P2DV PPC 25
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Each Pellicon filter is packed one per box and includes Operating Instructions. A Certificate of Quality is included in every box. 
Silicone intercassette gaskets are required for use with Pellicon 2 filters. Two gaskets are packed in the box with every Pellicon 2 filter.
+     = On request (custom order)
NA  = not available
Filters with V Screens (Loose Screen)
0.1 m2/1.1 ft2 0.5 m2/5.4 ft2 2.0 m2/21.5 ft2
P2B0 05V 01 P2B0 05V 05 P2B0 05V 20
P2B0 08V 01 P2B0 08V 05 P2B0 08V 20
P2B0 10V 01 P2B0 10V 05 P2B0 10V 20
P2B0 30V 01 P2B0 30V 05 P2B0 30V 20
P2B0 50V 01 P2B0 50V 05 P2B0 50V 20
P2B 100V 01 P2B1 00V 05 P2B1 00V 20
P2B3 00V 01 P2B3 00V 05 P2B3 00V 20
P2B5 00V 01 P2B5 00V 05 P2B5 00V 20
P2B0 1MV 01 P2B0 1MV 05 P2B0 1MV 20
P2C0 05V 01 P2C005V 05 P2C0 05V 20
P2C0 10V 01 P2C0 10V 05 P2C0 10V 20
P2C0 30V 01 P2C0 30V 05 P2C0 30V 20
P2C1 00V 01 P2C1 00V 05 P2C1 00V 20
P2C3 00V 01 P2C3 00V 05 P2C3 00V 20
P2C0 1MV 01 P2C0 1MV 05 P2C01MV 20
P2VV PPV 01 P2VV PPV 05 P2VV PPV 20
P2GV PPV 01 P2GV PPV 05 P2GV PPV 20
P2HV MPV 01 P2HV MPV 05 P2HV MPV 20
P2DV PPV 01 P2DV PPV 05 P2DV PPV 20
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Pellicon 2 Mini Holder
Pellicon 2 Mini holder operates one to
three Mini filters in parallel for total
areas of 0.1 to 0.3 m2 (1.1 – 3.3 ft2).
This sanitary holder is tightened with a
small torque wrench to compress the
filters between a manifold plate that
conveys fluids in and out of the filters
and an end plate that seals the filters
together. The Mini holder is designed
for process development and small
volume pharmaceutical manufacturing.
Materials of Construction
Manifold and End Plates:
316 L stainless steel
Base, Tie Rods, Spacers and Washers:
304 stainless steel
Feet:
Thermoplastic rubber
Gaskets:
Silicone
Nuts:
Silicone bronze
Separator Plates
An optional separator plate allows
processing simultaneously with up to
three 0.1 m2/1.1 ft2 cassettes to 
determine the best molecular weight
cut-off in a single study on the same
feed material.
Connections
All manifold connections are standard
∞-inch sanitary clamp type.
Operating Parameters
Temperature Range:
4 to 50 °C. The Mini holder can 
be autoclaved without filters 
installed. The filters themselves
cannot be autoclaved.
Maximum Pressure: 
6.8 bar
Dimensions
Height: 260 mm; Width: 114 mm
Length: 140 mm; Weight: 5 kg
Holder Manifold Volume:
Feed plus retentate: 5.3 mL 
Permeate:              6.4 mL
To Place an Order or Receive
Technical Assistance
For additional information call your
nearest Millipore office:
In the U.S. and Canada, 
call toll-free 1-800-MILLIPORE 
(1-800-645-5476)
In the U.S., Canada and Puerto Rico,
fax orders to 1-800-MILLIFX
(1-800-645-5439)
Outside of North America contact your
local office. To find the office nearest
you visit www.millipore.com/offices.
Internet: www.millipore.com
Technical Service:
www.millipore.com/techservice
Â
Stainless Steel Pellicon Holder
XX42P0080
The stainless steel Pellicon filter holder,
designed for sanitary applications, can
be used alone or to expand existing
cassette ultrafiltration (CUF) systems or
to replace existing holders.
It requires only to be connected to
an existing sanitary pump and piping
for tangential flow microporous filtration
or ultrafiltration. 
It can accomodate up to 5 m2/55 ft2
filter area as shipped with long tie
rods or 0.5 to 2.5 m2 (5.4 – 26.9 ft2)
with accessory short tie rods.
Materials of Construction
Wetted Surfaces:
316 L stainless steel  
Non-wetted Surfaces:
Silicon bronze nuts
Dimensions
Length: 28 cm; Width:19 cm
Height: 25 cm
Operating Parameters
Operating Temperature Range:
4 to 50 °C. The Pellicon holder can 
be autoclaved without pressure 
gauges and filters; holder with 
gauges cannot be steamed. 
Pellicon filters cannot be steamed 
or autoclaved.
Connections
Sanitary º" TC connections; 
1∞" TC connections for gauges.
Shipping Weight
24 kg
Process-scale Pellicon Holder
The Pellicon Process-scale Holder is a
unique innovation for production scale
Pellicon systems. This holder, vertically
mounted, can hold up to 80 m2/880 ft2
of membrane area.
Benefits
• Extremely compact footprint
• Easy to change cassettes
• Easy to vent and fully drain
• Simple connections
• Up to 4 levels. Can be easily
extended in levels for simple
membrane area expansion
• Each level up to 20 m2/220 ft2
• Uses standard and Maxi Cassettes
• Can be adapted for series or
parallel configurations
• Simplifies pipework connection
• Hydraulic closure systems are
available for the stainless-steel
Pellicon holder and the 
process-scale Pellicon holder. These
systems are convenient, reliable and
easy to use to enable rapid and
repeatable loading operation and
storage of Pellicon 2 cassettes.
Materials of Construction
Manifold segment, fitting blocks and
end plate 316 L stainless steel; tie
rods 304 and 304 L stainless steel.
Ordering Information
Pellicon 2 Filter Holders
Description Catalogue No.
Pellicon 2 Mini filter holder XX42 PMI NI
Pressure gauges XX42 PSG 01L
One diaphragm-protected digital pressure gauge,
0 – 7 bar, º-inch fittings
Pressure gauge adapters XX42 PM0 01
Fitting kit XX42 PFK 01
Contains all tees, clamps, gaskets and a valve to connect 
tubing and pressure gauges to the Pellicon 2 Mini holder
Pellicon filter holder (for cassettes and Maxi filters) XX42 P00 80
Pellicon 2 double thick gasket PSSP 2XC10
Pellicon Process-scale holder support and plate XX42 SSP LT
Pellicon Process-scale holder On request
A Typical Pellicon Production
Processing System
Millipore supplies a range of standard
and custom engineered systems. These
systems can contain from 1 m2/11 ft2 to
several hunded m2 of membrane area,
with Clean-in-Place (CIP) or Steam-in-
Place (SIP) integrated as appropriate.
Systems can also be supplied with
integrated process vessels in manual
or fully automatic versions.
All systems are designed, 
engineered and manufactured in 
ISO® 9001 registered facilities, and
are supplied with extensive validation
data support packages.
Please contact us to discuss your
specific application and process
requirements.
Pellicon XL Devices for Process
Development
For process development of volumes
from 50 mL to 1 liter, Millipore offers
Pellicon XL devices. This small volume
TFF filter is designed for true scalability
by providing the same flow path,
channel length, and channel height as
the Pellicon 2 cassettes. Based on
proven TFF membrane technology,
Pellicon XL devices ensure reliable,
consistent and predictable 
performance.
Millipore, Biomax, Durapore, Pellicon and Ultracel are
registered trademarks of Millipore Corporation.
ISO is a registered trademark of the International
Organization of Standardization.
Lit. No. DS1210EN00   Rev. A  10/04   
Printed in U.S.A.   04-324 
Copyright 2003, 2004 Millipore Corporation
Billerica, MA 01821 U.S.A. All rights reserved.
 
Pellicon® 3 Cassettes  
with Biomax® Membrane
The device of choice for applications requiring high flux,  
low to moderate protein binding, and harsh chemical  
cleaning and/or sanitization.
Data Sheet
Pellicon® 3 cassettes with Biomax® membrane 
are the optimum tangential flow filtration (TFF) 
devices for the filtration of solutions contain-
ing therapeutical proteins, albumin, hormones, 
vaccines and growth factors. These advanced, 
high-performance cassettes are ideal for today’s 
higher titer therapeutic antibodies as well as the 
more demanding filtration processes that require 
higher operating pressures, temperatures and 
caustic cleaning regimes.
From small-scale to full-scale production, Pellicon® 3 
cassettes are designed for use in research, process 
scale-up/scale-down, applications development and 
full-scale manufacturing. The Pellicon® 3 design and 
automated manufacturing process provides unbeat-
able performance consistency between cassette sizes.       
Pellicon® 3 devices also offer greater cassette size 
selection for improved scale-up and scale-down process 
development. The streamlined design allows operators 
to quickly and easily handle, install and remove  
Pellicon® 3 cassettes. The materials of construction  
are compatible with a broad range of chemical cleaning 
agents that many TFF systems require to ensure proper 
sanitization.
Benefits
•  Optimum product recovery using proven macrovoid-free 
membrane technology
•  Fast, reliable scale up/down from lab to production scale
•  Rugged, reliable design ideally suited to filtration  
processes with higher operating pressures, temperatures 
and caustic cleaning regimes
•  Automated manufacturing delivers unbeatable  
performance consistency and reliability
•  Easy to install and clean
•  Extreme temperature and chemical compatibility
EMD Millipore is a division of Merck KGaA, Darmstadt, Germany
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Streamlined Installation and  
Rugged Design
Pellicon® 3 cassettes incorporate a hard polypropylene 
jacket and end cap design that protects the membrane 
surface from impacts and potential damage. The end cap 
includes integral seals which simplify the installation by 
eliminating the need for external gaskets between each 
device.
Reliable Product Performance 
Delivering Exceptional Consistency 
and Reproducibility
Our controlled, automated manufacturing process 
provides the highest level of cassette performance 
consistency. The high level of process control ensures 
consistent, repeat performance in terms of scale up to 
scale down, from run to run and campaign to campaign.  
All cassettes are manufactured in accordance with GMP. 
Extreme Temperature and  
Chemical Capability
Pellicon® 3 cassettes are manufactured using the most 
modern polymers and plastics enabling continuous  
operation at 50 °C and 1.0N NaOH up to 200 hours.  
These materials of construction ensure low extractables  
in a wide range of solvents, acids and bases. 
Quality Assurance 
All Pellicon® 3 cassettes are manufactured using the 
same equipment, process and quality assurance. Each 
Pellicon® 3 cassette manufacturing lot is 100% integrity 
tested during manufacturing to ensure that every filter is 
integral, robust and within specification. Additionally, 
Pellicon® 3 cassettes are subjected to a complete array  
of quality control release tests. 
Each cassette is identified with a unique serial number 
and shipped with an individual Certificate of Quality.
Applications
•   Monoclonal antibodies
•  Albumin
•  Hormones
•   Vaccines
•  Growth Factors
•  Recombinant protein
•  Nanoparticules
Optimum Product Recovery  
and High Yields
High flux and retention properties of the Biomax®  
membrane result in faster processing speeds with higher 
yields, which means shortened processing times and a 
bioprocessing system that can be smaller and more 
compact.
Biomax®  membranes are composed of polyethersulfone  
and are resistant to harsh chemicals used in cleaning, 
biological decontamination and sanitization. The 
polyethersulfone Biomax®  membrane has been modified  
to reduce non-specific protein binding compared to 
conventional polyethersulfone membranes. The 
technology offers a mechanically robust design able  
to withstand process upsets and extreme operating 
conditions.
Fast, Reliable Linear  
Scale-Up from the Lab to  
the Production Plant 
Offered in four sizes, 88 cm2, 0.11 m2, 0.57 m2 and  
1.14 m2, all Pellicon® 3 cassettes are constructed of 
identical materials and have the same flow channel 
length, height, turbulence promoter and flow direction. 
This ensures that every Pellicon® 3 cassette maintains the 
same performance profile at every scale, from 250 
milliliters to thousands of liters.
* Contact your local representative for additional information.
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Single-Pass TFF 
Pellicon® 3 cassettes run in single-pass TFF mode is a 
simple and efficient way to increase production capacity 
by reducing process volumes and tank requirements. 
Single-Pass TFF systems can concentrate process streams 
without the recirculation required in traditional TFF 
steps and require a smaller pump and less piping 
resulting in a more compact footprint and lower cost. 
For concentrated final formulations, Single-Pass TFF  
can increase recovery due to lower hold-up volume.  
Single-Pass TFF also enables continuous processing 
where in-line concentration is coupled to other  
process steps.
Single-Pass TFF has several applications such as:
• Product concentration/volume reduction
• In-line delution/de-salting
• Final formulation/concentration
Feed
STEP 1
STEP 2
Feed
Feed
Buffer
Retentate
Retentate Retentate
Permeate
PermeatePermeate
Buffer
2A 2B 2CVolume reduction De-Salting Final Concentration
Feed
Pump
Feed
Pump
Filter
Module
Filter
Module
Permeate
Permeate
Retentate
Retentate
Feed Source
Recircu-
lation
Tank
Figure 1. 
Batch TFF vs. Single-Pass TFF
Batch TFF Single-Pass TFF
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Specifications
Materials and Assembly 
Materials of Construction: Polypropylene
 Polyethylene
 Polyethersulfone
 Thermoplastic elastomer
  Stainless steel  
(0.57 m2 and 1.14 m2 cassettes only)
Preservative: 1.6% Phosphoric Acid, 1.1% Acetic Acid,  
 20% glycerin and water
Membrane: Biomax® PES—Polyethersulfone
Assembly Design:  Automated assembly and testing of heat sealed 
packets bound together by an injection-molded 
polypropylene jacket
Maximum Operating Conditions
Recommended Feed Flow Rate: 4–8 L/m2/min
Maximum Inlet Pressure: <100 psi
Forward Transmembrane Pressure: 80 psi (5.5 bar) at 4-40 °C, 200 hours continuous 
 (4 hours continuous, micro format only)  
 40 psi (2.7 bar) at 4-50 °C, 50 hours continuous
Reverse Transmembrane Pressure: 30 psi (2.1 bar) at 25 °C, 3 min intervals, 10 cycles  
 (5 cycles, micro format only)
Maximum Caustic Exposure: 1.0 N NaOH at 50 °C up to 200 hours  
 (Contact EMD Millipore for exposure parameters.)
Operating pH Range:  2 - 14
Regulatory Information
Component Material Toxicity:  Component materials were tested and meet the 
criteria of the USP <88> Biological Reactivity Tests 
for Class VI Plastics. 
Good Manufacturing Practices:  These products are manufactured in an EMD 
Millipore facility which adheres to FDA Good 
Manufacturing Practices.
ISO® 9001 Quality Standard:  This product was manufactured in an EMD Millipore 
facility whose Quality Management System is 
approved by an accredited registering body to the 
appropriate ISO® 9001 Quality Systems Standard.
100% Integrity Tested Each unit must pass the EMD Millipore integrity  
in Manufacturing:   test based on air flow through the fully-wetted 
membranes of the filter.
Validated Production Process:  This product was fabricated using a  
validated manufacturing process.  
Principles of statistical process control  
and determinations of process capability  
have been applied to critical variables in the device 
fabrication process. In-process controls are used to 
assure stability of the process.
Pellicon® 3 Cassette (88 cm2)
Pellicon® 3 Cassette (0.11 m2)
Pellicon® 3 Cassette (0.57 m2)
Pellicon® 3 Cassette (1.14 m2)
Hold Up Volume
Area
Feed  
Channel (mL) 
Permeate 
Channel (mL)
88 cm2 1.8 2.8
0.11 m2 9 7
0.57 m2 69 39
1.14 m2 134 88
 
Ordering Information
Pellicon® 3 Cassettes with Biomax® Membrane
Description Catalogue No.
10kD NMWL 30kD NMWL 50kD NMWL
88 cm2 P3B 010 A00 P3B 030 A00 P3B 050 A00
0.11 m2 P3B 010 A01 P3B 030 A01 P3B 050 A01
0.57 m2 P3B 010 A05 P3B 030 A05 P3B 050 A05
1.14 m2 P3B 010 A10 P3B 030 A10 P3B 050 A10
 
  Accessories
Pellicon® 3 Cassette Holders
Holder Type Cassette Size Area Range Catalogue No.
Stainless Steel Mini-Holder 88 cm2 and 0.11 m2 88 cm2 to 0.55 m2 XX42PMINI
Acrylic Cassette Holder Low 
Retentate Volume
0.57 m2 and 1.14 m2 0.57 m2 to 5.7 m2 XX42PRV60
Stainless Steel Holder 0.57 m2 and 1.14 m2  0.57 m2 to 5.7 m2 XX42P0080
Stainless Steel Cassette Holder 
and Assembly
0.57 m2 and 1.14 m2  0.57 m2 to 5.7 m2 XX42P0K80
Manifold Support Plate 0.57 m2 1.14 m2 XXPEL3MAP
Process Scale Holder 0.57 m2 and 1.14 m2 1.14 m2 and up Contact Local 
Representative 
Hydraulic Process Scale Holder 0.57 m2 and 1.14 m2 1.14 m2 and up Contact Local 
Representative 
Cleaning
Description Catalogue No.
Sodium hydroxide solution 0.5 mol/L suitable for biopharmaceutical 
production EMPROVE® bio
137060
Sodium hydroxide solution 1 mol/L suitable for biopharmaceutical 
production EMPROVE® bio
137031
Sodium hydroxide solution 25% low iron suitable for biopharmaceutical 
production EMPROVE® bio
480659
Single-Pass TFF Accessories
Description Catalogue No.
Diverter plate and silicon gasket kit for 88 cm2 cassette  XXSPTFF01
Diverter plate for 0.57 and 1.14 m2 cassettes XXSPTFF02
Retentate collection plate for 0.57 and 1.14 m2 cassettes XXSPTFF03
EMD Millipore, the M logo, Pellicon and Biomax are registered trademarks of of Merck KGaA, Darmstadt, Germany. 
ISO is a registered trademark of The International Organization for Standardization or an affiliated company. 
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In ultrafiltration (UF) tangential flow filtration (TFF) 
systems, operating parameter selection will have far 
reaching impact as the process is scaled to full-scale 
manufacturing levels. While there are many factors that 
contribute to final system design, several key parameters 
should be optimized early in the process development 
phase. The goal is to develop a robust process with the 
following success criteria: superior product quality, 
consistent and high product yield, reproducible process 
flux and time, and a cleaning regime that allows extended 
membrane reuse.
The following basic experiments should be considered 
during development of processing methodology:
• Optimization
 – Impact of transmembrane pressure (TMP) and feed 
flow on process flux and retention 
 – Impact of product concentration and buffer 
conditions on process flux and retention
 – Impact of diavolumes on buffer exchange and 
contaminant removal
• Paper design and full process simulation with chosen 
processing parameters
Typically, the first three experiments are performed 
sequentially to bracket process performance and obtain 
data for analysis. This information is then combined with 
actual manufacturing considerations (batch volume, 
process time, etc.) to design a process simulation. 
The purpose of a process simulation is to duplicate the 
entire manufacturing process in a scale-down format, to 
confirm sizing, and to assess preliminary product quality 
and yield. The intent is to develop an optimized process, 
on the bench, that will efficiently scale-up to meet full-
scale manufacturing expectations.
Sequence  Purpose
1.   TMP Excursion at Initial Concentration 
(Cb initial)
↓
• Determine TMP for UF/DF
• Determine Feed Flow (QF) for UF/DF
• Demonstrate Flux Stability
• Confirm Retention of Product
2.   Concentration / Volume Reduction  
(Cb initial → Cb final)
↓
• Determine Flux as Function of Concentration
• Determine Placement of Diafiltration Step
• Determine Flux as Function of Buffer Conditions
3.   TMP Excursion at Final Concentration 
(Cb final)
↓
• Determine TMP for UF/DF
• Determine Feed Flow (QF) for UF/DF
• Confirm Retention of Product
4.   Diafiltration / Buffer Exchange
↓
• Determine Diavolume Requirement
• Confirm Retention of Product during DF
5.   Product Recovery • Crude Assessment of Step Yield
• Product Quality Evaluation
Figure 1. Basic Optimization Experiments
Use this step-by-step guide to develop a robust UF/
DF process with Pellicon® cassettes (cutoffs of 100 kD 
and lower) that will deliver superior product quality, 
reproducible results, and high yields.
Application Note
A Hands-On Guide to Ultrafiltration/
Diafiltration Optimization using  
Pellicon® Cassettes
EMD Millipore is a division of Merck KGaA, Darmstadt, Germany
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The following are step-by-step protocols for basic optimization experiments.
Set-up and Installation Procedure
Refer to the Maintenance Procedures for Pellicon® and  
Pellicon® 2 Cassette Filters (P17512) or the Pellicon® 3 Filters 
Installation and User Guide (AN1065EN00) when performing 
actual set-up and installation of Pellicon® cassettes. 
1. Assemble the TFF system as shown in Figure 2.
2. Install the Pellicon® cassette(s) (Pellicon® 2 Mini 
with 0.1 m2 membrane area, Pellicon® 3 with 0.11 m2 
membrane area) in the appropriate Pellicon® holder.
3. Flush the system with water, clean with the 
appropriate cleaning agent (per appropriate 
maintenance guide), and flush again. 
Feed
Tank
Retentate 
Valve
Filtration 
ModuleFeed
Pump
QR
QF
QP
PF
PP
PR
Diafiltration
Buffer Retentate 
Permeate 
Feed
Equilibration Procedure
1. Add 3 L/m2 of the appropriate buffer to the feed tank.
Example:  0.1 m2 membrane area x 3 L/m2 = 0.3 L buffer
2. Direct the retentate and permeate to a waste container.
3. Start the feed pump and achieve the following 
conditions by partially closing the retentate valve and 
adjusting the pump speed:
 – Feed flow of 5 L/min/m2
 – Retentate pressure of 2 – 15 psi (0.14 – 1.03 bar) to 
achieve approximately 30% conversion 
4. When half the buffer has been flushed, put the system 
in total recycle mode 1 and recirculate for 10 minutes; 
verify that the pH and conductivity in the system have 
been equilibrated to the level of the starting buffer.
5. Direct the retentate and permeate to a waste 
container.
6. When the feed tank level reaches the minimum level, 
open the retentate valve fully and stop the feed pump 
to prevent the introduction of air into the system.
Part 1. TMP Excursion at Initial Concentration
1. Add sufficient volume of product to the feed reservoir 
such that final volume or concentration target can be 
reached or slightly exceeded (approximately 1 – 1.5 L  
of final product at final concentration per m2). 
Example:  if Cinitial = 10 g/L and Cretentate = 80 g/L, 
then the concentration factor is 8X. If the minimum 
achievable final volume for 0.1 m2 is 0.1 L, calculate the 
required initial volume: 
Vinitial  =  Vminimum  x  VCF =  0.1 L  x  8X  =  0.8 L
2. Open the retentate valve fully and configure system in 
total recycle mode.
3. Start the feed pump and achieve the following 
conditions by partially closing the retentate valve  
and adjusting the pump speed:
 – Recommended feed flow (QF) rate for the membrane 
device, typically 5 L/min/m2 for Pellicon® 2 and 3 
cassettes
 – Minimal TMP, typically 2 – 5 psi (0.14 – 0.34 bar) for 
more open membranes and 10 psi (0.69 bar) for 
tighter membranes.
4. Recirculate the product for 10 – 15 minutes and ensure 
that stable process flux is achieved 2 . 
5. Record temperatures, pressures, and flows; sample 
feed and permeate for product retention 3 . 
6. Increase TMP by 5 – 10 psid (0.34 – 0.69 bar)  by 
manipulating the retentate valve while keeping the feed 
flow constant. For more open membranes increase by 
2 – 5 psid (0.14 – 0.34 bar). Repeat steps 4 and 5.
7. Repeat step 6 until flux begins to level off4;  
typically 4 – 6 TMP values are evaluated in total.
8. Open the retentate valve fully and allow system to 
continue in a total recycle.
9. Increase or decrease the feed flow by 2 – 3 L/min/m2 
and repeat steps 4 through 8. If desired, a third feed 
flow rate can be investigated.
10. Plot the data as shown in Figure 3.
Tight membranes (1 kD, 5 kD, etc.) Can use large TMP increases since optimum is typically > 30 psi
Open membranes (50 kD, 100 kD, etc.) Can use small TMP increases since optimum is typically < 10 psi
Figure 2. Schematic 
of a TFF System
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Q1 = 5 L/min/m2 Q2 = 3 L/min/m2 Q1/Q2
A [m2] Volume / Time / 150 LMH Volume / Time / 86 LMH 0.57
QF [L/min] (5 L/min/m2) x Volume / Time / 150 LMH (3 L/min/m2) x Volume / Time / 86 LMH 0.95
Calculations
The appropriate combination of feed flow rate and 
TMP will maximize flux while minimizing the impact of 
pumping and shear on the product. The appropriate 
combination of these two parameters will also minimize 
processing time and/or membrane area. To calculate the 
optimum feed flow, compare the required membrane area 
with the required pump rate at each of the two feed flow 
conditions, as shown in Table 1.
 Membrane Area [m2]  =  
  Process Volume [L] / (Flux [LMH] x Process Time [h]) 
 In Figure 3: 
 AreaQ1  =  0.57  x  AreaQ2
 Pump feed rate [L/min]  =  
  Feed flux [L/min/m2]  x  Area [m2] 
 In Figure 3:  
 Pump feed rateQ1  =  0.95  x  Pump feed rateQ2
In this example it is advantageous to run at the higher  
feed flow, Q1, since it only requires 57% of the membrane 
area used at the lower feed flow rate at almost the 
identical pump feed rate.
Note: 
• Anticipated final volume of over-concentrated product must exceed 
minimum working volume of membrane system at selected feed flow rate 
(QF); avoid introduction of air and maintain uniform mixing at end of volume 
reduction.
• Move from least to greatest fouling conditions:
 – Do not test into pressure-independent regime (past the knee of the flux 
vs. TMP curve) 4 
 – Avoid exceeding 30 – 40% conversion ratios
• Check hysteresis if possible by returning the system to the initial conditions 
and taking a final flux measurement; compare initial flux performance to 
final flux performance at initial conditions.
• Ensure that choice of TMP and feed flow have corresponding retention 
values that are acceptable (> 0.998) at both initial and final product 
concentration and in each buffer 5 .
• There is often very little performance difference versus feed flow rate at low 
product concentration. However, at the higher concentrations that will be 
investigated in Parts 2 and 3, the benefits of different feed flow rates should 
become more pronounced.
Figure 3. 
TMP Excursion at  
Two Feed Flows
Table 1. Membrane  
Area vs. Pump Feed  
Rate (Figure 3)
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Part 2. Concentration
1. Use the product from Part 1 in the starting buffer. 
Based on desired final product concentration factor, 
add additional feed volume as needed to ensure 
sufficient volume at end of concentration 6.
2. Sample feed to confirm product concentration.
3. Put the system in total recycle.
4. Start the feed pump and achieve the optimum TMP and 
feed flow as determined in Part 1 by partially closing 
the retentate valve and adjusting the pump speed.
5. Direct the permeate to a separate container to 
concentrate product and reduce volume.
6. Record temperatures, pressures, and flows throughout 
the concentration; sample feed and permeate for 
product retention 7. 
7. Concentrate slightly beyond desired final product 
concentration.
8. Repeat the TMP excursion outlined in Part 1 to 
determine optimum TMP at the final concentration in 
the starting buffer. 
9. Diafilter with one diavolume to get product into 
final buffer and dilute with final buffer back to initial 
concentration.
10. Repeat the TMP excursion to determine the optimum 
TMP at the initial concentration in the final buffer. 
11. Repeat Part 2 steps 2 – 7 once in final buffer using the 
optimum TMP as determined above.
12. Plot the data as shown in Figure 4, remembering  
to apply a temperature correction in the flux 
calculations8.
Fl
ux
 (L
M
H)
0.1 1 10 100 1000
Product Concentration [g/L] 
Diafiltration Buffer
Starting Buffer
Figure 4. Flux vs. 
Concentration
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Calculations
The tradeoff between flux and diafiltration buffer volume 
create an optimum bulk concentration at which to 
perform diafiltration; this can be calculated using the DF 
optimization parameter at each data point:
 DF Optimization Parameter  =  
  Concentration [g/L]  x  Flux [LMH]
Plotting the DF optimization parameter as a function of 
product concentration yields the optimum concentrations 
for diafiltration in both the starting and final buffers, as 
shown in Figure 5.
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There is an alternative approach that may be used 
to calculate the optimum concentration at which to 
perform diafiltration (Copt). It assumes that the product 
is completely retained and that the passage of the 
permeating species is constant.
If the flux versus concentration data is plotted as 
shown in Figure 4, then the gel concentration, Cg, is the 
concentration at which the permeate flux reaches zero 
(example: ~ 80 g/L in the starting buffer, ~ 110 g/L in the 
final buffer). The optimum concentration at which to 
perform diafiltration is then calculated as 9: 
 Copt [g/L] = Cg [g/L] / e
 In Figure 4:  
 Starting buffer Copt  =  80 / 2.71828  =  29.4 g/L 
 Final buffer Copt  =  110 / 2.71828  =  40.5 g/L
The Cg/e method can only be used when the flux vs. 
concentration data allows for accurate extrapolation  
to zero flux.
Note:
• Ensure enough feed material and appropriate system working volume in 
order to achieve the final concentration.
• Based on the results of the additional TMP excursions performed in Part 2, 
the TMPs used for concentration in both the starting and final buffers 
should be changed and the concentration should be repeated to obtain more 
accurate data. 
 – If the optimum TMP for the dilute solution occurs in the pressure-
independent region (past the knee of the curve) for the concentrated 
solution, then the TMP should be decreased to the lowest optimum value.
 – If the optimum TMP for the dilute solution occurs within the pressure-
dependent region (before the knee of the curve) for the concentrated 
solution, then the TMP may be increased to the highest optimum value  
to further optimize the flux and reduce the processing time.
• Optimum concentration for diafiltration will be different for each buffer; 
choose an average or the most conservative.
 – Restrictions on buffer usage or minimum recirculation volume often 
dictate the concentration at which diafiltration occurs.
 – If the required final concentration is significantly less than the optimum 
concentration for diafiltration, over concentration followed by dilution is 
a possible option, although rarely chosen. It should only be considered in 
cases where diafiltration buffer is limited and the product is stable at the 
higher concentrations.
Figure 5. DF 
Optimization
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Part 3. TMP Excursion at Final Concentration
1. Use the product from Part 2 at the final concentration in 
the final buffer.
2. Repeat steps 2 – 10 of Part 1.
Calculations
Reference Part 1.
Note:
Reference Part 1 and Part 2 notes.
Part 4. Diafiltration
1. Use the product from Part 3 at the optimum 
concentration for diafiltration; dilute as needed using 
the final buffer.
2. Configure the system for constant volume diafiltration.
3. Start the feed pump and achieve the optimum TMP and 
feed flow as determined in Part 1 and Part 3.
4. Diafilter the product with the chosen number of 
diavolumes:
 – Choose the number of diavolumes based on the 
product purity specifications (if known, see calculation 
below) and add a safety factor of 2 diavolumes, or
 – Use 3 – 5 diavolumes as an initial estimate  
for upstream UF/DF steps, or
 – Use 7 – 12 diavolumes as an initial estimate for  
final formulation UF/DF steps
5. Record temperatures, pressures, and flows at every 
diavolume; sample feed and permeate for both product 
retention, and retention and concentration of the 
contaminant of interest.
6. Plot the data as shown in Figure 6.
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Calculations
The percentage of the original contaminant in the retentate 
at each diavolume can be calculated from the retention 
values using the following: 
 Remaining Contaminant [%]  =  100  x  e (Retention – 1) x N
where N is the number of diavolumes.
However, since contaminant concentration is being directly 
measured in each feed sample throughout diafiltration, plot 
these concentrations as a percentage of the original and 
use the above equation to plot several lines of theoretical 
retention, as shown in Figure 6. This plot will help demonstrate 
the contaminant removal at various retentions.
Select the whole number of diavolumes based on the 
acceptable contaminant levels for the product; always 
add 2 – 3 diavolumes as a 10-fold safety factor for critical 
diafiltration steps, such as final formulation. For upstream 
steps, add 1 – 2 diavolumes. If the goal of diafiltration is not 
to wash out a contaminant but rather to reach a target pH 
or conductivity, then the measurement of that quality can 
be plotted against the number of diavolumes instead.
Note:
• If it appears necessary to diafilter past ~ 14 
diavolumes, any dead-legs or poor mixing areas in 
the system will increase the apparent retention of the 
contaminant and make further removal difficult.
• Ensure that choice of TMP and feed flow have 
corresponding product retention values that are 
acceptable (> 0.998) throughout diafiltration.
Figure 6. contaminant 
removal vs. Diavolumes
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Part 5. Product Recovery
There are various methods for product recovery at 
large-scale10. However, at small-scale, sufficient product 
recovery can be achieved by manually tilting the system 
and breaking the piping at low-points to drain the product. 
Samples of the final retentate should then be analyzed for 
product concentration and quality. 
1. After the product has been drained from the system, add 
one system volume of diafiltration buffer to the  
feed tank. 
2. Recirculate at the selected feed flow rate with  
the retentate valve fully open for 10 minutes. 
3. Recover the buffer in a separate container using the 
same methods that were used to recover the product. 
Samples of this buffer rinse should be analyzed for 
product concentration. 
4. After the product is recovered, the system should be 
cleaned with the appropriate solutions11.
Calculations
Ideally, the total product mass recovered in the retentate, 
permeate, and buffer flush as well as unrecoverable 
holdup volume should equal the total mass of product in 
the feed. If the total product mass recovered is less than 
the initial product mass, it is typically due to adsorption 
and/or solubility losses during processing12. However, it is 
important to perform a mass balance and calculate total 
yield to ensure optimum process parameters. 
The theoretical yield can also be calculated based on the  
membrane retention and compared to the actual yield.
 Theoretical Yield [%]  = 100  x  e (Retention – 1)(N + lnX)
where N = number of diavolumes and  X  = concentration  
factor.
 Actual Yield [%]  =  
 100  x  (Vretentate [L]  x  Cretentate [g/L]) / (Vinitial [L]  x  Cinitial [g/L])
 Mass Balance [%]  =  
 100  x  {(Vretentate [L]  x  Cretentate [g/L]) + (Vpermeate [L]  x  Cpermeate [g/L]) + (Vrinse [L]  x  Crinse [g/L])} / (Vinitial [L]  x  Cinitial [g/L])
Note:
• All calculations are estimates; during these optimization steps, 
the product has undergone more processing than normal. 
Product degradation and yield may be slightly affected. For a 
true indication of processing on product quality, perform the 
entire optimized process using fresh feed and new membranes.
• Product can be very viscous when recovered and may affect 
assays; perform serial dilutions for more accurate assay results.
• Actual yield and mass balance percentages should be close 
to 100% and/or theoretical yield. If significant losses occur, 
process parameters (including membrane type) may have to  
be changed and then re-optimized.
• In a robust process, adsorption and solubility losses should  
be very low.
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Paper Design and Process Simulation
The optimization parameters obtained from the previous 
experiments can be combined to design a full process 
simulation: concentration, diafiltration, (concentration,) 
and recovery. If time permits, a process simulation should 
be run immediately following the optimization work, and 
should employ the following:
• New set of cassettes; same membrane type,  
same cassette path length
• Fresh feedstock
• Fresh buffer(s)
• Optimized process parameters
• See detailed process simulation calculations below.
After performing the process simulation, the system 
should be cleaned with the appropriate solution according 
to EMD Millipore recommendations11. If possible, the 
process should be rerun using the cleaned membranes to 
determine the effectiveness of the cleaning cycle and the 
consistency of membrane performance from run-to-run. 
If the cleaning cycle does not prove effective, the cleaning 
parameters or cleaning solutions will need to be changed 
and the cleaning cycle will have to be tested again. 
Calculations
The membrane area can be optimized to allow the 
entire process (both concentration and diafiltration) to 
be completed in the specified timeframe (3 – 4 hours is 
recommended). The average flux for each concentration  
and diafiltration step can be estimated from the 
optimization data and combined with the desired volumes 
to be processed. The approximate required membrane 
area can then be calculated for both manufacturing scale 
and scale-down runs.
Assume an example process scenario (this would have 
been determined by optimization data, DF parameter, etc.):
• 2.9X Concentration:  
10 g/L to 29 g/L; flux decreases from 150 LMH to 80 LMH
• 7X Diafiltration:  
29 g/L; flux increases from 80 LMH to 85 LMH
• 3.4X Concentration:  
29 g/L to 100 g/L; flux decreases from 85 LMH to 20 LMH
• Desired process time is 4 hours
Manufacturing scale volumes as determined by the 
customer:
• Feed volume  = 5000 L
• Retentate volume at end of 2.9X concentration  =  
5000 L/2.9  =  1724 L
• Permeate volume removed during 2.9X concentration = 
5000 L – 1724 L  =  3276 L
• 7X Diafiltration buffer volume  =  7  x  1724 L = 12,068 L
• Retentate volume at end of 3.4X Concentration  =  
1724 L/3.4  = 507 L
• Permeate volume removed during 3.4X concentration  = 
1724 L – 507 L  = 1217 L
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Average process flux for concentration step13:
 Javg =  Jfinal + 0.33 (Jinitial – Jfinal)  =  Jinitial  x  0.33 + Jfinal  x  0.67
For 2.9X concentration:  
 Javg =  150 LMH  x  0.33 + 80 LMH  x  0.67 = 103 LMH
For 3.4X concentration:  
 Javg =  85 LMH  x  0.33 + 20 LMH  x  0.67 = 41 LMH
Average process flux for diafiltration step: 
For diafiltration the average flux can be estimated as the 
initial and final process flux during the diafiltration step.
Required area:
 Area = [(Permeate volume/Average flux) Concentration +  (Permeate volume/Average flux) Diafiltration + … ]  / Time
In this example:  
 Area = [(3,276 L/103 LMH) + (12,068 L/83 LMH) + (1,217 L/41 LMH)]  / 4 hours =  51.6 m2
Add 20% safety factor:  
 Area = 62 m2
To perform a scale-down process simulation, the same 
volume to area ratio is used and scaled based on either the 
feed volume that can be used for the simulation or the area 
of the desired filtration device. For example, if the process 
is to be performed on one Pellicon® 2 Mini cassette (with 
an area of 0.1 m2), then the required feed volume will be:
 Scale-down feed volume  =  0.1 m2  x  (5000 L/62 m2)  =  8 L
Instead, if there is a specific volume of feedstock to process 
(example: 25 L), then the required membrane area will be:
 Scale-down membrane area  =  25 L  x  (62 m2/5000 L)  =  0.3 m2
The process parameters, including Pellicon® device type, 
should be consistent between scales, allowing the process 
to be completed in a similar timeframe with similar fluxes, 
pressures and loadings. The concentration factors, number 
of diavolumes and feed quality should be kept consistent 
at all scales to ensure robust scalability. However, to 
demonstrate process robustness and repeatability, the 
process should be tested at pilot scale before proceeding to 
manufacturing.
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Definitions
Apparent Sieving (Sapp)
The fraction of a particular protein that passes through 
the membrane to the permeate stream based on the 
measurable protein concentrations in the feed and per-
meate streams. A sieving coefficient can be calculated for 
each protein in a feedstock.
 Sapp [–] =  (Concentration in permeate, CP) /  
(Concentration in feed, Cb) 
Concentration Factor (CF)
The amount that the product has been concentrated in 
the feed stream. This depends on both the volume con-
centration factor and the retention. As with the VCF, for a 
Fed-Batch concentration process, calculate CF based only 
on the volume of feedstock added to the TFF application.
 CF [–] =  Final product concentration / 
initial product concentration = VCF(Rapp)
Conversion Ratio (CR) 
The fraction of the feed side flow that passes through the 
membrane to the permeate.
 CR [–] = QP / QF 
Diavolume (DV or N) 
A measure of the extent of washing that has been per-
formed during a diafiltration step. It is based on the vol-
ume of diafiltration buffer introduced into the unit 
operation compared to the retentate volume. If a con-
stant-volume diafiltration is being performed, where the 
retentate volume is held constant and diafiltration buffer 
enters at the same rate that permeate leaves, a diavolume 
is calculated as:
 DV or N [–] =  Total buffer volume introduced  
to the operation during  
diafiltration/retentate volume 
Intrinsic Sieving (Si)
The fraction of a particular protein that passes through  
the membrane to the permeate stream. However, it is 
based on the protein concentration at the membrane sur-
face. Although it cannot be directly measured, it provides 
a better understanding of the membrane’s inherent sepa-
ration characteristics.
 Si [–] =  (Concentration in permeate, CP) / 
(Concentration at membrane wall, Cw) 
Mass Flux (Jm ) 
The mass flow of protein through the membrane normal-
ized for the area of membrane (m2) through which it is 
passing.
 Jm [g m–2 h–1] = QP  x  CP / area
Permeate Flux ( Jf ) 
The permeate flow rate normalized for the area of mem-
brane (m2) through which it is passing.
Pressure Drop (∆P) 
The difference in pressure along the feed channel of the 
membrane from inlet to outlet.
 ∆P [bar] = PF – PR 
Retention (R)
The fraction of a particular protein that is retained by the 
membrane. It can also be calculated as either apparent or 
intrinsic retention. Retention is often also called rejection.
 Rapp [–] = 1 – Sapp or Ri = 1 – Si
Transmembrane Pressure (TMP) 
The average applied pressure from the feed to the perme-
ate side of the membrane.
 TMP [bar] = [(PF + PR)/2] - PP
Volume Concentration Factor (VCF or X) 
The amount that the feed stream has been reduced in 
volume from the initial volume. For instance, if 20 L of 
feedstock are processed by ultrafiltration until 18 L have 
passed through to the permeate and 2 L are left in the 
retentate, a ten-fold concentration has been performed 
so the Volume Concentration Factor is 10. In a Fed-Batch 
concentration process, where the bulk feedstock is held in 
an external tank and added to the TFF operation continu-
ously as permeate is removed, VCF should be calculated 
based only on the volume that has been added to the TFF 
operation.
 VCF or X [–] =  Total starting feed volume added to 
the operation / current retentate volume
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Cassette Filters (P17512) or Pellicon® 3 Filters Installation and User 
Guide (AN1065EN00)
9. Ng P, Lundblad J, and Mitra G, Optimization of Solute Separation by 
Diafiltration, Separation Science, 11(5): 499-502, 1976.
10. See Technical Brief: Protein Concentration and Diafiltration by 
Tangential Flow Filtration (TB032)
11. See Guide: Maintenance Procedures for Pellicon® and Pellicon® 2 
Cassette Filters (P17512) or Pellicon® 3 Filters Installation and User 
Guide (AN1065EN00)
12. See Technical Note: Increase Product Yield in Your UF/DF Processes 
(AN1026EN00)
13. Average flux can also be calculated for each step by dividing the total 
process volume by the total process time
EMD Millipore and the M logo are trademarks of Merck KGaA, Darmstadt, Germany.  
Pellicon is a registered trademark of Merck KGaA, Darmstadt, Germany.
Lit No. AN2700EN00  Rev. B   PS-13-08448    5/2013  Printed in the USA. 
© 2013 EMD Millipore Corporation, Billerica, MA USA. All rights reserved.
www.emdmillipore.com/offices
To Place an Order or Receive
Technical Assistance
In the U.S. and Canada, call toll-free 1-800-645-5476
For other countries across Europe and the world, 
please visit: www.emdmillipore.com/offices
For Technical Service, please visit: 
www.emdmillipore.com/techservice
Millidisk® Cartridges and  
Millipak® Disposable Capsules
For the sterile filtration of liquids in  
pharmaceutical applications
Data Sheet
Millidisk® cartridges and Millipak® disposable capsules are 
stacked disc filters designed for the removal of particles and 
microorganisms from liquids and gases. The stacked disc 
design without a support fleece allows minimal hold-up  
volume and particle shedding, making Millipak® and  
Millidisk® filters ideally suited for high value-added  
applications. All Millipak® and Millidisk® filters are made 
with Durapore® PVDF membranes, providing high flow  
rates and throughputs, low extractables, broad chemical 
compatibility and the lowest protein binding of any  
membrane available.
Benefits
•  Unique stacked design allows minimal hold-up 
volume and particle shedding
•  Constructed with Durapore® PVDF membranes for 
high flow rates and throughputs
•  Various stack sizes for optimum flexibility
•  Some units supplied sterile for added convenience
•   2D barcode for simplified traceability
Membrane Types
•  Hydrophilic Durapore® PVDF membrane in 0.1 μm,  
0.22 μm, 0.45 μm and 5.0 μm pore sizes 
•  Hydrophobic Durapore® PVDF membrane in  0.22 μm  
pore size
Filter Formats
•  Millidisk® cartridges in 4 sizes from 500 to  
2,000 cm² of filtration area
• Millipak® disposable filters in 5 sizes from 100  
 to 1,000 cm² of filtration area
EMD Millipore Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany
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Flexibility and Scalability
Millipak® and Millidisk® filters are available in 0.1 μm,  
0.22 μm, 0.45 μm and 5.0 μm pore sizes. Various stack 
sizes allow optimum flexibility for easy scale up and sys-
tem sizing. Millidisk® filters are designed to be used with 
either Millidisk® or Millidisk®/ Milligard® housings. For 
added convenience, some Millipak® units are supplied 
pre-sterilized.
Quality
For traceability and easy identification, each Millipak® 
and Millidisk® filter is labeled with its catalogue number, 
lot number and serial number. Millipak® filters offer 
simplified traceability with an on-board 2D barcode con-
taining this information. Millipak® and Millidisk® filters 
are designed, developed, and manufactured in  
accordance with a Quality Management System approved 
by an accredited registering body to an ISO® 9001  
Quality Systems Standard. Each unit is 100% integrity 
tested during manufacturing. Each sterilizing-grade 
Millipak® and Millidisk® filter includes a Certificate of 
Quality for documentation accuracy.
Typical Applications
•  Sterile filtration of parenterals, diagnostics,  
and buffers
•  Sterile filtration of media and biologicals
•  Sterile filtration of gases and non-aqueous liquids
•  Particle removal at point of fill
•  Point-of-use filter for high purity water
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Millipak® Disposable Filter Units Specifications
Millipak® 20 Millipak® 40 Millipak® 60 Millipak® 100 Millipak® 200
Nominal Dimensions
      Maximum length: 10 cm (4.0 in.) 10 cm (4.0 in.) 10 cm (4.0 in.) 13 cm (5.1 in.) 15.5 cm (6.1 in.)
      Nominal diameter: 76 mm (3.0 in.) 76 mm (3.0 in.) 76 mm (3.0 in.) 76 mm (3.0 in.) 76 mm (3.0 in.)
Filtration Area 100 cm2 (0.11 ft2) 200 cm2 (0.22 ft2) 300 cm2 (0.32 ft2) 500 cm2 (0.54 ft2) 1000 cm2 (1.08 ft2)
Materials of Construction
      Filter membrane: Durapore® PVDF membrane
      Structural components: Polycarbonate
      Vent caps: PVDF vent caps
      Bell cap: Polyethylene (Bellcaps on Millipak® 20, 40 and 60 units only) – –
Housing Vent Adjustable vent with male luer and female Luer-Lok™ connections on inlet side of device.
Maximum Inlet Pressure 5.2 bar (75 psi) at 25 °C
Maximum Differential Pressure
      Forward: 4.1 bar (60 psid) at 25 °C
1.7 bar (25 psid) at 80 °C
      Reverse: 690 mbar (10 psid) at 25 °C
Bubble Point at 23 °C
      0.1 μm: ≥ 4830 mbar (70.0 psi) air with water*
      0.22 μm: ≥ 3450 mbar (50.0 psi) air with water
      0.45 μm: ≥ 1790 mbar (26.0 psi) air with water
Connections 1/4 in. (6 mm) stepped hose barbs with filling bell on outlet 1/4 in. NPTM
3/4 in. sanitary flange inlet and outlet (for 25 mm micro clamp) 3/4 in. sanitary flange (for 25mm micro-clamp)
1 1/2 in. sanitary flange (for 50.5 mm micro-clamp)
9/16 in. OD/ 3/8 in. ID (14 mm OD/9.5 mm ID) hose barb
Gravimetric Extractables Maximum values post autoclaving or gamma irradiation, a 200 mL flush and a 24 hour soak in ASTM® Type 1 reagent grade water at 
controlled room temperature:
1.0 mg 1.5 mg 2.0 mg 2.5 mg 5.0 mg
Oxidizable Substances Meets the requirements of the USP WFI Oxidizable Substance requirements after a water flush of 200 mL
Bacterial Endotoxin Aqueous extraction contains < 0.5 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test.
Bacterial Retention
      0.1 and 0.22 only Quantitative retention of 107 CFU/cm2 Brevundimonas diminuta ATCC® 19146 when tested following ASTM F838 methodology.
Sterilization May be autoclaved for 3 cycles of 90 minutes at 123 °C. Capable of 45 kilogray gamma exposure.  
(Cannot be steam sterilized in-line.)
Component Material Toxicity Millipak® Disposable Filter Units meet the requirements of USP <88> Biological Reactivity Tests for Plastics Class VI-70°C.   
Millipak® Disposable Filter Units also meet the requirements of the USP <88> Safety Test Utilizing a 0.9% Sodium Chloride  
extraction and the USP <87> L929 MEM Elution Test.
* Transient pressure excursion above the maximum differential and inlet pressures of the unit for integrity testing is acceptable.
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Millipak® 20/40/60 Capsule Filters with
0.1 μm Hydrophilic Durapore® Membrane
Millipak® 20/40/60 Capsule Filters with
0.22 μm Hydrophilic Durapore® Membrane
Millipak® 100/200 Capsule Filters with
0.1 μm Hydrophilic Durapore® Membrane
Millipak® 100/200 Capsule Filters with  
0.22 μm Hydrophilic Durapore® Membrane  
Millipak® 20/40/60 Capsule Filters with
0.45 μm Hydrophilic Durapore® Membrane
Millipak® 100/200 Capsule Filters with
0.45 μm Hydrophilic Durapore® Membrane
Millipak® Disposable Filter Units Typical Clean Water Flow Rates
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Millidisk® Cartridge Specifications
Millidisk® 10 Millidisk® 20 Millidisk® 30 Millidisk® 40
Filtration Area 500 cm2 (0.54 ft2) 1000 cm2 (1.08 ft2) 1500 cm2 (1.61 ft2) 2000 cm2 (2.15 ft2)
Materials of Construction
      Filter membrane
      Structural components
      O-rings
Durapore® PVDF membrane
Polysulfone
Silicone
Maximum Differential Pressure
      Forward:
      Reverse:
4.1 bar (60 psid) at 25 °C
1.7 bar (25 psid) at 80 °C
345 mbar (5 psid) at 123 °C
690 mbar (10 psid) at 25 °C
Pore Sizes 0.1 μm, 0.22 μm (hydrophilic and hydrophobic), 0.45 μm and 5.0 μm
Bubble Point at 23 °C
      0.1 μm:
      0.22 μm:
      0.45 μm:
      5.0 μm:
      0.22 μm hydrophobic:
≥ 4830 mbar (70.0 psig) in water
≥ 3450 mbar (50.0 psig) in water
≥ 1790 mbar (26.0 psig) in water
≥ 140 mbar (2.0 psig) in water
≥ 1170 mbar (17.0 psig) in 100% IPA using nitrogen as the test gas
Connections Millidisk® filters incorporate a double 2-118 (silicone) O-ring seal and are used with Millidisk® or Millidisk®/
Milligard® stainless steel housings.
Gravimetric Extractables Maximum values post autoclaving and a 24 hour soak in ASTM® Type 1 reagent grade water for 
hydrophilic units and in 70/30 IPA/Water solution for hydrophobic units: 
2.5 mg/unit 5 mg/unit 7.5 mg/unit 10 mg/unit
Oxidizable Substances (After steaming) A Millidisk® filter will meet the USP WFI Oxidizable Substances requirements after a  
200 mL flush with water per cartridge.
Bacterial Endotoxin An aqueous extraction from a Millidisk® filter contains < 0.5 EU/mL bacterial endotoxin as determined  
by the LAL test.
Bacterial Retention Millidisk® 0.1 μm and 0.22 μm units are qualified for quantitative retention of Brevundimonas diminuta  
(ATCC® 19146) at a minimum challenge level of 10⁷ CFU/cm² when tested following ASTM® F838 methodology. 
Sterilization Autoclave: 126 °C, 60 minutes, up to 5 times
Steam-in-place: 135 °C, 60 minutes, up to 5 times
Component Material Toxicity Component materials meet the requirements of USP <88> Biological Reactivity Tests for Plastics Class  
VI-70°C. Millidisk® filters also meet the requirements of the USP <88> Safety Test Utilizing a 0.9% Sodium 
Chloride extraction. 
* Transient pressure excursion above the maximum differential and inlet pressures of the unit for integrity testing is acceptable. 
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Millidisk® 0.22 μm Hydrophilic FiltersMillidisk® 0.1 μm Hydrophilic Filters Millidisk® 0.22 μm Hydrophobic Filters
Millidisk® 5.0 μm Hydrophilic FiltersMillidisk® 0.45 μm Hydrophilic Filters Millidisk® 0.22 μm Hydrophobic Filters
Air Flow Rate @ 25 ºC
Millidisk® Water Flow Rates at 25 °C
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Millipak® Filters
Ordering Information
Millipak® 
Filter
Nominal Pore Size 
VL = 0.1 μm
GL = 0.22 μm
HL = 0.45 μm
Package Quantity 
2 = 2 per package (Millipak® 20, 40, 60)
3 = 3 per package (Millipak® 100, 200)
Millipak® Series 
02G = Millipak® 20, Sterilized by gamma radiation
04G = Millipak® 40, Sterilized by gamma radiation
06G = Millipak® 60, Sterilized by gamma radiation
10C = Millipak® 100, Non-sterile
1GC = Millipak® 100, Sterilized by gamma radiation
20C = Millipak® 200, Non-sterile
2GC = Millipak® 200, Sterilized by gamma radiation
M P
Connection Type 
Millipak® 20, 40 & 60
F =  3/4 in. sanitary flange inlet and outlet  
(25 mm micro clamp)
H =  1/4 in. (6 mm) stepped hose barb inlet and  
outlet with filling bell
Millipak® 100 & 200
A =  9/16 in. (14 mm) hose barb inlet and outlet
B = 1/4 in. NPTM inlet and outlet 
F =  3/4 in. sanitary flange inlet and outlet  
(25 mm micro clamp)
L =  1 1/2 in. sanitary flange inlet and outlet  
(50.5 mm micro-clamp)
Example: MPVL 04G H2 would be identified as a sterile Millipak® 40 filter with 0.1 μm
Durapore® membrane. This example would have 1/4 in. (6mm) hose barb inlet and outlet fittings 
and comes in a package of 2.
Note: Millipak® filters can be manufactured with other inlet and outlet connection 
configurations. Please contact EMD Millipore Technical Service with your custom requirements.
Millidisk® Cartridges
Ordering Information
Millidisk® 
Cartridges
Nominal Pore Size
Hydrophilic
VL = 0.1 μm
GL = 0.22 μm
HL = 0.45 μm
SL = 5.0 μm
Hydrophobic
GB = 0.22 μm
Package Quantity
Hydrophilic 0.1 μm, 0.22 μm, 0.45 μm 
3 = 3 per package
Hydrophilic 5.0 μm, hydrophobic 0.22 μm
2 = 2 per package (Millidisk® 10, 20)
1 = 1 per package (Millidisk® 30, 40)
Millidisk® Stack Size
40S = 40-stack
30S = 30-stack
20S = 20-stack
10S = 10-stack
M C O
EMD Millipore, the M logo, Durapore, Millidisk, Milligard and Millipak are registered trademarks of  
Merck KGaA, Darmstadt, Germany. ATCC is a trademark of American Type Culture Collection.  
ASTM is a trademark of American Society for Testing and Materials. ISO is a registered trademark of  
the International Organization for Standardization.   Lit No. DS57770000  V 1.0     PS-13-08603     
08/2015      © 2015 EMD Millipore Corporation, Billerica, MA USA.   All rights reserved.
www.emdmillipore.com/offices
To place an order or receive
technical assistance
In the U.S. and Canada, call toll-free 1-800-645-5476
For other countries across Europe and the world, 
please visit: www.emdmillipore.com/offices
For Technical Service, please visit: 
www.emdmillipore.com/techservice
Get Connected!   
Join EMD Millipore on your favorite social  
media outlet for the latest updates, news, products, 
innovations, and contests!
facebook.com/EMDMillipore
twitter.com/EMD_Millipore
MA/BA Gen4 PRO SerieS
Manual Mask/Bond aligner 
for industrial research and Production
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iNNoVAtiVe excelleNce
 + High resolution (HR) optics allows patterning of  
 structures below 0.5 μm
 + Operator assisted and auto alignment permits  
 down to 0.25 μm alignment accuracy
 + Advanced automatic functions for  
 maximum process control
 + Process compatibility with automatic  
 equipment
 + Optimized splitfield microscope with direct  
      viewing and/or LCD flat screen options 
 + Easy conversion to bond align mode
 + Micro & nanoimprint lithography retrofit kit
 + Microlens imprinting toolset
 + Selective plasma tool set
 + Allows utilization of tool sets from the previous  
 MA/BA6 and MA/BA8 platform
FeAtUreS ANd beNeFitS
The MA/BA Gen4 Pro series represents the 
latest generation of SUSS MicroTec’s semi- 
automated Mask and Bond Aligner and intro-
duces a new platform concept that consist of 
an entry-level MA/BA Gen4 and the high-end 
MA/BA Gen4 Pro series. The Gen4 Pro series 
is the high-end model, for industrial research 
and operator-assisted production, available as 
MA/BA6 Gen4 Pro and MA/BA8 Gen4 Pro. 
The series has been designed to enable quick 
and effective development of new technologies 
and products. Research organizations will benefit 
from the enhanced capabilities of this machine 
as it allows them to develop their processes with 
industry standard equipment.
Because of their ability to easily process all kinds 
of wafer and substrate materials, semi-automa-
ted aligners are increasingly used in production 
environments. With the MA/BA Gen4 Pro series, 
SUSS MicroTec addresses the growing demand 
for tighter process control coupled with high 
yield. 
The MA/BA Gen4 Pro series is the benchmark 
in full-field lithography for MEMS, Advanced 
Packaging, 3D integration and compound 
semiconductor markets. It also handles processes 
like micro & nanoimprint, bond alignment, UV-
bonding, selective plasma activation as well as 
wafer level microlens imprinting and assembly.
Processes developed on the MA/BA Gen4 Pro 
series can be quickly transferred onto SUSS 
MicroTec‘s automated mask aligner platform 
for high volume production. Both platforms are 
based on the same SUSS technology.
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An unmatched alignment precision 
coupled with high resolution and maximum 
light uniformity makes the MA/BA 
Gen4 Pro series the tool of choice for a 
breAKiNG techNoloGy boUNdArieS
SELECT
Selective plasma activation on a 4" wafer
Courtesy: Fraunhofer IST
UV LIGA
Micro mechanical watch components
Courtesy: Mimotec
MEMS
Printed in 500 μm SU8 structures
Courtesy: mrt, Berlin
CMOS Image Sensor Packaging,TSV Lithography
Via top and bottom opening
Courtesy: Schott, IZM
Wafer Level CSP
Redistribution layer
Courtesy: Fraunhofer IZM
Microlens Imprint Lithography (SMILE)
Microlens array for WLC (lens dimensions:
30 μm thick, 1600 μm diameter)
Courtesy: SMO
UV Nanoimprint Lithography
160 nm wide holes positioned in concentric
rings as used for photonic crystals
Substrate Conformal Imprint Lithography (SCIL)
Large area nanoimprint lithography with soft stamp 
technology
Courtesy: Philips Research
Submicron Patterning
350 nm thick resist AZ6612
400 nm lines and spaces
Printed with SUSS UV400 HR Optics
Courtesy: FH Vorarlberg
variety of applications, ranging from 
MEMS, opto-electronics and 3D 
Packaging to micro-optics and nano-
technology.
400nm
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Innovation, high device performance, cost efficiency 
and short time-to-market are key drivers of product 
development and research at the beginning of 
the 21st century.
With the new generation of the MA/BA Gen4 Pro 
series SUSS MicroTec has developed an 
innovative, state-of-the-art manual aligner solution 
that offers high process flexibility including sub-
micron alignment and optimized thick resist 
lithography, UV micro- and nanoimprinting, 
microlens imprinting and assembly, UV bonding, 
SELECT and enhanced bond alignment.
Designed for R&D, pilot line and production 
environments, the MA/BA Gen4 Pro series 
enables production-friendly research. It allows 
easy and cost effective process transfer from 
laboratory to production. Key components such 
as optics, alignment system and graphical user 
interface perfectly match with the SUSS produc-
tion aligner platform.
coNNectiNG iNdUStriAl reSeArch ANd ProdUctioN
iNdUStry NeedS reSeArch – reSeArch NeedS eqUiPmeNt
The quality of our future lifestyle depends on 
investments we make in research today. In 
order to stay in the race, novel technologies and 
products are in development that later will be 
produced in large volumes. With their enabling 
technology, manual mask aligners from SUSS 
MicroTec contribute to research and development, 
thereby helping us to shape the future. 
Fully automated mask aligners from SUSS 
MicroTec are found in virtually all major advanced 
packaging, MEMS and compound semiconductor 
production environments where high yield 
and cost effective manufacturing are essential 
requirements.
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memS
The MA/BA Gen4 Pro series with its high intensity 
exposure optics is a very efficient exposure tool 
for thick resist MEMS applications.
Innovative features or toolsets like infrared 
alignment system (transmission and reflective), 
reSeArch
A quick changeover between options such 
as Lithography for thin and thick resists, 
micro- and nanoimprint, UV Bonding, Bond 
Alignment, Direct Bonding and selective 
plasma treatment make the MA/BA Gen4 
Pro series the perfect tool for the variety of 
imPriNt
The MA/BA Gen4 Pro series enables with its 
different options for micro- and nanoimprint 
to have the right solution from low to high 
resolution and from small up to large area 
imprint. The UV-NIL option will allow you to 
Bond Alignment, selective plasma activation or 
the capability to handle small substrates make 
the MA/BA Gen4 Pro series an enabling lithog-
raphy tool for the development and low volume 
production of MEMS devices.
print highest resolution on small substrates. 
For full wafer imprint up to 150 or 200 mm 
either SMILE, a micro imprint using soft stamps, 
or the unique SCIL nanoimprint technique for 
highest resolution is the optimal choice.
applications in research. The tool can be 
equipped as needed from a low cost manual 
tool for basic studies up to a highly automized 
tool with automatic alignment for industrial 
research.
.
tArGet mArKetS
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Highly precise alignment plays a significant role 
throughout the whole MEMS and semiconductor 
manufacturing process. The MA/BA Gen4 Pro 
series offers a variety of different alignment 
systems tailored to your specific process 
requirements. Depending on the alignment 
mode and alignment conditions, alignment 
precisions down to 0.25 μm (under special 
conditions) can be achieved.
SUPerior AliGNmeNt
The MA/BA Gen4 Pro series is a highly versatile 
system for R&D and operator-assisted production. 
In addition it allows easy and fast upgrades to 
complementary technologies. 
The MA/BA Gen4 Pro series offers you up to five 
system solutions in one single tool:
+ Full-field Photo Lithography
+ Bond Alignment: alignment of two substrates
   for subsequent substrate bonding
+ UV-Imprinting: UV-NIL, SCIL and SMILE
+ UV-Bonding: Wafer level assembly of devices 
   with UV curable material
+ Selective Plasma Activation for partial surface 
   activation and bond preparation
hiGhly iNteGrAted  
FUNctioNAlity
Achievable resolution depends on optics type, wafer size, wafer flatness, 
resist type, clean room class and therefore, might vary for different pro-
cesses. (1 μm thick resist, lines & spaces)
mA/bA GeN4 PrO SerieS reSolUtioN
exPoSUre mode UV400 UV300 UV250
Vacuum Contact 1.5 μm 0.5 μm 0.4 μm
Hard Contact 2.0 μm 1.0 μm -
Soft Contact 3.0 μm 2.0 μm -
Proximity (20 μm) 3.5 μm 2.5 μm -
excelleNt UV UNiFormity
meAN 
iNteNSity
wAFer SiZe
8" 6" < 4"
i-line* 40 mW/cm2 3.5 % 3.0 % 2.0 %
Broadband** 60 mW/cm2 3.5 % 3.0 % 2.0 %
 * measured with 365 nm probe
** measured with broadband probe
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All SUSS Mask Aligners can be equipped with 
a variety of optical configurations designed to 
compensate diffraction effects. SUSS Mask 
Aligners perform exposure not only by one 
parallel beam, but by several slightly inclined 
beams to reduce the peak intensity of the 
secondary diffraction images produced by inter-
ference effects.
Diffraction reducing exposure optics from SUSS 
MicroTec significantly improve resolution and 
sidewall profiles.
The MA/BA Gen4 Pro series is a full-field 
exposure system capable of exposing wafers 
and substrates from pieces up to 150 or 200 mm. 
SUSS MicroTec offers optimized solutions for 
dedicated spectral ranges such as UV250, 
UV300 and UV400 to address different resolution 
requirements. All optics deliver optimum light 
uniformity of 3.5 % depending on the application 
the user can choose between a High Resolution 
(HR) and a Large exposure Gap Optics (LGO). 
The high resolution optics have been optimized 
for small exposure gaps or contact exposure to 
achieve highest lines and spaces resolution. The 
SUSS LGO optics have been designed for large 
exposure gaps typically used for high topography 
(3D) and thick resist applications.
dedicAted oPticS  
SolUtioNS
StANdArd 
diFFrActioN redUciNG 
exPoSUre oPticS
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The LED lamp house concept of the MA/BA 
Gen4 Pro series convinces with efficiency - 
UV-LED light sources reach many times the service 
life of conventional mercury vapor lamps. Mo-
reover, they no longer need to warm up and 
cool down - the LED is only switched on during 
exposure. These factors significantly contribute 
to comparatively low energy consumption. 
Compared to conventional mercury vapor 
lamps, LED light sources not only work more 
efficiently but are also much more flexible to 
use. The UV-LED lamp house generally covers 
the same spectral region as mercury vapor 
lamps. The difference is that the UV-LED can 
switch specific wave lengths on and off. This 
eliminates the need to optically filter the light 
UV-led lAmP hoUSe
outside of the lamp house. Wave lengths are 
regulated via programed formulas which ful-
fill specific process requirements without filter 
change or recalibration.  
The operation of the MA/BA Gen4 Pro series 
significantly affects the operating costs the 
system. The service life of an LED exceeds 
that of conventional lamps many times over, 
thereby lowering costs generated by changing 
lamps. Downtimes, acquisition of new lamps, 
adjustments and disposal of old material have 
become a thing of the past.  
Working with the LED lamp house is both safe 
and environmentally sound and is a major step 
up in health and occupational safety, as well as 
in environmental protection.
UV-led lAmP hoUSe
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flExibility of spEctrum
STATE-OF-THE-ART
VARIABLE INTENSITy
NO LAMP WASTING
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toP Side AliGNmeNt (tSA)
The MA/BA Gen4 Pro series can be equipped with 
either a manual or motorized top side alignment 
system. It can reliably achieve an alignment accu-
racy down to 0.25 μm (under special conditions) 
supported by assisted or auto alignment.
bottom Side AliGNmeNt (bSA) 
allows to pattern the top side of the wafer with 
features accurately aligned to the bottom side. 
The MA/BA Gen4 Pro series BSA system offers 
an alignment accuracy of < 1 μm.
iNFrAred AliGNmeNt (ir)
allows the handling of opaque, yet IR-trans-
parent materials such as GaAs, InP, Silicon or 
adhesives. These are used for thin wafer handling 
or encapsulation applications.
AliGNmeNt methodS
SPlitField microScoPe with 
eye-PieceS 
Offers the operator a larger field of view, a higher 
depth of focus and a colored image.
Video microScoPe
The microscope with attached CCD cameras 
present the alignment on a LCD screen for 
easy and fast operation.
SPlitField / Video microScoPe
System with eye-pieces and CCD camera. It 
combines the advantages of both microscope 
options in one system. The splitfield microscope 
offers the operator a larger field of view, a higher 
depth of focus and a colored image.
toP Side microScoPe 
oPtioNS
STATE-OF-THE-ART
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The MA/BA Gen4 Pro series can be configured 
as mask and bond aligner combination or as 
a bond aligner only. The BA8 Gen4 Pro aligns 
and clamps wafers in fixtures to maintain the 
position during manual transfer to a SUSS 
Wafer Bonder. The innovative system meets 
customer‘s needs for high precision, flexibility 
and repeatability, as well as low cost of ownership. 
In case of direct bonding processes, the wafers 
can be prebonded in the aligner as well. For 
low temperature direct bonding applications 
the BA8 Gen4 Pro can be upgraded with a 
plasma activation toolkit for patterned and full 
boNd AliGNmeNt
wafer surface activation (SELECT).
The highly rigid and stable alignment stage of 
the BA8 Gen4 Pro in combination with assisted 
and auto alignment options ensures reliable and 
accurate alignment of substrates. The proven, 
patented SUSS MicroTec wedge error com-
pensation system guarantees highest possible 
planarity between wafers.
The BA8 Gen4 Pro accommodates even most 
demanding alignment processes in MEMS and 
LED production and growth markets like 3D in-
tegration.
mANUAl AliGNmeNt 
is based on a manual or motorized alignment 
stage that can be precisely operated either via 
micrometer screws or joystick by the operator.
AliGNmeNt modeS
ASSiSted AliGNmeNt 
represents the latest development for operator 
assisted, semi-automated alignment. During 
manual alignment the COGNEX® based pattern 
recognition software continuously measures the 
achieved accuracy and reports it to the operator. 
With its sub pixel resolution the system supports 
highest alignment precision, prevents misalignment 
and maximizes yield.
AUto AliGNmeNt 
is based on a motorized alignment stage. The 
COGNEX® based pattern recognition software 
automatically recognizes wafer target locations 
and controls the movement of the alignment 
stage. 
Coupled with SUSS MicroTec‘s DirectAlign® 
accuracies down to 0.25 μm can be achieved.
Auto Alignment enables highest repeatability of 
process results coupled with optimized throughput 
and minimum operator intervention.
11
techNicAl dAtA
mASK ANd wAFer / SUbStrAte
Wafer Size 1" to 150 or 200 mm
Max. Substrate Size 150 x 150 mm  or
200 x 200 mm
Min. Pieces 5 x 5 mm
Wafer Thickness max. 10 mm
Mask Size standard 2" x 2"
up to 7" x 7" (SEMI) or
up to 9" x 9" (SEMI)
exPoSUre modeS
Contact soft, hard, vacuum
Proximity exposure gap 1– 300 μm
Gap Setting Accuracy 1 μm
Vacuum Contact adjustable to -80 kPa
Modes constant power, constant dose
Options flood exposure, split exposure
exPoSUre oPticS
Resolution see page 6
Wavelength Range UV400 350–450 nm
UV300 280–350 nm
UV250 240–260 nm
Exposure Source Hg lamps 350–1000 W 
(optional 5000 W)
UV LED lamp house
Intensity Uniformity < 3.5 % (200 mm)
AliGNmeNt methodS
Top-Side Alignment (TSA) accuracy < 0.5 μm (with assisted 
alignment and SUSS MicroTec 
recommended wafer targets)
Bottom-Side Alignment (BSA) accuracy < 1.0 μm
TSA Focus Range 1– 400 μm (AL400 – motorized 
focus and image capturing)
Accuracy Bond Aligner 2 μm
Data, design and specification of custom built machines depend on individual 
process conditions and can vary according to equipment configurations. Not all 
specifications may be valid simultaneously. Illustrations in this brochure are not 
legally binding. SUSS MicroTec reserves the right to change machine specifications 
without prior notice.
AliGNmeNt StAGe
MA Movement Range X: ± 5 mm
y: ± 5 mm
θ: ± 5°
BA Movement Range X: ± 3 mm
y: ± 3 mm
θ: ± 3°
Resolution 0.1 μm
toPSide microScoPe (tSA)
Movement Range 6" 8"
X: 33 – 152 mm
y: +18 –100 mm
θ: ± 5°
X: 33 – 202 mm
y: +18 –100 mm
θ: ± 5°
bottomSide microScoPe (bSA)
Movement Range 6" 8"
X: 20 – 150 mm
y: ±22 mm
focus: 6 mm
X: 20 – 210 mm
y: ±22 mm
focus: 6 mm
GrAPhicAl USer iNterFAce
Windows 7
Unlimited Storage of Recipes
Remote Access Available
UtilitieS
Vacuum < –0.8 kPa
Compressed Air 0.6 - 0.8 MPa
Nitrogen > 0.5 MPa
Power reqUiremeNtS
Power voltage AC 230 V ±10 %
frequency 50–60 Hz
PhySicAl dimeNSioNS
Width x Depth 1350 x 1000 mm = 1.35 m2
Height 1803 mm
Weight  ~ 750 kg
oPerAtor SAFety ANd erGoNomicS
SEMI S2 Certificate
SEMI S8 Certificate
EMC
CE Compliant
www.suss.com
Visit www.suss.com/locations for your nearest SUSS representative or contact us:
SÜSS MicroTec AG  |  Phone: +49 89 32007-0  |  info@suss.com
North AmericA eUroPe ASiA
USA Singapore china
Korea
Japan
taiwan
Germany
Switzerland
France
United Kingdom
headquarters
Production
Sales
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DANGER:  High voltages exist and are accessible. Use extreme caution
when servicing internal components.
WARNINGS:  Tubing breakage may result in fluid being sprayed from
pump. Use appropriate measures to protect operator and equipment.
Turn drive off before removing or installing tubing. Fingers or loose
clothing could get caught in drive mechanism.
WARNINGS: Do not operate the pump drive in a manner not 
specified in the documentation. Misuse of the pump drive may result in
a hazard and may compromise the safety protection built into the pump
drive. If the pump drive is damaged, turn it off and not use it until serv-
ice-trained personnel can check its safety. 
Single-Phase Only. Not to be used with Split-Phase lines. 
The Power switch on the Back Panel is not the main disconnect. Main
disconnect is accomplished by disconnecting the detachable power
supply cord at the appliance coupler or at the main plug. Ensure the
power cord is easily accessible and removable, in the event of an emer-
gency, which requires immediate disconnection. 
The operator should check the detachable power supply cord condi-
tion. The equipment should not be operated if the power supply cord is
cracked or broken. Any obvious damage to the enclosure (from a drop
or fall) should be checked by service personnel for loose or damaged
parts inside.  
CAUTIONS:  Power must be turned off before connecting the external
remote control cable to prevent damage to the drive.
Do not contaminate the lubricant in the container, on the shaft or on the
seal with foreign material. 
Failure to observe this precaution may result in damage to the seal and
premature failure of the seal.
No foreign matter should be allowed under the gasket on the back of
the front plate or under the heads of the screws. 
Failure to observe this precaution may result in leakage during wash-
down of the drive
Do not block the rear panel of the pump drive. The power switch must
always be easy to access. The power cord must always be easy to dis-
connect.
Replace the power cord only with one of the same type and 
rating. The minimum power ratings are stated on the rear panel. 
The power cord set supplied with your pump drive meets the require-
ments of the country where you purchased the pump drive. If you use
the pump drive in another country, you must use a power cord set that
meets the requirements of that country.
When using hazardous chemical and biological agents, take all suit-
able protective measures, such as wearing protective glasses and
gloves resistant to the substances used. Follow local and/or national
regulations for safe operation and maintenance of the system.
Preface
Safety Precautions
SAFETY
PRECAUTIONS
iv MASTERFLEX® L/S Digital Pump Drive Operating Manual
CAUTION:  To avoid electrical shock, the power cord protective
grounding conductor must be connected to ground. Not for 
operation in wet locations as defined by EN61010-1.
CAUTIONS:  Keep fingers away from rotor while pump is in opera-
tion. Stop pump before loading or unloading tubing.
To reduce the possibility of tipping, use the stacking clip 
provided with the unit.
CAUTION:  Risk of Danger. Consult Operator’s manual for nature of haz-
ard and corrective actions.
CAUTION:  Risk of crushing. Keep fingers away from rotor while
pump is in operation. Stop pump before loading or unloading tub-
ing.
CAUTION:  Hot Surface. Do not touch.
CAUTION:  Risk of electric shock. Consult Operator’s manual for nature
of hazard and corrective actions.
This product is not designed for, nor intended for use in patient con-
nected applications; including, but not limited to, medical and dental
use, and accordingly has not been submitted for FDA approval.
This product is not designed for, nor intended for use in 
hazardous duty areas as defined by ATEX or the NEC (National
Electrical Code); including, but not limited to use with flammable liq-
uids. Consult the factory for products suitable for these types of appli-
cations
Preface
Safety Precautions
Explanation of
Symbols
WARNING:
Product Use
Limitation
SAFETY
PRECAUTIONS
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Application Solutions
Section 1 Introduction
The Digital drive controls the speed of MASTERFLEX® Pump Heads to
provide flow rates from 0.001 to 3400 mL/min.
Mount up to 2 (600 rpm) or 4 (100 rpm) MASTERFLEX  Pump Heads
and all MASTERFLEX-compatible Pump Heads.
Advantages of Peristaltic Pumps:
• Handle abrasive slurries and corrosive fluids with minimal wear. Ideal
for titanium dioxide or diatomaceous earth filter aid applications.
• No seals in contact with the medium pumped.
• No valves to clog.
• Inner surfaces are smooth and easy to clean.
• Fluid contacts only the tubing or tube material.
• Suction lift and priming up to 8m water column at sea level.
• Low shearing for handling the most shear sensitive of fluids like latex
or fire fighting foam.
• Capable of running dry and pumping fluids with high quantities of
entrained air, such as black liquor soap.
• High volumeteric efficiency allows operation in metering or dosing
applications where high accuracy is required.
• Handle extremely viscous fluids.
• Tubing and tube materials are available that are suitable for food and
pharmaceutical use.
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Section 1
Introduction
The MASTERFLEX L/S Digital Peristaltic Pump Drive offers flow rate
capacities from 0.001 mL/min to 3400 mL/min using MASTERFLEX
Standard, EASY-LOAD® or High-Performance Pump Heads. Even lower
flow rates can be achieved with our multichannel and cartridge Pump
Heads. Features include a small footprint, plus non-stainless steel drives
that are stackable.
The MASTERFLEX digital pump provides a motor speed repeatability of
0.1 percent to maximize productivity in precision liquid dosing, batch
dispensing and filling applications. A turndown ratio up to 6000-to-1,
bidirectional flow and self-priming capabilities allow for smooth, seamless
operation and an extremely broad flow range within one tubing size. 
In addition to high accuracy, precision, repeatability and resolution 
of speed (or flow rate), the MASTERFLEX drive features a 
multi-language, intuitive, man/machine interface with a four-line
graphical LCD display providing direct readout of pump speed (rpm), 
flow rate (user-selected units), number of dispenses, and menu options. 
The easy-to-use keypad eliminates setpoint overshoot and provides easy
navigation through menu options that include a number of on-screen
programming features.
These drives use high precision, no-maintenance brushless motors for
improved reliability. This, combined with its high turndown, superior
accuracy, and intuitive interface make the MASTERFLEX drives ideally
suited where ultra-precise, repeatable flow control is required. The pump
accommodates a variety of product fill volumes and batch dispensing
profiles, and fluid only contacts the tubing, providing for contamination-
free pumping. 
MASTERFLEX pumps are self-priming, can operate dry without damage,
are suitable for most chemicals and contain no valves or seals. See Pump
Head and Tubing Guides within this CD.
General Description
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Section 2  Installation and Setup
• The drive should be mounted on a flat horizontal surface, and no more
than two (2) Pump Heads should be added for 600 rpm drives or four
(4) Pump Heads for 100 rpm drives.
• The ambient air temperature should not exceed 104° F (40° C) and
adequate air flow should be provided for.
CAUTION: Do not block the rear panel of the pump drive. The
power switch must always be easy to access. The power cord
must always be easy to disconnect. 
• Tubing should be clean and routed so that bend radii are at a
minimum four (4) times the tube diameter and as short as possible.
WARNING: Turn drive off before removing or installing tubing.
Fingers or loose clothing could get caught in drive mechanism.
• Use a tube size of appropriate diameter for the flow rate and 
viscosity required.
• To maintain the best accuracy of flow rates, re-calibrate tubing
regularly. See Tubing Calibration Section of this manual.
• For tubing selection and compatibility, see Tubing Selection Guide
within this CD.
• For Pump Head information, see Pump Head information within 
this CD.
• When cleaning or performing maintenance, please remove power from
the drive.
CAUTION: The power cord set supplied with your pump drive
meets the requirements of the country where you purchased the
pump drive. If you use the pump drive in another country, you
must use a power cord set that meets the requirements of that
country. 
DANGER:  High voltages exist and are accessible. Use extreme
caution when servicing internal components.
Before Starting Drive
• Mount Pump Head and load tubing (See Pump Head information
within this CD). Check to make sure that rollers are clean and free of
defects.
CAUTION: When using hazardous chemical and biological
agents, take all suitable protective measures, such as wearing
protective glasses and gloves resistant to the substances used.
Follow local and/or national regulations for safe operation and
maintenance of the system. 
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Mounting the 
Pump Head
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WARNING: Do not operate the pump drive in a manner not speci-
fied in the documentation. Misuse of the pump drive may result
in a hazard and may compromise the safety protection built into
the pump drive. If the pump drive is damaged, turn it off and not
use it until service-trained personnel can check its safety. 
1. Plug the power cord into the IEC Connector, located on the rear of
the drive. Plug the opposite end of the power cord into an electrical
outlet.
2. Flip the power switch located on the rear of the drive.
3. Upon turning on the drive for the first time you will be prompted to
select a language. The selected language will be set as the default but
can be changed at any time by selecting “LANGUAGE” on the main
menu.
4. After selecting your language, the Main Menu will now appear on the
LCD screen. (NOTE: Each start-up after the initial will revert to the
mode of operation screen previously in use.)
5. If the language is accidently changed and the user would like to reset it
to the default language (English), press and hold the UP/DOWN
(▲/▼) keys during power up.
6. To restore drive to default settings, press and hold the LEFT/RIGHT
( / ) keys during power up.
▲
▲
Turning On the Drive
CAUTION:  To avoid electrical shock, the power cord protective
grounding conductor must be connected to ground. Not for 
operation in wet locations as defined by EN61010-1.
CAUTION:  Power must be turned off before connecting the exter-
nal remote control cable to prevent damage to the drive.
WARNING:  Tubing breakage may result in fluid being sprayed
from pump. Use appropriate measures to protect operator and
equipment.
Figure 3-1.  Control Panel
• To navigate all menus on the drive use the directional pad 
directly to the right of the LCD screen. 
• The (ENTER) key located in the middle of the directional pad
is used to enter or select a highlighted field or option. This key is often
referred to as the ENTER key in this manual.
• The (START/STOP) key located at the top right of the control
panel is used to start and pause the drive. This key is functional only
when in one of the four operating modes: Continuous, Time
Dispense, Copy Dispense, or Volume Dispense. This key is often
referred to as the START/STOP key in this manual.
• The (PRIME) key located at the bottom right of the control
panel is used to access the prime (fast forward) function. While
pressed, this key operates the drive at the maximum allowed
speed/flow rate and in the direction shown on the display. When
released, the drive returns to its original speed or flow rate.
1. Mount Pump Head to drive.
2. Insert appropriate tubing into Pump Head.
3. Insert tube inlet into supply fluid.
4. Insert supply outlet into desired container.
5. Turn on pump using switch located on the back of the drive.
6. Press and hold the PRIME key on the drive console to prime the
pump. Priming will stop when key is released.
CAUTION:  Keep fingers away from rotor while pump is in
operation. Stop pump before loading or unloading tubing.
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Priming the Pump
Control Panel
CONTINUOUS MODE refer to Continuous Mode in this manual.
TIME DISPENSE MODE refer to Time Dispense Mode in this manual.
COPY DISPENSE MODE refer to Copy Dispense Mode section in this
manual.
VOLUME DISPENSE MODE refer to Volume Dispense Mode section in
this manual.
REMOTE CONTROL MODE refer to Remote Control Mode section in
this manual.
CUMULATIVE VOLUME: The drive stores and displays the cumulative
volume in units based on flow rate units (see SETUP MENU in this
section). The Cumulative Volume can also be reset to zero.
NOTE: The Cumulative Volume is dependent on the Tubing Size selected.
(See SETUP MENU in this section.)
SOUNDS: An audible “beep” can be enabled to indicate a keypad press,
the end of a dispense and/or the end of a batch.
AUTOSTART: By default the drive will not restart when power is
applied. To enable this feature select AUTOSTART and then ON. The
drive will now restart when power is reapplied.
DISPLAY CONTRAST: This display can be adjusted using the
UP/DOWN (▲/▼) arrows after selecting this menu item.
LANGUAGE: After selecting this menu, the user will be able to select one
of seven different languages.
NOTE: If the language is accidentally changed and the user would like to
reset it to the default language (English), press and hold the UP/DOWN
(▲/▼) keys when power is reapplied.
DEFAULT SETTINGS: Selecting this menu item and pressing the
ENTER key will restore default settings. To restore drive to default
settings the user may also press and hold the LEFT/RIGHT ( / ) keys
when power is reapplied.
▲
▲
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Main Menu
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Tubing Calibration 1. Mount Pump Head to drive.
2. Insert appropriate tubing into Pump Head.
3. Insert tube inlet into supply fluid.
4. Insert tube outlet into desired container.  Container should be a
graduated container or a container placed on a scale may be used for
increased accuracy.
If using a scale, an acceptable weight to volume conversion for water 
is 1 gram = 1 mL.
5.  Turn on drive using power switch located on the rear of the drive.
6.  Go to the Main Menu or Mode Setup Menu by selecting the SETUP 
icon and pressing the ENTER key.  Use the UP and DOWN keys
to highlight TUBING CAL in the Main or Setup Menu and press the
ENTER key.
7.  Set the drive for the desired flow direction, tube size, and flow rate.
Note that these settings are retained and transferred to other mode
screens when entering or leaving the TUBING CAL screen. 
• The flow direction is set using the directional keypad to highlight
the directional arrow.  Pressing ENTER will toggle arrow between
CW and CCW.
• The tube size is set using the directional keypad to highlight the
tube size field. Press ENTER and use the UP/DOWN keys to
select the tube size. Press ENTER to SAVE the selection and
return to TUBING CAL screen.
• The estimated flow rate is set using the directional keypad to
highlight the flow rate field. Press ENTER and use the
LEFT/RIGHT keys to select the digit to be changed. Use the
UP/DOWN keys to adjust the flow rate value. Press ENTER to
SAVE the setting and EXIT field using arrow keys. The drive will
adjust this flow rate after calibration is complete.
• Note that the calibration volume is fixed and cannot be changed.
8.  Press and hold the prime key on the drive console to prime the
pump. Priming will stop when key is released.
9.  Place a measuring container at the pump outlet. Highlight the START
field and press the ENTER key. The drive will run based on the
default volume at the estimated flow rate selected. 
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10. Upon completion of the calibration run period, the CAL VOLUME
field will be highlighted.  Press the ENTER key and adjust the CAL
VOLUME to the measured quantity.  Use the LEFT/RIGHT keys to
select digit to be changed, use the UP/DOWN keys to adjust the
value, and press ENTER to SAVE setting and EXIT the field. 
A lower case “c” should now be displayed when the calibrated tubing
size is selected. The volume units will depend on the flow rate units.
The flow rate unit mL/min will result in a volume unit of mL; oz/min
will result in a volume unit of oz. 
Tubing Calibration Notes
• If the drive is stopped during calibration, empty the container and
re-start the procedure.
• Calibration time at maximum allowable flow rate (default max
flow rate) is 5-10 seconds and at minimum allowable flow rate
(approximately 4% of the maximum flow rate) is 4 minutes.
Select the CUSTOM tube size for other tubing sizes or lower 
flow rates.
• Minimum and maximum flow rates will change after a tubing
calibration due to a re-calculation of the vol/rev.
• Optimum results are best obtained after tubing has been broken in
by running in pump for at least 10 minutes. Steps 8-10 can be
repeated as necessary to optimize the accuracy of the tubing cal.
CAL RUN TIME FORMULA
60 / (flow rate [mL/min] / cal volume [mL]) = cal run time (seconds) 
INVALID CAL RUN TIME EXAMPLE 
• tube size 13 flow rate range is 0.006 mL/min – 36.0 mL/min
• at flow rate of 1 mL/min, cal run time calculation is as follows:
60 / (1 mL/min / 6 mL) = 360 seconds
360 seconds exceed the max run time of 4 minutes (240 seconds)
Tubing Calibration
(continued)
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All four operation mode screens contain a SETUP icon in the upper
right hand that gives quick access to the SETUP menu. The exact options
that can be accessed through the SETUP menu will depend on the
operating mode currently in use:
1. Selecting the SETUP Menu: In any of the four operating modes, use
the directional pad and enter key to select the SETUP icon from the
mode operation screen.
2. Navigating the SETUP Menu: Use the directional pad and the
ENTER key to select desired setting.
A breakdown of the setting features common to all modes follows. Other
settings are related to the specific operating mode currently in use and can
be accessed through the mode operation screen as well.
Flow Unit: Select desired flow unit to be displayed.
Tubing Size: Size and Maximum Flow Rate are displayed. Select desired
tubing size.
Flow Rate: Set the flow rate in flow unit listed at the top of the screen.
(NOTE: To change flow unit, see Flow Unit above.) When the entire rate
field is highlighted, press ENTER. The digits can be navigated
individually using the UP/DOWN arrows; switch between digits using the
LEFT/RIGHT arrows. After selecting an optimal flow rate, press ENTER
again to validate. 
Tubing Calibration: See Tubing Calibration.
Pump Direction: Select the direction of the pump flow.
Sounds: Select a beep for keypad, end of dispenses, and batches.
Remote Control: See Remote Control.
Keypad Lockout: Allows for the keypad to be locked and unlocked.
Cumulative Volume: View and reset cumulative volume.
Main Menu: Return to the Main Menu.
Exit: Return to the Mode Operation screen.
Setup Menu
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Display Legend: Below is a screenshot of the screen display for the drive in
Continuous Mode. An explanation of the information on the screen follows.
Figure 3-2.  Continuous Mode Screen
A. Mode Display: Current operating mode in which the drive will operate.
Pressing ENTER key when highlighted will cycle through the different
operation modes.
B. Setup : Pressing the ENTER key on this icon goes to the Setup
screen. The Setup screen contains most functions that can be accessed
from the Continuous Mode operation screen, including: flow units,
tubing size, flow rate, pump direction, remote control, and keypad
lockout. The Setup screen also provides access to tubing calibration,
sounds, cumulative volume and the Main Menu.
C. Flow Direction: Pressing the ENTER key on this icon toggles between
clockwise and counterclockwise flow direction.
D. Flow Units: Pressing the ENTER key on this icon goes to the Flow Unit
selection screen. NOTE: % and rpm are available in Continuous Mode only.
When switching to Copy Dispense or Volume Dispense Modes % and rpm
units will change to mL/min with values dependent on tubing size selected. 
E. Tubing Size: Pressing the ENTER key on this icon goes to the tubing
size selection screen.
F. Current Flow Rate: The center digits show the flow rate of the drive in the
unit of measure selected and shown to the right (see position D, Figure 3-2).
G. Local/Remote or : Pressing the ENTER key on this icon goes to
the Remote Control setup screen. This icon indicates whether your
drive is in local or remote control mode. If the solid rectangle appears
in the center of the figure the drive is set to be operated locally. If the
solid rectangle does not appear in the center of the figure the drive is
set to be operated by remote control.
H. Key Pad Lock : Pressing the ENTER key on this icon goes to the
Keypad Lockout screen. Locking the keypad will prevent someone from
changing the settings on the drive. When locked this icon changes to .
Continuous Mode
Screen 
CONTINUOUS MODE
100.00
17
mL/min
A
I
H
C
D
E
B
G
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Figure 3-3.  Continuous Mode Operation
1. Getting Started: From the Main Menu, use the ENTER key to 
select Continuous Mode to enter the Continuous Mode Operation
screen.
2. Calibrating Tubing: Before operating the pump, insert desired tubing into
the Pump Head. For more information, see “Tubing Calibration”.
3. Preparing External Supplies: Insert tube inlet into supply fluid. Next,
insert tube outlet into desired container.
4. Starting the Drive: From this operation screen, simply pressing the
START/STOP key will start the drive at the speed/flow rate and
direction shown. In Continuous Mode the drive will operate at the
displayed speed/flow rate and direction continuously.
5. Stopping the Drive: To pause or stop the drive, press the
START/STOP key in the top right hand corner of the console.
6. Changing Speed/Flow Rate: To change the speed/flow rate of the drive,
use the directional pad to highlight the numeric field in the center of the
display and press the ENTER key. This puts you in a position to change
the speed/flow rate of the drive at the farthest digit to the right (tenths,
hundredths, thousandths, etc depending on flow unit). Pressing the UP
arrow on the directional pad will increase the speed/flow rate by one
value and pressing the DOWN arrow will decrease the speed/flow rate by
one value. Pressing the ENTER key again will show all the possible digits
that can be manipulated for the specific flow unit currently in use; use the
LEFT/RIGHT arrows on the directional pad to move between digits and
the UP/DOWN arrows to increase or decrease the value, respectively.
Once desired speed/flow rate is selected, press ENTER key a final time
to set the drive to operate at that speed/flow rate. 
7. Changing Flow Unit: To change the flow unit of the drive pause the
drive using the START/STOP key. Next, use the directional pad to
select the Flow Units icon and press the ENTER key. Use the
UP/DOWN arrow on the directional pad to select the desired flow
unit and press the ENTER key to choose that unit. The drive will now
operate in that flow unit. Press the START/STOP key to resume
operating the drive.
Continuous Mode
Operation
CONTINUOUS MODE
100.00
17
mL/min
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Display Legend: Below is a screenshot of the screen display for the drive in
Time Dispense Mode. An explanation of the information on the screen follows.
Figure 3-4.  Time Dispense Mode Screen
A. Mode Display: Current operating mode.
B. Setup : The Setup screen can be used to select flow units, tubing size,
flow rate, tubing calibration, sounds, cumulative volume, and Main
Menu. The Setup screen contains some functions that can be accessed
from the Time Dispense Mode operation screen, including: pump
direction, on/off time, batch count, remote control, and keypad lockout.
C. Flow Direction: Pressing the ENTER key on this icon toggles between
clockwise and counterclockwise flow direction.
D. Pump ON Time: When this field is highlighted the drive is ON. 
NOTE: The drive will not show 00:00 when switching from ON to
OFF Time.
E. Pump OFF Time: When this field is highlighted the drive is OFF.
F. Batch Count: Displays the number of cycles dispensed in the batch.
G. Local/Remote or : Pressing the ENTER key on this icon goes to
the Remote Control setup screen. This icon indicates whether your
drive is in Local or Remote Control mode. If the solid rectangle
appears in the center of the figure the drive is set to be operated
locally. If the solid rectangle does not appear in the center of the figure
the drive is set to be operated by remote control.
H. Key Pad Lock  : Pressing the ENTER key on this icon goes to the
Keypad Lockout screen. Locking the keypad will prevent someone
from changing the settings on the drive. When locked this icon
changes to . 
I. Time Display: The center digits show the remaining time of the drive
in the ON or OFF Time highlighted on the right of the display
(position D or E, Figure 3-4).
Time Dispense Mode
Screen 
TIME DISP. MODE
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Figure 3-5.  Time Dispense Mode Operation
1. Getting Started: From the Main Menu, use the enter key to select Time
Dispense Mode to enter the Time Dispense Mode Operation screen.
2. Calibrating Tubing: Before operating the pump, insert desired tubing
into the Pump Head. For more information, see “Tubing Calibration”.
3. Choosing Settings: Select desired flow unit, tube size, flow rate, pump
direction, etc. For more information see “SETUP Menu.”
4. Preparing Tubing: Insert tube inlet into supply fluid. Next, insert tube
outlet into desired container.
5. Selecting Flow Rate: Use the directional pad and ENTER key to select
the Setup icon. Use the UP/DOWN arrows on the directional pad to
select Flow Rate. In the Flow Rate selection screen, press the ENTER
key and then use the UP/DOWN arrows on the directional pad to
select a desired flow rate. For faster entry, use the LEFT/RIGHT
arrows on the directional pad to move between digits and the
UP/DOWN arrows to increase or decrease the value, respectively.
Press ENTER one more time to validate the selected flow rate. Use the
directional pad to select EXIT to return to the Time Dispense Mode
Setup Screen.
6. Setting ON Time: To set the ON Time, use the directional pad and
ENTER key to select the ON field (see position D, Figure 3-4). Doing
so will highlight the timer in the center of the screen (see position I,
Figure 3-4). Pressing ENTER again, allows the timer to be set using
the UP/DOWN arrows. Switch between digits using the
LEFT/RIGHT arrows. Having selected an optimal ON Time, press
ENTER again to validate. The drive will now run for the time
appearing in the center of the screen.
Time Dispense
Mode Operation
TIME DISP. MODE
00:00:00
OFF
ON
1000/2000
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7. Setting OFF Time: To set the OFF Time, use the directional pad and
ENTER key to select the OFF field (see position E, Figure 3-4). Doing
so will highlight the timer in the center of the screen (see position I,
Figure 3-4). Pressing ENTER again, allows the timer to be set using
the UP/DOWN arrows. Switch between digits using the
LEFT/RIGHT arrows. Having selected an optimal OFF Time, press
ENTER again to validate. The drive will stop running for the time
appearing in the center of the screen. NOTE: If the OFF Time is set to
00:00:00, the drive requires a START/STOP input from the keypad
or the remote I/O Connector to start the next dispense.
8. Selecting Batch Size: Before running the drive at the selected ON/
OFF Times, select a batch size for the operation. To do so, use the
directional pad and the ENTER key to select the BATCH icon (see
position F, Figure 3-4). In the Batch Count screen, press the ENTER
key and then use the UP/DOWN arrows on the directional pad to
select a batch size. Switch between digits using the LEFT/RIGHT
arrows. Press ENTER one more time to validate the selected batch size.
When set to zero (0) the drive will run for an infinite number of cycles
and the ! symbol is displayed. Use the directional pad to select EXIT
to return to the Time Dispense Operation Screen.
9. Starting the Drive: The drive is now set to operate, press the
START/STOP key in the upper right hand corner to start the drive.
The drive can be paused at any time throughout the batch to adjust
flow direction, tubing size, flow units, flow rate, etc.
10. Resetting Batch: To reset a batch, use the directional pad and the
ENTER key to select the BATCH icon (see position F, Figure 3-4). In
the Batch Count screen, use directional pad to select RESET and press
the ENTER key to reset the batch count, select EXIT to return to the
main Time Dispense Mode operation screen.
Time Dispense Mode
Operation (continued)
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Copy Dispense Mode
Screen
Display Legend: Below is a screenshot of the screen display for the drive in
Copy Dispense Mode. An explanation of the information on the screen
follows.
Figure 3-6.  Copy Dispense Mode Screen
A. Mode Display: Current operating mode.
B. Setup : The Setup screen can be used to select flow units, tubing
size, flow rate, tubing calibration, sounds, cumulative volume, and
Main Menu. The Setup screen contains some functions that can be
accessed from the Time Dispense Mode operation screen, including:
pump direction, on/off time, batch count, remote control, and keypad
lockout.
C. Flow Direction: Pressing the ENTER key on this icon toggles between
clockwise and counterclockwise flow direction.
D. Copy Amount Screen: See Copy Setting Screen, Figure 3-8.
E. Pump OFF Time: Highlighted when the drive is OFF.
F. Batch Count: Displays the number of cycles dispensed in the batch.
G. Local/Remote or : Pressing the ENTER key on this icon goes to
the Remote Control setup screen. This icon indicates whether your
drive is in local or remote control mode. If the solid rectangle appears
in the center of the figure the drive is set to be operated locally. If the
solid rectangle does not appear in the center of the figure the drive is
set to be operated by remote control.
H. Keypad Lock : Pressing the ENTER key on this icon goes to the
Keypad Lockout screen. Locking the keypad will prevent someone
from changing the settings on the drive. When locked this icon
changes to . 
I. Percentage Completed: This icon displays the portion of fluid
dispensed as a percentage.
J. Copy Volume: Displays the Copy Volume while dispensing or the
OFF Time. 
K. Anti-Drip: A waterdrop icon present indicates that the Anti-Drip function
is on. For further information see Anti-Drip Function page 3-27.
COPY DISP. MODE
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OFF
COPY
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Copy Dispense Mode
Operation
Figure 3-7.  Copy Dispense Mode Operation
1. Getting Started: From the Main Menu, use the ENTER key to select
Copy Dispense Mode to enter the Copy Dispense Mode operation
screen.
2. Calibrating Tubing: Before operating the pump, insert desired tubing
into the Pump Head. For more information, see “Tubing Calibration”.
3. Choosing Settings: Select desired flow unit, tube size, flow rate, pump
direction, etc. For more information see “Using the SETUP Menu.”
4. Preparing Tubing: Insert tube inlet into supply fluid. Next, insert tube
outlet into desired container.
5. Setting Copy Amount: See Copy Setting Operation.
6. Setting OFF Time: Use the directional pad and ENTER key to select
OFF on the display to enter the Pump OFF Time. Use the directional
pad and ENTER key to set the Pump OFF Time. The timer in the
center of the screen will be highlighted, and using the UP/DOWN
arrows will increase/decrease the farthest right digit of the time
interval. Switch between digits using the LEFT/RIGHT arrows. After
selecting an optimal OFF Time, press ENTER again to validate. The
drive will now rest for the time appearing in the center of the screen.
NOTE: If the OFF Time is set to 00:00:00, the drive requires a
START/STOP input from the keypad or the remote I/O Connector 
to start the next dispense.
7. Setting Batch Size: Use the directional pad and ENTER key to select
the Batch Count icon from the operation screen (see position F, 
Figure 3-6). From Batch Count screen use the UP/DOWN arrows to
select batch size. Press ENTER to validate batch size. When set to zero
(0) the drive will run for an infinite number of cycles and the !
symbol is displayed. Select EXIT to return to the Copy Dispense
Mode screen.
• Batch count may be reset from BATCH COUNT screen by 
selecting RESET. 
COPY DISP. MODE
100.00
OFF
COPY
1000/2000
53 %
3-14 MASTERFLEX® L/S Digital Pump Drive Operating Manual Cole-Parmer
Section 3
Operation
8. Operating Drive: Press the START/STOP key to operate the drive at
the settings selected and displayed on the screen. Press again to pause
or stop the drive. Drive will automatically stop once batch is complete.
9. Reset Batch Count: Use the directional pad and the ENTER key to
select the BATCH COUNT icon (see position F, Figure 3-6). In the
BATCH COUNT screen, select RESET and press the ENTER key to
reset the batch count. Select EXIT to return to the Copy Mode
Operation screen.
10. Maximum Dispense Time: The specification for the maximum
dispense in Copy Mode is over 80+ hours at 600 rpm. Actual
maximum volume is dependant on tubing size and flow units selected.
Copy Dispense Mode
Operation (continued)
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Display Legend: Below is a screenshot of the screen display for the drive in
Copy Setting Mode. An explanation of the information on the screen follows.
Figure 3-8.  COPY Setting Screen
A. Mode Display: Current operating mode.
B. START: This icon will start drive allowing for copy volume to be set.
C. Flow Direction: Pressing the ENTER key on this icon toggles between
clockwise and counterclockwise flow direction.
D. Volume Unit: This is dependent on the flow rate selected.
E. STOP: This stops the Copy and sets the volume to be dispensed. It is
displayed in position H.
F. CLEAR: Selecting this will clear the number displayed on the screen
and will allow for a new copy volume to be selected.
G. EXIT: Return to Copy Dispense Mode.
H. Volume: This is the amount that was dispensed during the copy.
COPY Setting Screen
mL/min
COPY
STOPEXIT  
START
mL10000
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Figure 3-9.  COPY Setting Operation
1. Getting Started: From the COPY DISPENSE MODE Screen select
COPY and ENTER.
2. Clear Volume: Using the directional Keypad select CLEAR and ENTER.
3. Establish Copy Volume: 3 methods are available to the user.
a. Place the desired container at the tubing outlet. Press the
START/STOP key to initiate the dispensing of fluid. When you have
reached the desired volume press the START/STOP key again. Select
EXIT and press ENTER. The drive will store the value of the copy in
memory and use that value in the COPY DISPENSE MODE.
b. Place the desired container at the tubing outlet. Select the START field
on the screen and press the ENTER key to initiate the dispensing of
fluid. The drive will now highlight the STOP field on the screen. When
you have reached the desired volume press the ENTER key to stop.
Select EXIT and press ENTER. The drive will store the value of the
copy in memory and use that value in the COPY DISPENSE MODE.
c. Place the desired container at the tubing outlet. Close the contacts
on the START/STOP input to initiate the dispensing of fluid.
When you have reached the desired volume, close and release the
contacts on the START/STOP input. Select EXIT and press
ENTER. The drive will store the value of the copy in memory and
use that value in the COPY DISPENSE MODE.
NOTE: The value displayed as the volume in the COPY SETTING screen
and the COPY DISPENSE Mode screen depend on the flow units selected.
RPM, and % are invalid. If these units have been selected the drive will
display a volume in mL, in the COPY DISPENSE MODE, that is
dependent on the tubing size selected.
See TUBING CALIBRATION to improve the accuracy of this conversion. 
COPY Setting
Operation
mL/min
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mL10000
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Display Legend: Below is a screenshot of the screen display for the drive
in Volume Dispense Mode. An explanation of the information on the
screen follows.
Figure 3-10.  Volume Dispense Mode Screen
A. Mode Display: Current operating mode.
B. Setup : The Setup screen can be used to select flow units, tubing size,
flow rate, tubing calibration, sounds, cumulative volume, and Main
Menu. The Setup screen contains some functions that can be accessed
from the Time Dispense Mode operation screen, including: pump
direction, on/off time, batch count, remote control, and keypad lockout.
C. Flow Direction: Pressing the ENTER key on this icon toggles between
clockwise and counterclockwise flow direction.
D. Flow Units: Select desired flow unit.
E. Pump OFF Time: Highlighted when the drive is OFF.
F. Batch Count: Displays the number of cycles dispensed in the batch.
G. Local/Remote or : Pressing the ENTER key on this icon goes to
the Remote Control setup screen. This icon tells you whether your
drive is in local or remote control mode. If the solid rectangle appears
in the center of the figure the drive is set to be operated locally. If the
solid rectangle does not appear in the center of the figure the drive is
set to be operated by remote control.
H. Keypad Lock : Pressing the ENTER key on this icon goes to the
Keypad Lockout screen. Locking the keypad will prevent someone from
changing the settings on the drive. When locked this icon changes to . 
I. Volume: Displays the Volume while dispensing or the OFF Time.
J. Anti-Drip: A waterdrop icon present indicates that the Anti-Drip function
is on. For further information see Anti-Drip Function page 3-27.
Volume Dispense
Mode Screen
VOL DISP. MODE
100.00
OFF
mL
1000/2000
A
I
H
C
D
E
B
F
G
or
J
3-18 MASTERFLEX® L/S Digital Pump Drive Operating Manual Cole-Parmer
Section 3
Operation
Figure 3-11.  Volume Dispense Mode Operation
1. Getting Started: From the Main Menu, use the ENTER key to select Volume
Dispense Mode to enter the Volume Dispense Mode operation screen.
2. Calibrating Tubing: Before operating the pump, insert desired tubing
into the Pump Head. For more information, see “Tubing Calibration”.
3. Choosing Settings: Select desired flow unit, tube size, flow rate, pump
direction, etc. For more information see “SETUP Menu.”
4. Preparing Tubing: Insert tube inlet into supply fluid. Next, insert tube
outlet into desired container.
5. Setting Desired Volume: Using the directional pad highlight the numeric
field in the center of the display and press the ENTER key. This puts you
in a position to change the fluid volume of the drive at the farthest digit to
the right (tenths, hundredths, thousandths, etc., depending on your volume
unit). Pressing the UP arrow on the directional pad will increase the
volume by one value and pressing the DOWN arrow will decrease the
volume by one value. Pressing the ENTER key again will show all the
possible digits that can be manipulated for the specific volume unit
currently in use; use the LEFT/RIGHT arrows on the directional pad to
move between digits and the UP/DOWN arrows to increase or decrease
the value, respectively. Once desired volume is selected, press ENTER a
final time to set the drive to operate at that volume. Press the
START/STOP key to resume operating the drive.
6. Setting Pump OFF Time: Use the directional pad and ENTER key to
select OFF on the display (see position E, Figure 3-10) to enter the OFF
TIME. Use the directional pad and ENTER key to set the pump rest time.
The timer in the center of the screen will be highlighted, and using the
UP/DOWN arrows will increase/decrease the farthest right digit of the
time interval. If ENTER is pressed a second time while the timer is
highlighted, the digits can be navigated individually using the UP/DOWN
arrows; switch between digits using the LEFT/RIGHT arrows. After
selecting an optimal OFF time, press ENTER again to validate. The drive
will now rest for the time appearing in the center of the screen. NOTE: If
the OFF Time is set to 00:00:00, the drive requires a START/STOP input
from the keypad or the remote I/O Connector to start the next dispense. 
Volume Dispense
Mode Operation
VOL DISP. MODE
100.00
OFF
mL
1000/2000
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7. Setting Batch Size: Use the directional pad and ENTER key to select
the Batch Count icon from the operation screen (see position F, 
Figure 3-10). From Batch Count screen use the UP/DOWN arrows to
select batch size. Press ENTER to validate batch size. When set to zero
(0) the drive will run for an infinite number of cycles and the ∞
symbol is displayed. Select EXIT to return to drive operation screen.
• Batch count may be reset from the Batch Count screen by selecting
RESET.
8. Operating the Drive: Press the START/STOP key to operate the drive
continuously at the settings selected and displayed on the screen. Press
again to pause or stop the drive. Drive will automatically stop once
batch is complete.
9. Reset Batch Count: Use the directional pad and the ENTER key to
select the BATCH COUNT icon (see position F, Figure 3-10). In the
BATCH COUNT screen, select RESET and press the ENTER key to
reset the batch count. Select EXIT to return to the COPY MODE
OPERATION screen.
10. Maximum Dispense Time: The specification for the maximum
dispense volume in Volume Mode is over 80+ hours at 600 rpm.
Actual maximum volume is dependant on tubing size and flow units
selected.
Volume Dispense
Mode Operation
(continued)
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Figure 3-12.  Remote Control Menu Screen
NAVIGATION: From the Main Menu or SETUP Menu select
REMOTE CONTROL and ENTER.
LOCAL: When this is selected the drive is controlled by the front panel
keypad, Start/Stop Input, Directional Input or Prime Input.
CURRENT INPUT: When this is selected, the drive is in remote control.
This allows the user to input a current signal to control the flow. The user has
an option to adjust the minimum, maximum and middle set points for
current and flow.  By default the minimum (MIN) current is set to 4.2 mA
and the flow is set to 0. The maximum (MAX) is set to 20 mA and the flow is
set to maximum. The middle (MID) is auto calculated for a current and flow
that is centered between the MIN and the MAX. The MID can be adjusted if
other profiles are needed. The scaling can be inverted if necessary. To confirm
CURRENT INPUT MODE is selected, select EXIT after returning to the
Remote Control Menu, then select CONTINUOUS PUMP MODE. To
deselect Remote Current Input Mode select LOCAL and ENTER.
NOTE: When Current Input is selected the drive will not start until the
REMOTE CONTROL MODE is exited and CONTINUOUS PUMP
MODE is selected.
CURRENT OUTPUT: This allows the user to adjust the current output for a
given flow. The user has an option to adjust the minimum, maximum and
middle setpoints for current and flow. By default the minimum (MIN) flow is set
to 0.00 and the current is set to 4.0 mA. The maximum (MAX) is set to
maximum flow and the current is set to 20.0 mA. The middle (MID) is auto
calculated for a current and flow that is centered between the MIN and the
MAX. The MID can be adjusted if other profiles are needed. This allows for a
three-point calibration of the current output. The flow is linear between these
points. The scaling can be inverted if necessary. NOTE: Selecting Current Output
will not put user into REMOTE CONTROL MODE. Only selecting
VOLTAGE INPUT or CURRENT INPUT will put the user into Remote
Control Mode, as indicated by the empty house icon (see position G, Figure 3-2).
NOTE: The Current Output indicates the Running Command Speed. Use the
Motor Running contacts (normally open/closed) to indicate if pump is running.
Remote Control Menu REMOTE CONTROL
LOCAL
CURRENT INPUT
CURRENT OUTPUT
VOLTAGE INPUT
VOLTAGE OUTPUT
START/STOP
EXIT
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Remote Control Menu
(continued)
VOLTAGE INPUT: When this is selected, the drive is in remote control.
This allows the user to input a voltage signal to control the flow. The user
has an option to adjust the minimum, maximum and middle setpoints 
for voltage and flow.  By default the minimum (MIN) voltage is set to
00.1 V DC and the flow is set to 00.0.  The maximum (MAX) is set to
10.0 V DC and the flow is set to maximum. The middle (MID) is auto-
calculated for a voltage and flow that is centered between the MIN and 
the MAX. The MID can be adjusted if other profiles are needed. The
scaling can be inverted, if necessary. To confirm VOLTAGE INPUT
MODE is selected, select EXIT after returning to the Remote Control Menu,
then select CONTINUOUS PUMP MODE. To deselect Remote Voltage
Input Mode select Local and ENTER.
NOTE: When Voltage Input is selected the drive will not start until the
REMOTE CONTROL MODE is exited and CONTINUOUS PUMP
MODE is selected.
VOLTAGE OUTPUT: This allows the user to adjust the voltage output for a
given flow. The user has an option to adjust the minimum, maximum and
middle set points for voltage and flow.  By default the minimum (MIN) flow
is set to 00.00 and the voltage is set to 00.0V DC. The maximum (MAX) is
set to maximum flow and the voltage is set to 10.0V DC. The middle (MID)
is auto calculated for a voltage and flow that is centered between the MIN and
the MAX. The MID can be adjusted if other profiles are needed. This allows
for a three point calibration of the voltage output. The flow is linear between
these points. The scaling can be inverted if necessary. NOTE: Selecting Voltage
Output will not put the user into Remote Control Mode. Only selecting
Voltage Input or Current Input will put the user into Remote Control Mode,
as indicated by the empty house icon (see position G, Figure 3-2).  NOTE: The
Voltage Output indicates the Running Command Speed. Use the Motor
Running contacts (normally open/closed) to indicate if pump is running.
START/STOP: The START/STOP input can be configured to be OFF
(factory default), or ON for the drive to run.
With the OFF selected (factory default), use of the START/STOP input is
optional. When the START/STOP input is open, the drive can still be started
using the START/STOP key, PRIME key, or PRIME input. In remote modes
the drive will also run if there is sufficient current or voltage at the input.
Closing the START/STOP input will cause the drive to run until the
START/STOP input opens or the START/STOP key is pressed. In Time
dispense, Copy dispense, and Volume dispense mode, only a momentary
START/STOP closure is needed to start the drive. If the drive is already
running in one of the dispense modes, a momentary START/STOP
closure will stop the drive. In SET COPY MODE, the START/STOP
input functions the same as in CONTINUOUS MODE; closing it will
cause the drive to run until it opens. 
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The function of the START/STOP input is considerably simplified when
the ON is selected. The drive will not run under any condition unless the
START/STOP input is closed.
Table 3-1. Continuous Mode Operation
MENU SETTINGS START/STOP INTERNAL MODE mA or V MODE
SETUP OPTIONS INPUT
AUTO START/STOP Drive State When Drive Response When Drive Running 
START REQUIRED Powered OFF Powered ON (sufficient level) 
When Powered OFF
Drive Response when 
Powered ON 
(sufficient level present)
OFF OFF OPEN Running Not running Not running
OFF OFF OPEN Not running Not running Not running
OFF OFF CLOSED Forced run due Not running Not running
to S/S CLOSED
OFF ON OPEN Forced not running Not running Not running 
due to S/S OPEN
OFF ON CLOSED Forced run due Not running Not running
to S/S CLOSED
ON OFF OPEN Running Running Running
ON OFF OPEN Not running Not running Running
ON OFF CLOSED Forced run due Running Running
to S/S CLOSED
ON ON OPEN Forced not running Not running Not running 
due to S/S OPEN
ON ON CLOSED Forced run due Running Running
to S/S CLOSED
NOTE: In Continuous Mode when using the START/STOP input the drive is started with a closed contact and
stopped when the contacts are opened.
Table 3-2. Dispense Mode Operation
MENU SETTING SETUP OPTIONS START/STOP Drive State When Drive Response When 
INPUT Powered OFF Powered ON
AUTO START START/STOP 
REQUIRED
OFF OFF OPEN Running Not running
OFF OFF OPEN Not running Not running
OFF OFF CLOSED* Forced run due Not running 
to S/S CLOSED
OFF ON OPEN Forced not running  Not running 
due to S/S OPEN
OFF ON CLOSED Forced run due Not running 
to S/S CLOSED
ON OFF OPEN Running Running
ON OFF OPEN Not running Not running
ON OFF CLOSED* Forced run due Running 
to S/S CLOSED
ON ON OPEN Forced not running Not running 
due to S/S OPEN
ON ON CLOSED Forced run due Running 
to S/S CLOSED
* NOTE:  In Dispense Modes and START/STOP MENU SETUP Option OFF the drive will start a dispense
with a momentary contact closure and stop with a momentary contact closure during both the dispense
period and interval period.
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DB-25 Pin
Configuration with
Wiring Scheme
Contact Arrangements
CAUTION:  Power must be turned off before connecting the 
external remote control cable to prevent damage to the drive.
NOTE: Open collector outputs in "low impedance" state are at earth
ground and when in "high impedance" state are essentially  See
Open Collector page following.
Figure 3-13.  DB-25 Pin  with Wiring Scheme
A. START/STOP
B. CW/CCW
C. OUTPUT 0-20mA; 4-20mA
D. INPUT 0-20mA; 4-20mA
E. INPUT 0-10V
F. OUTPUT 0-10V
G. TACH OUTPUT
K H A
G B
J I C E
D
FM
L
13 112 11 10 9 8 7 6 5 4 3 2
25 24 23 22 21 20 19 18 17 16 15 14
H. PRIME
I. MOTOR RUNNING N.O.  (1A @ 24 V)
J. MOTOR RUNNING N.C.  (1A @ 24 V)
K. 24V (150mA max.)
L. General Alarm 
M. Local.Remote Indicator
Pin No. Description
DB-25
1 Speed Control Voltage Input (0-10 V)
2 Speed Control Current Input (0-20 mA)
3 Speed Control Input Ground Return
4 Speed Signal Current Output (0-20 mA)
5 Speed Signal Output Ground Reference
6 (Motor Running N.O. Default) 1A @24 V (open collector) 
7 Motor Running Ground Return
8 (Motor Running N.C. Default) 1A @24 V (open collector) 
14 Speed Signal Voltage Output (0-10 V)
15 Remote Start/Stop Input
16 Remote CW/CCW Input
17 Remote Start/Stop, CW/CCW, Prime Grnd Ref.
18 Tach Ground Reference
19 Tach Output (open collector)
20 Remote Prime Input
9 Reserved – Not Used
10 Reserved – Not Used
11 Reserved – Not Used
12 Reserved – Not Used
21 Reserved – Not Used
22 Reserved – Not Used
23 General Alarm (Open Collector)
24 Local.Remote Indicator (Open Collector)
25 Aux 24V+ (150 mA)
13 Aux 24V-  (150 mA)
NOTE: Pins 5, 13, 17, and 18 are at earth ground, all are suitable for use
with START/STOP, PRIME, Direction, Tach, LOCAL/REMOTE,
General Alarm Signals and Current and Voltage Outputs.
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31-Pin 
Configuration with
Wiring Scheme
Contact Arrangements
Pin No. Description
1 Speed Control Voltage Input (0-10 V)
2 Speed Signal Voltage Output (0-10 V)
3 Speed Control Current Input (0-20 mA)
4 Remote Start/Stop Input
5 Speed Control Input Ground Return
6 Remote CW/CCW Input
7 Speed Signal Current Output (0-20 mA)
8 Remote Start/Stop, CW/CCW, Prime Grnd Ref.
9 Speed Signal Output Ground Reference
10 Tach Ground Reference
11 (Motor Running N.O. Default) 1A @24 V (open collector)
12 Tach Output (open collector)
13 Motor Running Ground Return
14 Remote Prime Input
15 (Motor Running N.C. Default) 1A @24 V (open collector)
16 Reserved – Not Used
17 Reserved – Not Used
18 Reserved – Not Used
19 Reserved – Not Used
20 General Alarm
21 Reserved – Not Used
22 Local.Remote Indicator
23 Reserved – Not Used
24 Aux 24V+ (150 mA)
25 Aux 24V- (150 mA)
26 Reserved – Not Used
27 Reserved – Not Used
28 Reserved – Not Used
29 Reserved – Not Used
30 Reserved – Not Used
31 Reserved – Not Used
25
19
31- #20
14 8
3
1
2
7
131824
29
31
30
Figure 3-14.  31-Pin Configuration with Wiring Scheme
CAUTION:  Power must be turned off before connecting the 
external remote control cable to prevent damage to the drive.
NOTE: Open collector outputs in "low impedance" state are at earth
ground and when in "high impedance" state are essentially floating. See
Open Collector page following.
NOTE: Pins 8, 9, 10, and 25 are at earth ground, all are suitable for use
with START/STOP, PRIME, Direction, Tach, LOCAL/REMOTE,
General Alarm Signals and Current and Voltage Outputs.
INPUTS
Remote CW/CCW, Remote Start/Stop, Remote Prime, & Aux. In: 
The remote control inputs work with current sinking outputs (open-
collector NPN transistor outputs without passive pull-up resistors) or
contact closures to DC common (earth ground).  A continuous active low
to the Remote Start/Stop input causes the drive to run, while a continuous
active low to the Remote CW/CCW input causes the drive to run CCW.
The motor is brought to a controlled stop before reversing direction.  A
continuous active low to the Remote Prime input causes the drive to run
at full rated speed.
CURRENT CLOSED INPUT   1 mA TYP
VOLTAGE OPEN INPUT   3.2 V TYP 
THRESHOLD CURRENT TO ACTIVATE    0.5 mA TYP
Remote Analog Input:
4-20 mA Input: 250 ohms typical input impedance ref. to signal
ground. 4 mA, Stop; 20 mA, Full Speed (Default
Settings) 10 Bit Resolution
Overload Capability: 10 V or 40 mA max.
0-10 V Input: 10 K ohms typical input impedance ref. to signal
ground. 0 V, Stop; 10 V, Full Speed (Default
Settings) 10 Bit Resolution
OUTPUTS
4-20 mA Output: 0 to 600 ohms max. load referenced to earth ground.
4 mA, Stop; 20 mA, Full Speed (Default
Settings) 10 Bit Resolution
0-10 V Output: 1.0 K ohms min. load referenced to earth
ground. 0 V, Stop; 10 V, Full Speed (Default
Settings) 10 Bit Resolution
Tach Output: Open Collector, 1.0A @ 28V DC
Frequency range: 100 to 6000 Hz or 100 to 1000 Hz, 50% Duty
Cycle. (10 Hz = 1 pump rpm)
Logic Outputs: Open Collector, 1.0 A @ 28V DC
Motor Running Outputs: Normally Open and Normally Closed when drive is
running.
General Alarm Output: Open (High Impedance) when an alarm is displayed.
Local/Remote Indicator: Open (High Impedance) when in remote
control mode (Voltage Input, Current Input, or
RS232). 
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Remote Control Inputs
and Outputs
Table 3-3.  Remote Control Inputs and Outputs
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Some remote outputs (Tachometer, Local/Remote, Motor Running and
Alarm) are “open collector” type outputs and cannot be wired in the same
manner as relay outputs.  An open collector output is not isolated and
must be configured differently than a relay output.When the open
collector output is active, the output is effectively switched to earth ground
and if improperly terminated could result in damage to the drive and/or
external equipment.
Recommendation
When connecting to open collector outputs, the output should be
connected to a current limiting resistor and then to a positive supply
source which is less than 28V DC. Typically this would be connected to a
24V PLC input (see Figure 3-15).
NOTE: when using the 24V supply on the interface connector, current
draw must be limited to 150 mA.
NOTE: DO NOT connect 120V supply lines to open collector outputs!
Figure 3-15.  Terminating Open Collector Outputs to a PLC
Open Collector
Outputs
+24V
To PLCOutput
10k
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The same drive offers an Anti-Drip feature. The tendency of fluid to drip
after a dispense is dependant on several factors including tubing size,
tubing orientation, and the viscosity of the fluid. To minimize this drip
the drive will reverse direction after a dispense to draw the fluid back at
the end of the tubing.
To access this feature select in either Copy Dispense Mode or Volume
Dispense Mode ANTI-DRIP.
Figure 3-16.  Anti-Drip Screen
If the ANTI-DRIP function is desired, select ON and a second screen will
appear which will allow the user to input how many degrees of reverse
rotation the drive will perform. Typical values range from 5 to 45 degrees.
To exit without changing the current setup select EXIT.
Figure 3-17.  Anti-Drip Degrees Screen
With the number highlighted press the ENTER key and use the UP and
DOWN, and RIGHT and LEFT arrows to change the digits. Press the
ENTER key and then select EXIT to save the setting. The drive will now
reverse after every dispense.
Anti-Drip Function
ANTI-DRIP
ON
OFF
EXIT
ANTI-DRIP
EXIT
°45
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and Accessories
Description Part Number
Fuse-T3.15A, 5 x 20 mm  77500-25
Gear Service Kit (600) 07553-06
Gear Only (600 rpm) 07553-09
Gear Service Kit (100 rpm) 07553-08
Replacement seal kit (NEMA)* 07575-01
Replacement gear and shaft kit (NEMA)* 07575-02   
*For washdown drives only
WARNINGS: The Power switch on the Back Panel is not 
the main disconnect. Main disconnect is accomplished by 
disconnecting the detachable power supply cord at the 
appliance coupler or at the main plug. Ensure the power cord is
easily accessible and removable, in the event of an emergency,
which requires immediate disconnection. 
The operator should check the detachable power supply cord
condition. The equipment should not be operated if the power
supply cord is cracked or broken. Any obvious damage to the
enclosure (from a drop or fall) should be checked by service 
personnel for loose or damaged parts inside. 
CAUTIONS: Replace the power cord only with one of the same
type and rating. The minimum power ratings are stated on the
rear panel. 
The power cord set supplied with your pump drive meets the
requirements of the country where you purchased the pump
drive. If you use the pump drive in another country, you must use
a power cord set that meets the requirements of that country.
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Fuse Replacement
A
B
C D
A F
E
B
C D
H
B
C
D
G
Item Description
A I/O Receptacle DB-25 Pin (Style A and B)
B IEC Power Entry Module / Line Cord
C T3.15A (5 × 20 mm) Fuse – Do Not
Substitute
D Power Switch – All settings are 
retained in memory
1. Place the power switch in the off position.
2. Disconnect the AC power input line cord from the receptacle.
3. Remove and check the fuse and replace if defective.
Item Description
E RS-232C IN (Style B)
F RS-232C OUT (Style B)
G USB Port (Style B)
H I/O Receptacle 31-Pin (Style C)
Figure 4-1. Fuse Replacement
Style “A”
Style “B”
Style “C”
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A
B
C
D
Gear Replacement
Figure 4-2. Motor
1. Remove any pump(s) attached to the front of the drive. Clean any
foreign material from the outside diameter of the drive shaft.
2. Remove the four (4) screws (see Figure 4-3, Item B) that hold the
front plate assembly (see Figure 4-3, Item A) to the drive, and pull the
front plate assembly off the drive. #8-32 screws may be installed in the
pump-mounting holes to provide handles for pulling the plate
assembly off. Retain Item B screws for Step 8. DO NOT substitute
screws.
Shaft Seal Inspection
(Stainless Steel and
Powder Coated
Enclosures Only)
A. 6-600 rpm gear assembly (included in service kit 07553-06)
B. Gasket
C. 1-100 rpm gear set (included in service kit 07553-08)
D. Gear Case cover assembly
A
B
Figure 4-3. Shaft Seal Inspection
A. Front plate assembly 
B. Front plate assembly screws (4)
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Shaft Seal Inspection
(continued)
Cleaning Keep the drive enclosure clean with mild detergents. Do not immerse or
use excessive fluid when cleaning.
3. Turn the front plate over so that the seal is visable. Wipe the
elastomeric seal lips with a clean cloth to remove any grease and foreign
material.
4. Inspect the elastomeric seal lips for tears or cuts or missing material. If
any of the above mentioned conditions exist, replace the seal assembly
using the 07575-01 replacement seal kit.
5. Wipe the exposed part of the drive shaft with a clean cloth. Wipe from
the drive outward, to remove all grease and foreign matter.
6. Inspect the shaft surface, in the area touched by the seal. Look for a
rough finish, or grooves parallel to the shaft length. If the shaft end is
worn or damaged as described above, replace the gear and shaft with
the 07575-02 kit. A polished groove, concentric to the outside of the
shaft, is not a defect, as long as the groove is no more than 0.002
inches deep.
7. Prior to re-assembly, re-lubricate the shaft and the seal with the food-
grade lubricant provided with the unit. 
CAUTION: Do not contaminate the lubricant in the container, on
the shaft or on the seal with foreign material. 
Failure to observe this precaution may result in damage to the
seal and premature failure of the seal.
8. Slide the front plate assembly back over the shaft and onto the locating
pins, in the orientation desired. (4 configurations, each 90 degrees of
rotation apart, are possible.) Reinstall the four (4) screws, removed in
step 2 (see Figure 4-3).
CAUTION: No foreign matter should be allowed under the gasket
on the back of the front plate or under the heads of the screws. 
Failure to observe this precaution may result in leakage during
washdown of the drive.
Symptom Cause Remedy
Motor does not rotate, No Power. 1. Check fuse and replace,
Display does not light. if necessary.
2. Check that unit is plugged 
into a live line.
3. Check connection of 
power cord.
4. Check the line cord for 
continuity and replace 
if defective.
5. Return for servicing.
Motor does not rotate. Defective Remote Control or 1. Place power switch in
Display lights. Setting Error. OFF position.
2. Check that remote cable 
connector is fully inserted  
into the receptacle. 
3. Reapply power.
4. If motor still does not rotate, 
select remote control in Main 
Menu or Setup Menu and 
verify settings.
5. Return to Mode screen and 
verify icon shows  
Remote Control Mode.
6. See Remote Control Mode in 
this manual for further details.
START/STOP Mode “ON” with- 1. See Remote Control Mode in
out an input at I/O Connector. this manual for further details.
2. Select “OFF” in START/STOP 
Menu to run without an input 
at the I/O Connector cable.
Drive does not follow  Hardware or Firmware issue. 1. Verify cable connection to 
Serial or USB Commands drive.
2. COM Port selection error. 
See WINLIN software. (Hyper 
terminal not included)
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Troubleshooting Chart
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Error #2 Motor Overspeed
Description: The drive has exceeded commanded speed value.
Error Condition(s): The motor has exceeded the commanded speed value 
by 20%.
Actions: Drive will stop immediately. Verify load is correct and power 
cycle drive. If error persists consult factory.
Error #3: Instantaneous Over-Current
Description: Motor is drawing too much current for a short duration 
of time.
Error Condition(s): The motor current is above 4.0 A peak.
Actions: Drive will stop immediately. Verify that pump head is not 
binding and that the load is not above recommended 
maximum load. If error persists consult factory.
Error #4: Bad Flash Checksum
Description: Run-time checksum (checked at power-on) contains a 
bad checksum value.
Error Condition(s): Checksum is checked at power-on for an invalid value.
Actions: Power cycle the drive. If error persists consult factory.
Error #7: Bad EEPROM Checksum (Settings)
Description: Bad EEPROM checksum on parameter values and settings, or
its data is out of range.
Error Condition(s): 1) Checksum value in EEPROM does not match 
calculated value.
2) Data in EEPROM is out of range.
Actions: Error will be cleared after 10 seconds and parameters will be
reset to default values. If error persists consult factory.
Error #8: Bad EEPROM Checksum (Factory Cal)
Description: Bad EEPROM checksum for Factory Cal
Error Condition(s): 1) Checksum value in EEPROM does not match 
calculated value.
2) Data in EEPROM is out of range.
Actions: Error will be cleared after 10 seconds and parameters will be
reset to default values. If error persists consult factory.
Error Definitions
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Error #9: EEPROM Write Verification Error
Description: Data written to EEPROM does not match.
Error Condition(s): Data values do not match.
Actions: Error will be cleared after 10 seconds and parameters will 
be reset. If error persists consult factory.
Error #10: Bus Over Voltage
Description: The measured AC voltage reported by the drive is too high.
Error Condition(s): The drive voltage is above 260V AC.
Actions: The pump will stop immediately, check the supply line 
voltage. If error persists consult factory.
Error #11: Bus Under Voltage
Description: The measured AC voltage reported by the drive is too low.
Error Condition(s): The drive voltage is below 90V AC.
Actions: The pump will stop immediately, check the supply line 
voltage.
NOTE: This error when displayed during power down is considered 
normal and proper. If error persists consult factory.
Error #12: Motor Stall / Motor Under Speed
Description: The motor was commanded to run, but has either slowed 
down significantly or has stopped.
Error Condition(s): The motor speed is below 95% of the desired speed for too 
long a period of time.
Actions: The motor will be commanded to stop. Verify the pump turns 
freely and is not binding. If error persists consult factory.
Error #14: Ambient Over Temperature
Description: The motor control board is overheating.
Error Condition(s): The temperature value from motor control board is above
given threshold value.
Actions: The pump will stop immediately. Verify that the ambient air 
temperature is less than 104° F (40° C). Verify the pump 
turns freely and that there is no restriction of air flow. 
If error persists consult factory.
Error Definitions
(continued)
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Error #15: Motor Feedback Fault
Description: Communications to the motor control board is not correct,
has disappeared, or some other communications fault.
Error Condition(s): No data coming back over the serial port from the motor 
control board.
Actions: The drive will attempt to stop the pump. Power cycle drive. 
If error persists consult factory.
Error #16: Invalid Interrupt or Address
Description: Software jumps to an invalid address, invalid interrupt, 
or other abort/exception (i.e., Data Abort Exception). 
This may occur due to invalid pointer references, or ram 
memory corruption, etc.
Error Condition(s): These are handled by an Abort Exception/Interrupt within the
CPU and should branch out to their respective exception 
handler functions.
Actions: Power cycle the drive to reset error. If error persists 
consult factory.
Error #18: Watchdog Error
Description: Program has stopped running as the watch dog has not 
been updated, i.e., Software Locked up.
Error Condition(s): Interrupt triggered when the Watchdog has not been 
updated.
Actions: Power cycle drive to reset error. If error persists 
consult factory.
Error Definitions
(continued)
Section 6  Accessories
1. Footswitch w/DB-25 male 07523-92
2. Connector DB-25 male 07523-94
3. Dispensing Wand DB-25 male 07523-97
4. Footswitch (NEMA)* 07575-84
5. Remote control cable (NEMA)*, 25ft (7.62 m) 07575-80
*For washdown drives only.
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Section 7  Specifications
Output
Speed:
600 rpm models 0.1 to 600 rpm 
100 rpm models 0.02 to 100 rpm 
Torque output, Maximum:
600 rpm models 180 oz-in (13 
540 oz-in Starting
100 rpm models 360 oz-in (26 
1080 oz-in Starting
Speed regulation:
All models Line ±0.1% F.S.
Load ±0.1% F.S.
Drift ±0.1% F.S.
Display: 
All models 128 x 64 LCD w/ LED Backlight 
Remote outputs:
All models Voltage speed output 
(0–10V DC @ 1 kΩ
All models Current speed output 
(0–20 mA @ 0–600Ω
600 rpm models Tach output 
(100 to 6000 Hz, 50% duty cycle, 
10 
100 rpm models Tach output 
(100 to 1000 Hz, 50% duty cycle, 
10 Hz/rpm
All models Motor running output 
(N.O. & N.C. open collector, 1A @ 28V DC
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Input
Supply voltage limits: 
All models 90 to 260 Vrms @ 50/60 Hz
(Universal Input) Single Phase Only
Current, max.:
All models 1.8A @ 115 Vrms, or 1.1A @ 230 Vrms
Remote Inputs:
All  models STOP/START, CW/CCW, PRIME 
(Contact closure)
All models Voltage input (0–10V DC @ 10 kΩ), 
±50V common mode range
All models Current input 
(0–20 mA or 4–20mA @ 250 Ω), 
±50V common mode range
Construction
Dimensions (L × W × H):
Models w/plastic enclosure 10.5 in × 8 in × 8 in
(267 × 203 × 203 mm)
Models w/stainless 14.0 in x 9 in x 9.5 in
steel or powder coated steel (356 × 229 × 241 mm)
enclosure
Weight:
Models w/plastic enclosure 13 lb (5.9 kg)
Models w/stainless 26 lb (11.8 kg)      
steel or powder coated steel
enclosure 
Enclosure Rating:
Models w/plastic enclosure IP 33 per IEC 60529
Models w/stainless IP 66 per IEC 60529/NEMA 4X – indoor use
steel or powder coated steel
enclosure
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Section 7
Specifications
Environment
Temperature, Operating: 
All models 0° to 40°C (32° to 104°F)
Temperature, Storage:
All models –25° to 65°C (–13° to 149°F)
Humidity (non-condensing):
Models w/plastic enclosure 10% to 90%
Models w/stainless steel or 10% to 100%
powder coated steel enclosure 
Altitude:
All models Less than 2000 m
Pollution Degree:
Models w/plastic enclosure Pollution Degree 2 
(Indoor use — lab, office)
Models w/stainless steel or Pollution Degree 3 
powder coated steel enclosure (Indoor use — Sheltered locations)
Chemical Resistance: 
Models w/plastic enclosure Exposed material is aluminum, 
ABS plastic and vinyl
Models w/stainless steel or Exposed material is 316 enclosure 
powder coated steel enclosure stainless steel, vinyl and powder coated 
steel 
Compliance: Conforms to ANSI/UL Std 61010-1
Certified to CAN/CSA Std C22.2 
No. 61010-1. This product has been tested
to the requirements of CAN/CSA-C22.2
No. 61010-1, second edition, including
Amendment 1, or a later version of the
same standard incorporating the same
level of testing requirements.
(For CE Mark):
EN61010-1 (EU Low Voltage Directive) and
EN61326 (EU EMC Directive)
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Section 7
Specifications
Section 8  Warranty, Product Return and
Technical Assistance
Use only MASTERFLEX precision tubing with MASTERFLEX pumps to
ensure optimum performance. Use of other tubing may void applicable
warranties.
This product is warranted against defects in material or workmanship, and
at the option of the manufacturer or distributor, any defective product will
be repaired or replaced at no charge, or the purchase price will be refunded
to the purchaser, provided that: (a) the warranty claim is made in writing
within the period of time specified on the warranty card, (b) proof of
purchase by bill of sale or receipted invoice is submitted concurrently with
the claim and shows that the product is within the applicable warranty
period, and (c) the purchaser complies with procedures for returns set
forth in the general terms and conditions contained in the manufacturer's
or distributor's most recent catalog.
This warranty shall not apply to: (a) defects or damage resulting from: (i)
misuse of the product, (ii) use of the product in other than its normal and
customary manner, (iii) accident or neglect, (iv) improper testing,
operation, maintenance, service, repair, installation, or storage, (v)
unauthorized alteration or modification, or (b) post-expiration dated
materials.
THIS WARRANTY IS THE EXCLUSIVE REMEDY OF THE
PURCHASER, AND THE MANUFACTURER AND DISTRIBUTOR
DISCLAIM ALL OTHER WARRANTIES, WHETHER EXPRESS,
IMPLIED, OR STATUTORY, INCLUDING WITHOUT
LIMITATION, WARRANTIES OF MERCHANTABILITY AND
FITNESS FOR A PARTICULAR PURPOSE. NO EMPLOYEE,
AGENT, OR REPRESENTATIVE OF THE MANUFACTURER OR
DISTRIBUTOR IS AUTHORIZED TO BIND THE
MANUFACTURER OR DISTRIBUTOR TO ANY OTHER
WARRANTY. IN NO EVENT SHALL THE MANUFACTURER OR
DISTRIBUTOR BE LIABLE FOR INCIDENTAL, INDIRECT,
SPECIAL OR CONSEQUENTIAL DAMAGES.
The warranty period for this product is two (2) years from date of purchase.
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Section 8
Warranty, Product Return and 
Technical Assistance
To limit charges and delays, contact the seller or Manufacturer for
authorization and shipping instructions before returning the product, either
within or outside of the warranty period. When returning the product, please
state the reason for the return. For your protection, pack the product
carefully and insure it against possible damage or loss. Any damages resulting
from improper packaging are your responsibility.
If you have any questions about the use of this product, contact the
Manufacturer or authorized seller.
Product Return
Technical Assistance
Printed in U.S.A.
1-800-MASTERFLEX (627-8373) (U.S. and Canada only)
11 (847) 549-7600 (Outside U.S.)
(847) 549-7600 (Local)
www.masterflex.com
techinfo@coleparmer.com
® ®
Built specifically to protect the most critical
of samples, Thermo Scientific™ TSU Series
-86ºC freezers achieve outstanding thermal
performance, safety and security through
state-of-the-art engineering.
Performance:
Outstanding BTU (British Thermal Unit)
reserve, leading to fast door-opening
recovery times so sample integrity is not
compromised.*
Capacity:
Store up to 700 2-inch boxes in a 12.85 sq.
ft. (1.19 m2) footprint. That’s 70,000 2mL
vials or 118,300 1mL tubes!
Energy-Efficiency:
Save up to 15% in energy usage with our
energy-savings mode.** Or choose our
high-performance mode for applications
requiring ultra-tight temperature uniformity.
Both modes are accessible through our
easy-to-use touch-screen interface.
Features and Benefits:
• Touch-screen interface featuring freezer
health monitoring system, event log,
advanced settings and USB port
• On-board data storage – store up to 15
years worth of temperature and event
data on our on-board computer
• Polystyrene insulated inner doors help
maintain cabinet temperature during
openings and feature embedded rare
earth magnets, eliminating the need for
exposed latches or magnets
• Optional proximity card access control for
enhanced security
• 4x7 heated outer door gaskets provide
four touchpoints of security and seven
zones of protection, maximizing cabinet
temperature and minimizing frost build-up
• Rugged steel construction with a
corrosion-resistant coating
• Pressure equalization port (PEP) allows
for quick re-entries after door opening
Thermo Scientific
TSU700 Series -86ºC Freezers
Ultimate protection, optimum capacities, energy savings
CO L D S T O R A G E
P
rod
uct
S
p
ecifications
* Internal performance data, data on file
** Comparison to high-performance mode
TSU700 0214
P
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Thermo Scientific TSU700 Series -86ºC Freezers (Temperature Range: -50ºC to -86ºC)
Model No. CabinetCapacity
Sample
Capacity Voltage (Hz)
Amps/Breaker
(Plug)
Maximum
Shelf Weight
Interior Dimensions
H x D x W
Exterior Dimensions
H x D x W
Shipping
Weight
TSU700D 33.5 cu. ft.
(949 liters)
700 boxes
(2-inch)
208-230V/60Hz 12/15 (NEMA 6-15) 285 lbs.
(128.4 kg)
51.2 x 28.3 x 40 in.
(130 x 71.9 x 101.6 cm)
78 x 37.6 x 49.2*
(198.1 x 95.5 x 125 cm)
951 lbs.
(432 kg)TSU700V 230V/50Hz 12/15 (European)
www.thermoscientific.com/cold
© 2014 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific
Inc. and its subsidiaries. Specifications, terms and pricing are subject to change. Not all products are available in
all countries. Please consult your local sales representative for details.
Australia +61 39757 4300
Austria +43 1 801 40 0
Belgium +32 53 73 42 41
China +86 21 6865 4588 or
+86 10 8419 3588
France +33 2 2803 2180
Germany national toll-free 0800 1 536 376
Germany international +49 6184 90 6000
India toll free 1800 22 8374
India +91 22 6716 2200
Italy +39 02 95 05 92 54
Japan +81 45 453 9220
Netherlands +31 76 579 55 55
New Zealand +64 9 980 6700
Nordic/Baltic/CIS Countries
+358 9 329 10200
Russia +7 812 703 42 15
Spain/Portugal +34 93 223 09 18
Switzerland +41 44 454 12 22
UK/Ireland +44 870 609 9203
USA/Canada +1 866 984 3766 (866-9-THERMO)
Other Asian Countries +852 2885 4613
Countries not listed: +49 6184 90 6000
Options (Field-Installed Requires Qualified Professional)
Model No. Description
LN4567 Factory-installed LN2 back-up
FLN4567 Field-installed LN2 back-up
CO4567 Factory-installed CO2 back-up
FCO4567 Field-installed CO2 back-up
CR4567 Factory-installed inkless chart recorder
FCR567FT Field-installed inkless chart recorder
CRP4567 Factory-installed ink chart recorder
FCRP567FT Field-installed ink chart recorder
RAC34567 Factory-installed access key option
FFAC34567 Field-installed access key option
WC34567 Factory-installed water-cooled condenser
SS34567 Factory-installed stainless steel interior
Accessories
Model No. Description
ACU34567 Access key pack U.S. (ISO15693 protocol)
ACE34567 Access key pack EU (ISO14443 protocol)
RSK700SD4 Racking shelf kit (7 racks, 175 boxes)
SK700 Shelf kit (one shelf and clips)
17020 Chart paper ink (pack of 50)
AF34567 Replacement air filter
400159 Replacement back-up battery
6903 Alarm delay module
4425 Cryo gloves (medium)
4426 Cryo gloves (large)
TF-ULT700 Seismic restraint kit
Speciality Plugs (Factory-Installed)
Model No. Description
AR230V16A Argentina
AU230V16A Australia
BR230V16A Brazil
CH230V16A China
DK230V16A Denmark
UK230V16A Great Britain
IN230V16A India
IS230V16A Israel
IT230V16A Italy
SW230V16A Switzerland
* Door opening clearance is 34.5” (86 cm).
Racking Systems for Boxes
Model No. Description DimensionsH x W x D
Boxes/
Rack
Racks/
Shelf
Racks/
Freezer
Boxes/
Freezer
920090 Sliding drawer for 2-inch boxes 11.9 x 5.5 x 26.9 in.(30.2 x 14 x 68.3 cm) 25 7 28 700
1950520 Adjustable side access for 2-inch boxes 11.6 x 5.4 x 26.75 in.(29.5 x 13.7 x 67.9 cm) 25 7 28 700
920091 Sliding drawer for 3-inch boxes 11.9 x 5.5 x 26.9 in.(30.2 x 14 x 68.3 cm) 15 7 28 420
1950521 Adjustable side access for 3-inch boxes 11.6 x 5.4 x 26.75 in.(29.5 x 13.7 x 67.9 cm) 15 7 28 420
Racking Systems for Microplates
Model No. Description DimensionsH x W x D
Plates/
Rack
Racks/
Shelf
Racks/
Freezer
Plates/
Freezer
1950642 Sliding drawer for standard or deepwell 11.9 x 5.5 x 26.9 in.(30.2 x 14 x 68.3 cm) 35 7 28 980
1950523 Side access for standard plates 11.9 x 5.5 x 25.7 in.(30.2 x 14 x 65.3 cm) 105 7 28 2940
1950592 Side access with locking rod for standardor deepwell plates
11.9 x 5.5 x 25.7 in.
(30.2 x 14 x 65.3 cm) 147 7 28 4116
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Introduction 
 
 Warning 
Warnings alert you to a possibility of 
personal injury. 
 
Caution 
Cautions alert you to a possibility of 
damage to the equipment. 
 
Note 
Notes alert you to pertinent facts and 
conditions. 
 
 
Hot surfaces alert you to a possibility 
of personal injury if you come in 
contact with a surface during use or 
for a period of time after use. 
 
 
Caution 
Risk  of electric shock. 
 
 
Warning 
These freezers are not approved for 
the storage of blood or blood 
products! 
 
Warning 
This product is not intended, nor can it 
be used, as a sterile or patient 
connected device. In addition, this 
apparatus is not designed for use in 
Class I,II or III locations as defined by 
the National Electrical Code, unless 
otherwise noted. 
 
Warning 
As a routine laboratory precaution, 
always wear safety glasses when 
working with this apparatus. 
 DANGER: RISK OF CHILD 
ENTRAPMENT. BEFORE YOU 
THROW AWAY YOUR OLD 
FREEZER: 
• TAKE OFF DOORS 
• LEAVE THE SHELVES IN 
PLACE SO THAT CHILDREN 
MAY NOT EASILY CLIMB 
INTO UNIT. 
 
Warning 
High voltage is supplied to PC board 
when key switch is OFF. 
 
 
 
 
This manual is intended to provide installation and 
operating instructions for your general purpose 
laboratory freezer.   
 
Your satisfaction and safety are important to us. A 
complete understanding of this unit is necessary to attain 
these objectives. 
 
As the ultimate user of this apparatus, it is your 
responsibility to understand its proper function and 
operational characteristics. This instruction manual should 
be thoroughly read and all operators given adequate 
training before
 
Warning 
    • This manual must be carefully read and 
thoroughly understood before operating the 
unit.  Failure to follow directions or 
precautionary measures could result in 
serious adverse effects. 
 
• This equipment must be used only as specified 
in these instructions. If used in a manner other 
than as specified, the protection provided by the 
equipment may be impaired. 
 
• This equipment is intended for indoor use only. 
 
• This equipment must be earth grounded for safe 
operation. 
 
• Disconnect unit line cord from power source 
before performing any servicing or maintenance. 
 
 attempting to place this unit in service. 
Awareness of the stated cautions and warnings, and 
compliance with recommended operating parameters - 
together with maintenance requirements - are important 
for safe and satisfactory operation. The unit should be 
used for its intended application; alterations or 
modifications will void the Warranty. 
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Unpacking 
Save all packing material if apparatus is received damaged.  
This merchandise was carefully packed and thoroughly 
inspected before leaving our factory. 
 
Responsibility for its safe delivery was assumed by 
the carrier upon acceptance of the shipment; 
therefore, claims for loss or damage sustained in 
transit must be made upon the carrier by the recipient 
as follows: 
 
 
 
Visible Loss or Damage 
Note any external evidence of loss or damage on the 
freight bill, or express receipt, and have it signed by the 
carrier’s agent.  Failure to adequately describe such 
external evidence of loss or damage may result in the 
carrier’s refusing to honor your damage claim.  The 
carrier will supply the form required to file such a claim. 
 
 
 
Concealed Loss or Damage 
Concealed loss or damage refers to loss or damage, 
which does not become apparent until the merchandise 
has been unpacked and inspected.  Should either occur, 
make a written request to the carrier’s agent within 15 
days of the delivery date; then file a claim with the carrier 
since the damage is the carrier’s responsibility. 
 
If you follow the above instructions carefully, we will 
guarantee our full support of your claim to be 
compensated for loss from concealed damage. 
 
DO NOT – FOR ANY REASON – RETURN THIS UNIT 
WITHOUT FIRST OBTAINING AUTHORIZATION 
Installation  
INSTALLATION 
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Packing List 
The following items are located inside the freezer chamber. 
If any of the following items are not present, report the 
missing item to your local representative. 
 
• Instruction Manual 
 
• Warranty information 
 
• Door Lock and Power Switch Keys 
 
•       Shelves and Casters 
 
Selecting a Location 
Choose a location for the freezer that will provide  at 
least  three  inches  of  clearance
 
 
 
Note 
  between the cabinet and 
any adjacent vertical surface at the sides and rear.  At least
12 inches of clearance is needed above the unit for air 
circulation.  Appropriate electrical power must be available.
Locate the freezer within 6 feet of the power outlet so that
no extension cord is required. 
 
 
The freezer must be level in order to 
provide adequate condensation 
drainage as well as proper door 
alignment and operation. The freezer 
should be in its final operating location 
and set so that it is firmly positioned 
on the floor. 
Leveling the Unit 
The freezer must be level in order to provide adequate 
condensation drainage as well as proper door alignment 
and operation. The freezer should be in its final operating 
location and set so that it is firmly positioned on the floor. 
 
 
   INSTALLATION  
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Caution 
If the unit was tilted in excess of 30 
degrees, level it and do not apply 
electrical power for a minimum of 
12 hours. 
Installing and Leveling Casters 
Freezers come with four casters, which thread into the 
base of the unit, one in each corner. Remove the 
leveling screws from the unit and use the wrench 
provided to thread the casters completely into the   
base of the unit.  
See Figure 1. 
 
 
 
 
 
 
 
 
Lamps 
 
 
Caution 
Improperly installed lamps may cause 
damage to the lighting circuit. 
Prior to applying power to the unit, verify that all of the 
internal lamps are properly installed and fully engaged in 
the lamp holders.  
 
Tighten 
using 
wrench 
provided 
Freezer 
Base 
Thread casters directly 
into base at four 
corners 
Figure 1 
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 Shelves 
Shipped inside each cabinet are shelves packed in plastic 
and a bag of shelf supports. 
 
Two different shelf supports are provided. The shorter tab 
length version is used on the front of the shelf. Shelf 
spacing is adjustable to suit user requirements. Insert four 
shelf supports for each shelf into the pilasters as shown.  
Place the shelf on the pilasters as shown in Fig’s 2 and 3. 
 
 
Replacement shelves are available individually.  Call Technical
Service at 800­438­4851 for shelf part numbers.  Proper shelf 
orientation is illustrated in Figures 2 & 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
 
 
 
Figure 3 - Place shelves at desired height on four 
shelf supports. 
Note 
Note the numbers on the pilasters.  
Place supports on the same numbers 
on each pilaster to ensure the shelf 
will be level. 
   INSTALLATION  
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Warning 
Insufficient line voltage is often the 
cause of compressor start-up failure. 
It is strongly recommended that a 
dedicated circuit, conforming to the 
National Electrical Code, Article 440, 
be used for powering the freezer. 
 
 
Caution 
Be sure that the power supply is the 
same voltage that is specified on the 
freezer's data plate. 
 
 
 
Warning 
For personal safety this unit must be 
properly grounded. 
 
 
 
Warning 
DO NOT under any circumstances cut 
or remove the third (ground) prong 
from the power cord.  DO NOT use a 
two-prong adapter plug. 
 
 
 
Warning 
Do not use an extension cord. Use 
of an ungrounded cord or an 
overloaded circuit VOIDS the 
compressor warranty. 
Electrical Connection 
The frequency and nominal voltage requirements for the 
unit are specified on the data plate, which is located on 
the interiors upper left side.  Only plug the unit into a 
power source that meets these requirements.  Low line 
voltage is often the cause of service complaints. 
With the unit running, check that the line voltage is 
within ±10% of that specified on the data plate. 
 
The power cord on most units has a three prong 
(grounding) plug (NEMA 5-15P).  This plug mates with a 
standard three prong (grounding) wall receptacle (NEMA  
5-15R) to minimize the potential of an electrical shock 
hazard. Where necessary models are equipped with a 
linecord and NEMA 5-20P plug.  This plug requires a 
NEMA 5-20R receptacle.  Where necessary models are
equiped with a linecord and NEMA L14­20P plug.
This plug requires a L14­20R receptacle.  
 
The customer should have the wall receptacle and circuit 
checked by a qualified electrician to verify the receptacle 
is properly grounded and meets power requirements 
specified on the data plate. 
 
Where a two prong wall receptacle is encountered, it is 
the personal responsibility and obligation of the user to 
have it replaced with a properly grounded three prong 
receptacle. 
 
During compressor start-up, the unit will momentarily 
draw more current than under normal running conditions. 
To avoid nuisance tripping of circuit breakers, it may be 
necessary to install an HACR rated breaker. 
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Controls 
 
Panel Controls 
The control system provides both audible and visual                                
indication of alarm conditions in an easy to read display 
format.  In addition, there are two sets of contacts 
available for remote alarm switching. 
 
                                                                                                                                             Temperature and alarm set points are directly entered in 
°C or °F.   
Before operation, it is necessary to become familiar with 
the freezer controls. All the freezer controls are located 
on the header panel.  A layout of the controller and 
LED’s are given below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                
 
                                                Performance Characteristics 
                                                                                                                                              
Temperature Range:  -30.0° to 0°C (-22.0° to 32.0°F)        
Temperature Stability:  ±3°C 
 
 
     Displays and Features 
         On the right side of the header panel is the key switch.  
         The key switch has three positions, OFF (O), Set-up (I) 
and Alarm Enable (  ).  With the freezer plugged in and 
the key switch in the OFF position, the displays and  
Warning 
High voltage is supplied to PC board 
when key switch is OFF. 
 
CONTROLS
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refrigeration system are off.  The control board remains 
energized in order to supply a charge to the battery. 
 
 
Key Switch 
Turning the key switch to the middle position energizes 
the circulation fans and the controller display. When the 
controller is in the Set-Up mode, the menu items can be 
set to the desired values. See Controller Set Up for a 
description of each.  Once all menu items are set, the 
freezer should then be switched to the Alarm Enabled 
position. While in the Alarm Enabled position, the menu 
items can be viewed but not changed. The key can be 
removed to secure the values entered. 
 
Temperature Display 
The temperature display indicates chamber temperature 
while in the control mode of operation and menu titles and 
values while entering menu items (see Menus).  
 
Units LED’S 
The temperature display indicates chamber temperature 
in both °C and °F.  The current units are indicated by the 
corresponding LED located to the right of the temperature 
display. 
 
Mode LED 
The Mode LED is lit when the Menu keypad has been 
pressed.  It indicates to the user that the controller is in 
the menu selection mode. 
 
Cool LED 
The Cool LED is lit when the controller calls for cooling. 
When this LED comes on the compressor should 
energize. 
 
Alarm LED’S 
Door Ajar - This LED is illuminated when a freezer 
door(s) is opened.   
 
Over Temp – Indicates the current chamber temperature 
exceeds the high alarm temperature set point. 
 
Under Temp – Indicates the current chamber temperature 
is lower than the low alarm temperature set point. 
 
Power Out – Indicates AC power to the freezer is 
disrupted. 
 
Alarm Test – Indicates the controller is running an alarm 
test. 
 
Note 
The key can be removed in the 
Off or the Alarm Enabled 
position. 
 
Caution 
Alarms will only activate with the 
key in the Alarm Enabled   
position. 
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Keypads 
Menu Keypad – Pressing the Menu keypad enters the 
controller into the menu selection mode, designated by 
the illumination of the MODE LED.  Repeatedly pressing 
the Menu keypad cycles through the list of menu items 
(see Menus).  After the final menu, the controller returns 
to the control mode and the MODE LED turns off. 
 
Up Arrow Keypad – Increases or changes menu values.  
 
Down Arrow Keypad - Decreases or changes menu values. 
 
 
Interior Light Switch 
The interior lamp(s) is controlled by a rocker switch located 
on the control panel.  This light may be operated any time 
the cabinet power is turned on at the keyed power switch.  
If the interior lamp fails, replace with the same size and 
wattage lamp.  DO NOT USE REDUCED WATTAGE 
LAMPS.  The reduced wattage lamps generally fail to light 
below 60°F (15°C). 
 
Be sure that lamps are properly installed. Failure to 
install lamps properly may cause damage to the lighting 
circuit. 
 
 
• Solid door models – The control panel light 
switch controls the interior light when the doors 
are open. 
  
CONTROLS
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Operation 
 
 
 
 
 
 
Note 
The “Pout” display is a normal 
occurrence when power is first 
applied to the controller.  Press any 
key to clear it. 
 
 
The freezer is started by inserting the power switch key, 
which is found inside the unit, into the key switch.  Turn 
the key to the middle (set up) position.  The internal fans 
will start and the display will flash between Pout and the 
current chamber temperature.  The “Pout” (power out) 
display indicates to the user that the controller has 
sensed a low voltage condition. This condition is normal 
during any start-up.  See the Alarms section for details 
on the Pout message.   Press any keypad to clear the 
Pout. 
 
 
 
Controller Set-Up (Menus) 
During normal operation, the freezer temperature is 
displayed on the 4-character display.  The compressor 
cycles on and off to control the chamber temperature 
between -30.0° and 0.0°C (-22.0 to 32.0°F), selectable 
by the user.  The temperature set point, high and low 
alarm set-points, units and display offset can be 
changed while the key switch is in the set-up (middle) 
position.  These values can be viewed but not changed 
with the key switch is in the alarm enabled position.  
The menu options are explained in the following 
sections. 
 
There are 8 menus to select from, each can be 
accessed by pressing the Menu keypad.  Pressing the 
Menu key- pad once brings up the first menu, which is 
the temperature set point.  The displays initially flash 
SP followed by the last set temperature value.  
Pressing the Menu key- pad again, accepts the value 
and displays the next menu, units select (CF).  Each 
menu value is entered this way. The menus can be 
changed only while the key switch is in the set up (I) 
position.  They can be viewed but not changed while 
the key switch is in the alarm enable( ) position.  The 
individual menus are described below. 
 
 
Temperature Set point 
•  
Temperature Set Point is factory pre­set at          
-30.0°C (-22.0°F). Adjusting the temperature Set 
Point is not recommended. 
•  
Temperature Set Point (SP) – Adjustable from     
-30.0 to 0.0°C or -22.0 to 32.0°F.  Use the 
Up/Down Arrow keypads to change the 
temperature and the Menu keypad to enter the 
value and switch to the next menu. 
 
OPERATION 
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Units 
• Units select (C,F) – Selects the desired 
temperature display units in °C or °F.  Use the Up 
Arrow keypad to change the units from C to F. Use 
the Down Arrow keypad to switch from F to C.  
Press the Menu keypad to enter the units 
value and continue. The appropriate units LED 
will indicate the selected units. 
 
 
 
High Alarm Set Point 
• High Alarm Set Point (AH) – Use the Up/Down 
Arrow keypad to adjust the value that triggers a 
high alarm condition if the chamber temperature 
rises above it.  The high alarm temperature 
range is from 3.5°C (6.3°F) above the Temperature
Set Point to 37.0°C (98.6°F). 
•         Factory pre­set at ­14.0°C (6.8°F). 
 
NOTE:  The High and Low alarm set points can be 
adjusted to be within 3.5°C (6.3°F) of one another and no 
closer. 
 
 
Low Alarm Set Point 
• Low Alarm Set Point (AL) – Use the Up/Down 
Arrow keypad to adjust the value that triggers a 
low alarm condition.  The low alarm condition 
occurs when the actual chamber temperature 
drops below the Low Alarm Set Point.  The low 
alarm range is from 3.5°C (6.3°F) below the
Temperature Set Point to -36.0°C (-32.8°F). 
•         Factory pre­set at -33.0°C (­27.4°F).  
 
Alarm Silencing Menu 
• Alarm Silencing (AS) – During an alarm condition, 
while the key switch is in the Alarm Enable Mode, 
this menu allows the user to silence the audible 
alarm for 5 minutes. After the AS stops flashing, 
the display will show n, press the Up Arrow keypad 
to change the display to y.  Press the Menu 
Keypad and the audible alarm will turn off for 5 
minutes. 
OPERATION 
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Alarm Test Menu 
• Alarm Test (At) –Use the Up Arrow keypad to 
change the n to H.  By subsequently pressing 
the Menu Keypad the controller will perform a 
High Alarm Test (see Alarm Test in Alarms 
section).  Use the Down Arrow Keypad to 
change the display to L.  Pressing the Menu 
Keypad will activate the Low Alarm Test.  
Pressing the Menu Keypad while the display 
shows n returns the unit to control mode (MODE 
LED off). 
 
NOTE:  While in any of the above menu options, the 
controller will wait 15 seconds for a new value to be 
entered. If there is no keypad activity within 15-seconds, 
the freezer will automatically shift to the Control Mode and 
the Mode LED will turn off. 
 
 
 
Control Mode 
The Control Mode of operation is indicated when the 
Mode LED is OFF.  With the desired temperature set 
point and alarm values entered, the freezer will then 
begin to control to the set temperature.  There is a time 
delay between compressor activations.  This delay begins 
the moment the controller is energized or the moment the 
compressor turns off during normal operation.  The delay 
is added to provide time for the system pressure to drop 
before the compressor tries to start again. 
 
 
Loading 
Follow the guidelines below in order to provide optimal 
freezer performance: 
 
• When loading with critical samples, verify all 
alarms and features are operating properly. 
 
• Space samples uniformly in the chamber. 
 
• Keep samples away from the back wall that may 
obstruct airflow. 
 
• It is best to load the freezer from bottom to top.  
Keeping the area next to the air intake and 
exhaust clear will help assure proper airflow. 
 
 
 
OPERATION 
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Temperature Digression 
By pressing the Increase keypad while the freezer is 
in the Control Mode, the display will show the warmest 
temperature recorded since the unit was energized or the 
digression values were reset.  Pressing the Decrease 
keypad will display the coldest temperature recorded 
since the unit was energized or the digression values 
were reset. 
 
To reset the temperature digression values, simply press 
the Increase and Decrease keypads at the same time. 
The display will show Clr, indicating the controller will 
begin recording new warm and cold digressions once 
more. 
 
 
Alarms 
Freezers are equipped with audible and visual alarms.  
They also feature remote alarm contacts.  The key switch 
must be in the Alarm Enable position for the audible alarm 
and remote alarm contacts to activate.  Alarm messages 
are shown on both the temperature display and in the row 
of Alarm LED’s located above the temperature display.  The 
following conditions will trigger an alarm: 
 
• Chamber temperature is greater than the high 
alarm set point. 
 
• Chamber temperature is less than the low alarm 
set point. 
 
• Door has been left open for 3 minutes or more. 
 
• AC power has been interrupted to the freezer. 
 
• Open sensor 
 
 
 
Over Temp Alarm 
If the freezer chamber temperature rises above the 
High Alarm Set Point, the display will alternately flash the 
freezer chamber temperature and “HigH”.  The Over 
Temp LED will be lit, the audible alarm will sound and the 
remote contacts will change state. 
 
  
Under Temp Alarm 
If the freezer chamber temperature falls below the 
Low Alarm Set Point, the display will alternately flash the 
freezer chamber temperature and “Lo”.  The Under Temp 
LED will be lit, the audible alarm will sound and the 
remote contacts will change state. 
 
Note  
The Over Temp Alarm is disabled 
for a period of 2 hours after the 
defrost cycle begins to remove frost
buildup at the refrigeration unit and 
allow the temperature to stabilize.
OPERATION 
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Door Ajar Alarm (swinging door models only) 
When a swinging door is opened, the Door Ajar LED 
lights and the display alternately flashes between the 
 freezer temperature and “door”.  If a door is opened for 
3 minutes, the audible alarm will sound and the remote 
alarm contacts change state. 
 
 
Power Out Alarm 
When AC power is lost, the display will alternately flash 
between the current freezer temperature and “Pout”, the 
Power Out LED will light, the audible alarm will sound 
and the remote contacts will change state.  When power 
is restored, the display will continue flashing the “Pout” 
message until it is cleared by the user by pressing any of 
the keypads. 
 
 
Alarm Silencing 
The audible alarm can be silenced by deactivating it at 
the Alarm Silence Menu (see section earlier in this 
manual).  The audible alarm will silence for 5 minutes.  It 
will sound again at the end of the 5 minutes if the alarm 
condition persists. Alarm silencing does not affect the 
visual alarms. 
 
 
Alarm Test 
The Alarm Test feature is used to verify proper alarm 
operation by simulating an increase or decrease in 
chamber temperature.  The alarm test function will work 
for any value of high or low alarm set points.  With the 
key switch in the Set Up Position the remote and audible 
alarms are not activated during an alarm test, as is the 
case in an actual alarm condition. 
 
 
 
The procedure for testing the alarms is simple.  Press the 
Menu Keypad repeatedly until the display shows At (alarm 
test).  Momentarily, the display will change to n.  Press 
the Up Arrow Keypad to change the display from n to H in 
order to perform a high alarm test.  With the display 
showing H, press the Menu Keypad again and the 
temperature display will begin to rise until it reaches the 
High Alarm Set Point.  Once the set point is reached, both 
audible and visual alarms should be activated (with the 
key switch in alarm enable position) and the remote alarm 
contacts should change state.   To perform a low alarm 
Note  
The key switch should be in the 
Alarm Enabled Position in order to 
test all alarm features 
OPERATION 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
test, simply press the Down Arrow Keypad when the 
display shows n.  The display will then show L.  Press 
the Menu Keypad again in order to activate the low 
alarm test. 
 
 
Remote Alarm Contacts 
In addition to the audible and visual alarms, there are two 
sets of remote contacts on the side of the header panel, 
which change state during an alarm.  The upper set of 
contacts provides both normally open and normally 
closed switching.   
 
 
 
 
Remote Alarm 
Contacts 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 
 
 
 
 
 
All contacts are capable of switching up to 24 volts 
AC/DC @ 2 amps.  The common (C) and normally closed 
(NC) contacts open during an alarm.  The common (C) 
and normally open (NO) contacts close during and alarm. 
The contacts for the Deluxe Remote Alarm are normally 
closed and open during and alarm.  Figure 4 shows the 
location of the remote and deluxe alarm contacts. 
 
 
Note  
Remote alarm contacts are active 
only with the key switch in the Alarm 
Enabled position. 
OPERATION 
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Open Sensor 
When the controller is unable to read from the sensor, the 
display will show SnSr, indicating that a sensor error 
exists  The display will alternately flash SnSr and HigH. 
The audible alarm will sound, the remote alarm contacts 
will change state and the over temp LED will illuminate. 
 
 
Battery Back Up 
The freezers are supplied with a rechargeable battery 
backup.  The battery will continue to supply power to the 
controller and alarm features in the event of a power 
outage.  A fully charged battery can continue powering the 
controller for up to 8 hours during a power failure. 
 
The battery is recharged by the temperature controller 
during normal operation.  The battery should be checked 
every six months and replaced when necessary (see 
Replacement Parts).  Check the battery by unplugging the 
freezer and monitoring the controller operation.  If the 
controller does not properly activate the alarm features for 
2 hours, replace the battery.   Under normal operation, 
the battery backup should last up to four years or 200 
charge/discharge cycles. 
   
 
 
 
 
 
 
 
 
 
Caution 
Moving location of control sensor 
voids warranty 
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Controller Service (Menus) 
The two final menu items, calibration offset and hold-off 
time (oS and Ho), are not accessible from the main menu. 
In order to view and/or change them, the Menu keypad 
must be pressed and held for 5 seconds.  The calibration 
offset (oS) menu will then be displayed briefly followed by 
the most recent offset value. 
 
 
Calibration Offset 
 
• Display Offset (oS) – Use the Up/Down Arrow 
keypads to adjust the offset value.  Adjustable to 
+/- 5.0°C (+/- 9.0°F).  This value is added to the 
temperature display to correct for differences 
between actual and displayed chamber 
temperature.  See Calibration… for details.  
Press the Menu keypad to enter the new value 
or to continue to the next menu. 
 
 
 
Hold-Off Time 
• Hold-Off (Ho) – Use the Up/Down Arrow keypads to 
adjust the Hold-Off time in minutes. Adjustable  
from 3 to 10.  This value represents the delay time 
between compressor activations. Increasing the 
Hold-Off time can help prevent evaporator freeze-
up by increasing the defrost cycle time.  Press the 
Menu keypad to enter the new value and return to 
temperature control mode. 
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Caution 
INCREASING the offset value 
DECREASES the temperature at 
which the system controls.  If the offset 
is inadvertently set too high, the 
chamber temperature will drop below 
desired temperature and can 
lead to evaporator freeze-up. 
 
 
 
 
 
 
Temperature Offset 
In the event the freezer needs to be calibrated, a simple 
routine is available to adjust the display and control point to 
a referenced standard.  To set a temperature off- set while 
in the Control Mode (mode LED off), simply press and hold 
the Menu key for 5 seconds.  The display will flash oS 
followed by the last temperature offset value. The factory 
setting is 0.0.  To change the offset value, press the 
Increase or Decrease keypad to the value which when 
algebraically added to the last displayed temperature, will 
agree with the reference temperature.  Next, press the 
Menu key until the Mode LED turns off. 
 
For Example: 
The display indicates -30°C but a reference thermometer 
in the freezer chamber indicates -28°C.  The operator 
presses and holds the Menu KEY until the display shows 
(oS) offset, then the value.  Change the value from 0.0 to 
2.0. The Menu key is then pressed repeatedly until the 
Mode LED turns off.  Now the display indicates a 
chamber temperature of -28.0°C (approx.) and the 
controller begins to cool to the desired temperature of -
30.0°C. Allow an additional 30 to 40 minutes for the 
freezer to again stabilize.  If the display is still inaccurate, 
repeat the calibration procedure. 
 
 
Defrost Timer 
All freezers come equipped with a 24 hour defrost timer. 
The timer will trigger a defrost cycle 4 times per 24 hours. 
When a defrost cycle begins, the display will alternately 
flash dfSt and the current chamber temperature.  The 
defrost cycle typically lasts for 30 minutes or so,     
depending on the last freezer temperature. 
 
When a defrost cycle begins, the High Alarm is disabled 
for a period of 2 hours.  This is to provide enough time for 
the defrost cycle to occur and for the freezer temperature 
to drop below the high alarm set point after the defrost 
period has ended. 
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Caution 
When servicing the unit, disconnect 
plug from the electrical power source 
 
 
 
Caution 
Do not use any type of abrasive such 
as steel wool or fluids, such as gaso- 
line, Naptha or paint thinner, that 
could be harmful to plastic materials, 
door gasket and/or painted surfaces 
for cleaning. 
Cabinet  
The cabinet interior should be cleaned frequently. Any 
spilled liquid should be wiped off immediately.  Stains 
resulting from some spills can be permanent if not quickly 
removed.  The cabinet exterior should be cleaned 
occasionally.  A mild detergent and lukewarm water or a 
solution of bicarbonate of soda (1 tablespoon per gallon 
of water) is recommended for cleaning the interior and 
exterior of the cabinet. All surfaces should be rinsed and 
thoroughly dried. 
 
 
 
Condenser 
The condenser is located in front of the compressor fan, 
which is behind the base grill.  The condenser should be 
cleaned before becoming clogged with dirt/dust.  
Construction or other dirt causing environments may 
significantly increase the required frequency.  The 
condenser should be cleaned at least once a year. 
 
 
 
Condensate Evaporator Pan  
The condensate evaporator pan is located behind the 
compressor fan, which is behind the base grill.  This pan 
should be cleaned at least once a year to prevent foul 
odors and operate efficiently.  Vacuum clean if dry, or 
sponge clean with soapy water. 
22
   
 
 
 
Troubleshooting 
 
 
 
This table is intended to assist in resolving user-correctable Freezer problems by relating symptoms to 
their likely causes.  If service beyond the scope of this table is required, contact Service Division at 1-800-
438-4851. 
  
Symptom Probable Cause Action 
Does Not Run Unit Unplugged Plug in Unit 
 
Blown fuse or tripped circuit breaker Check fuse or circuit breaker at 
breaker box 
Runs Continuously Frost buildup on refrigeration Turn unit off and allow it to defrost. 
coils. 
 
Freezer over-loaded. Remove contents from top shelf of 
unit. 
Clicking Sound The compressor is equipped with Disconnect power and allow unit to 
a thermal protector. This device      sit for about an hour, then retry.  If 
shuts off the compressor when it condition persists, call for service. 
becomes too hot. A clicking sound 
occurring about every 30 seconds 
indicates this protector is working 
Insufficient Cooling Set temp is too high Reduce temperature setting, verify 
Cool LED turns on in 3 minutes. 
Condenser coil dirty Clean condenser coil with a vacuum 
cleaner 
 
Unit frosted Defrost unit 
 
Offset (oS) value is too low.                    Increase offset value. 
 
 
Defrost mode activated.                         Allow enough time for defrost mode 
                                                               to end (2 hours maximum). 
Replacement Parts 
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Replacements for Laboratory Freezer parts serviceable by the user may be ordered, by part number, from 
Service at 1­800-438-4851. 
 
Solid  State  Relay (K2)  25A                                                                                               88616 
Magnetic Relay (K1)  SPST         102259 
Magnetic Relay (K1)  DPDT          102260 
Alarm Version Temperature Controller   316637H01  
Shelf Support (Front)                                                                                                        103264
Chart Recorder Manual   316983H01  
Rechargeable Battery          104711 
Temperature  Sensor           104163   
Solid  State  Relay (K2)  45A                                                                                        316734H01
Shelf Support (Rear)                                                                                                         103265 
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Introduction 
 
 
Warning 
Warnings alert you to a possibility of 
personal injury. 
 
Caution 
Cautions alert you to a possibility of 
damage to the equipment. 
 
Note 
Notes alert you to pertinent facts and 
conditions. 
 
 Hot surfaces alert you to a possibility of personal injury if you come in 
contact with a surface during use or 
for a period of time after use. 
 
 
Caution 
Risk  of electric shock. 
 
 
Warning 
These refrigerators are not approved 
for the storage of blood or blood 
products! 
 
Warning 
This product is not intended, nor can it 
be used, as a sterile or patient 
connected device. In addition, this 
apparatus is not designed for use in 
Class I,II or III locations as defined by 
the National Electrical Code, unless 
otherwise noted. 
 
Warning 
As a routine laboratory precaution, 
always wear safety glasses when 
working with this apparatus. 
 
DANGER: RISK OF CHILD 
ENTRAPMENT. BEFORE YOU 
THROW AWAY YOUR OLD 
REFRIGERATOR OR FREEZER: 
• TAKE OFF DOORS 
• LEAVE THE SHELVES IN PLACE
   SO THAT CHILDREN MAY NOT 
   EASILY CLIMB INTO UNIT 
 
                Warning 
High voltage is supplied to PC board 
when key switch is OFF. 
 
 
 
 
This manual is intended to provide installation and 
operating instructions for your general purpose and 
chromatography refrigerators.   
 
Your satisfaction and safety are important to us.  A 
complete understanding of this unit is necessary to attain 
these objectives. 
 
As the ultimate user of this apparatus, it is your 
responsibility to understand its proper function and 
operational characteristics. This instruction manual should 
be thoroughly read and all operators given adequate 
training before
 
Warning 
    • This manual must be carefully read and 
thoroughly understood before operating the 
unit.  Failure to follow directions or 
precautionary measures could result in 
serious adverse effects. 
 
• This equipment must be used only as specified 
in these instructions. If used in a manner other 
than as specified, the protection provided by the 
equipment may be impaired. 
 
• This equipment is intended for indoor use only. 
 
• This equipment must be earth grounded for safe 
operation. 
 
• Disconnect unit line cord from power source 
before performing any servicing or maintenance. 
 
 attempting to place this unit in service. 
Awareness of the stated cautions and warnings, and 
compliance with recommended operating parameters - 
together with maintenance requirements - are important 
for safe and satisfactory operation. The unit should be 
used for its intended application; alterations or 
modifications will void the Warranty. 
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Unpacking 
Save all packing material if apparatus is received damaged.  
This merchandise was carefully packed and thoroughly 
inspected before leaving our factory. 
 
Responsibility for its safe delivery was assumed by 
the carrier upon acceptance of the shipment; 
therefore, claims for loss or damage sustained in 
transit must be made upon the carrier by the recipient 
as follows: 
 
 
 
Visible Loss or Damage 
Note any external evidence of loss or damage on the 
freight bill, or express receipt, and have it signed by the 
carrier’s agent.  Failure to adequately describe such 
external evidence of loss or damage may result in the 
carrier’s refusing to honor your damage claim.  The 
carrier will supply the form required to file such a claim. 
 
 
 
Concealed Loss or Damage 
Concealed loss or damage refers to loss or damage, 
which does not become apparent until the merchandise 
has been unpacked and inspected.  Should either occur, 
make a written request to the carrier’s agent within 15 
days of the delivery date; then file a claim with the carrier 
since the damage is the carrier’s responsibility. 
 
If you follow the above instructions carefully, we will 
guarantee our full support of your claim to be 
compensated for loss from concealed damage. 
 
DO NOT – FOR ANY REASON – RETURN THIS UNIT 
WITHOUT FIRST OBTAINING AUTHORIZATION 
Installation  
INSTALLATION 
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Packing List 
The following items are located inside the refrigerator 
chamber. If any of the following items are not present, 
report the missing item to your local representative. 
 
• Instruction Manual 
 
• Warranty information 
 
• Door Lock and Power Switch Keys 
 
 
Selecting a Location 
Choose a location for the refrigerator that will provide  at 
least  three  inches  of  clearance
 
 
 
Note 
  between the cabinet and 
any adjacent vertical surface at the sides and rear. 
Appropriate electrical power must be available.  Locate 
the refrigerator within 6 feet of the power outlet so that no 
extension cord is required. 
 
 
The refrigerator must be level in order 
to provide adequate condensation 
drainage as well as proper door 
alignment and operation. The 
refrigerator should be in its final 
operating location and set so that it is 
firmly positioned 
on the floor. 
Leveling the Unit 
The refrigerator must be level in order to provide adequate 
condensation drainage as well as proper door alignment 
and operation. The refrigerator should be in its final 
operating location and set so that it is firmly positioned on 
the floor. 
 
There are four leveling screws, one on each corner. Level  
the cabinet front to rear and side-to-side using the corner 
leveling screws. 
 
The front leveling screws are accessed by removing the 
base grille, as described below: 
1.  Remove the lower grille attachment screws. 
 
2.  Grasp the grille with both hands. 
 
3.  Lift the grille approximately 1/2”. 
 
4.  Pull grille away from the refrigerator. 
•       Shelves and Casters 
INSTALLATION  
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Caution 
If the unit was tilted in excess of 30 
degrees, level it and do not apply 
electrical power for a minimum of 
12 hours. 
Installing and Leveling Casters 
Refrigerators come with four casters, which thread into 
the base of the unit, one in each corner. Remove the 
leveling screws from the unit and use the wrench 
provided to thread the casters completely into the   
base of the unit.  
See Figure 1. 
 
 
 
 
 
 
 
 
Lamps 
 
 
Caution 
Improperly installed lamps may cause 
damage to the lighting circuit. 
Prior to applying power to the unit, verify that all of the 
internal lamps are properly installed and fully engaged in 
the lamp holders. Proper lamp engagement is achieved 
by rotating the lamp 90° from its insertion position until it 
“snaps” or “clicks” into place. 
 
Since the lamps in this unit are protected by shields, it is 
necessary to physically verify that the lamp has been 
rotated and locked into place. 
 
 
Door Removal 
(Sliding Door Models Only) 
Each door has its own closing spring located at the top 
of the door track.  Each spring is set for proper tension.  
If doors do not close properly: 
1. Check for cabinet level (see above). 
 
2. Remove the door(s) by opening slightly then 
lifting it.  While maintaining upward pressure on 
the door, pull the bottom outward until it clears 
the bottom track. 
 
3. Check that spring in top track moves freely and 
that bottom track is free of debris. Check that 
rollers on bottom of door rotate freely. 
Tighten 
using 
wrench 
provided 
Refrigerator 
Base 
Thread casters directly 
into base at four 
corners 
Figure 1 
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Note 
Chromatography units include 
additional 1/2 shelves, which can 
be used in place of the full shelves. 
Shelves 
Shipped inside each cabinet are shelves packed in plastic 
and a bag of shelf supports. 
 
Two different shelf supports are provided. The shorter tab 
length version is used on the front of the shelf. Shelf 
spacing is adjustable to suit user requirements. Insert four 
shelf supports for each shelf into the pilasters as shown.  
Place the shelf on the pilasters as shown in Fig’s 2 and 3. 
 
 
Replacement shelves are available individually.  Call 
Technical Service at 800­438­4851 for shelf part numbers.
Proper shelf orientation is illustrated in Figures 2 & 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
 
 
 
Figure 3 - Place shelves at desired height on four 
shelf supports. 
Note 
Note the numbers on the pilasters.  
Place supports on the same numbers 
on each pilaster to ensure the shelf will 
be level. 
 INSTALLATION  
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Warning 
Insufficient line voltage is often the 
cause of compressor start-up failure. 
It is strongly recommended that a 
dedicated circuit, conforming to the 
National Electrical Code, Article 440, 
be used for powering the 
refrigerator. 
 
 
Caution 
Be sure that the power supply is the 
same voltage that is specified on the 
refrigerator's data plate. 
 
 
 
Warning 
For personal safety this unit must be 
properly grounded. 
 
 
 
Warning 
DO NOT under any circumstances cut 
or remove the third (ground) prong 
from the power cord.  DO NOT use a 
two-prong adapter plug. 
 
 
 
Warning 
Do not use an extension cord. Use 
of an ungrounded cord or an 
overloaded circuit VOIDS the 
compressor warranty. 
Electrical Connection 
The frequency and nominal voltage requirements for the 
unit are specified on the data plate, which is located on 
the interiors upper left side.  Only plug the unit into a 
power source that meets these requirements.  Low line 
voltage is often the cause of service complaints. 
With the unit running, check that the line voltage is 
within ±10% of that specified on the data plate. 
 
The power cord on most units has a three prong 
(grounding) plug (NEMA 5-15P).  This plug mates with a 
standard three prong (grounding) wall receptacle (NEMA  
5-15R) to minimize the potential of an electrical shock 
hazard. Where necessary models are equipped with a 
linecord and NEMA 5-20P plug.  This plug requires a 
NEMA 5-20R receptacle. 
 
The customer should have the wall receptacle and circuit 
checked by a qualified electrician to verify the receptacle 
is properly grounded and meets power requirements 
specified on the data plate. 
 
Where a two prong wall receptacle is encountered, it is 
the personal responsibility and obligation of the user to 
have it replaced with a properly grounded three prong 
receptacle. 
 
During compressor start-up, the unit will momentarily 
draw more current than under normal running conditions. 
To avoid nuisance tripping of circuit breakers, it may be 
necessary to install an HACR rated breaker. 
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Controls 
 
Panel Controls 
The control system provides both audible and visual                                
indication of alarm conditions in an easy to read display 
format.  In addition, there are two sets of contacts 
available for remote alarm switching. 
 
                                                                                                                                             Temperature and alarm set points are directly entered in 
°C or °F.   
Before operation, it is necessary to become familiar with 
the refrigerator controls. All the refrigerator controls are 
located on the header panel.  A layout of the controller 
and LED’s are given below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                
 
                                                Performance Characteristics 
                                                                                                                                              
Temperature Range:  1.0° to 12.0°C (33.8° to 53.6°F)        
Temperature Stability:  ±3°C 
 
 
     Displays and Features 
         On the right side of the header panel is the key switch.  
         The key switch has three positions, OFF (O), Set-up (I) 
and Alarm Enable (  ).  With the refrigerator plugged in 
and the key switch in the OFF position, the displays and 
 
Warning 
High voltage is supplied to PC board 
when key switch is OFF. 
CONTROLS 
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refrigeration system are off.  The control board remains 
energized in order to supply a charge to the battery. 
 
 
Key Switch 
Turning the key switch to the middle position energizes 
the circulation fans and the controller display. When the 
controller is in the Set-Up mode, the menu items can be 
set to the desired values. See Controller Set Up for a 
description of each.  Once all menu items are set, the 
refrigerator should then be switched to the Alarm 
Enabled position. While in the Alarm Enabled position, 
the menu items can be viewed but not changed. The key 
can be removed to secure the values entered. 
 
Temperature Display 
The temperature display indicates chamber temperature 
while in the control mode of operation and menu titles and 
values while entering menu items (see Menus).  
 
Units LED’S 
The temperature display indicates chamber temperature 
in both °C and °F.  The current units are indicated by the 
corresponding LED located to the right of the temperature 
display. 
 
Mode LED 
The Mode LED is lit when the Menu keypad has been 
pressed.  It indicates to the user that the controller is in 
the menu selection mode. 
 
Cool LED 
The Cool LED is lit when the controller calls for cooling. 
When this LED comes on the compressor should 
energize. 
 
Alarm LED’S 
Door Ajar - This LED is illuminated when a refrigerator 
door(s) is opened.  This feature is not used in the sliding 
glass door models, since the circulating fans run 
continuously and the doors are spring loaded. 
 
Over Temp – Indicates the current chamber temperature 
exceeds the high alarm temperature set point. 
 
Under Temp – Indicates the current chamber temperature 
is lower than the low alarm temperature set point. 
 
Power Out – Indicates AC power to the refrigerator is 
disrupted. 
 
Alarm Test – Indicates the controller is running an alarm 
test. 
 
 
Note 
The key can be removed in the 
Off or the Alarm Enabled 
position. 
 
Caution 
Alarms will only activate with the 
key in the Alarm Enabled   
position. 
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Keypads 
Menu Keypad – Pressing the Menu keypad enters the 
controller into the menu selection mode, designated by 
the illumination of the MODE LED.  Repeatedly pressing 
the Menu keypad cycles through the list of menu items 
(see Menus).  After the final menu, the controller returns 
to the control mode and the MODE LED turns off. 
Up Arrow Keypad – Increases or changes menu values. 
Down Arrow Keypad - Decreases or changes menu 
Values. 
 
 
Interior Light Switch 
The interior lamp(s) is controlled by a rocker switch located 
on the control panel.  This light may be operated any time 
the cabinet power is turned on at the keyed power switch.  
If the interior lamp fails, replace with the same size and 
wattage lamp.  DO NOT USE REDUCED WATTAGE 
LAMPS.  The reduced wattage lamps generally fail to light 
below 60°F (15°C). 
 
Be sure that lamps are properly installed by inserting 
ends into sockets and rotating lamp 90°. Failure to install 
lamps properly may cause damage to the lighting circuit. 
 
 
• Glass door models - The control panel light 
switch controls the interior light with the doors 
open or closed. 
• Solid door models – The control panel light 
switch controls the interior light when the doors 
are open. 
  
CONTROLS 
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Operation 
 
 
 
 
 
 
Note 
The “Pout” display is a normal 
occurrence when power is first 
applied to the controller.  Press any 
key to clear it. 
 
 
The refrigerator is started by inserting the power switch 
key, which is found inside the unit, into the key switch.  
Turn the key to the middle (set up) position.  The internal 
fans will start and the display will flash between Pout and 
the current chamber temperature.  The “Pout” (power 
out) display indicates to the user that the controller has 
sensed a low voltage condition. This condition is normal 
during any start-up.  See the Alarms section for details 
on the Pout message.   Press any keypad to clear the 
Pout. 
 
 
 
Controller Set-Up (Menus) 
During normal operation, the refrigerator temperature is 
displayed on the 4-character display.  The compressor 
cycles on and off to control the chamber temperature 
between 1.0° and 12.0°C (33.8 to 53.6°F), selectable by 
the user.  The temperature set point, high and low alarm 
set-points, units and display offset can be changed while 
the key switch is in the set-up (middle) position.  These 
values can be viewed but not changed with the key 
switch is in the alarm enabled position.  The menu 
options are explained in the following sections. 
 
There are 8 menus to select from, each can be 
accessed by pressing the Menu keypad.  Pressing the 
Menu key- pad once brings up the first menu, which is 
the temperature set point.  The displays initially flash 
SP followed by the last set temperature value.  
Pressing the Menu key- pad again, accepts the value 
and displays the next menu, units select (CF).  Each 
menu value is entered this way. The menus can be 
changed only while the key switch is in the set up (I) 
position.  They can be viewed but not changed while 
the key switch is in the alarm enable( ) position.  The 
individual menus are described below. 
 
 
Temperature Set point 
•  
Temperature Set Point is factory pre­set at 4.0°C       
(39.2°F). Adjusting the temperature Set Point is 
not recommended. 
•  
Temperature Set Point (SP) – Adjustable from 
1.0 to 12.0°C or 33.8 to 53.6°F.  Use the 
Up/Down Arrow keypads to change the 
temperature and the Menu keypad to enter the 
value and switch to the next menu. 
 
OPERATION 
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Units 
• Units select (C,F) – Selects the desired 
temperature display units in °C or °F.  Use the Up 
Arrow keypad to change the units from C to F. Use 
the Down Arrow keypad to switch from F to C.  
Press the Menu keypad to enter the units 
value and continue. The appropriate units LED 
will indicate the selected units. 
 
 
 
High Alarm Set Point 
• High Alarm Set Point (AH) – Use the Up/Down 
Arrow keypad to adjust the value that triggers a 
high alarm condition if the chamber temperature 
rises above it.  The high alarm temperature 
range is from -33.0°C (-27.4°F) to 37.0°C 
(98.6°F). 
•         Factory pre­set at 16.0°C (60.8°F). 
 
NOTE:  The High and Low alarm set points can be 
adjusted to be within 3.5°C (6.3°F) of one another and no 
closer. 
 
 
Low Alarm Set Point 
• Low Alarm Set Point (AL) – Use the Up/Down 
Arrow keypad to adjust the value that triggers a 
low alarm condition.  The low alarm condition 
occurs when the actual chamber temperature 
drops below the Low Alarm Set Point.  The low 
alarm range is from -36.0°C (-32.8°F) to 34.0°C 
(93.2°F). 
•         Factory pre­set at -2.0°C (28.4°F). 
 
 
Alarm Silencing Menu 
• Alarm Silencing (AS) – During an alarm condition, 
while the key switch is in the Alarm Enable Mode, 
this menu allows the user to silence the audible 
alarm for 5 minutes. After the AS stops flashing, 
the display will show n, press the Up Arrow keypad 
to change the display to y.  Press the Menu 
Keypad and the audible alarm will turn off for 5 
minutes. 
OPERATION  
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Alarm Test Menu 
• Alarm Test (At) –Use the Up Arrow keypad to 
change the n to H.  By subsequently pressing 
the Menu Keypad the controller will perform a 
High Alarm Test (see Alarm Test in Alarms 
section).  Use the Down Arrow Keypad to 
change the display to L.  Pressing the Menu 
Keypad will activate the Low Alarm Test.  
Pressing the Menu Keypad while the display 
shows n returns the unit to control mode (MODE 
LED off). 
 
NOTE:  While in any of the above menu options, the 
controller will wait 15 seconds for a new value to be 
entered. If there is no keypad activity within 15-seconds, 
the refrigerator will automatically shift to the Control Mode 
and the Mode LED will turn off. 
 
 
 
Control Mode 
The Control Mode of operation is indicated when the 
Mode LED is OFF.  With the desired temperature set 
point and alarm values entered, the refrigerator will then 
begin to control to the set temperature.  There is a time 
delay between compressor activations.  This delay begins 
the moment the controller is energized or the moment the 
compressor turns off during normal operation.  The delay 
is added to provide time for the system pressure to drop 
before the compressor tries to start again. 
 
 
Loading 
Follow the guidelines below in order to provide optimal 
refrigerator performance: 
 
• When loading with critical samples, verify all 
alarms and features are operating properly. 
 
• Space samples uniformly in the chamber. 
 
• Keep samples away from the back wall that may 
obstruct airflow. 
 
• It is best to load the refrigerator from bottom to 
top.  Keeping the area next to the air intake and 
exhaust clear will help assure proper airflow. 
 
 
 
OPERATION 
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Temperature Digression 
By pressing the Increase keypad while the refrigerator is 
in the Control Mode, the display will show the warmest 
temperature recorded since the unit was energized or the 
digression values were reset.  Pressing the Decrease 
keypad will display the coldest temperature recorded 
since the unit was energized or the digression values 
were reset. 
 
To reset the temperature digression values, simply press 
the Increase and Decrease keypads at the same time. 
The display will show Clr, indicating the controller will 
begin recording new warm and cold digressions once 
more. 
 
 
Alarms 
Refrigerators are equipped with audible and visual alarms.  
They also feature remote alarm contacts.  The key switch 
must be in the Alarm Enable position for the audible alarm 
and remote alarm contacts to activate.  Alarm messages 
are shown on both the temperature display and in the row 
of Alarm LED’s located above the temperature display.  The 
following conditions will trigger an alarm: 
 
• Chamber temperature is greater than the high 
alarm set point. 
 
• Chamber temperature is less than the low alarm 
set point. 
 
• Door has been left open for 3 minutes or more. 
 
• AC power has been interrupted to the 
refrigerator. 
 
• Open sensor 
 
NOTE:  The Door Ajar Alarm is not available on the 
sliding glass door models. 
 
 
Over Temp Alarm 
If the refrigerator chamber temperature rises above the 
High Alarm Set Point, the display will alternately flash the 
refrigerator chamber temperature and “HigH”.  The Over 
Temp LED will be lit, the audible alarm will sound and the 
remote contacts will change state. 
 
 
Under Temp Alarm 
If the refrigerator chamber temperature falls below the 
Low Alarm Set Point, the display will alternately flash the 
refrigerator chamber temperature and “Lo”.  The Under 
OPERATION 
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Temp LED will be lit, the audible alarm will sound and the 
remote contacts will change state. 
 
 
Door Ajar Alarm (swinging door models only) 
When a swinging door is opened, the Door Ajar LED 
lights and the display alternately flashes between the 
refrigerator temperature and “door”.  If a door is opened 
for 3 minutes, the audible alarm will sound and the 
remote alarm contacts change state. 
 
 
Power Out Alarm 
When AC power is lost, the display will alternately flash 
between the current refrigerator temperature and “Pout”, 
the Power Out LED will light, the audible alarm will sound 
and the remote contacts will change state.  When power 
is restored, the display will continue flashing the “Pout” 
message until it is cleared by the user by pressing any of 
the keypads. 
 
 
Alarm Silencing 
The audible alarm can be silenced by deactivating it at 
the Alarm Silence Menu (see section earlier in this 
manual).  The audible alarm will silence for 5 minutes.  It 
will sound again at the end of the 5 minutes if the alarm 
condition persists. Alarm silencing does not affect the 
visual alarms. 
 
 
Alarm Test 
The Alarm Test feature is used to verify proper alarm 
operation by simulating an increase or decrease in 
chamber temperature.  The alarm test function will work 
for any value of high or low alarm set points.  With the 
key switch in the Set Up Position the remote and audible 
alarms are not activated during an alarm test, as is the 
case in an actual alarm condition. 
 
 
 
The procedure for testing the alarms is simple.  Press the 
Menu Keypad repeatedly until the display shows At (alarm 
test).  Momentarily, the display will change to n.  Press 
the Up Arrow Keypad to change the display from n to H in 
order to perform a high alarm test.  With the display 
showing H, press the Menu Keypad again and the 
temperature display will begin to rise until it reaches the 
High Alarm Set Point.  Once the set point is reached, both 
audible and visual alarms should be activated (with the 
key switch in alarm enable position) and the remote alarm 
contacts should change state.   To perform a low alarm 
Note  
The key switch should be in the 
Alarm Enabled Position in order to 
test all alarm features 
OPERATION 
17 
 
 
 
 
 
 
 
 
 
 
 
 
test, simply press the Down Arrow Keypad when the 
display shows n.  The display will then show L.  Press 
the Menu Keypad again in order to activate the low 
alarm test. 
 
 
Remote Alarm Contacts 
In addition to the audible and visual alarms, there are two 
sets of remote contacts on the side of the header panel, 
which change state during an alarm.  The upper set of 
contacts provides both normally open and normally 
closed switching.   
 
 
 
Remote Alarm 
Contacts 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    Figure 4 
 
 
 
 
 All contacts are capable of switching up to 24 volts 
AC/DC @ 2 amps.  The common (C) and normally closed 
(NC) contacts open during an alarm.  The common (C) 
and normally open (NO) contacts close during and alarm. 
The contacts for the Deluxe Remote Alarm are normally 
closed and open during and alarm.  Figure 4 shows the 
location of the remote and deluxe alarm contacts. 
 
 
Note  
Remote alarm contacts are active 
only with the key switch in the Alarm 
Enabled position. 
OPERATION 
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Open Sensor 
When the controller is unable to read from the sensor, the 
display will show SnSr, indicating that a sensor error 
exists  The display will alternately flash SnSr and HigH. 
The audible alarm will sound, the remote alarm contacts 
will change state and the over temp LED will illuminate. 
 
 
Battery Back Up 
The refrigerators are supplied with a rechargeable battery 
backup.  The battery will continue to supply power to the 
controller and alarm features in the event of a power 
outage.  A fully charged battery can continue powering the 
controller for up to 8 hours during a power failure. 
 
The battery is recharged by the temperature controller 
during normal operation.  The battery should be checked 
every six months and replaced when necessary (see 
Replacement Parts).  Check the battery by unplugging the 
refrigerator and monitoring the controller operation.  If the 
controller does not properly activate the alarm features for 
2 hours, replace the battery.   Under normal operation, 
the battery backup should last up to four years or 200 
charge/discharge cycles. 
 
 
Convenience Outlet 
(Chromatography Refrigerators Only) 
Chromatography Refrigerators are equipped with a 
convenience outlet located in the back wall.  The power 
to the outlets is protected by a circuit breaker.  The 
breaker is located just below and to the right of the 
outlet.  Pressing the breaker button resets the breaker 
after a fault. 
 
The total load to the convenience outlet should not 
exceed 4 amps. 
 
 
 
 
 
Caution 
Moving location of control sensor 
voids warranty 
 
 
Warning 
The convenience outlet is LIVE at 
any time the unit is connected to an 
electrical power source, regardless 
of the position of the key switch. 
OPERATION 
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Controller Service (Menus) 
The two final menu items, calibration offset and hold-off 
time (oS and Ho), are not accessible from the main menu. 
In order to view and/or change them, the Menu keypad 
must be pressed and held for 5 seconds.  The calibration 
offset (oS) menu will then be displayed briefly followed by 
the most recent offset value. 
 
 
Calibration Offset 
 
• Display Offset (oS) – Use the Up/Down Arrow 
keypads to adjust the offset value.  Adjustable to 
+/- 5.0°C (+/- 9.0°F).  This value is added to the 
temperature display to correct for differences 
between actual and displayed chamber 
temperature.  See Calibration… for details.  
Press the Menu keypad to enter the new value 
or to continue to the next menu. 
 
 
 
Hold-Off Time 
• Hold-Off (Ho) – Use the Up/Down Arrow keypads to 
adjust the Hold-Off time in minutes. Adjustable  
from 3 to 10.  This value represents the delay time 
between compressor activations. Increasing the 
Hold-Off time can help prevent evaporator freeze-
up by increasing the defrost cycle time.  Press the 
Menu keypad to enter the new value and return to 
temperature control mode. 
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Caution 
INCREASING the offset value 
DECREASES the temperature at 
which the system controls.  If the offset 
is inadvertently set too high, the cham- 
ber temperature can fall below zero 
and lead to evaporator freeze-up. 
 
 
 
 
 
 
Temperature Offset 
In the event the refrigerator needs to be calibrated, a 
simple routine is available to adjust the display and control 
point to a referenced standard.  To set a temperature off- 
set while in the Control Mode (mode LED off), simply press 
and hold the Menu key for 5 seconds.  The display will 
flash oS followed by the last temperature offset value. The 
factory setting is 0.0.  To change the offset value, press the 
Increase or Decrease keypad to the value which when 
algebraically added to the last displayed temperature, will 
agree with the reference temperature.  Next, press the 
Menu key until the Mode LED turns off. 
 
For Example: 
The display indicates 4°C but a reference thermometer in 
the refrigerator chamber indicates 6°C.  The operator 
presses and holds the Menu KEY until the display shows 
(oS) offset, then the value.  Change the value from 0.0 to 
2.0. The Menu key is then pressed repeatedly until the 
Mode LED turns off.  Now the display indicates a 
chamber temperature of 6.0°C (approx.) and the 
controller begins to cool to the desired temperature of 
4.0°C. Allow an additional 30 to 40 minutes for the 
refrigerator to again stabilize.  If the display is still 
inaccurate, repeat the calibration procedure. 
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Caution 
When servicing the unit, disconnect 
plug from the electrical power source 
 
 
 
Caution 
Do not use any type of abrasive such 
as steel wool or fluids, such as gaso- 
line, Naptha or paint thinner, that 
could be harmful to plastic materials, 
door gasket and/or painted surfaces 
for cleaning. 
Cabinet  
The cabinet interior should be cleaned frequently. Any 
spilled liquid should be wiped off immediately.  Stains 
resulting from some spills can be permanent if not quickly 
removed.  The cabinet exterior should be cleaned 
occasionally.  A mild detergent and lukewarm water or a 
solution of bicarbonate of soda (1 tablespoon per gallon 
of water) is recommended for cleaning the interior and 
exterior of the cabinet. All surfaces should be rinsed and 
thoroughly dried.] 
 
 
 
Condenser 
The condenser is located in front of the compressor fan, 
which is behind the base grill.  The condenser should be 
cleaned before becoming clogged with dirt/dust.  
Construction or other dirt causing environments may 
significantly increase the required frequency.  The 
condenser should be cleaned at least once a year. 
 
 
 
Condensate Evaporator Pan  
The condensate evaporator pan is located behind the 
compressor fan, which is behind the base grill.  This pan 
should be cleaned at least once a year to prevent foul 
odors and operate efficiently.  Vacuum clean if dry, or 
sponge clean with soapy water. 
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Troubleshooting 
 
 
 
This table is intended to assist in resolving user-correctable Refrigerator problems by relating symptoms to 
their likely causes.  If service beyond the scope of this table is required, contact Service Division at 1-800-
438-4851. 
  
Symptom Probable Cause Action 
Does Not Run Unit Unplugged Plug in Unit 
 
Blown fuse or tripped circuit breaker Check fuse or circuit breaker at 
breaker box 
Runs Continuously Frost buildup on refrigeration Turn unit off and allow it to defrost. 
coils. 
 
Refrigerator over-loaded. Remove contents from top shelf of 
unit. 
Clicking Sound The compressor is equipped with Disconnect power and allow unit to 
a thermal protector. This device    sit for about an hour, then retry.  If 
shuts off the compressor when it condition persists, call for service. 
becomes too hot. A clicking sound 
occurring about every 30 seconds 
indicates this protector is working 
Insufficient Cooling Set temp is too high Reduce temperature setting, verify 
Cool LED turns on in 3 minutes. 
Condenser coil dirty Clean condenser coil with a vacuum 
cleaner 
 
Unit frosted Defrost unit 
 
 
Offset (oS) value is too low.                    Increase offset value. 
  
Replacement Parts 
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Replacements for Laboratory Refrigerator parts serviceable by the user may be ordered, by part number, from 
Service at 1­800-438-4851. 
 
Solid  State  Relay (K2) 25A                                                                                                88616 
Magnetic Relay (K1)  SPST         102259 
Magnetic Relay (K1)  DPDT          102260 
Alarm Version Temperature Controller   316637H01  
Chart Recorder Manual   316983H01  
Rechargeable Battery          104711 
Temperature  Sensor           104163
 
  
Solid  State  Relay (K2)  45A                                                                                        316764H01
Shelf Support  (Front)                                                                                                       103264 
Shelf Support (Rear)                                                                                                         103265 
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Hinged Glass Door Models 
POWER CORD
115 VAC
COM
K1
NO
CHART RECORDER
OPTIONAL
COMPRESSOR
LIGHT SWITCH LAMP BALLAST
12
K2
CONDENSER 
FAN
7
6
5
3
2
1
C
A
1
2
3
OUTPUT TO 
REMOTE 
ALARM
TB2
BATTERY
(+)
(-)
B1
2
1
OUTPUT 
TO DELUXE 
ALARM 
SYSTEM
TB1
SYSTEM 
RELAY
12 VDC
0
1
K1
WHITE
BLACK
GREEN
12 VDC RED
BROWN
SW1
CONTROL ON/OFF CIRCUIT
PURPLE/WHITE
ALARM ENABLE
BLUE/WWITE
YELLOW/WHITE
PURPLE
J4
J3
KEY SWITCH
RED
BROWN
GRAY
GRAY
Y
YELLOW/WHITE
G/Y
WB
PURPLE/WHITE
COM
143625
TEMPERATURE
CONTROLLER
2
5
4
1
6
3
NC
NO
DOOR
AJAR
NEUTLINE EARTH
12 VDC
4 3
COMPRESSOR 
RELAY
K2
(-) (+)
BLACK WHITE
EVAPORATOR FANS
(QTY MAY VARY)
DOOR SWITCH
(QTY MAY VARY)
CHROMATOGRAPHY UNITS ONLY (QTY MAY VARY)
CIRCUIT BREAKER
- 4/5/11 INITIAL RELEASE
REV. ECN #  DATE  DESCRIPTION
REVISIONS
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Hinged Solid Door Models 
POWER CORD
115 VAC
COM
K1
NO
CHART RECORDER
OPTIONAL
COMPRESSOR
LIGHT SWITCH
LAMP BALLAST
12
K2
CONDENSER 
FAN
2
1
OUTPUT TO 
DELUXE 
ALARM 
SYSTEM
TB1
BATTERY (+)(-)
B1
1
2
3
OUTPUT 
TO 
REMOTE 
ALARM
TB2
7
6
5
3
2
1
C
A
SYSTEM 
RELAY
12 VDC
0
1
K1
BLACK WHITE
DOOR SWITCHS
(QTY MAY VARY)
EVAPORATOR FANS
(QTY MAY VARY)
(+)(-)
K2
COMPRESSOR 
RELAY
34
12 VDC
EARTHLINE NEUT
DOOR
AJAR
NO
NC
3
6
1
4
5
2
TEMPERATURE
CONTROLLER
5 2 6 3 4 1
COM
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The Mueller PyroPure P6000 Series is Built to Last
Mueller PyroPure multiple-effect stills (MES) are the simplest, most reliable means of producing pyrogen-free water-
for-injection (WFI) that meets all U.S. Pharmacopoeia requirements. The MES is designed with efficiency in mind.
Because the system recovers the latent heat of vaporization occurring within its own process to heat feedwater and
uses feedwater as its primary source of cooling, the MES is an energy and money-saving model of ingenuity. Due to
the absence of moving parts, the PyroPure MES requires less maintenance and is much quieter than mechanical
compression stills. Multiple-effect stills also lack the seal and associated oil supply required by mechanical compression
stills; therefore, there is no danger of contamination due to seal breakdown associated with mechanical compression.
The PyroPure MES is manufactured according to FDA current Good Manufacturing Practices (cGMPs) and ASME-BPE
requirements.  
Each PyroPure MES is designed to minimize operating costs associated with production of WFI by minimizing the
required utility steam and coolant consumption. This is accomplished by utilizing sources of energy within the various
process streams to preheat the feedwater and thus use the feedwater as a cooling source. Using the feedwater as a
coolant source also reduces the utility steam consumed to elevate the temperature of the feedwater. The feedwater
ultimately enters the tubes of the first effect evaporator where utility steam is applied to the shell to evaporate the
feedwater. The resulting steam produced is then directed to the separation column where a tangential inlet produces
centrifugal force that separates the entrained water droplets away from the pure steam. This pure steam is then used
as the heating source for the subsequent effect. 
PyroPure Multiple-Effect Stills
• External evaporators access for inspection and
preventative maintenance on critical o-rings and gaskets.
• The separation columns contain no internal components
that require inspection or periodic maintenance.
• All maintenance, including replacement of critical
components, can be performed with only 24" of space
on all sides (including the top) of the equipment.
• ASME-BPE certified fittings are used throughout.
• WFI condensers have removable tube bundles
for easy cleaning and inspection of product
contact surfaces.
• Minimal instrumentation is required upon
operation of the equipment. Only two control
loops are needed which minimizes the
calibration required as well as the potential
for downtime.
• All elastomers in contact with feedwater and
product are provided with USP Class VI
certifications.
• All components are fully drainable including
the optional feedwater pump.
Simple Design, Reliable Operation
14
System Components
Condenser. PyroPure condensers have a double-tube-
sheet design that provides users with the efficiency of
heat exchange and at the same time ensures that pure
vapor and distillate will never come into contact with
feedwater and coolant. To facilitate maintenance, all
PyroPure condensers are mounted at an angle to allow
full drainage of the pure distillate through the distillate
outlet port installed at the lowest point of the vessel. The
condenser is designed to allow the removal of the U-tube
bundle, making it easy for the user to inspect the critical
pure distillate contact surfaces. 
Controls. The standard control system is an Allen Bradley
PLC with an Allen Bradley operator interface mounted in
a NEMA rated panel. Ethernet is provided on the standard
control system to facilitate communications with adjacent
equipment or data archiving systems. Mueller can also
provide other Allen Bradley control components, as well
as control systems from Siemens and Mitsubishi. Control
and electrical panels are supplied with a UL 508a label.
Steam Separator. Mixture of water and vapor leaves the
evaporator at high velocity and enters the separator
through a tangential port, a natural vortex is formed. The
centrifugal force of the vortex separates water droplets
and contaminants out of the spiraling vapor. Pure vapor
rises up through the steam separator and out of the port
at the top of the separator. The steam separator has no
baffles or demister, there are no auxiliary surfaces for
condensation to collect and stagnate. Concerns over the
potential for bacterial growth are eliminated.
Preheaters. Each still is equipped with a preheater for
each effect to provide for maximum energy recovery and
 efficiency. As the water flows under pressure from each
effect to the next the pressure of the water is reduced
which will result in “flashing” of the water into steam.
The preheater recovers this energy into the feedwater to
reduce the overall plant steam consumption.
Evaporator. The natural circulation design of the
PyroPure evaporator ensures maximum surface wetting,
eliminating the hot, dry areas that lead to the stress-
cracking associated with other designs. The tube bundle
creates a large heat transfer surface which vaporizes
feedwater on contact. The PyroPure multiple-effect still
has fully drainable external evaporators, eliminating the
need for the excess headroom required for evaporator
removal with other designs. The evaporator on the first
effect of the multiple-effect still is double tube-sheet to
prevent cross-contamination. All other effects have single-
tubesheet evaporators.
Options
Feedwater Pump System. The feedwater pump system
enhances feedwater pressure and is required if feedwater
supply pressure is not equivalent to the plant steam
pressure. When purchased, the feedwater pump system
will be installed on the MES framework.
Pure Steam Option. Multiple-effect stills can be configured
to produce pure steam from the first effect. Simultaneous
WFI and pure steam production is also available.
As the pure steam is condensed in the shell side of the subsequent evaporator, the resulting WFI flows through
feedwater preheating devices and to the WFI condenser for subcooling to the required product temperature. Only
pure steam discharged from the last effect of the still is condensed in the product condenser. The final product as well
as the feedwater supplied to the still is measured for conductivity to ensure compliance with specifications.
Control of the multiple-effect still is accomplished by two control loops. The first control loop monitors the first effect
temperature and manipulates the plant steam control valve as needed to maintain the specified temperature. The second
control loop monitors the product temperature and manipulates a coolant control valve to maintain the specified product
temperature. Level switches in the separation columns provide control for the feedwater supply and provide alarm
capabilities to ensure that all effects are operating correctly. The control and operational simplicity results in a design
that requires no rotating equipment, flow measurement devices or pressure transmitters.
Models are available with 3 to 6 effects to provide the best solution for your application. Additional effects will result
in further reduced utility consumption while a minimum of effects will provide the lowest capital cost solution and
occupy the smallest footprint. All product contact surfaces are polished to 20 Ra maximum and electropolished. Surfaces
in contact with feedwater are polished to 25 Ra maximum. All surfaces in contact with feedwater and product are
manufactured from 316/316L stainless steel.
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CLEAN STEAM GENERATORS 
BMT Clean Steam Generators are designed with the latest 3D paramet-
ric and MRP soware. Our engineering staff has over 15 years experi-
ence in steam generator design and opera'on.  Combined with over 60 
years of custom fabrica'on and our lean manufacturing principles, we 
offer a state-of-the-art solu'on that is unsurpassed in quality and relia-
bility without sacrificing value. 
 
BMT Clean Steam Generators provide clean steam for use with steam 
sterilizers, steam-in-place systems, humidifica'on and any other appli-
ca'ons where clean steam is required.  When fed with Water-for-
Injec'on the unit will produce pyrogen-free, pure steam.  When fed 
with RO/DI feed water the unit will produce clean steam. 
 
• Sanitary feed water systems  
• US FDA cGMP Design & Construcon 
• Industry standard PLC controls 
• High grade Non-proprietary Components 
• All stainless steel skid – no rusng  
• Custom built to specific needs  
 
. . . the total solu'on provider 
 CUSTOM ENGINEERED TO MEET YOUR DEMANDS 
 STEAM OR ELECTRIC HEATED 
STEAM HEATED GENERATORS 
BMT Steam-to-Steam Clean Steam generators u'lize 
plant steam as the hea'ng source to produce clean 
steam.  The tube and shell heat exchanger is made 
from 316L stainless steel and can be built in single-
tube or double-tube construc'on.  The evaporator 
u'lizes a we5ed design that minimizes the tempera-
ture difference between the feed water and the 
hea'ng steam which results in less stress on the evap-
orator tube sheet.     
ELECTRIC HEATED GENERATORS 
BMT Electric Clean Steam Generators are available for 
facili'es that do not have sufficient plant steam to u'lize 
as a hea'ng source.  The generators are equipped with a 
highly corrosion resistant 316L stainless steel  pressure 
vessel for increased reliability and longevity.  Hea'ng ele-
ments are constructed of 316L stainless steel to withstand 
aggressive feed water. Automa'c 'med blow-down en-
sures that impuri'es are carried to drain and not carried 
over in the generated clean steam.   
Control Systems 
Each steam generator is equipped with industrial-grade Allen Bradley or Siemens PLC’s for repeatability and ease of 
use.  When constant steam quality monitoring is desired, the units can be equipped with conduc'vity monitoring 
devices.  Recorders and printers are available to document temperature, pressure, and quality of feed water and 
clean steam for a permanent record. 
 
cGMP Compliance 
 Each steam generator can be constructed in strict compliance with cGMP requirements. Standard features include 
316L stainless steel piping and sanitary components, tri-clamp fi;ngs and orbital welding, extensive instrumenta'on 
and documenta'on. 
 
Feed Water Systems 
 A stainless steel feed water booster pump system can be equipped when the pressure is less than 10 psi greater 
than the desired pure steam pressure.  Sanitary feed water booster pump systems are available when feeding the 
unit with either USP Purified Water or Water-For-Injec'on. 
 
 
BMT USA, LLC 
14532 169th DR. SE, Ste. 142 
Monroe, WA  98272 
P: 360-863-2252  
F: 360-863-2366  
E: sales@bmtus.com  
 www.bmtus.com 
EXAMPLES OF CAPACITIES @ VARIOUS PLANT STEAM PRESSURES                                                                       
(45 psig clean steam pressure)  
MODELS 
100 psig 
lbs\hr 
7 bar    
kg\hr 
80 psig 
lbs\hr 
6 bar   
kg\hr 
65 psig 
lbs\hr 
5 bar   
kg\hr 
Electric Heated 
Models lbs\hr 
CSG 100 100 45   68  31 36   16 100 
CSG 250 250 113 170 77 90 40 250 
CSG 500 500 227 340 154 180 81 500 
CSG 1000 1000 454 680 308 360 163 1000 
CSG 1500 1500 680 1020 462 540 244 1500 
CSG 2000 2000 908 1360 616 720 326 2000 
CSG 3000 3000 1360 2040 925 1080 489 3000 
CSG 4000 4000 1814 2720 1233 1440 653 4000 
CSG 5000 5000 2268 3400 1542 1800 816 5000 
Many other sizes available, contact our offices for details 
 STEAM OR ELECTRIC HEATED 
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The operations described in this SOP
should be performed in the following
sequence:
1. SIP of the hydrophobic filter
assembly, like Millipore’s Aervent®
CTGR 5 inch or 10 inch or LAGR
4 inch devices, used for the venting
of a sterile holding tank (vent filter). 
2. Post-SIP, pre-use integrity testing
of the vent filter.
3. SIP of the hydrophilic sterilizing-
grade filter assembly, like
Millipore’s Durapore® CVGL
10 inch, LAGL 4 inch or MCGL
devices, used for the sterile filtration
of the product (product filter).
4. Post-SIP, pre-use integrity testing
of the product filter.
The recommended post-SIP, pre-use
filter integrity test for hydrophobic vent
The intent of this technical brief is to provide a Standard Operating Procedure
(SOP) for the steam sterilization and integrity testing of a filter assembly typically
used in aseptic processing (see figure 1). Because steam sterilization is the most
common source of damaging a filter, it is recommended to test the integrity of
sterilizing-grade filters after sterilization, before the filtration process.1,2,3
Therefore, the SOP includes both the Steaming-In-Place (SIP) and the post-SIP,
pre-use integrity testing of the vent and product filters.
Millipore Steam
Sterilization & Integrity
Testing Procedures  
Steaming-in-place and
integrity testing of
a sterilizing-grade filter
assembly 
Sterile Filter Assembly: Product Filter,
Sterile Tank and Vent Filter
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filters is the HydroCorr™ test. Unlike
classical testing procedures like
diffusion and bubble point for these
filters, which require alcohol/water
mixtures as a wetting agent, the
HydroCorr™ test requires only clean
water. As this test is performed at the
upstream side of the vent filter and no
downstream manipulation is required, it
is perfectly suited to assess the integrity
of the filter and to demonstrate that the
SIP procedure has been adequately
conducted, without damaging the
vent filter.
The recommended post-SIP, pre-
use filter integrity test for hydrophilic
product filters is the Enhanced Bubble
Point test. 
Integrity testing involves wetting
of the filter with the standard wetting
medium and is a possible source of
breaking sterility of the sterilized
system. From the product filter to
the vent filter on the sterile tank is
a sealed, closed and sterile system.
Water used to wet the filter before
integrity testing cannot be drained
downstream of the closed filter system,
and will remain in the sterile product
tank. Using the product to be filtered
as the wetting agent facilitates pre-
use integrity testing and avoids the
downstream evacuation of the testing
medium since the product can be
directly routed to the holding tank. 
Product bubble point test is perfectly
suited to assess the integrity of the
filter as well as to demonstrate that
the SIP procedure has been adequately
conducted, without damaging the
product filter.
Filter Characteristics
Millipore’s Aervent filters are sterilizing-
grade vent filters that are constructed
with a PTFE membrane. These filters
have been qualified to withstand at
least 40 SIP cycles at 135 °C for
30 minutes in the forward direction,
as well as 40 cycles in the reverse
direction (see the Validation Guide
of the respective filters). 
The maximum differential pressure
allowed during SIP in the forward
direction is 350 mbar. For reverse
SIP, the recommended maximum
differential pressure is 100 mbar
throughout the entire SIP cycle.
Millipore’s Durapore® filters are
sterilizing grade filters that are
constructed with a PVDF membrane.
These filters have been qualified to
withstand 5 to 30 SIP cycles at 135 °C
for 30 minutes in the forward direction
(see the Validation Guide of the
respective filters). The maximum differ-
ential pressure allowed during SIP in
the forward direction is 350 mbar.
Integrity Testing Parameters 
The minimum bubble point speci-
fication for hydrophilic sterilizing-
grade (0.22 µm) Durapore filters
is 3450 mbar, after wetting with
pure water for 5 min. at 200 mbar
differential pressure. 
The minimum product bubble point
is determined by the bubble point
ratio laboratory scale study. The
bubble point ratio (BPR) approach is a
proven method used for determining
minimum bubble point values for non-
specified wetting fluids (see Millipore’s
Application Note No. AN1505EN00).
The recommended pressure
for filling the housing prior to the
HydroCorr test is 1 barg. Table 2
shows the HydroCorr integrity test
criteria for Aervent type of filters.
Specifications
SIP Parameters
Minimum required steam supply pressure: >1.2 barg
Minimum required compressed air supply: > 1.5 barg (300 mbar 
above steam pressure)
Minimum temperature in the coldest points: > 121.1 °C 
Maximum reverse differential pressure across
the filter during SIP: < 100 mbar
Maximum forward differential pressure across
the filter during cooling: < 350 mbar
Minimum sterilization time: 30 min. at 121.1 °C
Cooling time: 30 min. (approximately)
Table 1: Recommended volume for
wetting Durapore filters prior to Bubble
Point testing.
Filter type Wetting volume (L)
Millidisk® 20 5
Millidisk 40 10
Optiseal® 4 inch 10
Durapore 5 inch 18
Durapore 10 inch 35
Type of Aervent Filter Catalogue number Specification
4 inch Optiseal LAGR04TP6 < 0.20 mL/min. @ 2620 mbar
5 inch Cartridge CTGR75S01 < 0.38 mL/min. @ 2620 mbar
10 inch Cartridge CTGR_1TP1 < 0.75 mL/min. @ 2620 mbar
20 inch Cartridge CTGR_2TP1 < 1.50 mL/min. @ 2620 mbar
30 inch Cartridge CTGR_3TP1 < 2.25 mL/min. @ 2620 mbar
Table 2: HydroCorr integrity test criteria for Aervent filters.
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Steam-In-Place Procedure
for a Sterile Tank Equipped
With a Vent Filter
The manual operations that are
described in this SOP should be
performed respecting the given
sequence. For automatic SIP
procedures refer to Millipore’s
Technical Brief No. TB011EN00.
Prior to commencing the procedure,
the following is assumed:
• Tank and adjacent piping is clean
(e.g. by means of CIP) and empty;
• Filter housing is installed and the
correct vent filter is put in place;
• All connections are checked for
proper fitting;
• System has been checked for leak-
tightness by means of a pressure
hold test;
• All valves are closed and silicone
tubing are attached to bleed valves
and directed to a condensate drain;
• Use caution to avoid contact
with steam or hot stainless steel
surfaces;
• Wear protective glasses at all times
and heat resistant protective gloves
when necessary.
Standard Operating Procedure
1. Check that the steam supply and
compressed gas pressures are set
up at the required values.
2. Respectively open V2, V3, V4, V5,
and V1 to introduce steam to the
system and to purge air from the
system. 
3. Partially close bleed valves V2 and
V5 to build tank pressure to at least
0.5 bar and wait for the temper-
ature gauges T1 and T3 to indicate
more than 100 °C.
4. Then, slowly open V6 to introduce
steam to the vent filter. Crack open
bleed valves V7 and V8 to establish
a steady flow of steam and allow
for condensate drainage and air
removal from the filter housing. 
Note: It is of utmost importance to
control the difference between
pressure gauges P1 and P2 and
keep the delta-P over the filter to a
maximum of 100 mbar. For reverse
direction SIP, use an Optiseal filter
or a code 7* filter. Do not use a
code 0** filter. 
5. Ensure all air and condensate are
effectively removed by keeping V2,
V5, V7 and V8 cracked open so
that a 15 cm wisp of steam and
a continuous drip of water can be
seen exiting.
6. When the temperature throughout
the system reaches over 121.1 °C,
as measured by the temperature
gauges T1, T2 and T3, the timer
is started. Sterilization time should
be at least 30 minutes or longer if
validation has decreed so. 
During the sterilization phase both
pressure and temperature should
be recorded regularly.
7. When the required sterilization
time has been achieved, close the
steam supply valve V1 and slowly
open V9 to introduce sterile
compressed gas into the system. 
CAUTION: Make sure that the
system remains under positive
pressure (as indicated by pressure
gauges P1, P2 and P3) and control
that the delta-P over the filter does
not exceed 350 mbar.
8. Allow for steam purge from all
bleed valves and close valves V7
and V8 to increase the flow of
sterile gas through the system.
Maintain the gas flow to cool
down the system until the temper-
ature gauges T1, T2 and T3
indicate approximately 40 °C.
9. Respectively close valves V5,
V2 and V4, and keep V6 and
V9 open to maintain a positive
pressure into the sterile system 
while it is not in use.
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Recommended SIP Process for a Sterile Tank Equipped with a Vent Filter
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Post SIP, Pre-Use Vent Filter Integrity
Test Procedure
1. Close the compressed gas valve
V9, keep V6 open, and open V7
to vent the system. Wait for the
pressure as measured by P1 and
P2 to drop to atmospheric pressure.
2. Fill the pressure vessel with clean
pure water and attach the inlet of
the vessel to a compressed gas
supply at 1 bar. Attach the outlet
tubing of the pressure vessel to V10.
3. Slowly open V10 to have water
entering the filter housing. Ensure
that the filling pressure does not
exceed 1 bar and that air cannot
enter the housing (e.g. empty
pressure vessel). Continue filling
until water is seen exiting the hose
attached to V7.
Note: Should the filter housing 
be installed on top of a rather
tall tank, it may prove useful to
increase the pressure to adjust for
gravity influence while the filling
operation commences.
4. Close V10 and bleed air from
the pressure vessel by slowly
opening the pressure relief valve
on top of the vessel until atmos-
pheric conditions are reached.
5. Close V7, open V12 and attach an
automatic filter integrity tester to V12.
6. Double check that V6 is open and
that V7, V8, V9 and V10 are all fully
closed and run the HydroCorr test.
7. When the test is finished and a
positive result (i.e. pass) is obtained,
close V6 and V12 and detach the
filter integrity tester. 
8. Open V7 and V8 to drain water
from the housing. The draining can
be facilitated by carefully opening
V9 and applying pressure until the
system is empty.
9. Fully open V9 to allow for drying of
the filter over a period of 30 min.
10.Close V7 and V8, open V6
and keep V9 open to build and
maintain a positive pressure into
the system while it is not in use.
Steam-In-Place Procedure
for Product Filter
The manual operations that are
described in this SOP should be
performed respecting the given
sequence. For automatic SIP
procedures refer to Millipore’s
Technical Brief No. TB011EN00.
Prior to commencing the procedure,
the following is assumed:
• Filter housing is installed and the
correct product filter is put in place;
• Product filter is dry;
• All valves are closed and silicone
tubing are attached to bleed valves
and directed to a condensate drain;
• Use caution to avoid contact with
steam or hot stainless steel surfaces;
• Wear protective glasses at all times
and heat resistant protective gloves
when necessary.
Standard Operating Procedure
1. Check that the steam supply and
compressed gas pressures are set
up at the required values.
2. Open MV1 and MV2 and purge
the steam line until complete
absence of condensate.
3. Fully open MV4 and MV5 to allow
for subsequent air and condensate
evacuation.
4. Slowly open MV3 to progressively
introduce steam and heat up the filter. 
5. Partially close bleed valves MV2,
MV4 and MV5 so that a wisp of
steam and a continuous drip of
water can be seen exiting.
6. Respectively open V11 and crack
open bleed valve V5 to establish
a steady flow of steam and allow
for condensate drainage and air
removal from the filter housing. 
Note: It is of utmost importance
to control the difference between
pressure gauges P3 and P4 and
keep the delta-P over the filter to
a maximum of 350 mbar. 
7. Ensure all air and condensate are
effectively removed by keeping
MV2, MV4, MV5, and V5 cracked
open so that a 15 cm wisp of
steam and a continuous drip of
water can be seen exiting.
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8. When the temperature downstream
of the product filter, as measured
by the temperature gauge T3,
reaches over 121.1 °C, the timer
is started. Sterilization time should
be at least 30 minutes or longer,
as established during validation.
During the sterilization phase both
pressure and temperature should be
recorded regularly.
9. At completion of the sterilization
cycle, close the steam supply valve
MV1 and slowly open MV6 to
introduce compressed gas into
the system. 
CAUTION: Make sure that the
system remains under positive
pressure (as indicated by pressure
gauges P3 and P4) and control
that the delta-P over the filter does
not exceed 350 mbar.
10. Allow for steam purge from all
bleed valves and close valves MV2
and MV4 to increase the flow of
gas through the system. Maintain
the gas flow to cool down the
system until the temperature gauge
T3 indicates approximately 30 °C.
11. Respectively close valves V5, V11
and MV5, and keep MV6 and
MV3 open to maintain a positive
pressure into the sterile filter system
while it is not in use.
Post SIP, Pre-Use Filter Integrity Test
Procedure
1. Ensure that V3, V6 and V7 on
the vent filter are open and that
the sterile tank downstream of
the product filter is vented at the
atmospheric pressure.
2. Maintain MV3 open, close the
compressed gas supply valve MV6,
and open MV5 to vent the system.
Wait for the pressure as measured by
P4 to drop to atmospheric pressure.
3. If possible, set the inlet product
pressure at 2.8 bar. Gradually
open MV7 to fill the filter housing
with product and vent the filter
housing from MV5, until all
upstream air has been released. 
4. When product is seen exiting the
hose attached to MV5, close the
vent valve MV5 and continue to
maintain the 2.8 bar pressure for 
at least one minute to dissolve any
residual gas within the filter and
ensure membrane wetting.
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Discover the More in Millipore™
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and solutions that integrate it all. For higher yields, improved process
economics and faster speed to market, discover the more in Millipore.
5. Fully open the downstream valve
V11 and gradually open V4 to set
the differential pressure (P4–P3) at
approximately 200 mbar.
6. Continue to flow product through
the filter to the sterile tank at
appropriate pressure differential
for at least five minutes. 
7. Then close MV7 and MV3 to
isolate the filter and fully open V4.
8. Open MV8 and attach an
automatic filter integrity tester.
9. Double-check that MV8, V11, V4,
V3, V6 and V7 are open and 
that MV3 and MV4 are all fully
closed and run the enhanced
bubble point test.
10. When the test is finished and a
positive result (i.e. pass) is obtained
close MV8 and detach the filter
integrity tester. 
11.Open MV7, MV3 and MV5 to re-
start the filtration of the product. 
12.When product is seen through
MV5, close MV5 and continue
the filtration of the product.
Laboratory Gas Generators
LABGAS 
Pure & Simple 
PAYBACK INLESS THAN1 YEAR
 I 
 
Don’t Buy Gas, Make It!
Generate laboratory gases for 
all of your analytical applications.
Increased flexibility, Improved economy, Greater control
• Performance
Ultra high purity gas generators
will improve your analysis
• Safety
Low pressure, minimal stored gas -
no cylinder handling
• Reliability
Never run out of gas
• Compact design
Free up laboratory floor space
• Cost effective
Quick paybacks, can be less than one year
• GC-FID, NPD, FPD, TCD, ELCD, HALL
• GC-carrier gas
• Total Hydrocarbon Analysers (THA)
Nitrogen
Eliminate high pressure 
cylinders by producing nitrogen 
gas from compressed air 
simply and cost effectively.
• LCMS (single and multiple units)
• ICP
• ELSD
Zero Air
Through the purification of a
compressed air supply Zero Air
Generators are ideal 
for use in FID applications.
Hydrogen
Eliminate high pressure cylinders
from the laboratory by generating 
a continuous source of UHP
hydrogen gas.
• GC-FID, ECD, NPD, AED
• GC-carrier gas
• Solvent evaporation
• GC-FID, NPD, FPD
• THA
Clean Dry Air
Desiccant dryers to provide a constant flow of clean, 
dry compressed air.
• NMR, AA, GC, ATD, 
Rheometer, Sample Prep, 
Auto-Samplers and many 
other applications
CO2 free air
Replace high pressure O2 and N2
cylinders with CO2 moisture free
compressed gas.
• TOC analyser
• FT-IR Purge
• Microscope Purge
All domnick hunter gas generators carry 
a 2 year warranty which can be supported 
by IQ/OQ certification if requested.
An evolutionary development of domnick hunter 
gas generators provide real benefits in the laboratory:
• Compact design
- Can be used anywhere in the laboratory
• Aesthetic and ergonomic design
- Designed to integrate into any laboratory 
and complement scientific instrumentation
• Quiet operation
- No need to worry about disruption 
to your laboratory operations
• Minimal maintenance
- Maximum reliability with low cost
of ownership
- domnick hunter gas generators require 
minimal attention and maintenance. 
Diagnostic capabilities include audible 
and visual indicators.
• Modular construction
- Common design
- Common spares
- Common operator interface
- Easy to operate and maintain
• Global product approvals
- We take care of the approvals process - 
leaving you free to concentrate on the key 
tasks in the laboratory
Diagnostic Indication 
Common Operator Interface 
Applications Guide
Other laboratory applications
Sample Prep Nitrogen for solvent evaporation 95% to 99% up to 130L/min Nitrogen
Autosamplers Air for pneumatic controls Clean and dry 28L/min Clean Dry Air
Nitrogen for sample injector UHP, zero grade 550cc/min Zero Nitrogen
Circular Dichroism Nitrogen UHP, zero grade Zero  Nitrogen
ELSD Detector Nitrogen 98% 2-8 L/min Nitrogen or
Particle sizing Clean and dry air Clean Dry Air
by Laser Diffraction for nebulizing gas Clean and dry air
Products for Spectroscopy
FT-IR Spectrometer Purge gas for sample compartment, Clean dry, CO2 free 14 to 85L/min CO2 free air
optics, air bearing and microscope
NMR Spectrometer Air for lifting spinning and ejecting Clean and dry air up to 300L/min Clean Dry Air
ICP Spectrometer Nitrogen or zero nitrogen for purge gas 99.99 + % up to 9L/min Nitrogen or 
Zero Nitrogen
AA Spectrometer Air for oxidant gas Clean and dry air 28 to 200L/min Clean Dry Air
TOC Dry air or Nitrogen for carrier Clean dry, CO2 free/ 100-500 cc/min CO2 free air/ 
gas or combustion gas hydrocarbon free Zero Air
UHP 50-700 cc/min Zero Nitrogen
THA Zero air for FID Hydrocarbon free 50 to 500 cc/min Zero Air
Hydrogen for fuel gas UHP 5 to 50 cc/min Hydrogen
DSC Air for air shield Clean and dry 100cc/min Clean Dry Air
TGA Nitrogen or dry air as furnace gas Clean and dry air or  100cc/min Clean Dry Air or 
high purity N2 Nitrogen
TOD Nitrogen carrier gas UHP, Zero grade 300cc/min Zero Nitrogen
CO2 analyzer Calibration air Clean dry, CO2 free 550 to 1000cc/min CO2 free air
hydrocarbon free
Products for Analyzers
Products for LCMS Instruments
LCMS API/ LCMS Air for nebulizer gas Clean and dry air, 18L/min Clean Dry Air or
APCI, Electrospray, Nitrogen for curtain and hydrocarbon free 99.5% 5 to 35L/min Zero Air
LCMS/MS, TOF sheath shield gas Nitrogen
GC-FID Hydrogen for fuel gas UHP 30-50 cc/min Hydrogen
Zero air for flame gas Hydrocarbon-free 300-500 cc/min Zero Air
Hydrogen for capillary carrier gas UHP up to 10 cc/min Hydrogen
Nitrogen for packed carrier gas UHP, zero grade 20-50 cc/min Zero Nitrogen
Nitrogen for make-up gas UHP, zero grade 30-50 cc/min Zero Nitrogen
GC-FPD Hydrogen for fuel gas UHP 60-90 cc/min Hydrogen
Zero Air for flame gas Hydrocarbon free 90-120 cc/min Zero Air
GC-NPD Hydrogen for capillary gas UHP up to 50 cc/min Hydrogen
Nitrogen for make up gas UHP, zero grade up to 30 cc/min Zero Nitrogen
GC-ECD Nitrogen for carrier gas UHP, zero grade up to 60 cc/min Zero Nitrogen
Nitrogen for make up gas UHP, zero grade up to 100 cc/min Zero Nitrogen
GC-TCD Hydrogen as carrier gas UHP up to 50 cc/min Hydrogen
GC-ATD Dry air purge Clean and dry air less than 2L/min Clean Dry Air
GC-AED Nitrogen for carrier gas UHP, zero grade less than 1L/min Zero Nitrogen
GC-ELCD,HALL Hydrogen as reaction gas UHP 70 to 200 cc/min Hydrogen
Products for Gas Chromatography
Instrument Gas Requirement Purity Flow Rate GeneratorRecommendation
domnick hunter gas generators
improve your analysis
H2 generator
CO2 removal
Zero Air
Hydrogen Generators
Eliminate high pressure hydrogen cylinders from the laboratory 
by generating a continuous source of UHP hydrogen gas 
for applications such as:
• GC-FID, NPD, FPD, TCD, ELCD, HALL
• GC-carrier gas
• THA
Benefits
Continuous supply of GC quality hydrogen 
gas on demand
Ultra compact design
Improved productivity and chromatography 
results - Hydrogen is a faster carrier gas and 
more sensitive when compared to helium, 
reducing analysis times by 25 to 35% without 
significant loss of resolution
Extended column life - Hydrogen, when used 
as a carrier gas, requires lower elution 
temperatures and thus improves the column 
service life
Safety - Hydrogen production at low pressure 
and only when required, eliminates the risks 
of explosion. Eliminates problems relating to 
handling gas cylinders.
Improved laboratory safety - Through automatic 
leak and low water detection, remote 
start/stop/alarm and elimination of long 
gas lines
Economy - No gas cylinder rental, no price inflation
Increased efficiency in the laboratory - 24 hour 
operation; no interruption of analysis due to 
cylinder changes
No caustic solutions required
Recommended by major instrument 
manufacturers
Technical Features
Self test fault diagnosis with digital display and 
audible alarm: detection of internal and external 
H2 leaks, H2 overpressure, water level, water 
conductivity, display of H2 product flow and total flow
Simplified use and attention by easy access to 
maintenance components (desiccant cartridge and 
de-ionisation cartridge)
Improved independent operation due to its 5 litre 
water tank 
Automatic water filling (optional feature)
Generator protected against the harsh lab 
environment by means of domnick hunter patented 
filters (avoids rapid degradation of the generator 
water quality and thus increases service life)
How the generator works
Water/hydrogen
separator
Water/oxygen
separator
Water
tank
Float
chamber
Pump
Ion exchange
membrane 
Gas drying
membrane
Auto-pressure
regulator
Desiccant
cartridge
Output
solenoid
valve
Hydrogen
output
domnick hunter hydrogen generators use a special ion
exchange membrane to produce a flow of ultra-pure
hydrogen. Use of the electrolytic dissociation process
enables water to be broken down into hydrogen and
oxygen. 
The oxygen is released into the air, while the hydrogen
is retained to form the product flow.
A long-life desiccant cartridge purifies the hydrogen
even further so that it attains the desired grade of
purity and ensures constant reproducible results.
Having proved its worth in thousands of systems
throughout the world, this technology eliminates 
the need to use liquid electrolytes, such as caustic
solutions; since it only uses de-ionised water and
electricity, continuous operation is assured.
342mm
45
6m
m
437mm
Model 20H 40H 60H
H2 Flow rate cc/min 160 250 500
H2 Purity * >99.99999%
H2 Pressure (electronically adjustable) 0-7 bar  (0-100 psi)
De-ionised Water Quality >1 Megohm
Water Capacity  5 Litres
Supply Voltage  90 - 264 Volts (47 - 63 Hz)
Electrical Consumption 100W 170W 240W
Weight (Empty) 24Kg (53 lbs)
Drying Type Desiccant
Ambient Operating Temperature +5 - 40°C (41 - 104°F)
Outlet Connector 1/8" Compression (Swagelok)
Dimensions
Technical Specifications
* When used with palladium purifier
Nitrogen Generators
(Including Zero N2 and dry air)
Produce nitrogen gas from compressed air simply and 
cost effectively. Replace nitrogen gas cylinders for the
following applications:
• LCMS (single and multiple units)
• ICP 
• ELSD
• GC-carrier gas
• GC-FID, NPD, ECD, AED
• Solvent evaporation
Technical Features
Principle: passage of compressed air through a bed 
of carbon molecular sieve (CMS) using presure swing
adsorption technology, the most reliable on the
market
N2 flow: 550 cc/min to 30L/min (for larger
capacities please consult domnick hunter)
O2 purity: 3% to 10 ppm
On-line purity monitoring capability
Digital hours counter 
Audible and visual maintenance indicator
Economy mode option: Enables the
compressor to switch off when nitrogen supply
is not required
Oil-free air compressor available: The quietest
models available
Available with or without built-in air compressor
Quick and easy servicing: less than 10 minutes 
every 6 months
A 25L/min version is also available
Benefits
Designed to meet specific analytical instrument
gas purity and flow requirements
Improved analytical performance - Production 
of a constant flow of gas improves the consistency 
of the analysis results and hence reproducibility
Increased laboratory efficiency with a constant, 
guaranteed supply
Improved safety - No handling high-pressure gas
cylinders or liquid dewars. Nitrogen production 
at controlled low pressures
Simple installation - Only one set up operation
required for reliable service over time. Installation
on or below a laboratory bench top, saving space
in the laboratory
Economy - Quick return on investment - No gas
cylinder rental bottles, no price inflation
Recommended by major instrument
manufacturers 
Combined N2 and Dry Air Generators - In addition
to the stand alone nitrogen, zero N2 and dry air
gas generators, domnick hunter also
manufactures models that provide nitrogen and
dry air from a single unit (models G6 and G7).
Dimensions
Weights
How the generator works
Purge line
Non-return valve
CMS columns
Cooling coil
Air 
intake
Compressed
air filter
Solenoid
exhaust
valves
Oxygen Oxygen
Solenoid
intake 
valves
Nitrogen tank
Nitrogen
flow regulator
Nitrogen
The technology used to produce a continuous flow of high purity
N2 is pressure swing adsorption (PSA).
This technology uses a combination of molecular sieves to
selectively eliminate O2 and other contaminants in the ambient air.
The CMS column(s) alternate between the purification and
regeneration modes to ensure continuous N2 production.
The gas generator is designed to take pre-filtered compressed
air at 7 or 8.5 barg (102 or 123 psi g) (depending on model) 
from the existing laboratory supply or via the integrated oil-free
compressor.
This flow of filtered compressed air then passes through the 
CMS column which is in the purification mode. At this point, 
the O2, CO2, humidity and hydrocarbons are eliminated from 
the compressed air, producing a flow of clean and dry high 
purity nitrogen.
For zero N2 generators, a heated catalyst oxidises additional
hydrocarbons from the N2 gas flow providing zero grade N2 
with a remaining hydrocarbon content of <0.1ppm
Model
Gas Flow
L/min
(up to)
Outlet
Pressure
bar g
Purity
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m
345mm 663mm
84
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m
345mm 413mmModels
G1 / G5 / G6 / 
G8 / G9
Models
G2 - G4 / G7
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1 6 - 0.1
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N2 : 600 cc/min 10 -
Air : 1.5 -55°C adp
N2 : 3 10 -
Air : 3 -55°C adp
0
0 5
5
3 0 1 EG4
Without compressor0
With compressor1
Without Economy Mode0
With Economy Mode**1
230 V / 50 HZE
110 V / 60 HZW
Please Note:
1 All 5 bar (72.5 psi g) delivery generators without compressor require 7 bar (102 psi) air inlet
2 All 7 bar delivery generators without compressor require 8.5 bar (123 psi) air inlet
3 *This unit is only available without compressor
4 **Economy mode only available on models G1-G4
Selected Product CodeG1 52 56
G2 / G4 77 90
G3 71 83
G5 51 55
G6 54 58
G7 80 93
G8 / G9 50 54
Model without compressor (Kg) with compressor (Kg)
Benefits
Improved analytical performance - The reduction
of methane (CH4) to less than 0.1 ppm reduces
background noise and improves the base line
stability. This enables a lower detection limit and
hence increases the sensitivity of your analysis
Simple installation - From any source of clean, 
dry compressed air, this generator will provide 
gas free from any trace of hydrocarbons. 
Improved Safety - Elimination of high pressure 
gas cylinders. Only needs compressed air and 
a standard electrical socket
Consistent gas purity improves instrument 
performance
Economy - Quick return on investment typically 
1 year. No gas cylinder rental, no price inflation
Increased efficiency in the laboratory - 24 hour
operation; no interruption of analyses due to gas
cylinder replacement. Reduced re-calibration of
equipment
Recommended by major instrument 
manufacturers
Dimensions
Zero Air Generators
By simply connecting to a clean, dry compressed air supply, 
a Zero Air Generator will remove hydrocarbons, making it
ideal for use in FID applications:
• GC-FID, NPD, FPD
• THA
Technical Features
Elimination of the main contaminants in your
compressed air, (hydrocarbons including CH4) 
via a heated platinised catalyst
Models:
UHP-10ZA Zero Air Purifier 1L/min
UHP-35ZA Zero Air Purifier 3.5L/min
Larger flowrates (up to 50L/min) on request
G1/4  air connections
Purity < 0.1 ppm (CH4)
Quick and easy servicing : changing the filters
once a year takes just a few minutes
200mm
29
5m
m
22
9m
m
94mm 320mm
Clean dry air
CO2 free air
domnick hunter desiccant dryers are
ideal for laboratory use, providing a
constant flow of clean, dry compressed
air for: 
• NMR, AA, GC, ATD, Rheometer, 
Sample Prep, Auto Samplers 
and many other applications
Benefits
Point of use installation provides dry 
and clean air where you need it
Quiet operation
Compact and lightweight
Can be bench or wall mounted
Quick and easy servicing. Maintenance alarm
activates every 12000 hours of operation
Larger flowrate models available
Replaces high pressure oxygen or
nitrogen gas cylinders with CO2 and
moisture free compressed gas for:
• TOC Analyser
• FT-IR Purge
• Microscope purge
Benefits
Reduced signal to noise ratio improves 
instrument performance
Protects sensitive optics and air bearings 
from moisture
Constant, guaranteed purity supply 
increases laboratory efficiency
Tested and approved by most TOC 
and FT-IR instrument manufacturers
Compact design frees up floor space
DAS 1 70 (2.5) 422 (16.6) 11 (24.2)
DAS 2 115 (4.1) 500 (19.7) 13 (28.7)
DAS 3 182 (6.4) 616 (24.2) 16 (35.3)
DAS 4 227 (8.0) 692 (27.2) 18 (39.7)
DAS 5 295 (10.4) 847 (33.3) 20 (44.1)
DAS 6 340 (12.0) 906 (35.7) 23 (50.7)
DAS 7 453 (16.0) 1098 (43.2) 28 (61.7)
Model
Output 
Air Flow
L/min (cfm)
Dimension A 
mm (ins)
Weight
Kg (lbs)
Max. Working pressure: 12 bar g (175 psi g)
Dewpoint: -40°C (-40°F)
Purity: Non-methane HC’s <0.01 ppm
particles <0.1 micron
oil <0.01mg/m3
A
289 149
Model Output Air FlowL/min
Weight
Kg (lbs)
Dimensions mm (ins)
A B C
C02RP015 1.5 380 (15) 310 (12) 90 (4) 8 (18)
C02RP140 14 470 (18) 310 (12) 90 (4) 10 (22)
C02RP280 28 710 (28) 310 (12) 90 (4) 12 (27)
C02RP850 85 1020 (40) 420 (17) 150 (6) 36 (80)
Max. Working pressure: 10.5 bar g (152 psi g)
C02 Content: <1ppm
Pressure Dewpoint @ 7bar g (100 psi g): -70°C (-100°F)
Purity : Non methane HC’s <0.003 ppm
particles <0.1 micron
A
B
C
Compressed Air
Filters
Laboratory Gas
Generators
Compressed Air
Desiccant Dryers
Sterile Air Filters
Compressed Air
Filter Elements
Compressed Air 
Refrigeration Dryers
Condensate Drains Oil / Water
Separators
Breathing Air Purifiers
Carbon Dioxide Purifiers Liquid FiltersMixed Gas Dispense
Systems
domnick hunter also manufactures:
For further information about these and many other filtration, purification
and separation products please contact domnick hunter or visit our website
at www.domnickhunter.com
dh, domnick hunter, OIL-X and PNEUDRI are registered trademarks of
domnick hunter limited.
a member of the domnick hunter group plc Copyright domnick hunter limited 2003
Publication Reference: LABGAS 01/04 Rev. 002
Stock No. 17 626 0786
domnick hunter limited has a continuous policy of product
development and although the Company reserves the right to change
specifications, it attempts to keep customers informed of any
alterations. This publication is for general information only and
customers are requested to contact our Gas Generation Division Sales
Department for detailed information and advice on a product’s
suitability for specific applications. All products are sold subject to the
Company’s standard conditions of sale.
www.domnickhunter.com
domnick hunter limited
Dukesway, Team Valley Trading Estate, 
Gateshead, Tyne and Wear, 
England  NE11 0PZ
Tel: +44 (0)191 402 9000 
Telefax: +44 (0)191 482 6296
Email: indsales@domnickhunter.com
http://www.domnickhunter.com
Company names, product/service names and logos used in this publication are trademarks and trade names of Shimadzu Corporation and its affi liates. In this publication, those names
and logos may be used without trademark symbol “TM” or “®”.
Third-party trademarks and trade names may be used in this publication to refer to either the entities claiming the marks and names or their products. Shimadzu Corporation disclaims
any proprietary interest in trademarks and trade names other than its own.
For Research Use Only. Not for use in diagnostic procedures. The contents of this publication are subject to change without notice. Shimadzu does not assume any responsibility or liability
for any damage, whether direct or indirect, relating to, or arising out of the use of this publication.
LRQ 4005852/B
Founded in 1875, Shimadzu Corporation, a leader in the
development of advanced technologies, has a
distinguished history of innovation built on the
foundation of contributing to society through science and
technology. We maintain a global network of sales,
service, technical support and applications centers on six
continents, and have established long-term relationships
with a host of highly trained distributors located in over
100 countries. For information about Shimadzu, and to
contact your local offi ce, please visit our Web site at
www.shimadzu.com
Kratos Analytical Ltd.
Wharfside, Trafford Wharf Road, Manchester M17 1GP, UK
Phone: +44 161 888 4400 Fax: +44 161 888 4402
URL http://www.shimadzu.com/an/
Taking MALDI-TOF MS Beyond the Standard
AXIMA ConfidenceTM
MO305
Axima ConfidenceTM - Sensitivity and Flexibility Axima ConfidenceTM - Software solutions
The Axima Confidence™ is designed with 
the general analytical and life science 
laboratory in mind. Incorporating a 
variable repetition rate 50Hz N2 laser, the 
system provides rapid, high quality MALDI 
mass spectra and an array of software 
tools for data processing and reporting.
Linear mode allows the interrogation of high molecular weight 
samples, whilst reflectron mode, incorporating the patented 
curved-field reflectron (CFR), provides the high resolution and 
mass accuracy necessary for successful proteomics and life 
science experiments.
Positive and negative ion modes are included as standard 
allowing greater flexibility and extending the compound 
categories that may be analysed. The system also incorporates 
a patented beam blanker to optionally remove unwanted low 
mass ions and prevent detector saturation.
Excellent sensitivity is achieved using near normal
(on-axis) laser irradiation and advanced ion optics for 
enhanced ion transmission. Pulsed extraction of ions from 
the MALDI source, in combination with the unique reflectron 
design, improves resolution and enhanced calibration 
algorithms with easy to use software facilitate the generation 
of more accurate data.
MS/MS may be easily performed using a seamless approach – 
ions of interest can be isolated using a precursor ion selection 
device, incorporated as standard, and data-rich fragment 
ion spectra quickly and simply acquired. The newly improved 
curved field reflectron design augments the low mass 
fragment region providing useful additional information.
Unparalleled flexibility is achieved by a variety of sample target 
formats including standard microtitre plate format 96 or 384 
well targets. Fleximass™ microscope slide (plain or 48 well 
targets) and a wide variety of adaptors for unconventional 
sample layouts are also available. The standard sample target 
formats are fully compatible with common laboratory robots 
including the CHIP™.
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Intuitive software incorporating data 
dependent workflows for achieving 
maximum results with minimum user 
input, making the system ideal for novice 
and expert users alike.
The Axima Confidence™ is controlled by the Launchpad™ 
suite of software, common to all Axima mass spectrometers, 
permitting manual or fully automated operation facilitating the 
seamless analysis of as few or as many samples as required. 
Intelligent optimization of acquisition conditions may be 
employed allowing auto-tuning for specific samples.
Ideally suited for life science and analytical environments alike, 
the system offers software packages specifically created for:
• Proteomics experiments
 • LC MALDI
  • Polymer analysis
   • Tissue imaging/biomarker discovery
    • Oligonucleotide/primer analysis
Application-centric data processing software packages
are available to provide solutions to many commonly asked 
questions. 
Intellimarque™ for proteomics experiments 
Designed with the flexibility to adapt to user workflows: from 
a handful of samples to high throughput fully automated data 
generation, data-dependent peptide mass fingerprinting and 
MS/MS for protein identification are integrated into easy-to-
use intuitive software.
• Peptide mass fingerprints are acquired and subjected to an 
optional integrated Mascot® database search.
• User definable limits for acceptance of PMF-based
protein identification.
• Data-dependent MS/MS: using the results of the PMF 
search, MS/MS may be performed on ions that matched to 
the top ranked protein hit (confirmation MS/MS), in addition 
to those that were not (investigation MS/MS). 
• Batch searching of these MS/MS spectra is then performed 
automatically to provide further and higher confidence 
protein identification.
• Data may be reprocessed and resubmitted for database 
searching at a later time to provide additional information.
PolymerAnalysis™
Polymers and copolymers can be characterised using our 
unique polymer software, PolymerAnalysis™, providing useful 
structural information and statistics in a text report format.
OliogoAnalysis™
Offers fully automated QC analysis of large numbers of 
oligonucleotides or peptides, complete with a report indicating 
the presence or absence of the target compound, an estimate 
of the purity and occurrence of known contaminants, adducts 
or truncated/extended analogues.
Biomarker discovery/Tissue imaging
This exciting area encompassing clinical sample screening, 
tissue imaging and profiling is comprehensively addressed 
using automated acquisition methods and refined data 
processing. Protein/peptide biomarkers, drugs and their 
metabolites can be rapidly screened directly from tissue 
sections and their location mapped and visualized using 
integrated software tools. Data can also easily be exported 
to alternative processing packages, including BioMap and 
NonLinear Dynamics PG600.
System support
All Axima systems can be fully supported throughout their 
lifetime using sophisticated web based service diagnostics and 
real time remote monitoring. Highly trained specialist local 
service support engineers are available to install and maintain 
Axima mass spectrometers. A wide range of service contracts 
are available, catering for all budgets and requirements, 
including IQ/OQ environments.
Full training courses are offered by MALDI experts at our 
regional corporate training centers or at the customer site and 
may be tailored for specific requirements
and applications.
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Axima Confi denceTM
Glycogen phosphorylase B peptide mass fingerprint
Specifi cation
Sample Handling
• Fully automated sample introduction mechanism
• XY stage (10 µm step, 10 µm repeatability) for microtiter plate 
footprint MALDI target
• 2 mm thick plain, 96 and 384 sample targets
• Accepts thick (10 mm) targets with optional adaptor for a variety of 
biochip designs and alternative formats
• Turbomolecular pump (nominal 250 l/s) for fast SAC pumping with
rotary backing
• Computer software driven target stage for accurate positioning of 
sample under the laser focus
• Raster software for scanning samples for ‘sweet spots’
Sample Viewing System
• Monochrome CCD camera (25x magnification) controlled by 
software embedded in LAUNCHPAD™
Ionization Source
• Matrix assisted laser desorption ionization
• Pulsed Extraction (mass calibrated variable delay) or Continuous 
Extraction, under software control
• Variable ion extraction energy (linear +25 kV/-20 kV, reflectron +20 
kV/-20 kV) under software control
• Positive and negative ion operation, as standard, through
software selection
Laser
• 337 nm nitrogen laser, fixed focus
• 3 ns pulse width
• Nominal energy - 100 µJ per laser shot
• Maximum pulse rate - 50 Hz (50 laser shots per second)
• Near normal (on-axis) incidence of the laser beam to the sample
• Laser power and laser aim under software control
Analyzer
• Linear flight tube of 1.2 m drift length
• Reflectron effective drift length - 2.0 m
• Vacuum maintained by two turbomolecular pumps (nominal 250 l/s) 
with rotary backing
• Unique curved field reflectron system for seamless generation of MS/
MS ions in a single spectrum
• Beam blanking to deflect unwanted strong signals e.g. matrix ions
• Precursor ion gate - pulsed electrostatic deflector
Detector
• Linear mode - electron multiplier (multiple dynode)
• Reflectron mode - fast micro-channel plate
• 2 GHz, 8 bit transient recorder, 16 bit accumulator
• Second transient recorder for simultaneous neutral detection -
125 MHz, 8 bit, 64 kB RAM
Control and Data System*
• Intel core i3 3.3GHz PC with 19” monitor
• 3 GB RAM
• 500 GB hard disc, DVD-RW
• Network adaptor and frame grabber
• Microsoft® Windows® 7 operating system
*Minimum specification subject to continuous improvement
Software
• LAUNCHPAD™ - operates under Microsoft® Windows® 7
• Software for automatic optimization of data generation
• Calculator for determination of theoretical masses of chemicals
• Calculator for determination and manipulation of peptide sequences
• Scanning software for the identification of ‘sweet spots’
• Sample layout editor
• Sample scanning editor
• KOLA™ to access internet and intranet (Mascot® from Matrix Science 
Ltd.) database search engines for protein identification
Technical Data
MO302
AXIMA ConfidenceTM
www.shimadzu.com/an/
Kratos Analytical Ltd is a Shimadzu Group Company.
AXIMA, AXIMA Resonance, LAUNCHPAD, Rapid RF Start-Up, Helium Hypercool,
PolymerAnalysis, OligoAnalysis and PTM Finder are trademarks of Kratos Analytical Ltd, Manchester.
MASCOT is a registered trademark of Matrix Science Ltd, London.
Microsoft, Windows, Windows XP and Vista are registered trademarks of Microsoft Corporation.
Installation Data
Dimensions
• Size (w h d) - 0.7 m x 1.92 m x 0.85 m, minimum distance to wall at back is 100 mm
• Weight - 345 kg excluding data system
Installation Requirements
• Electrical - 200 VAC, 50/60 Hz, 1000 VA single phase OR
 230 VAC, 50/60 Hz, 1000 VA single phase
• A ‘clean’, stable and continuous mains supply is required for reliable operation
• PC - selectable 100-120 VAC, 50/60 Hz, 2.0 A single phase OR
 220-240 VAC, 50/60 Hz, 1.0 A single phase
• Monitor - auto-sensing 100-240 VAC, 50/60 Hz, 1.4-0.6 A
• Temperature - ambient 18° to 26° Celsius
• Relative humidity - less than 70% non condensing
• Vibration free, firm, level floor, at least 345 kg supported at four points
Performance Data
• Mass range linear - 1 to 500 kDa
  reflectron - 1 to 80 kDa
• Mass resolution linear - >5000 FWHM - ACTH 18-39((M+H)+ 2465 Da)
  reflectron - >15,000 FWHM - ACTH 7-38 ((M+H)+ 3660 Da)
  MS/MS - isotopic resolution of fragments - Angiotensin II
• Accuracy linear - <30 ppm with internal calibration
    <200 ppm with external calibration**
  reflectron - <10 ppm with internal calibration
    <100 ppm with external calibration**
  MS/MS - 0.02% of parent
• Ion gate resolution   >200 FWHM @ 1000 Da
• Sensitivity linear - 250 fmol (loaded) - bovine serum albumin
    250 amol - Glu-1-Fibrinopeptide B (loaded)
  reflectron - 500 amol - Glu-1-Fibrinopeptide B (loaded)
  MS/MS - 25 fmol (loaded) - Glu-1-Fibrinopeptide B
**Nearest neighbour external calibration on 384 well sample target, within 30 minutes.
All specifications are run on a standard 2 mm, 384 well, stainless steel sample plate unless 
otherwise stated.
The AXIMA range of instruments is designed and manufactured under the Kratos
Analytical Ltd Quality Management System and is CE compliant.
Installation and initial training will be provided by a team of experienced
engineers and application specialists world-wide. The instrument is covered by a
12 month warranty.
Please contact your local representative for details on full service contracts.
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Section 1
General Information
1.1 Introduction
Criterion is the next generation of dedicated precast gel systems. The innovative, easy-to-use design
produces superior resolution while allowing you to run more samples per gel. Compared to any other precast
gel system, Criterion produces more results while providing significant cost and time savings. Some of the
unique features and benefits provided are:
• 12 month shelf life for Bis-Tris gels
• 8 month shelf life for Tris-acetate gels
• Room temperature storage for Bis-Tris gels
• Easy sample preparation without extra anti-oxidant addition steps
• Patented integral buffer chamber that eliminates buffer leaks
• Up to 26 sample capacity per gel
• Flexibility to run one or two gels
• Multichannel pipet compatible gels
• Outlined and numbered wells that simplify sample loading
• J-foot that improves gel drying and blotting results
US Patents #5,073,246, #5,656,145, #6,093,301 and other patents issued and pending.
1
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1.2 Criterion XT Precast Gels
Criterion XT precast gels are formulated at pH near neutrality to optimize gel matrix stability, significantly
delaying acrylamide hydrolysis, which occurs in traditional Laemmli systems. Specially optimized buffers
result in tight, consistently resolved bands throughout the life of the gel.
This versatile system allows the separation of small to large proteins using just two gel buffer systems:
Criterion XT Bis-Tris precast gels for small to mid-sized proteins and Criterion XT Tris-acetate precast gels for
large proteins.
The Criterion XT Bis-Tris gels are based on a Bis-Tris.HCl buffer system (pH 6.4) that uses discontinuous
chloride and MES or MOPS ion fronts to form moving boundaries to stack and then separate denatured
proteins by size. The chemistry of the XT Bis-Tris gels allows maximum stability and consistent results for a
minimum of one year. Running the same XT Bis-Tris gels with the XT MES denaturing running buffer or the XT
MOPS denaturing running buffer will produce different migration patterns. A combination of these two running
buffers and our three XT Bis-Tris gels can produce up to six different migration patterns in the small and mid-
size range.
The Criterion XT Tris-acetate gels are based on a Tris-acetate buffer system (pH 7.0). It uses discontinuous
acetate and Tricine ion fronts to form moving boundaries to stack and then separate large denatured proteins
by molecular weight. The Criterion XT Tris-acetate gels can also be used to separate proteins by their charge-
to-mass ratio (under native-PAGE conditions). This is possible because the XT Tris-acetate gels are made
without SDS, allowing the sample buffer and running buffer to dictate the separation mechanism. The
nonreducing and nondenaturing environment of native PAGE allows the detection of biological activity and
can improve antibody detection. Native PAGE can also be used to resolve multi-protein bands where
molecular mass separation by SDS-PAGE would reveal only one and for the separation of intact protein
2
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complexes. Separation by native PAGE with XT Tris-acetate gels uses discontinuous acetate and glycine
ion fronts to form moving boundaries to stack and separate proteins by both size and charge.
Protein samples for the Criterion XT precast gel system are prepared in a reducing denaturing sample buffer.
The sample buffer contains XT reducing agent, a pH neutralized and stabilized solution of TCEP as the
reducing agent; heat and SDS are used to denature the proteins. In addition, the use of TCEP in combination
with Bio-Rad’s optimized running buffers maintains proteins in a fully reduced state during the electrophoresis
run, eliminating the need for an anti-oxidant in the upper buffer chamber. Criterion XT Tris-acetate precast
gels can also be used for native PAGE. Proteins are prepared in a nonreducing, nondenaturing sample buffer,
which maintains the proteins’ native structure and charge density.
3
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1.3 Criterion System Specifications
Gel material Polyacrylamide
Gel dimensions (W x L) 13.3 x 8.7 cm
Gel thickness 1.0 mm
Resolving gel height 6.5 cm
Cassette dimensions (W x L) 15.0 x 10.6 cm
Cassette material Styrene copolymer 
Comb material Polycarbonate 
Storage tray material PET 
Upper running buffer volume 60 ml
Lower running buffer volume 800 ml
Storage conditions Bis-Tris gels: Store flat at ambient temperature; DO NOT FREEZE
Tris-acetate gels: Store flat at 4°C; DO NOT FREEZE
Gel shelf life 12 months for Bis-Tris gels; 8 months for Tris-acetate gels
1.4 Criterion XT Comb Configurations
Comb Load Volume Comments
12+2 well 45 µl with two 15 µl reference wells Multichannel pipet compatible
18-well 30 µl 
26-well 15 µl Multichannel pipet compatible
Prep+2 well 800 µl with two 15 µl reference wells
IPG 11 cm ReadyStrip™ IPG strip
IPG+1 well 11 cm ReadyStrip IPG strip with one 15 µl reference well
4
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Section 2
Setup and Basic Operation
2.1 Setting Up and Running Criterion XT Gels
1. Each Criterion XT gel is packaged individually in a plastic storage tray. Remove the cover by gently pulling
the corner tab up and diagonally across the package. Remove the gel from the package.
2. Remove the comb and gently rinse the wells with ddH2O or running buffer.
3.  Remove the tape from the bottom of the cassette by pulling the
tab across the gel.
4. Insert the Criterion XT gel into one of the slots in the Criterion cell
tank. Ensure that each integral buffer chamber faces the center of
the cell. 
5. Fill each integral buffer chamber with 60 ml running buffer.
6. Load samples using a Hamilton syringe or a pipet with gel loading
tips. A sample loading guide can be placed on the outer edge of
the cassette to aid in aligning pipet tips with the wells. This is
especially useful with multichannel pipets.
7.  Fill each half of the lower buffer tank with 400 ml of running buffer
to the marked fill line.
5
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8. Place the lid on the tank, aligning the color-coded banana plugs and jacks. See section 3.6 for power
conditions.
2.2 Opening Criterion XT Cassettes and 
Removing the Gels
1. After electrophoresis is complete, turn off the power supply
and disconnect the electrical leads.
2. Remove the lid from the tank and remove the Criterion XT
gel(s) from the cell. Pour off and discard the upper running
buffer.
3. Invert the cassette and place the integral buffer chamber over
the cassette-opening tool built into the Criterion cell lid.
4. Firmly press down on the cassette to crack the cassette welds
on both sides of the cassette. The cassette will split open
approximately 1/3 of the way.
5. Alternatively, the gel cassette can be opened by sliding the
tapered back of the comb into the slits on either side of the
cassette.
6. Pull the two halves of the cassette apart to completely expose
the gel.
7. Remove the gel by either floating the gel into a fixing or staining
solution or by carefully lifting the gel from the cassette.
6
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Section 3
SDS-PAGE and Native PAGE
3.1 Criterion XT Gel Selection Guide
Criterion XT gels are available in a wide selection of single acrylamide percentages and gradients for the
separation of proteins by SDS-PAGE or native PAGE.
Optimal Separation
Bis-Tris Gels With XT MES Running Buffer With XT MOPS Running Buffer
10% 2.5–200 kD 14–220 kD
12% 1–30 kD 6–66 kD
4–12% 2.5–200 kD 10–300 kD 
Tris-Acetate Gels* With XT Tricine Running Buffer With Tris/Glycine Running Buffer
7% 36–200 kD N/A
3–8% 40–400 kD N/A
*Because Criterion XT Tris-acetate gels are made without SDS, they can be used to separate proteins by both SDS-PAGE and native PAGE.
7
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Bis-Tris gels with
XT MES running buffer:
ideal for 
SMALL proteins
Bis-Tris gels with
XT MOPS running buffer:
ideal for 
MID-SIZE proteins
Tris-acetate gels with
XT Tricine running buffer:
ideal for 
LARGE proteins
Criterion XT Protein Migration Chart
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3.2 Bis-Tris Gel Composition
Gel buffer Bis-Tris.HCl, pH 6.4
Cross linker 5% C
Stacking gel 4% T, 5% C
Storage buffer Bis-Tris.HCl, pH 6.4
Shelf life 12 months; individual expiration date is printed on each cassette; store flat at ambient temperature
3.3 Tris-Acetate Gel Composition
Gel buffer Tris-acetate, pH 7.0
Cross linker 3.8% C
Stacking gel 4% T, 3.8% C
Storage buffer Tris-acetate, pH 7.0
Shelf life 8 months; individual expiration date is printed on each cassette, store flat at 4°C
3.4 Criterion XT Buffers and Reagents
Bis-Tris running buffer 20x XT MOPS (dilute to 1x) or XT MES (dilute to 1x)
for SDS-PAGE For separation of mid-size proteins For separation of small proteins
Catalog #161-0788 Catalog #161-0789
Tris-acetate running buffer 20x XT Tricine (dilute to 1x)
for SDS-PAGE For separation of large proteins
Catalog #161-0790
Tris-acetate running buffer 10x Tris-Glycine (dilute to 1x)
for Native-PAGE Catalog #161-0732
XT sample buffer Catalog #161-0791
XT reducing agent Catalog #161-0792
9
4110130B.qxd  3/25/2003  2:19 PM  Page 9
3.5 Sample Preparation
Determine the appropriate protein concentration of your sample based on the detection method and load
volume used. (See section 4.1 for approximate stain sensitivities.) XT sample buffer is a 4x concentrate and
can be used with both dilute and concentrated samples. Refer to the sample preparation guide below:
Sample Preparation Guide
SDS-PAGE Native-PAGE
25 µl XT sample buffer 50 µl Native sample buffer
5 µl XT reducing agent x µl sample
x µl sample
Make up to 100 µl with ddH20 Make up to 100 µl with ddH2O
Heat sample at 95°C for 5 min. Do not heat sample
3.6 Running Conditions
Bis-Tris Bis-Tris Tris-Acetate Tris-Acetate 
Gel type (for SDS-PAGE) (for SDS-PAGE) (for SDS-PAGE) (for Native-PAGE)
Running buffer XT MOPS XT MES XT Tricine Tris/Glycine
Power conditions 200 V constant 200 V constant 150 V constant 200 V constant
Run time 60 min 45 min 65 min 75 min
Starting current 165–175 mA/gel 185–200 mA/gel 170–180 mA/gel 70–80 mA/gel
Final current 60–70 mA/gel 90–110 mA/gel  85–95 mA/gel 25–35 mA/gel
10
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Section 4
2-D Electrophoresis
4.1 Equilibration
Use existing equilibration protocols as described in the ReadyPrep 2-D Starter Kit (catalog #163-2105 or
bulletin 411009) or existing protocols and buffers used for Tris-HCl gels.
4.2 Agarose Overlay
Make a solution of 0.6% low melt agarose and 0.002% Bromophenol blue. To make 10 ml of the agarose
overlay, mix 9.5 ml of the above agarose with 0.5 ml of 20x XT Running Buffer. Use the XT Running Buffer that
will be used to run the second dimension gel.
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Section 5 
Staining and Detection
5.1 SDS-PAGE and Native PAGE Detection
Total Protein Gel Stain
Method Sensitivity Optimal Protein Load Advantages Disadvantages
Coomassie Blue R-250 36–47 ng ~0.5 µg/band Laboratory standard Requires MeOH
Bio-Safe™ Coomassie 8–28 ng ~0.5 µg/band Nonhazardous, uses More steps than 
stain no MeOH Coomassie R-250
Zinc stain 6–12 ng ~0.2 µg/band High-contrast, fast, Negative stain, must 
reversible stain be photographed;
SDS-PAGE only
Silver Stain Plus™ kit 0.6–1.2 ng ~0.01 µg/band Simple, robust, mass Will not stain
spectrometry compatible glycoproteins
Silver stain 0.6–1.2 ng ~0.01 µg/band Stains complex Not mass
proteins: i.e., glycoproteins spectrometry
and lipoproteins compatible
SYPRO Orange protein 4–8 ng ~0.2 µg/band Will not stain nucleic Optimization required
stain acids; mass for maximum
spectrometry compatible sensitivity
SYPRO Ruby protein 1–10 ng ~0.2 µg/band Broad dynamic range, Requires imaging
gel stain simple robust protocol instrument for
maximum sensitivity
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Total Protein Blot Stain
Method Sensitivity Optimal Protein Load Advantages Disadvantages
SYPRO Ruby protein 2–8 ng ~0.2 µg/band Compatible with mass Multiple-step protocol;
blot stain spectrometry, Edman-based Requires imaging 
sequencing, and standard instrument for 
immunological procedures maximum sensitivity
Colloidal gold stain 1 ng ~0.1 µg/band Sensitive, one step Not compatible with
nylon membranes
Enhanced colloidal 10–100 pg ~0.1 µg/band Increases sensitivity of Multiple steps
gold detection kit colloidal gold stain
Amido Black 100–1,000 ng ~5 µg/band Standard membrane Low sensitivity
stain, economical 
Immunoblot Detection
Method Sensitivity Optimal Protein Load Advantages Disadvantages
4CN colorimetric (HRP)* 500 pg ~0.25 µg/band Fast detection Results may fade
DAB colorimetric (HRP) 500 pg ~0.25 µg/band Fast detection Contains toxic
chemicals
Opti-4CN colorimetric 100 pg ~0.05 µg/band Color does not fade More expensive than
(HRP) 4CN
Amplified Opti-4CN™ 10 pg ~0.005 µg/band High sensitivity, low Amplification requires
colorimetric (HRP) background additional steps
BCIP/NBT colorimetric 100 pg ~0.05 µg/band Sensitive; multiple antigens May detect endogenous 
(AP) enzyme activity
Amplified AP* 10 pg ~0.005 µg/band High sensitivity Amplification requires 
additional steps
Immun-Star™ 10 pg ~0.005 µg/band Long-lasting signal, Requires visualization
chemiluminescent (AP) short and multiple on film or instrumentation
exposures possible
*(HRP) horseradish peroxidase; (AP) alkaline phosphatase
13
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Section 6
Blotting
Criterion XT gels are blotted using the same buffers and protocols used to blot Tris-HCl and other
polyacrylamide gels. Please refer to the Criterion blotter instruction manual (bulletin 4006190) for detailed
instructions on how to blot gels. Tris/Glycine (Towbin) transfer buffer is recommended for western transfer of
the Criterion XT pre-cast gels.
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Section 7
Troubleshooting
Improper storage of Criterion XT gels can produce numerous artifacts. Criterion XT Bis-Tris gels should be
stored flat at ambient temperature. Criterion XT Tris-acetate gels should be stored flat at 4°C. Avoid freezing. If
you suspect your gels have been stored improperly, DO NOT USE THEM.
Problem Possible Cause Solution
Samples do not migrate into gel Tape at the bottom of the cassette Remove tape
not removed
Insufficient buffer in integral buffer chamber Fill integral buffer chamber with 60 ml 
running buffer
Insufficient lower electrode buffer Fill both halves of the lower buffer tank with
400 ml running buffer when running two gels
Electrical disconnection Check electrodes and connections
Bands “smile” across gel, band pattern Excess heating of gel Check buffer composition 
curves upward at both sides of the gel Completely fill both halves of the lower buffer
tank with 400 ml running buffer when running
two gels
Do not exceed recommended running
conditions
Skewed or distorted bands, lateral Excess salt in samples Remove salts from sample by dialysis or
band spreading desalting column prior to sample 
preparation
Insufficient sample buffer Check buffer composition and dilution 
or wrong formulation instructions
15
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Problem Possible Cause Solution
Vertical streaking Samples overloaded Dilute sample
Selectively remove predominant protein in
the sample
Sample precipitation Centrifuge samples to remove
particulates prior to sample loading
Gels run too fast, provide poor resolution, Running buffer is too concentrated Check buffer composition
and gel temperature is too high
Artifact bands at ~60–70 kD Possible skin keratin contamination Wear gloves while cleaning all dishware 
and while handling and loading gel
Filter all solutions through nitrocellulose
Use 10% iodoacetamide to eliminate 
keratin bands
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Section 8 Ordering Information
8.1 Criterion XT Gels
Criterion XT Bis-Tris Gels 12+2 Well 18-Well 26-Well Prep Well IPG+1 Well IPG Well
10% Bis-Tris 345-0111 345-0112 345-0113 345-0114 345-0115 345-0116
12% Bis-Tris 345-0117 345-0118 345-0119 345-0120 345-0121 345-0122
4–12% Bis-Tris 345-0123 345-0124 345-0125 345-0126 345-0127 345-0128
Criterion XT Tris-Acetate Gels 12+2 Well 18-Well 26-Well Prep Well IPG+ 1 Well IPG Well
3–8% Tris-Acetate 345-0129 345-0130 345-0131 345-0132 345-0133 345-0134
7% Tris-Acetate 345-0135 345-0136 345-0137 345-0138 345-0139 345-0140
8.2 Criterion XT Buffers and Kits
Catalog # Description
161-0788 XT MOPS Running Buffer, 20x, 500 ml
161-0789 XT MES Running Buffer, 20x, 500 ml
161-0790 XT Tricine Running Buffer, 20x, 500 ml
161-0791 XT Sample buffer, 4x, 10 ml
161-0792 XT Reducing Agent, 20x, 1 ml
161-0793 XT MOPS Buffer Kit, includes 500 ml 20x XT MOPS running buffer, 10 ml 4x XT sample buffer, 1 ml 20x XT reducing agent 
161-0796 XT MES Buffer Kit, includes 500 ml 20x XT MOPS running buffer, 10 ml 4x XT sample buffer, 1 ml 20 x XT reducing agent 
161-0797 XT Tricine Buffer Kit, includes 500 ml 20x XT MOPS running buffer, 10 ml 4x XT sample buffer, 1 ml 20x XT reducing agent
8.3 Other Related Products
161-0738 Native Sample Buffer, 30 ml
161-0734 10x Tris/Glycine, 1 L
161-0404 Bromophenol Blue, 10 g
161-0311 Certified Low-Melt Agarose, 25 g
163-2107 ReadyPrep 2-D Starter Kit Equilibration Buffer I, with DTT
163-2108 ReadyPrep 2-D Starter Kit Equilibration Buffer II, with DTT
17
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8.4 Criterion Gels
12+2 Well 18-Well  26-Well  Prep+2 Well IPG Well IPG+1 Well
Criterion Tris-HCl Gels 45 µl Samples 30 µl Samples 15 µl Samples 800 µl Samples 11 cm IPG Strip 11 cm IPG Strip
5% Tris-HCl 345-0001 345-0002 345-0003 345-0004 - -
7.5% Tris-HCl 345-0005 345-0006 345-0007 345-0008 - -
10% Tris-HCl 345-0009 345-0010 345-0011 345-0012 345-0013 345-0101
12.5% Tris-HCl 345-0014 345-0015 345-0016 345-0017 345-0018 345-0102
15% Tris-HCl 345-0019 345-0020 345-0021 345-0022 - -
18% Tris-HCl 345-0023 345-0024 345-0025 345-0026 - -
4–15% Tris-HCl 345-0027 345-0028 345-0029 345-0030 345-0031 345-0103
4–20% Tris-HCl 345-0032 345-0033 345-0034 345-0035 345-0036 345-0104
8–16% Tris-HCl 345-0037 345-0038 345-0039 345-0040 345-0041 345-0105
10.5–14% Tris-HCl 345-9949 345-9950 345-9951 345-9952 345-9953 345-0106
10-20% Tris-HCl 345-0042 345-0043 345-0044 345-0045 345-0046 345-0107
12+2 Well 18-Well  26-Well  Prep+2 Well
Criterion TBE Gels 45 µl Samples 30 µl Samples 15 µl Samples 800 µl Samples
5% TBE 345-0047 345-0048 345-0049 345-0050
10% TBE 345-0051 345-0052 345-0053 345-0054
15% TBE 345-0055 345-0056 345-0057 345-0058
4–20% TBE 345-0059 345-0060 345-0061 345-0062
12+2 Well 18-Well  26-Well  Prep+2 Well
Criterion Peptide Gels 45 µl Samples 30 µl Samples 15 µl Samples 800 µl Samples
16.5% Peptide 345-0063 345-0064 345-0065 345-0066
10–20% Peptide 345-0067 345-0068 345-0069 345-0070
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12+2 Well 18-Well  26-Well  Prep+2 Well
Criterion IEF Gels 45 µl Samples 30 µl Samples 15 µl Samples 800 µl Samples
IEF pH 3–10 345-0071 345-0072 345-0073 345-0074
IEF pH 5–8 345-0075 345-0076 345-0077 345-0078
12+2 Well 18-Well  26-Well  Prep+2 Well
Criterion Zymogram Gels 45 µl Samples 30 µl Samples 15 µl Samples 800 µl Samples
10% Zymogram, gelatin 345-0079 345-0080 345-0081 -
12.5% Zymogram, casein 345-0082 345-0083 345-0084 -
12+2 Well 18-Well  26-Well  Prep+2 Well
Criterion TBE-Urea Gels 45 µl Samples 30 µl Samples 15 µl Samples 800 µl Samples
5% TBE-Urea 345-0085 345-0086 345-0087 -
10% TBE-Urea 345-0088 345-0089 345-0090 -
15% TBE-Urea 345-0091 345-0092 345-0093 -
19
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8.5 Criterion Gel Accessories 
345-9920 Criterion Staining/Blotting Trays, 12
345-9901 Criterion Empty Cassettes, 1.0 mm with 12+2 comb, 10
345-9902 Criterion Empty Cassettes, 1.0 mm with 18-well comb, 10
345-9903 Criterion Empty Cassettes, 1.0 mm with 26-well comb, 10
345-9904 Criterion Empty Cassettes, 1.0 mm with prep+2 comb, 10
345-9905 Criterion Empty Cassettes, 1.0 mm with IPG comb, 10
165-6006 Criterion Sample Loading Guide, 12+2 well, 1
165-6007 Criterion Sample Loading Guide, 18-well, 1
165-6008 Criterion Sample Loading Guide, 26-well, 1
8.6 Protein Standards
161-0362 Precision Plus Protein™ Unstained Standards (10–250 kD), 500 µl, 100 applications
161-0373 Precision Plus Protein All Blue Standards (10–250 kD), 500 µl, 100 applications
161-0317 SDS-PAGE Standards, broad range, 200 µl
161-0303 SDS-PAGE Standards, high range, 200 µl
161-0304 SDS-PAGE Standards, low range, 200 µl
161-0324 Kaleidoscope Prestained Standards, broad range, 500 µl
161-0325 Kaleidoscope Polypeptide Standards, 500 µl
161-0326 Polypeptide SDS-PAGE Standards (1.4–26.6 kD), 200 µl, 400 applications
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8.7 Detection Reagents
Total Protein Gel Stains Total Protein Blot Stains
161-0436 Coomassie Blue R-250 Stain Solution, 1 L 170-3127 SYPRO Ruby Protein Blot Stain, 200 ml
161-0438 Coomassie Blue R-250 Destain Solution, 1 L 170-6527 Colloidal Gold Total Protein Stain, 500 ml
161-0400 Coomassie Brilliant Blue R-250, 10 g 170-6517 Enhanced Colloidal Gold Detection Kit
161-0786 Bio-Safe Coomassie Stain, 1 L 161-0402 Amido Black 10B, 25 g
161-0440 Zinc Stain and Destain Kit
161-0449 Silver Stain Plus Kit
161-0443 Bio-Rad Silver Stain Kit
170-3120 SYPRO Orange Protein Stain, 500 µl
170-3125 SYPRO Ruby Protein Gel Stain, 1 L
161-0434 IEF Gel Staining Solution, 1 L
Immunoblot Detection
170-6431 HRP Conjugate Substrate Kit, 4CN
170-6535 HRP Color Development Reagent, DAB
170-8238 Amplified Opti-4CN Kit
170-8235 Opti-4CN Substrate Kit
170-6432 BCIP/NBT AP Conjugate Substrate Kit
170-6412 Amplified Alkaline Phosphatase Kit
170-5012 Immun-Star™ Substrate Pack
170-5040 Immun-Star HRP Substrate, 500 ml
21
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8.8 Blotting Membranes
162-0175 Immun-Blot PVDF Membrane, 10 x 15 cm, 10 sheets
162-0232 0.2 µm Nitrocellulose/Filter Paper Sandwich, 8.5 x 13.5 cm, 20 pack
162-0233 0.2 µm Nitrocellulose/Filter Paper Sandwich, 8.5 x 13.5 cm, 50 pack
162-0234 0.45 µm Nitrocellulose/Filter Paper Sandwich, 8.5 x 13.5 cm, 20 pack
162-0235 0.45 µm Nitrocellulose/Filter Paper Sandwich, 8.5 x 13.5 cm, 50 pack
162-0236 Sequi-Blot™ PVDF/Filter Paper Sandwich, 8.5 x 13.5 cm, 20 pack
162-0237 Sequi-Blot PVDF/Filter Paper Sandwich, 8.5 x 13.5 cm, 50 pack
8.9 Equipment
165-6001 Criterion Cell, includes tank, lid with power cables, three sample loading guides
170-4070 Criterion Blotter With Plate Electrodes
170-4071 Criterion Blotter With Wire Electrodes
Coomassie is a trademark of Imperial Chemical Industries PLC. SYPRO is a trademark of Molecular Probes, Inc. Bio-Rad is licensed to sell
SYPRO products for research use only, under US patent 5,616,502. 
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ELECTROPHORESIS
Criterion™ XT Precast Gels
Get unsurpassed results 
with the Criterion system:
n  Separate up to 26 
samples on one gel
n  Resolve more proteins 
on every gel
n  Never lose track of  
critical gel information
n  Eliminate gel trimming  
with the patented*  
J-foot design 
n  Load gels quickly and  
easily with sample  
loading guides and  
multichannel pipet- 
compatible combs
n  Open cassettes safely 
and easily without a 
separate tool
All the Benefits of the Criterion™ Format  
With an Extended Shelf Life
Criterion XT gels separate more samples with comparable resolution. 
Precision Plus Protein™ standards separated on a Criterion XT 12% Bis-Tris 18-well 
gel with XT MOPS buffer (left) and a competitor’s 12% Bis-Tris 10-well mini gel  
(right). Both gels were stained with Bio-Safe™ Coomassie stain and imaged on a  
Molecular Imager® GS-800™ calibrated densitometer.
* U.S. patent 6,093,301.
Bis-Tris gel with XT MOPS
running buffer for 
midsized proteins
(Criterion XT system)
Bis-Tris gel with XT MES 
running buffer for
small proteins
(Criterion XT system)
Tris-acetate gel with XT Tricine
running buffer for
large proteins
(Criterion XT system)
Tris-HCI gel with 
Tris/glycine buffer
(Laemmli system)
Introduction
The Criterion system is a convenient, high-quality precast gel 
system. Its superior features and numerous benefits are ideally 
suited for use with Criterion XT precast gels, which offer a shelf life 
of 12 months for Bis-Tris gels and 8 months for Tris-acetate gels.
Criterion XT precast gels are formulated at a near-neutral pH, 
significantly delaying acrylamide hydrolysis compared to traditional 
Laemmli systems. Their chemical composition allows maximum 
stability and consistent results for up to one year.
Criterion XT gels are designed to work with optimized sample  
and running buffers without the need for antioxidant addition.  
Like traditional Laemmli systems, Criterion XT gels use 
discontinuous buffer ion fronts that form moving boundaries  
to stack and then separate proteins (see diagram to right).
This high-performance, versatile system allows separation of small 
to large proteins using just two types of gels: Criterion XT Bis-Tris 
gels for small to midsized proteins and Criterion XT Tris-acetate 
gels for large proteins.
© 2007 Bio-Rad Laboratories, Inc. Bulletin 2911
Choice of Separation Mechanism
Bis-Tris Gels
Criterion XT Bis-Tris gels are formulated using a  
Bis-Tris-HCl buffer system (pH 6.4) for separation  
of proteins by molecular weight. By selecting from  
two running buffers, you can expand the separation  
capability of a single Bis-Tris gel type. To further refine 
your resolution range, refer to the migration chart on  
the right for the acrylamide concentration appropriate  
for your proteins of interest.
Tris-Acetate Gels
Criterion XT Tris-acetate gels are formulated using a  
Tris-acetate buffer system (pH 7.0) that separates large 
denatured proteins by molecular weight when run with  
XT Tricine running buffer. These gels are made without 
SDS, so they can also be used with nondenaturing 
sample and running buffers (native PAGE conditions)  
to separate proteins by mass-to-charge ratio. The 
nonreducing, nondenaturing conditions of native PAGE 
preserve biological activity and can improve antibody 
detection. Native PAGE can also resolve multiple protein 
bands where molecular mass separation by SDS-PAGE 
would reveal only one.
For native PAGE on Criterion XT gels, nonreducing, 
nondenaturing native sample buffer and Tris/glycine 
running buffer can be used to maintain protein secondary 
structure and native charge density.
Gel and Buffer Selection Guide 
The banding patterns below indicate the optimal 
separation ranges (in kD) for each acrylamide percentage 
in combination with the buffer system specified.
Recommended Standards
Because of the pH differences between traditional 
Laemmli and Criterion XT buffer systems, some 
prestained protein standards may migrate differently.  
The standards listed below are recommended with 
Criterion XT gels. 
For molecular weight determination:
n Precision Plus Protein unstained standards 
n Unstained SDS-PAGE standards
For molecular weight estimation:
n Precision Plus Protein all blue standards
n Kaleidoscope™ prestained standards
n Prestained SDS-PAGE standards
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Bis-Tris gels 
with XT MES running
buffer — ideal for
small proteins
Bis-Tris gels 
with XT MOPS running
buffer — ideal for
midsized proteins
Tris-acetate gels
with XT Tricine
running buffer — 
ideal for large proteins
The Criterion precast gel system.
Criterion Blotter
The Criterion blotter is highly efficient,  
transferring most proteins in 30–60 min  
using 1.3 L of buffer. The unique gel  
blot assembly tray facilitates setup. 
© 2007 Bio-Rad Laboratories, Inc. Bulletin 2911
Criterion Cell
The Criterion cell runs 1 or 2 Criterion gels.  
Lower buffer chamber holds 720 ml;  
upper buffer chamber/gel cassette  
chamber holds 60 ml.
Criterion™ Dodeca™ Cell 
The Criterion Dodeca cell runs up  
to 12 gels and uses 6 L of buffer.
Greater Resolving Area for 1-D and 2-D Electrophoresis
Compared to traditional mini formats, the Criterion system provides 60%  
more resolving area in the first dimension and 24% more resolving area in  
the second dimension.* Use existing IPG strip equilibration protocols for 
second-dimension analysis on Criterion XT gels.
Converting to Criterion XT Gels
Existing Gel Criterion XT Gel
10–20%, 16.5% peptide/Tricine 10%, 12%, 4–12% Bis-Tris with XT MES buffer
10% Tris-HCl 10% Bis-Tris with XT MOPS buffer
12% Tris-HCl 12% Bis-Tris with XT MOPS buffer
15%, 4–15%, 4–20% Tris-HCl 4–12% Bis-Tris with XT MOPS buffer
5% Tris-HCl 3–8% Tris-acetate with XT Tricine buffer
7.5% Tris-HCl 7% Tris-acetate with XT Tricine buffer
Blotting Criterion XT Gels
Criterion XT gels provide excellent transfer efficiency when blotting  
with standard Tris/glycine and Towbin buffer in the Criterion blotter. For 
instructions and tips on blotting Criterion gels, refer to the Criterion Blotter 
Instruction Manual.
*  Criterion XT gels and buffers are formulated at near-neutral pH, resulting in better protein  
stability (ideal for downstream applications such as mass spectrometry). 
Criterion Gel Cassette
The Criterion gel cassette (15.0 x 10.5 cm)  
with integral buffer chamber runs exclusively  
on Criterion cells. The Criterion gel is 13.3 cm 
wide x 8.5 cm long (1.0 mm thick).
Criterion XT gels yield excellent 2-D electrophoresis results. Mouse liver extract separated on  
an 11 cm ReadyStrip™ IPG strip, pH 3–10, followed by second-dimension separation on a 4–12% 
Criterion XT Bis-Tris gel with Precision Plus Protein standards. The gel was run with XT MES running 
buffer, stained with SYPRO Ruby protein gel stain, and imaged on the Molecular Imager FX™ system.
Improvement of shelf life and gel quality with neutral pH formulation. Left, a typical neutral-pH 
gel at 20 weeks; right, a typical Tris-HCl (Laemmli system) gel at 14 weeks. 
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Catalog # Description 
Criterion XT Buffers and Reagents
161-0788 XT MOPS Running Buffer, 20x, 500 ml
161-0789 XT MES Running Buffer, 20x, 500 ml
161-0790 XT Tricine Running Buffer, 20x, 500 ml
161-0791 XT Sample Buffer, 4x, 10 ml
161-0792 XT Reducing Agent, 20x, 1 ml
161-0793  XT MOPS Buffer Kit, includes 500 ml of 20x XT 
MOPS running buffer, 10 ml of 4x XT sample buffer,  
1 ml of 20x XT reducing agent
161-0796  XT MES Buffer Kit, includes 500 ml of 20x XT MES 
running buffer, 10 ml of 4x XT sample buffer, 1 ml of 20x 
XT reducing agent
161-0797  XT Tricine Buffer Kit, includes 500 ml of 20x XT Tricine 
running buffer, 10 ml of 4x XT sample buffer, 1 ml of 20x 
XT reducing agent
161-0738 1x Native Sample Buffer, 3 ml
161-0734 10x Tris/Glycine, 1 L
Criterion Cell and Systems
165-6001  Criterion Cell, includes electrophoresis buffer tank,  
lid with power cables, 3 sample loading guides  
(12+2 well, 18-well, 26-well), instructions
165-6024  Criterion Cell/Plate Blotter System, includes Criterion 
cell and Criterion blotter with plate electrodes
165-6025  Criterion Cell/Wire Blotter System, includes Criterion 
cell and Criterion blotter with wire electrodes
Criterion Dodeca Cell
165-4130  Criterion Dodeca Cell, includes electrophoresis buffer 
tank with built-in cooling coil, lid with power cables, 
instructions
Catalog # Description
Criterion Accessories
345-9921 Criterion Staining/Blotting Trays, with lids, 2
345-9920 Criterion Staining/Blotting Trays, with lids, 12
Criterion Membrane/Filter Paper Sandwiches
162-0232  Nitrocellulose/Filter Paper Sandwiches, 0.2 µm,  
8.5 x 13.5 cm, 20 pack
162-0234  Nitrocellulose/Filter Paper Sandwiches, 0.45 µm, 8.5 
x 13.5 cm, 20 pack
162-0238  Immun-Blot PVDF/Filter Paper Sandwiches,  
8.5 x 13.5 cm, 20 pack
162-0236  Sequi-Blot PVDF/Filter Paper Sandwiches,  
8.5 x 13.5 cm, 20 pack
Bio-Safe Coomassie Stain
161-0786 Bio-Safe Coomassie Stain, 1 L 
161-0787 Bio-Safe Coomassie Stain, 5 L
Protein Standards
161-0324  Kaleidoscope Prestained Standards, broad range, 500 µl
161-0309 Prestained SDS-PAGE Standards, high range, 500 µl
161-0305 Prestained SDS-PAGE Standards, low range, 500 µl
161-0318  Prestained SDS-PAGE Standards, broad range, 500 µl
161-0363  Precision Plus Protein Unstained Standards, 1 ml, 
100 applications
161-0373  Precision Plus Protein All Blue Standards, 500 µl,  
50 applications
161-0303 SDS-PAGE Standards, high range, 200 µl
161-0304 SDS-PAGE Standards, low range, 200 µl
161-0317 SDS-PAGE Standards, broad range, 200 µl
Ordering Information
Description   12+2 Well*, ** 18-Well  26-Well* Prep+2 Well  IPG+1 Well**
   45 µl  30 µl  15 µl  800 µl  11 cm IPG Strip
Criterion XT Bis-Tris Gels
10% Resolving Gel 345-0111 345-0112 345-0113 — 345-0115
12% Resolving Gel 345-0117 345-0118 345-0119     345-0120*** 345-0121
4–12% Resolving Gel 345-0123 345-0124 345-0125     345-0126*** 345-0127
Criterion XT Tris-Acetate Gels    
7% Resolving Gel  345-0135     345-0136***     345-0137*** — —
3–8% Resolving Gel 345-0129 345-0130 345-0131 —     345-0133***
PREP + 2 WELL 800ul + 15ul
IPG
12 + 2 WELL 45ul + 15ul
18 WELL 30ul
26 WELL 15ul
PREP + 2 WELL 800ul + 15ul
IPG
12 + 2 WELL 45ul + 15ul
18 WELL 30ul
26 WELL 15ul
PREP + 2 WELL 800ul + 15ul
IPG
12 + 2 WELL 45ul + 15ul
18 WELL 30ul
26 WELL 15ul IPG+1PREP + 2 WELL 800ul + 15ul
IPG
12 + 2 WELL 45ul + 15ul
18 WELL 30ul
26 WELL 15ul
Specifications
Gel dimensions   13.3 x 8.7 cm (W x L), 1.0 mm thick
Cassette dimensions 10.6 x 15.0 cm (W x L)
Cassette material Styrene copolymer
Comb material Polycarbonate
Storage tray material PET
Gel storage conditions  Store flat; do not freeze 
Ambient temperature for Bis-Tris gels  
4°C for all other gel types
Gel shelf life  12 months for Bis-Tris gels 
(from date of manufacture)  8 months for Tris-acetate gels 
  12 weeks for Tris-HCl, Tris-Tricine, 
  zymogram, TBE, TBE-urea gels  
  26 weeks for IEF gels
Buffer volume  Upper, 60 ml; lower, 400 ml
* Multichannel pipet compatible.    **  Includes reference well(s).    *** Please allow up to 2 weeks for delivery.
Coomassie is a trademark of BASF Aktiengesellschaft. SYPRO is a trademark of Molecular Probes, Inc. Bio-Rad Laboratories, Inc. is licensed by  
Molecular Probes, Inc. to sell SYPRO products for research use only, under U.S. patent 5,616,502.
Purchase of Criterion XT Bis-Tris gels, XT MOPS running buffer, XT MES running buffer, XT MOPS buffer kit, and XT MES buffer kit is accompanied by a limited 
license under U.S. Patent Numbers 6,143,154; 6,096,182; 6,059,948; 5,578,180; 5,922,185; 6,162,338; and 6,783,651 and corresponding foreign patents. 
Timeless Beauty.
With up to a 12-month shelf life, new Criterion™ XT gels 
give you beautiful results any time.
SDS-PAGE Gel to Criterion XT Gel Conversion Table
If you use … Then go with …
10–20%, 16.5% peptide/ 10%, 12%, 4–12% Bis-Tris gels
Tricine gels with XT MES buffer
10% Tris-HCl gels 10% Bis-Tris gels with XT MOPS buffer
12% Tris-HCl gels 12% Bis-Tris gels with XT MOPS buffer
15%, 4–15%, 4–20% 4–12% Bis-Tris gels with XT MOPS buffer
Tris-HCl gels
5% Tris-HCl gels 3–8% Tris-acetate gels with XT Tricine buffer
7.5% Tris-HCl gels 7% Tris-acetate gels with XT Tricine buffer
Ordering Information
Description 12+2 Well Comb* 18-Well Comb 26-Well Comb* Prep+2 Well Comb IPG+1 Well Comb IPG-Well Comb
45 µl Samples 30 µl Samples 15 µl Samples 800 µl Samples 11 cm IPG Strip 11 cm IPG Strip
Criterion XT Bis-Tris Gels
10% Resolving Gel 345-0111 345-0112 345-0113 345-0114 345-0115 345-0116
12% Resolving Gel 345-0117 345-0118 345-0119 345-0120 345-0121 345-0122
4–12% Resolving Gel 345-0123 345-0124 345-0125 345-0126 345-0127 345-0128
Criterion XT Tris-Acetate Gels
3–8% Resolving Gel 345-0129 345-0130 345-0131 345-0132 345-0133 345-0134
7% Resolving Gel 345-0135 345-0136 345-0137 345-0138 345-0139 345-0140
* Multichannel pipet compatible.
Criterion Cell
165-6001 Criterion Cell, includes tank, lid with power cables, sample loading guides and instructions
Criterion XT Precast Gels
With eXTended shelf life and room temperature storage!
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Criterion XT gels are the highest-quality extended shelf-life gels
available for protein electrophoresis with all the benefits of the
Criterion system, including an integrated upper buffer chamber
for ease-of-use, and gels that run up to 26 samples in an hour.
• Formulated at near-neutral pH to ensure:
– Long shelf life (12 months for Bis-Tris, 8 months for
Tris-acetate)
– Better protein stability — Ideal for downstream applications
such as protein sequencing and mass spectrometry
• Optimized sample and running buffers for sharp bands and
minimal preparation time
• Choose from 3 buffer systems for flexibility in protein
separations (see migration charts at right)
Visit criterion.bio-rad.com to schedule a demo.
Criterion XT Gels Separate More Samples: Demonstrated by Bio-Rad
Precision Plus Protein™ standards separated on a Criterion XT 12% Bis-Tris gel
(left) and the leading competitor’s 12% Bis-Tris gel (right).
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10% 12% 4–12% 10% 12% 4–12% 7% 3–8%
Bis-Tris gels with 
XT MES running buffer:
ideal for small proteins
Bis-Tris gels with 
XT MOPS running 
buffer: ideal for 
mid-size proteins
Tris-acetate gels 
with XT Tricine 
running buffer: ideal
for large proteins
Criterion XT Buffers and Reagents
161-0788 XT MOPS Running Buffer, 20x, 500 ml 
161-0789 XT MES Running Buffer, 20x, 500 ml
161-0790 XT Tricine Running Buffer, 20x, 500 ml
161-0791 XT Sample Buffer, 4x, 10 ml
161-0792 XT Reducing Agent, 1 ml
161-0793 XT MOPS Buffer Kit, includes  500 ml 20x XT MOPS running buffer, 
10 ml 4x sample buffer, 1 ml XT reducing agent
161-0796 XT MES Buffer Kit, includes 500 ml 20x XT MES running buffer, 
10 ml 4x sample buffer, 1 ml XT reducing agent
161-0797 XT Tricine Buffer Kit, includes 500 ml 20x XT Tricine running buffer, 
10 ml 4x sample buffer, 1 ml XT reducing agent
Know more with Acclaro  
Sample Intelligence technology
Save days of troubleshooting experiments when you make 
informed decisions on sample suitability for your application. 
Acclaro technology offers enhanced sample analysis with:
•  Contaminant identification and corrected results
•  Instant feedback about sample quality with on-demand technical 
support and guided troubleshooting
•  Embedded sensor and digital image analysis that ensures 
measurement integrity
Move one step closer to success  
with NanoDrop One
Quantify and qualify DNA, RNA, and protein samples with only 
1–2 µL in seconds with no dilutions using the Thermo Scientific™
NanoDrop™ One microvolume UV-Vis spectrophotometers. Gain a more 
complete understanding of sample quality before using samples in  
downstream applications with Thermo Scientific™ Acclaro™ Sample 
Intelligence technology built into every NanoDrop One instrument.
Acclaro technology detects dsDNA sample contaminated with protein.  
The absorbance contribution from the protein (orange) is subtracted from the original 
result (blue) to obtain the corrected dsDNA concentration (green). 
Pipette.   Measure.   Know.
•  Fast and easy evaluation of nucleic acids and proteins with  
Auto-Measure and pre-programmed applications
•  Modern standalone design with local control and high-resolution 
touchscreen interface saves bench space
•  Accurate measurements up to 27,500 ng/µL (dsDNA) with 
extended auto-range pathlength technology
•  No consumables needed – pipette directly onto the pedestal  
sample-retention system
•  Enhanced connectivity with data transfer via USB, Ethernet, 
Bluetooth® and Wi-Fi options; PC software available for data management
•  Optional cuvette position for measuring dilute solutions and 
performing temperature sensitive experiments
www.thermoscientific.com/nanodrop
©2015 Thermo Fisher Scientific Inc. All rights reserved. Bluetooth is a registered trademark of Bluetooth SIG, Inc. DYMO is a registered trademark of Esselte Corporation.  
LabelWriter is a registered trademark of DYMO Corporation. All other trademarks are the property of Thermo Fisher Scientific and its subsidiaries. Specifications, terms  
and pricing are subject to change. Not all products are available in all countries. Please consult your local sales representative for details. 
For research use only. Not for diagnostic purposes. All NanoDrop instruments are approved to CE and UL/CSA.
FL52746_E 09/15M
Qualify nucleic acid samples
Accurate concentration and purity evaluation of RNA and  
DNA samples is critical to the success of your downstream 
experiments. Choose from a selection of pre-programmed 
applications that include:
•  Direct A260 quantitation; custom factor option
•  A260/A280 purity ratios
•  A260/A230 purity ratios
•  Labeled Nucleic Acids quantitation
•  Oligo Calculator 
Evaluate protein 
samples effectively
Quantify protein samples accurately and 
reproducibly. A selection of pre-programmed 
protein applications guides you to 
high-quality results.
•  Direct A280 quantitation with Protein Editor
•  A205 peptide bond absorbance
•  Quantitation of labeled proteins 
•  Colorimetric protein assays: Bradford, 
BCA, Lowry and Thermo Scientific™ 
Pierce™ 660 nm Protein Assay
View multiple 
samples at 
once on your 
measurement 
screen. Here 
Acclaro has 
flagged dsDNA 
sample #3 for the 
presence of a 
contaminant.
Total protein concentration for 
three samples shown as red 
squares on a BCA assay 
standard curve. 
Four different purified protein 
samples were measured using 
the Protein A280 application.
Ordering Information
Instruments Product Number
NanoDrop One spectrophotometer (Pedestal position only) ND-ONE-W*
NanoDrop OneC spectrophotometer (Pedestal and cuvette positions) ND-ONEC-W*
Accessories and Consumables Product Number
NanoDrop One Productivity kit  
(Contains: 0.2–2.0 µL pipette, screen wipe, USB device, PR-1 kit, and PV-1 solution)
ND-PP1
NanoDrop OneC Productivity kit 
(Contains: 0.2–2.0 µL pipette, screen wipe, USB device, PR-1 kit, PV-1, stir bars, and quartz cuvette)
ND-PP1C
DYMO® LabelWriter® 450 printer with labels PNTR-LW400
PR-1 Reconditioning Compound kit CHEM-PR1-KIT
PV-1 Performance Verification solution CHEM-PV-1
*  Wi-Fi model not available in all countries. Please contact your NanoDrop distributor to confirm the correct  
part number in your region.
Request a trial instrument to evaluate in your  
lab at: www.thermoscientific.com/nanodrop
NanoDrop One. One step closer.
FREE Trial Program
Contact your local NanoDrop representative.
Email nanodrop@thermofisher.com for ordering information and
technical support.
Instruments for microvolume analysis of biomolecules
NanoDrop™ 2000c Spectrophotometer
Full-spectrum microvolume and cuvette measurements in a single instrument
A full-spectrum UV-Vis spectrophotometer offering a complete solution by integrating both  
a patented sample-retention system* for microvolume samples and a cuvette option.  
Dual sampling modes accommodate very low and very high-concentration samples.  
NanoDrop™ 2000 Spectrophotometer 
Full-spectrum microvolume measurements
Provides the same accuracy, full-spectrum analysis, and benefits as the NanoDrop 2000c 
without the added flexibility and sensitivity of the cuvette option.
NanoDrop™ 8000 Spectrophotometer 
Higher throughput, full-spectrum microvolume measurements
Delivers full-spectrum UV-Visible absorbance measurements for up to eight samples at 
one time. Use an eight-channel pipette to dispense samples from tubes or plates onto a 
linear array of pedestals, measure and wipe clean. 
NanoDrop™ Lite Spectrophotometer 
Basic microvolume measurements
A basic microvolume instrument which uses our patented sample-retention system  
to deliver the same exceptional accuracy and reproducibility as other NanoDrop  
instruments. It’s ideal for labs looking for trusted NanoDrop technology, but not  
requiring the full performance of a NanoDrop 2000|2000c or NanoDrop 8000. 
NanoDrop™ 3300 Fluorospectrometer
Full-spectrum microvolume fluorescence measurements
Brings the sensitivity and selectivity of fluorescence spectroscopy to microvolume  
samples. Using our patented sample-retention technology, it performs broad-spectrum 
fluorescence analysis in a versatile, high-performance instrument. 
*Patents US6628382 and US6809826
Revolutionary technology. 
Pipetting 1 µL onto pedestal
Measuring 1 µL sample
Elegant simplicity.
Thermo Scientific NanoDrop Products
Choose the NanoDrop instrument  
   that’s right for you
   UV-Vis   Fluorescence  
  NanoDrop 2000c NanoDrop 2000   NanoDrop 8000 NanoDrop Lite NanoDrop 3300 
Full-Spectral Data  3 3 3	 			 3		
Pre-Programmed Methods for  
Nucleic Acids 3 3 3	 3		 3
Measures Nucleic Acids 
260/280 Ratio  3 3 3	 3		 	
Measures Nucleic Acids 
260/230 Ratio  3 3 3	 			 	
Pre-Programmed Methods  
for Protein 3 3 3	 3			 3			
Measures Purified Protein A280 3 3 3	 3		 	
Pre-Programmed Methods for  
Colorimetric Assays (i.e. BCA)  3 3 3	 			 	
Measures Fluorescently-Labeled 
Samples 3 3 3	 			 3
Custom Methods Editor 3 3 3	 			 3
PC Based 3 3 3	 			 3
Built-in Cuvette Mode 3 	 		 			 	
Qualification Procedures IQ/OQ 3 3 3	 		 	
User Calibration Verification 3 3 3	 3		 	
Realize the difference. 
Try any NanoDrop instrument for FREE.
Our trial program allows you to try any NanoDrop instrument in your lab with your  
own samples, completely free of charge. Once you have used a NanoDrop instrument, 
we are confident you will quickly realize the benefits of our revolutionary technology. 
Visit www.thermoscientific.com/nanodrop to request your free trial instrument or  
contact your local authorized NanoDrop dealer. 
© 2012 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific Inc., and its subsidiaries. Copyrights in and to the cellular images are owned by a third party 
and licensed for limited use only to Thermo Fisher Scientific by iStock.
FREE
TrialOffer!
 NanoDrop 2000c|2000  
 Spectrophotometer
 NanoDrop Lite  
 Spectrophotometer 
NanoDrop 8000  
Spectrophotometer
NanoDrop 3300  
Fluorospectrometer
NEW!
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Step 2
Vortex for 15 minutes.
Step 1
Reconstitute Control Standard Endotoxin (CSE) with LAL 
Reagent Water (LRW) to yield a solution containing 50 EU/
ml or 100 EU/ml depending on assay method being used.
Step 3
Label the tubes with the appropriate endotoxin  
concentration and add 0.9 ml of LRW to each.
Step 8
Pour LAL into a reagent reservoir and mix gently.
Step 9
Use an eight channel pipettor to dispense 100 µl of LAL into 
the appropriate wells of the microplate.
Step 10
Initiate the test by clicking the OK button  
in the WinKQCL™ Software.
Step 7
Immediately prior to use, reconstitute LAL and gently swirl.
Step 5
Dispense 100 µl of the LRW blank,  
endotoxin standards,  
product samples,  
positive controls, etc.  
into the appropriate wells  
of the microplate.
Step 6
Pre-incubate the plate for ≥10 minutes at  
37°C ± 1°C in the microplate reader.
Pharma&Biotech
Traditional Kinetic Limulus Amebocyte Lysate 
(LAL) Assay Procedure Quick Guide
Step 4
Prepare a series of endotoxin standards. 
0.1 ml0.1 ml 0.1 ml 0.1 ml
kinetic chromogenic kinetic turbidimetric
(Example based on a test with an operating standard curve of 0.005–50 EU/ml.)
This is a step by step guide depicting how  
to perform a traditional kinetic LAL assay.  
Prior to initiating the assay procedure,  
allow reagent vials to equilibrate to room  
temperature. The incubating microplate  
reader should also be turned on and a plate 
template created in the WinKQCL™ Software. 
Materials, Equipment & Documents Needed
Reagents
 – Limulus Amebocyte Lysate (LAL) Reagent (Kinetic-QCL™ or PYROGENT™-5000 Reagent)
 – Control Standard Endotoxin (CSE)
 – LAL Reconstitution Buffer (Required for the PYROGENT™-5000 Kinetic Turbidimetric LAL Assay)
 – LAL Reagent Water (LRW) (# W50-640, W50-100, W50-500)
Kits are available in a wide range of sizes and configurations.  
Please contact your local sales representative for additional information.
Accessories
 – Glass dilution tubes (# N207)
 – Individually wrapped serological pipettes (optional)
 – Tips
 – 96-well plates (# 25-340)
 – Reagent reservoirs (# 00190035)
Use pyrogen-free accessories that have been qualified for endotoxin testing. 
Equipment and Software
 – Eight channel pipettor
 – Incubating absorbance microplate reader 
 – WinKQCL™ Software 
 – Pipettors
 – Timer
 – Vortex mixer 
Supporting Documents
 – Certificate of Analysis (CoA), www.lonza.com/coa
 – Limulus Amebocyte Lysate (LAL) Kinetic-QCL™ Package Insert or  
Limulus Amebocyte Lysate (LAL) PYROGENT™-5000 Package Insert
North America
Customer Service: 800 638 8174 (toll free)
order.us@lonza.com
Scientific Support: 800 521 0390 (toll free)
scientific.support@lonza.com
Europe
Customer Service: +32 87 321 611
order.europe@lonza.com
Scientific Support: +32 87 321 611
scientific.support.eu@lonza.com
International
Contact your local Lonza distributor
Customer Service: +1 301 898 7025
Fax: +1 301 845 8291
scientific.support@lonza.com
The information contained herein is believed to be correct 
and corresponds to the latest state of scientific and technical 
knowledge. However, no warranty is made, either expressed 
or implied, regarding its accuracy or the results to be obtained 
from the use of such information. Some products may not be 
available in all markets or for every type of application. Any 
user must make his own determination and satisfy himself 
that the products supplied by Lonza Group Ltd and the informa-
tion and recommendations given by Lonza Group Ltd are (i) 
suitable for intended process or purpose, (ii) in compliance 
with environmental, health and safety regulations, and (iii) 
will not infringe any third party’s intellectual property rights.
© 2013 Lonza Ltd TS-RT-DS013 10/13
www.lonza.com/pharmabiotech
www.lonza.com/kqcl
www.lonza.com/turb 
 Points to Consider
 – Use matched LAL and CSE reagents 
 – Plastic tubes are not recommended for making endotoxin dilutions
 – Follow all suggested endotoxin vortexing times 
 – Use pyrogen-free accessories that have been qualified for endotoxin testing
 – Equilibrate reagents to room temperature before use
 – Do not vortex the LAL
 – Avoid bubbles when plating reagents into the 96-well plate
 – Avoid contaminating samples, standards, LRW and accessories
 – Equipment should be installed, validated and maintained appropriately
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These units are TUV CUE listed as orbital shaking incubators for professional, industrial, or 
educational use where the preparation or testing of materials is done at approximately 
atmospheric pressure and no flammable, volatile, or combustible materials are being 
heated. 
These units have been tested to the following requirements: 
CAN/CSA C22.2 No. 61010-1:2012 
CAN/CSA C22.2 No. 61010-2-010 + R:2009 
UL 61010-1:2004 + R:2005-07 + R:2008-10 
UL 61010A-2-010:2002 
UL 61010-1:2012 
EN 61010-1:2010 
EN 61010-2-010:2003 
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Using the Unit Safely 
Introduction 
Thank you for choosing a SHEL LAB shaking orbital 
incubator. SHEL LAB sets the standard for quality and 
reliability. Your unit is backed by over 30 years of design and 
manufacturing excellence in the scientific, research, and 
medical equipment industries. 
Your unit is a general-purpose incubator designed for 
professional, industrial or educational use where  
x the preparation or testing of materials is done at 
approximately atmospheric pressure, and  
x no flammable, volatile or combustible materials are 
being heated. 
These units are not intended for use at hazardous or 
household locations. 
Before you use the unit, read this entire manual carefully to 
understand how to install, operate, and maintain the unit in a 
safe manner. Your satisfaction with the unit will be 
maximized as you read about its safety and operational 
features. Keep this manual on-hand so it can be used by all 
operators of the unit. Be sure all operators of the unit are 
given appropriate training before you put the unit in service. 
Use the unit only in the way described in this manual. 
Failure to follow the guidelines and instructions in this 
manual may be dangerous and illegal. 
General Safety Considerations 
Your incubator and its recommended accessories have been 
designed and tested to meet strict safety requirements. 
For continued safe operation of your incubator, always follow 
basic safety precautions including: 
x Read this entire manual before using the incubator. 
x Be sure you follow any city, county, or other ordinances 
in your area regarding the use of this unit. 
x Use only approved accessories. Do not modify system 
components. Any alterations or modifications to your 
incubator may be dangerous and will void your 
warranty. 
x Always plug the unit’s power cord into a grounded 
electrical outlet that conforms to national and local 
electrical codes. If the unit is not grounded, parts such 
as knobs and controls may conduct electricity and 
cause serious injury. 
x Do not connect the unit to a power source of 
any other voltage or frequency beyond the 
range stated on the power rating overlay at 
the rear of the unit. 
x Do not modify the power cord provided with 
the unit. If the plug does not fit an outlet, 
have a proper outlet installed by a qualified 
electrician. 
x Avoid damaging the power cord. Do not 
bend it excessively, step on it, place heavy 
objects on it. A damaged cord can easily 
become a shock or fire hazard. Never use a 
power cord after it has become damaged. 
Precautions for Your Unit 
Observe the following additional safety guidelines for 
your unit. 
x Operating Conditions For optimum performance, 
use your incubator at room temperatures between 
18 and 25qC, at no greater than 80% relative 
humidity (at 25qC). If you intend to operate the unit 
in conditions outside of these limits, contact 
customer service. 
x Installing the Unit Installation of the unit can be 
performed by the end user 
x Lifting and Handling The incubator is heavy and 
should be moved by a lifting device, such as pallet 
jack. If you must lift the device by hand, always 
observe the following guidelines: 
o Do not move the incubator while it is plugged 
into the power source. 
o Remove all moving parts, such as shelves 
and trays, before you move the unit. Make 
sure the door is securely shut. 
o Use at least four people to lift the incubator. 
o Lift the unit from its bottom surface only. 
o Do not use doors, handles or knobs to lift or 
stabilize the unit. 
o Keep the unit from tipping. 
x  Servicing Your Unit Only qualified personnel 
should service your unit. Faulty service may be 
dangerous and will invalidate the unit’s warranty.  
Do not operate the unit if any parts are damaged 
or missing. 
x Maintenance Unplug the unit from its power 
source before attempting any maintenance. 
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Meanings of Symbols 
In this manual and on labels attached to the product, graphic 
symbols have the following meanings: 
Symbol Indcation 
 You should consult this manual for a 
description or discussion of a 
control or item 
 Temperature 
 Over Temperature Safety 
qC Degrees Centigrade 
 AC Power 
 Manual Adjustable Components 
 Oscillator 
 Timer 
 Light 
 
Indicates “Unit should be 
recycled” (Not disposed of in land-
fill) 
 
About this Manual 
Throughout this manual, the words WARNING 
and CAUTION have the following meanings: 
WARNING 
A potentially hazardous situation that, if not 
avoided, could result in serious injury or 
death. 
CAUTION 
A potentially hazardous situation that, if not 
avoided, may result in minor or moderate 
injury or damage to the equipment.
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Features of Your Unit 
Product description 
Your shaking orbital incubator provides: 
x Controlled environment For continuous 
growth of biological organisms. 
x Vibration-free operation A unique 
adjustable counterbalance system provides 
vibration-free operation regardless of load. 
x Large chamber A large six cubic foot 
chamber facilitates throughput. Shelves in 
the top provide space for static incubation 
during shaking sessions. 
x Refrigeration The SSI5R and SSI5R-2  
(SI6R SI6R-2) are refrigerated, which 
supports insect cell culture and entomology 
studies. 
x Load Flexibility Our unique counterbalance 
weighting system is adjustable to 
accommodate off-center loads, varying 
capacities and stroke lengths, which in turn 
allows smoother running. 
x Oxygen transfer An adjustable orbit 
provides maximum oxygen transfer and 
offers three circular/stroke sizes, from 
vigorous to gentle, to accommodate different 
types of cells. 
x Sample protection All major functions—
temperature, RPM, and time—have audio 
and visual alarms that immediately alert you 
to deviations from set parameters. 
x Over-temperature protection Provided by a 
safety thermostat that is independent of the 
main temperature controller. Guards your 
samples from inadvertent overheating. 
Key Features 
x A brushless DC motor offers quiet and 
maintenance-free orbital shaking 
motion. 
x A PID microprocessor controller 
provides precise uniformity. 
x The rotation platform is included with 
each unit and is self-centering for easy 
installation. 
x Large LED displays are easy to read. 
x Digital keypad operation allows 
calibration of the main temperature 
controller to a reference thermometer. 
x A fluorescent light allows you to see all 
that's going on. 
x An interior electrical outlet and a one-
inch hermetically sealed, double-paned 
glass viewing window. 
x Unit exteriors are formed of cold-rolled 
steel finished with corrosion resistant 
powder coat paint. 
x Chamber interiors and shelves are 
made of polished stainless steel, which 
provides excellent durability and an 
easy-to-clean surface. 
x An interlock switch stops the shaking 
mechanism if the door is opened. 
x The SSI5R and SSI5R-2 (SI6R SI6R-2) 
refrigerate using a 1/6-horsepower 
motorized compressor that does not use 
CFCs or HCFC’s.
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Receiving Your Unit 
Unpacking and Inspecting 
Your Unit 
Before leaving our factory, all units are packaged 
in high quality shipping materials designed to 
provide protection from transportation related 
damage. 
Once a unit leaves our factory, however, safe 
delivery becomes the responsibility of the carrier 
who is liable for loss or damage to your unit. 
Damage sustained during transit is not covered 
under your unit warranty. 
When you receive your unit, inspect it for 
concealed loss or damage to its interior and 
exterior. Should you find any damage to the unit, 
follow the carrier’s procedure for claiming 
damage or loss. 
Inspection Guidelines 
x Carefully inspect the package for damage. If 
the package is damaged, report the damage 
to the carrier service that delivered the unit. 
x If the carton is not damaged, open the crate 
and remove its contents. Verify that all of the 
following equipment is included with the unit: 
x 1 shelf 5100531 
x 1 sample tray 9750758 
x 4 shelf clips 1250512 
x 6 counter weights (some of which are 
located in the metal pocket at the back 
of the unit) 
x 4 leveling feet 
x Carefully check all packaging before 
discarding. 
Save the unit’s shipping crate until you are sure 
all is well. If you need to return your unit for any 
reason, see “Getting Your Unit Serviced” on page 
20. 
Recording Data Plate 
Information 
Once you have determined the unit is free from 
damage, locate the data plate at the back of the 
unit. 
The data plate indicates your unit’s model 
number and serial number. Record this 
information on the space provided on page 20, 
“Getting Your Unit Serviced” for easy future 
reference.
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Installing the Unit 
Installation Overview 
To install your unit, you need to: 
1. Select a suitable operating location for the 
unit. 
2. Level the unit. 
3. Sterilize the unit. 
4. Install the sample tray. 
5. Plug the unit into a power source. 
Selecting a Location for the 
Unit 
The operating location of your unit has a 
significant impact on your unit’s performance and 
how often it must be cleaned and disinfected. 
Use the following guidelines to select the best 
location for your unit. 
 
CAUTION 
DO NOT MOUNT YOU UNIT TO A 
FLAMMABLE SURFACE. 
x Operating Conditions For optimum 
performance, use your incubator at room 
temperatures between 18 to 25qC (65 to 77 
qF) and at no greater than 80% relative 
humidity (at 25qC). 
If you intend to operate the unit in conditions 
outside of these limits, contact your 
customer service representative. 
x Exposure Avoid exposing the unit to the 
following: 
x Direct sun 
x High air movement, such as air vents, 
heating and cooling ducts, doors and 
other heavy traffic areas. 
x Extreme heat from steam radiators, 
stoves, ovens, autoclaves, or other 
sources of heat. 
x Level Surface The unit must be located on a 
solid, flat and level surface. 
x Space requirements Allow a minimum of 20 
cm (8 in.) between the rear and sides of the 
unit, and any walls or partitions that can 
obstruct free airflow.  Allow enough room so 
that the door can swing open at least 90 
degrees. Do not block access to the 
power cord, circuit breaker or fuses. 
x Cleanliness Good laboratory quality control 
practice is the most efficient and reliable way 
to keep your unit free from contamination. 
If it is important that the interior of your unit 
remain sterile, always pay attention to the 
following guidelines: 
x Keep the air in the laboratory as clean 
as possible. 
x Keep the floor around the unit clean. 
x If the unit must be placed at the floor 
level, use a platform, such as a caster 
platform. This facilitates movement of 
the unit during cleaning and allows for 
easier access to the back of the unit. 
x Minimize the number of times access is 
made to the chamber during normal 
operation.  Each time the door is 
opened, room air is drawn in and can 
lead to contamination of the unit. 
After deciding on the location for your unit, follow 
the installation instructions below. 
Leveling the Unit 
The unit must sit level from side to side and from 
front to back. While the unit does not have to be 
absolutely level, each of the four feet should be in 
firm contact with the surface on which the 
incubator is to be run. 
Install the four leveling feet in the four holes in 
the bottom of the unit. When the feet are 
installed, you can raise or lower a corner of the 
unit by turning its foot clockwise or 
counterclockwise, respectively. 
To level the incubator 
1. Insert a leveling foot into each of the four 
holes at the bottom of the unit. 
2. Adjust the foot at each corner until the unit 
stands level and solid without rocking. 
If you move the incubator to a different location, 
be sure to re-level the incubator at the new 
location. 
Sterilizing Your Unit 
The interior of your incubator was cleaned at the 
factory but is not sterile. For information on 
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sterilizing your unit, see “Disinfecting Your Unit“ 
on page 14. 
Installing Sample Tray 
Your unit comes with a sample tray as standard 
equipment. 
To install the sample tray 
1. Enclose all corners of the shaking mechanism 
within the lips of the sample tray. This can be done 
easily by positioning the front two corners and 
then setting the rest of the tray down. 
2. Shake the tray by its handles to confirm that it is 
firmly in place. 
Plugging the Unit into a 
Power Source 
We recommend that you plug your incubator into a 
circuit separate from other equipment. This prevents 
damage or destruction of the incubator caused by 
overloading or failure of other equipment on the same 
circuit. 
The electrical supply circuit to the incubator must 
conform to all national and local electrical codes. The 
voltage supplied to your unit should not vary more than 
10%. 
WARNING 
For your own safety, do not plug the unit into a power 
source until you have read and understood the safety and 
operational instructions in this manual. 
To connect the unit to a power source 
1. Be sure the plug and the cord are in good 
condition. If the power cord is worn, cut or 
damaged in any way, do not use it. Contact 
customer service for a replacement power cord. 
For information on contacting customer service, 
see page 20. 
2. Plug the service cord firmly into a grounded 
electrical outlet. If the plug does not fit the outlet, 
have a proper outlet installed by a qualified 
electrician. 
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Operating the Unit 
Control Panel Overview 
Before turning the incubator on for the first time, 
take a moment to familiarize yourself with its 
controls and features. Following is an overview of 
the control panel. 
1. Main temperature control 
x Displays current chamber temperature. 
x Controls temperature set point and 
calibration. 
2. Shaker Speed (RPM) Control 
x Displays shaker platform speed. 
x Controls the rotational speed (RPM) of 
the shaker mechanism. 
3. Oscillation timer 
x Permits timed shaking at a preset RPM. 
4. Over Temperature Protection 
x Provides backup protection for the main 
temperature control. 
x Keeps the chamber temperature from 
inadvertently rising above the set point. 
5. Alarms 
x Error status lights and an audible alarm 
immediately alerts you to deviations of 
temperature, RPM, or time. 
6. RPM Switch 
x Activates and deactivates the shaker 
platform. 
7. Light Switch 
x Controls the fluorescent light inside the 
chamber. 
8. Timer Switch 
x Activates and deactivates the timer. 
9. Power Switch 
x Controls all power to the unit. The 
switch is lit by a green light when the 
power is on. 
Getting the Unit Ready for 
Use 
WARNING 
This equipment is NOT intended for 
the processing of Flammable 
materials. 
 
Use the following guidelines to prepare the unit 
for regular use. The guidelines illustrate how to 
use all the features of your incubator. Your 
laboratory protocol will determine your actual use 
of these features. 
1. Turn the unit on. 
See “Turning the Unit On” below on this 
page. 
2. Set the chamber to the desired temperature 
and wait for the chamber temperature to 
stabilize. 
See “Setting the Chamber Temperature” on 
page 11. 
3. Calibrate the main temperature control. 
At any time, use the following features when 
appropriate. 
x Turn the shaking mechanism on and adjust 
the speed of the shaking mechanism. 
See on page 11. 
x Set the Over Temperature Protection (OTP) 
to guard your samples from inadvertent over-
heating. 
See on page 12. 
x To account for the weight of different sample 
loads, you will need to adjust the number of 
counterweights being used. 
See on page 12. 
x To adjust the movement of the shaking 
mechanism from vigorous to gentle, you will 
need to adjust the shaking stroke and 
counterweight position. 
See on page 13. 
Turning the Unit On 
The unit is equipped with an On/OFF switch that 
controls power to the entire unit. The switch is lit 
by a green light when the power is on. 
To turn the unit on 
1. Be sure the unit is plugged in. 
2. Push the Power switch to the On (I) position. 
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3. When you turn the unit on for the first time, 
use a screwdriver or coin to turn the Safety 
Temp knob fully clockwise to its maximum 
position. This deactivates the Over-
Temperature Protection (OTP) feature. For 
more information on the OTP, see on page 
12. 
Setting the Chamber 
Temperature 
You raise or lower the temperature in the 
chamber using the main temperature controller, 
which consists of a digital display and UP and 
DOWN arrow pads marked Set Temp. 
To set the chamber temperature 
x To set temperature, press and release either up or 
down key and display will blink.  Then, press and 
hold either up or down key to scroll up or down for 
set point. 
When you press either the Up or Down arrow key, 
the display starts to blink from bright to dim and 
shows the temperature set point, which is the 
temperature to which the unit will stabilize. 
The incubator accepts the new set point after you 
release the arrow pads for 5 seconds. At that time, 
the display stops blinking and indicates the 
present chamber temperature. 
After setting the chamber temperature, wait at 
least 1 hour for the chamber temperature to 
stabilize to ambient conditions. To achieve 
maximum temperature stability, wait 24 hours 
before you begin using the unit. 
Calibrating the Main 
Temperature Control 
Calibrating your unit ensures that the temperature 
inside the incubator matches the temperature reading 
of a certified reference thermometer. 
We recommend that you calibrate your unit once it has 
been installed in its working environment and the 
chamber temperature has been stable at the set point 
for several hours. 
You should calibrate your unit at or as close to the 
temperature set point as possible. To maximize your 
results, calibrate the unit each time you operate the unit 
at a new temperature. 
Use only a Certified (NIST) temperature-measuring 
device to calibrate your unit. 
To verify that your unit needs calibration 
1. Be sure the temperature within the chamber has 
stabilized at the set point for several hours. 
2. Insert a certified reference thermometer through 
the access porthole. To attain the best calibration, 
place the thermometer as close to the location of 
the samples. Be sure the thermometer is not 
touching any shelving. 
3. Allow the reference thermometer to stabilize until it 
displays a constant value for one hour. 
4. Compare the temperatures displayed by the 
incubator and reference thermometer. 
If they match, you do not need to calibrate your unit for 
that temperature. If they do not match, you need to 
calibrate your unit. 
To calibrate your unit 
1. Simultaneously press and hold the Set Temp Up 
and Down arrow keys. 
After approximately 5 seconds, the temperature reading 
will blink off and on. Release the Up and Down arrow 
key. 
2. While the display is blinking, press the Up or Down 
arrow keys to select the temperature that matches 
your reference thermometer. When you hold an 
arrow key, the display scrolls through the 
temperature settings. 
The incubator accepts the new temperature reading 
after you release the arrow pads for 5 seconds. At that 
time, the display stops blinking. 
3. For best results, re-verify the calibration after 
the unit has remained on for 24 hours and its 
temperature has varied by no more than + 1 
qC. 
Setting the Shaker Speed 
Your unit is equipped with a shaker mechanism that 
provides maximum oxygenation of your samples. 
You control the shaking mechanism using the shaker 
control—which consists of a digital display that shows 
RPM (rotations per minute) in increments of 1 and 
UP/DOWN arrow pads marked Set RPM—and the 
RPM switch. 
To turn the shaking mechanism on 
1. Be sure the door is completely closed. 
2. Push the RPM switch to the On (I) position. 
The shaker mechanism will increase the speed up 
to the current set point, which is the speed at 
which the unit will rotate per minute. Note that the 
shaker motor runs continuously as long the RPM 
switch is On (I). 
To adjust the shaker speed (RPM) 
1. Press either the Up or Down arrow key once. The 
display starts to blink from bright to dim and shows 
the RPM set point. 
2. Press the Up or Down arrow keys to select the 
desired RPM. 
The incubator accepts the new set point after you 
release the arrow pads for 5 seconds. At that time, 
the display stops blinking and indicates the 
present RPM. 
Even if you turn the RPM switch off (O), the 
controller remembers the last RPM value used. 
You can adjust the movement of the shaking 
mechanism. See page 13. 
SHEL LAB SI6/SI6R Shaking Incubator Operational Manual 
12 
Using the Timer 
Using the incubator’s timer, you can run the shaker 
platform at a preset RPM for a preset time. The timer 
can be set at intervals of one (1) minute up to a 
maximum of a 999 (16 hours 39 minutes). 
Upon completion of the timing cycle, the TIMER alarm 
LIGHT will turn ON and an alarm will sound. 
You can interrupt the timer if you need to access the 
shaking platform before the timer completes. 
To start a timed shaking process 
1. Turn the TIMER switch to the ON (I) position. 
2. Press the set timer up or down arrow key once.  
The display starts to blink off and on and shows 
the current set time.  Press the up or down arrow 
to select the desired time. 
Approximately five seconds after you release the Up or 
Down arrow keys, the display stops flashing and the 
timing interval begins. 
To interrupt a timed shaking process 
x Turn the TIMER switch and the RPM switch 
to the OFF (O) position. 
CAUTION 
Wait for the mechanism to come to a complete stop 
before entering the chamber. 
To restart an interrupted timed shaking 
process 
x Turn the RPM and TIMER switch to the ON (I) 
position. 
Setting the Safety 
Temperature Alarm 
You can prevent the chamber temperature from 
inadvertent over-heating by using the unit’s Over-
Temperature Protection (OTP), which consists of: 
x a thermostat independent of the main temperature 
control. 
x a knob, marked Safety Temp, to set the safety 
temperature threshold. The numbered scale 
around the knob is for reference only and does not 
correspond to any temperature points. 
x an alarm, marked Temp, that sounds if the 
temperature exceeds the user-defined 
temperature threshold. 
To set the safety temperature thermostat 
1. For best results, calibrate your unit before you set 
the safety thermostat. 
See “Calibrating the Main Temperature Control” on 
page 11. 
2. Be sure the temperature within the chamber has 
stabilized at the set point for several hours. 
3. Using a screw driver or a small coin, turn the 
Safety Temp knob counterclockwise until the 
Temp alarm light turns on and off, which 
designates that your OTP has been activated.  
The light will cycle on and off as the element is 
trying to energize on and off. 
4. Turn the Safety Temp knob slightly clockwise until 
the Temp alarm light turns off. 
NOTE:  Temp Alarm will only sound off when 
temp overshoot 1°C from setpoint. 
 
The OTP is now set at approximately 1qC above the 
main temperature set point. If, for any reason, the 
chamber temperature rises to the safety thermostat 
setting, the Temp alarm will go off and the heating 
element will not raise the chamber temperature any 
further. 
Adding or Removing 
Counterweights 
To allow the smoothest operation of the shaker, you 
should adjust the number of counterweights used 
based on the weight of the load. 
To add or remove counterweights 
1. Unplug the unit from its power source. When the 
shaker mechanism comes to a complete halt, 
remove the sample tray. 
2. Rotate the counterweight platform until the 
counterweight appears. Remove the wing nuts 
and add or remove counterweights according to 
the total weight of your samples, as shown below. 
Total Sample 
Weight 
Number of 
Counterweights 
Up to 2.3 kg (5 lbs.) 2 
Up to 4.5 kg (10 lbs.) 3 
Up to 6.8 kg (15 lbs.) 4 
Up to 9 kg (20 lbs.) 5 
Up to 11.3 kg (25 lbs.) 6 
3. Replace the wingnuts and sample tray. 
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Adjusting the Shaker 
Movement 
You can adjust the shaker movement to gentle, 
moderate, or vigorous shaking. Which shaking 
movement you use depends on the oxygenation needs 
and cell strength of your samples. 
When you change the stroke of the shaker mechanism, 
you also need to adjust the counterbalance position. 
WARNING 
Always disconnect the unit from its power supply 
before attempting this procedure. Serious injury 
can result if the drive plate operates accidentally. 
To adjust the shaker movement 
1. Unplug the unit from its power source. Remove 
the sample tray. 
2. Rotate the counterweight platform until the stoke 
adjuster is in full view. Remove the wing nut and 
adjust the arm to any of the available options. 
3. Re-add the wing nut. 
 
 
 
 
 
 
 
 
 
 
Oscillation Plate Overview 
 
 
 
 
 
 
 
 
 
 
¾” (1.9 cm) Stroke Setup – Moderate Shaking 
(middle counterweight stud) 
4. Rotate the counterweight platform until the 
counterweights are in full view. Remove the 
wingnuts and adjust the counterweights according 
to the diagrams shown below. 
5. Replace the counterweight wingnuts. 
The following diagrams show the various positions of 
the shaker mechanism and counterweights. The 
dimensions shown are the total stroke of the oscillator. 
For example, ½ designates a pattern that is + ¼ inch 
from center. The indicated parts on the mechanism are: 
1. Drive plate 
2. Counterweight 
3. Pivot nut: Do not adjust. 
4. Stroke adjuster 
5. Counterweight studs: secure using wingnuts. 
6. Stroke adjuster bolt: secure using wingnut. 
Oscillation Plate Overview ½” (1.3 cm) stroke 
setup -- light shaking ¾” (1.9 cm) stroke setup 
-- moderate shaking 1” (2.5 cm) stroke setup -
- vigorous shaking 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
½” (1.3 cm) Stroke Setup – Light Shaking 
(left-hand counterweight stud) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1” 2/5 cm) Stroke Setup – Vigorous Shaking 
(right-hand counterweight stud) 
1 
2 
3 
4 
5 
6 
5 
6 
5 
6 
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Interior Accessory Outlet  
This unit features an accessory outlet to provide power 
for equipment such as magnetic stirrers, rockers, etc. 
The weight of this equipment should not exceed 22 
pounds (10 kg) per shelf.  This equipment may provide 
additional heat that could affect the temperature range 
of this incubator.  We recommend testing the incubator 
and any accessory equipment to ensure that the 
desired operating conditions can be met.  
Caution: This incubator operates at conditions that 
might damage accessory equipment.  
Verify that your accessory equipment is 
capable of operating under the same 
conditions as the incubator. 
The outlet is located inside the incubator in the upper 
right rear of the chamber.  The voltage available at the 
accessory outlet is the SAME as the voltage supplied to 
the incubator.  For example, a 120-vac incubator will 
have 120 vac at the accessory outlet, and a 240-vac 
incubator will have 240 vac at the accessory outlet.  DO 
NOT exceed 500 va rating of the accessory outlet. 
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Maintaining the Unit 
The only regular maintenance required for your unit is 
to keep it clean and free from contamination. Use the 
guidelines and instructions in this section to maximize 
the life of your incubator and help prevent 
contamination of your samples.  
 
WARNING 
Do NOT Use Flammable Cleaning Detergents. 
Do NOT store Flammable materials In, On or Near 
this equipment. 
Disinfecting Your Unit 
Although your operating conditions and related protocol 
should determine the actual decontamination 
procedures you use, always keep the following 
guidelines in mind when decontaminating your unit: 
x Use cleaning materials known to be 
compatible with your unit. If any questions 
arise about compatibility issues, contact 
Customer Service, see page-21. 
x Clean and disinfect the incubator interior on a 
regular basis. If the inside of your incubator 
smells strangely or contains rust, mold, or dirt, 
you need to clean your incubator more 
frequently 
x Dust the outside walls of the incubator at least 
every two months. 
x For incubators placed on the floor, move the 
incubator every two months to clean and 
disinfect the floor below. 
x Clean all gaskets and hinges every month. 
x Do not use chlorine-based bleaches or 
cleaners with abrasives as they will corrode 
and pit the interior of you incubator and any 
other stainless steel surfaces. Use only non-
abrasive cleaners. 
x Do not use spray cleaners that might leak 
through openings and cracks and get on 
electrical parts.  These cleaners may also 
contain solvents that will harm the coatings. 
x Do not use hard tools such as metal wire 
brushes or steel wool. Use only soft tools such 
as plastic brushes. 
x Do not depend on the use of antibiotics to 
maintain completely sterile conditions, as this is 
an inadequate technique for sterilization. 
Instead, use the aseptic techniques described 
in this section to maintain sterile conditions in 
the incubator. 
x You can use an autoclave to decontaminate 
stainless steel parts by following the 
manufacturer’s instructions. 
Otherwise, wash all parts and surfaces with 
soap and water to remove any organic material. 
Disinfect the parts with a 70% alcohol solution. 
Rinse with distilled water and wipe dry with a 
soft cloth. 
A Typical Decontamination 
Procedure 
Following is decontamination procedure that will suit 
most situations. 
WARNING 
Regardless of which decontamination procedure 
you follow, always turn the unit off and disconnect 
the service cord from its power supply. 
Before you reattach the unit to its power supply, be 
sure all cleaners are evaporated and dry. 
To decontaminate the unit 
1. Unplug the unit from its power source. 
2. Remove all interior parts, including shelves and 
shelf clips. 
3. Remove all gaskets and hinges. Clean and 
disinfect all mounting grooves for the door 
gaskets. 
4. Clean and disinfect all rubber or plastic tubing, as 
well as the fan and fan housing. 
5. Clean and disinfect all access ports, shaft holes, 
electrical pass-throughs and any other passages 
into the chamber. 
6. Wash and disinfect all interior surfaces. 
7. Let the chamber dry out fully before replacing the 
removed parts or reattaching the unit to a power 
supply. 
Control Maintenance 
The main temperature controller, over-temperature 
protection thermostat and main temperature probe do 
not require any maintenance. If the unit appears to be 
having trouble maintaining a temperature, see 
“Troubleshooting” on page 15.
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Troubleshooting 
Solving Problems 
Should the proper function of your unit come into 
question, use this section to help you determine what 
the problem is and how to fix it. 
Check if your question is similar to those listed below.  
Then follow the guidelines found in that section: 
x The temperature control inside the unit does not 
appear to be working correctly. What’s wrong? 
x The refrigeration of my SSI5R (SI6R) does not 
appear to be working correctly. What’s wrong? 
 
WARNING 
Replacing fuses with wrong type and value can 
result in serious damage to the equipment and 
property. ONLY Replace fuses with the same type 
and amperage indicated on the replacement fuse 
labels. 
There are no user serviceable components inside 
the unit. Potentially lethal voltages exist. Do not 
attempt to service your unit beyond the procedures 
described here. See “Getting Your Unit Serviced on 
page-21” 
 
Temperature 
The temperature inside the unit is difficult to control.  What’s wrong? 
What is the problem? Possible Causes To solve the problem... 
The temperature indicated by the 
Main Temperature Control is 
higher than my reference 
thermometer. 
x Controller is calibrated too 
high. 
 
1. Calibrate the Main 
Temperature Controller. See 
page 11. 
2. Call customer service. See 
page 21. 
Display reads “HI” or “400+”. x Probe is unplugged 
- Or -
x Wire to the probe is broken.
- Or -
x Probe is plugged in 
backwards.
1. Be sure the temperature 
probe is properly plugged in. 
If this doesn’t solve the 
problem... 
2. Call customer service. See 
page 21 
Chamber temperature spikes over 
the set point. 
x Unit is not calibrated 
properly.
1. Calibrate the Main 
Temperature Controller. See 
page 11. 
The temperature indicated by the 
Main Temperature Control is 
lower than my reference 
thermometer. 
 
x The temperature inside the 
unit has not yet stabilized 
after the door has been 
opened. 
- Or -
x The temperature inside the 
unit has not yet stabilized 
after the unit has been 
turned off or a power failure. 
- Or -
x Controller is calibrated too 
low. 
- Or -
1. Wait for the temperature 
indicated by the Main 
Temperature Controller to 
stabilize. If you have just 
turned the unit on, wait 24 
hours for the incubator to 
stabilize at a warmer 
temperature.  A fluctuation of 
no more than + 0.1 qC is 
normal. 
If this is not the problem... 
2. Recalibrate the Main 
Temperature Controller. See 
page 11. 
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What is the problem? Possible Causes To solve the problem... 
x Over Temperature 
Protection (OTP) is set too 
low. 
- Or -
x Heating element failure. 
 
If this doesn’t solve the 
problem... 
3. Be sure your reference 
thermometer is certified. 
If this is not the problem... 
4. Turn the OTP fully clockwise. 
If this doesn’t solve the 
problem... 
Call customer service. See 
page 21
The Main Temperature Control 
displays “LO”. 
 
x Probe has shorted out. 

Call customer service. See 
page 21 
The unit will not heat up to set 
point. 
x The amperage and voltage 
of the unit’s power source 
do not match the unit’s 
requirements. 
- Or -
x Over Temperature 
Protection (OTP) is set too 
low.
1. Make sure the power source 
matches the data plate. (ie. 
voltage, hz, etc.) 
If this does not solve the 
problem... 
2. Turn the OTP clockwise until 
the heating light or safety 
light turns on. 
 
The unit will not heat at all.  
 
x The OTP is not set high 
enough. 
- Or -
x Temperature Controller 
failure. 
- Or -
x Element failure.
1. For diagnostics purposes, 
turn the OTP fully clockwise. 
See OTP section. 
Call customer service. See 
page 21 
The indicated temperature inside 
the chamber is fluctuating more 
than + 0.1 qC. 
 
x The unit has not had time to 
stabilize to ambient 
conditions. 
- Or -
x Temperature sensor not 
positioned properly. 
- Or -
x The temperature sensor is 
faulty. 
- Or -
x Electrical noise
1. If you have just turned the 
unit on, wait 24 hours for the 
incubator to stabilize at a 
warmer temperature. 
If this is not the problem... 
2. If you have just opened the 
unit’s door, wait for the 
temperature to stabilize. 
If this is not the problem... 
3. Stabilize ambient conditions. 
If this is not the problem... 
4. Call customer service. See 
page 21 
Cannot adjust set points or 
calibration. 
 
x This is a controller failure. 1. Turn entire unit off and then 
on to reset the unit.  This 
may temporarily solve the 
problem, but controller may 
be faulty. 
If this does not solve the 
problem... 
2. Call customer service. See 
page 21 
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What is the problem? Possible Causes To solve the problem... 
Refrigeration (SSI5R models only) (SI6R) 
The unit will not cool. 
 
x The evaperator has too much 
ice built up on it. 
- Or -
x The unit is not calibrated 
correctly. 
- Or -
x There is not enough space 
between the unit and adjacent 
walls or partitions. 
- Or -
x The door seal does not work 
properly. 

1. For diagnostics purposes, turn 
the OTP fully clockwise. See 
OTP section. 
If this does not solve the 
problem... 
2. Recalibrate the Main 
Temperature Controller. See “ “ 
on page . 
If this does not solve the 
problem... 
3. Be sure there is 5 cm (2 in.) of 
space between the rear and 
sides of the unit, and any walls 
or partitions that can obstruct 
free airflow. 
Ice built up in the chamber. 
 
x The door gasket leaks. 
x The door is opened too often. 
x There’s an open container 
letting moisture collect inside 
the chamber. 

1. Check door seal. 
2. Try to limit door opening/closing. 
3. Seal the container. 
Power 
The unit will not turn on. 
 
x Power cord not firmly plugged 
into the outlet. 
- Or -
x The unit or wall fuse/circuit 
breaker has blown. 
- Or -
x The outlet is defective. 
- Or -
x The unit is plugged into a circuit 
that already has too many 
electrical loads.
1. Be sure the voltage and 
frequency specifications of the 
outlet are within the range stated 
on the power rating overlay at 
the rear of the unit. 
If this does not solve the 
problem... 
2. Check the power cord at the 
electrical outlet for proper fit. 
3. Make sure the unit is plugged in 
firmly. 
If this does not solve the 
problem... 
4. Replace fuse/circuit breaker in 
the unit or wall as necessary. 
If this does not solve the 
problem... 
5. Make sure the outlet is in proper 
working condition. 
6. Replace if defective. 
If this does not solve the 
problem... 
7. Check to see what other loads 
are on the same circuit as the 
unit. We recommend that you 
plug your incubator into a circuit 
separate from other equipment. 
8. Call customer service. See page 
21 
The unit fuse/circuit breaker blows 
often. 
x Wrong fuse installed.
x Wire is shorting out.
1. Check fuse for right amperage. 
2. Call customer service. See page 
21 
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What is the problem? Possible Causes To solve the problem... 
The wall fuse/circuit break blows 
often. 
x Too many things may be 
plugged in.
1. Check to see what other loads 
are on the same circuit as the 
unit.  We recommend that you 
plug your incubator into a circuit 
separate from other equipment. 
The front panel displays fail to turn on 
but the rest of the unit receives power. 
x Controller failure 1. Call customer service. See page 
21 
The Main Temperature Controller is 
locked up. 
x Controller failure 1. Turn entire unit off and then on 
to reset the unit.  This may 
correct the problem, but the 
controller may still be faulty. 
2. Call customer service. 
Mechanical 
The door is not sealing. x The door gasket does not 
function properly. 
- Or -
x The door latch bolts are not 
tightened enough. 
- Or -
x The hinges are not adjusted 
properly. 
- Or -
x The door has been twisted. 
- Or -
x The unit has been damaged 
and the body is not square.
1. Check the gasket visually.  Make 
sure it’s secure and smooth and 
free from rolls or tears, which 
would interfere with the 
magnetic seal. 
If this does not solve the 
problem... 
2. Tighten the door latch bolts with 
a screwdriver. 
If this does not solve the 
problem... 
3. To tighten hinges, use wrench to 
adjust and to check if the bolts 
are tight. 
If this does not solve the 
problem... 
4. Call customer service. See page 
21 
The shaker motor squeals 
continuously with a constant pitch. 
Changes in intensity only when rpm 
varies. Stops when the oscillate switch 
is turned off. Sound appears to be 
coming directly from the motor, not the 
mechanism. 
x Motor cable plugs not seated 
properly. 
- Or -
x May have motor bearing 
failure..
1. May need to replace motor.  
Perform a visual inspection on 
motor to decide. 
If this does not solve the 
problem... 
2. Call customer service. See page 
21 
Contamination 
The chamber is contaminated. x Your unit is not cleaned and 
decontaminated often enough. 
- Or -
x If your unit becomes 
contaminated even after you 
follow an appropriate 
maintenance regimen, the 
source of the contamination is 
probably not the incubator.
1. See “Maintaining the Unit” on 
page 14 for recommendations 
and instructions on 
decontaminating your unit. 
If this does not solve the 
problem... 
2. There are many sources of 
contamination, such as water 
baths, hoods, autoclaves, 
reagents, disposables, 
incubators and personnel. If your 
unit becomes contaminated 
even after you follow an 
appropriate maintenance 
regimen, the source of the 
contamination is probably not 
the incubator. 
3. Call customer service. 
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Getting Your Unit Serviced 
 
Getting Assistance 
Your incubator will provide years of trouble-free operation. 
Should you require assistance, however, SHEL LAB’s 
customer service and support is available to assist you. 
If your unit is still covered under warranty, repair or 
replacement will be made at no cost to you according to the 
warranty given at the back of this manual. If the warranty for 
your unit has expired, you can still return the unit for repair. If 
the unit proves to be beyond repair, we will promptly inform 
you of its condition and, if you want, return the unit to you. 
Obtaining Nameplate Information 
Before you contact customer service, obtain the following 
information about your unit from the data plate at the back of 
the unit. Use the spaces below to record the information. 
x________________________________________ 
Model Number 
x________________________________________ 
Serial Number 
 
Returning Your Unit 
If you need to return your unit for any reason, first contact 
your customer representative for return authorization 
number (RA#). Be sure to print the RA# clearly on the 
package in which you ship your unit. 
No return is accepted without: 
xprior authorization by SHEL LABS 
xa clearly visible RA# on the package. 
SHEL LAB Contact Information 
Please allow at least 24 hours from the time that you 
contact our service manager for service to be scheduled. 
Contact Information 
Sheldon Manufacturing Inc. 
P.O. Box 627 
Cornelius, Oregon 97113 
Phone: (503) 640-3000 
Toll free: 1-800-322-4897 
Fax: (503) 640-1366 
Email:tech@Shellab.com 
Internet:http://www.Shellab.com/~Shellab 
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Replacement Parts and Accessories 
Replacement Parts 
 
 
Part 115V 220V 
Adjustable feet 2700500 2700500 
Alarm Display Vertical 1750681 1750681 
Counterweight, Single 5460662 5460662 
Door Gasket 3450562 3450562 
Drive Belt, Oscillator 0500512 0500512 
Element Coil 9570703 9570738 
Flask Clamps, 1 Liter 9530532 9530531 
Flask Clamps, 125ml 9530530 9530530 
Flask Clamps, 250ml 9530531 9530531 
Flask Clamps, 500ml 9530526 9530526 
Fluorescent Lamp 4650528 4650528 
Fuse 120V 3300513 N/A 
Fuse 230V N/A 3300515 
Fuse Holder 3300501 3300501 
Knob, Safety Thermostat 4450506 4450506 
Light Ballast 4660501 4660506 
Light Cover 9510502 9510502 
Light Cover Gasket 3450538 3450538 
Light Holder 4660502 4660502 
 
Part 115V 220V 
Motor, Circulation 4880527 4880528 
Outlet, Interior 4200518 6100531 
Platform (Sample Tray) 9750758 9750758 
Power Cord 1800510 1800500 
Refrigeration Unit, 
SSI5R (SI6R) 7010521 7010543 
Safety Thermostat 1750862 1750862 
Shelf 5100531 5100531 
Shelf Clips 1250512 1250512 
Switch, Door 7850578 7850578 
Switch, RPM, Timer 
Light 7850553 7850553 
Switch, Power 4650554 4650554 
Temp. Display Board 1750677 1750677 
Timer Display Board 1750679 1750679 
Transformer, Speed 
Control 8350508 8350508 
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Specifications 
 SSI5 (SI6) SSI5R (SI6R) 
Temperature 
Unit Range Ambient +8qC to 60 qC 10qC to 60qC  
Uniformity +0.8 qC at 37 qC +0.8 qC at 37 qC 
Accuracy +0.1 qC +0.1 qC 
Alarms Visual Safety Lamps Visual Safety Lamps 
Capacity 
Volume 156 m3 (5.5 cu. ft.) 156 m3 (5.5 cu. ft.) 
Shelves Supplied 2 stainless steel 2 stainless steel 
Shelf Dimensions 47 × 47 cm (18.5 × 18.5 in.) 47 × 47 cm (18.5 × 18.5 in.) 
Total Shelf Capacity 10 kg (22 lbs) 10 kg (22 lbs) 
Dimensions 
Interior 
(Width × Depth × Height) 
48.3 × 48.9 × 59.7 cm 
(19 × 19.25 × 23.5 in.) 
48.3 × 48.9 × 59.7 cm 
(19 × 19.25 × 23.5 in.) 
Exterior 
(Width × Depth × Height) 
72.4 × 73.6 × 106.7 cm 
(28.5 × 29 × 42 in.) 
72.4 × 73.6 × 106.7 cm 
(28.5 × 29 × 42 in.) 
Shaking Mechanism 
Motor Brushless DC Brushless DC 
Speed, Sample 30 to 400rpm, +4 rpm 
(1 rpm increments) 
30 to 400rpm, +4 rpm 
(1 rpm increments) 
Controller Microprocessor/Digital LED Microprocessor/Digital LED 
Stroke Length 1.3, 1.9, 2.54 cm 
(0.5, 0.75, 1.0 in.) 
1.3, 1.9, 2.54 cm 
(0.5, 0.75, 1.0 in.) 
Orbit Diameter 12 mm, 19 mm or 25 mm 12 mm, 19 mm or 25 mm 
Shaking Capacity 
(stroke-limited) 
10 kg (22 lbs.) 10 kg (22 lbs.) 
Door Switch Yes Yes 
Platform Dimensions 44 × 44 x 1.9 cm 
(17.25 × 17.25 x .75 in.) 
44 × 44 x 1.9 cm 
(17.25 × 17.25 x .75 in.) 
Refrigeration 
Compressor Type NA 1/6 HP 
Refrigerant NA R-134A (6.5 oz.) 
Electrical 
Watts / Amps       110 – 120V~ 850 watts / 8.5A 1100 watts / 11.5A 
Watts / Amps       208 – 240V~ 850 watts / 5.5A 1100 watts / 6.5A 
Cycle / Phase 50/60 Hz / Single Phase 50/60 Hz / Single Phase 
Certifications CE (220V only) CE (220V only) 
Weight 
Net Weight 90 kg (198 lbs.) 114 kg (250 lbs.) 
Shipping Weight 118 kg (260 lbs.) 136 kg (300 lbs.) 
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WIRE DIAGRAMS 
SSI5 (SI6) 110V 
(9851457) 
1 2
4
OTL 1750862
FAN
CHAMBER FAN
4880569
2800502
EMI FILTER
POWER SWITCH 7850533
INLET 
4200505
MAIN 
CONTROL 
BOARD
1750786
MOTOR
MOTOR N
LOAD HOT
EARTH
H
E
A
TE
R
V
A
LV
E
RED BROWN ORANGE
MOTOR
HALLS
J11
J10
J16
J9
J12
J8
TEMP DISPLAY
1750791
RPM DISPLAY
1750788
TIMER DISPLAY
1750679
ALARM BOARD
1750681
DOOR SWITCH
7850578
RPM SWITCH
7850553
FERRITE BEAD
7830500
TEMPERATURE
SENSOR
BODINE
MOTOR
4880514
BODINE
MOTOR 
CABLE
0860503
RPMOTP TIMER
LIGHT BALLEST 
4660501 FLUORECENT LAMP
4660528 LAMP
HOLDERS
4660502
LIGHT SWITCH
7850553
ORANGE
BROWN
BROWN
BROWN
B
R
O
W
N
BROWN
BROWN
YELLOW
YELLOW
BLUE
BLUE
BLUE
BLUE
RED
RED
ORANGE
O
R
A
N
G
E
RED
OUTLET 
4200518
17.1Ω  800W
BLACK/WHITE
BLACK
BLACK/VIOLET
BLACK/YELLOW
120V / 240V TO 90V
STEP DOWN 
TRANFORMER
8350509
TIMER 
SWITCH
7850553
POWER INDICATOR
4650554BROWN BLUE
BROWN BLUE
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SSI5-2 (SI6-2) 220V 
(9851458) 
1 2
4
OTL 1750862
FAN
CHAMBER FAN
4880570
2800502
EMI FILTER
B
LA
C
K/
W
H
IT
EBLACK
B
LA
C
K
/V
IO
LE
T
BLACK/YELLOW
120V / 240V TO 90V
STEP DOWN 
TRANFORMER
8350509
POWER SWITCH 7850533
INLET 
4200505
MAIN 
CONTROL 
BOARD
1750786
MOTOR
MOTOR N
LOAD HOT
EARTH
H
E
A
TE
R
V
A
LV
E
RED BROWN ORANGE
MOTOR
HALLS
J11
J10
J16
J9
J12
J8
TEMP DISPLAY
1750791
RPM DISPLAY
1750788
TIMER DISPLAY
1750679
ALARM BOARD
1750681
DOOR SWITCH
7850578
RPM SWITCH
7850553
TIMER 
SWITCH
7850553
FERRITE BEAD
7830500
TEMPERATURE
SENSOR
BODINE
MOTOR
4880514
BODINE
MOTOR 
CABLE
0860503
RPMOTP TIMER
LIGHT BALLEST 
4660506 FLUORECENT LAMP
4660528 LAMP
HOLDERS
4660502
LIGHT SWITCH
7850553
ORANGE
BROWN
BROWN
BROWN
B
R
O
W
N
BROWN
BROWN
YELLOW
YELLOW
BLUE
BLUE
BLUE
BLUE
BLUE
RED
RED
ORANGE
O
R
A
N
G
E
RED
OUTLET 
6100532
68.4Ω  750W
POWER INDICATOR
4650554BROWN BLUE
BROWN
BLUE
 
 
SHEL LAB SI6/SI6R Shaking Incubator Operational Manual 
 
25 
Copyright © 2002 Sheldon Manufacturing. All rights reserved. 
All specifications and features for this product are subject to change without notice. 
SSI5R (SI6R) 110V 
(9851459) 
1 2
4
OTL 1750862
FAN
CHAMBER FAN
4880569
2800502
EMI FILTER
COMPRESSOR
1 2
4
POWER SWITCH 7850533
INLET 
4200505
MAIN 
CONTROL 
BOARD
1750786
MOTOR
MOTOR N
LOAD HOT
EARTH
H
E
A
TE
R
V
A
LV
E
RED BROWN ORANGE
MOTOR
HALLS
J11
J10
J16
J9
J12
J8
TEMP DISPLAY
1750791
RPM DISPLAY
1750788
TIMER DISPLAY
1750679
ALARM BOARD
1750681
DOOR SWITCH
7850578
RPM SWITCH
7850553
FERRITE BEAD
7830500
TEMPERATURE
SENSOR
BODINE
MOTOR
4880514
BODINE
MOTOR 
CABLE
0860503
RPMOTP TIMER
LIGHT BALLEST 
4660501 FLUORECENT LAMP
4660528 LAMP
HOLDERS
4660502
LIGHT SWITCH
7850553
HIGH LIMIT
CUT OFF 42°C
1750862
CF
REFRIGERATION 
CONDENSING
UNIT
7010521
ORANGE
BROWN
BROWN
BROWN
B
R
O
W
N
BROWN
BROWN
BROWN
YELLOW
YELLOW
BLUE
BLUE
BLUE
BLUE
BLUE
RED
RED
ORANGE
O
R
A
N
G
E
BROWN
RED
OUTLET 
4200518
17.1Ω  800W
BLACK/WHITE
BLACK
BLACK/VIOLET
BLACK/YELLOW
120V / 240V TO 90V
STEP DOWN 
TRANFORMER
8350509
TIMER 
SWITCH
7850553
POWER INDICATOR
4650554BROWN BLUE
BROWN BLUE
 
 
SHEL LAB SI6/SI6R Shaking Incubator Operational Manual 
 
26 
Copyright © 2002 Sheldon Manufacturing. All rights reserved. 
All specifications and features for this product are subject to change without notice. 
SSI5R-2 (SI6R-2) 220V 
(9851460) 
1 2
4
OTL 1750862
FAN
CHAMBER FAN
4880570
2800502
EMI FILTER
COMPRESSOR
B
LA
C
K
/W
H
IT
EBLACK
B
LA
C
K/
V
IO
LE
T
BLACK/YELLOW
1 2
4
120V / 240V TO 90V
STEP DOWN 
TRANFORMER
8350509
POWER SWITCH 7850533
INLET 
4200505
MAIN 
CONTROL 
BOARD
1750786
MOTOR
MOTOR N
LOAD HOT
EARTH
H
EA
TE
R
VA
LV
E
RED BROWN ORANGE
MOTOR
HALLS
J11
J10
J16
J9
J12
J8
TEMP DISPLAY
1750791
RPM DISPLAY
1750788
TIMER DISPLAY
1750679
ALARM BOARD
1750681
DOOR SWITCH
7850578
RPM SWITCH
7850553
TIMER 
SWITCH
7850553
FERRITE BEAD
7830500
TEMPERATURE
SENSOR
BODINE
MOTOR
4880514
BODINE
MOTOR 
CABLE
0860503
RPMOTP TIMER
LIGHT BALLEST 
4660506 FLUORECENT LAMP
4660528 LAMP
HOLDERS
4660502
LIGHT SWITCH
7850553
HIGH LIMIT
CUT OFF 42°C
1750862
CF
REFRIGERATION 
CONDENSING
UNIT
7010543
ORANGE
BROWN
BROWN
BROWN
B
R
O
W
N
BROWN
BROWN
BROWN
YELLOW
YELLOW
BLUE
BLUE
BLUE
BLUE
BLUE
BLUE
RED
RED
ORANGE
O
R
A
N
G
E
BROWN
RED
OUTLET 
6100532
68.4Ω  750W
POWER INDICATOR
4650554BROWN BLUE
BROWN BLUE
 
 
 
SAFETY DATA SHEET
Document Type  AGHS - OSHA GHS Revision date  21-Jul-2016 Version  3
1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING
Product name BL21(DE3) Competent E.coli
Product No C2527
Recommended use of the chemical and restrictions on use 
Recommended use This product is for research and development only
Uses advised against No information available
Details of the supplier of the safety data sheet 
Supplier Address New England BioLabs
240 County Road
Ipswich, MA 01938
USA
Company Phone Number 978-927-5054
800-632-5227 (toll free)
Telefax 978-921-1350
E-mail address info@neb.com
Emergency telephone number 
Emergency telephone 978-927-5054
800-632-5227 (toll free)
9:00am - 5:00pm Monday-Friday EST
_____________________________________________________________________________________________
Specification No  No information available
Product name  BL21(DE3) Competent
E.coli
Page  1 / 8 Product No  C2527
_____________________________________________________________________________________________
4. FIRST AID MEASURES
First aid measures
General advice
Immediate medical attention is required. In case of accident or unwellness, seek medical advice immediately (show directions for
use or safety data sheet if possible). Remove from exposure, lie down. Do not breathe dust/fume/gas/mist/vapors/spray.
Eye contact
Rinse thoroughly with plenty of water for at least 15 minutes, lifting lower and upper eyelids. Consult a physician.
Skin contact
Wash skin with soap and water.
Inhalation
Remove to fresh air.
2. HAZARDS IDENTIFICATION
Classification 
Not a dangerous substance or mixture according to the Globally Harmonized System (GHS)
Label elements 
Hazards not otherwise classified (HNOC)  
Other information  
Per Centers for Disease Control and Prevention (CDC) Guidelines (Biosafety in Microbiological and Biomedical Laboratories, 5th
Edition), this material can be handled at Biological Safety Level One (BSL-1) containment.
Biological Safety Level One (BSL-1) containment, using standard microbiological practices, is suitable for work involving
well-characterized microbiological organisms not known to consistently cause disease in immunocompetent adult humans, and
present minimal potential hazard to laboratory personnel and the environment.
Note:  No data available  
3. COMPOSITION/INFORMATION ON INGREDIENTS
Mixture  
Chemical Name CAS No Weight-% Trade Secret
Trade Secret Proprietary 5 - 10 *
Trade Secret Proprietary 1 - 5 *
The product contains no substances which at their given concentration, are considered to be hazardous to health.
Emergency Overview
The product contains no substances which at their given concentration, are considered to be hazardous to health.
Appearance  Colorless Physical state  Liquid Odor  None
_____________________________________________________________________________________________
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Ingestion
Clean mouth with water and drink afterwards plenty of water.
Most important symptoms and effects, both acute and delayed 
No information available.
Indication of any immediate medical attention and special treatment needed
Note to physicians
Treat symptomatically.
5. FIRE-FIGHTING MEASURES
Suitable extinguishing media
Use extinguishing measures that are appropriate to local circumstances and the surrounding environment.
Unsuitable extinguishing media
CAUTION: Use of water spray when fighting fire may be inefficient.
Specific hazards arising from the chemical
No information available.
Protective equipment and precautions for firefighters
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full
protective gear.
6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures  
Personal precautions
Ensure adequate ventilation, especially in confined areas.
Personal protective equipment [PPE]
Use personal protection recommended in Section 8.
Environmental precautions  
See Section 12 for additional Ecological Information.
Methods and material for containment and cleaning up  
Methods for containment
Prevent further leakage or spillage if safe to do so.
Methods for cleaning up
Soak up with inert absorbent material. Pick up and transfer to properly labeled containers. This material and its container must be
disposed of as hazardous waste.
7. HANDLING AND STORAGE
Precautions for safe handling  
Handle in accordance with good industrial hygiene and safety practice.
Conditions for safe storage, including any incompatibilities
Storage temperature
Refer to www.neb.com for specific information.
_____________________________________________________________________________________________
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Storage Conditions
Keep/store only in original container.
_____________________________________________________________________________________________
Incompatible materials
None known based on information supplied.
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control Parameters  
Exposure Guidelines
This product, as supplied, does not contain any hazardous materials with occupational exposure limits established by the region
specific regulatory bodies.
Chemical Name ACGIH TLV OSHA PEL NIOSH IDLH
Glycerol
 56-81-5
- TWA: 15 mg/m3  mist, total
particulate
TWA: 5 mg/m3  mist, respirable
fraction
(vacated) TWA: 10 mg/m3  mist,
total particulate
(vacated) TWA: 5 mg/m3  mist,
respirable fraction
-
Trade Secret TWA: 0.02 mg/m3 Mn respirable
fraction
TWA: 0.1 mg/m3 Mn inhalable
fraction
(vacated) Ceiling: 5 mg/m3
Ceiling: 5 mg/m3 Mn
IDLH: 500 mg/m3 Mn
TWA: 1 mg/m3  Mn
STEL: 3 mg/m3 Mn
NIOSH IDLH  Immediately Dangerous to Life or Health
Other information
Vacated limits revoked by the Court of Appeals decision in AFL-CIO v. OSHA, 965 F.2d 962 (11th Cir., 1992).
Appropriate engineering controls 
Showers. Eyewash stations.
Individual protection measures, such as personal protective equipment
Eye/face protection
Wear safety glasses with side shields (or goggles).
Skin and body protection
Wear suitable protective clothing and gloves.
Respiratory protection
Use in well ventilated areas.
General hygiene considerations
Handle in accordance with good industrial hygiene and safety practice.
9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
Physical state Liquid
Appearance Colorless
Odor None
Property Remarks • Method 
pH 6.2
Melting point / freezing point No information available
Boiling point / boiling range No information available
Flash point No information available
Evaporation rate No information available
Flammability (solid, gas) No information available
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Other information
10. STABILITY AND REACTIVITY
Reactivity  
Chemical stability 
Stable under normal conditions.
Possibility of hazardous reactions 
Can react briskly with oxidizers - danger of explosion.
Conditions to avoid 
Incompatible materials. Ignition sources. Heat.
Incompatible materials 
Strong oxidizing agents.
Hazardous decomposition products 
Thermal decomposition can lead to release of irritating and toxic gases and vapors. Carbon monoxide. Carbon dioxide (CO2).
11. TOXICOLOGICAL INFORMATION
Information on likely routes of exposure  
Inhalation
Avoid breathing vapors or mists. May cause irritation of respiratory tract.
Eye contact
Redness. May cause slight irritation.
Skin contact
Prolonged contact may cause redness and irritation. Repeated exposure may cause skin dryness or cracking.
Ingestion
May cause drowsiness or dizziness. Ingestion causes burns of the upper digestive and respiratory tracts. Symptoms include
Flammability Limit in Air No information available
Upper flammability limit
Lower flammability limit
Vapor pressure No information available
Vapor density No information available
Relative density No information available
Specific gravity No information available
Water solubility No information available
Solubility in other solvents No information available
Partition coefficient No information available
Autoignition temperature No information available
Decomposition temperature No information available
Kinematic viscosity No information available
Dynamic viscosity No information available
Explosive properties No information available
Oxidizing properties No information available
Softening point No information available
Molecular weight No information available
VOC content (%) No information available
Density No information available
Bulk density No information available
No data available.
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burning sensation, coughing, wheezing, shortness of breath, headache, nausea, and vomiting.
Chemical Name Oral LD50 Dermal LD50 Inhalation LC50
Trade Secret = 14500 mg/kg  ( Rat ) = 40 g/kg  ( Rat ) -
Trade Secret = 1000 mg/kg  ( Rat ) = 2630 mg/kg  ( Rat ) -
Information on toxicological effects  
Symptoms No information available.
Delayed and immediate effects as well as chronic effects from short and long-term exposure  
Skin corrosion/irritation Mild
Serious eye damage/eye irritation Mild
Irritation Mild
Corrosivity Mild
Sensitization
Skin No information available
Respiratory No information available
Germ cell mutagenicity No information available
Carcinogenicity No information available
Reproductive toxicity No information available
Developmental toxicity No information available
Teratogenicity No information available
STOT - single exposure No information available
STOT - repeated exposure No information available
Chronic toxicity May cause adverse effects on the bone marrow and blood-forming system
Subchronic toxicity No information available
Target organ effects Blood, Central nervous system, Eyes, Kidneys, Respiratory system, Skin.
Neurological effects No information available
Other adverse effects No information available
Aspiration hazard No information available
Numerical measures of toxicity  - Product information  
The following values are calculated based on chapter 3.1 of the GHS document  .  mg/kg  mg/l
12. ECOLOGICAL INFORMATION
Marine pollutant
No information available
Ecotoxicity 
No information available
0.4 % of the mixture consists of component(s) of unknown hazards to the aquatic environment.
Chemical Name Algae/aquatic plants Fish Toxicity to
microorganisms
Crustacea
Glycerol
 56-81-5
- 51 - 57: 96 h Oncorhynchus
mykiss mL/L LC50 static
- 500: 24 h Daphnia magna
mg/L EC50
Trade Secret 12350 - 25500: 96 h
Skeletonema costatum mg/L
EC50
34000: 96 h Pimephales
promelas mg/L LC50 40: 96
h Lepomis macrochirus g/L
LC50 static 33 - 37: 96 h
Oncorhynchus mykiss g/L
LC50 static 41.7: 96 h
Cyprinus carpio g/L LC50
- 7000: 24 h Daphnia species
mg/L EC50
Trade Secret - 10650: 96 h Lepomis
macrochirus mg/L LC50
- 2400: 48 h Daphnia magna
mg/L LC50
_____________________________________________________________________________________________
Specification No  No information available
Product name  BL21(DE3) Competent
E.coli
Page  6 / 8 Product No  C2527
_____________________________________________________________________________________________
static
Trade Secret 2200: 72 h Desmodesmus
subspicatus mg/L EC50
4210: 96 h Gambusia affinis
mg/L LC50 static 1970 -
3880: 96 h Pimephales
promelas mg/L LC50 static
- 140: 48 h Daphnia magna
mg/L EC50 Static 1400: 24 h
Daphnia magna mg/L EC50
Trade Secret - 6800: 96 h Oncorhynchus
mykiss mg/L LC50
semi-static
- 7170: 24 h Daphnia magna
mg/L EC50
Persistence and degradability
No information available
Bioaccumulation
No information available
Mobility
No information available
Chemical Name Partition coefficient
Trade Secret -2.03
Other adverse effects 
Ozone No information available
Ozone depletion potential (ODP) No information available
13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Relevant Information
Keep out of drains, sewers, ditches and waterways.
Disposal considerations
Use a licensed professional waste disposal service to dispose of this product. Product  may be dissolved in a combustible solvent
or absorbed onto a combustible material and burned by a chemical incinerator.
Contaminated packaging
Empty containers must be tripled rinsed prior to disposal.
This product contains one or more substances that are listed with the State of California as a hazardous waste.
14. TRANSPORT INFORMATION
DOT Not regulated
15. REGULATORY INFORMATION
International Inventories 
TSCA Complies
 Legend:   
_____________________________________________________________________________________________
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 TSCA  - United States Toxic Substances Control Act Section 8(b) Inventory
_____________________________________________________________________________________________
US Federal Regulations 
CWA (Clean Water Act)
This product does not contain any substances regulated as pollutants pursuant to the Clean Water Act (40 CFR 122.21 and 40
CFR 122.42).
CERCLA
This material, as supplied, does not contain any substances regulated as hazardous substances under the Comprehensive
Environmental Response Compensation and Liability Act (CERCLA) (40 CFR 302) or the Superfund Amendments and
Reauthorization Act (SARA) (40 CFR 355).  There may be specific reporting requirements at the local, regional, or state level
pertaining to releases of this material.
US State Regulations 
California Proposition 65
This product does not contain any Proposition 65 chemicals.
U.S. State Right-to-Know Regulations
Chemical Name New Jersey Massachusetts Pennsylvania
Trade Secret X - -
U.S. EPA Label Information  
EPA Pesticide Registration Number Not applicable
16. OTHER INFORMATION
Prepared by EH&S Manager
978-927-5054
Prepared by New England BioLabs
Issue date No data available
Revision note SDS is valid 3 years from revision date. Contact info@neb.com for latest revision.
Disclaimer
IMPORTANT:  The information in this SDS is provided in good faith based on our knowledge as of the issue date (or
subsequent revision date, if any), and is to be used only as a guide.  This SDS does not constitute a guarantee (express
or implied) of any kind and we make no warranties or merchantability or fitness for a particular purpose.  This information
relates only to the designated product as shipped and may not be valid if the product is used in combination with any
other materials or is not used in accordance with our instructions.  It is the responsibility of the buyer/user to ensure that
its activities comply with all applicable governmental requirements. Since conditions of use of the product are not under
the control of New England Biolabs, it is the duty of the buyer/user to determine the necessary conditions for the safe use
of the product.  New England Biolabs will not be liable for any damages resulting from handling or contact with the
product.
End of Safety Data Sheet
NFPA  Health hazards  0 Flammability  0 Instability  0 Special Hazard  -
HMIS  Health hazards  0 Flammability  0 Physical hazards  0 Personal protection  -
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Specification No  No information available
Product name  BL21(DE3) Competent
E.coli
Page  8 / 8 Product No  C2527
 
Safety Data Sheet (SDS) 
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Date of Issue: 4/14/2015 
SuperBroth 
 
Section 1. Identification 
Product Identifier  
Catalog Number: S0130 
Recommended use of the chemical and restrictions on use 
For research use only. Not intended for human or animal diagnostic or therapeutic uses 
Manufacture/Supplier Details: Alpha Teknova, Inc. 
2290 Bert Dr. 
Hollister, CA 95023 
Telephone Number: 831-637-1100 
Emergency Telephone Numbers 
CHEMTREC Emergency Phone Number: (800) 424-9300 
 
Section 2. Hazard Identification 
Classification of the substance/mixture: Not a hazardous substance or mixture. 
GHS Label elements, including precautionary statements 
The substance is classified and labeled according to the Globally Harmonized System (GHS). 
Not a hazardous substance or mixture. 
Hazard statements: None 
Signal word: None 
Precautionary Statements: None 
HMIS rating (Scale 0-4): 
HEALTH 0 
 FIRE 0 
REACTIVITY 0 
 
NFPA Rating: 
 
Hazards not otherwise classified: None 
 
Section 3. Composition/Information On Ingredients 
Chemical Name Identifiers Hazardous Approximate Percentage % 
SuperBroth Premix CAS:N/A nonhazardous 6.69% 
Water CAS: N/A nonhazardous - 
 
Chemical Characterization: Mixture 
Any concentration shown as a range is to protect confidentiality or is due to batch variation. 
 
0 
0 
0 
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Section 4. First-Aid Measures 
Description of necessary measures 
Inhalation: 
Remove victim to fresh air and keep at rest in a position comfortable for breathing. If not breathing, if breathing is irregular or if 
respiratory arrest occurs, provide artificial respiration or oxygen by trained personnel. It may be dangerous to the person 
providing aid to give mouth-to-mouth resuscitation. Get medical attention if adverse health effects persist or are severe. If 
unconscious, place in recovery position and get medical attention immediately.  Maintain an open airway. 
Skin: 
Flush contaminated skin with plenty of water. Remove contaminated clothing and shoes. Get medical aid if irritation develops 
or persists 
Eye: 
Immediately flush eyes with plenty of water, occasionally lifting the upper and lower eyelids. Check for and remove any 
contact lenses. Continue to rinse for at least 10 minutes. Get medical attention. 
Ingestion: Do not induce vomiting. Get medical attention if adverse health effects develop or persist. 
Most important symptoms/effects, acute and delayed 
Non further relevant information available  
 
Indication of any immediate medical attention and special treatment needed 
All treatment should be based on observed sign and symptoms of distress in the patient. Consideration should be given to the possibility that 
overexposure to materials other than this product may have occurred. 
 
Section 5. Fire Fighting Measures 
Extinguishing media:  
Suitable extinguishing media: 
This is a nonflammable aqueous solution 
Use an extinguishing agent suitable for the surrounding fire. 
Unsuitable Extinguishing: None known 
Special hazards arising from the substance or mixture 
Unusual fire and explosion hazards:  
Hazardous Combustions products:  
No specific fire or explosion hazard  
None known 
Special protective equipment and precautions 
for the fire-fighters 
No special measures required 
 
Section 6. Accidental Release Measures 
Personal precautions, protective equipment and emergency procedures 
Wear appropriate protective equipment including respiratory protection as conditions warrant. Do not touch or walk through spilled material. Do not touch 
damaged containers or spilled materials unless wearing appropriate protective clothing. 
Environmental precautions 
Avoid run off to waterways and sewers. 
Methods and materials for containment and cleaning up 
Absorb with liquid-binding material.  
Dispose contaminated material as waste according to item 13.   
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Section 7. Handling And Storage 
Precautions for safe handling: No special handling requirements for normal use of this material. 
Conditions for safe storage, including and incompatibilities 
Storage: 
 
Keep labeled container tightly closed and upright. 
Incompatible materials or Ignition sources: Keep away from strong oxidizers. 
 
Section 8. Exposure Controls/Personal Protection 
Control parameters 
Occupational exposure Limit values: 
 
 
Contains no substances with occupational exposure limit values. 
Appropriate engineering controls: General industrial hygiene practice. 
Personal protective equipment  
Eye protection: 
Use equipment for eye protection tested and approved under appropriate government standards such 
as NIOSH (US) or EN 166(EU). 
Hand Protection: 
Protective gloves. The glove material has to be impermeable and resistant to the product/the 
substance/ the preparation. 
Respiratory Protection: None required under normal conditions of use 
 
Section 9. Physical And Chemical Properties 
 
Appearance : Liquid 
Odor : none 
Odor Threshold  : no data available 
pH : no data available 
Melting point/freezing point : no data available 
Initial boiling point & boiling range : no data available 
Flash point : Product does not sustain combustion  
Evaporation rate : no data available 
Flammability (solid, gas) : no data available 
Partition coefficient : no data available 
Vapor pressure : no data available 
Vapor density : no data available 
Relative density (water) : no data available 
Solubility : Soluble in water 
Upper/lower flammability or explosive limits : no data available 
Auto-ignition temperature : no data available 
Decomposition temperature : no data available 
Viscosity : no data available 
Other information: None 
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Section 10. Stability And Reactivity 
Reactivity: No specific test data related to reactivity available for this product or its ingredients 
Chemical stability Stable under recommended storage conditions. 
Possibility of hazardous reactions 
 
Under normal conditions of storage and used, hazardous reactions should not occur. 
Conditions to avoid No specific data 
Incompatible materials No specific data 
Hazardous decomposition products: 
Under normal conditions of storage and used, hazardous decomposition products should not be 
produced. 
 
Section 11. Toxicological Information 
Information on toxicological effects 
Acute toxicity 
 
Product/Ingredient Name CAS Result Species Dose Exposure 
SuperBroth - - - - - 
 
Irritation/Corrosion 
 
Product/Ingredient Name Result Species Score Exposure/Observation 
SuperBroth - - - 
- 
- 
 
Sensitization: Not available 
Mutagenicity: Not available 
 
Carcinogenicity 
 
Product/Ingredient Name OSHA IARC NTP 
SuperBroth None of the ingredients 
listed 
None of the ingredients listed None of the ingredients listed 
 
 
Reproductive toxicity: Not available 
Teratogenicity: Not available 
Specific target organ toxicity- single exposure Not available 
Specific target organ toxicity- repeated exposure Not available 
Aspiration Hazard Not available 
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Information on the likely routes of exposure 
Routes of entry anticipated: Oral 
Symptoms related to the physical, chemical and toxicological characteristics 
Delayed and immediate effects and also chronic effects from short and long term exposure  
No known significant effects or critical hazards.  
Eye contact: No specific data 
Inhalation: No specific data 
Skin contact: No specific data 
Ingestion: No specific data 
Aspiration Hazard No specific data 
Numerical measures of toxicity 
Not available 
 
Section 12. Ecological Information 
Toxicity 
 
Product/ingredient name Result Species Exposure 
SuperBroth - 
 
- - 
 
 
Persistence and degradability: Not available 
Bioaccumulative potential Not available 
Mobility in soil Not available 
Other adverse effects Not available 
Aspiration Hazard No known significant effects or critical hazards. 
  
Section 13. Disposal Considerations 
Waste treatment methods 
 
Product waste: Dispose of content and/or container in accordance with local, regional, national, and/or international regulations 
 
Packaging waste: Dispose of content and/or container in accordance with local, regional, national, and/or international regulations 
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Section 14. Transport Information 
 UN Number UN proper shipping name 
Transport hazard 
class(es) 
Packaging group 
Environmental 
Hazards 
DOT Not regulated  - - - none 
IMDG Not regulated - - - none 
IATA Not regulated - - - none 
 
Transport in bulk according to Annex ll of Marpol 73/78 and the IBC code 
This product is provided only in non-bulk containers 
 
Special Precautions for user 
None specified 
 
Section 15. Regulatory Information 
Safety health and environmental regulations/ legislation specific for the substance or mixture 
 
Sara : Not applicable 
Section 355 (Extremely hazardous substances) : Substance is not listed 
Section  313 (Specific toxic chemical listings) : Substance is not listed 
SARA 311/312 Hazards 
No SARA Hazards 
TSCA (Toxic substances control act) 
Proposition 65: 
: Substance is not listed 
Chemicals known to cause cancer : Substance is not listed 
Chemicals known to cause reproductive toxicity  
or females 
: Substance is not listed 
Chemicals known to cause reproductive toxicity for males : Substance is not listed 
Chemicals known to cause developmental toxicity : Substance is not listed 
Carcinogenic categories 
EPA (Environmental protection agency) : Substance is not listed 
TLV (Threshold limit value established by ACGIH) : Substance is not listed 
NIOSH-CA (National institute for occupational safety and health) : Substance is not listed 
OSHA-CA (occupational safety & health administration) : Substance is not listed 
GHS label elements : 
The product is classified and labeled according to the Globally 
Harmonized System (GHS). 
Hazard pictograms : Not applicable 
Decomposition temperature : Not applicable 
Viscosity : Not applicable 
Signal Word : Not applicable 
Hazard-determining components of labeling : Not applicable 
Hazard statements : Not applicable 
Precautionary statements : Not applicable 
National regulations : Substance is not listed 
State right to know : Substance is not listed 
Chemical safety assessment  A Chemical Safety Assessment has not been carried out. 
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Section 16. Other Information 
Disclaimer/Statement of Liability: The information contained herein is believed to be accurate but is not warranted to be so. Data and calculation are 
based on information furnished by the manufacturers of the components of the product. Uses are advised to confirm in advance of need that information 
is current, applicable and suited to the circumstance of use. Vendor assumes no responsibility for injury to vendee or third persons proximately caused 
by the material if reasonable safety procedures are not adhered to as stipulated in the data sheet. Furthermore, vendor assumes no responsibility for 
injury caused by abnormal use of this material even if reasonable safety procedures are followed. Any questions regarding this product should be 
directed to the manufacturer of the product as described in section 1. 
 
Warranty  
The above information is believed to be correct but does not purport to 
Be all inclusive and shall be used only as a guide. Teknova, inc. Shall not be held liable for any damage resulting from handling or from contact with the 
above product. 
Teknova, inc. 
 
Key to abbreviations: NDA= No data available 
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Section 1. Identification 
Product Identifier  
Catalog Number: G0750 
Recommended use of the chemical and restrictions on use 
For research use only. Not intended for human or animal diagnostic or therapeutic uses 
Manufacture/Supplier Details: Alpha Teknova, Inc. 
2290 Bert Dr. 
Hollister, CA 95023 
Telephone Number: 831-637-1100 
Emergency Telephone Numbers 
CHEMTREC Emergency Phone Number: (800) 424-9300 
 
Section 2. Hazard Identification 
Classification of the substance/mixture: Not a hazardous substance or mixture. 
GHS Label elements, including precautionary statements 
The substance is classified and labeled according to the Globally Harmonized System (GHS). 
Not a hazardous substance or mixture. 
Hazard statements: None 
Signal word: None 
Precautionary Statements: None 
HMIS rating (Scale 0-4): 
HEALTH 0 
 FIRE 0 
REACTIVITY 0 
 
NFPA Rating: 
 
Hazards not otherwise classified: None 
 
Section 3. Composition/Information On Ingredients 
Chemical Name Identifiers Hazardous Approximate Percentage % 
Glucose CAS: N/A nonhazardous 70.00% 
Water CAS: N/A nonhazardous - 
 
Chemical Characterization: Mixture 
Any concentration shown as a range is to protect confidentiality or is due to batch variation. 
 
0 
0 
0 
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Section 4. First Aid Measures 
Description of necessary measures 
Inhalation: 
Remove victim to fresh air and keep at rest in a position comfortable for breathing. If not breathing, if breathing is irregular or if 
respiratory arrest occurs, provide artificial respiration or oxygen by trained personnel. It may be dangerous to the person 
providing aid to give mouth-to-mouth resuscitation. Get medical attention if adverse health effects persist or are severe. If 
unconscious, place in recovery position and get medical attention immediately.  Maintain an open airway. 
Skin: 
Flush contaminated skin with plenty of water. Remove contaminated clothing and shoes. Get medical aid if irritation develops 
or persists 
Eye: 
Immediately flush eyes with plenty of water, occasionally lifting the upper and lower eyelids. Check for and remove any 
contact lenses. Continue to rinse for at least 10 minutes. Get medical attention. 
Ingestion: Do not induce vomiting. Get medical attention if adverse health effects develop or persist. 
Most important symptoms/effects, acute and delayed 
Non further relevant information available  
 
Indication of any immediate medical attention and special treatment needed 
All treatment should be based on observed sign and symptoms of distress in the patient. Consideration should be given to the possibility that 
overexposure to materials other than this product may have occurred. 
 
Section 5. Fire Fighting Measures 
Extinguishing media:  
Suitable extinguishing media: 
This is a nonflammable aqueous solution 
Use an extinguishing agent suitable for the surrounding fire. 
Unsuitable Extinguishing: None known 
Special hazards arising from the substance or mixture 
Unusual fire and explosion hazards:  
Hazardous Combustions products:  
No specific fire or explosion hazard  
None known 
Special protective equipment and precautions 
for the fire-fighters 
No special measures required 
 
Section 6. Accidental Release Measures 
Personal precautions, protective equipment and emergency procedures 
Wear appropriate protective equipment including respiratory protection as conditions warrant. Do not touch or walk through spilled material. Do not touch 
damaged containers or spilled materials unless wearing appropriate protective clothing. 
Environmental precautions 
Avoid run off to waterways and sewers. 
Methods and materials for containment and cleaning up 
Absorb with liquid-binding material.  
Dispose contaminated material as waste according to item 13.   
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Section 7. Handling And Storage 
Precautions for safe handling: No special handling requirements for normal use of this material. 
Conditions for safe storage, including and incompatibilities 
Storage: 
 
Keep labeled container tightly closed and upright. 
Incompatible materials or Ignition sources: Keep away from strong oxidizers. 
 
Section 8. Exposure Controls/Personal Protection 
Control parameters 
Occupational exposure Limit values: 
 
 
Contains no substances with occupational exposure limit values. 
Appropriate engineering controls: General industrial hygiene practice. 
Personal protective equipment  
Eye protection: 
Use equipment for eye protection tested and approved under appropriate government standards such 
as NIOSH (US) or EN 166(EU). 
Hand Protection: 
Protective gloves. The glove material has to be impermeable and resistant to the product/the 
substance/ the preparation. 
Respiratory Protection: None required under normal conditions of use 
 
Section 9. Physical And Chemical Properties 
 
Appearance : liquid 
Odor : none 
Odor Threshold  : no data available 
pH : no data available 
Melting point/freezing point : no data available 
Initial boiling point & boiling range : no data available 
Flash point : Product does not sustain combustion  
Evaporation rate : no data available 
Flammability (solid, gas) : no data available 
Partition coefficient : no data available 
Vapor pressure : no data available 
Vapor density : no data available 
Relative density (water) : no data available 
Solubility : Soluble in water 
Upper/lower flammability or explosive limits : no data available 
Auto-ignition temperature : no data available 
Decomposition temperature : no data available 
Viscosity : no data available 
Other information: None 
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Section 10. Stability And Reactivity 
Reactivity: No specific test data related to reactivity available for this product or its ingredients 
Chemical stability Stable under recommended storage conditions. 
Possibility of hazardous reactions 
 
Under normal conditions of storage and used, hazardous reactions should not occur. 
Conditions to avoid No specific data 
Incompatible materials No specific data 
Hazardous decomposition products: 
Under normal conditions of storage and used, hazardous decomposition products should not be 
produced. 
 
Section 11. Toxicological Information 
Information on toxicological effects 
Acute toxicity 
 
Product/Ingredient Name CAS Result Species Dose Exposure 
70% Glucose - - - - - 
 
Irritation/Corrosion 
 
Product/Ingredient Name Result Species Score Exposure/Observation 
70% Glucose - - - 
- 
- 
 
Sensitization: Not available 
Mutagenicity: Not available 
 
Carcinogenicity 
 
Product/Ingredient Name OSHA IARC NTP 
70% Glucose None of the ingredients 
listed 
None of the ingredients listed None of the ingredients listed 
 
 
Reproductive toxicity: Not available 
Teratogenicity: Not available 
Specific target organ toxicity- single exposure Not available 
Specific target organ toxicity- repeated exposure Not available 
Aspiration Hazard Not available 
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Information on the likely routes of exposure 
Routes of entry anticipated: Oral 
Symptoms related to the physical, chemical and toxicological characteristics 
Delayed and immediate effects and also chronic effects from short and long term exposure  
No known significant effects or critical hazards.  
Eye contact: No specific data 
Inhalation: No specific data 
Skin contact: No specific data 
Ingestion: No specific data 
Aspiration Hazard No specific data 
Numerical measures of toxicity 
Not available 
 
Section 12. Ecological Information 
Toxicity 
 
Product/ingredient name Result Species Exposure 
70% Glucose - 
 
- - 
 
 
Persistence and degradability: Not available 
Bioaccumulative potential Not available 
Mobility in soil Not available 
Other adverse effects Not available 
Aspiration Hazard No known significant effects or critical hazards. 
  
Section 13. Disposal Considerations 
Waste treatment methods 
 
Product waste: Dispose of content and/or container in accordance with local, regional, national, and/or international regulations 
 
Packaging waste: Dispose of content and/or container in accordance with local, regional, national, and/or international regulations 
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Section 14. Transport Information 
 UN Number UN proper shipping name 
Transport hazard 
class(es) 
Packaging group 
Environmental 
Hazards 
DOT Not regulated  - - - none 
IMDG Not regulated - - - none 
IATA Not regulated - - - none 
 
Transport in bulk according to Annex ll of Marpol 73/78 and the IBC code 
This product is provided only in non-bulk containers 
 
Special Precautions for user 
None specified 
 
Section 15. Regulatory Information 
Safety health and environmental regulations/ legislation specific for the substance or mixture 
 
Sara : Not applicable 
Section 355 (Extremely hazardous substances) : Substance is not listed 
Section  313 (Specific toxic chemical listings) : Substance is not listed 
SARA 311/312 Hazards 
No SARA Hazards 
TSCA (Toxic substances control act) 
Proposition 65: 
: Substance is not listed 
Chemicals known to cause cancer : Substance is not listed 
Chemicals known to cause reproductive toxicity  
or females 
: Substance is not listed 
Chemicals known to cause reproductive toxicity for males : Substance is not listed 
Chemicals known to cause developmental toxicity : Substance is not listed 
Carcinogenic categories 
EPA (Environmental protection agency) : Substance is not listed 
TLV (Threshold limit value established by ACGIH) : Substance is not listed 
NIOSH-CA (National institute for occupational safety and health) : Substance is not listed 
OSHA-CA (occupational safety & health administration) : Substance is not listed 
GHS label elements : 
The product is classified and labeled according to the Globally 
Harmonized System (GHS). 
Hazard pictograms : Not applicable 
Decomposition temperature : Not applicable 
Viscosity : Not applicable 
Signal Word : Not applicable 
Hazard-determining components of labeling : Not applicable 
Hazard statements : Not applicable 
Precautionary statements : Not applicable 
National regulations : Substance is not listed 
State right to know : Substance is not listed 
Chemical safety assessment  A Chemical Safety Assessment has not been carried out. 
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Section 16. Other Information 
Disclaimer/Statement of Liability: The information contained herein is believed to be accurate but is not warranted to be so. Data and calculation are 
based on information furnished by the manufacturers of the components of the product. Uses are advised to confirm in advance of need that information 
is current, applicable and suited to the circumstance of use. Vendor assumes no responsibility for injury to vendee or third persons proximately caused 
by the material if reasonable safety procedures are not adhered to as stipulated in the data sheet. Furthermore, vendor assumes no responsibility for 
injury caused by abnormal use of this material even if reasonable safety procedures are followed. Any questions regarding this product should be 
directed to the manufacturer of the product as described in section 1. 
 
Warranty  
The above information is believed to be correct but does not purport to 
Be all inclusive and shall be used only as a guide. Teknova, inc. Shall not be held liable for any damage resulting from handling or from contact with the 
above product. 
Teknova, inc. 
 
Key to abbreviations: NDA= No data available 
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Material Safety Data Sheet
Kanamycin sulfate MSDS
Section 1: Chemical Product and Company Identification
Product Name: Kanamycin sulfate
Catalog Codes: SLK1033, SLK1111
CAS#: 25389-94-0
RTECS: NZ3225030
TSCA: TSCA 8(b) inventory: Kanamycin sulfate
CI#: Not available.
Synonym:  
Chemical Name: Not available.
Chemical Formula: C18H36N4O11.H2SO4
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Kanamycin sulfate 25389-94-0 100
Toxicological Data on Ingredients: Kanamycin sulfate LD50: Not available. LC50: Not available.
Section 3: Hazards Identification
Potential Acute Health Effects: Hazardous in case of eye contact (irritant), of ingestion, of inhalation.
Potential Chronic Health Effects:
Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. CARCINOGENIC EFFECTS:
Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL
TOXICITY: Not available. The substance is toxic to the nervous system. Repeated or prolonged exposure to the substance
can produce target organs damage.
Section 4: First Aid Measures
Eye Contact: Check for and remove any contact lenses. Do not use an eye ointment. Seek medical attention.
Skin Contact: No known effect on skin contact, rinse with water for a few minutes.
Serious Skin Contact: Not available.
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Inhalation: Allow the victim to rest in a well ventilated area. Seek immediate medical attention.
Serious Inhalation: Not available.
Ingestion:
Do not induce vomiting. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not breathing, perform
mouth-to-mouth resuscitation. Seek immediate medical attention.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...), sulfur oxides (SO2,
SO3...).
Fire Hazards in Presence of Various Substances: Not available.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a
fume hood. Ground all equipment containing material. Do not breathe dust. Avoid contact with eyes Wear suitable protective
clothing In case of insufficient ventilation, wear suitable respiratory equipment If you feel unwell, seek medical attention and
show the label when possible.
Storage:
Keep container dry. Keep in a cool place. Ground all equipment containing material. Keep container tightly closed. Keep in a
cool, well-ventilated place. Combustible materials should be stored away from extreme heat and away from strong oxidizing
agents.
Section 8: Exposure Controls/Personal Protection
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Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection: Splash goggles. Lab coat.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Boots. Gloves. Suggested protective clothing might not be sufficient; consult a specialist BEFORE
handling this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Crystalline solid.)
Odor: Not available.
Taste: Not available.
Molecular Weight: 582.58 g/mole
Color: White.
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: Decomposes.
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: Not available.
Solubility: Not available.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
p. 4
Polymerization: No.
Section 11: Toxicological Information
Routes of Entry: Eye contact. Inhalation. Ingestion.
Toxicity to Animals:
LD50: Not available. LC50: Not available.
Chronic Effects on Humans: The substance is toxic to the nervous system.
Other Toxic Effects on Humans: Hazardous in case of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans: Not available.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are more toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Kanamycin sulfate
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC): R36- Irritating to eyes.
HMIS (U.S.A.):
Health Hazard: 2
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Fire Hazard: 1
Reactivity: 0
Personal Protection: j
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Not applicable. Lab coat. Not applicable. Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:20 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
Safety Data Sheet 
SDS Print Date: Aug 17  2016
V2.0 SDS Revision Date: May 19  2015
www.tocris.com
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING
1.1 Product identifiers
Product Name: IPTG
Catalog Number: 5509
CAS Number: 367-93-1 EC Number: 206-703-0
IUPAC Name: 1-Methylethyl 1-thio-β-D-galactopyranoside
1.2 Relevant identified uses of the substance or mixture and uses advised against
Identified Uses: Laboratory chemicals, Manufacture of substances
1.3 Details of the supplier of the safety data sheet
Company: Tocris Bioscience Telephone: + 44 (0)117 916-3333
The Watkins Building, Fax: + 44 (0)117 916-3344
Atlantic Road, Internet: www.tocris.com
Bristol, BS11 9QD, UK E-mail address: customerservice@tocris.co.uk
1.4 Emergency Telephone number
Emergency Tel: + 44 (0)117 916-3333 (09.00 - 17.00 GMT)
2. HAZARDS IDENTIFICATION
2.1 Classification of the substance or mixture
This substance does not meet the classification criteria of the EC Directives 67/548/EEC, 1999/45/EC or 1272/2008. 
2.2 Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
2.3 Other hazards - none
3. COMPOSITION/INFORMATION ON INGREDIENTS
3.1 Substances
Product Name: IPTG
Formula: C9H18O5S Molecular Weight: 238.3
CAS Number: 367-93-1 EC Number: 206-703-0
4. FIRST AID MEASURES
4.1 Description of first aid measures
General advice 
Consult a doctor and show this safety data sheet. 
If inhaled 
Remove to fresh air and monitor breathing. If breathing becomes difficult, give oxygen. If breathing stops, give artificial 
respiration. Consult a doctor. 
In case of skin contact 
Immediately wash skin with copious amounts of soap and water for at least 15 minutes. Remove contaminated clothing 
and shoes and wash before reuse. Consult a doctor. 
In case of eye contact 
Flush with copious amounts of water for at least 15 minutes. Consult a doctor. 
If swallowed 
Rinse mouth with water. Do not induce vomiting unless directed to do so by medical personnel. Never give anything by 
mouth to an unconscious person. Consult a doctor. 
4.2 Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical and toxicological properties have not been thoroughly investigated.
4.3 Indication of immediate medical attention and special treatment needed
Show this safety data sheet to the doctor in attendance. Immediate medical attention is required.
5. FIRE-FIGHTING MEASURES
5.1 Extinguishing media
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
5.2 Special hazards arising from the substance or mixture
In combustion, may emit toxic fumes. 
5.3 Precautions for fire-fighters
Wear suitable protective clothing to prevent contact with skin and eyes and self-contained breathing apparatus.
th
th
6. ACCIDENTIAL RELEASE MEASURES
6.1 Personal precautions, protective equipment and emergency procedures
Do not take action without suitable protective clothing - see section 8 of SDS. Evacuate personnel to safe areas. Ensure 
adequate ventilation. Avoid breathing vapors, mist, dust or gas.
6.2 Environmental precautions
Do not let product enter drains.
6.3 Methods and materials for containment and cleaning up
Cover spillage with suitable absorbent material. Using non-spark tools, sweep up material and place in an appropriate 
container. Decontaminate spill site with 10% caustic solution and ventilate area until after disposal is complete. Hold all 
material for appropriate disposal as described under section 13 of SDS.
6.4 Reference to other sections
For required PPE see section 8. For disposal see section 13.
7. HANDLING AND STORAGE
7.1 Precautions for safe handling
Use in a chemical fume hood, with air supplied by an independent system. Avoid inhalation, contact with eyes, skin and 
clothing. Avoid the formation of dust and aerosols. Use in a well-ventilated area. Keep away from sources of ignition. Avoid 
prolonged or repeated exposure.
7.2 Conditions for safe storage, including any incompatibilities.
Store in cool, well-ventilated area. Keep away from direct sunlight. Keep container tightly sealed until ready for use. 
Recommended storage temperature: Store at +4°C
7.3 Specific end uses
Use in a laboratory fume hood where possible. Refer to employer's COSHH risk assessment.
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
8.1 Control parameters
Components with workplace control parameters 
Contains no substances with occupational exposure limit values.
8.2 Exposure controls
Appropriate engineering controls 
Use in a fume hood where applicable. Ensure all engineering measures described under section 7 of SDS are in place. 
Ensure laboratory is equipped with a safety shower and eye wash station. 
Personal protective equipment
Eye/face protection 
Use appropriate safety glasses. 
Skin protection 
Use appropriate chemical resistant gloves (minimum requirement use standard BS EN 374:2003). Gloves should be 
inspected before use. Wash and dry hands thoroughly after handling. 
Body protection 
Wear appropriate protective clothing. 
Respiratory protection 
If risk assessment indicates necessary, use a suitable respirator. 
9. PHYSICAL AND CHEMICAL PROPERTIES
9.1 Information on basic physical and chemical properties
Appearance White solid Vapor pressure No data available
Odor No data available Vapor density No data available
Odor threshold No data available Relative density No data available
pH No data available Solubility(ies) Soluble to 100 mM in water 
Melting / freezing point No data available Partition coefficient No data available
Boiling point / range No data available Auto-ignition temperature No data available
Flash point No data available Decomposition temperature No data available
Evaporation rate No data available Viscosity No data available
Flammability (solid, gas) No data available Explosive properties No data available
Upper / lower flammability or 
explosive limits
No data available Oxidising properties No data available
9.2 Other safety information
No data available
10. STABILITY AND REACTIVITY
10.1 Reactivity
Stable under recommended transport or storage conditions.
10.2 Chemical stability
Stable under recommended storage conditions.
10.3 Possibility of hazardous reactions
Hazardous reactions will not occur under normal transport or storage conditions. Decomposition may occur on exposure to 
conditions or materials listed below.
10.4 Conditions to avoid
Heat, moisture.
10.5 Incompatible materials
Strong acids/alkalis, strong oxidising/reducing agents.
10.6 Hazardous decomposition products
In combustion may emit toxic fumes. No known decomposition information.
11. TOXICOLOGICAL INFORMATION
11.1 Information on toxicological effects
Acute Toxicity 
No data available 
Skin corrosion/irritation 
Classification criteria are not met based on available data 
Serious eye damage/irritation 
Classification criteria are not met based on available data 
Respiratory or skin sensitization 
Classification criteria are not met based on available data 
Germ cell mutagenicity 
Classification criteria are not met based on available data 
Carcinogenicity 
Classification criteria are not met based on available data 
Reproductive toxicity 
Classification criteria are not met based on available data 
Specific target organ toxicity - single exposure 
Classification criteria are not met based on available data 
Specific target organ toxicity - repeated exposure 
Classification criteria are not met based on available data 
Aspiration hazard 
Classification criteria are not met based on available data 
Symptoms / Routes of exposure 
Inhalation: There may be irritation of the throat with a feeling of tightness in the chest.
Ingestion: There may be irritation of the throat.
Skin: There may be mild irritation at the site of contact.
Eyes: There may be irritation and redness.
Delayed / Immediate Effects: No known symptoms.
Additional Information 
RTECS No: Not available 
Exposure may cause irritaiton of eyes, mucous membranes, upper respiratory tract and skin. 
To the best of our knowledge, the chemical, physical and toxicological properties have not been fully investigated
12. ECOLOGICAL INFORMATION
12.1 Toxicity
No data available
12.2 Persistence and degradability
No data available
12.3 Bioaccumlative potential
No data available
12.4 Mobility in soil
No data available
12.5 Results of PBT and vPvB assessment
No data available
12.6 Other adverse effects
May be harmful to the aquatic environment. 
13. DISPOSAL CONSIDERATIONS
13.1 Waste treatment methods
Product 
Transfer to a suitable container and arrange for collection by specialized disposal company in accordance with National 
legislation. 
Contaminated packaging 
Dispose of in a regulated landfill site or other method for hazardous or toxic wastes in accordance with National legislation. 
14. TRANSPORT INFORMATION
Classified according to the criteria of the UN Model Regulations as reflected in the IMDG Code, ADR, RID and IATA.
14.1 UN-Number
Does not meet the criteria for classification as hazardous for transport. 
14.2 UN proper shipping name
Does not meet the criteria for classification as hazardous for transport. 
14.3 Transport hazard class(es)
Does not meet the criteria for classification as hazardous for transport. 
14.4 Packaging group
Does not meet the criteria for classification as hazardous for transport. 
14.5 Environmental hazards
This product is not classified as environmentally hazardous according to the UN Model Regulations, nor a marine pollutant 
according to the IMDG Code. 
14.6 Special precautions for users
No data available
15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 453/2010.
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture
No data available
15.2 Chemical safety assessment
A Chemical Safety Assessment has not been made for this product.
16. OTHER INFORMATION
Further Information 
Copyright © 2016 Tocris Bioscience. This company shall not be held liable for any damage resulting from handling or from 
contact with the above product. This material must only be handled by suitably qualified experienced scientists in 
appropriately equipped and authorized facilities. The above information is believed to be correct but does not purport to be 
all inclusive and should be used as a guide only for experienced personnel. Always consult your safety advisor and follow 
appropriate local and national safety legislature. The absence of warning must not, under any circumstance, be taken to 
mean that no hazard exists. 
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SAFETY DATA SHEET
Product name
B-PER® Bacterial Protein Extraction Reagent
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by Regulation (EU) No. 453/2010 -
Europe
:
Not available.Other means of 
identification
:
1.1 Product identifier
1.3 Details of the supplier of the safety data sheet
Liquid.Product type :
Product description : Not available.
1.2 Relevant identified uses of the substance or mixture and uses advised against
SECTION 1: Identification of the substance/mixture and of the company/
undertaking
Product code : 0078243 0078248 78248B 0078248S 0090084 0090084F 1861468 1861469 
1862487 1900286
1.4 Emergency telephone number
National advisory body/Poison Center
:Telephone number
Not applicable.
SDS # : 2673
National contact
Thermo Fisher Scientific Europe
Perbio Science
Industriezone III
Industrielaan 27
9320 Erembodegem Belgium
Manufacturer
Thermo Fisher Scientific 
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747 or
800.874.3723
7 AM - 5 PM Central Time (GMT -06:00)
CHEMTREC: 703-527-3887
CHEMTREC UK: +(44) 870 8200418
National Poisons Information Service (UK Only): 0870 600 6266 
QA.Rockford@thermofisher.com:e-mail address of person responsible for this SDS
Classification Not classified.:
See Section 11 for more detailed information on health effects and symptoms.
Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Product definition : Mixture
See Section 16 for the full text of the R phrases or H statements declared above.
Classification according to Directive 1999/45/EC [DPD]
The product is not classified as dangerous according to Directive 1999/45/EC and its amendments.
2.2 Label elements
Signal word :
Hazard statements :
No signal word.
No known significant effects or critical hazards.
Not classified.
The product is not classified as hazardous according to Regulation (EC) 1272/2008 as amended.
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SECTION 2: Hazards identification
:Other hazards which do 
not result in classification
None known.
Prevention :
Precautionary statements
Response :
Storage :
Disposal :
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Supplemental label 
elements
: Not applicable.
2.3 Other hazards
Annex XVII - Restrictions 
on the manufacture,
placing on the market and 
use of certain dangerous 
substances, mixtures and 
articles
: Not applicable.
Substance/mixture Mixture:
SECTION 3: Composition/information on ingredients
There are no ingredients present which, within the current knowledge of the supplier and in the concentrations 
applicable, are classified as hazardous to health or the environment, are PBTs or vPvBs or have been assigned a 
workplace exposure limit and hence require reporting in this section.
Wash out mouth with water.  Remove victim to fresh air and keep at rest in a 
position comfortable for breathing.  If material has been swallowed and the exposed 
person is conscious, give small quantities of water to drink.  Do not induce vomiting 
unless directed to do so by medical personnel.  Get medical attention if symptoms 
occur.
Skin contact
Immediately flush eyes with plenty of water, occasionally lifting the upper and lower 
eyelids.  Check for and remove any contact lenses.  Get medical attention if irritation 
occurs.
Flush contaminated skin with plenty of water.  Remove contaminated clothing and 
shoes.  Get medical attention if symptoms occur.
4.1 Description of first aid measures
Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical attention if symptoms occur.
Ingestion
Inhalation
Eye contact
:
:
:
:
Protection of first-aiders : No action shall be taken involving any personal risk or without suitable training.
SECTION 4: First aid measures
4.2 Most important symptoms and effects, both acute and delayed
Potential acute health effects
Inhalation : No known significant effects or critical hazards.
No known significant effects or critical hazards.:Ingestion
Skin contact : No known significant effects or critical hazards.
No known significant effects or critical hazards.:Eye contact
Over-exposure signs/symptoms
Skin contact
Ingestion
Inhalation No specific data.
No specific data.
No specific data.
:
:
:
Eye contact : No specific data.
4.3 Indication of any immediate medical attention and special treatment needed
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SECTION 4: First aid measures
Notes to physician Treat symptomatically.  Contact poison treatment specialist immediately if large 
quantities have been ingested or inhaled.
:
Specific treatments No specific treatment.:
Promptly isolate the scene by removing all persons from the vicinity of the incident if 
there is a fire.  No action shall be taken involving any personal risk or without 
suitable training.
Hazardous thermal 
decomposition products
Hazards from the 
substance or mixture
No specific data.
In a fire or if heated, a pressure increase will occur and the container may burst.
Fire-fighters should wear appropriate protective equipment and self-contained 
breathing apparatus (SCBA) with a full face-piece operated in positive pressure 
mode.  Clothing for fire-fighters (including helmets, protective boots and gloves)
conforming to European standard EN 469 will provide a basic level of protection for 
chemical incidents.
Special protective 
equipment for fire-fighters
Use an extinguishing agent suitable for the surrounding fire.
5.1 Extinguishing media
:
:
:
None known.
Suitable extinguishing 
media
:
Unsuitable extinguishing 
media
:
SECTION 5: Firefighting measures
5.2 Special hazards arising from the substance or mixture
5.3 Advice for firefighters
Special protective actions 
for fire-fighters
:
6.2 Environmental 
precautions
Stop leak if without risk.  Move containers from spill area.  Prevent entry into sewers,
water courses, basements or confined areas.  Wash spillages into an effluent 
treatment plant or proceed as follows.  Contain and collect spillage with non-
combustible, absorbent material e.g. sand, earth, vermiculite or diatomaceous earth 
and place in container for disposal according to local regulations.  Dispose of via a 
licensed waste disposal contractor.
Avoid dispersal of spilled material and runoff and contact with soil, waterways,
drains and sewers.  Inform the relevant authorities if the product has caused 
environmental pollution (sewers, waterways, soil or air).
Large spill :
Stop leak if without risk.  Move containers from spill area.  Dilute with water and mop 
up if water-soluble.  Alternatively, or if water-insoluble, absorb with an inert dry 
material and place in an appropriate waste disposal container.  Dispose of via a 
licensed waste disposal contractor.
Small spill :
6.3 Methods and materials for containment and cleaning up
SECTION 6: Accidental release measures
6.1 Personal precautions, protective equipment and emergency procedures
For non-emergency 
personnel
:
For emergency responders :
6.4 Reference to other 
sections
See Section 1 for emergency contact information.
See Section 8 for information on appropriate personal protective equipment.
See Section 13 for additional waste treatment information.
No action shall be taken involving any personal risk or without suitable training.
Evacuate surrounding areas.  Keep unnecessary and unprotected personnel from 
entering.  Do not touch or walk through spilled material.  Put on appropriate 
personal protective equipment.
If specialised clothing is required to deal with the spillage, take note of any 
information in Section 8 on suitable and unsuitable materials.  See also the 
information in "For non-emergency personnel".
:
:
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Store between the following temperatures: 20 to 25°C (68 to 77°F).  Store in accordance with local regulations.  Store 
in original container protected from direct sunlight in a dry, cool and well-ventilated area, away from incompatible 
materials (see Section 10) and food and drink.  Keep container tightly closed and sealed until ready for use.
Containers that have been opened must be carefully resealed and kept upright to prevent leakage.  Do not store in 
unlabeled containers.  Use appropriate containment to avoid environmental contamination.
SECTION 7: Handling and storage
The information in this section contains generic advice and guidance. The list of Identified Uses in Section 1 should be 
consulted for any available use-specific information provided in the Exposure Scenario(s).
7.1 Precautions for safe handling
Protective measures :
Advice on general 
occupational hygiene
:
7.2 Conditions for safe storage, including any incompatibilities
7.3 Specific end use(s)
Recommendations :
:Industrial sector specific 
solutions
Not available.
Not available.
Put on appropriate personal protective equipment (see Section 8).
Eating, drinking and smoking should be prohibited in areas where this material is 
handled, stored and processed.  Workers should wash hands and face before 
eating, drinking and smoking.  Remove contaminated clothing and protective 
equipment before entering eating areas.  See also Section 8 for additional 
information on hygiene measures.
Recommended monitoring 
procedures
No exposure limit value known.
Occupational exposure limits
If this product contains ingredients with exposure limits, personal, workplace 
atmosphere or biological monitoring may be required to determine the effectiveness 
of the ventilation or other control measures and/or the necessity to use respiratory 
protective equipment.  Reference should be made to monitoring standards, such as 
the following:  European Standard EN 689 (Workplace atmospheres - Guidance for 
the assessment of exposure by inhalation to chemical agents for comparison with 
limit values and measurement strategy)  European Standard EN 14042 (Workplace 
atmospheres - Guide for the application and use of procedures for the assessment 
of exposure to chemical and biological agents)  European Standard EN 482 
(Workplace atmospheres - General requirements for the performance of procedures 
for the measurement of chemical agents)  Reference to national guidance 
documents for methods for the determination of hazardous substances will also be 
required.
:
Appropriate engineering 
controls
: Good general ventilation should be sufficient to control worker exposure to airborne 
contaminants.
8.2 Exposure controls
No DNELs/DMELs available.
PNECs
No PNECs available.
SECTION 8: Exposure controls/personal protection
8.1 Control parameters
DNELs/DMELs
Individual protection measures
The information in this section contains generic advice and guidance.  Information is provided based on typical 
anticipated uses of the product.  Additional measures might be required for bulk handling or other uses that could 
significantly increase worker or exposure or environmental releases.
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SECTION 8: Exposure controls/personal protection
Hand protection
Use a properly fitted, air-purifying or air-fed respirator complying with an approved 
standard if a risk assessment indicates this is necessary.  Respirator selection 
must be based on known or anticipated exposure levels, the hazards of the product 
and the safe working limits of the selected respirator.
Chemical-resistant, impervious gloves complying with an approved standard should 
be worn at all times when handling chemical products if a risk assessment indicates 
this is necessary.
Safety eyewear complying with an approved standard should be used when a risk 
assessment indicates this is necessary to avoid exposure to liquid splashes, mists,
gases or dusts.  If contact is possible, the following protection should be worn,
unless the assessment indicates a higher degree of protection:  safety glasses with 
side-shields.
Eye/face protection
Respiratory protection :
:
:
Skin protection
Personal protective equipment for the body should be selected based on the task 
being performed and the risks involved and should be approved by a specialist 
before handling this product.
:
Environmental exposure 
controls
: Emissions from ventilation or work process equipment should be checked to 
ensure they comply with the requirements of environmental protection legislation.
In some cases, fume scrubbers, filters or engineering modifications to the process 
equipment will be necessary to reduce emissions to acceptable levels.
Wash hands, forearms and face thoroughly after handling chemical products,
before eating, smoking and using the lavatory and at the end of the working period.
Appropriate techniques should be used to remove potentially contaminated clothing.
Wash contaminated clothing before reusing.  Ensure that eyewash stations and 
safety showers are close to the workstation location.
Hygiene measures :
Body protection :
Other skin protection Appropriate footwear and any additional skin protection measures should be 
selected based on the task being performed and the risks involved and should be 
approved by a specialist before handling this product.
Not available.
Physical state
Melting point/freezing point
Initial boiling point and 
boiling range
Vapor pressure
Relative density
Vapor density
Solubility(ies)
Liquid. [Clear sparkling liquid.]
Not available.
Not available.
Not available.
Not available.
Easily soluble in the following materials: cold water and hot water.
Not available.Odor
pH
Colorless.Color
Evaporation rate Not available.
Auto-ignition temperature
Flash point
Not available.
 [Product does not sustain combustion.]
Not available.
Not available.
7.4 to 7.6
Not available.Odor threshold
Partition coefficient: n-octanol/
water
Upper/lower flammability or 
explosive limits
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
9.1 Information on basic physical and chemical properties
Appearance
Burning time Not applicable.
Burning rate Not applicable.
:
:
SECTION 9: Physical and chemical properties
Flammability (solid, gas) : Not available.
Solubility in water : Not available.
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SECTION 9: Physical and chemical properties
Viscosity Not available.:
Not available.Oxidizing properties :
9.2 Other information
Decomposition temperature : Not available.
No additional information.
10.6 Hazardous 
decomposition products
10.4 Conditions to avoid No specific data.
Under normal conditions of storage and use, hazardous decomposition products 
should not be produced.
The product is stable.10.2 Chemical stability
No specific data.
:
:
:
10.5 Incompatible materials :
10.3 Possibility of 
hazardous reactions
: Under normal conditions of storage and use, hazardous reactions will not occur.
SECTION 10: Stability and reactivity
10.1 Reactivity : No specific test data related to reactivity available for this product or its ingredients.
Acute toxicity
Conclusion/Summary : To the best of our knowledge, the toxicological properties of this product have not 
been thoroughly investigated.
Carcinogenicity
Conclusion/Summary : Not available.
Mutagenicity
Conclusion/Summary : Not available.
Teratogenicity
Conclusion/Summary : Not available.
Reproductive toxicity
Conclusion/Summary : Not available.
Irritation/Corrosion
Conclusion/Summary : Not available.
Sensitization
Conclusion/Summary : Not available.
SECTION 11: Toxicological information
11.1 Information on toxicological effects
Acute toxicity estimates
Not available.
Specific target organ toxicity (single exposure)
Specific target organ toxicity (repeated exposure)
Aspiration hazard
Not available.
Not available.
Not available.
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SECTION 11: Toxicological information
Potential chronic health effects
Potential acute health effects
Inhalation : No known significant effects or critical hazards.
No known significant effects or critical hazards.:Ingestion
Skin contact : No known significant effects or critical hazards.
No known significant effects or critical hazards.:Eye contact
No known significant effects or critical hazards.General :
No known significant effects or critical hazards.Carcinogenicity :
No known significant effects or critical hazards.Mutagenicity :
No known significant effects or critical hazards.Teratogenicity :
Not available.
Conclusion/Summary : Not available.
Developmental effects : No known significant effects or critical hazards.
Fertility effects : No known significant effects or critical hazards.
Symptoms related to the physical, chemical and toxicological characteristics
Skin contact
Ingestion
Inhalation No specific data.
No specific data.
No specific data.
:
:
:
Eye contact : No specific data.
Routes of entry anticipated: Oral, Dermal, Inhalation.Information on the likely 
routes of exposure
:
Delayed and immediate effects and also chronic effects from short and long term exposure
Short term exposure
Long term exposure
Potential immediate 
effects
Potential delayed effects :
:
Potential immediate 
effects
Potential delayed effects :
:
Other information :
Not available.
Not available.
Not available.
Not available.
Not available.
Mobility Not available.:
12.3 Bioaccumulative potential
Not available.
12.1 Toxicity
Conclusion/Summary : Not available.
12.2 Persistence and degradability
Conclusion/Summary : Not available.
SECTION 12: Ecological information
12.4 Mobility in soil
Soil/water partition 
coefficient (KOC)
Not available.:
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SECTION 12: Ecological information
12.6 Other adverse effects No known significant effects or critical hazards.
PBT : Not applicable.
vPvB : Not applicable.
12.5 Results of PBT and vPvB assessment
:
Within the present knowledge of the supplier, this product is not regarded as 
hazardous waste, as defined by EU Directive 91/689/EEC.
Hazardous waste :
:Methods of disposal
SECTION 13: Disposal considerations
The information in this section contains generic advice and guidance. The list of Identified Uses in Section 1 should be 
consulted for any available use-specific information provided in the Exposure Scenario(s).
13.1 Waste treatment methods
Product
Packaging
Methods of disposal :
Special precautions :
The generation of waste should be avoided or minimized wherever possible.  Waste 
packaging should be recycled.  Incineration or landfill should only be considered 
when recycling is not feasible.
This material and its container must be disposed of in a safe way.  Empty containers 
or liners may retain some product residues.  Avoid dispersal of spilled material and 
runoff and contact with soil, waterways, drains and sewers.
The generation of waste should be avoided or minimized wherever possible.
Disposal of this product, solutions and any by-products should at all times comply 
with the requirements of environmental protection and waste disposal legislation 
and any regional local authority requirements.  Dispose of surplus and non-
recyclable products via a licensed waste disposal contractor.  Waste should not be 
disposed of untreated to the sewer unless fully compliant with the requirements of 
all authorities with jurisdiction.
-
-
-
-
-
-
Not available.
Not available.
-
Not available.Not regulated. Not regulated.
- - -
SECTION 14: Transport information
ADR/RID IMDG IATA
14.1 UN number
14.2 UN proper 
shipping name
14.3 Transport 
hazard class(es)
14.4 Packing 
group
ADN
Additional 
information
14.5 
Environmental 
hazards
14.6 Special precautions for 
user
No. No. No. No.
Transport within user’s premises: always transport in closed containers that are 
upright and secure. Ensure that persons transporting the product know what to do in 
the event of an accident or spillage.
Not regulated.
-
-
-
-
:
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SECTION 14: Transport information
14.7 Transport in bulk 
according to Annex II of 
MARPOL 73/78 and the IBC 
Code
: Not available.
Other EU regulations
1 Appendix No. 4German hazard class for 
water
:
Not applicable.Annex XVII - Restrictions 
on the manufacture,
placing on the market 
and use of certain 
dangerous substances,
mixtures and articles
:
Europe inventory : Not determined.
SECTION 15: Regulatory information
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture
EU Regulation (EC) No. 1907/2006 (REACH)
Annex XIV - List of substances subject to authorization
15.2 Chemical Safety 
Assessment
Not applicable.
Substances of very high concern
:
None of the components are listed.
Seveso II Directive
This product is not controlled under the Seveso II Directive.
Annex XIV
None of the components are listed.
8/13/2015.Date of printing :
Not applicable.Full text of abbreviated R 
phrases
:
Not applicable.:Full text of classifications 
[DSD/DPD]
Indicates information that has changed from previously issued version.
SECTION 16: Other information
Full text of abbreviated H 
statements
:
Abbreviations and 
acronyms
: ATE = Acute Toxicity Estimate
CLP = Classification, Labelling and Packaging Regulation [Regulation (EC) No.
1272/2008]
DMEL = Derived Minimal Effect Level
DNEL = Derived No Effect Level
EUH statement = CLP-specific Hazard statement
PBT = Persistent, Bioaccumulative and Toxic
PNEC = Predicted No Effect Concentration
RRN = REACH Registration Number
vPvB = Very Persistent and Very Bioaccumulative
Procedure used to derive the classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]
Classification Justification
Not classified.
Full text of classifications 
[CLP/GHS]
:
Not applicable.
Not applicable.
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SECTION 16: Other information
Date of issue/ Date of 
revision
Version
To the best of our knowledge, the information contained herein is accurate. However, neither the above-
named supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or 
completeness of the information contained herein.
Final determination of suitability of any material is the sole responsibility of the user. All materials may 
present unknown hazards and should be used with caution. Although certain hazards are described herein,
we cannot guarantee that these are the only hazards that exist.
Notice to reader
Date of previous issue
:
:
:
8/13/2015.
10/28/2013.
1.01
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Not available.
Liquid.
CHEMTREC: 800.424.9300
Outside US: 703.527.3887
SAFETY DATA SHEET
GHS product identifier
Other means of identification
Product type
Emergency telephone 
number (with hours of 
operation)
Section 1. Identification
:
:
:
Supplier's details : Thermo Fisher Scientific 
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
815.968.0747 or
800.874.3723
7 AM - 5 PM Central Time (GMT -06:00)
HisPur Cobalt Superflow Agarose
Relevant identified uses of the substance or mixture and uses advised against
Not applicable.
Product code
SDS #
CAS #
Chemical formula
:
:
:
:
:
0025228 0025228S 0025229 0025230 0025231 1862760
8960
Not applicable.
Not applicable.
Section 2. Hazards identification
FLAMMABLE LIQUIDS - Category 3
SKIN CORROSION/IRRITATION - Category 2
SERIOUS EYE DAMAGE/ EYE IRRITATION - Category 2A
RESPIRATORY SENSITIZATION - Category 1
SKIN SENSITIZATION - Category 1
CARCINOGENICITY - Category 1B
TOXIC TO REPRODUCTION (Fertility) - Category 1A
TOXIC TO REPRODUCTION (Unborn child) - Category 1B
Classification of the 
substance or mixture
:
Signal word : Danger
Hazard statements : Flammable liquid and vapor.
Causes serious eye irritation.
Causes skin irritation.
May cause allergy or asthma symptoms or breathing difficulties if inhaled.
May cause an allergic skin reaction.
May cause cancer.
May damage fertility or the unborn child.
Hazard pictograms :
Precautionary statements
GHS label elements
OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard 
(29 CFR 1910.1200).
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Section 2. Hazards identification
Prevention : Obtain special instructions before use.  Do not handle until all safety precautions have 
been read and understood.  Use personal protective equipment as required.  Wear 
protective gloves.  Wear eye or face protection.  In case of inadequate ventilation wear 
respiratory protection.  Keep away from heat, hot surfaces, sparks, open flames and 
other ignition sources. No smoking.  Use explosion-proof electrical, ventilating, lighting 
and all material-handling equipment.  Use only non-sparking tools.  Take precautionary 
measures against static discharge.  Keep container tightly closed.  Avoid breathing vapor.
Wash hands thoroughly after handling.  Contaminated work clothing should not be 
allowed out of the workplace.
Response : IF exposed or concerned:  Get medical attention.  IF INHALED:  If breathing is difficult,
remove victim to fresh air and keep at rest in a position comfortable for breathing.  If 
experiencing respiratory symptoms:  Call a POISON CENTER or physician.  IF ON SKIN 
(or hair):  Take off immediately all contaminated clothing.  Rinse skin with water or 
shower.  IF ON SKIN:  Wash with plenty of soap and water.  Take off contaminated 
clothing.  If skin irritation or rash occurs:  Get medical attention.  IF IN EYES:  Rinse 
cautiously with water for several minutes.  Remove contact lenses, if present and easy to 
do. Continue rinsing.  If eye irritation persists:  Get medical attention.
Storage : Store locked up.  Store in a well-ventilated place.  Keep cool.
Disposal : Dispose of contents and container in accordance with all local, regional, national and 
international regulations.
Hazards not otherwise 
classified
: None known.
Section 3. Composition/information on ingredients
ethanol 10 - 20 64-17-5
Cobalt chloride (CoCl2), hexahydrate 0.1 - 1 7791-13-1
Ingredient name CAS number%
There are no additional ingredients present which, within the current knowledge of the supplier and in the 
concentrations applicable, are classified as hazardous to health or the environment and hence require reporting in 
this section.
Other means of 
identification
: Not available.
CAS number : Not applicable.
Substance/mixture
CAS number/other identifiers
:
Occupational exposure limits, if available, are listed in Section 8.
Mixture
Any concentration shown as a range is to protect confidentiality or is due to batch variation.
Immediately flush eyes with plenty of water, occasionally lifting the upper and lower 
eyelids.  Check for and remove any contact lenses.  Continue to rinse for at least 10 
minutes.  Get medical attention.
Remove victim to fresh air and keep at rest in a position comfortable for breathing.  If it is 
suspected that fumes are still present, the rescuer should wear an appropriate mask or 
self-contained breathing apparatus.  If not breathing, if breathing is irregular or if 
respiratory arrest occurs, provide artificial respiration or oxygen by trained personnel.  It 
may be dangerous to the person providing aid to give mouth-to-mouth resuscitation.  Get 
medical attention.  If necessary, call a poison center or physician.  If unconscious, place 
in recovery position and get medical attention immediately.  Maintain an open airway.
Loosen tight clothing such as a collar, tie, belt or waistband.  In the event of any 
complaints or symptoms, avoid further exposure.
Section 4. First aid measures
Eye contact
Inhalation :
:
Description of necessary first aid measures
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Section 4. First aid measures
Wash out mouth with water.  Remove dentures if any.  Remove victim to fresh air and 
keep at rest in a position comfortable for breathing.  If material has been swallowed and 
the exposed person is conscious, give small quantities of water to drink.  Stop if the 
exposed person feels sick as vomiting may be dangerous.  Do not induce vomiting 
unless directed to do so by medical personnel.  If vomiting occurs, the head should be 
kept low so that vomit does not enter the lungs.  Get medical attention.  Never give 
anything by mouth to an unconscious person.  If unconscious, place in recovery position 
and get medical attention immediately.  Maintain an open airway.  Loosen tight clothing 
such as a collar, tie, belt or waistband.
Wash with plenty of soap and water.  Remove contaminated clothing and shoes.  Wash 
contaminated clothing thoroughly with water before removing it, or wear gloves.
Continue to rinse for at least 10 minutes.  Get medical attention.  In the event of any 
complaints or symptoms, avoid further exposure.  Wash clothing before reuse.  Clean 
shoes thoroughly before reuse.
Skin contact
Ingestion :
:
Protection of first-aiders : No action shall be taken involving any personal risk or without suitable training.  If it is 
suspected that fumes are still present, the rescuer should wear an appropriate mask or 
self-contained breathing apparatus.  It may be dangerous to the person providing aid to 
give mouth-to-mouth resuscitation.  Wash contaminated clothing thoroughly with water 
before removing it, or wear gloves.
Notes to physician : Treat symptomatically.  Contact poison treatment specialist immediately if large 
quantities have been ingested or inhaled.
Specific treatments : No specific treatment.
Most important symptoms/effects, acute and delayed
Inhalation : May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Irritating to mouth, throat and stomach.:Ingestion
Skin contact : Causes skin irritation.  May cause an allergic skin reaction.
Causes serious eye irritation.:Eye contact
Over-exposure signs/symptoms
Skin contact
Ingestion
Inhalation Adverse symptoms may include the following:
wheezing and breathing difficulties
asthma
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
irritation
redness
reduced fetal weight
increase in fetal deaths
skeletal malformations
:
:
:
Eye contact : Adverse symptoms may include the following:
pain or irritation
watering
redness
Potential acute health effects
See toxicological information (Section 11)
Indication of immediate medical attention and special treatment needed, if necessary
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Section 5. Fire-fighting measures
Promptly isolate the scene by removing all persons from the vicinity of the incident if 
there is a fire.  No action shall be taken involving any personal risk or without suitable 
training.  Move containers from fire area if this can be done without risk.  Use water spray 
to keep fire-exposed containers cool.
Hazardous thermal 
decomposition products
Specific hazards arising 
from the chemical
Decomposition products may include the following materials:
carbon dioxide
carbon monoxide
Flammable liquid and vapor.  In a fire or if heated, a pressure increase will occur and the 
container may burst, with the risk of a subsequent explosion.  Runoff to sewer may 
create fire or explosion hazard.
Fire-fighters should wear appropriate protective equipment and self-contained breathing 
apparatus (SCBA) with a full face-piece operated in positive pressure mode.
Special protective 
equipment for fire-fighters
Use dry chemical, CO₂, water spray (fog) or foam.
Extinguishing media
:
:
:
Do not use water jet.
Suitable extinguishing 
media
:
Unsuitable extinguishing 
media
:
Special protective actions 
for fire-fighters
:
Section 6. Accidental release measures
Environmental precautions
Personal precautions, protective equipment and emergency procedures
Stop leak if without risk.  Move containers from spill area.  Use spark-proof tools and 
explosion-proof equipment.  Approach release from upwind.  Prevent entry into sewers,
water courses, basements or confined areas.  Wash spillages into an effluent treatment 
plant or proceed as follows.  Contain and collect spillage with non-combustible,
absorbent material e.g. sand, earth, vermiculite or diatomaceous earth and place in 
container for disposal according to local regulations (see Section 13).  Dispose of via a 
licensed waste disposal contractor.  Contaminated absorbent material may pose the 
same hazard as the spilled product.  Note: see Section 1 for emergency contact 
information and Section 13 for waste disposal.
:
: No action shall be taken involving any personal risk or without suitable training.
Evacuate surrounding areas.  Keep unnecessary and unprotected personnel from 
entering.  Do not touch or walk through spilled material.  Shut off all ignition sources.  No 
flares, smoking or flames in hazard area.  Avoid breathing vapor or mist.  Provide 
adequate ventilation.  Wear appropriate respirator when ventilation is inadequate.  Put on 
appropriate personal protective equipment.
Avoid dispersal of spilled material and runoff and contact with soil, waterways, drains and 
sewers.  Inform the relevant authorities if the product has caused environmental pollution 
(sewers, waterways, soil or air).
Large spill :
Stop leak if without risk.  Move containers from spill area.  Use spark-proof tools and 
explosion-proof equipment.  Dilute with water and mop up if water-soluble.  Alternatively,
or if water-insoluble, absorb with an inert dry material and place in an appropriate waste 
disposal container.  Dispose of via a licensed waste disposal contractor.
Small spill :
Methods and materials for containment and cleaning up
For non-emergency 
personnel
For emergency responders : If specialised clothing is required to deal with the spillage, take note of any information in 
Section 8 on suitable and unsuitable materials.  See also the information in "For non-
emergency personnel".
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Section 7. Handling and storage
Advice on general 
occupational hygiene
Conditions for safe storage,
including any 
incompatibilities
Eating, drinking and smoking should be prohibited in areas where this material is handled,
stored and processed.  Workers should wash hands and face before eating, drinking and 
smoking.  Remove contaminated clothing and protective equipment before entering 
eating areas.  See also Section 8 for additional information on hygiene measures.
Store in accordance with local regulations.  Store in a segregated and approved area.
Store in original container protected from direct sunlight in a dry, cool and well-ventilated 
area, away from incompatible materials (see Section 10) and food and drink.  Store 
locked up.  Eliminate all ignition sources.  Separate from oxidizing materials.  Keep 
container tightly closed and sealed until ready for use.  Containers that have been 
opened must be carefully resealed and kept upright to prevent leakage.  Do not store in 
unlabeled containers.  Use appropriate containment to avoid environmental 
contamination.
:
:
Protective measures Put on appropriate personal protective equipment (see Section 8).  Persons with a history 
of skin sensitization problems or asthma, allergies or chronic or recurrent respiratory 
disease should not be employed in any process in which this product is used.  Avoid 
exposure - obtain special instructions before use.  Avoid exposure during pregnancy.  Do 
not handle until all safety precautions have been read and understood.  Do not get in 
eyes or on skin or clothing.  Do not ingest.  Avoid breathing vapor or mist.  Use only with 
adequate ventilation.  Wear appropriate respirator when ventilation is inadequate.  Do not 
enter storage areas and confined spaces unless adequately ventilated.  Keep in the 
original container or an approved alternative made from a compatible material, kept 
tightly closed when not in use.  Store and use away from heat, sparks, open flame or any 
other ignition source.  Use explosion-proof electrical (ventilating, lighting and material 
handling) equipment.  Use only non-sparking tools.  Take precautionary measures 
against electrostatic discharges.  Empty containers retain product residue and can be 
hazardous.  Do not reuse container.
:
Precautions for safe handling
ethanol ACGIH TLV (United States, 2000).
  TWA: 1880 mg/m³ 8 hours.
OSHA (United States, 0/1989).
  CEIL: 7600 ppm
  TWA: 1000 ppm
  TWA: 1900 mg/m³
MSHA (United States).
  TWA: 1900 mg/m³
NIOSH (United States, 0/1994).
  TWA: 1000 ppm
  TWA: 1900 mg/m³
ACGIH (United States, 0/1996).
  TWA: 1880 mg/m³
ACGIH (United States).
  TWA: 1000 ppm
ACGIH TLV (United States, 6/2013).
  STEL: 1000 ppm 15 minutes.
NIOSH REL (United States, 4/2013).
  TWA: 1900 mg/m³ 10 hours.
  TWA: 1000 ppm 10 hours.
OSHA PEL (United States, 2/2013).
  TWA: 1900 mg/m³ 8 hours.
  TWA: 1000 ppm 8 hours.
OSHA PEL 1989 (United States, 3/1989).
  TWA: 1900 mg/m³ 8 hours.
  TWA: 1000 ppm 8 hours.
Cobalt chloride (CoCl2), hexahydrate ACGIH TLV (United States, 6/2013). Notes:
Section 8. Exposure controls/personal protection
Ingredient name Exposure limits
Control parameters
Occupational exposure limits
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Section 8. Exposure controls/personal protection
as Co
  TWA: 0.02 mg/m³, (as Co) 8 hours. Form:
Inorganic
ACGIH TLV (United States).
  : 0.02 mg/m³
OSHA PEL (United States).
  : 0.1 mg/m³
Hand protection
Use a properly fitted, air-purifying or air-fed respirator complying with an approved 
standard if a risk assessment indicates this is necessary.  Respirator selection must be 
based on known or anticipated exposure levels, the hazards of the product and the safe 
working limits of the selected respirator.
Chemical-resistant, impervious gloves complying with an approved standard should be 
worn at all times when handling chemical products if a risk assessment indicates this is 
necessary.  Considering the parameters specified by the glove manufacturer, check 
during use that the gloves are still retaining their protective properties.  It should be noted 
that the time to breakthrough for any glove material may be different for different glove 
manufacturers.  In the case of mixtures, consisting of several substances, the protection 
time of the gloves cannot be accurately estimated.
Safety eyewear complying with an approved standard should be used when a risk 
assessment indicates this is necessary to avoid exposure to liquid splashes, mists,
gases or dusts.  If contact is possible, the following protection should be worn, unless the 
assessment indicates a higher degree of protection:  chemical splash goggles.
Eye/face protection
Respiratory protection :
:
:
Body protection Personal protective equipment for the body should be selected based on the task being 
performed and the risks involved and should be approved by a specialist before handling 
this product.  When there is a risk of ignition from static electricity, wear anti-static 
protective clothing.  For the greatest protection from static discharges, clothing should 
include anti-static overalls, boots and gloves.
:
Environmental exposure 
controls
: Emissions from ventilation or work process equipment should be checked to ensure they 
comply with the requirements of environmental protection legislation.  In some cases,
fume scrubbers, filters or engineering modifications to the process equipment will be 
necessary to reduce emissions to acceptable levels.
Appropriate engineering 
controls
: Use only with adequate ventilation.  Use process enclosures, local exhaust ventilation or 
other engineering controls to keep worker exposure to airborne contaminants below any 
recommended or statutory limits.  The engineering controls also need to keep gas, vapor 
or dust concentrations below any lower explosive limits.  Use explosion-proof ventilation 
equipment.
Wash hands, forearms and face thoroughly after handling chemical products, before 
eating, smoking and using the lavatory and at the end of the working period.  Appropriate 
techniques should be used to remove potentially contaminated clothing.  Contaminated 
work clothing should not be allowed out of the workplace.  Wash contaminated clothing 
before reusing.  Ensure that eyewash stations and safety showers are close to the 
workstation location.
Hygiene measures :
Individual protection measures
Skin protection
Other skin protection : Appropriate footwear and any additional skin protection measures should be selected 
based on the task being performed and the risks involved and should be approved by a 
specialist before handling this product.
Section 9. Physical and chemical properties
Physical state
Melting point
Liquid. [Resin slurry.]
Not available.
Alcohol-like.Odor
pH
Not available.Color
Not available.
Not available.Odor threshold
:
:
:
:
:
:
Appearance
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Section 9. Physical and chemical properties
Vapor pressure
Relative density
Vapor density
Solubility
Not available.
Not available.
Not available.
Not available.
Evaporation rate Not available.
Auto-ignition temperature
Flash point
Not available.
Closed cup: 23.333°C (74°F)
Not available.
Viscosity Not available.
Partition coefficient: n-
octanol/water
:
:
:
:
:
:
:
:
:
Boiling point : Not available.
Flammability (solid, gas) : Highly flammable in the presence of the following materials or conditions: open flames,
sparks and static discharge and heat.
Lower and upper explosive 
(flammable) limits
: Not available.
Burning rate Not applicable.:
Burning time : Not applicable.
SADT Not available.:
Decomposition temperature : Not available.
Solubility in water : Not available.
Section 10. Stability and reactivity
Hazardous decomposition 
products
Conditions to avoid Avoid all possible sources of ignition (spark or flame).  Do not pressurize, cut, weld,
braze, solder, drill, grind or expose containers to heat or sources of ignition.
Under normal conditions of storage and use, hazardous decomposition products should 
not be produced.
The product is stable.Chemical stability
Reactive or incompatible with the following materials:
oxidizing materials
:
:
:
Incompatible materials :
Possibility of hazardous 
reactions
: Under normal conditions of storage and use, hazardous reactions will not occur.
Reactivity : No specific test data related to reactivity available for this product or its ingredients.
Section 11. Toxicological information
Acute toxicity
ethanol LC50 Inhalation Vapor Rat 124700 mg/m³ 4 hours
LD50 Oral Rat 7 g/kg -
Cobalt chloride (CoCl2),
hexahydrate
LD50 Oral Rat 766 mg/kg -
Product/ingredient name Result Species Dose Exposure
Conclusion/Summary : To the best of our knowledge, the toxicological properties of this product have not been 
thoroughly investigated.
Irritation/Corrosion
Information on toxicological effects
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Section 11. Toxicological information
Carcinogenicity
Mutagenicity
ethanol DNA Damage Subject: Bacteria Positive
DNA Damage Subject: Bacteria Positive
Mutation in 
Microorganisms
Subject: Bacteria Positive
Mutation in 
Microorganisms
Subject: Bacteria Positive
Gene Conversion and 
Mitotic Recombination
Subject: Bacteria Positive
Sex chromosome loss 
and nondisjunction.
Subject: Insect Positive
Cytogenetic Analysis Subject: Mammalian-Animal Positive
Cytogenetic Analysis Subject: Mammalian-Animal Positive
Cytogenetic Analysis Subject: Mammalian-Animal Positive
Cytogenetic Analysis Subject: Mammalian-Animal Positive
DNA Adduct Subject: Mammalian-Animal Positive
DNA Adduct Subject: Mammalian-Animal Positive
DNA Damage Subject: Mammalian-Animal Positive
Micronucleus Test Subject: Mammalian-Animal Positive
- Subject: Mammalian-Animal Positive
Other Mutation Test 
Systems
Subject: Mammalian-Animal Positive
Other Mutation Test 
Systems
Subject: Mammalian-Animal Positive
Sister Chromatid 
Exchange
Subject: Mammalian-Animal Positive
Specific Locus Test Subject: Mammalian-Animal Positive
Sperm Morphology Subject: Mammalian-Animal Positive
Cytogenetic Analysis Subject: Mammalian-Human Positive
Cytogenetic Analysis Subject: Mammalian-Human
Cell: Germ
Positive
Micronucleus Test Subject: Mammalian-Human
Cell: Somatic
Positive
Micronucleus Test Subject: Mammalian-Human Positive
DNA Inhibition Subject: Mammalian-Human Positive
Cytogenetic Analysis Subject: Mammalian-Human Positive
Cytogenetic Analysis Subject: Mammalian-Human Positive
Cytogenetic Analysis Subject: Mammalian-Human Positive
Sister Chromatid 
Exchange
Subject: Mammalian-Human Positive
Product/ingredient name Test Experiment Result
ethanol Eyes - Mild irritant Rabbit - 24 hours 500 
milligrams
-
Eyes - Moderate irritant Rabbit - 0.066666667 
minutes 100 
milligrams
-
Eyes - Moderate irritant Rabbit - 100 
microliters
-
Eyes - Severe irritant Rabbit - 500 milligrams -
Skin - Mild irritant Rabbit - 400 milligrams -
Skin - Moderate irritant Rabbit - 24 hours 20 
milligrams
-
Product/ingredient name Result Score Exposure Observation
Sensitization
Not available.
Species
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Section 11. Toxicological information
ethanol Equivocal - Oral - TD Mouse 400 g/kg 57 weeks 
Intermittent
Equivocal - Unreported - TDLo Mouse 120 g/kg 18 weeks 
Intermittent
Equivocal - Oral - TDLo Mouse 320 mg/kg 50 weeks 
Intermittent
Product/ingredient name Result Species Dose Exposure
Teratogenicity
ethanol Positive - Oral Woman - Female 41 g/kg -
Product/ingredient name Result Species Dose Exposure
Reproductive toxicity
Product/ingredient name Maternal 
toxicity
Fertility Development 
toxin
Species Dose Exposure
ethanol - - - Mouse Intraperitoneal:
2.9 g/kg
8 days
- - - Mouse Intraperitoneal:
2900 mg/
kg
8 days
- - - Dog - Male Unreported:
100 mg/kg
1 days
- Positive - Rat Intraperitoneal:
600 mg/kg
15 days
Positive - - Mammal - species 
unspecified
Oral: 206 
g/kg
-
- Positive - Rat - Male Unreported:
400 mg/kg
1 days
- - Positive Mouse Intraperitoneal:
15 g/kg
8 days
- Positive - Rat - Female Unreported:
2400 mg/
kg
10 days
- Positive - Woman - Female Unreported:
200 mg/kg
5 days
- Positive - Dog Oral: 221 
g/kg
-
- Positive - Mammal - species 
unspecified
Oral: 78 g/
kg
-
- - Positive Mouse Intraperitoneal:
22.8 g/kg
8 days
- - Positive Mouse Intraperitoneal:
5.8 g/kg
5 days
- - Positive Rat Intraperitoneal:
600 mg/kg
15 days
- Positive Positive Mouse Intraperitoneal:
2900 mg/
kg
8 days
- - Positive Mammal - species 
unspecified
Intravenous -
- - - Mouse - Male Oral:
1680 g/kg
70 days
Specific target organ toxicity (single exposure)
Specific target organ toxicity (repeated exposure)
Not available.
Classification
ethanol + 1 -
Cobalt chloride (CoCl2),
hexahydrate
+ 2B -
Product/ingredient name NTPIARCOSHA
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Section 11. Toxicological information
Not available.
Information on the likely 
routes of exposure
Inhalation : May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Irritating to mouth, throat and stomach.:Ingestion
Skin contact : Causes skin irritation.  May cause an allergic skin reaction.
Causes serious eye irritation.:Eye contact
Once sensitized, a severe allergic reaction may occur when subsequently exposed to 
very low levels.
General :
May cause cancer.  Risk of cancer depends on duration and level of exposure.Carcinogenicity :
No known significant effects or critical hazards.Mutagenicity :
May damage the unborn child.Teratogenicity :
Developmental effects : No known significant effects or critical hazards.
Fertility effects : May damage fertility.
Symptoms related to the physical, chemical and toxicological characteristics
Skin contact
Ingestion
Inhalation Adverse symptoms may include the following:
wheezing and breathing difficulties
asthma
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
irritation
redness
reduced fetal weight
increase in fetal deaths
skeletal malformations
:
:
:
Eye contact : Adverse symptoms may include the following:
pain or irritation
watering
redness
Potential chronic health effects
Delayed and immediate effects and also chronic effects from short and long term exposure
Not available.
Numerical measures of toxicity
Aspiration hazard
Not available.
: Routes of entry anticipated: Oral, Dermal, Inhalation.
Potential acute health effects
Potential immediate 
effects
: Not available.
Short term exposure
Potential delayed effects : Not available.
Potential immediate 
effects
: Not available.
Long term exposure
Potential delayed effects : Not available.
Date of issue/Date of revision : 2/28/2014. Date of previous issue : No previous validation. Version : 1 10/14
HisPur Cobalt Superflow Agarose
Section 11. Toxicological information
Not available.
Acute toxicity estimates
Section 12. Ecological information
LogPow BCF Potential
Bioaccumulative potential
Other adverse effects : No known significant effects or critical hazards.
Product/ingredient name
ethanol -0.35 0.66 low
Product/ingredient name Aquatic half-life Photolysis Biodegradability
ethanol - - Readily
Toxicity
ethanol Acute EC50 17.921 mg/l Marine water Algae - Ulva pertusa 96 hours
Acute EC50 2000 µg/l Fresh water Daphnia - Daphnia magna 48 hours
Acute LC50 25500 µg/l Marine water Crustaceans - Artemia 
franciscana - Larvae
48 hours
Acute LC50 42000 µg/l Fresh water Fish - Oncorhynchus mykiss 4 days
Chronic NOEC 4.995 mg/l Marine water Algae - Ulva pertusa 96 hours
Chronic NOEC 0.375 ul/L Fresh water Fish - Gambusia holbrooki -
Larvae
12 weeks
Product/ingredient name SpeciesResult Exposure
Persistence and degradability
Soil/water partition 
coefficient (KOC)
: Not available.
Mobility in soil
Section 13. Disposal considerations
The generation of waste should be avoided or minimized wherever possible.  Disposal of 
this product, solutions and any by-products should at all times comply with the 
requirements of environmental protection and waste disposal legislation and any regional 
local authority requirements.  Dispose of surplus and non-recyclable products via a 
licensed waste disposal contractor.  Waste should not be disposed of untreated to the 
sewer unless fully compliant with the requirements of all authorities with jurisdiction.
Waste packaging should be recycled.  Incineration or landfill should only be considered 
when recycling is not feasible.  This material and its container must be disposed of in a 
safe way.  Care should be taken when handling emptied containers that have not been 
cleaned or rinsed out.  Empty containers or liners may retain some product residues.
Vapor from product residues may create a highly flammable or explosive atmosphere 
inside the container.  Do not cut, weld or grind used containers unless they have been 
cleaned thoroughly internally.  Avoid dispersal of spilled material and runoff and contact 
with soil, waterways, drains and sewers.
:Disposal methods
Section 14. Transport information
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Section 14. Transport information
Flammable liquids, n.o.s. (ethanol)
3
III
Flammable liquids, n.o.s. (ethanol)
UN1993
3
III
UN1993
- -
DOT Classification IATA
UN number
UN proper 
shipping name
Transport 
hazard class(es)
Packing group
Additional 
information
Environmental 
hazards
Special precautions for user
Transport in bulk according 
to Annex II of MARPOL 
73/78 and the IBC Code
No. No.
Transport within user’s premises: always transport in closed containers that are 
upright and secure. Ensure that persons transporting the product know what to do in the 
event of an accident or spillage.
: Not available.
:
Section 15. Regulatory information
U.S. Federal regulations :
Clean Air Act  Section 112
(b) Hazardous Air 
Pollutants (HAPs)
: Not listed
Clean Air Act Section 602 
Class I Substances
: Not listed
Clean Air Act Section 602 
Class II Substances
: Not listed
DEA List I Chemicals 
(Precursor Chemicals)
: Not listed
DEA List II Chemicals 
(Essential Chemicals)
: Not listed
TSCA 8(a) CDR Exempt/Partial exemption: Not determined
United States inventory (TSCA 8b): All components are listed or exempted.
SARA 302/304
SARA 304 RQ : Not applicable.
No products were found.
Composition/information on ingredients
SARA 311/312
Classification : Fire hazard
Immediate (acute) health hazard
Delayed (chronic) health hazard
Composition/information on ingredients
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Section 15. Regulatory information
The following components are listed: ETHYL ALCOHOL
WARNING: This product contains a chemical known to the State of California to cause birth defects or other reproductive 
harm.
Massachusetts :
SARA 313
Product name CAS number %
SARA 313 notifications must not be detached from the SDS and any copying and redistribution of the SDS shall include 
copying and redistribution of the notice attached to copies of the SDS subsequently redistributed.
ethanol No. Yes. No. No.
methanol No. Yes. No. 23000 µg/day 
(ingestion)
47000 µg/day 
(inhalation)
Ingredient name Cancer Reproductive No significant risk 
level
Maximum 
acceptable dosage 
level
Cobalt chloride (CoCl2), hexahydrate 7791-13-1 0.1 - 1
Cobalt chloride (CoCl2), hexahydrate 7791-13-1 0.1 - 1
Form R - Reporting 
requirements
Supplier notification
California Prop. 65
New York : None of the components are listed.
New Jersey : The following components are listed: Agarose; ETHYL ALCOHOL; ALCOHOL; COBALT 
compounds
Pennsylvania : The following components are listed: Agarose; DENATURED ALCOHOL; COBALT 
COMPOUNDS
State regulations
ethanol 10 - 20 Yes. No. No. Yes. Yes.
Cobalt chloride (CoCl2), hexahydrate 0.1 - 1 No. No. No. Yes. Yes.
Name % Fire 
hazard
Sudden 
release of 
pressure
Reactive Immediate 
(acute)
health 
hazard
Delayed 
(chronic)
health 
hazard
Canada inventory : All components are listed or exempted.
Australia inventory (AICS): All components are listed or exempted.
China inventory (IECSC): All components are listed or exempted.
Japan inventory: Not determined.
Korea inventory: All components are listed or exempted.
Malaysia Inventory (EHS Register): Not determined.
New Zealand Inventory of Chemicals (NZIoC): All components are listed or exempted.
Philippines inventory (PICCS): All components are listed or exempted.
Taiwan inventory (CSNN): Not determined.
International regulations
International lists :
Chemical Weapons 
Convention List Schedule I 
Chemicals
: Not listed
Chemical Weapons 
Convention List Schedule 
II Chemicals
: Not listed
Chemical Weapons 
Convention List Schedule 
III Chemicals
: Not listed
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Section 16. Other information
2/28/2014.
History
Date of printing
Date of issue/Date of 
revision
Version
To the best of our knowledge, the information contained herein is accurate. However, neither the above-named 
supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or completeness of the 
information contained herein.
Final determination of suitability of any material is the sole responsibility of the user. All materials may present 
unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot 
guarantee that these are the only hazards that exist.
Notice to reader
Date of previous issue
:
:
:
:
Indicates information that has changed from previously issued version.
References : Not available.
Key to abbreviations : ATE = Acute Toxicity Estimate
BCF = Bioconcentration Factor
GHS = Globally Harmonized System of Classification and Labelling of Chemicals
IATA = International Air Transport Association
IBC = Intermediate Bulk Container
IMDG = International Maritime Dangerous Goods
LogPow = logarithm of the octanol/water partition coefficient
MARPOL 73/78 = International Convention for the Prevention of Pollution From Ships,
1973 as modified by the Protocol of 1978. ("Marpol" = marine pollution)
UN = United Nations
2/28/2014.
No previous validation.
1
Hazardous Material Information System (U.S.A.)
2
3
0
0
3
2
National Fire Protection Association (U.S.A.)
Health
Special
Instability/Reactivity
Flammability
Health
Flammability
Caution: HMIS® ratings are based on a 0-4 rating scale, with 0 representing minimal hazards or risks, and 4 
representing significant hazards or risks Although HMIS® ratings are not required on SDSs under 29 CFR 1910.
1200, the preparer may choose to provide them. HMIS® ratings are to be used with a fully implemented HMIS® 
program. HMIS® is a registered mark of the National Paint & Coatings Association (NPCA). HMIS® materials may 
be purchased exclusively from J. J. Keller (800) 327-6868.
The customer is responsible for determining the PPE code for this material.
Reprinted with permission from NFPA 704-2001, Identification of the Hazards of Materials for Emergency 
Response Copyright ©1997, National Fire Protection Association, Quincy, MA 02269. This reprinted material is 
not the complete and official position of the National Fire Protection Association, on the referenced subject 
which is represented only by the standard in its entirety.
Copyright ©2001, National Fire Protection Association, Quincy, MA 02269. This warning system is intended to be 
interpreted and applied only by properly trained individuals to identify fire, health and reactivity hazards of 
chemicals. The user is referred to certain limited number of chemicals with recommended classifications in NFPA 
49 and NFPA 325, which would be used as a guideline only. Whether the chemicals are classified by NFPA or not,
anyone using the 704 systems to classify chemicals does so at their own risk.
Physical hazards
Chronic Health Hazard
MSDS (Regulatory Specialist)Prepared by :
Date of issue/Date of revision : 2/28/2014. Date of previous issue : No previous validation. Version : 1 14/14
(In accordance with COMMISSION REGULATION (EU) No 453/2010)
______________________________________________________________________________________________________
SAFETY DATA SHEET
SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifier
Product code 88270
Product name Endotoxin Removal Resin
Chemical Name Not applicable
REACH registration number No registration number is given yet for this substance / substances in this mixture
since the annual import quantity is less than one tonnage per annum or the
transition period for its registration according to Article 23 of REACH has not yet
expired.
Relevant identified uses of the substance or mixture and uses advised against
Use Description Code Not Available
Uses advised against Not for consumer use.
Details of the supplier of the safety data sheet
Manufacturer/Supplier
24 hour Emergency Response: 866-536-0631
301-431-8585
Outside of the U.S. ++1-301-431-8585
Country specific Emergency Number (if available):  ,  ,  ,  ,
Relevant identified uses Use as laboratory reagent, Scientific research and development
LIFE TECHNOLOGIES EUROPE BV
KWARTSWEG 2
2665 NN BLEISWIJK
NETHERLANDS
31-(0)180 392 400
Email: MSDS@lifetech.com
Thermo Fisher Scientific
Pierce Biotechnology
P.O. Box 117
Rockford, IL 61105
United States
1.815.968.0747 or
1.800.874.3723
CHEMTREC Ireland (Dublin)
CHEMTREC UK (London)
+(353)-19014670 (Greeting Language: English and Irish)
+(44)-870-8200418 (Greeting Language: English)
______________________________________________________________________________________________________
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SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [CLP]
Health hazards 
Not classified
Environmental Hazards 
Not classified
Additional information
Not applicable
Label elements
Labelling according to Regulation (EC) No 1272/2008 [CLP]
Hazard pictograms
No Pictogram
Signal word
None
hazard statements
Not applicable
Precautionary Statements
Not applicable
Other Hazards
This mixture does not contain any substances that are assessed to be a PBT or a vPvB
SECTION 3: Composition/information on ingredients
Component CAS-No. EINECS-No. Weight percent REACH registration
number
Classification
according to
Regulation (EC) No
1272/2008 [CLP]
Ethyl alcohol
 64-17-5 ( 10-20 )
64-17-5 200-578-6 10-20 01-2119457610-43-X
XXX
Flam. Liq. 2 - H225
Physical hazards 
Not classified
______________________________________________________________________________________________________
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SECTION 4: First aid measures
Description of first aid measures
Skin contact Rinse with plenty of water. Immediate medical attention is not required.
Eye contact Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do.
INGESTION Not expected to present a significant ingestion hazard under anticipated conditions
of normal use. If you feel unwell, seek medical advice.
Inhalation Not expected to be an inhalation hazard under anticipated conditions of normal
use of this material.  Consult a physician if necessary.
Notes to Physician Treat symptomatically.
Most important symptoms and effects, both acute and delayed
Not applicable.
Indication of any immediate medical attention and special treatment needed
None.
SECTION 5: Firefighting measures
Extinguishing media
Suitable Extinguishing Media Water spray. Carbon dioxide (CO2). Foam. Dry chemical.
Unsuitable Extinguishing Media No information available.
Special hazards arising from the substance or mixture Not known.
Advice for fire-fighters Standard procedure for chemical fires.
SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Ensure adequate ventilation. Always wear recommended Personal Protective Equipment. Use personal protection
equipment. See Section 8 for more detail.
Environmental precautions
No special environmental precautions required.
Methods and material for containment and cleaning up
Soak up with inert absorbent material.
Reference to other sections
See section 8 for more information.
SECTION 7: Handling and storage
Precautions for safe handling
Use personal protective equipment as required. No special handling advices are necessary.
Conditions for safe storage, including any incompatibilities
Keep in a dry, cool and well-ventilated place. Keep in properly labelled containers.
Specific end use(s)
______________________________________________________________________________________________________
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Use as laboratory reagent. Scientific research and development.
SECTION 8: Exposure controls/personal protection
Control parameters
Exposure Limits
Chemical Name EU OEL (TWA) EU OEL (STEL) EU Skin Notation
Ethyl alcohol
 64-17-5
None None None
Chemical Name Austria Belgium (TWA) Denmark (TWA) Finland OEL (TWA)
Ethyl alcohol
 64-17-5
1000 ppm
1900 mg/m3
1000 ppm
1907 mg/m3
1000 ppm
1900 mg/m3
1000 ppm
1900 mg/m³
Chemical Name France OEL (VME) Germany OEL (TWA) Ireland (TWA) Italy OEL (TWA)
Ethyl alcohol
 64-17-5
1000 ppm
1900 mg/m3
500 ppm exposure factor 2
960 mg/m3 exposure factor 2
None None
Chemical Name Sweden - Occupational
Exposure Limits - TLVs
(LLVs)
Netherlands OEL (MAC) Spain OEL (TWA) United Kingdom
Ethyl alcohol
 64-17-5
500 ppm LLV; 1000 mg/m3
LLV
260 mg/m3 None 1000 ppm
1920 mg/m³
Chemical Name European Union United Kingdom France OEL (VME) Germany OEL (TWA)
Ethyl alcohol
 64-17-5
None None 1000 ppm
1900 mg/m3
500 ppm exposure factor 2
960 mg/m3 exposure factor 2
Chemical Name Italy OEL (TWA) Portugal Netherlands OEL (MAC) Finland OEL (TWA)
Ethyl alcohol
 64-17-5
None None 260 mg/m3 1000 ppm
1900 mg/m³
Chemical Name Austria Denmark Poland Switzerland
Ethyl alcohol
 64-17-5
1000 ppm
1900 mg/m3
None None None
Chemical Name Ireland Norway Lithuania OEL (TWA) Spain OEL (TWA)
Ethyl alcohol
 64-17-5
None None 500 ppm
1000 mg/m3
None
Engineering measures Ensure adequate ventilation, especially in confined areas.
Exposure controls
Personal protection equipment
Respiratory protection In case of insufficient ventilation wear respirators and components tested and
approved under appropriate government standards.
Hand Protection Wear suitable gloves Glove material: Compatible chemical-resistant gloves.
Eye protection Tight sealing safety goggles.
Skin and body protection Wear suitable protective clothing.
Hygiene measures Handle in accordance with good industrial hygiene and safety practice.
Environmental exposure controls
______________________________________________________________________________________________________
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No special environmental precautions required.
SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
Appearance Liquid
Odour no data available
Evaporation rate no data available
Flammability (solid, gas) no data available
Upper explosion limit Mixture has not been tested
Lower explosion limit Mixture has not been tested
Vapour Pressure Mixture has not been tested
Relative density Mixture has not been tested
Specific gravity no data available
Solubility no data available
Partition coefficient:
n-octanol/water
no data available
Explosive properties Mixture has not been tested
OTHER INFORMATION no data available
SECTION 10: Stability and reactivity
Reactivity None known.
Chemical stability Stable under normal conditions.
Possibility of hazardous
reactions
Hazardous reaction has not been reported.
Conditions to Avoid No information available.
Incompatible Materials No dangerous reaction known under conditions of normal use.
Hazardous decomposition
products
no data available.
Melting point / melting range °C  Mixture has not been tested °F  Mixture has not been tested
Boiling point / boiling range °C  Mixture has not been tested °F  Mixture has not been tested
Flash point °C  Mixture has not been tested °F  Mixture has not been tested
Autoignition temperature °C  Mixture has not been tested °F  Mixture has not been tested
Decomposition temperature °C  Mixture has not been tested °F  Mixture has not been tested
______________________________________________________________________________________________________
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SECTION 11: Toxicological information
Information on toxicological effects
Chemical Name LD50 (oral,rat/mouse) LD50 (dermal,rat/rabbit) LC50 (inhalation,rat/mouse)
Ethyl alcohol = 7060 mg/kg (Rat) no data available =124.7mg/L(Rat)
Principle Routes of Exposure, Potential health effects
Irritation Conclusive but not sufficient for classification
Corrosivity Conclusive but not sufficient for classification
Sensitisation Conclusive but not sufficient for classification
STOT - Single Exposure Conclusive but not sufficient for classification
STOT - Repeated Exposure Conclusive but not sufficient for classification
Carcinogenicity Conclusive but not sufficient for classification
Mutagenicity Conclusive but not sufficient for classification
Reproductive toxicity Conclusive but not sufficient for classification
SECTION 12: Ecological information
Toxicity
Chemical Name Freshwater Algae
Data
Water Flea Data Freshwater Fish
Species Data
Microtox Data log Pow
Ethyl alcohol no data available Daphnia magna
EC50=10800 mg/L (24
h) Daphnia magna
EC50=2 mg/L (48 h)
Daphnia magna
LC509268 - 14221
mg/L (48 h)
no data available no data available logPow-0.32
Persistence and degradability No information available.
Bioaccumulative potential No information available.
Results of PBT and vPvB assessment
This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other adverse effects No information available.
SECTION 13: Disposal considerations
______________________________________________________________________________________________________
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Waste treatment methods
The generation of waste should be avoided or minimized wherever possible. Empty containers or liners may retain
some product residues. This material and its container must be disposed of in according to approved disposal
technique. Disposal of this product, its solutions or of any by-products, shall comply with the requirements of all
applicable local, regional or national/federal regulations.
SECTION 14: Transport information
IATA / ADR / DOT-US / IMDG
Not classified as dangerous in the meaning of transport regulations.
UN Number Not applicable
UN proper shipping name Not applicable
Transport hazard class(es) Not applicable
Packing group Not applicable
Environmental Hazards Not applicable
Special precautions for user Not applicable
______________________________________________________________________________________________________
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Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
Not applicable.
SECTION 15: Regulatory information
Safety, health and environmental regulations/legislation specific for the substance or mixture
Substances of Very High Concern
None.
Restricted substances under EC 1907/2006, Annex XVII
None.
Substances listed under Annex I of Regulation (EC) No 689/2008
None.
Restricted substances under Annex V of Regulation (EC) No 689/2008
None.
Substances under Regulation (EC) No 850/2004 of the European Parliament and of the Council of 29 April
2004 on persistent organic pollutants and amending Directive 79/117/EEC
None.
German Water hazard classes (Wassergefährdungsklassen)
Chemical Name Weight percent Germany - Water
Classification (VwVwS) -
Annex 1
Germany - Water
Classification (VwVwS) -
Annex 2 - Water Hazard
Classes
Germany - Water
Classification (VwVwS) -
Annex 3
Ethyl alcohol 10-20 hazard class 1 - low hazard
to waters
Other International Inventories
Chemical Name EINECS (European
Union)
ELINCS (European
List of Notified
Chemical
Substances)
ENCS (Japan) PICCS (Philippines)
Ethyl alcohol Listed - Listed Listed
Chemical Name AICS (Australia) South Korea
(KECL)
Canada (DSL) NDSL
Ethyl alcohol Listed Listed Listed -
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Chemical Safety Assessment
No Chemical safety assessment has been carried out.
SECTION 16: Other information
Reason for revision Update according to Commission Regulation (EU) No 453/2010.
Classification and procedure used to derive the classification for mixtures according to Regulation (EC)
1272/2008 [CLP]:
"The above information was acquired by diligent search and/or investigation and the recommendations are based on
prudent application of professional judgment. The information shall not be taken as being all inclusive and is to be
used only as a guide. All materials and mixtures may present unknown hazards and should be used with caution.
Since the Company cannot control the actual methods, volumes, or conditions of use, the Company shall not be held
liable for any damages or losses resulting from the handling or from contact with the product as described herein.
THE INFORMATION IN THIS SDS DOES NOT CONSTITUTE A WARRENTY, EXPRESSED OR IMPLIED,
INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PUPOSE"
______________________________________________________________________________________________________
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Material Safety Data Sheet
Urea MSDS
Section 1: Chemical Product and Company Identification
Product Name: Urea
Catalog Codes: SLU1063, SLU1132, SLU1093, SLU1162
CAS#: 57-13-6
RTECS: YR6250000
TSCA: TSCA 8(b) inventory: Urea
CI#: Not available.
Synonym:   Carbamide
Chemical Name: carbonyldiamide
Chemical Formula: (NH2)2CO or CH4N2O
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Urea 57-13-6 100
Toxicological Data on Ingredients: Urea: ORAL (LD50): Acute: 8471 mg/kg [Rat]. 11000 mg/kg [Mouse].
Section 3: Hazards Identification
Potential Acute Health Effects: Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells.
TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. The substance may be toxic to
blood, cardiovascular system. Repeated or prolonged exposure to the substance can produce target organs damage.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention.
Skin Contact:
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In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove contaminated
clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical
attention.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...).
Fire Hazards in Presence of Various Substances: Slightly flammable to flammable in presence of heat.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep locked up.. Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate
the residue under a fume hood. Ground all equipment containing material. Do not ingest. Do not breathe dust. Wear suitable
protective clothing. In case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice
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immediately and show the container or the label. Avoid contact with skin and eyes. Keep away from incompatibles such as
oxidizing agents.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 23°C (73.4°F).
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Crystals solid.)
Odor:
Almost odorless; May gradually develop slight odor of ammonia, especially in presence of moisture.
Taste: Cooling. Saline
Molecular Weight: 60.06 g/mole
Color: White.
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: 132.7°C (270.9°F)
Critical Temperature: Not available.
Specific Gravity: 1.323 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: 2.07 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: The product is more soluble in water; log(oil/water) = -2.1
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water, hot water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
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Instability Temperature: Not available.
Conditions of Instability: Excess heat, excess dust generation, incompatible materials.
Incompatibility with various substances: Reactive with oxidizing agents.
Corrosivity: Not available.
Special Remarks on Reactivity:
Hygroscopic. Aborbs moisture from air. Reacts violently with Gallum Perchlorate. Reacts with chlorine to form chloramines. It
also reacts with the following: sodium hypochlorite, sodium nitrate, calcium hypochlorite, NaNO2, P2Cl5, nitrosyl perchlorate,
strong oxidizing agents (permanganate, nitrate, dichromate, chloride)
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 8471 mg/kg [Rat].
Chronic Effects on Humans:
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. May cause damage to the following organs: blood,
cardiovascular system.
Other Toxic Effects on Humans: Hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans:
May cause adverse reproductive effects (fetotoxicity) and genetic material (mutagenicity) based on animal studies. Passes
through the placental barrier in human and is present in breast milk.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Causes skin irritation. Eyes: Causes eye irritation. Inhalation: Causes irritation of the
respiratory tract, nose, and throat, coughing and sneezing. May also affect blood, metabolsim and urinary system. Ingestion:
Causes digestive (gastrointestinal) tract irritation with nausea, vomiting, and diarrhea. May affect behavior (altered sleep
time, change in motor activity), cardiovascular system (heart rate), and the brain. May also affect the blood and may cause
tumorigenic effects. Chronic Potential Health Effects: Prolonged exposure may cause adverse reproductive effects. Laboratory
experiments on animals have resulted in mutagenic effects. Prolonged exposure or exposure at high concentrations may
cause eye damage.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
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Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations:
Minnesota: Urea TSCA 8(b) inventory: Urea
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200). EINECS: This product is on the
European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R36/38- Irritating to eyes and skin. R40- Possible risks of irreversible effects. S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:32 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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1 Identification
· Product identifier
· Trade name: Imidazole
· Article number:102031
· CAS Number:
288-32-4
· EC number:
206-019-2
· Molecular Formula C₃H₄N₂
· Molecular Weight68.08 g/mol
· Application of the substance / the mixtureResearch use only.
· Details of the supplier of the safety data sheet
· Manufacturer/Supplier:
MP Biomedicals, LLC
29525 Fountain Parkway
Solon, OH 44139
United States
www.mpbio.com
· Information department:Product safety department
· Emergency telephone number:CHEMTREC: 1-800-424-9300 (1-703-527-3887)
2 Hazard(s) identification
· Classification of the substance or mixture
GHS08 Health hazard
Repr. 1A H360 May damage fertility or the unborn child.
GHS05 Corrosion
Skin Corr. 1B H314 Causes severe skin burns and eye damage.
Eye Dam. 1 H318 Causes serious eye damage.
GHS07
Acute Tox. 4 H302 Harmful if swallowed.
· Label elements
· GHS label elements
The substance is classified and labeled according to the Globally Harmonized System (GHS).
· Hazard pictograms
GHS05 GHS07 GHS08
· Signal wordDanger
· Hazard statements
Harmful if swallowed.
Causes severe skin burns and eye damage.
May damage fertility or the unborn child.
· Precautionary statements
Do not breathe dusts or mists.
(Contd. on page 2)
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Wear eye protection / face protection.
Wash thoroughly after handling.
Do not eat, drink or smoke when using this product.
Obtain special instructions before use.
Do not handle until all safety precautions have been read and understood.
If on skin (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower.
If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do.
Continue rinsing.
Immediately call a POISON CENTER/doctor.
Specific treatment (see on this label).
IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell.
IF INHALED: Remove person to fresh air and keep comfortable for breathing.
Wash contaminated clothing before reuse.
IF exposed or concerned: Get medical advice/attention.
If swallowed: Rinse mouth. Do NOT induce vomiting.
Store locked up.
Dispose of contents/container in accordance with loca /regional/national/international regulations.
· Classification system:
· NFPA ratings (scale 0 - 4)
3
1
0
Health = 3
Fire = 1
Reactivity = 0
· HMIS-ratings (scale 0 - 4)
  HEALTH
  FIRE
  REACTIVITY
*3
1
0
Health = *3
Fire = 1
Reactivity = 0
· Other hazards
· Results of PBT and vPvB assessment
· PBT: Not applicable.
· vPvB: Not applicable.
3 Composition/information on ingredients
· Chemical characterization: Substances
· CAS No. Description
288-32-4 Imidazole
· Identification number(s)
· EC number:206-019-2
4 First-aid measures
· Description of first aid measures
· General information:
Immediately remove any clothing soiled by the product.
Symptoms of poisoning may even occur after several hours; therefore medical observation for at least 48
hours after the accident.
· After inhalation: In case of unconsciousness place patient stably in side position for transportation.
· After skin contact:Immediately wash with water and soap and rinse thoroughly.
· After eye contact:Rinse opened eye for several minutes under running water. Then consult a doctor.
· After swallowing:
Immediately call a doctor.
Drink copious amounts of water and provide fresh air. Immediately call a doctor.
· Information for doctor:
· Most important symptoms and effects, both acute and delayedNo further relevant information available.
(Contd. on page 3)
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· Indication of any immediate medical attention and special treatment needed
No further relevant information available.
5 Fire-fighting measures
· Extinguishing media
· Suitable extinguishing agents:Use fire fighting measures that suit the environment.
· Special hazards arising from the substance or mixture
During heating or in case of fire poisonous gases are produced.
· Advice for firefighters
· Protective equipment:Mouth respiratory protective device.
6 Accidental release measures
· Personal precautions, protective equipment and emergency procedures
Mount respiratory protective device.
Wear protective equipment. Keep unprotected persons away.
· Environmental precautions:Do not allow to enter sewers/ surface or ground water.
· Methods and material for containment and cleaning up:
Use neutralizing agent.
Dispose contaminated material as waste according to item 13.
Ensure adequate ventilation.
· Reference to other sections
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment.
See Section 13 for disposal information.
7 Handling and storage
· Handling:
· Precautions for safe handling
Thorough dedusting.
Ensure good ventilation/exhaustion at the workplace.
Open and handle receptacle with care.
· Information about protection against explosions and fires: Keep respiratory protective device available.
· Conditions for safe storage, including any incompatibilities
· Storage:15 - 30 °C
· Requirements to be met by storerooms and receptacles: No special requirements.
· Information about storage in one common storage facility: Not required.
· Further information about storage conditions:Keep receptacle tightly sealed.
· Specific end use(s)No further relevant information available.
8 Exposure controls/personal protection
· Additional information about design of technical sytems:No further data; see item 7.
· Control parameters
· Components with limit values that require monitoring at the workplace:Not required.
· Additional information: The lists that were valid during the creation were used as basis.
· Exposure controls
· Personal protective equipment:
· General protective and hygienic measures:
Keep away from foodstuffs, beverages and feed.
Immediately remove all soiled and contaminated clothing.
(Contd. on page 4)
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Wash hands before breaks and at the end of work.
Store protective clothing separately.
Avoid contact with the eyes.
Avoid contact with the eyes and skin.
· Breathing equipment:
In case of brief exposure or low pollution use respiratory filter device. In case of intensive or longer exposure
use respiratory protective device that is independent of circulating air.
· Protection of hands:
Protective gloves
The glove material has to be impermeable and resistant to the product/ the substance/ the preparation.
Due to missing tests no recommendation to the glove mat rial can be given for the product/ the preparation/
the chemical mixture.
Selection of the glove material on consideration of the penetration times, rates of diffusion and the
degradation
· Material of gloves
The selection of the suitable gloves does not only depend on the material, but also on further marks of quality
and varies from manufacturer to manufacturer.
· Penetration time of glove material
The exact break through time has to be found out by the manufacturer of the protective gloves and has to be
observed.
· Eye protection:
Tightly sealed goggles
9 Physical and chemical properties
· Information on basic physical and chemical properties
· General Information
· Appearance:
Form: Crystalline
Color: White
· Odor: Indeterminate
· Odor threshold: Not determined.
· pH-value (100 g/l) at 23 °C (73 °F): 9 - 11
· Change in condition
Melting point/Melting range: 85 - 95 °C (185 - 203 °F)
Boiling point/Boiling range: 256 °C (493 °F)
· Flash point: 145 °C (293 °F)
· Flammability (solid, gaseous): Product is not flammable.
· Ignition temperature: 480 °C (896 °F)
· Decomposition temperature: Not determined.
· Auto igniting: Not determined.
· Danger of explosion: Product does not present an explosion hazard.
· Explosion limits:
Lower: Not determined.
Upper: Not determined.
(Contd. on page 5)
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· Vapor pressure at 20 °C (68 °F): 0.003 hPa
· Density at 20 °C (68 °F): 1.03 g/cm³ (8.595 lbs/gal)
· Relative density Not determined.
· Vapor density Not applicable.
· Evaporation rate Not applicable.
· Solubility in / Miscibility with - 
· Water at 20 °C (68 °F): 633 g/l
· Partition coefficient (n-octanol/water):Not determined.
· Viscosity:
Dynamic: Not applicable.
Kinematic: Not applicable.
· Other information No further relevant information available.
10 Stability and reactivity
· ReactivityNo further relevant information available.
· Chemical stability
· Thermal decomposition / conditions to be avoided:No decomposition if used according to specifications.
· Possibility of hazardous reactionsNo dangerous reactions known.
· Conditions to avoidNo further relevant information available.
· Incompatible materials:No further relevant information available.
· Hazardous decomposition products:No dangerous decomposition products known.
11 Toxicological information
· Information on toxicological effects
· Acute toxicity:
· LD/LC50 values that are relevant for classification:
Oral LD50 880 mg/kg (mouse)
970 mg/kg (rat)
· Primary irritant effect:
· on the skin:Caustic effect on skin and mucous membranes.
· on the eye:
Strong caustic effect.
Strong irritant with the danger of severe eye injury.
· Sensitization:No sensitizing effects known.
· Additional toxicological information:
Swallowing will lead to a strong caustic effect on mouth and throat and to the danger of perforation of
esophagus and stomach.
· Carcinogenic categories
· IARC (International Agency for Research on Cancer)Substance is not listed.
· NTP (National Toxicology Program)Substance is not listed.
· OSHA-Ca (Occupational Safety & Health Administration) Substance is not listed.
12 Ecological information
· Toxicity
· Aquatic toxicity:No further relevant information available.
· Persistence and degradabilityNo further relevant information available.
· Behavior in environmental systems:
· Bioaccumulative potentialNo further relevant information available.
(Contd. on page 6)
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· Mobility in soil No further relevant information available.
· Additional ecological information:
· General notes:
Water hazard class 1 (Assessment by list): slightly hazardous for water
Do not allow undiluted product or large quantities of it to reach ground water, water course or sewage
system.
Must not reach bodies of water or drainage ditch undiluted or unneutralized.
· Results of PBT and vPvB assessment
· PBT: Not applicable.
· vPvB: Not applicable.
· Other adverse effectsNo further relevant information available.
13 Disposal considerations
· Waste treatment methods
· Recommendation:
Must not be disposed of together with household garbage. Do not allow product to reach sewage system.
· Uncleaned packagings:
· Recommendation:Disposal must be made according to official regulations.
· Recommended cleansing agent:Water, if necessary with cleansing agents.
14 Transport information
· UN-Number
· DOT, ADR, IMDG, IATA UN3263
· UN proper shipping name
· DOT, IATA Corrosive solid, basic, organic, n.o.s. (Imidazole)
· ADR 3263 Corrosive solid, basic, organic, n.o.s. (Imidazole)
· IMDG CORROSIVE SOLID, BASIC, ORGANIC, N.O.S. (Imidazole)
· Transport hazard class(es)
· DOT
· Class 8 Corrosive substances
· Label 8 
· ADR, IMDG, IATA
· Class 8 Corrosive substances
· Label 8 
· Packing group
· DOT, ADR, IMDG, IATA III
· Environmental hazards: Not applicable.
· Special precautions for user Warning: Corrosive substances
· Danger code (Kemler): 80
· EMS Number: F-A,S-B
· Stowage Category A 
(Contd. on page 7)
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· Segregation Code SG35 Stow "separated from" acids.
· Transport in bulk according to Annex II of
MARPOL73/78 and the IBC Code Not applicable.
· Transport/Additional information:
· DOT
· Quantity limitations On passenger aircraft/rail: 25 Kg
On cargo aircraft only: 100 Kg
· ADR
· Excepted quantities (EQ) Code: E1
Maximum net quantity per inner packaging: 30 g
Maximum net quantity per outer packaging: 1000 g
· UN "Model Regulation": UN 3263 CORROSIVE SOLID, BASIC, ORGANIC, N.O.S.
(IMIDAZOLE), 8, III
15 Regulatory information
· Safety, health and environmental regulations/legislation specific for the substance or mixture
· Sara
· Section 355 (extremely hazardous substances):Substance is not listed.
· Section 313 (Specific toxic chemical listings):Substance is not listed.
· TSCA (Toxic Substances Control Act):Substance is listed.
· Proposition 65
· Chemicals known to cause cancer:Substance is not listed.
· Chemicals known to cause reproductive toxicity for emales:Substance is not listed.
· Chemicals known to cause reproductive toxicity for males:Substance is not listed.
· Chemicals known to cause developmental toxicity:Substance is not listed.
· Carcinogenic categories
· EPA (Environmental Protection Agency)Substance is not listed.
· TLV (Threshold Limit Value established by ACGIH)Substance is not listed.
· NIOSH-Ca (National Institute for Occupational Safety and Health)Substance is not listed.
· GHS label elements
The substance is classified and labeled according to the Globally Harmonized System (GHS).
· Hazard pictograms
GHS05 GHS07 GHS08
· Signal wordDanger
· Hazard statements
Harmful if swallowed.
Causes severe skin burns and eye damage.
May damage fertility or the unborn child.
· Precautionary statements
Do not breathe dusts or mists.
Wear eye protection / face protection.
Wash thoroughly after handling.
Do not eat, drink or smoke when using this product.
Obtain special instructions before use.
Do not handle until all safety precautions have been read and understood.
If on skin (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower.
If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do.
Continue rinsing.
(Contd. on page 8)
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Immediately call a POISON CENTER/doctor.
Specific treatment (see on this label).
IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell.
IF INHALED: Remove person to fresh air and keep comfortable for breathing.
Wash contaminated clothing before reuse.
IF exposed or concerned: Get medical advice/attention.
If swallowed: Rinse mouth. Do NOT induce vomiting.
Store locked up.
Dispose of contents/container in accordance with loca /regional/national/international regulations.
· Chemical safety assessment:A Chemical Safety Assessment has not been carried out.
16 Other information
This information is based on our present knowledge. However, this shall not constitute a guarantee for any
specific product features and shall not establish a legally valid contractual relationship.
· Department issuing SDS:Product safety department
· Date of preparation / last revision12/29/2015 / -
· Abbreviations and acronyms:
ADR: Accord européen sur le transport des marchandises dangereuses par Route (European Agreement concerni g the International
Carriage of Dangerous Goods by Road)
IMDG: International Maritime Code for Dangerous Goods
DOT: US Department of Transportation
IATA: International Air Transport Association
ACGIH: American Conference of Governmental Industrial Hygienists
EINECS: European Inventory of Existing Commercial Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
NFPA: National Fire Protection Association (USA)
HMIS: Hazardous Materials Identification System (USA)
LC50: Lethal concentration, 50 percent
LD50: Lethal dose, 50 percent
PBT: Persistent, Bioaccumulative and Toxic
vPvB: very Persistent and very Bioaccumulative
NIOSH: National Institute for Occupational Safety
OSHA: Occupational Safety & Health
TLV: Threshold Limit Value
PEL: Permissible Exposure Limit
REL: Recommended Exposure Limit
Acute Tox. 4: Acute toxicity, Hazard Category 4
Skin Corr. 1B: Skin corrosion/irritation, Hazard Category 1B
Eye Dam. 1: Serious eye damage/eye irritation, Hazard Category 1
Repr. 1A: Reproductive toxicity, Hazard Category 1A
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Material Safety Data Sheet
MES MSDS
Section 1: Chemical Product and Company Identification
Product Name: MES
Catalog Codes: SLM3343, SLM1198
CAS#: 4432-31-9
RTECS: KI7970000
TSCA: TSCA 8(b) inventory: MES
CI#: Not available.
Synonym:   2-(N-Morpholino)ethanesulfonic acid
Chemical Name: Not available.
Chemical Formula: C6H13NO4S.H2O
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
MES 4432-31-9 100
Toxicological Data on Ingredients: MES LD50: Not available. LC50: Not available.
Section 3: Hazards Identification
Potential Acute Health Effects: Very hazardous in case of ingestion. Hazardous in case of skin contact (irritant), of eye
contact (irritant).
Potential Chronic Health Effects:
Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. CARCINOGENIC EFFECTS:
Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL
TOXICITY: Not available. The substance is toxic to lungs, mucous membranes. Repeated or prolonged exposure to the
substance can produce target organs damage.
Section 4: First Aid Measures
Eye Contact: Check for and remove any contact lenses. Do not use an eye ointment. Seek medical attention.
Skin Contact:
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After contact with skin, wash immediately with plenty of water. Gently and thoroughly wash the contaminated skin with running
water and non-abrasive soap. Be particularly careful to clean folds, crevices, creases and groin. Cover the irritated skin with an
emollient. If irritation persists, seek medical attention. Wash contaminated clothing before reusing.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical attention.
Inhalation: Allow the victim to rest in a well ventilated area. Seek immediate medical attention.
Serious Inhalation: Not available.
Ingestion:
Do not induce vomiting. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not breathing, perform
mouth-to-mouth resuscitation. Seek immediate medical attention.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...), sulfur oxides (SO2,
SO3...).
Fire Hazards in Presence of Various Substances: Not available.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a
fume hood. Ground all equipment containing material. Do not breathe dust. Wear suitable protective clothing If you feel unwell,
seek medical attention and show the label when possible. Avoid contact with skin and eyes
Storage:
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Keep container dry. Keep in a cool place. Ground all equipment containing material. Keep container tightly closed. Keep in a
cool, well-ventilated place. Combustible materials should be stored away from extreme heat and away from strong oxidizing
agents.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Powdered solid.)
Odor: Not available.
Taste: Not available.
Molecular Weight: 213.26 g/mole
Color: Colorless.
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: Not available.
Solubility: Not available.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
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Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: No.
Section 11: Toxicological Information
Routes of Entry: Eye contact. Ingestion.
Toxicity to Animals:
LD50: Not available. LC50: Not available.
Chronic Effects on Humans: The substance is toxic to lungs, mucous membranes.
Other Toxic Effects on Humans:
Very hazardous in case of ingestion. Hazardous in case of skin contact (irritant).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans: Not available.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are more toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: MES
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Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada): CLASS D-2A: Material causing other toxic effects (VERY TOXIC).
DSCL (EEC): R36/38- Irritating to eyes and skin.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Wear appropriate respirator
when ventilation is inadequate. Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 06:06 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
p. 1
          0
          1           0
He a lt h
Fire
Re a c t iv it y
Pe rs o n a l
Pro t e c t io n
1
0
0
E
Material Safety Data Sheet
Sodium phosphate, dibasic MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium phosphate, dibasic
Catalog Codes: SLS2365, SLS2986, SLS4408
CAS#: 7558-79-4
RTECS: WC4500000
TSCA: TSCA 8(b) inventory: Sodium phosphate, dibasic
CI#: Not available.
Synonym:   Dibasic Sodium Phosphate; Disodium
hydrogen phosphate; Disodium monohydrogen phosphate;
Disodium orthophosphate; Disodium phosphoric acid;
Phosphoric acid, disodium salt; Soda phosphate; Sodium
hydrogen phosphate
Chemical Name: Sodium Monohydrogen Phosphate(2:1:1)
Chemical Formula: Na2HPO4
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium phosphate, dibasic 7558-79-4 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
Eye Contact:
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Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill: Use a shovel to put the material into a convenient waste disposal container.
Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe dust. Wear suitable protective clothing. In case of insufficient ventilation, wear suitable
respiratory equipment. If ingested, seek medical advice immediately and show the container or the label. Keep away from
incompatibles such as acids, alkalis.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Hygroscopic
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Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid powder.)
Odor: Odorless.
Taste: Saline.
Molecular Weight: 141.96 g/mole
Color: White.
pH (1% soln/water): 9.1 [Basic.]
Boiling Point: Not available.
Melting Point:
Decomposition temperature: 240°C (464°F) Converted to Sodium Pyrophosphate @ about 240 deg. C
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
Vapor Density: 4.9 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in hot water. Soluble in cold water. Insoluble in methanol, n-octanol.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability:
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Exposure to moisture and to incompatible materials. When heated to decompostition, it emits toxic fumes of phosphoxides and
sodium oxide.
Incompatibility with various substances: Reactive with acids, alkalis.
Corrosivity: Not available.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed. Incompatible with magnesium, alkaloids, antipyrine, chloral hydrate, lead acetate,
pyrogallol, resorcinol, strong mineral acids, strong organic acids.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 17000 mg/kg [Rat].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Causes mild skin irritation. May cause dermatitis. Eyes: Causes mild eye irritation.
Ingestion: May cause irritation of the digestive tract and may cause purging. It is slowly aborbed. Expected to be a low
ingestion hazard for usual industrial handling. Ingestion of large doses may affect behavior/central nervous system (tetany).
However, if a significant amount of phosphate is absorbed, hypophosphatemia will occur. Severe hypophosphatemia may
result in hypocalcemia and tetany. Cardiovasular, respiratory, neurologic, and musculoskeletal effects may occur secondary
to hypernatremia, hypophosphatemia, and hypocalcemia Inhalation: May cause respiratory tract and mucous membrane
irritation. Low hazard for usual industrial handling. Chronic Potential Health Effects: Skin: High and repeated exposure may
cause dermatitis.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
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Identification: : Not available. UNNA: 9147 PG: III
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations:
New York release reporting list: Sodium phosphate, dibasic Pennsylvania RTK: Sodium phosphate, dibasic Massachusetts
RTK: Sodium phosphate, dibasic New Jersey: Sodium phosphate, dibasic California Director's List of Hazardous Sustances:
Sodium phosphate, dibasic TSCA 8(b) inventory: Sodium phosphate, dibasic CERCLA: Hazardous substances.: Sodium
phosphate, dibasic: 5000 lbs. (2268 kg)
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according to the EU regulations. S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Safety glasses.
Section 16: Other Information
References: -Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987.
Other Special Considerations: Not available.
Created: 10/09/2005 06:34 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium chloride MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium chloride
Catalog Codes: SLS3262, SLS1045, SLS3889, SLS1669,
SLS3091
CAS#: 7647-14-5
RTECS: VZ4725000
TSCA: TSCA 8(b) inventory: Sodium chloride
CI#: Not applicable.
Synonym:   Salt; Sea Salt
Chemical Name: Sodium chloride
Chemical Formula: NaCl
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium chloride 7647-14-5 100
Toxicological Data on Ingredients: Sodium chloride: ORAL (LD50): Acute: 3000 mg/kg [Rat.]. 4000 mg/kg [Mouse].
DERMAL (LD50): Acute: &gt;10000 mg/kg [Rabbit]. DUST (LC50): Acute: &gt;42000 mg/m 1 hours [Rat].
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for
bacteria and/or yeast. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. Repeated or
prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
Eye Contact:
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Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention if symptoms appear.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: When heated to decomposition it emits toxic fumes.
Special Remarks on Explosion Hazards:
Electrolysis of sodium chloride in presence of nitrogenous compounds to produce chlorine may lead to formation of explosive
nitrogen trichloride. Potentially explosive reaction with dichloromaleic anhydride + urea.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep locked up.. Do not ingest. Do not breathe dust. Avoid contact with eyes. Wear suitable protective clothing. If ingested,
seek medical advice immediately and show the container or the label. Keep away from incompatibles such as oxidizing
agents, acids.
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Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Hygroscopic
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid crystalline powder.)
Odor: Slight.
Taste: Saline.
Molecular Weight: 58.44 g/mole
Color: White.
pH (1% soln/water): 7 [Neutral.]
Boiling Point: 1413°C (2575.4°F)
Melting Point: 801°C (1473.8°F)
Critical Temperature: Not available.
Specific Gravity: 2.165 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in cold water, hot water. Soluble in glycerol, and ammonia. Very slightly soluble in alcohol. Insoluble in
Hydrochloric Acid.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
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Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, high temperatures.
Incompatibility with various substances: Reactive with oxidizing agents, metals, acids.
Corrosivity: Not considered to be corrosive for metals and glass.
Special Remarks on Reactivity:
Hygroscopic. Reacts with most nonnoble metals such as iron or steel, building materials (such as cement) Sodium chloride is
rapidly attacked by bromine trifluoride. Violent reaction with lithium.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute oral
toxicity (LD50): 3000 mg/kg [Rat.]. Acute dermal toxicity (LD50): >10000 mg/kg [Rabbit]. Acute toxicity of the dust (LC50):
>42000 mg/m3 1 hours [Rat].
Chronic Effects on Humans: MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/
or yeast.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Lowest Published Lethal Dose (LDL) [Man] - Route: Oral; Dose: 1000 mg/kg
Special Remarks on Chronic Effects on Humans:
Causes adverse reproductive effects in humans (fetotoxicity, abortion, ) by intraplacental route. High intake of sodium chloride,
whether from occupational exposure or in the diet, may increase risk of TOXEMIA OF PREGNANCY in susceptible women
(Bishop, 1978). Hypertonic sodium chloride solutions have been used to induce abortion in late pregnancy by direct infusion
into the uterus (Brown et al, 1972), but this route of administration is not relevant to occupational exposures. May cause
adverse reproductive effects and birth defects in animals, particularly rats and mice (fetotoxicity, abortion, musculoskeletal
abnormalities, and maternal effects (effects on ovaries, fallopian tubes) by oral, intraperitoneal, intraplacental, intrauterine,
parenteral, and subcutaneous routes. While sodium chloride has been used as a negative control n some reproductive
studies, it has also been used as an example that almost any chemical can cause birth defects in experimental animals
if studied under the right conditions (Nishimura & Miyamoto, 1969). In experimental animals, sodium chloride has caused
delayed effects on newborns, has been fetotoxic, and has caused birth defects and abortions in rats and mice (RTECS, 1997).
May affect genetic material (mutagenic)
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May cause skin irritation. Eyes: Causes eye irritation. Ingestion: Ingestion of large
quantities can irritate the stomach (as in overuse of salt tablets) with nausea and vomiting. May affect behavior (muscle
spasicity/contraction, somnolence), sense organs, metabolism, and cardiovascular system. Continued exposure may
produce dehydration, internal organ congestion, and coma. Inhalation: Material is irritating to mucous membranes and upper
respiratory tract.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
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Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium chloride
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R40- Possible risks of irreversible effects. S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Splash goggles.
Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -SAX, N.I.
Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -The Sigma-Aldrich Library of
Chemical Safety Data, Edition II.
Other Special Considerations: Not available.
Created: 10/11/2005 12:33 PM
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Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Guanidine hydrochloride MSDS
Section 1: Chemical Product and Company Identification
Product Name: Guanidine hydrochloride
Catalog Codes: SLG1618, SLG2116
CAS#: 50-01-1
RTECS: MF4300000
TSCA: TSCA 8(b) inventory: Guanidine hydrochloride
CI#: Not available.
Synonym:   Aminomethanamidine hydrochloride
Chemical Name: Not available.
Chemical Formula: CH5N3.HCl
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Guanidine hydrochloride 50-01-1 100
Toxicological Data on Ingredients: Guanidine hydrochloride: ORAL (LD50): Acute: 475 mg/kg [Rat].
Section 3: Hazards Identification
Potential Acute Health Effects:
Extremely hazardous in case of ingestion. Very hazardous in case of skin contact (irritant), of eye contact (irritant).
Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is characterized by itching,
scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
Extremely hazardous in case of ingestion. Very hazardous in case of skin contact (irritant), of eye contact (irritant), of
inhalation. CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS:
Not available. DEVELOPMENTAL TOXICITY: Not available. The substance is toxic to the nervous system. Repeated or
prolonged exposure to the substance can produce target organs damage. Repeated or prolonged inhalation of dust may lead
to chronic respiratory irritation.
Section 4: First Aid Measures
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Eye Contact:
Check for and remove any contact lenses. Immediately flush eyes with running water for at least 15 minutes, keeping eyelids
open. Cold water may be used. Do not use an eye ointment. Seek medical attention.
Skin Contact:
After contact with skin, wash immediately with plenty of water. Gently and thoroughly wash the contaminated skin with running
water and non-abrasive soap. Be particularly careful to clean folds, crevices, creases and groin. Cold water may be used.
Cover the irritated skin with an emollient. If irritation persists, seek medical attention. Wash contaminated clothing before
reusing.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation: Allow the victim to rest in a well ventilated area. Seek immediate medical attention.
Serious Inhalation: Not available.
Ingestion:
Do not induce vomiting. Examine the lips and mouth to ascertain whether the tissues are damaged, a possible indication that
the toxic material was ingested; the absence of such signs, however, is not conclusive. Loosen tight clothing such as a collar,
tie, belt or waistband. If the victim is not breathing, perform mouth-to-mouth resuscitation. Seek immediate medical attention.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...).
Fire Hazards in Presence of Various Substances: Not available.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
p. 3
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a
fume hood. Ground all equipment containing material. Do not ingest. Do not breathe dust. If ingested, seek medical advice
immediately and show the container or the label. Avoid contact with skin and eyes
Storage:
Keep container dry. Keep in a cool place. Ground all equipment containing material. Keep container tightly closed. Keep in a
cool, well-ventilated place. Combustible materials should be stored away from extreme heat and away from strong oxidizing
agents.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid crystalline powder.)
Odor: Not available.
Taste: Not available.
Molecular Weight: 95.53 g/mole
Color: White.
pH (1% soln/water): 6 [Acidic.]
Boiling Point: Not available.
Melting Point: Decomposes.
Critical Temperature: Not available.
Specific Gravity: 1.4 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, methanol.
Solubility:
p. 4
Easily soluble in methanol. Soluble in cold water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: No.
Section 11: Toxicological Information
Routes of Entry: Eye contact. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 475 mg/kg [Rat].
Chronic Effects on Humans: The substance is toxic to the nervous system.
Other Toxic Effects on Humans:
Extremely hazardous in case of ingestion. Very hazardous in case of skin contact (irritant).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans: Not available.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are more toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
p. 5
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Guanidine hydrochloride
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada):
CLASS D-1B: Material causing immediate and serious toxic effects (TOXIC). CLASS D-2B: Material causing other toxic effects
(TOXIC).
DSCL (EEC):
R22- Harmful if swallowed. R38- Irritating to skin. R41- Risk of serious damage to eyes.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Wear appropriate respirator
when ventilation is inadequate. Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 05:41 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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SIGMA-ALDRICH sigma-aldrich.com 
SAFETY DATA SHEET 
Version 5.2 
Revision Date 06/27/2014 
Print Date 03/27/2017 
 
1. PRODUCT AND COMPANY IDENTIFICATION 
1.1 Product identifiers 
Product name : 1-Oleoyl-rac-glycerol 
 
Product Number : 49960 
Brand : Aldrich 
   
CAS-No. : 111-03-5 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Manufacture of substances 
1.3 Details of the supplier of the safety data sheet 
Company : Sigma-Aldrich 
3050 Spruce Street 
SAINT LOUIS MO  63103 
USA 
 
Telephone : +1 800-325-5832 
Fax : +1 800-325-5052 
1.4 Emergency telephone number 
Emergency Phone # : +1-703-527-3887 (CHEMTREC) 
 
2. HAZARDS IDENTIFICATION 
2.1 Classification of the substance or mixture 
 
Not a hazardous substance or mixture. 
2.2 GHS Label elements, including precautionary statements 
Not a hazardous substance or mixture. 
2.3 Hazards not otherwise classified (HNOC) or not covered by GHS - none 
 
3. COMPOSITION/INFORMATION ON INGREDIENTS 
3.1 Substances 
Synonyms : rac-Glycerol 1-monooleate 
Glyceryl cis-9-octadecenoate 
Monoolein 
DL-α-Monoolein 
1-(cis-9-Octadecenoyl)-rac-glycerol 
 
Formula : C21H40O4  
Molecular Weight : 356.54 g/mol 
CAS-No. : 111-03-5 
EC-No. : 203-827-7 
 
No ingredients are hazardous according to OSHA criteria. 
No components need to be disclosed according to the applicable regulations. 
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4. FIRST AID MEASURES 
4.1 Description of first aid measures 
If inhaled 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. 
In case of skin contact 
Wash off with soap and plenty of water. 
In case of eye contact 
Flush eyes with water as a precaution. 
If swallowed 
Never give anything by mouth to an unconscious person. Rinse mouth with water. 
4.2 Most important symptoms and effects, both acute and delayed 
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 
4.3 Indication of any immediate medical attention and special treatment needed 
no data available 
 
5. FIREFIGHTING MEASURES 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
Carbon oxides 
5.3 Advice for firefighters 
Wear self contained breathing apparatus for fire fighting if necessary. 
5.4 Further information 
no data available 
 
6. ACCIDENTAL RELEASE MEASURES 
6.1 Personal precautions, protective equipment and emergency procedures 
Avoid breathing vapours, mist or gas. 
For personal protection see section 8. 
6.2 Environmental precautions 
Do not let product enter drains. 
6.3 Methods and materials for containment and cleaning up 
Keep in suitable, closed containers for disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
7. HANDLING AND STORAGE 
7.1 Precautions for safe handling 
For precautions see section 2.2. 
7.2 Conditions for safe storage, including any incompatibilities 
Keep container tightly closed in a dry and well-ventilated place.  
hygroscopic Store under inert gas. Air and light sensitive.  
7.3 Specific end use(s) 
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated 
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8. EXPOSURE CONTROLS/PERSONAL PROTECTION 
8.1 Control parameters 
Components with workplace control parameters 
Contains no substances with occupational exposure limit values. 
8.2 Exposure controls 
Appropriate engineering controls 
General industrial hygiene practice. 
Personal protective equipment 
Eye/face protection 
Use equipment for eye protection tested and approved under appropriate government standards such as 
NIOSH (US) or EN 166(EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without 
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after 
use in accordance with applicable laws and good laboratory practices. Wash and dry hands. 
 
Full contact 
Material: Nitrile rubber 
Minimum layer thickness: 0.11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
Splash contact 
Material: Nitrile rubber 
Minimum layer thickness: 0.11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, test method: 
EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, contact the 
supplier of the CE approved gloves. This recommendation is advisory only and must be evaluated by an 
industrial hygienist and safety officer familiar with the specific situation of anticipated use by our customers. It 
should not be construed as offering an approval for any specific use scenario. 
 
Body Protection 
impervious clothing, The type of protective equipment must be selected according to the concentration and 
amount of the dangerous substance at the specific workplace. 
Respiratory protection 
Respiratory protection not required. For nuisance exposures use type OV/AG (US) or type ABEK (EU EN 
14387) respirator cartridges. Use respirators and components tested and approved under appropriate 
government standards such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
Do not let product enter drains. 
 
9. PHYSICAL AND CHEMICAL PROPERTIES 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: liquid 
b) Odour no data available 
c) Odour Threshold no data available 
d) pH no data available 
e) Melting point/freezing 
point 
35.0 °C (95.0 °F) 
f) Initial boiling point and no data available 
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boiling range 
g) Flash point 154.0 °C (309.2 °F) - closed cup 
h) Evapouration rate no data available 
i) Flammability (solid, gas) no data available 
j) Upper/lower 
flammability or 
explosive limits 
no data available 
k) Vapour pressure no data available 
l) Vapour density no data available 
m) Relative density no data available 
n) Water solubility no data available 
o) Partition coefficient: n-
octanol/water 
no data available 
p) Auto-ignition 
temperature 
no data available 
q) Decomposition 
temperature 
no data available 
r) Viscosity no data available 
s) Explosive properties no data available 
t) Oxidizing properties no data available 
9.2 Other safety information 
no data available 
 
10. STABILITY AND REACTIVITY 
10.1 Reactivity 
no data available 
10.2 Chemical stability 
Stable under recommended storage conditions. 
10.3 Possibility of hazardous reactions 
no data available 
10.4 Conditions to avoid 
no data available 
10.5 Incompatible materials 
Strong oxidizing agents 
10.6 Hazardous decomposition products 
Other decomposition products - no data available 
In the event of fire: see section 5 
 
11. TOXICOLOGICAL INFORMATION 
11.1 Information on toxicological effects 
Acute toxicity 
no data available 
Inhalation: no data available 
Dermal: no data available 
no data available 
Skin corrosion/irritation 
no data available 
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Serious eye damage/eye irritation 
no data available 
Respiratory or skin sensitisation 
no data available 
Germ cell mutagenicity 
no data available 
 
Carcinogenicity 
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as a 
carcinogen or potential carcinogen by ACGIH. 
NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a 
known or anticipated carcinogen by NTP. 
OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a 
carcinogen or potential carcinogen by OSHA. 
Reproductive toxicity 
no data available 
no data available 
Specific target organ toxicity - single exposure 
no data available 
Specific target organ toxicity - repeated exposure 
no data available 
Aspiration hazard 
no data available 
Additional Information 
RTECS: Not available 
 
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly 
investigated. 
 
 
12. ECOLOGICAL INFORMATION 
12.1 Toxicity 
no data available 
12.2 Persistence and degradability 
no data available 
12.3 Bioaccumulative potential 
no data available 
12.4 Mobility in soil 
no data available 
12.5 Results of PBT and vPvB assessment 
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted 
12.6 Other adverse effects 
 
no data available 
 
13. DISPOSAL CONSIDERATIONS 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company.  
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Contaminated packaging 
Dispose of as unused product.  
 
14. TRANSPORT INFORMATION 
DOT (US) 
Not dangerous goods 
 
IMDG 
Not dangerous goods 
 
IATA 
Not dangerous goods 
 
15. REGULATORY INFORMATION 
SARA 302 Components 
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302. 
SARA 313 Components 
SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the 
threshold (De Minimis) reporting levels established by SARA Title III, Section 313. 
SARA 311/312 Hazards 
No SARA Hazards 
Massachusetts Right To Know Components 
No components are subject to the Massachusetts Right to Know Act. 
Pennsylvania Right To Know Components 
 
2,3-Dihydroxypropyl oleate 
CAS-No. 
111-03-5 
Revision Date 
 
New Jersey Right To Know Components 
 
2,3-Dihydroxypropyl oleate 
CAS-No. 
111-03-5 
Revision Date 
 
California Prop. 65 Components 
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other 
reproductive harm. 
 
 
 
16. OTHER INFORMATION 
HMIS Rating 
Health hazard: 0 
Chronic Health Hazard:  
Flammability: 1 
Physical Hazard 0 
NFPA Rating 
Health hazard: 0 
Fire Hazard: 1 
Reactivity Hazard: 0 
Further information 
Copyright 2014 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a 
guide. The information in this document is based on the present state of our knowledge and is applicable to the 
product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the 
product. Sigma-Aldrich Corporation and its Affiliates shall not be held liable for any damage resulting from handling 
or from contact with the above product. See www.sigma-aldrich.com and/or the reverse side of invoice or packing 
slip for additional terms and conditions of sale. 
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Preparation Information 
Sigma-Aldrich Corporation 
Product Safety – Americas Region 
1-800-521-8956 
 
Version: 5.2 Revision Date: 06/27/2014 Print Date: 03/27/2017 
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SIGMA-ALDRICH sigma-aldrich.com 
SAFETY DATA SHEET 
Version 4.11 
Revision Date 06/02/2016 
Print Date 04/15/2017 
 
1. PRODUCT AND COMPANY IDENTIFICATION 
1.1 Product identifiers 
Product name : Sodium hydroxide 
 
Product Number : 221465 
Brand : Sigma-Aldrich 
Index-No. : 011-002-00-6 
   
CAS-No. : 1310-73-2 
1.2 Relevant identified uses of the substance or mixture and uses advised against 
Identified uses : Laboratory chemicals, Synthesis of substances 
 
1.3 Details of the supplier of the safety data sheet 
Company : Sigma-Aldrich 
3050 Spruce Street 
SAINT LOUIS MO  63103 
USA 
 
Telephone : +1 800-325-5832 
Fax : +1 800-325-5052 
1.4 Emergency telephone number 
Emergency Phone # : +1-703-527-3887 (CHEMTREC) 
 
2. HAZARDS IDENTIFICATION 
2.1 Classification of the substance or mixture 
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) 
Corrosive to metals (Category 1), H290 
Skin corrosion (Category 1A), H314 
Serious eye damage (Category 1), H318 
Acute aquatic toxicity (Category 3), H402 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
2.2 GHS Label elements, including precautionary statements 
Pictogram 
  
Signal word Danger 
 
Hazard statement(s) 
H290 May be corrosive to metals. 
H314 Causes severe skin burns and eye damage. 
H402 Harmful to aquatic life. 
 
Precautionary statement(s) 
P234 Keep only in original container. 
P260 Do not breathe dust or mist. 
P264 Wash skin thoroughly after handling. 
P273 Avoid release to the environment. 
P280 Wear protective gloves/ protective clothing/ eye protection/ face 
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protection. 
P301 + P330 + P331 IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. 
P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. 
Rinse skin with water/shower. 
P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for 
breathing. Immediately call a POISON CENTER/doctor. 
P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove 
contact lenses, if present and easy to do. Continue rinsing. Immediately 
call a POISON CENTER/doctor. 
P363 Wash contaminated clothing before reuse. 
P390 Absorb spillage to prevent material damage. 
P405 Store locked up. 
P406 Store in corrosive resistant stainless steel container with a resistant inner 
liner. 
P501 Dispose of contents/ container to an approved waste disposal plant. 
 
2.3 Hazards not otherwise classified (HNOC) or not covered by GHS - none 
 
3. COMPOSITION/INFORMATION ON INGREDIENTS 
3.1 Substances 
Synonyms : ‘Caustic soda’ 
 
Formula : HNaO 
Molecular weight : 40.00 g/mol 
CAS-No. : 1310-73-2 
EC-No. : 215-185-5 
Index-No. : 011-002-00-6 
Registration number : 01-2119457892-27-XXXX 
 
Hazardous components 
Component Classification Concentration 
Sodium hydroxide 
   Met. Corr. 1; Skin Corr. 1A; 
Eye Dam. 1; Aquatic Acute 3; 
H290, H314, H318, H402 
<= 100 % 
For the full text of the H-Statements mentioned in this Section, see Section 16. 
 
4. FIRST AID MEASURES 
4.1 Description of first aid measures 
General advice 
Consult a physician. Show this safety data sheet to the doctor in attendance. 
If inhaled 
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician. 
In case of skin contact 
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Consult a physician. 
In case of eye contact 
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.Continue rinsing eyes during 
transport to hospital. 
If swallowed 
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a 
physician. 
4.2 Most important symptoms and effects, both acute and delayed 
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 
 
4.3 Indication of any immediate medical attention and special treatment needed 
No data available 
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5. FIREFIGHTING MEASURES 
5.1 Extinguishing media 
Suitable extinguishing media 
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 
5.2 Special hazards arising from the substance or mixture 
No data available 
5.3 Advice for firefighters 
Wear self-contained breathing apparatus for firefighting if necessary. 
5.4 Further information 
No data available 
 
6. ACCIDENTAL RELEASE MEASURES 
6.1 Personal precautions, protective equipment and emergency procedures 
Wear respiratory protection. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. 
Evacuate personnel to safe areas. Avoid breathing dust. 
For personal protection see section 8. 
6.2 Environmental precautions 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment 
must be avoided. 
6.3 Methods and materials for containment and cleaning up 
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for 
disposal. 
6.4 Reference to other sections 
For disposal see section 13. 
 
7. HANDLING AND STORAGE 
7.1 Precautions for safe handling 
Avoid formation of dust and aerosols.Further processing of solid materials may result in the formation of combustible 
dusts. The potential for combustible dust formation should be taken into consideration before additional processing 
occurs. 
Provide appropriate exhaust ventilation at places where dust is formed. 
For precautions see section 2.2. 
7.2 Conditions for safe storage, including any incompatibilities 
Keep container tightly closed in a dry and well-ventilated place.  
Storage class (TRGS 510): Non-combustible, corrosive hazardous materials 
7.3 Specific end use(s) 
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated 
 
8. EXPOSURE CONTROLS/PERSONAL PROTECTION 
8.1 Control parameters 
Components with workplace control parameters 
Component CAS-No. Value Control 
parameters 
Basis 
Sodium hydroxide 1310-73-2 TWA 2.000000 
mg/m3 
USA. Occupational Exposure Limits 
(OSHA) - Table Z-1 Limits for Air 
Contaminants 
  C 2.000000 
mg/m3 
USA. ACGIH Threshold Limit Values 
(TLV) 
 Remarks Upper Respiratory Tract irritation 
Eye irritation 
Skin irritation 
 
Sigma-Aldrich - 221465  Page 4  of  8 
 
  C 2 mg/m3 USA. ACGIH Threshold Limit Values 
(TLV) 
  Upper Respiratory Tract irritation 
Eye irritation 
Skin irritation 
  C 2.000000 
mg/m3 
USA. NIOSH Recommended 
Exposure Limits 
  C 2 mg/m3 California permissible exposure 
limits for chemical contaminants 
(Title 8, Article 107) 
Derived No Effect Level (DNEL) 
Application Area Exposure 
routes 
Health effect Value 
Workers Inhalation Long-term local effects 1 mg/m3 
Consumers Inhalation Long-term local effects 1 mg/m3 
8.2 Exposure controls 
Appropriate engineering controls 
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of 
workday. 
Personal protective equipment 
Eye/face protection 
Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate 
government standards such as NIOSH (US) or EN 166(EU). 
Skin protection 
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without 
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after 
use in accordance with applicable laws and good laboratory practices. Wash and dry hands. 
 
Full contact 
Material: Nitrile rubber 
Minimum layer thickness: 0.11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
Splash contact 
Material: Nitrile rubber 
Minimum layer thickness: 0.11 mm 
Break through time: 480 min 
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M) 
 
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, test method: 
EN374 
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, contact the 
supplier of the CE approved gloves. This recommendation is advisory only and must be evaluated by an 
industrial hygienist and safety officer familiar with the specific situation of anticipated use by our customers. It 
should not be construed as offering an approval for any specific use scenario. 
 
Body Protection 
Complete suit protecting against chemicals, The type of protective equipment must be selected according to 
the concentration and amount of the dangerous substance at the specific workplace. 
Respiratory protection 
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type 
N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the 
sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and 
approved under appropriate government standards such as NIOSH (US) or CEN (EU). 
Control of environmental exposure 
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the 
environment must be avoided. 
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9. PHYSICAL AND CHEMICAL PROPERTIES 
9.1 Information on basic physical and chemical properties 
a) Appearance Form: pellets 
Colour: white 
b) Odour odourless 
c) Odour Threshold No data available 
d) pH 14 at 50 g/l at 20 °C (68 °F) 
e) Melting point/freezing 
point 
Melting point/range: 318 °C (604 °F) - lit. 
f) Initial boiling point and 
boiling range 
1,390 °C (2,534 °F) 
g) Flash point Not applicable 
h) Evaporation rate No data available 
i) Flammability (solid, gas) No data available 
j) Upper/lower 
flammability or 
explosive limits 
No data available 
k) Vapour pressure < 24.00 hPa (< 18.00 mmHg) at 20 °C (68 °F) 
4.00 hPa (3.00 mmHg) at 37 °C (99 °F) 
l) Vapour density 1.38 - (Air = 1.0) 
m) Relative density 2.1300 g/cm3 
n) Water solubility ca.1,260 g/l at 20 °C (68 °F) 
o) Partition coefficient: n-
octanol/water 
No data available 
p) Auto-ignition 
temperature 
No data available 
q) Decomposition 
temperature 
No data available 
r) Viscosity No data available 
s) Explosive properties No data available 
t) Oxidizing properties No data available 
9.2 Other safety information 
 Bulk density ca.1,150 kg/m3 
 Relative vapour density 1.38 - (Air = 1.0) 
 
10. STABILITY AND REACTIVITY 
10.1 Reactivity 
No data available 
10.2 Chemical stability 
Stable under recommended storage conditions. 
10.3 Possibility of hazardous reactions 
No data available 
10.4 Conditions to avoid 
No data available 
10.5 Incompatible materials 
Strong oxidizing agents, Strong acids, Organic materials 
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10.6 Hazardous decomposition products 
Hazardous decomposition products formed under fire conditions. - Sodium oxides 
Other decomposition products - No data available 
Hazardous decomposition products formed under fire conditions. - Sodium oxides 
In the event of fire: see section 5 
 
11. TOXICOLOGICAL INFORMATION 
11.1 Information on toxicological effects 
Acute toxicity 
No data available 
Inhalation: No data available 
Dermal: No data available 
No data available 
Skin corrosion/irritation 
Skin - Rabbit 
Result: Causes severe burns. - 24 h 
 
Serious eye damage/eye irritation 
Eyes - Rabbit 
Result: Corrosive - 24 h 
 
Respiratory or skin sensitisation 
Will not occur 
Germ cell mutagenicity 
No data available 
 
Carcinogenicity 
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by IARC. 
NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a 
known or anticipated carcinogen by NTP. 
OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a 
carcinogen or potential carcinogen by OSHA. 
Reproductive toxicity 
No data available 
No data available 
Specific target organ toxicity - single exposure 
No data available 
Specific target organ toxicity - repeated exposure 
No data available 
Aspiration hazard 
No data available 
Additional Information 
RTECS: WB4900000 
 
Material is extremely destructive to tissue of the mucous membranes and upper respiratory tract, eyes, and skin. 
 
 
12. ECOLOGICAL INFORMATION 
12.1 Toxicity 
 
Toxicity to fish LC50 - Gambusia affinis (Mosquito fish) - 125 mg/l  - 96 h 
 
 LC50 - Oncorhynchus mykiss (rainbow trout) - 45.4 mg/l  - 96 h 
 
Toxicity to daphnia and Immobilization EC50 - Daphnia (water flea) - 40.38 mg/l  - 48 h 
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other aquatic 
invertebrates 
12.2 Persistence and degradability 
The methods for determining the biological degradability are not applicable to inorganic substances. 
12.3 Bioaccumulative potential 
No data available 
12.4 Mobility in soil 
No data available 
12.5 Results of PBT and vPvB assessment 
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted 
12.6 Other adverse effects 
An environmental hazard cannot be excluded in the event of unprofessional handling or disposal. 
Harmful to aquatic life. 
 
13. DISPOSAL CONSIDERATIONS 
13.1 Waste treatment methods 
Product 
Offer surplus and non-recyclable solutions to a licensed disposal company.  
Contaminated packaging 
Dispose of as unused product.  
 
14. TRANSPORT INFORMATION 
DOT (US) 
UN number: 1823 Class: 8 Packing group: II 
Proper shipping name: Sodium hydroxide, solid 
Reportable Quantity (RQ): 1000 lbs 
 
Poison Inhalation Hazard: No 
 
IMDG 
UN number: 1823 Class: 8 Packing group: II EMS-No: F-A, S-B 
Proper shipping name: SODIUM HYDROXIDE, SOLID 
  
IATA 
UN number: 1823 Class: 8 Packing group: II 
Proper shipping name: Sodium hydroxide, solid 
 
15. REGULATORY INFORMATION 
SARA 302 Components 
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302. 
SARA 313 Components 
This material does not contain any chemical components with known CAS numbers that exceed the threshold (De 
Minimis) reporting levels established by SARA Title III, Section 313. 
SARA 311/312 Hazards 
No SARA Hazards 
Massachusetts Right To Know Components 
 
Sodium hydroxide 
CAS-No. 
1310-73-2 
Revision Date 
2007-03-01 
Pennsylvania Right To Know Components 
 
Sodium hydroxide 
CAS-No. 
1310-73-2 
Revision Date 
2007-03-01 
New Jersey Right To Know Components 
 CAS-No. Revision Date 
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Sodium hydroxide 1310-73-2 2007-03-01 
California Prop. 65 Components 
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other 
reproductive harm. 
 
 
 
16. OTHER INFORMATION 
Full text of H-Statements referred to under sections 2 and 3. 
Aquatic Acute Acute aquatic toxicity 
Eye Dam. Serious eye damage  
H290 May be corrosive to metals. 
H314 Causes severe skin burns and eye damage. 
H318 Causes serious eye damage. 
H402 Harmful to aquatic life. 
Met. Corr. Corrosive to metals 
HMIS Rating 
Health hazard: 3 
Chronic Health Hazard:  
Flammability: 0 
Physical Hazard 0 
NFPA Rating 
Health hazard: 3 
Fire Hazard: 0 
Reactivity Hazard: 0 
Health hazard: 2 
Fire Hazard: 0 
Reactivity Hazard: 0 
Further information 
Copyright 2016 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies for internal use only. 
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a 
guide. The information in this document is based on the present state of our knowledge and is applicable to the 
product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the 
product. Sigma-Aldrich Corporation and its Affiliates shall not be held liable for any damage resulting from handling 
or from contact with the above product. See www.sigma-aldrich.com and/or the reverse side of invoice or packing 
slip for additional terms and conditions of sale. 
 
Preparation Information 
Sigma-Aldrich Corporation 
Product Safety – Americas Region 
1-800-521-8956 
 
Version: 4.11 Revision Date: 06/02/2016 Print Date: 04/15/2017 
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Ethanol, Denatured, 95%
Section 1 Product Description
Product Name: Ethanol, Denatured, 95%
Recommended Use: Science education applications
Synonyms: Alcohol, Ethyl alcohol
Distributor: Carolina Biological Supply Company
2700 York Road, Burlington, NC 27215
1-800-227-1150
Chemical Information: 800-227-1150 (8am-5pm (ET) M-F)
Chemtrec: 800-424-9300 (Transportation Spill Response 24 hours)
Section 2 Hazard Identification
Classification of the chemical in accordance with paragraph (d) of §1910.1200;
DANGER
Highly flammable liquid and vapor. May cause damage to organs.
GHS Classification:
Flammable Liquid Category 2, Specific Target Organ Systemic Toxicity (STOT) - Single Exposure Category 2
Other Safety Precautions: IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.
Section 3 Composition / Information on Ingredients
Chemical Name CAS # % 
Ethanol 64-17-5 85.98
Water 7732-18-5 5
2-Propanol 67-63-0 4.75
Methanol 67-56-1 4.28
Section 4 First Aid Measures
Emergency and First Aid Procedures
Inhalation: In case of accident by inhalation: remove casualty to fresh air and keep at rest.
Eyes: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
Skin Contact: After contact with skin, wash immediately with plenty of water.
Ingestion: If swallowed, do not induce vomiting: seek medical advice immediately and show this container or label.
Section 5 Firefighting Procedures
Extinguishing Media: Use dry chemical, CO2 or appropriate foam.
Fire Fighting Methods and Protection: Firefighters should wear full protective equipment and NIOSH approved self-contained 
breathing apparatus.
Fire and/or Explosion Hazards: Vapors may travel back to ignition source. Closed Containers exposed to heat may 
explode. 
Hazardous Combustion Products: Carbon dioxide, Carbon monoxide
Section 6 Spill or Leak Procedures
Safety Data Sheet
Ethanol, Denatured, 95% Page 2 of 4
Steps to Take in Case Material Is 
Released or Spilled:
No health affects expected from the clean-up of this material if contact can be avoided. 
Follow personal protective equipment recommendations found in Section 8 of this (M)SDS  
Ventilate the contaminated area. Evaporation of volatile substances can lead to the 
displacement of air creating an environment that can cause asphyxiation. Isolate area. Keep 
unnecessary personnel away.
 Ventilate the area by opening door and/or turning on fans and blowers. Use an inert 
absorbent such as sand or vermiculite. Place in properly labeled closed container.
Section 7 Handling and Storage
Handling: Keep away from heat/sparks/open flames/hot surfaces. – No smoking. Keep container tightly closed. 
Ground/bond container and receiving equipment. Use explosion-proof electrical/ventilating/lighting/…/ 
equipment. Use only non-sparking tools. Take precautionary measures against static discharge. Do not breathe 
dust/fume/gas/mist/vapors/spray. Wash thoroughly after handling. Do no eat, drink or smoke when using this 
product. Wear protective gloves/protective clothing/eye protection/face protection.
Storage: Keep container tightly closed. Store in a well-ventilated place. Keep cool. Store locked up. Suitable for any 
general chemical storage.
Storage Code: Red - Flammables. Store in approved flammable containers. Store away from oxidizing materials.
Section 8 Protection Information
ACGIH OSHA PEL
Chemical Name (TWA) (STEL) (TWA) (STEL)
Ethanol N/A 1000 ppm STEL 1000 ppm TWA; 
1900 mg/m3 TWA
N/A
2-Propanol 200 ppm TWA 400 ppm STEL 400 ppm TWA; 980 
mg/m3 TWA
N/A
Methanol 200 ppm TWA 250 ppm STEL 200 ppm TWA; 260 
mg/m3 TWA
N/A
Control Parameters
Engineering Measures: Local exhaust ventilation or other engineering controls are normally required when 
handling or using this product to avoid overexposure.
Personal Protective Equipment (PPE): Lab coat, apron, eye wash, safety shower.
Respiratory Protection: No respiratory protection required under normal conditions of use. Provide general room 
exhaust ventilation if symptoms of overexposure occur as explained Section 11. A 
respirator is not normally required.
Respirator Type(s): None required where adequate ventilation is provided. If airborne concentrations are 
above the applicable exposure limits, use NIOSH/MSHA approved respiratory protection.
Eye Protection: Wear chemical splash goggles when handling this product. Have an eye wash station 
available.
Skin Protection: Wear protective gloves. Inspect gloves for chemical break-through and replace at regular 
intervals. Clean protective equipment regularly. Wash hands and other exposed areas 
with mild soap and water before eating, drinking, and when leaving work
Gloves: Nitrile
Section 9 Physical Data
Formula: CH3CH2OH Vapor Pressure: 57.3 hPa at 20°C
Molecular Weight: (Ethanol) 46.07 Evaporation Rate (BuAc=1): 3.3
Appearance: Colorless Liquid Vapor Density (Air=1): 1.6
Odor: Moderate Alcohol Odor Specific Gravity: (Ethanol) 0.789 at 20 °C
Odor Threshold: No data available Solubility in Water: Soluble
pH: No data available Log Pow (calculated): -0.32
Melting Point: -114 C Autoignition Temperature: 363 C
Boiling Point: 79 C Decomposition Temperature: No data available
Flash Point: 17 C Viscosity: No data available
Flammable Limits in Air: 3.3 -  19% (Ethanol) Percent Volatile by Volume: 95%
Section 10 Reactivity Data
Reactivity: Not generally reactive under normal conditions.
Chemical Stability: Stable under normal conditions.
Conditions to Avoid: Temperatures above flash point in combination with sparks, open flames, or other 
sources of ignition.
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Incompatible Materials: Organic Peroxides, Strong acids, Oxidizing materials, Water-reactive materials
Hazardous Decomposition Products: Carbon dioxide
Hazardous Polymerization: Will not occur
Section 11 Toxicity Data
Routes of Entry Inhalation and ingestion.
Symptoms (Acute): Respiratory Irritation, Dermititis, Central Nervous System Depression
Delayed Effects: Liver disorders
Acute Toxicity:
Chemical Name CAS Number Oral LD50 Dermal LD50 Inhalation LC50
Water 7732-18-5 Oral LD50 Rat 
90000 mg/kg
2-Propanol 67-63-0 Oral LD50 Rat 
5045 mg/kg
Oral LD50 Mouse 
3600 mg/kg
INHALATION 
LC50 Rat 16000 
ppm
Methanol 67-56-1 Oral LD50 Mouse 
7300 mg/kg
INHALATION 
LC50 Rat 64000 
ppm
Carcinogenicity:
Chemical Name CAS Number IARC NTP OSHA
Ethanol 64-17-5 Listed Listed Listed
2-Propanol 67-63-0 Listed Not listed Not listed
Methanol 67-56-1 Not listed Not listed Not listed
Chronic Effects:
Mutagenicity: No evidence of a mutagenic effect.
Teratogenicity: No evidence of a teratogenic effect (birth defect).
Sensitization: No evidence of a sensitization effect.
Reproductive: No evidence of negative reproductive effects.
  Target Organ Effects:
Acute: Central Nervous System, Eyes
Chronic: Eyes
Section 12 Ecological Data
Overview: Slight ecological hazard. In high concentrations, this product may be dangerous to plants and/or 
wildlife.
Mobility: This material is expected to have moderate mobility in soil. It absorbs to most soil types.
Persistence: Biodegradation
Bioaccumulation: Bioconcentration is not expected to occur.
Degradability: Biodegrades quickly.
Other Adverse Effects: No data
Chemical Name CAS Number Eco Toxicity
Ethanol
Water
2-Propanol
Methanol
64-17-5
7732-18-5
67-63-0
67-56-1
96 HR LC50 PIMEPHALES PROMELAS > 100 MG/L [STATIC]
No data available
96 HR LC50 LEPOMIS MACROCHIRUS > 1400000 µG/L
96 HR LC50 PIMEPHALES PROMELAS 11130 MG/L [STATIC]
48 HR EC50 DAPHNIA MAGNA 2 MG/L [STATIC]
24 HR EC50 DAPHNIA MAGNA 10800 MG/L
48 HR LC50 DAPHNIA MAGNA 9268 - 14221 MG/L
48 HR EC50 DAPHNIA MAGNA 13299 MG/L
72 HR EC50 DESMODESMUS SUBSPICATUS > 1000 MG/L
96 HR EC50 DESMODESMUS SUBSPICATUS > 1000 MG/L
Section 13 Disposal Information
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Disposal Methods: Dispose in accordance with all applicable Federal, State and Local regulations.  Always 
contact a permitted waste disposer (TSD) to assure compliance.
Waste Disposal Code(s): If discarded, this product is considered a RCRA ignitable waste, D001.
Section 14 Transport Information
Ground - DOT Proper Shipping Name: Air - IATA Proper Shipping Name:
UN1170Ethanol SolutionsClass 3P.G. II UN1170
Ethanol Solutions
Class 3
P.G. II
Section 15 Regulatory Information
TSCA Status: All components in this product are on the TSCA Inventory.
Chemical Name CAS 
Number
§ 313 Name § 304 RQ CERCLA RQ § 302 TPQ CAA 112(2) 
TQ
Ethanol 64-17-5 No No No No No
2-Propanol 67-63-0 Isopropyl 
alcohol
No No No No
Methanol 67-56-1 No No No No No
California Prop 65: WARNING: This product contains a chemical known to the state of California 
to cause cancer and birth defects or other reproductive harm. 
Section 16 Additional Information
Revised:  10/26/2015 Replaces: 10/20/2015 Printed: 10-29-2015
The information provided in this (Material) Safety Data Sheet represents a compilation of data drawn directly from various sources 
available to us. Carolina Biological Supply makes no representation or guarantee as to the suitability of this information to a particular 
application of the substance covered in the (Material) Safety Data Sheet.
Glossary
ACGIH
CAS
CERCLA
DOT
IARC
N/A
American Conference of Governmental
Industrial Hygienists
Chemical Abstract Service Number
Comprehensive Environmental Response,
Compensation, and Liability Act
U.S. Department of Transportation
International Agency for Research on Cancer
Not Available
NTP
OSHA
PEL
ppm
RCRA
SARA
TLV
TSCA
IDLH
National Toxicology Program
Occupational Safety and Health Administration
Permissible Exposure Limit
Parts per million
Resource Conservation and Recovery Act
Superfund Amendments and Reauthorization Act
Threshold Limit Value
Toxic Substances Control Act
Immediately dangerous to life and health
 
SAFETY DATA SHEET
1. IDENTIFICATION
Product identifier
Product code: P1169
Product Name: POLOXAMER 188, NF
Other means of identification
Synonyms: Pluronic F68; Polyethylene-polypropylene glycol; Polyoxyethylene-Polyoxypropylene
Block Copolymer; Poly(Ethylene oxide-co-Polypropylene oxide), Block; Block
Copolymer of Ethylene Oxide and Propylene Oxide; Ethylene oxide/Polypropylene
oxide copolymer; Methyl-oxirane polymer with oxirane; Oxirane, methyl,-polymer with
oxirane, block
CAS #: 9003-11-6
RTECS # MD0911050
CI#: Not available
Recommended use of the chemical and restrictions on use
Recommended use: No information available.
Uses advised against No information available
Supplier: Spectrum Chemicals and Laboratory Products, Inc.
14422 South San Pedro St.
Gardena, CA  90248
(310) 516-8000
Order Online At: https://www.spectrumchemical.com
Emergency telephone number Chemtrec 1-800-424-9300
Contact Person: Martin LaBenz (West Coast)
Contact Person: Regina Wachenheim (East Coast)
2. HAZARDS IDENTIFICATION
Classification
This chemical is not considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200)
Not a dangerous substance or mixture according to the Globally Harmonized System (GHS)
Label elements
Hazards not otherwise classified (HNOC)
Not Applicable
Revision Date: 6/30/2014
Not classified
Revision Number:  G1
Product code: P1169 Product name: POLOXAMER 188, NF  1 / 11
Preparation Date: 6/30/2014
Other hazards
Not available
3. COMPOSITION/INFORMATION ON INGREDIENTS
Components CAS-No. Weight % Trade Secret
Poloxamer 188
9003-11-6
9003-11-6 100 *
4. FIRST AID MEASURES
First aid measures
General Advice: Poison information centres in each State capital city can provide additional
assistance for scheduled poisons (13 1126)
Skin Contact: Wash off immediately with soap and plenty of water removing all contaminated clothes and
shoes. Get medical attention if irritation develops. Consult a physician if necessary.
Eye Contact: Flush eye with water for 15 minutes. Get medical attention if irritation occurs. If symptoms
persist, call a physician.
Inhalation: Move to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Get medical attention.
Ingestion: Do not induce vomiting without medical advice. Never give anything by mouth to an
unconscious person. Consult a physician if necessary.
Most important symptoms and effects, both acute and delayed
Symptoms May cause eye/skin irritation. May cause hypermotility, diarrhea.
Indication of any immediate medical attention and special treatment needed
Notes to Physician: Treat symptomatically
Protection of first-aiders
First-Aid Providers:  Avoid exposure to blood or body fluids.  Wear gloves and other necessary protective clothing.  Dispose of
contaminated clothing and equipment as bio-hazardous waste
5. FIRE-FIGHTING MEASURES
Extinguishing Media
Suitable Extinguishing Media: Carbon dioxide (CO2). Dry chemical. Water spray mist or
foam.
Unsuitable Extinguishing Media: No information available.
Specific hazards arising from the chemical
Hazardous Combustion Products: Carbon monoxide; Carbon dioxide
Specific hazards: May be combustible at high temperatures.
Special Protective Actions for Firefighters
Specific Methods: No information available.
Product name: POLOXAMER 188, NF  2 / 11Product code: P1169
Special Protective Equipment for Firefighters: As in any fire, wear self-contained breathing apparatus
pressure-demand, MSHA/NIOSH (approved or equivalent)
and full protective gear
6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Personal Precautions: Ensure adequate ventilation. Use personal protective equipment. Avoid contact with skin, eyes
and clothing. Avoid dust formation. Remove all sources of ignition.
Environmental precautions No information available.
Methods and material for containment and cleaning up
Methods for containment Stop leak if you can do it without risk. Cover with plastic sheet to prevent spreading.
Methods for cleaning up Sweep up and shovel into suitable containers for disposal. Clean contaminated
surface thoroughly.
7. HANDLING AND STORAGE
Precautions for safe handling
Technical Measures/Precautions:
Provide sufficient air exchange and/or exhaust in work rooms. Avoid dust formation. Keep away from incompatible
materials.
Safe Handling Advice:
Wear personal protective equipment. Avoid contact with skin, eyes and clothing. Keep away from heat and sources
of ignition. Avoid dust formation. Do not ingest. Do not breathe vapours/dust. Handle in accordance with good
industrial hygiene and safety practice.
Conditions for safe storage, including any incompatibilities
Technical Measures/Storage Conditions:
Keep containers tightly closed in a dry, cool and well-ventilated place. Store away from incompatible materials.
Incompatible Materials:
Strong oxidizing agents.
8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
National occupational exposure limits
U.S Occupational Exposure Limits: Not determined
United States
Components OSHA NIOSH ACGIH AIHA WHEEL
Poloxamer 188 - 9003-11-6
None None None None
Canada
Canada Occupational Exposure Limits: Not determined
Components Alberta British Columbia Ontario Quebec
Poloxamer 188 - 9003-11-6
None None None None
Product name: POLOXAMER 188, NF  3 / 11Product code: P1169
Australia and Mexico
Occupational Exposure Limits for Australia and Mexico: Not determined
Components Australia Mexico
Poloxamer 188
9003-11-6
None None
Appropriate engineering controls
Engineering measures to reduce exposure: Ensure adequate ventilation. Use process enclosures, local
exhaust ventilation, or other engineering controls to keep
airborne levels below recommended exposure limits.  If user
operations generate dust, fume or mist, use ventilation to
keep exposure to airborne contaminants below the exposure
limit.
Individual protection measures, such as personal protective equipment
Personal Protective Equipment
Eye protection: Safety glasses. Safety glasses with side-shields.
Skin and body protection: Long sleeved clothing. Chemical resistant apron. Gloves.
Respiratory protection: Effective dust mask. Wear respirator with dust filter..
Hygiene measures: Avoid contact with skin, eyes and clothing. Wash hands before breaks and
immediately after handling the product. When using, do not eat, drink or smoke.
9. PHYSICAL AND CHEMICAL PROPERTIES
Product name: POLOXAMER 188, NF  4 / 11Product code: P1169
9. PHYSICAL AND CHEMICAL PROPERTIES
10. STABILITY AND REACTIVITY
Reactivity
Chemical stability
Stability: Stable at normal conditions
Possibility of Hazardous Reactions: Hazardous polymerization does not occur
Conditions to avoid: Heat. Avoid dust formation. Incompatible materials.
Incompatible Materials: Strong oxidizing agents.
Hazardous decomposition products: Carbon monoxide. Carbon dioxide.
Other Information
Corrosivity: No information available
Special Remarks on Corrosivity: No information available
11. TOXICOLOGICAL INFORMATION
Information on likely routes of exposure
Principal Routes of Exposure:
Ingestion. Inhalation.
pH:
No information available
Melting point/range(°C/°F):
52 °C/125.6 °F
Formula:
Polymer or (C3-H6-O.C2-H4-O)x
Boiling point/range(°C/°F):
No information available
Decomposition temperature(°C/°F):
No information available
Specific gravity:
No information available
Molecular/Formula weight:
Av. M.W.  7680-9510
Density (g/cm3):
No information available
Color:
White.
Bulk density:
No information available
Vapor pressure @ 20°C (kPa):
No information available
Flash point (°C):
No data available
Evaporation rate:
No information available
Vapor density:
No information available
VOC content (g/L):
No information available
Flashpoint (°C/°F):
No information available.
Odor threshold (ppm):
No information available
Physical state:
Solid.
Partition coefficient
(n-octanol/water):
No information available
Viscosity:
No information available
Flash Point Tested according to:
Not available
Miscibility:
Miscible with water
Odor:
No information available
Solubility:
No information available
Lower Explosion Limit (%):
No information available
Upper Explosion Limit (%):
No information available
Appearance:
Prills.
Product code: P1169
Autoignition Temperature (°C/°F):
No information available
Product name: POLOXAMER 188, NF
Taste
No information available
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Reactive with oxidizing agents
Acute Toxicity
Component Information
Product Information
LD50/oral/rat =
VALUE- Acute Tox Oral = >5000mg/kg
LD50/oral/mouse =
Value - Acute Tox Oral =  No information available
LD50/dermal/rabbit
VALUE-Acute Tox Dermal = >2000mg/kg
LD50/dermal/rat
VALUE -Acute Tox Dermal = No information available
LC50/inhalation/rat
VALUE-Vapor = No information available
VALUE-Gas = No information available
VALUE-Dust/Mist = 320mg/m3 (4-hr.)
LC50/Inhalation/mouse
VALUE-Vapor =  No information available
VALUE - Gas = No information available
VALUE - Dust/Mist =  No information available
Symptoms
Skin Contact: May cause skin irritation.
Eye Contact: Contact with eyes may cause irritation.
Inhalation This material is in the form of prills and is unlikely to cause respiratory tract irritation.
Ingestion May cause hypermotility, diarrhea. May affect behavior/central nervous system
(somnolence). May cause muscle weakness.
Aspiration hazard No information available
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Chronic Toxicity No information available.
Sensitization: No information available
Mutagenic Effects: No information available
Carcinogenic effects: No information available.
LC50/inhalation/rat = 320 mg/m3 Inhalation LC50 Rat 4 h
LD50/oral/mouse = No information available
LC50/inhalation/mouse = No infomation available
LD50/oral/rat = > 5000 mg/kg
Other LD50 or LC50information = No information available
LD50/dermal/rabbit = > 2000 mg/kg
Product code: P1169
Poloxamer 188 - 9003-11-6
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LD50/dermal/rat = No information available
Components ACGIH -
Carcinogens
IARC NTP OSHA HCS -
Carcinogens
Australia - Prohibited
Carcinogenic
Substances
Australia - Notifiable
Carcinogenic
Substances
Poloxamer 188 Not listed Not listed Not listed Not listed Not listed Not listed
Reproductive toxicity No data is available
Reproductive Effects: No information available
Developmental Effects: No information available
Teratogenic Effects: No information available
Specific Target Organ Toxicity
STOT - single exposure No information available
STOT - repeated exposure No information available
Target Organs: No information available
12. ECOLOGICAL INFORMATION
Ecotoxicity
Ecotoxicity effects: Aquatic environment.
Persistence and degradability: No information available
Bioaccumulative potential: No information available
Mobility: No information available
13. DISPOSAL CONSIDERATIONS
Disposal Methods
Waste from residues / unused products:
Waste must be disposed of in accordance with Federal, State and Local regulation.
Contaminated packaging:
Empty containers should be taken for local recycling, recovery or waste disposal
Components RCRA - F Series
Wastes
RCRA - K Series
Wastes
RCRA - P
Series
Wastes
RCRA - U Series Wastes
Poloxamer 188 None None None None
14. TRANSPORT INFORMATION
DOT
UN-No: Not regulated
Proper Shipping Name: No information available
Product code: P1169
Freshwater Fish Species Data: Oncorhynchus mykiss  LC50 96 h:  >120 mg/kg
Product name: POLOXAMER 188, NF  7 / 11
Poloxamer 188 - 9003-11-6
14. TRANSPORT INFORMATION
Hazard Class: No information available
Subsidiary Risk: Not applicable
Packing Group: None
Marine Pollutant No data available
ERG No: No information available
DOT RQ (lbs): No information available
TDG (Canada)
UN-No: Not Regulated
Proper Shipping Name: No information available
Hazard Class: No information available
Subsidiary Risk: No information available
Packing Group: No information available
Description: No information available
ADR
UN-No: Not Regulated
Proper Shipping Name: No information available
Hazard Class: No information available
Packing Group: No information available
Subsidiary Risk: No information available
Classification Code: No information available
Description: No information available
CEFIC Tremcard No: No information available
IMO / IMDG
UN-No: Not Regulated
Proper Shipping Name: No information available
Hazard Class: No information available
Subsidiary Risk: No information available
Packing Group: No information available
Description: No information available
IMDG Page: No information available
Marine Pollutant No information available
MFAG: No information available
Maximum Quantity: No information available
RID
UN-No: Not Regulated
Proper Shipping Name: No information available
Hazard Class: No information available
Subsidiary Risk: No information available
Packing Group: No information available
Classification Code: No information available
Description: No information available
ICAO
UN-No: Not Regulated
Proper Shipping Name: No information available
Hazard Class: No information available
Subsidiary Risk: No information available
Packing Group: No information available
Description: No information available
IATA
UN-No: Not Regulated
Proper Shipping Name: No information available
Product name: POLOXAMER 188, NF  8 / 11Product code: P1169
14. TRANSPORT INFORMATION
Hazard Class: No information available
Subsidiary Risk: No information available
Packing Group: No information available
Description: No information available
15. REGULATORY INFORMATION
International Inventories
Components U.S. TSCA KOREA KECL Philippines
(PICCS)
Japan ENCS CHINA Australia
(AICS)
EINECS-No.
Poloxamer 188 Present XU Present KE-
24574
Present Present (7)-
1246
Present Present Not present
U.S. Regulations
California Prop. 65: Safe Drinking Water and Toxic Enforcement Act of 1986.
Chemicals Known to the State of California to Cause Cancer:
This product does not contain a chemical requiring a warning under California Prop. 65. (See table below)
Chemicals Known to the State of California to Cause Reproductive Toxicity:
This product does not contain a chemical requiring a warning under California Prop. 65. (See table below)
Components Carcinogen Developmental Toxicity Male Reproductive
Toxicity
Female Reproductive
Toxicity:
Poloxamer 188 Not Listed Not Listed Not Listed Not Listed
CERCLA/SARA
Components CERCLA - Hazardous
Substances and their
Reportable Quantities
Section 302 Extremely
Hazardous
Substances and TPQs
Section 302 Extremely
Hazardous
Substances and RQs
Section 313 -
Chemical Category
Section 313 - Reporting
 de minimis
Poloxamer 188 None None None None None
U.S. TSCA
Components TSCA Section 5(a)2 - Chemicals With Significant
New Use Rules (SNURS)
TSCA 8(d) -Health and Safety Reporting
Poloxamer 188 Not Applicable Not Applicable
Canada
WHMIS hazard class:
Non-controlled
Canada Controlled Products Regulation:
This product has been classified according to the hazard criteria of the CPR (Controlled Products Regulation) and the MSDS contains
all of the information required by the CPR.
Inventory
Components Canada (DSL) Canada  (NDSL)
Poloxamer 188 Present Not Listed
Product name: POLOXAMER 188, NF  9 / 11Product code: P1169
Components CEPA Schedule I - Toxic Substances CEPA - 2010 Greenhouse Gases Subject to Manditory
Reporting
Poloxamer 188 Not listed Not listed
EU Classification
R-phrase(s)
not determined
S -phrase(s)
none
Components Classification Concentration Limits: Safety Phrases
Poloxamer 188 No information
The product is classified in accordance with Annex VI to Directive 67/548/EEC
Indication of danger:
Not dangerous
16. OTHER INFORMATION
Product code: P1169 Product name: POLOXAMER 188, NF 10 / 11
16. OTHER INFORMATION
Revision Date: 6/30/2014
Prepared by: Sonia Owen
Disclaimer: All chemicals may pose unknown hazards and should be used with caution. This
Safety Data Sheet (SDS) applies only to the material as packaged. If this product is
combined with other materials, deteriorates, or becomes contaminated, it may pose
hazards not mentioned in this SDS. The physical properties reported in this SDS are
obtained from the literature and do not constitute product specifications. Information
contained herein does not constitute a warranty, whether expressed or implied, as to
the safety, merchantability or fitness of the goods for a particular purpose. Spectrum
Chemicals & Laboratory Products, Inc. assumes no responsibility for results obtained
or for incidental or consequential damages, including lost profits, arising from the use
of these data. No warranty against infringement of any patent, copyright or trademark
is made or implied. It shall be the user's responsibility to develop proper methods of
handling and personal protection based on the actual conditions of use. While this
SDS is based on technical data judged to be reliable, Spectrum assumes no
responsibility for the completeness or accuracy of the information contained herein.
End of Material Safety Data Sheet
Product code: P1169
Preparation Date: 6/30/2014
Product name: POLOXAMER 188, NF 11 / 11
See Section 8.
HMIS Personal Protective EquipmentNFPA
